data_2kzk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kzk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.325 -0.62 . . . . 75.25 109.325 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 252' ' ' VAL . 0.6 OUTLIER -121.23 103.15 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 64.53 109.259 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -61.38 134.37 56.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 74.33 109.618 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.467 ' CG2' HD21 ' A' ' 250' ' ' LEU . 89.9 t -142.36 164.95 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 72.32 109.295 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.418 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 4.1 tp10 -146.05 129.5 16.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 75.33 110.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.473 HG12 ' CG2' ' A' ' 314' ' ' THR . 89.0 t -102.82 118.28 49.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.538 1.148 . . . . 73.05 109.273 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 18.0 m -87.78 -65.56 1.0 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 64.13 110.019 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 58.36 63.5 1.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.472 1.108 . . . . 74.34 109.325 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.8 pt-20 -162.42 -175.01 4.29 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 74.43 110.321 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.67 24.21 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.552 1.158 . . . . 73.44 109.281 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 72.42 18.63 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 75.3 109.272 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 257' ' ' GLU . 4.2 m -165.28 -167.11 1.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 53.34 109.997 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 312' ' ' LEU . 9.4 mt -101.25 166.21 10.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.478 1.111 . . . . 74.11 109.321 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . 0.458 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 0.3 OUTLIER -163.2 95.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 72.24 109.636 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.411 ' CZ ' HD12 ' A' ' 261' ' ' LEU . 97.4 m-85 -97.46 149.33 22.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 72.1 110.986 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.561 HG23 ' CE1' ' A' ' 266' ' ' TYR . 48.4 mt -142.24 112.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.53 1.144 . . . . 72.43 109.293 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 306' ' ' LEU . 0.0 OUTLIER -111.48 143.99 41.42 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.564 1.165 . . . . 64.05 109.306 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.561 ' CE1' HG23 ' A' ' 264' ' ' ILE . 2.1 m-85 -128.56 111.9 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.528 1.142 . . . . 75.21 110.979 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.484 ' OD1' ' CD1' ' A' ' 273' ' ' ILE . 26.2 t30 -60.47 101.34 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 75.45 109.292 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 300' ' ' ILE . 3.7 mmpt? -101.56 -19.17 15.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 75.13 109.333 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.6 p -48.0 175.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.484 1.115 . . . . 71.11 110.384 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -72.78 -57.39 4.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 73.4 109.307 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 271' ' ' ILE . 0.0 OUTLIER -69.3 166.8 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 64.14 109.303 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.48 131.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 75.12 109.262 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.484 ' CD1' ' OD1' ' A' ' 267' ' ' ASN . 1.3 mp -40.55 140.2 1.03 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.51 1.131 . . . . 71.12 109.298 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -34.87 3.55 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 63.51 110.999 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 106.2 159.38 22.27 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.488 1.117 . . . . 74.11 110.989 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 8.8 t30 69.18 23.6 6.32 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 0.778 . . . . 72.03 109.259 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.4 ' C ' ' OG1' ' A' ' 278' ' ' THR . 60.9 m -70.62 -179.15 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 62.32 108.274 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.456 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.9 m -153.96 136.26 14.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 74.11 110.4 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.559 ' CD2' HD11 ' A' ' 306' ' ' LEU . 1.5 t80 -89.54 179.03 6.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 74.24 110.98 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.461 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 11.2 tt0 -176.73 101.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.108 . . . . 72.15 110.316 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 1.3 p90 -116.26 147.81 41.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 74.41 111.006 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 53.2 p -100.67 -175.27 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 71.04 109.997 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.575 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 74.23 110.029 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 2.6 p . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.255 -0.646 . . . . 73.32 109.255 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -152.88 142.95 22.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.42 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.411 ' OG ' ' CG2' ' A' ' 278' ' ' THR . 32.4 t -107.32 127.89 53.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 73.14 109.999 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.3 mt -101.04 137.22 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 73.31 109.287 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -77.47 113.0 14.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 73.53 109.317 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.442 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 63.0 mtp -84.13 165.51 18.41 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 72.31 110.973 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.441 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -64.47 151.42 50.51 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.473 1.108 . . . . 74.5 111.021 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.28 6.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.441 1.758 . . . . 71.52 110.961 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.56 ' CE1' ' OE1' ' A' ' 297' ' ' GLU . 57.6 t-80 -68.14 143.11 55.53 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 71.21 109.598 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.56 ' OE1' ' CE1' ' A' ' 296' ' ' HIS . 0.6 OUTLIER -65.38 179.36 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.135 . . . . 73.43 110.304 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 44.3 mt -105.77 -76.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 74.23 109.329 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 128.0 149.74 7.13 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.469 1.106 . . . . 65.41 111.056 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.494 ' O ' ' CE ' ' A' ' 268' ' ' LYS . 4.2 mt -46.75 -25.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.531 0.783 . . . . 73.52 109.342 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -115.6 -37.69 3.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 53.35 109.304 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -40.9 151.03 0.14 Allowed Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.571 1.169 . . . . 73.41 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.27 -177.49 3.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.512 0.772 . . . . 72.42 110.27 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.441 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 35.3 tptt -154.51 143.6 21.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.433 1.083 . . . . 72.43 109.301 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.54 ' HB2' ' CZ2' ' A' ' 307' ' ' TRP . 10.7 mt-10 -114.83 150.39 35.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 72.22 110.308 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.559 HD11 ' CD2' ' A' ' 279' ' ' PHE . 82.7 mt -141.15 62.58 1.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.113 . . . . 73.53 109.266 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.54 ' CZ2' ' HB2' ' A' ' 305' ' ' GLU . 0.9 OUTLIER -59.29 134.86 57.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.95 -1.13 . . . . 75.35 107.95 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 312' ' ' LEU . 10.2 t80 -137.23 155.14 49.87 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 74.4 111.019 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.668 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -135.6 147.36 61.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 74.25 111.013 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -53.72 0.15 OUTLIER 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.005 -2.498 . . . . 64.24 111.007 -0.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 178.44 174.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 71.44 109.982 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.56 HD12 ' CE1' ' A' ' 308' ' ' PHE . 3.7 mp -138.82 158.42 70.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 74.53 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 145.25 31.06 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.487 1.783 . . . . 74.31 110.992 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.476 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.7 OUTLIER -123.02 162.54 38.61 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 71.44 110.404 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -175.45 16.03 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.015 -2.494 . . . . 75.34 111.023 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.571 HD21 ' CD2' ' A' ' 319' ' ' TYR . 1.8 mt -109.8 57.79 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 63.43 109.281 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.3 p -85.38 134.74 34.07 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 73.02 109.985 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 32.0 t30 83.19 2.63 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 73.43 109.319 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.575 ' CE2' ' HA ' ' A' ' 283' ' ' SER . 9.0 m-85 -81.13 -178.47 6.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 75.42 111.017 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.503 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -97.57 -58.28 2.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.32 110.373 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.61 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 1.0 OUTLIER 28.59 64.63 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 75.13 111.032 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.445 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 40.2 mttm -92.68 -172.57 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 73.43 109.299 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.9 t -141.84 130.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 74.14 109.304 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 5.6 m -109.52 176.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.081 . . . . 71.23 109.278 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 2.6 t30 -101.04 -165.56 1.22 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 71.23 109.322 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -70.1 -7.93 45.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 71.31 110.3 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -107.82 13.33 26.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.22 109.302 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 62.33 27.61 69.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.544 1.152 . . . . 70.22 110.99 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -102.83 127.19 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.464 0.743 . . . . 71.14 110.295 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 56.0 m -54.07 111.02 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.42 110.377 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 5.1 pt -94.33 -37.91 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.41 109.279 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.478 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 9.3 mt -139.36 176.18 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.472 1.107 . . . . 75.21 109.328 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.441 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -151.05 131.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.515 1.134 . . . . 61.32 109.323 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -83.76 130.2 9.6 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.504 1.128 . . . . 62.03 110.977 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.442 ' CE ' ' HA ' ' A' ' 342' ' ' ILE . 0.0 OUTLIER -61.08 -26.59 67.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.566 0.803 . . . . 74.24 109.297 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 316' ' ' LEU . 0.8 OUTLIER 48.23 76.62 0.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 53.45 108.305 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -88.27 -178.75 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 1.164 . . . . 64.53 109.316 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -75.91 62.44 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 71.2 109.288 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.7 m -173.59 150.68 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 74.03 110.024 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -58.9 -17.62 25.91 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 65.32 109.279 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -77.95 146.43 35.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.125 . . . . 74.22 110.289 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.61 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 65.9 mt -147.98 141.23 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 75.21 109.31 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.428 ' N ' HG21 ' A' ' 342' ' ' ILE . 8.7 p -138.77 97.81 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 73.24 110.396 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 8.5 mp -46.83 133.49 10.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.131 . . . . 72.42 109.329 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -98.06 -76.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 73.25 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 2.9 p 159.84 142.06 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 75.45 110.011 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -80.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.449 1.763 . . . . 72.52 110.955 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 75.31 109.286 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.256 -0.646 . . . . 73.23 109.256 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.496 HD23 ' CD2' ' A' ' 344' ' ' LEU . 0.5 OUTLIER -114.43 102.21 9.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.502 1.126 . . . . 70.21 109.287 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.539 ' CE1' ' HG2' ' A' ' 341' ' ' GLU . 14.3 t60 -90.88 166.17 13.2 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.469 1.105 . . . . 75.32 109.558 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.447 ' H ' ' CD2' ' A' ' 251' ' ' HIS . 66.7 t -153.48 155.51 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 71.12 109.324 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -117.62 146.16 43.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.3 110.308 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.565 HG13 ' CE1' ' A' ' 263' ' ' PHE . 38.6 t -128.83 94.97 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 73.14 109.344 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.1 m -69.13 -63.34 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 73.31 110.027 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 312' ' ' LEU . 5.2 t-20 60.82 82.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.528 1.143 . . . . 74.23 109.307 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.29 166.5 13.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.502 1.126 . . . . 73.5 110.296 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 259' ' ' ASN . 23.8 t0 -42.69 -58.32 2.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.573 1.171 . . . . 75.03 109.31 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 258' ' ' ASP . 80.4 m-20 -40.06 -61.94 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 74.24 109.295 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 176.27 -173.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 74.23 109.992 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.466 ' CD1' HD12 ' A' ' 312' ' ' LEU . 19.6 mt -80.98 161.2 24.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 72.2 109.263 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.68 95.74 2.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 74.04 109.604 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.63 ' CD2' ' CE2' ' A' ' 308' ' ' PHE . 75.0 m-85 -103.6 112.02 24.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 75.3 110.965 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.495 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 73.8 mt -111.03 117.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 63.0 109.325 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.451 ' CD1' HD13 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -106.01 151.72 24.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 74.45 109.342 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.9 OUTLIER -138.11 117.58 12.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.484 1.115 . . . . 74.15 110.98 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.401 ' OD1' ' OG1' ' A' ' 269' ' ' THR . 17.1 t-20 -79.74 106.52 11.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 72.53 109.305 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -11.84 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 75.32 109.276 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.401 ' OG1' ' OD1' ' A' ' 267' ' ' ASN . 22.6 p -66.34 154.75 39.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.503 1.127 . . . . 74.03 110.368 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.55 -40.78 84.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.493 1.121 . . . . 75.31 109.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 9.1 pt -54.37 167.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.14 . . . . 75.21 109.299 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.54 157.74 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 75.21 109.275 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.476 ' CG2' ' HD2' ' A' ' 274' ' ' PRO . 1.2 mm -82.42 141.21 45.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.508 1.13 . . . . 75.43 109.29 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.476 ' HD2' ' CG2' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.01 -14.88 20.99 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.496 1.787 . . . . 62.42 111.0 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 84.62 151.21 13.09 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.52 1.137 . . . . 71.25 111.039 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.8 t30 70.27 50.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 0.767 . . . . 73.54 109.32 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.97 -179.72 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.52 1.137 . . . . 74.34 108.3 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.455 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 2.6 m -153.94 137.17 15.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.091 . . . . 75.24 110.347 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -85.85 176.98 7.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 71.4 110.978 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.454 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 55.4 tt0 -152.7 65.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 75.45 110.246 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 289' ' ' PHE . 9.9 p90 -96.14 130.47 43.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 75.41 110.957 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 17.9 p -121.79 -178.44 3.83 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 73.4 110.003 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.467 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 3.5 p . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 72.32 109.991 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.454 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 7.4 p . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.236 -0.653 . . . . 72.1 109.236 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.545 ' HB3' ' CE1' ' A' ' 281' ' ' PHE . 2.8 t80 -115.8 133.38 56.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 64.01 110.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.0 p -112.48 120.67 42.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.564 1.165 . . . . 74.52 109.988 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 12.5 mt -105.8 127.73 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 74.04 109.356 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -67.02 116.7 8.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 75.13 109.287 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 92.6 mtp -85.11 150.3 24.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 75.25 111.002 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -45.65 150.71 1.25 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 23.45 110.983 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -28.01 9.46 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.531 1.806 . . . . 74.4 110.954 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -65.1 143.3 57.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.083 . . . . 73.55 109.576 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.68 138.06 31.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.43 110.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.435 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -65.28 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.13 109.307 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.84 -155.35 18.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.518 1.136 . . . . 75.43 111.016 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.446 ' CG2' ' HD3' ' A' ' 301' ' ' LYS . 0.9 OUTLIER -86.93 133.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 0.79 . . . . 72.21 109.313 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 301' ' ' LYS . 0.3 OUTLIER 68.79 6.51 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 74.4 109.314 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.435 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -85.68 162.61 36.16 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.511 1.132 . . . . 72.22 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.47 174.82 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 0.767 . . . . 75.01 110.283 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -149.46 152.11 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.4 109.328 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.59 141.22 45.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.493 1.12 . . . . 62.53 110.307 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 12.3 mt -145.53 61.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 1.118 . . . . 75.25 109.32 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -79.27 121.61 25.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 73.4 107.98 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.8 m-30 -109.29 -174.13 2.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 65.34 111.043 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.9 OUTLIER -164.91 160.19 14.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 74.11 110.998 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.02 -36.29 2.64 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.005 -2.498 . . . . 71.44 111.022 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 2.9 p 169.74 131.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.107 . . . . 73.2 110.012 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.466 HD12 ' CD1' ' A' ' 261' ' ' LEU . 5.7 mp -111.59 158.94 34.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.15 . . . . 75.53 109.339 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 147.36 33.66 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.463 1.77 . . . . 74.32 110.973 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.497 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -123.91 164.43 29.3 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 73.2 110.4 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.497 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 -174.66 14.53 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.022 -2.491 . . . . 74.42 110.989 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.558 HD22 ' CE2' ' A' ' 319' ' ' TYR . 3.4 mt -102.36 60.12 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.44 109.294 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -82.91 131.81 35.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 73.3 110.047 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.4 t-20 76.66 21.97 1.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 74.0 109.322 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.558 ' CE2' HD22 ' A' ' 316' ' ' LEU . 4.0 m-85 -99.13 -170.06 1.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.22 111.001 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.46 ' CG2' ' HG3' ' A' ' 322' ' ' LYS . 28.2 m -107.81 -64.92 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.513 1.133 . . . . 75.2 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.586 ' SD ' ' CE1' ' A' ' 263' ' ' PHE . 2.8 mtm 34.09 35.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 74.12 110.998 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.46 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 27.9 mttm -75.98 169.82 17.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 72.21 109.284 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 74.8 t -119.1 133.71 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 73.23 109.275 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 278' ' ' THR . 8.9 m -118.23 172.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 63.15 109.284 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -96.06 -166.48 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 74.51 109.337 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -71.13 -5.72 33.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 71.41 110.338 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.46 12.09 26.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 1.137 . . . . 74.11 109.303 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.24 8.39 50.12 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.498 1.124 . . . . 75.41 111.047 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -78.9 129.95 35.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.757 . . . . 73.2 110.281 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.414 ' N ' HG12 ' A' ' 324' ' ' VAL . 4.1 m -62.97 108.08 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.43 110.38 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 2.7 pt -90.94 -43.68 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.511 1.132 . . . . 74.22 109.324 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 9.4 mt -136.1 168.45 19.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 74.41 109.292 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.451 ' CG1' ' HD3' ' A' ' 322' ' ' LYS . 1.2 m -151.75 131.71 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 71.55 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -85.34 121.04 5.5 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 72.4 111.008 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.467 ' CE ' ' HA ' ' A' ' 342' ' ' ILE . 0.0 OUTLIER -44.32 -26.93 0.37 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 0.753 . . . . 74.41 109.263 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.419 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.5 OUTLIER 45.68 71.72 0.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 75.32 108.296 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.437 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -84.77 -176.79 6.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 75.13 109.294 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.79 64.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.45 109.327 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.8 t -178.95 148.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.129 . . . . 73.23 109.967 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -57.65 -17.93 17.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 74.13 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.539 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 14.4 mt-10 -71.93 131.96 43.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.107 . . . . 75.5 110.271 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.571 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 45.4 mt -142.88 118.05 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.506 1.128 . . . . 74.2 109.286 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 18.5 p -117.57 87.28 2.68 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 75.24 110.39 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.496 ' CD2' HD23 ' A' ' 250' ' ' LEU . 8.5 mp -40.01 132.1 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 72.34 109.295 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.0 ptpt -117.72 -58.77 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.557 1.161 . . . . 73.11 109.265 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 158.98 158.19 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.32 110.007 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 -67.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.461 1.769 . . . . 74.33 110.969 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 72.22 109.323 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.494 ' O ' ' CD2' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.317 -0.623 . . . . 75.12 109.317 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.544 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -111.32 98.7 7.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.135 . . . . 71.3 109.293 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.521 ' CE1' ' HG2' ' A' ' 341' ' ' GLU . 20.3 t-80 -96.33 130.38 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 74.04 109.624 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.446 HG22 ' CD2' ' A' ' 265' ' ' LEU . 16.5 t -120.5 171.35 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 74.44 109.271 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -133.96 128.55 34.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 73.2 110.268 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.444 ' O ' ' ND2' ' A' ' 340' ' ' ASN . 4.5 t -105.72 112.56 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 74.43 109.318 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 53.2 109.994 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.459 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 3.1 t-20 60.48 67.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.528 1.143 . . . . 70.3 109.299 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.48 163.81 12.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 71.14 110.29 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.37 -44.74 68.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 73.14 109.303 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -55.11 -61.15 2.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 74.24 109.289 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 29.3 m -174.21 -176.7 1.17 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.437 1.086 . . . . 63.22 110.022 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 ' CD1' ' A' ' 312' ' ' LEU . 39.8 mt -77.5 171.05 15.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.12 . . . . 73.41 109.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -160.49 103.76 1.4 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 70.42 109.588 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.657 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 68.8 m-85 -109.3 90.51 3.32 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 74.53 111.008 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.568 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 54.3 mt -90.23 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 63.01 109.314 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.446 ' CD2' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -91.51 137.04 32.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.13 109.323 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' A' ' 264' ' ' ILE . 1.8 m-85 -120.65 110.41 16.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 74.42 111.014 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.415 ' ND2' HD13 ' A' ' 273' ' ' ILE . 12.3 t30 -68.38 96.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 71.22 109.319 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -101.09 28.3 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.22 109.29 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.404 ' OG1' ' OD1' ' A' ' 267' ' ' ASN . 4.5 p -102.9 143.48 32.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 74.34 110.419 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -44.29 -58.06 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.438 1.086 . . . . 71.12 109.306 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.7 pt -54.61 172.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 74.52 109.345 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.14 123.16 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.443 1.09 . . . . 75.51 109.306 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.415 HD13 ' ND2' ' A' ' 267' ' ' ASN . 1.7 mp -40.4 137.55 1.29 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 71.45 109.311 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -24.18 13.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.502 1.791 . . . . 70.23 111.007 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 89.37 162.81 38.79 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.501 1.126 . . . . 61.41 111.001 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.6 t30 69.26 34.24 3.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.754 . . . . 61.21 109.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 52.3 m -83.39 -179.22 7.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 71.44 108.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.0 m -151.85 132.58 14.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 74.32 110.41 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.54 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 0.9 OUTLIER -90.19 -178.63 5.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.429 1.08 . . . . 72.32 111.007 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.457 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 1.9 tt0 -171.68 89.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.135 . . . . 72.43 110.329 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.741 ' CZ ' ' CG ' ' A' ' 308' ' ' PHE . 22.7 p90 -116.89 128.58 55.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 74.21 111.046 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 36.7 p -95.54 165.24 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.137 . . . . 72.43 109.976 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.567 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.5 p . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.446 1.091 . . . . 74.13 110.021 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.457 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 13.9 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.319 -0.623 . . . . 73.55 109.319 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -134.89 145.46 48.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 75.41 111.016 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 60.2 p -104.3 129.76 52.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 71.45 110.011 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.48 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 2.0 mt -95.96 127.31 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 74.35 109.31 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.18 107.62 3.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.49 1.118 . . . . 72.34 109.257 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 85.5 mtp -78.11 158.61 29.06 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.577 1.173 . . . . 73.34 111.04 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -64.06 147.11 50.73 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.481 1.113 . . . . 74.4 111.025 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -29.66 7.97 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 72.51 110.952 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -54.12 152.58 5.87 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 72.54 109.594 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -85.35 154.31 21.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.45 110.299 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 86.4 mt -92.56 -79.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.122 . . . . 75.0 109.293 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.24 -177.1 21.42 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.547 1.154 . . . . 54.12 111.004 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 267' ' ' ASN . 8.9 mt -53.66 -86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.503 0.767 . . . . 74.01 109.268 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -23.8 66.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.147 . . . . 75.25 109.293 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -50.65 135.03 29.76 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.498 1.124 . . . . 62.52 111.023 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.54 176.81 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 0.766 . . . . 74.45 110.273 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 18.8 tptt -152.0 144.26 23.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 60.22 109.339 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -102.72 163.71 12.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 75.21 110.298 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 8.2 mt -161.27 73.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 74.32 109.277 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.25 127.38 32.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 74.34 107.988 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.741 ' CG ' ' CZ ' ' A' ' 281' ' ' PHE . 16.5 m-30 -114.15 38.49 3.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.113 . . . . 75.23 110.971 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.495 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 6.6 p90 -37.63 157.34 0.09 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 74.32 110.979 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -36.94 2.43 Favored 'Cis proline' 0 C--N 1.36 1.177 0 C-N-CA 120.99 -2.504 . . . . 70.23 111.052 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 37.0 p 176.13 144.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 65.13 109.987 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.48 ' CD1' HD12 ' A' ' 261' ' ' LEU . 3.7 mp -129.18 159.39 69.24 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 72.43 109.312 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 144.09 29.84 Favored 'Trans proline' 0 C--N 1.359 1.132 0 O-C-N 124.48 1.779 . . . . 74.44 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.16 162.58 47.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 73.52 110.378 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.1 Cg_endo -74.98 177.98 36.66 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.009 -2.496 . . . . 64.42 110.977 -0.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.458 ' CD1' ' HE2' ' A' ' 321' ' ' MET . 3.8 mt -92.85 64.4 4.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 75.2 109.276 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.7 t -83.97 135.77 34.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 74.35 109.963 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 72.12 10.86 6.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 71.44 109.303 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 282' ' ' SER . 4.8 m-30 -96.29 124.96 40.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 70.53 111.0 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -40.0 -61.48 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 72.42 110.384 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.548 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 3.9 ttm 31.19 68.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.459 1.099 . . . . 72.41 110.973 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 80.8 mttt -103.78 -171.29 1.91 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.094 . . . . 73.01 109.316 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.504 HG22 ' CE1' ' A' ' 279' ' ' PHE . 19.2 t -141.53 123.47 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 74.51 109.332 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.469 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 22.6 m -110.84 -172.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.464 1.103 . . . . 75.31 109.315 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -126.55 -171.92 2.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 74.51 109.268 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.51 -6.99 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 74.22 110.328 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -89.02 -14.82 35.58 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 73.11 109.292 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.61 1.66 89.07 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.484 1.115 . . . . 65.1 111.028 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.457 ' O ' ' ND2' ' A' ' 325' ' ' ASN . 14.0 pt-20 -94.54 153.22 18.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 0.79 . . . . 72.21 110.312 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.3 m -83.47 128.89 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 74.54 110.397 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.479 ' CG2' ' ND2' ' A' ' 325' ' ' ASN . 33.6 pt -103.64 -37.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.114 . . . . 75.14 109.28 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.476 ' C ' ' CG1' ' A' ' 333' ' ' VAL . 12.3 mt -134.14 168.77 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 73.23 109.291 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.476 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -152.79 122.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 72.04 109.336 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -77.53 119.53 5.32 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 71.22 110.987 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 342' ' ' ILE . 0.0 OUTLIER -44.27 -27.0 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 0.783 . . . . 75.1 109.271 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 49.14 76.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 65.02 108.289 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -88.2 -178.68 5.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 65.12 109.276 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -76.04 61.15 1.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.477 1.111 . . . . 73.11 109.295 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 341' ' ' GLU . 4.2 m 179.43 141.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 61.52 110.019 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 13.9 m-20 -46.65 -26.13 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.151 . . . . 65.13 109.294 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.521 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 3.2 mt-10 -63.04 125.29 23.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 75.14 110.345 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.548 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 66.4 mt -141.65 123.38 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 71.13 109.345 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 15.2 p -126.25 87.84 2.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.132 . . . . 71.0 110.417 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 334' ' ' GLY . 10.3 mp -40.77 138.93 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.526 1.141 . . . . 74.13 109.299 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -112.57 -64.58 1.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 75.55 109.268 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 159.7 145.91 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 72.33 110.011 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -81.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.474 1.776 . . . . 74.42 111.049 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.471 ' CD2' ' C ' ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 74.54 109.261 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.486 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.291 -0.633 . . . . 73.31 109.291 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.435 HD23 ' CG2' ' A' ' 252' ' ' VAL . 0.6 OUTLIER -128.51 103.34 7.06 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 72.01 109.304 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -66.56 139.68 57.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 71.11 109.605 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.435 ' CG2' HD23 ' A' ' 250' ' ' LEU . 60.2 t -144.33 167.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 75.35 109.303 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 254' ' ' VAL . 53.6 tt0 -122.93 154.49 38.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 74.41 110.281 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.466 ' CG1' HG21 ' A' ' 314' ' ' THR . 82.4 t -135.75 95.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.142 . . . . 70.0 109.307 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 2.5 t -69.1 -67.4 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 62.1 109.963 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.402 ' OD1' ' OG1' ' A' ' 314' ' ' THR . 5.0 t-20 60.91 64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 71.25 109.291 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -91.45 145.56 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 75.21 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.26 -34.16 4.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.517 1.136 . . . . 62.13 109.348 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -65.89 -52.03 53.6 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 74.41 109.261 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.9 m -171.14 -175.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 53.34 110.063 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.453 ' CD1' HD11 ' A' ' 312' ' ' LEU . 10.9 mt -88.12 176.38 7.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.446 1.091 . . . . 73.12 109.324 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . 0.55 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 4.3 t-160 -176.2 103.51 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 75.02 109.618 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 93.8 m-85 -112.54 127.02 55.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 75.32 111.023 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.643 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 76.5 mt -119.42 116.83 52.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 71.22 109.272 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.25 130.01 50.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 64.45 109.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.643 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 1.3 m-85 -119.66 109.17 15.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.03 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 267' ' ' ASN . 14.5 t30 -69.81 75.51 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 70.04 109.301 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.97 52.85 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 72.43 109.322 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.5 p -127.58 -178.08 4.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 74.44 110.419 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.32 18.19 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 74.23 109.33 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.59 169.22 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 71.02 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.3 mt -121.11 137.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.512 1.132 . . . . 73.1 109.358 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.75 137.49 58.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 75.2 109.271 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -26.25 11.09 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.519 1.799 . . . . 73.21 111.007 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.443 ' O ' ' ND2' ' A' ' 276' ' ' ASN . . . 83.94 -157.38 33.79 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.527 1.142 . . . . 45.44 111.034 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 275' ' ' GLY . 0.2 OUTLIER 39.89 30.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.463 0.743 . . . . 64.33 109.269 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.433 ' N ' ' C ' ' A' ' 275' ' ' GLY . 18.0 m -87.04 -173.41 4.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.538 1.149 . . . . 74.5 108.304 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.474 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.5 m -152.93 126.37 8.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 75.42 110.356 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 1.7 t80 -79.99 172.66 13.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 75.22 110.984 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.45 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 2.3 tt0 -167.08 91.05 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.115 . . . . 63.13 110.312 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 32.8 p90 -111.7 120.98 43.85 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.476 1.11 . . . . 71.2 110.983 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.604 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 81.8 p -109.93 161.56 15.36 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 54.45 110.017 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.568 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 33.3 t . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 53.31 109.986 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.45 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 8.8 p . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.268 -0.641 . . . . 74.42 109.268 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -137.49 146.57 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 75.11 111.011 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 95.0 p -117.74 123.46 46.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 72.51 109.996 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.9 mt -101.77 126.94 55.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 73.01 109.259 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 122.69 18.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 74.31 109.321 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 97.2 mtp -84.45 148.94 26.3 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.096 . . . . 72.03 111.015 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.583 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -52.62 156.23 4.69 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 63.02 111.02 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -26.64 10.86 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.492 1.785 . . . . 72.31 110.985 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.563 ' CE1' ' HD3' ' A' ' 304' ' ' LYS . 28.4 p80 -52.82 -176.28 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 75.32 109.596 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.63 175.71 7.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 1.13 . . . . 73.31 110.289 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.441 HG23 ' CB ' ' A' ' 267' ' ' ASN . 3.9 mp -134.74 61.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.12 . . . . 75.02 109.321 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.71 -122.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.487 1.117 . . . . 62.42 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.402 ' C ' ' HG2' ' A' ' 301' ' ' LYS . 2.2 mt -98.73 138.11 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.513 0.772 . . . . 73.22 109.3 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.402 ' HG2' ' C ' ' A' ' 300' ' ' ILE . 1.1 mmmm 67.07 9.23 6.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 75.42 109.331 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -103.28 146.5 16.53 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.473 1.108 . . . . 74.43 110.986 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.02 -177.58 4.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 0.779 . . . . 64.51 110.302 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.583 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 57.0 tptt -149.38 150.11 31.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 72.14 109.28 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 10.3 mt-10 -110.36 160.07 16.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 71.03 110.307 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 13.6 mt -155.97 70.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 70.21 109.287 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.55 ' CD1' ' NE2' ' A' ' 262' ' ' HIS . 0.1 OUTLIER -74.97 129.29 37.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 75.13 108.02 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 12.8 m-30 -117.75 -172.02 2.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.45 1.094 . . . . 72.24 110.998 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.8 p90 -169.75 159.43 6.94 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 74.32 110.955 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.03 -36.17 2.68 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.046 -2.481 . . . . 73.35 110.994 0.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.2 p 170.25 131.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.538 1.149 . . . . 54.12 110.016 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.453 HD11 ' CD1' ' A' ' 261' ' ' LEU . 5.4 mp -114.79 158.81 39.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.32 109.355 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 145.73 31.95 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.491 1.785 . . . . 73.52 110.971 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.49 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -127.12 164.49 35.1 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 75.21 110.404 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.49 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.02 176.51 43.14 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.013 -2.495 . . . . 73.25 110.991 0.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 319' ' ' TYR . 4.9 mt -92.16 66.41 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.549 1.156 . . . . 74.32 109.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 2.4 p -81.27 128.15 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 65.24 110.006 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.93 21.31 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 73.35 109.27 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.604 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.5 m-30 -103.7 134.13 47.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 74.43 110.982 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' A' ' 322' ' ' LYS . 60.4 m -45.91 -67.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 73.44 110.389 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.57 ' HG2' ' CE2' ' A' ' 279' ' ' PHE . 4.3 ttm 33.53 56.92 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.41 111.016 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 28.1 mttm -95.14 -166.38 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.13 109.303 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 12.7 t -145.02 126.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 72.13 109.304 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.474 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 11.8 m -109.69 -172.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 75.05 109.252 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -120.25 -170.85 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 64.51 109.304 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.42 -8.23 17.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 64.3 110.299 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 -8.76 35.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 75.12 109.278 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.59 -4.5 78.25 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.115 . . . . 63.23 111.026 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -80.84 140.48 35.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.484 0.755 . . . . 75.22 110.27 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 324' ' ' VAL . 7.7 m -66.53 122.89 18.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 73.04 110.388 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.8 pt -97.46 -41.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 64.21 109.263 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.473 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 6.1 mt -141.59 170.9 14.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 74.53 109.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.434 ' CG1' ' HD3' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.46 128.54 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 74.02 109.304 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -89.08 113.87 4.19 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.451 1.095 . . . . 74.04 110.977 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -26.79 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 0.788 . . . . 74.33 109.294 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.469 ' SG ' ' CE ' ' A' ' 321' ' ' MET . 0.1 OUTLIER 42.12 67.81 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 74.34 108.263 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -71.89 -172.93 0.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 71.3 109.314 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.29 57.95 2.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 74.34 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 50.4 m -168.28 141.87 3.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 73.21 110.009 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -45.56 -31.73 1.96 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 73.02 109.271 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -63.85 147.54 51.59 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 75.11 110.315 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.403 ' O ' ' O ' ' A' ' 250' ' ' LEU . 16.9 mt -150.05 141.26 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 75.33 109.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 62.6 p -140.89 107.53 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 72.35 110.397 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 10.6 mp -61.25 134.51 57.06 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 74.14 109.253 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 2.0 mtpt -104.55 -76.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 65.13 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.78 143.84 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.538 1.149 . . . . 73.12 110.025 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.493 1.786 . . . . 72.25 111.006 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.325 -0.46 0 O-C-N 124.465 1.103 . . . . 73.22 109.332 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.331 -0.618 . . . . 74.04 109.331 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.474 HD22 ' CD2' ' A' ' 344' ' ' LEU . 0.5 OUTLIER -97.6 101.5 13.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 74.12 109.311 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.52 ' CD2' ' OE1' ' A' ' 341' ' ' GLU . 0.5 OUTLIER -87.15 143.96 27.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.435 1.084 . . . . 70.41 109.602 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.488 ' N ' ' CD2' ' A' ' 251' ' ' HIS . 84.3 t -126.26 144.47 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.516 1.135 . . . . 75.21 109.314 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -119.39 121.58 39.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 62.23 110.283 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.38 107.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 72.15 109.263 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 72.6 m -68.43 -57.6 5.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 63.52 110.033 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 55.43 69.62 0.72 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.522 1.139 . . . . 74.44 109.311 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -114.63 161.73 17.7 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 75.53 110.3 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -42.21 -53.62 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 73.23 109.289 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -43.57 -64.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 75.32 109.284 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.8 m -179.61 -174.8 0.31 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 74.14 109.981 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.479 HD12 ' CD1' ' A' ' 312' ' ' LEU . 14.7 mt -78.14 169.29 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.487 1.117 . . . . 73.41 109.314 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -165.1 112.39 0.99 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.05 109.61 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -116.18 106.51 13.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 75.42 110.987 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.465 HG23 ' CE2' ' A' ' 266' ' ' TYR . 16.6 mt -99.55 103.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 73.53 109.331 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.488 ' CD2' ' CG2' ' A' ' 252' ' ' VAL . 0.2 OUTLIER -105.01 126.42 52.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 75.24 109.283 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.465 ' CE2' HG23 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -113.2 119.21 36.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 71.01 111.018 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 271' ' ' ILE . 25.4 t30 -80.71 95.52 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 61.42 109.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -88.68 -54.55 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.424 1.078 . . . . 72.31 109.294 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 1.7 t -100.48 173.83 6.38 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.08 . . . . 74.41 110.39 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 269' ' ' THR . 2.5 t-20 81.93 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 72.32 109.295 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.444 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 0.0 OUTLIER -81.62 -174.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 75.32 109.318 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.411 ' N ' HG12 ' A' ' 271' ' ' ILE . 21.9 mt -92.75 126.76 45.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.01 109.349 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.416 ' O ' ' CG ' ' A' ' 297' ' ' GLU . 1.4 mp -43.78 137.65 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.542 1.151 . . . . 75.2 109.309 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.97 -31.07 6.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.487 1.783 . . . . 74.41 111.0 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 102.14 154.2 25.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.48 1.112 . . . . 74.04 110.991 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 5.2 t30 74.49 32.63 0.91 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.466 0.745 . . . . 72.24 109.268 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 16.3 m -78.91 -176.66 5.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.159 . . . . 74.4 108.322 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 1.9 m -154.53 139.96 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 74.2 110.404 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.626 ' CD1' ' CD1' ' A' ' 306' ' ' LEU . 1.8 t80 -88.93 -177.26 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 73.24 110.991 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.426 ' HG2' ' CG2' ' A' ' 288' ' ' VAL . 22.2 tt0 -177.35 100.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.135 . . . . 73.23 110.281 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.7 p90 -123.62 146.59 48.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 71.43 110.988 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.602 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 92.0 p -77.99 162.25 26.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 74.32 110.033 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.435 ' CB ' HD22 ' A' ' 312' ' ' LEU . 72.3 p . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.521 1.138 . . . . 62.43 110.046 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.426 ' CG2' ' HG2' ' A' ' 280' ' ' GLU . 14.5 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.325 -0.62 . . . . 62.42 109.325 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -116.4 -175.96 2.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 72.52 110.961 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 278' ' ' THR . 3.6 t -163.49 123.58 2.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 42.41 109.967 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 308' ' ' PHE . 10.9 mt -98.77 136.05 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.21 109.297 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 106.98 12.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 73.04 109.291 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.478 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.2 mtp -80.74 153.25 27.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 74.01 110.997 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.72 153.08 8.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.484 1.115 . . . . 72.25 110.999 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -18.84 18.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.438 1.757 . . . . 74.32 111.035 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -72.49 161.48 30.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 61.24 109.601 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 36.6 mt-10 -88.15 175.47 7.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 72.23 110.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 8.3 mt -98.3 -74.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.479 1.112 . . . . 73.34 109.258 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 121.0 159.76 10.85 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.119 . . . . 70.12 110.992 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 21.6 mt -58.61 -29.49 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 73.41 109.3 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -109.63 -34.95 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 73.11 109.255 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -46.81 168.79 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.496 1.123 . . . . 71.53 111.007 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -133.17 -178.44 4.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 72.13 110.299 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 38.1 tptt -137.5 156.74 47.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 74.23 109.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -133.57 100.83 4.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 72.42 110.304 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 279' ' ' PHE . 20.6 mt -97.74 30.74 2.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 75.45 109.3 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -43.09 126.88 4.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.34 107.989 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.472 ' CG ' ' N ' ' A' ' 309' ' ' PHE . 53.8 t80 -127.35 172.92 10.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 74.42 110.98 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -146.3 162.08 36.22 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 74.22 110.97 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.04 -53.8 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.001 -2.499 . . . . 74.02 111.006 0.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 14.5 p -175.29 146.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.102 . . . . 73.52 110.049 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.479 ' CD1' HD12 ' A' ' 261' ' ' LEU . 2.8 mp -123.63 159.19 56.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 73.15 109.299 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 145.84 31.73 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.533 1.807 . . . . 73.41 111.0 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.485 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -126.55 164.03 36.94 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 73.53 110.381 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 178.48 34.5 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.021 -2.491 . . . . 73.5 110.988 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.574 HD21 ' CE2' ' A' ' 319' ' ' TYR . 1.5 mt -104.91 61.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.543 1.152 . . . . 75.05 109.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.4 OUTLIER -86.52 138.08 32.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 75.2 110.034 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 82.89 -1.56 1.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 74.01 109.298 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.602 ' CD2' ' OG ' ' A' ' 282' ' ' SER . 10.5 m-85 -80.15 -172.87 3.67 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.105 . . . . 73.11 110.998 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.494 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -106.37 -58.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 74.52 110.36 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.511 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 0.8 OUTLIER 29.84 61.06 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 74.43 110.984 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.438 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 25.1 mttm -90.03 -172.46 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 72.53 109.284 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 90.6 t -141.46 125.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 75.02 109.273 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 278' ' ' THR . 7.0 m -109.38 172.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 75.25 109.274 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.471 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 12.6 t30 -101.53 -164.29 1.09 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 74.02 109.313 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -69.1 -7.49 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 65.44 110.287 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.03 11.73 25.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.11 109.28 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.12 67.78 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.541 1.15 . . . . 75.3 110.994 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 8.9 pt-20 -96.43 119.34 34.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 0.748 . . . . 75.44 110.295 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.407 ' N ' HG11 ' A' ' 324' ' ' VAL . 3.8 m -52.68 98.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 74.25 110.379 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.471 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 14.0 pt -77.51 -39.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.495 1.122 . . . . 74.31 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 11.6 mt -138.76 174.26 10.72 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.469 1.106 . . . . 71.22 109.28 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.57 118.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 75.4 109.278 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.459 ' CA ' HD13 ' A' ' 344' ' ' LEU . . . -68.7 127.41 22.7 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.495 1.122 . . . . 74.01 110.988 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.509 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -48.73 -27.18 2.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 75.33 109.33 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.0 83.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.11 108.297 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.485 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -101.11 -173.54 2.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 63.42 109.332 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.83 56.26 1.51 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 74.41 109.297 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 72.4 p -172.79 136.31 0.7 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.117 . . . . 74.52 110.002 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.401 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 29.7 m-20 -44.92 -33.42 1.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 64.51 109.316 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.52 ' OE1' ' CD2' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -62.66 139.26 58.64 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.479 1.112 . . . . 73.11 110.319 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.511 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 86.6 mt -144.96 120.67 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.527 1.142 . . . . 75.42 109.293 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.471 ' HB ' ' CD2' ' A' ' 249' ' ' LEU . 16.8 p -109.98 82.27 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 75.52 110.446 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.474 ' CD2' HD22 ' A' ' 250' ' ' LEU . 8.3 mp -39.45 147.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 1.135 . . . . 74.44 109.28 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -124.78 -87.35 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 74.32 109.312 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 40.3 p -176.19 137.97 0.49 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 64.44 109.977 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.545 1.813 . . . . 74.43 111.0 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 71.15 109.251 -179.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.486 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.3 -0.63 . . . . 72.4 109.3 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.539 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -122.08 100.31 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 1.109 . . . . 71.3 109.29 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -94.86 131.43 40.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 65.54 109.555 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 265' ' ' LEU . 17.2 t -112.09 163.16 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 74.01 109.31 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -123.31 122.45 38.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.113 . . . . 75.13 110.289 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 316' ' ' LEU . 47.2 t -101.75 110.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.533 1.146 . . . . 71.22 109.285 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 m -85.59 -55.54 3.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.34 109.981 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.445 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 2.4 t-20 60.53 73.14 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.122 . . . . 75.13 109.307 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 260' ' ' SER . 33.6 mm-40 -82.69 145.68 29.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.561 1.163 . . . . 73.24 110.303 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.85 -22.33 14.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 71.42 109.302 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -82.79 -41.48 19.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.557 1.161 . . . . 65.24 109.314 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 257' ' ' GLU . 12.3 m -173.4 -175.07 1.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 1.136 . . . . 74.25 110.032 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 312' ' ' LEU . 11.2 mt -87.02 178.93 6.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.533 1.145 . . . . 73.4 109.31 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -178.46 108.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 75.33 109.631 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 68.9 m-85 -110.6 110.65 21.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 54.33 110.995 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.52 HG21 ' CZ ' ' A' ' 266' ' ' TYR . 56.9 mt -103.26 109.34 26.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 62.43 109.287 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 252' ' ' VAL . 0.0 OUTLIER -114.47 137.75 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.144 . . . . 74.44 109.258 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -120.9 127.08 51.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 71.33 110.967 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -84.35 93.29 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 73.23 109.312 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.38 18.54 12.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.153 . . . . 74.14 109.3 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 12.5 p -77.54 -172.6 2.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 64.43 110.388 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -87.06 -59.65 2.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 71.24 109.308 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.8 pt -58.86 157.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 73.44 109.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.44 130.33 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 71.42 109.289 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 6.0 mm -53.69 136.0 54.47 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.4 109.259 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -23.61 13.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.532 1.806 . . . . 74.13 110.986 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 86.52 170.91 47.37 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.517 1.136 . . . . 65.23 111.034 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . 0.404 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 58.1 t-20 66.8 45.09 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 0.767 . . . . 62.24 109.323 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.41 ' C ' ' OG1' ' A' ' 278' ' ' THR . 73.8 m -84.24 178.44 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.33 108.326 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.481 ' CG2' ' OG ' ' A' ' 290' ' ' SER . 1.8 m -154.74 98.86 2.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 73.43 110.339 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.521 ' CD1' HG23 ' A' ' 323' ' ' VAL . 1.2 t80 -54.31 -172.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.536 1.148 . . . . 75.24 110.996 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 322' ' ' LYS . 18.2 tt0 173.77 105.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 75.3 110.279 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -126.33 170.09 12.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 74.23 111.012 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.1 t -101.33 -172.82 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.15 . . . . 75.25 110.01 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.598 ' OG ' ' CE2' ' A' ' 319' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.156 . . . . 64.03 109.976 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.275 -0.639 . . . . 75.23 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -153.28 155.52 36.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 74.1 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.481 ' OG ' ' CG2' ' A' ' 278' ' ' THR . 28.4 t -109.21 136.06 49.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 64.33 109.999 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.7 mt -103.47 133.72 46.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 75.04 109.312 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.38 112.47 9.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 72.32 109.261 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.47 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 84.8 mtp -92.9 135.49 34.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 74.35 111.008 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.61 147.55 0.08 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.486 1.116 . . . . 52.4 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.404 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.06 -24.13 13.02 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.508 1.794 . . . . 62.24 111.015 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -53.01 144.87 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.467 1.104 . . . . 74.33 109.579 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.02 150.28 33.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 74.33 110.332 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 61.3 mt -80.09 -75.39 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.455 1.097 . . . . 63.3 109.25 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.01 166.29 12.77 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.477 1.111 . . . . 51.42 110.981 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.47 -31.37 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.521 0.777 . . . . 75.2 109.305 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -110.72 -23.26 11.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.487 1.117 . . . . 75.11 109.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -58.78 157.86 20.61 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 53.33 111.002 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -120.3 -174.94 2.89 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.467 0.745 . . . . 75.33 110.309 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 293' ' ' MET . 6.3 tptp -147.66 154.69 40.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 75.2 109.256 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 4.1 mt-10 -123.52 135.7 54.17 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 74.41 110.328 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.585 ' O ' ' CE1' ' A' ' 308' ' ' PHE . 17.4 mt -136.38 60.0 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 74.51 109.268 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 3.3 p90 -70.86 131.1 43.26 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 74.41 107.993 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.8 m-30 -118.37 172.5 7.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.21 110.982 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.3 OUTLIER -148.91 145.69 20.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 75.02 111.026 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.96 -44.71 0.53 Allowed 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.043 -2.482 . . . . 74.24 110.987 0.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 24.1 p 177.63 172.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.516 1.135 . . . . 74.33 109.971 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -137.62 161.82 58.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 74.54 109.315 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 144.57 30.31 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.494 1.786 . . . . 74.11 111.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.9 OUTLIER -128.04 159.93 64.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 75.44 110.389 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.96 169.61 74.06 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.034 -2.486 . . . . 74.13 110.995 -0.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.457 ' CB ' ' HE2' ' A' ' 321' ' ' MET . 5.2 mp -80.34 63.67 4.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 74.52 109.288 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.3 p -83.63 133.57 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 75.53 109.978 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 70.11 27.57 4.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 74.41 109.286 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.598 ' CE2' ' OG ' ' A' ' 283' ' ' SER . 7.7 m-85 -101.31 176.59 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.539 1.149 . . . . 72.42 110.966 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.533 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.9 OUTLIER -109.34 -50.5 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 74.22 110.429 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.533 ' C ' ' O ' ' A' ' 320' ' ' THR . 3.9 ptp 26.6 61.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 75.33 111.015 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.442 ' C ' ' CG2' ' A' ' 323' ' ' VAL . 22.3 mttm -78.95 -173.43 3.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 71.53 109.299 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.521 HG23 ' CD1' ' A' ' 279' ' ' PHE . 3.4 t -151.73 125.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 75.14 109.315 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.475 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 26.6 m -113.9 -177.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 73.51 109.325 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.49 -161.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 72.01 109.301 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -74.21 -2.14 23.5 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.512 1.133 . . . . 72.32 110.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -101.77 0.55 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.21 109.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.8 8.33 47.3 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.542 1.151 . . . . 75.14 111.013 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 12.4 pt-20 -95.16 123.61 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 0.762 . . . . 71.12 110.272 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.475 ' CG2' HG13 ' A' ' 333' ' ' VAL . 14.6 m -55.93 113.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 65.43 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.3 pt -86.67 -38.3 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 75.14 109.279 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.491 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 11.1 mt -146.21 165.95 27.67 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 75.12 109.303 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.475 HG13 ' CG2' ' A' ' 330' ' ' THR . 1.1 m -150.29 124.34 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 70.12 109.32 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -64.0 125.99 33.36 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.533 1.146 . . . . 73.33 111.0 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -61.69 -27.61 68.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 0.754 . . . . 74.05 109.281 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 335' ' ' LYS . 0.5 OUTLIER 87.38 179.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 75.03 108.353 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 336' ' ' CYS . . . 163.89 157.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.099 . . . . 74.41 109.32 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.25 56.88 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.435 1.084 . . . . 71.43 109.352 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 m -178.93 179.68 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.107 . . . . 74.23 110.022 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.42 -10.03 59.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 73.32 109.282 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' HG13 ' A' ' 342' ' ' ILE . 1.1 mp0 -76.9 116.84 17.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 72.44 110.294 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.435 ' CD1' ' SD ' ' A' ' 321' ' ' MET . 93.1 mt -144.98 124.75 6.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 71.14 109.299 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 344' ' ' LEU . 11.7 p -125.16 96.56 4.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.108 . . . . 75.42 110.402 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.491 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 7.5 mp -39.41 139.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 75.12 109.32 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 346' ' ' SER . 1.9 ptmm? -109.93 -47.37 3.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 75.11 109.279 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.4 OUTLIER 156.32 154.43 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 74.22 109.966 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 -51.6 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 65.01 111.007 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 75.32 109.324 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.502 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.309 -0.626 . . . . 72.14 109.309 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.545 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -119.88 103.28 9.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 74.01 109.3 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -81.81 123.62 28.95 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 61.31 109.58 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.47 ' CG2' HD21 ' A' ' 265' ' ' LEU . 80.2 t -122.29 165.05 18.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.31 109.324 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.425 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 27.7 tp10 -123.36 133.29 54.13 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.523 1.14 . . . . 63.43 110.312 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.5 t -109.3 108.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.495 1.122 . . . . 75.22 109.341 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 4.8 t -85.64 -61.86 1.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 72.3 110.012 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 57.01 63.37 1.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.446 1.092 . . . . 75.11 109.314 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -84.44 146.75 27.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 71.51 110.265 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -49.5 -25.67 2.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.452 1.095 . . . . 73.13 109.354 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -75.73 -48.69 20.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 75.33 109.294 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.2 p -172.62 -175.13 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 71.53 110.008 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 312' ' ' LEU . 11.6 mt -85.43 -178.24 6.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 65.52 109.314 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . 0.41 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 5.3 t-160 -176.62 100.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 75.3 109.542 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.413 ' CZ ' HD21 ' A' ' 261' ' ' LEU . 89.1 m-85 -117.42 94.07 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 71.44 111.03 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.584 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 18.5 mt -86.97 128.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.493 1.121 . . . . 74.44 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.47 HD21 ' CG2' ' A' ' 252' ' ' VAL . 0.4 OUTLIER -110.48 137.25 48.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 74.41 109.297 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.584 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 9.5 m-85 -129.7 127.37 40.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.535 1.147 . . . . 75.43 111.024 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.428 ' CB ' HG22 ' A' ' 298' ' ' ILE . 22.5 t30 -82.67 102.58 11.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 74.54 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.93 19.81 19.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.479 1.112 . . . . 74.44 109.307 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.2 p -104.02 -165.48 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.485 1.116 . . . . 70.22 110.385 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.13 -51.31 5.65 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 72.42 109.335 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.9 pt -53.82 161.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 75.35 109.35 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 1.9 mp -117.67 111.17 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.453 1.095 . . . . 70.21 109.329 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.47 HG22 ' CD1' ' A' ' 298' ' ' ILE . 1.3 mp -53.82 139.78 51.13 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.15 109.258 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.414 ' HG2' ' ND2' ' A' ' 325' ' ' ASN . 18.2 Cg_endo -74.98 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 54.45 111.03 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 294' ' ' GLY . . . 89.72 -36.65 3.48 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 64.45 111.007 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -76.04 57.9 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 0.766 . . . . 72.45 109.311 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 324' ' ' VAL . 7.6 m -101.9 -175.09 2.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 75.41 108.302 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.487 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.6 m -152.92 97.34 2.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 75.44 110.363 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.517 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -56.04 171.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 74.03 110.982 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 69.3 tt0 -167.38 96.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 71.34 110.317 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.2 p90 -123.19 138.09 54.73 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.138 . . . . 74.22 110.982 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 88.5 p -99.46 -178.24 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 73.13 109.977 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.427 1.079 . . . . 73.2 109.981 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.46 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 1.6 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.293 -0.632 . . . . 74.0 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.417 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 2.7 t80 -145.05 156.08 43.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.538 1.149 . . . . 73.33 110.981 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.3 m -117.34 130.13 56.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.22 110.011 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 11.9 mt -97.98 125.21 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.508 1.13 . . . . 74.33 109.241 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.12 99.58 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.554 1.159 . . . . 75.15 109.27 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.472 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 84.2 mtp -71.71 135.94 47.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 75.41 111.003 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.442 ' N ' ' HZ3' ' A' ' 304' ' ' LYS . . . -48.02 155.19 1.3 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 64.14 110.971 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.61 6.94 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.466 1.772 . . . . 73.12 110.993 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -49.49 116.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 75.34 109.585 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -62.62 151.25 38.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.112 . . . . 73.31 110.28 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.542 ' CG2' ' N ' ' A' ' 299' ' ' GLY . 13.5 mt -78.28 -88.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.483 1.114 . . . . 75.35 109.317 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.542 ' N ' ' CG2' ' A' ' 298' ' ' ILE . . . 89.34 -161.69 30.24 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.517 1.136 . . . . 73.44 110.989 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.469 ' CG2' ' HD3' ' A' ' 301' ' ' LYS . 8.3 mt -77.09 124.5 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.557 0.798 . . . . 74.42 109.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 301' ' ' LYS . 2.6 mptt 68.48 7.22 5.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.565 1.166 . . . . 74.02 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -91.87 53.38 2.96 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.566 1.166 . . . . 73.13 111.012 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 302' ' ' GLY . 6.3 pt20 -42.16 165.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.577 0.81 . . . . 64.12 110.321 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.442 ' HZ3' ' N ' ' A' ' 294' ' ' GLY . 38.8 tptt -131.67 150.55 52.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 73.42 109.308 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 mt-10 -115.02 114.15 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.513 1.133 . . . . 71.1 110.289 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.517 HD13 ' CG ' ' A' ' 279' ' ' PHE . 11.1 mt -114.61 48.65 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.497 1.123 . . . . 65.04 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.412 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 5.2 p-90 -59.1 141.77 53.22 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.23 108.024 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 312' ' ' LEU . 5.1 t80 -139.78 165.77 26.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 73.43 111.013 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -145.72 158.12 50.24 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.23 110.973 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -45.87 0.42 Allowed 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.001 -2.499 . . . . 75.1 111.011 -0.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.7 p -176.69 164.32 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.147 . . . . 64.14 110.007 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.566 HD13 ' CE1' ' A' ' 308' ' ' PHE . 4.1 mt -137.04 158.51 72.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.548 1.155 . . . . 72.32 109.308 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 148.03 34.94 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.51 1.795 . . . . 74.12 111.057 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 1.0 OUTLIER -137.3 159.62 68.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 75.14 110.367 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.01 170.31 72.21 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 75.05 110.966 0.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 319' ' ' TYR . 3.2 mt -90.85 56.65 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 72.24 109.296 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.2 p -73.37 116.79 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 72.23 110.042 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 317' ' ' SER . 18.6 t-20 79.71 39.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 74.14 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.56 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.2 m-85 -115.83 143.89 44.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 73.21 111.025 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.518 ' O ' ' C ' ' A' ' 321' ' ' MET . 9.9 m -54.94 -61.54 2.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.522 1.139 . . . . 75.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 320' ' ' THR . 1.1 ptp 28.01 50.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.53 111.013 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.454 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 85.4 mttt -82.17 -179.95 7.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 74.12 109.33 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 279' ' ' PHE . 19.9 t -142.05 131.0 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 73.42 109.288 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.487 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 15.8 m -113.03 173.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 65.42 109.3 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 274' ' ' PRO . 0.3 OUTLIER -109.59 -168.98 1.4 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 73.13 109.289 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.2 -7.86 14.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.474 1.109 . . . . 72.24 110.322 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 327' ' ' ASP . 1.9 p30 -88.79 -12.38 42.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 75.43 109.263 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 80.74 -5.94 63.5 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.512 1.132 . . . . 74.14 111.017 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -90.6 143.94 26.24 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 0.742 . . . . 73.21 110.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.423 ' N ' HG11 ' A' ' 324' ' ' VAL . 27.7 m -58.86 130.99 49.61 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 1.102 . . . . 72.14 110.332 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 18.8 pt -112.7 -37.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 64.24 109.273 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.47 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 9.6 mt -139.7 168.42 19.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.33 109.298 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.1 m -151.81 127.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 74.55 109.332 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -76.24 147.81 35.07 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 72.11 110.971 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.444 ' NZ ' ' OG1' ' A' ' 343' ' ' THR . 0.1 OUTLIER -89.14 -35.96 15.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.512 0.772 . . . . 73.53 109.332 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 316' ' ' LEU . 0.3 OUTLIER 41.52 86.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 72.03 108.312 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -104.28 73.95 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.446 1.091 . . . . 72.25 109.324 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.8 t0 41.44 53.72 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.117 . . . . 75.13 109.3 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -160.6 123.79 3.39 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 74.12 109.986 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -41.2 -33.43 0.36 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.091 . . . . 70.2 109.308 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.68 146.38 46.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 73.21 110.3 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 4.3 mt -146.08 138.96 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 75.43 109.34 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.444 ' OG1' ' NZ ' ' A' ' 335' ' ' LYS . 16.6 p -132.44 84.85 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 72.3 110.405 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 9.8 mp -39.42 130.11 1.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 65.33 109.336 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 346' ' ' SER . 22.8 mttt -97.64 -74.01 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 71.44 109.292 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 2.7 p 159.9 146.92 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 73.12 109.989 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 -58.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.497 1.788 . . . . 74.41 110.966 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 73.52 109.316 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.29 -0.633 . . . . 72.04 109.29 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.471 HD23 ' CD2' ' A' ' 344' ' ' LEU . 0.5 OUTLIER -121.41 103.78 9.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 72.54 109.324 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.519 ' CE1' HG21 ' A' ' 343' ' ' THR . 8.2 m-70 -83.73 167.14 17.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 74.02 109.562 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.472 ' CG1' HD21 ' A' ' 265' ' ' LEU . 21.9 t -152.45 166.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 72.2 109.32 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -134.26 134.88 42.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 75.12 110.317 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 263' ' ' PHE . 56.9 t -119.74 101.7 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 75.23 109.253 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -54.37 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.496 1.123 . . . . 75.43 110.016 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.472 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 5.6 t-20 60.33 77.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.549 1.155 . . . . 63.11 109.339 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.28 152.09 35.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.532 1.145 . . . . 72.03 110.302 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -42.27 -47.26 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 72.33 109.315 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.49 -64.24 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.464 1.102 . . . . 73.05 109.301 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.2 m -173.42 -174.83 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 70.32 110.012 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.475 ' CD1' ' HG ' ' A' ' 312' ' ' LEU . 14.0 mt -86.76 150.98 23.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 74.31 109.29 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -137.45 108.0 6.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 74.23 109.628 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 82.7 m-85 -112.37 104.35 12.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.476 1.11 . . . . 74.55 111.039 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 266' ' ' TYR . 98.6 mt -105.03 111.62 35.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 73.43 109.271 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.473 HD13 ' CD1' ' A' ' 306' ' ' LEU . 0.4 OUTLIER -98.89 128.91 45.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 75.44 109.317 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.634 ' CE2' ' CG2' ' A' ' 264' ' ' ILE . 1.1 m-85 -116.86 106.57 13.6 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.504 1.128 . . . . 73.21 110.999 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -70.75 85.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 74.11 109.294 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -90.37 53.38 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 74.01 109.273 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 18.7 p -125.19 166.87 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 75.52 110.384 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -75.91 -49.62 17.31 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.556 1.16 . . . . 72.0 109.303 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 26.7 pt -51.63 -179.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.15 . . . . 75.14 109.341 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.3 126.71 73.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 75.23 109.267 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 5.8 mm -56.82 136.17 78.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 74.51 109.266 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.02 -24.12 13.1 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.503 1.791 . . . . 64.24 111.016 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.95 -163.63 51.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.511 1.132 . . . . 63.32 111.027 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 49.07 33.74 5.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 73.31 109.339 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 64.3 m -85.39 173.87 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 64.24 108.305 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.516 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.5 m -152.32 99.33 2.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 73.4 110.361 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.525 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.9 t80 -52.08 -179.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 72.4 111.016 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.97 100.24 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 72.44 110.245 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.692 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 17.0 p90 -115.02 152.27 32.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 72.15 111.032 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 t -87.41 179.19 6.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 74.44 110.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.601 ' OG ' ' CE2' ' A' ' 319' ' ' TYR . 1.4 m . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 70.02 110.006 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.318 -0.623 . . . . 75.23 109.318 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.74 162.52 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.431 1.082 . . . . 75.13 111.044 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.504 ' OG ' ' CG2' ' A' ' 278' ' ' THR . 17.7 t -120.83 128.67 53.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 74.55 110.001 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 3.7 mt -93.55 130.56 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 73.41 109.341 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.429 ' HD2' ' CG2' ' A' ' 278' ' ' THR . 2.7 mptp? -71.96 113.09 8.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 74.53 109.294 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.402 ' CE ' ' HE2' ' A' ' 304' ' ' LYS . 92.4 mtp -79.87 162.75 24.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 73.34 110.993 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -67.09 155.31 52.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.133 . . . . 52.12 111.013 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -33.3 4.67 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.501 1.79 . . . . 64.11 110.991 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -46.14 144.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 75.14 109.626 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.55 126.76 41.06 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 64.2 110.301 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.409 HG21 ' N ' ' A' ' 303' ' ' GLN . 14.8 mt -64.18 -77.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.572 1.17 . . . . 65.41 109.328 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 79.47 -156.7 41.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.507 1.129 . . . . 75.53 111.017 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.446 ' C ' ' N ' ' A' ' 302' ' ' GLY . 2.0 mt -69.42 156.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.518 0.775 . . . . 73.14 109.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.28 30.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 73.41 109.308 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 300' ' ' ILE . . . -108.38 153.32 16.85 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.485 1.116 . . . . 75.01 111.018 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.409 ' N ' HG21 ' A' ' 298' ' ' ILE . 5.6 pt20 -126.23 -179.06 4.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 0.755 . . . . 73.03 110.289 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 265' ' ' LEU . 40.8 tptt -152.62 149.37 28.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 73.33 109.288 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.55 130.3 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 75.5 110.317 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 13.2 mt -139.38 61.64 1.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.123 . . . . 74.51 109.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.586 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 7.0 p90 -75.22 113.46 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 75.51 107.949 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.0 m-30 -102.01 173.62 6.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 73.34 111.013 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.473 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.1 p90 -158.93 159.1 29.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 74.32 110.946 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.98 -36.71 2.5 Favored 'Cis proline' 0 C--N 1.36 1.166 0 C-N-CA 121.045 -2.481 . . . . 72.5 110.963 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.4 p 167.52 150.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 74.5 109.968 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 281' ' ' PHE . 0.0 OUTLIER -123.21 172.93 4.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.472 1.108 . . . . 73.42 109.287 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.86 34.6 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.535 1.808 . . . . 75.22 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 1.1 p -133.08 159.45 72.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.508 1.13 . . . . 74.42 110.391 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.06 171.46 68.02 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.985 -2.506 . . . . 71.32 110.958 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.4 mt -89.07 62.33 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.46 1.1 . . . . 74.23 109.266 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 5.4 p -87.62 136.52 32.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.129 . . . . 71.22 110.029 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.6 OUTLIER 76.22 6.8 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 74.23 109.32 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.601 ' CE2' ' OG ' ' A' ' 283' ' ' SER . 8.6 m-85 -80.34 179.04 7.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 74.31 110.99 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.526 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.8 OUTLIER -105.72 -53.05 2.71 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 74.54 110.361 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.584 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 5.0 mtm 27.31 57.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 73.45 111.017 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -87.78 -168.81 2.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 73.22 109.317 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -148.91 137.65 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.14 . . . . 75.11 109.28 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 15.9 m -107.88 178.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 75.5 109.325 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.574 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.47 -172.43 2.03 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.495 1.122 . . . . 75.43 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.07 -3.67 14.09 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 74.13 110.345 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.02 -5.41 28.14 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.456 1.097 . . . . 73.11 109.291 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 70.3 58.94 5.67 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.474 1.109 . . . . 73.34 111.013 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -154.76 119.48 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.456 0.739 . . . . 74.4 110.276 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 324' ' ' VAL . 24.3 m -46.1 124.18 5.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 74.13 110.395 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.5 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 0.8 OUTLIER -105.53 -39.47 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 71.22 109.306 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.476 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 8.5 mt -130.47 167.79 18.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 73.04 109.284 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.452 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.2 m -151.9 132.18 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.15 109.259 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.43 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -85.44 122.1 5.86 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.511 1.132 . . . . 65.21 110.984 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.64 -26.82 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 74.52 109.302 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.43 ' N ' ' C ' ' A' ' 334' ' ' GLY . 1.2 m 50.42 63.2 2.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.116 . . . . 74.44 108.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -70.04 -179.56 1.96 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.489 1.118 . . . . 60.05 109.275 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -76.66 62.52 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 74.42 109.297 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 14.9 m -174.09 146.29 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.15 . . . . 75.24 109.999 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 79.0 m-20 -53.09 -21.19 4.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.435 1.084 . . . . 71.44 109.303 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.59 143.32 42.41 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 63.21 110.298 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.584 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 63.3 mt -147.55 139.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 72.52 109.31 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.519 HG21 ' CE1' ' A' ' 251' ' ' HIS . 11.8 p -133.58 94.73 3.35 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 75.52 110.427 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.471 ' CD2' HD23 ' A' ' 250' ' ' LEU . 5.4 mp -47.66 133.03 13.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 75.52 109.286 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.4 ptpt -117.88 -60.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 74.11 109.317 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.29 150.85 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 60.34 109.984 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -56.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.482 1.78 . . . . 71.32 111.047 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.45 109.336 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.326 -0.62 . . . . 75.31 109.326 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.537 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.21 98.24 6.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 71.43 109.304 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.477 ' CE1' ' CD ' ' A' ' 341' ' ' GLU . 2.3 t-160 -96.63 130.23 43.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.472 1.107 . . . . 75.33 109.574 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 265' ' ' LEU . 3.6 t -116.06 171.16 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 71.3 109.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -134.76 121.99 21.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.519 1.137 . . . . 75.1 110.27 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.57 HG11 ' CE2' ' A' ' 263' ' ' PHE . 21.8 t -103.61 111.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 75.0 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -64.94 0.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 61.11 109.962 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.496 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 0.3 OUTLIER 66.97 67.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 72.43 109.312 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.09 169.08 11.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 75.22 110.298 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -73.52 -14.49 61.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.472 1.108 . . . . 71.14 109.318 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 260' ' ' SER . 1.8 p-10 -87.51 -45.37 10.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 75.35 109.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.473 ' N ' ' ND2' ' A' ' 259' ' ' ASN . 3.8 p -176.15 -177.31 0.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 70.33 110.004 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.468 ' CD1' HD13 ' A' ' 312' ' ' LEU . 16.8 mt -90.18 174.46 7.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.11 . . . . 74.11 109.255 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . 0.405 ' NE2' ' HG2' ' A' ' 305' ' ' GLU . 4.2 t-160 -171.97 104.51 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.44 109.59 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.608 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 87.9 m-85 -107.05 91.68 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 75.32 110.993 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.512 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 48.9 mt -88.84 109.9 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.21 109.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 252' ' ' VAL . 0.1 OUTLIER -110.62 130.33 55.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 74.31 109.331 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.512 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 2.0 m-85 -114.99 136.74 52.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.496 1.123 . . . . 75.45 111.003 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 273' ' ' ILE . 9.2 p-10 -79.72 118.58 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 75.44 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -11.53 22.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 71.42 109.309 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.5 p -72.1 175.67 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 63.42 110.345 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -88.52 -43.21 11.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 65.15 109.308 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.3 pt -53.15 175.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 74.31 109.299 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.12 134.42 62.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 72.33 109.319 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 267' ' ' ASN . 1.1 mp -57.59 139.18 81.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 74.12 109.313 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -30.96 6.61 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.474 1.776 . . . . 71.35 111.005 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 276' ' ' ASN . . . 86.76 -159.67 31.9 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.518 1.136 . . . . 75.34 110.981 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 275' ' ' GLY . 56.9 t-20 40.35 32.44 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 75.43 109.287 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.407 ' O ' ' OG1' ' A' ' 278' ' ' THR . 86.4 m -88.61 -176.77 5.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 74.2 108.298 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.466 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 33.1 m -157.4 119.94 3.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 75.23 110.428 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.427 ' CD1' ' CD1' ' A' ' 306' ' ' LEU . 3.1 t80 -65.79 173.36 2.92 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.457 1.098 . . . . 74.04 110.962 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.448 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 39.6 tt0 -155.99 79.61 0.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 73.14 110.339 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.56 151.07 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.12 . . . . 74.05 111.0 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 p -120.82 -177.25 3.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 71.14 110.015 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.483 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 26.5 p . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.52 1.137 . . . . 72.34 110.018 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.448 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 2.4 p . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 109.235 -0.654 . . . . 73.2 109.235 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.33 131.96 54.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 73.13 110.998 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 65.4 m -101.99 116.99 33.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 73.53 109.996 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.7 mt -98.63 125.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 72.13 109.302 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -67.61 117.77 9.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.437 1.086 . . . . 73.33 109.27 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.467 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 94.1 mtp -81.96 151.8 27.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 73.42 110.967 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.633 ' N ' ' HZ3' ' A' ' 304' ' ' LYS . . . -44.55 145.7 1.9 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.546 1.154 . . . . 52.1 110.981 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -25.97 11.41 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.534 1.807 . . . . 73.54 111.001 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -67.42 178.78 1.45 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.03 109.626 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 73.2 mt-10 -113.48 130.62 56.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 73.31 110.327 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 3.4 mt -44.08 -62.46 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 74.34 109.314 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 267' ' ' ASN . . . 111.21 -165.15 12.11 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 44.25 111.018 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 301' ' ' LYS . 9.7 mt -63.56 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.534 0.784 . . . . 71.53 109.343 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 300' ' ' ILE . 0.0 OUTLIER -89.22 14.6 10.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.32 109.278 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -62.25 178.47 5.06 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 71.33 111.0 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -141.24 176.79 8.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 0.766 . . . . 75.2 110.285 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.633 ' HZ3' ' N ' ' A' ' 294' ' ' GLY . 31.3 tptt -139.37 145.53 39.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.55 109.297 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.405 ' HG2' ' NE2' ' A' ' 262' ' ' HIS . 4.1 mt-10 -116.31 128.78 55.85 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.469 1.106 . . . . 74.14 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.59 ' O ' ' CE1' ' A' ' 308' ' ' PHE . 9.4 mt -132.14 56.9 1.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 72.22 109.312 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -70.94 123.6 22.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 71.15 107.985 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.7 m-30 -110.14 -166.48 1.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.431 1.082 . . . . 73.25 111.018 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.479 ' CD1' ' C ' ' A' ' 308' ' ' PHE . 1.2 p90 -172.09 160.51 4.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 65.44 111.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.01 -36.26 2.65 Favored 'Cis proline' 0 C--N 1.36 1.145 0 C-N-CA 121.003 -2.499 . . . . 70.42 110.998 0.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.2 p 169.63 130.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 74.14 110.029 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.468 HD13 ' CD1' ' A' ' 261' ' ' LEU . 5.6 mp -111.69 158.66 35.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 70.14 109.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 148.4 35.1 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.475 1.776 . . . . 73.24 110.954 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.496 ' CG2' ' OD1' ' A' ' 256' ' ' ASN . 0.3 OUTLIER -126.13 164.08 35.88 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 65.45 110.38 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.489 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -173.87 13.07 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 120.991 -2.504 . . . . 73.32 111.028 -0.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.564 HD22 ' CE2' ' A' ' 319' ' ' TYR . 2.4 mt -107.73 58.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.502 1.126 . . . . 74.11 109.241 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.415 ' CB ' ' HA ' ' A' ' 338' ' ' ASP . 0.9 OUTLIER -81.87 133.32 35.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 50.3 109.989 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 317' ' ' SER . 6.8 t-20 75.26 26.13 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.04 109.302 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.564 ' CE2' HD22 ' A' ' 316' ' ' LEU . 16.4 m-85 -101.33 -171.56 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 73.44 110.984 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.483 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -100.54 -64.28 1.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 65.24 110.391 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.598 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 1.8 mtm 30.54 70.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 73.43 110.975 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.461 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 91.4 mttt -100.93 -167.1 1.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.451 1.094 . . . . 73.21 109.317 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 11.7 t -151.94 127.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 71.15 109.284 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.466 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 22.2 m -107.34 177.32 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.434 1.084 . . . . 74.53 109.288 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -110.88 -172.32 2.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 73.53 109.289 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.77 -3.87 13.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 75.02 110.305 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.51 -7.78 30.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.55 109.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.12 54.09 6.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.508 1.13 . . . . 75.12 110.995 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.447 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.43 128.83 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 0.756 . . . . 74.12 110.271 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.432 ' N ' HG11 ' A' ' 324' ' ' VAL . 1.2 m -57.86 117.75 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 74.35 110.363 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.49 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.6 pt -96.39 -37.22 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 72.43 109.275 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.455 ' C ' ' CG1' ' A' ' 333' ' ' VAL . 7.0 mt -132.53 168.87 17.44 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 74.1 109.296 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.455 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.24 133.7 5.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 74.43 109.309 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.46 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -86.88 121.7 5.88 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.481 1.113 . . . . 73.13 110.998 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.466 ' CE ' ' HA ' ' A' ' 342' ' ' ILE . 0.0 OUTLIER -44.21 -27.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 0.768 . . . . 71.31 109.28 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 54.58 63.22 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.572 1.17 . . . . 75.23 108.306 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.435 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -71.35 -175.0 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 75.42 109.301 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 317' ' ' SER . 0.1 OUTLIER -81.53 53.38 2.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.2 109.282 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.1 t -169.1 142.26 2.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 63.51 109.997 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -47.04 -25.43 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.505 1.128 . . . . 75.32 109.281 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.477 ' CD ' ' CE1' ' A' ' 251' ' ' HIS . 14.0 mt-10 -69.35 140.45 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 73.1 110.295 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.598 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 67.0 mt -147.36 135.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 65.23 109.327 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.4 p -127.63 87.21 2.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 75.34 110.439 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -39.97 134.71 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.549 1.156 . . . . 71.41 109.287 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.505 ' O ' ' CB ' ' A' ' 346' ' ' SER . 3.5 mtpt -106.2 -74.86 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 75.35 109.305 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.32 136.27 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.31 109.995 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -70.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.525 1.803 . . . . 74.21 111.058 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.8 tp . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 73.14 109.307 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.307 -0.627 . . . . 74.53 109.307 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.544 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -112.87 99.0 7.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 74.13 109.328 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 266' ' ' TYR . 2.4 m80 -93.08 131.38 38.16 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 73.13 109.582 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.47 ' CG1' HD22 ' A' ' 265' ' ' LEU . 95.0 t -119.8 167.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.447 1.092 . . . . 74.12 109.321 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.446 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 9.0 tt0 -130.97 120.16 23.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 70.13 110.259 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 340' ' ' ASN . 39.6 t -90.81 119.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 75.12 109.285 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.42 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.4 t -92.51 -63.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.477 1.11 . . . . 64.32 109.993 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.47 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 5.3 t-20 56.77 63.89 1.82 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.14 . . . . 65.32 109.272 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.94 163.64 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 73.01 110.278 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.4 -13.39 61.45 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 64.44 109.258 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.89 -39.11 10.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 73.14 109.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 m -174.98 -174.51 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 73.01 110.013 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.476 HD21 ' CZ ' ' A' ' 263' ' ' PHE . 9.8 mt -89.29 179.49 6.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.533 1.146 . . . . 73.05 109.323 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 1.7 t-160 -178.26 107.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 72.34 109.597 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 91.2 m-85 -121.88 101.17 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 75.12 111.013 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.407 ' CG2' ' O ' ' A' ' 304' ' ' LYS . 23.9 mt -90.04 132.73 33.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 72.02 109.297 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.47 HD22 ' CG1' ' A' ' 252' ' ' VAL . 0.2 OUTLIER -113.64 149.01 35.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 74.23 109.282 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.9 OUTLIER -128.04 115.66 18.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 72.42 111.016 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 298' ' ' ILE . 8.8 t-20 -73.97 78.82 1.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 1.088 . . . . 75.24 109.234 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -101.8 13.43 34.88 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 75.52 109.28 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.7 p -76.36 -166.15 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 75.45 110.398 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.99 -65.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 70.41 109.268 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -68.3 -178.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 75.01 109.343 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 273' ' ' ILE . 2.5 mp -122.32 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 71.21 109.263 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 272' ' ' ILE . 1.4 mp -40.7 139.47 1.15 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 74.05 109.308 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.417 ' HG2' ' ND2' ' A' ' 325' ' ' ASN . 18.2 Cg_endo -75.02 -33.17 4.76 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.513 1.796 . . . . 72.34 110.999 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 103.82 153.05 23.2 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 60.15 111.018 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 57.8 t30 71.86 26.85 2.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 0.768 . . . . 74.52 109.314 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.405 ' C ' ' OG1' ' A' ' 278' ' ' THR . 21.5 m -69.78 -179.17 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.553 1.158 . . . . 74.33 108.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 4.4 m -155.1 138.46 15.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 75.23 110.427 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.496 ' CG ' HD12 ' A' ' 306' ' ' LEU . 1.3 t80 -91.1 -173.58 3.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 70.34 111.032 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 178.03 102.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.21 110.277 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.665 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 1.2 p90 -128.44 128.95 45.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 75.1 110.979 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.478 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 0.8 OUTLIER -107.73 154.22 21.81 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.533 1.145 . . . . 64.41 110.014 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.546 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 10.5 p . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.536 1.147 . . . . 73.42 110.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.317 -0.623 . . . . 73.12 109.317 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -135.99 138.55 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 73.12 110.992 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 96.8 p -110.59 125.85 53.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 61.12 109.983 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 11.4 mt -97.73 133.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 73.04 109.295 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.39 102.19 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 73.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.427 ' CE ' ' HE2' ' A' ' 304' ' ' LYS . 73.9 mtp -73.28 152.13 41.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 70.34 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -38.69 141.78 0.44 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.46 1.1 . . . . 65.01 110.959 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.06 -23.81 13.33 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.52 1.8 . . . . 73.44 110.952 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -73.43 175.94 6.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 73.14 109.624 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -94.85 155.15 16.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 71.55 110.291 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 66.3 mt -77.19 -83.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 74.15 109.322 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 126.66 141.01 5.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.51 1.131 . . . . 54.32 110.996 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 58.6 mt -40.57 -33.15 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 0.751 . . . . 75.55 109.292 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.15 -29.47 7.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 73.42 109.332 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -48.05 136.35 15.43 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.498 1.124 . . . . 72.2 111.002 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -89.65 -172.48 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 0.757 . . . . 73.54 110.297 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.427 ' HE2' ' CE ' ' A' ' 293' ' ' MET . 32.8 tptt -160.49 145.12 14.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 73.44 109.33 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -124.54 144.46 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.473 1.108 . . . . 73.14 110.296 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.601 ' O ' ' CE1' ' A' ' 308' ' ' PHE . 11.8 mt -144.13 61.18 1.36 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 74.23 109.299 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 132.29 46.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.53 107.989 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.1 m-30 -118.4 174.49 6.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 75.42 110.988 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -155.74 155.03 29.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.559 1.162 . . . . 65.03 111.001 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -37.14 2.35 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.03 -2.487 . . . . 74.42 111.003 -0.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.4 p 172.61 149.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 64.55 110.003 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.45 HD12 ' CD1' ' A' ' 261' ' ' LEU . 1.7 mp -128.78 157.97 73.74 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 73.31 109.285 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 148.5 35.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.465 1.771 . . . . 75.51 110.979 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.7 OUTLIER -134.51 161.96 60.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 71.21 110.395 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.0 Cg_endo -75.07 173.71 56.52 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.983 -2.507 . . . . 75.24 110.961 0.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.553 HD22 ' CE2' ' A' ' 319' ' ' TYR . 1.4 mt -95.07 64.02 2.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.528 1.143 . . . . 75.34 109.282 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 4.7 p -77.37 121.6 23.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 73.22 110.027 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 78.92 31.44 0.31 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 73.14 109.326 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.553 ' CE2' HD22 ' A' ' 316' ' ' LEU . 4.2 m-85 -112.14 141.14 46.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 63.45 110.997 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.3 m -51.89 -62.79 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 74.11 110.426 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.531 ' C ' ' O ' ' A' ' 320' ' ' THR . 0.9 OUTLIER 26.87 60.78 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 1.144 . . . . 74.11 111.012 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.466 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 49.0 mttm -97.44 -174.76 3.01 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 75.25 109.302 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.72 136.31 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 72.41 109.291 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 278' ' ' THR . 4.4 m -116.66 -179.57 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 74.33 109.307 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.468 ' OD1' ' CG2' ' A' ' 331' ' ' ILE . 0.8 OUTLIER -105.03 -171.23 1.88 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 73.21 109.282 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.47 -9.27 24.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 71.44 110.312 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -99.08 -7.25 27.01 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 75.24 109.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.36 14.3 76.74 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.5 1.125 . . . . 70.01 111.033 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -92.94 132.78 36.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 0.744 . . . . 63.54 110.248 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 324' ' ' VAL . 16.6 m -61.39 130.87 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 73.23 110.417 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.468 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 19.8 pt -115.72 -39.24 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 73.23 109.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 9.9 mt -138.79 166.26 24.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 73.4 109.272 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' HD3' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.2 123.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 74.14 109.303 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -70.27 137.43 27.86 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.525 1.141 . . . . 44.42 111.042 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.502 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -74.11 -36.82 64.25 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.53 0.782 . . . . 72.54 109.244 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 335' ' ' LYS . 0.1 OUTLIER 40.9 87.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 1.16 . . . . 71.12 108.275 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.88 72.58 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 73.3 109.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.15 55.08 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.41 109.311 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.9 m -163.49 131.84 3.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 75.44 109.997 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.455 ' O ' ' CG2' ' A' ' 254' ' ' VAL . 8.5 m120 -46.9 -38.11 9.95 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 74.02 109.252 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.27 146.61 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 73.14 110.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 9.3 mt -146.26 121.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 63.13 109.301 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.554 HG23 ' CD2' ' A' ' 251' ' ' HIS . 14.5 p -115.33 79.17 1.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 74.33 110.382 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 334' ' ' GLY . 9.9 mp -38.82 149.87 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.1 . . . . 70.42 109.258 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -126.21 -55.01 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.14 109.343 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 157.41 154.81 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 74.32 110.001 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 348' ' ' LEU . 18.4 Cg_endo -74.96 -45.92 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.502 1.79 . . . . 74.23 111.018 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 347' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 63.33 109.305 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.499 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.275 -0.639 . . . . 74.3 109.275 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.562 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -121.36 105.56 10.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.22 109.318 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.42 ' NE2' ' HG2' ' A' ' 341' ' ' GLU . 55.7 t-80 -73.17 124.19 25.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.01 109.628 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.531 ' CG1' ' CD2' ' A' ' 265' ' ' LEU . 56.6 t -118.49 168.69 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.553 1.158 . . . . 74.02 109.281 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 45.7 tp10 -129.8 146.88 51.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 75.45 110.27 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.76 103.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 62.42 109.308 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.2 m -76.15 -70.04 0.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 73.42 109.949 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.466 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 3.2 t-20 60.52 66.56 0.92 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.529 1.143 . . . . 45.55 109.324 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.3 pt-20 -166.21 -174.39 2.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 72.44 110.298 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 18.1 t0 67.05 15.14 10.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.24 109.327 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 9.3 t-20 82.24 19.66 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 73.15 109.284 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 257' ' ' GLU . 2.7 p -164.22 -175.39 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 72.55 109.999 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.466 ' CD2' ' HA ' ' A' ' 256' ' ' ASN . 13.6 mt -100.55 174.23 6.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.134 . . . . 73.31 109.286 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.2 117.72 0.3 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 72.0 109.583 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -129.18 117.84 21.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 74.34 110.993 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.632 ' CG2' ' CE2' ' A' ' 266' ' ' TYR . 86.1 mt -102.5 112.48 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 74.5 109.329 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.531 ' CD2' ' CG1' ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.06 123.8 42.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 72.14 109.306 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 264' ' ' ILE . 1.3 m-85 -112.58 140.25 47.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 73.43 111.019 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 271' ' ' ILE . 62.8 t-20 -91.16 88.66 7.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.12 . . . . 55.01 109.319 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -3.45 21.84 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 74.02 109.298 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 0.9 OUTLIER -56.66 -17.3 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 74.31 110.389 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 269' ' ' THR . 3.7 m120 83.75 43.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.44 109.327 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.508 ' CD1' ' OG1' ' A' ' 269' ' ' THR . 0.1 OUTLIER -152.03 177.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 71.14 109.303 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 271' ' ' ILE . 71.2 mt -106.62 130.64 58.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 65.14 109.309 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.434 HG12 ' ND2' ' A' ' 267' ' ' ASN . 3.4 mm -71.04 138.12 84.86 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 74.05 109.297 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.549 1.815 . . . . 71.41 110.982 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 76.47 179.38 47.08 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.504 1.127 . . . . 71.41 111.03 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 326' ' ' GLN . 50.8 t-20 62.79 31.42 16.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 0.763 . . . . 74.15 109.322 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.403 ' C ' ' OG1' ' A' ' 278' ' ' THR . 68.6 m -90.58 178.71 6.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.35 108.293 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.482 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.7 m -153.8 127.87 9.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 64.13 110.413 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.505 ' CG ' HD12 ' A' ' 306' ' ' LEU . 1.8 t80 -80.47 164.11 23.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 75.34 110.991 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -151.52 88.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.2 110.286 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.786 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 15.5 p90 -120.6 128.67 53.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 73.11 111.028 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.592 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 23.8 t -113.99 178.33 4.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.4 109.983 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.528 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 3.4 t . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 61.14 109.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.295 -0.631 . . . . 74.42 109.295 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -116.4 139.42 50.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.537 1.148 . . . . 72.53 111.015 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 90.8 p -119.7 122.06 40.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 73.4 110.048 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 21.6 mt -103.44 129.25 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 74.54 109.335 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.429 ' CD ' HG21 ' A' ' 278' ' ' THR . 18.3 mmtp -71.24 115.99 11.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 74.32 109.298 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 81.6 mtp -78.27 164.31 25.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 75.43 111.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -66.53 147.73 50.05 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.519 1.137 . . . . 72.14 111.018 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -30.24 7.36 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.506 1.793 . . . . 73.32 110.966 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.93 138.3 58.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 74.4 109.617 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -73.44 141.19 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 72.2 110.307 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 27.0 mt -67.03 -81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 73.25 109.26 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 300' ' ' ILE . . . 109.59 156.63 16.71 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.508 1.13 . . . . 74.43 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 299' ' ' GLY . 54.2 mt -39.13 -72.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.522 0.778 . . . . 74.14 109.352 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.38 -28.08 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 71.23 109.298 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -50.13 158.44 1.65 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.498 1.124 . . . . 71.41 110.963 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -129.23 -174.24 3.22 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 0.762 . . . . 74.25 110.322 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -156.92 156.92 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 75.33 109.321 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -134.76 147.14 49.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 62.03 110.314 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 16.5 mt -144.82 64.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 73.21 109.294 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -73.17 134.63 44.46 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.977 -1.119 . . . . 74.23 107.977 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.786 ' CD2' ' CE2' ' A' ' 281' ' ' PHE . 7.3 m-85 -121.69 167.07 13.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 75.05 111.024 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -142.71 143.4 25.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.21 110.997 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.0 -54.0 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.027 -2.489 . . . . 75.21 110.969 0.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.99 109.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 50.33 110.023 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 3.9 mp -70.69 158.09 88.7 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 72.32 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.06 33.4 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.476 1.777 . . . . 72.24 110.995 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.482 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.4 OUTLIER -118.02 163.76 23.13 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 65.24 110.427 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.97 -173.19 11.86 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.021 -2.491 . . . . 74.3 111.016 -0.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.642 ' O ' ' CD1' ' A' ' 319' ' ' TYR . 4.6 mp -102.71 11.31 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.553 1.158 . . . . 75.24 109.311 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -46.27 119.26 2.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 71.31 110.005 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 317' ' ' SER . 8.4 t-20 87.15 42.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 71.14 109.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.642 ' CD1' ' O ' ' A' ' 316' ' ' LEU . 3.7 m-85 -120.85 -171.16 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 74.21 111.014 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.563 ' O ' ' C ' ' A' ' 321' ' ' MET . 52.3 m -105.04 -55.85 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 74.51 110.365 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.563 ' C ' ' O ' ' A' ' 320' ' ' THR . 3.8 ptp 23.81 57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 75.41 110.977 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.473 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 84.1 mttt -91.89 176.97 6.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.472 1.108 . . . . 63.42 109.339 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.63 129.52 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 75.4 109.306 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.482 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 6.5 m -109.1 -172.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.086 . . . . 70.43 109.307 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.458 ' HB3' ' CG2' ' A' ' 331' ' ' ILE . 39.8 p30 -121.38 -170.27 2.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 72.2 109.301 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.423 ' HB2' ' ND2' ' A' ' 276' ' ' ASN . 2.0 pt20 -63.2 -10.95 17.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 73.34 110.258 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -94.56 -13.96 25.51 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.466 1.104 . . . . 75.55 109.284 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.25 80.27 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.57 1.169 . . . . 72.55 111.028 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.25 134.79 38.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.514 0.773 . . . . 74.2 110.262 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.457 ' CG2' HG12 ' A' ' 333' ' ' VAL . 10.3 m -61.87 115.1 3.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 64.51 110.439 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 325' ' ' ASN . 8.1 pt -88.97 -37.82 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.534 1.147 . . . . 72.35 109.304 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 9.4 mt -141.64 169.6 17.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.554 1.159 . . . . 75.34 109.283 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.457 HG12 ' CG2' ' A' ' 330' ' ' THR . 1.0 OUTLIER -148.47 136.13 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 74.31 109.296 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -92.51 118.8 5.66 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.466 1.104 . . . . 62.52 111.026 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.422 ' NZ ' ' CB ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -50.04 -26.86 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 0.759 . . . . 72.13 109.307 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.6 t 46.05 77.03 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 53.42 108.333 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.422 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -81.51 -172.2 3.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 75.03 109.321 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.414 ' HA ' ' CB ' ' A' ' 317' ' ' SER . 0.8 OUTLIER -80.56 58.01 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 74.32 109.271 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.85 162.7 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 75.01 109.96 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.94 -38.49 86.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.11 109.319 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.42 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -61.77 133.06 55.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.114 . . . . 75.52 110.305 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.463 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 86.0 mt -143.77 131.33 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 75.3 109.289 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 344' ' ' LEU . 49.3 p -129.56 94.91 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.419 1.074 . . . . 74.41 110.404 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 10.0 mp -39.72 152.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 61.14 109.276 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 5.7 ptpt -125.67 -60.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 73.12 109.311 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.2 p 159.38 151.35 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.125 . . . . 62.33 109.978 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -79.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.514 1.797 . . . . 73.24 110.993 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.451 ' CD2' ' C ' ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.512 1.133 . . . . 75.12 109.312 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.291 -0.633 . . . . 75.3 109.291 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 344' ' ' LEU . 0.7 OUTLIER -105.58 101.12 10.66 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 74.42 109.319 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -82.07 168.1 18.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 74.21 109.632 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 22.4 t -155.05 150.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 74.11 109.328 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -124.57 151.05 45.25 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 74.21 110.313 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.78 106.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 75.52 109.327 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.8 t -73.55 -62.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 64.14 109.963 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.422 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 3.1 t-20 60.89 63.41 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 73.32 109.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -95.62 158.98 15.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 1.124 . . . . 75.34 110.325 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -48.25 -49.03 34.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 71.31 109.29 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -51.47 -53.41 37.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 64.11 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.8 p 178.75 -174.69 0.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.511 1.132 . . . . 74.31 109.993 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.615 ' CD1' ' CD1' ' A' ' 312' ' ' LEU . 34.8 mt -77.65 178.76 7.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 64.44 109.308 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -171.22 108.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 73.53 109.577 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.814 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 79.3 m-85 -115.79 93.13 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 75.1 111.036 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.565 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 84.6 mt -87.31 103.39 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 74.42 109.273 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.18 132.82 44.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 73.5 109.288 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.565 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 1.1 m-85 -118.27 125.98 51.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.32 110.988 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -64.0 79.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 72.33 109.266 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 266' ' ' TYR . 1.1 mmpt? -90.91 40.55 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.519 1.137 . . . . 73.43 109.259 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.6 p -119.65 177.78 4.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 64.34 110.402 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -85.56 -12.49 51.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 72.11 109.283 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.2 pt -101.46 160.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 75.52 109.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 273' ' ' ILE . 3.8 mp -120.58 121.58 65.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 65.32 109.278 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 272' ' ' ILE . 1.0 OUTLIER -40.01 142.4 0.7 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 75.42 109.313 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -44.41 0.34 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.797 . . . . 62.34 111.023 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 123.19 149.33 7.8 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.523 1.139 . . . . 52.43 110.977 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.9 t30 67.35 73.86 0.32 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 0.743 . . . . 72.21 109.308 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 293' ' ' MET . 0.8 OUTLIER -119.91 -179.15 3.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 72.25 108.286 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.475 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 22.3 m -153.51 137.52 16.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.535 1.147 . . . . 75.03 110.393 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.655 ' CD1' ' CD1' ' A' ' 306' ' ' LEU . 2.6 t80 -86.04 -167.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 73.14 110.993 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 176.5 104.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.458 1.099 . . . . 73.21 110.287 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.589 ' CZ ' ' CG ' ' A' ' 308' ' ' PHE . 3.0 p90 -133.56 144.0 49.05 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 73.01 111.021 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 37.3 p -104.43 143.27 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 74.12 110.011 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 312' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 O-C-N 124.461 1.101 . . . . 70.44 109.988 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 289' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.337 -0.616 . . . . 75.35 109.337 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.435 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 5.7 t80 -134.83 149.14 50.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.438 1.086 . . . . 75.31 110.949 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.452 ' HB3' ' CG2' ' A' ' 278' ' ' THR . 11.0 m -109.31 127.14 54.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 72.25 110.0 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.423 HD13 ' CD1' ' A' ' 308' ' ' PHE . 8.2 mt -97.06 125.63 50.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 75.13 109.289 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -70.26 116.57 10.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 73.32 109.3 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.482 ' CE ' ' SG ' ' A' ' 277' ' ' CYS . 86.2 mtp -84.74 170.0 13.68 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.571 1.169 . . . . 74.33 111.018 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.558 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -64.01 143.02 47.06 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.484 1.115 . . . . 60.34 111.023 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -27.93 9.55 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.514 1.797 . . . . 73.43 111.013 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -71.34 155.76 40.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 74.24 109.607 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.38 169.39 17.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.53 1.143 . . . . 71.22 110.284 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 79.0 mt -99.22 -74.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 64.15 109.308 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.408 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 122.15 135.95 4.82 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.545 1.153 . . . . 53.21 110.986 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 4.0 mt -41.52 -28.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 0.781 . . . . 72.2 109.299 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 299' ' ' GLY . 0.0 OUTLIER -108.08 -31.19 8.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 71.12 109.303 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -57.76 146.6 38.19 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.497 1.123 . . . . 64.51 110.998 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -173.91 2.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.427 0.722 . . . . 63.25 110.277 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.558 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 28.8 tptt -159.99 144.6 14.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 75.25 109.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -107.69 155.03 20.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 72.2 110.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.655 ' CD1' ' CD1' ' A' ' 279' ' ' PHE . 9.7 mt -149.06 60.34 1.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 75.14 109.268 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.37 133.08 55.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 75.32 107.957 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.814 ' CD2' ' CE1' ' A' ' 263' ' ' PHE . 17.9 m-30 -119.38 39.52 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.494 1.121 . . . . 73.3 110.96 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -36.44 148.03 0.18 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 74.24 111.007 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.03 -46.45 0.37 Allowed 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.959 -2.517 . . . . 74.23 111.002 0.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 34.2 p 176.27 162.11 0.36 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 71.55 109.984 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.615 ' CD1' ' CD1' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -132.87 164.78 41.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.401 1.063 . . . . 73.21 109.275 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 145.24 31.28 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.52 1.8 . . . . 65.3 111.017 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.473 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.21 163.09 44.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 74.33 110.353 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.03 174.91 50.27 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.963 -2.515 . . . . 75.02 111.006 0.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.636 ' O ' ' CD1' ' A' ' 319' ' ' TYR . 8.2 mt -89.63 12.55 16.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 74.44 109.278 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.1 t -46.56 118.52 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 72.12 110.023 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.0 t-20 88.58 41.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.2 109.327 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.636 ' CD1' ' O ' ' A' ' 316' ' ' LEU . 4.9 m-85 -122.86 -174.28 2.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.53 110.982 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.1 m -103.76 -56.71 2.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 73.4 110.45 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.542 ' C ' ' O ' ' A' ' 320' ' ' THR . 2.5 ptp 25.29 67.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.53 1.144 . . . . 75.41 110.993 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.473 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 38.9 mttt -104.35 -176.77 3.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 1.126 . . . . 72.01 109.26 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 279' ' ' PHE . 65.4 t -136.56 158.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.111 . . . . 70.25 109.314 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 278' ' ' THR . 16.0 m -137.35 171.85 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 75.14 109.283 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -104.24 -162.87 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 1.129 . . . . 71.34 109.293 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -72.27 -4.84 32.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.528 1.143 . . . . 74.41 110.337 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -102.44 0.56 34.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 72.02 109.278 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.47 1.87 58.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.496 1.123 . . . . 72.15 111.011 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -83.54 141.17 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 0.753 . . . . 75.12 110.307 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 43.1 m -65.74 124.17 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 74.23 110.397 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.7 pt -102.5 -38.35 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 73.54 109.256 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 12.5 mt -144.33 171.71 13.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 74.32 109.272 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.458 ' CG2' ' HG2' ' A' ' 322' ' ' LYS . 0.2 OUTLIER -161.29 125.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.14 109.349 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.433 ' CA ' ' CD1' ' A' ' 344' ' ' LEU . . . -77.22 119.2 5.29 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.525 1.141 . . . . 71.13 110.982 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -26.02 0.73 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.537 0.787 . . . . 62.22 109.28 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.401 ' N ' ' C ' ' A' ' 334' ' ' GLY . 5.7 t 46.03 85.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.168 . . . . 72.44 108.3 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -95.67 -171.08 2.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.456 1.098 . . . . 64.54 109.262 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 338' ' ' ASP . 0.0 OUTLIER -81.04 56.16 2.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 75.13 109.288 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 341' ' ' GLU . 15.2 m -168.27 136.92 2.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 70.0 110.0 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -46.11 -26.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 65.2 109.301 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 339' ' ' SER . 3.4 mt-10 -69.75 141.31 53.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.104 . . . . 74.21 110.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.402 ' CD1' ' SD ' ' A' ' 321' ' ' MET . 66.0 mt -147.24 139.34 18.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 74.12 109.314 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 10.1 p -135.37 99.17 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 64.31 110.417 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.485 ' CD2' HD23 ' A' ' 250' ' ' LEU . 6.5 mp -52.07 132.97 33.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 74.45 109.318 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.3 ptpt -118.7 -61.45 1.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 64.44 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.9 OUTLIER 159.53 149.05 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 74.52 110.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 348' ' ' LEU . 18.5 Cg_endo -74.97 -46.24 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.51 1.795 . . . . 74.14 111.043 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 347' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.496 1.123 . . . . 74.32 109.32 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.48 HD23 ' CE1' ' A' ' 251' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.346 -0.613 . . . . 73.43 109.346 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.542 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.39 101.07 8.8 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.468 1.105 . . . . 74.51 109.266 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.48 ' CE1' HD23 ' A' ' 249' ' ' LEU . 41.8 m170 -94.47 131.12 40.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.15 109.621 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 265' ' ' LEU . 21.9 t -128.55 169.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.44 109.303 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -125.31 146.62 49.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 72.24 110.304 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.454 ' CG1' HG21 ' A' ' 314' ' ' THR . 38.9 t -130.58 95.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.24 109.312 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -56.84 6.54 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 1.148 . . . . 61.31 109.999 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 59.73 74.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 74.15 109.333 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' ASP . 8.5 pt-20 -108.64 156.24 19.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.44 110.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 257' ' ' GLU . 46.2 m-20 -40.33 -57.86 1.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 72.44 109.291 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -39.94 -65.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.15 109.347 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.79 -170.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.122 . . . . 73.13 109.965 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.465 HD13 ' CD1' ' A' ' 312' ' ' LEU . 13.5 mt -81.69 162.27 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 70.44 109.255 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . 0.551 ' NE2' ' CD1' ' A' ' 264' ' ' ILE . 1.3 t-160 -148.66 103.0 3.35 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 72.21 109.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.443 ' CE1' HG23 ' A' ' 254' ' ' VAL . 84.4 m-85 -116.15 130.68 56.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 65.34 110.995 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.64 ' CG2' ' CE2' ' A' ' 266' ' ' TYR . 45.6 mt -131.81 105.21 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 75.33 109.289 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 304' ' ' LYS . 0.1 OUTLIER -95.82 128.12 42.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 74.41 109.272 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.64 ' CE2' ' CG2' ' A' ' 264' ' ' ILE . 3.5 m-85 -114.31 113.84 25.13 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 72.14 111.018 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -72.34 87.35 1.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.5 109.329 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 300' ' ' ILE . 3.1 mmpt? -96.22 31.28 2.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.24 109.328 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 6.6 p -102.56 143.73 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 75.42 110.376 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -47.35 -53.42 13.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 75.11 109.309 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 37.5 pt -62.25 177.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 75.42 109.34 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.1 mt -118.96 136.06 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 75.4 109.282 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.28 140.18 97.66 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.145 . . . . 74.1 109.323 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 -34.16 3.97 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.484 1.781 . . . . 71.21 110.948 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 87.11 177.39 48.95 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.462 1.101 . . . . 71.34 111.036 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.99 27.49 8.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 0.789 . . . . 74.14 109.274 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.417 ' C ' ' OG1' ' A' ' 278' ' ' THR . 6.2 m -75.19 -177.07 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 73.42 108.313 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.4 m -154.51 100.02 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 65.13 110.364 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.554 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 0.4 OUTLIER -54.76 170.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.23 111.019 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.451 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 70.8 tt0 -160.58 84.21 0.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 73.15 110.302 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 29.6 p90 -115.32 133.1 56.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 74.22 110.983 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 2.8 t -128.72 -172.08 2.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.544 1.153 . . . . 74.31 109.991 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.56 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 22.0 t . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 75.53 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.459 ' HA ' ' CB ' ' A' ' 282' ' ' SER . 7.7 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.306 -0.627 . . . . 72.0 109.306 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -147.34 134.74 20.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 74.4 111.048 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 8.2 p -115.73 117.3 29.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.428 1.08 . . . . 72.41 110.007 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.1 mt -106.47 128.46 61.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 74.24 109.317 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.8 108.85 4.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 72.23 109.287 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 90.0 mtp -75.02 139.55 42.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 72.45 111.02 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.72 144.49 0.17 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.478 1.111 . . . . 74.4 110.995 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -24.43 12.8 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.515 1.797 . . . . 74.42 111.005 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -75.35 141.55 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 71.44 109.637 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.75 -174.18 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 74.4 110.327 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 39.1 mt -110.93 -74.2 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 73.42 109.278 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 123.53 162.95 11.63 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.468 1.105 . . . . 53.34 111.005 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.423 ' O ' ' CE ' ' A' ' 268' ' ' LYS . 36.5 mt -62.09 -30.58 49.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.519 0.776 . . . . 74.3 109.273 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.408 ' HA ' ' NZ ' ' A' ' 268' ' ' LYS . 48.6 mmtt -110.77 -22.88 11.35 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 75.23 109.27 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -59.08 164.63 9.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.527 1.142 . . . . 75.21 111.03 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -131.73 -179.84 5.63 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.519 0.776 . . . . 73.42 110.295 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 25.2 tptt -143.6 144.66 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 75.31 109.337 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.555 ' HG2' ' CH2' ' A' ' 307' ' ' TRP . 8.8 mp0 -112.71 143.6 43.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 64.43 110.302 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 12.7 mt -140.83 62.34 1.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.55 109.304 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.555 ' CH2' ' HG2' ' A' ' 305' ' ' GLU . 1.5 m-90 -68.82 118.72 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.9 m-30 -111.97 168.57 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 74.22 111.023 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.8 OUTLIER -155.02 160.76 30.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 74.51 110.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.0 -40.19 1.27 Allowed 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.023 -2.491 . . . . 73.35 110.986 0.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.1 p 175.56 132.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 73.52 110.029 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.465 ' CD1' HD13 ' A' ' 261' ' ' LEU . 5.5 mp -113.5 158.23 39.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 70.03 109.282 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 147.06 33.54 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.497 1.788 . . . . 73.42 110.966 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.467 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.4 OUTLIER -131.92 163.52 49.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 73.53 110.349 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 175.73 46.54 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.967 -2.514 . . . . 64.22 111.021 -0.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.473 ' CD2' ' HE2' ' A' ' 321' ' ' MET . 5.3 mp -93.52 65.57 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.502 1.126 . . . . 74.52 109.294 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 125.37 29.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.494 1.121 . . . . 74.5 109.998 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 73.51 29.1 1.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.03 109.306 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.4 m-85 -110.49 134.22 52.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.548 1.155 . . . . 74.52 110.988 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.468 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -49.32 -64.72 0.72 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 73.45 110.398 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.554 ' HG2' ' CE2' ' A' ' 279' ' ' PHE . 4.3 ttm 31.87 42.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 75.53 110.98 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.466 ' CE ' HG21 ' A' ' 320' ' ' THR . 16.9 pttt -80.09 -160.33 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.565 1.166 . . . . 74.11 109.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.448 HG23 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -151.96 133.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.142 . . . . 64.04 109.324 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 22.1 m -112.33 177.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 71.54 109.303 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.59 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.73 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.538 1.149 . . . . 74.42 109.306 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -1.91 12.7 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.489 1.118 . . . . 71.14 110.341 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.42 -8.19 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 72.31 109.357 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.89 5.86 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.516 1.135 . . . . 65.12 110.987 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.425 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.4 OUTLIER -149.64 129.81 13.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 0.758 . . . . 74.41 110.326 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.43 ' N ' HG11 ' A' ' 324' ' ' VAL . 1.3 m -64.1 113.39 3.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 74.54 110.39 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.501 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 1.7 pt -91.22 -34.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 70.43 109.279 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 9.7 mt -138.1 165.53 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 72.44 109.285 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -153.57 121.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 73.15 109.303 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.434 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -70.11 126.82 17.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.506 1.129 . . . . 42.03 111.014 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.499 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -44.8 -26.56 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 0.788 . . . . 74.22 109.314 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.6 OUTLIER 47.09 65.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.53 108.285 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -77.09 -171.23 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 73.4 109.299 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 54.66 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.126 . . . . 73.42 109.267 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.2 m -169.62 163.09 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 65.12 110.033 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -65.93 -32.49 74.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.43 109.323 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.32 135.41 57.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.495 1.122 . . . . 74.21 110.339 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.468 ' CD1' ' HE1' ' A' ' 321' ' ' MET . 82.1 mt -143.62 120.78 5.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.33 109.297 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 344' ' ' LEU . 16.2 p -123.27 84.57 2.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.568 1.168 . . . . 74.43 110.422 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 8.2 mp -38.75 147.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 72.55 109.306 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -128.87 -48.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 74.21 109.354 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 155.22 147.36 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 75.42 110.004 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -70.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.528 1.804 . . . . 72.04 111.014 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 74.43 109.317 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.488 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.29 -0.633 . . . . 74.14 109.29 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.406 ' CD2' HD21 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -129.78 105.15 7.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 75.02 109.274 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.497 ' O ' ' CG2' ' A' ' 252' ' ' VAL . 9.7 t-160 -71.24 163.63 27.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 75.55 109.616 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 251' ' ' HIS . 54.8 t -158.38 126.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 65.54 109.29 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -96.84 135.82 38.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.565 1.165 . . . . 70.3 110.296 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 340' ' ' ASN . 48.1 t -108.27 100.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 72.5 109.302 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -60.66 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.52 1.138 . . . . 75.24 109.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 0.1 OUTLIER 53.72 68.89 0.78 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 63.54 109.298 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.25 157.27 15.97 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.492 1.12 . . . . 71.52 110.301 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -52.06 -33.54 39.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 72.33 109.291 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -68.08 -50.96 51.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 72.41 109.363 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p 178.49 -178.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.466 1.104 . . . . 75.44 109.979 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.471 ' CD1' ' HG ' ' A' ' 312' ' ' LEU . 77.7 mt -76.07 178.56 6.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 72.4 109.279 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -176.44 86.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.116 . . . . 75.3 109.619 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 263' ' ' PHE . 4.8 m-30 -96.84 134.09 40.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 75.21 110.995 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.604 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 23.1 mt -127.88 109.62 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 73.44 109.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.468 ' CB ' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.52 129.31 45.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 72.34 109.305 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.653 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -104.19 113.12 26.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 74.35 110.953 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -68.5 72.91 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 72.24 109.248 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.8 mmtt -87.35 53.59 2.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.51 109.294 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 30.7 p -120.64 -176.38 3.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.521 1.138 . . . . 73.23 110.381 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.21 -59.42 2.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 72.45 109.315 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.404 HG12 ' N ' ' A' ' 272' ' ' ILE . 0.1 OUTLIER -78.06 -176.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 74.43 109.308 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.404 ' N ' HG12 ' A' ' 271' ' ' ILE . 2.3 mp -120.22 143.42 32.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.501 1.125 . . . . 63.41 109.29 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.66 142.44 1.87 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.453 1.095 . . . . 74.23 109.335 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -38.15 1.71 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.439 1.757 . . . . 73.41 110.983 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 99.51 160.18 28.98 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.523 1.139 . . . . 74.43 111.007 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 8.1 t-20 81.7 17.34 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 0.749 . . . . 62.52 109.29 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 87.3 m -66.61 170.57 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 74.33 108.303 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.481 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.8 m -153.64 99.24 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.554 1.159 . . . . 72.23 110.405 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.524 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.9 OUTLIER -50.79 171.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.111 . . . . 71.41 111.035 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -172.99 99.4 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 73.22 110.299 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.0 p90 -122.9 141.98 51.29 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.57 1.168 . . . . 73.41 111.015 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 54.7 p -74.88 159.13 32.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 71.15 109.983 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.148 . . . . 74.43 110.003 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.313 -0.625 . . . . 74.23 109.313 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.22 162.36 37.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 74.53 110.992 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.0 t -137.05 124.92 22.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.097 . . . . 74.53 109.983 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 12.5 mt -103.67 148.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.558 1.161 . . . . 73.13 109.295 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 292' ' ' LYS . 0.3 OUTLIER -79.86 123.71 28.0 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 61.51 109.284 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 37.5 mtp -92.77 15.0 15.59 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.561 1.163 . . . . 75.44 110.999 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.19 151.91 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.482 1.114 . . . . 64.2 110.963 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -16.44 20.13 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.53 1.805 . . . . 74.42 110.993 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -62.84 151.14 39.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 73.42 109.6 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -87.6 165.4 15.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.56 1.163 . . . . 71.41 110.319 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 2.7 mm -89.05 -95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 73.43 109.305 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 120.11 168.88 13.9 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.468 1.105 . . . . 74.14 111.013 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.42 ' CG2' ' HD3' ' A' ' 301' ' ' LYS . 15.5 mm -60.36 -43.05 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.507 0.769 . . . . 75.25 109.304 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.42 ' HD3' ' CG2' ' A' ' 300' ' ' ILE . 0.5 OUTLIER -108.94 -12.8 14.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 70.33 109.357 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -81.27 49.62 4.04 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 61.42 111.019 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.524 ' HG2' ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -41.89 164.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 0.784 . . . . 73.41 110.29 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 41.9 tptt -118.4 165.69 13.56 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.13 . . . . 72.1 109.315 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -134.86 144.96 47.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 72.24 110.346 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.524 HD13 ' CG ' ' A' ' 279' ' ' PHE . 45.3 mt -140.72 61.69 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.44 109.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -72.19 123.02 22.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.963 -1.125 . . . . 74.4 107.963 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 309' ' ' PHE . 57.0 t80 -119.24 172.09 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 74.4 111.001 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -147.24 162.66 31.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.148 . . . . 74.24 110.972 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.03 -46.13 0.4 Allowed 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.025 -2.49 . . . . 64.22 110.952 0.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 28.7 p 177.83 170.41 0.68 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.11 110.011 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.471 ' HG ' ' CD1' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -153.7 161.12 29.99 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.459 1.099 . . . . 73.2 109.288 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 312' ' ' LEU . 18.3 Cg_endo -74.96 144.09 29.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.509 1.794 . . . . 73.13 111.006 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.1 OUTLIER -126.06 165.45 27.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 75.32 110.356 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.04 -176.11 17.43 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.987 -2.505 . . . . 63.1 111.031 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.561 HD23 ' CD2' ' A' ' 319' ' ' TYR . 2.0 mt -98.21 61.42 1.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 75.3 109.311 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.9 p -74.62 119.9 19.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 74.52 110.034 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 317' ' ' SER . 45.3 t30 79.42 40.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.453 1.096 . . . . 71.03 109.338 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.561 ' CD2' HD23 ' A' ' 316' ' ' LEU . 24.3 m-85 -119.84 142.99 48.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 74.03 111.013 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.524 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.3 m -59.75 -56.76 17.76 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 74.42 110.383 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.524 ' C ' ' O ' ' A' ' 320' ' ' THR . 0.9 OUTLIER 26.93 58.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 74.2 110.953 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 29.6 mttm -94.86 -168.17 1.77 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 73.41 109.321 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.414 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 2.9 t -150.35 133.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 74.3 109.268 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.481 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 10.9 m -109.98 172.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 72.52 109.23 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -109.61 -163.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.494 1.121 . . . . 73.44 109.268 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.16 -12.86 22.1 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.133 . . . . 71.52 110.303 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.5 22.81 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 70.34 109.356 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.27 25.66 0.79 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.543 1.152 . . . . 74.23 111.012 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -106.78 128.66 54.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 0.76 . . . . 72.22 110.286 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 9.0 m -54.29 135.02 45.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.112 . . . . 75.41 110.413 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.4 pt -114.99 -42.09 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.136 . . . . 64.21 109.293 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 12.6 mt -136.42 171.25 14.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 70.0 109.273 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.443 HG13 ' CG ' ' A' ' 322' ' ' LYS . 14.6 m -153.31 141.24 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.41 109.336 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -84.97 136.89 14.95 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.489 1.118 . . . . 71.21 110.988 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.433 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -67.2 -38.56 85.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 0.749 . . . . 75.35 109.302 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.433 ' N ' ' HG2' ' A' ' 335' ' ' LYS . 0.1 OUTLIER 40.18 88.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.496 1.123 . . . . 70.5 108.299 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -116.81 81.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 72.44 109.28 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 338' ' ' ASP . 3.4 p-10 39.93 49.9 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.15 . . . . 75.31 109.258 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 26.9 m -157.21 136.67 12.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 74.45 109.997 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.486 ' O ' ' CG2' ' A' ' 254' ' ' VAL . 7.1 m120 -58.14 -36.82 73.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 75.11 109.326 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.19 134.41 48.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.549 1.156 . . . . 74.41 110.315 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 252' ' ' VAL . 4.8 mt -136.35 134.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 64.42 109.31 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 344' ' ' LEU . 39.3 p -125.27 86.38 2.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 65.44 110.363 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.406 HD21 ' CD2' ' A' ' 250' ' ' LEU . 7.2 mp -40.38 130.85 2.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 71.25 109.32 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.9 ptpt -117.54 -60.04 1.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.107 . . . . 65.3 109.292 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.47 157.28 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 75.24 110.012 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 -61.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.536 1.809 . . . . 73.05 110.999 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 74.13 109.282 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.444 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.296 -0.631 . . . . 75.45 109.296 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.556 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -110.8 99.94 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.582 1.176 . . . . 73.15 109.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.412 ' NE2' ' HG2' ' A' ' 341' ' ' GLU . 2.4 t-160 -90.33 131.54 36.07 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 73.45 109.614 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 253' ' ' GLU . 79.7 t -121.08 164.64 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 75.02 109.306 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.434 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 17.4 tp10 -129.72 147.26 51.48 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 74.35 110.325 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.462 ' CG1' HG23 ' A' ' 314' ' ' THR . 61.6 t -121.19 106.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.145 . . . . 71.25 109.335 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 t -72.85 -61.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.12 110.002 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.45 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 5.9 t-20 53.42 57.03 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 62.35 109.287 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 260' ' ' SER . 5.0 pt-20 -161.15 -174.54 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 75.25 110.344 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 71.86 17.15 5.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 71.33 109.268 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 3.6 m-20 82.61 18.77 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 75.14 109.317 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 257' ' ' GLU . 0.0 OUTLIER -170.05 -170.07 0.94 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 54.03 109.983 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -98.87 165.72 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.546 1.154 . . . . 73.54 109.298 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.85 102.38 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 73.11 109.611 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.438 ' CE2' HG23 ' A' ' 254' ' ' VAL . 85.1 m-85 -107.73 142.15 38.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.535 1.147 . . . . 73.31 110.977 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.486 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 53.2 mt -132.84 124.25 50.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.528 1.142 . . . . 74.44 109.314 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -120.53 141.87 49.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 64.02 109.291 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 1.1 m-85 -127.78 140.52 52.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.516 1.135 . . . . 73.13 110.986 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 267' ' ' ASN . 46.7 p-10 -89.79 64.24 6.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 72.52 109.275 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.479 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -58.03 -15.96 11.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 74.1 109.284 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 268' ' ' LYS . 43.8 p -54.68 -166.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 74.25 110.39 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -99.15 -59.03 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 74.34 109.331 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 4.1 pt -60.29 152.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.463 1.102 . . . . 75.44 109.282 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.77 149.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 73.4 109.291 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 3.5 mm -67.18 139.13 94.91 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.127 . . . . 74.43 109.317 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -26.95 10.52 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.486 1.782 . . . . 73.11 110.973 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 81.36 -178.51 53.86 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.504 1.128 . . . . 55.4 111.047 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 57.16 49.48 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 0.76 . . . . 70.11 109.323 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.414 ' CB ' ' SD ' ' A' ' 293' ' ' MET . 12.2 m -94.73 178.97 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 61.23 108.325 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.0 OUTLIER -152.22 97.31 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 61.21 110.378 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.596 ' CG ' ' CD1' ' A' ' 306' ' ' LEU . 0.2 OUTLIER -53.79 159.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 74.55 110.969 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 321' ' ' MET . 13.3 tt0 -143.61 75.94 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 75.3 110.327 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -109.45 121.79 45.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.145 . . . . 73.12 110.962 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.558 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 3.7 p -109.19 179.61 4.11 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 73.14 109.981 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.568 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.4 p . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 54.5 110.01 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 282' ' ' SER . 14.8 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.299 -0.63 . . . . 75.24 109.299 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -131.69 137.83 48.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 74.32 111.054 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 54.1 p -116.75 126.21 52.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.122 . . . . 73.41 109.987 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 8.5 mt -105.11 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 73.22 109.289 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 278' ' ' THR . 8.7 mmtp -67.32 110.81 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.531 1.144 . . . . 71.15 109.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.459 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 93.0 mtp -81.76 134.79 35.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 74.24 111.006 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.68 145.52 0.13 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.515 1.135 . . . . 73.21 111.031 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -20.95 16.5 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.516 1.798 . . . . 73.42 111.013 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.74 129.14 38.77 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 73.21 109.577 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.09 153.16 30.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.124 . . . . 74.12 110.254 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.6 ' CG2' ' N ' ' A' ' 299' ' ' GLY . 3.2 mt -70.22 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 71.2 109.293 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.6 ' N ' ' CG2' ' A' ' 298' ' ' ILE . . . 108.69 -177.04 20.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.505 1.128 . . . . 71.1 111.004 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 299' ' ' GLY . 59.6 mt -38.24 -90.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 74.24 109.282 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -91.3 23.93 3.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.21 109.272 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -83.74 45.14 3.42 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 75.15 111.006 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 302' ' ' GLY . 1.4 pt20 -39.99 161.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 0.761 . . . . 73.52 110.283 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.506 ' HB2' ' CG1' ' A' ' 298' ' ' ILE . 30.5 tptt -121.92 152.35 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 72.44 109.281 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 11.9 mp0 -118.37 133.83 55.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 71.41 110.307 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.596 ' CD1' ' CG ' ' A' ' 279' ' ' PHE . 35.5 mt -126.35 55.57 1.49 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 74.23 109.303 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 138.34 55.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 75.34 107.999 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.552 ' CE2' HD13 ' A' ' 312' ' ' LEU . 37.2 t80 -134.64 166.59 22.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.14 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -138.99 148.09 56.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 74.34 111.028 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.01 -53.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.005 -2.498 . . . . 73.15 110.975 0.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 23.6 p -178.8 162.66 1.35 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.503 1.127 . . . . 63.53 109.971 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.552 HD13 ' CE2' ' A' ' 308' ' ' PHE . 1.0 OUTLIER -128.61 159.16 69.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.157 . . . . 74.01 109.292 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 145.07 31.03 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.483 1.781 . . . . 73.11 111.007 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.9 OUTLIER -125.81 160.27 57.24 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 74.33 110.395 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.9 170.35 71.98 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.032 -2.487 . . . . 75.53 111.057 -0.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.462 ' CD2' ' HE3' ' A' ' 321' ' ' MET . 5.7 mp -87.68 66.26 8.81 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.536 1.147 . . . . 75.4 109.28 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.6 p -81.78 127.31 32.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 1.145 . . . . 73.35 109.975 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.2 OUTLIER 76.66 21.47 1.27 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 74.43 109.262 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 283' ' ' SER . 3.3 m-85 -103.93 134.08 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.521 1.138 . . . . 73.43 111.039 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 321' ' ' MET . 88.7 m -51.25 -60.54 3.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 62.4 110.42 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 3.5 ttm 33.08 40.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 74.25 110.996 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.455 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 36.1 mttt -72.81 -174.0 1.34 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 74.51 109.287 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 t -143.51 121.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 72.31 109.32 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 28.4 m -110.12 171.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 75.44 109.356 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.477 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 0.1 OUTLIER -109.17 -155.51 0.56 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 72.54 109.296 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -77.38 -4.0 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.56 1.163 . . . . 75.44 110.324 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -105.25 8.98 34.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 70.12 109.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.74 14.89 24.4 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.472 1.108 . . . . 72.24 110.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 7.3 pt-20 -95.83 116.39 28.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 71.04 110.279 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.8 m -50.83 96.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.45 110.386 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 3.1 pt -66.81 -36.87 78.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 74.21 109.312 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 12.6 mt -147.19 170.7 16.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 73.44 109.323 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.463 ' CG1' ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -147.17 119.3 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 75.45 109.291 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -71.45 125.09 11.42 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.543 1.152 . . . . 73.4 111.004 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.488 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -48.85 -26.44 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.563 0.802 . . . . 72.41 109.324 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 48.33 62.08 2.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 75.0 108.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.458 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -73.39 -176.78 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 74.35 109.315 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.62 55.98 1.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 73.31 109.262 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.7 m -169.08 149.16 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 61.33 109.973 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . 0.418 ' N ' ' HB3' ' A' ' 315' ' ' PRO . 10.2 m-20 -55.31 -19.95 10.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 74.41 109.29 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.412 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 18.4 mt-10 -72.69 141.37 48.22 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 73.13 110.302 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.475 ' HA ' ' CE ' ' A' ' 335' ' ' LYS . 64.5 mt -146.84 120.84 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.13 . . . . 73.13 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 344' ' ' LEU . 15.4 p -123.94 85.44 2.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.451 1.095 . . . . 73.24 110.345 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 8.4 mp -39.31 152.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 75.41 109.31 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -129.87 -51.72 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 60.14 109.306 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 158.18 146.97 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 70.05 110.018 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . 0.463 ' HA ' ' CG1' ' A' ' 333' ' ' VAL . 18.1 Cg_endo -74.98 -50.71 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.502 1.791 . . . . 74.22 110.986 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.13 . . . . 74.24 109.308 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.495 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.332 -0.618 . . . . 72.22 109.332 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 343' ' ' THR . 0.5 OUTLIER -116.58 103.21 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.41 109.302 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -67.35 147.35 53.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 72.53 109.592 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 45.1 t -145.37 161.92 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 71.21 109.358 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -134.39 132.48 39.47 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.138 . . . . 73.52 110.296 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.462 ' CG1' HG22 ' A' ' 314' ' ' THR . 94.8 t -109.69 110.72 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 72.12 109.246 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.428 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.7 t -77.93 -67.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.13 . . . . 63.41 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.408 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 4.8 t-20 61.15 63.91 1.18 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.56 1.162 . . . . 71.21 109.287 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -88.86 148.61 23.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 72.41 110.291 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.04 -24.58 1.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.474 1.109 . . . . 75.21 109.322 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -76.18 -55.37 5.64 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 72.04 109.306 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.9 m -168.37 -175.02 2.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.529 1.143 . . . . 73.41 109.942 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 312' ' ' LEU . 13.1 mt -86.48 176.02 8.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.24 109.316 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 10.7 t-160 -174.71 107.93 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.54 109.573 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -112.13 118.56 35.7 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 75.45 111.032 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.505 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 13.7 mt -112.39 104.59 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 64.01 109.254 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.47 ' CD1' HD11 ' A' ' 306' ' ' LEU . 0.8 OUTLIER -101.4 129.79 47.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 75.34 109.319 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -102.54 119.05 38.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 72.25 110.983 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.486 ' OD1' ' CD1' ' A' ' 273' ' ' ILE . 34.9 t30 -65.71 75.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.132 . . . . 75.44 109.276 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.1 mmtt -92.07 64.63 4.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 74.2 109.305 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 72.5 p -142.67 160.43 40.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 74.21 110.406 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.48 -54.27 45.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 73.53 109.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.4 pt -69.8 163.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 73.42 109.292 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 17.9 mt -114.74 139.14 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 73.5 109.333 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.486 ' CD1' ' OD1' ' A' ' 267' ' ' ASN . 1.8 mp -54.68 137.23 63.25 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 75.4 109.296 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.2 Cg_endo -75.01 -26.34 10.99 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.494 1.787 . . . . 70.21 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.61 157.76 29.61 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.504 1.127 . . . . 72.23 111.011 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.5 t30 73.41 39.44 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 0.755 . . . . 75.44 109.277 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.45 -174.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 63.45 108.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.445 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 7.3 m -155.12 156.26 35.47 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.44 1.087 . . . . 63.42 110.384 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 322' ' ' LYS . 1.9 t80 -108.75 171.07 7.64 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 74.33 110.968 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -161.59 93.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 71.11 110.31 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.407 ' HZ ' ' CD1' ' A' ' 308' ' ' PHE . 13.9 p90 -113.6 133.91 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 74.42 110.991 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -94.4 -175.18 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 73.45 109.987 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 24.8 t . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 64.34 110.017 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.274 -0.639 . . . . 73.43 109.274 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -148.23 149.31 31.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.527 1.142 . . . . 74.4 110.965 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.9 p -118.43 128.09 54.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 73.54 109.984 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 17.7 mt -101.63 129.01 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.107 . . . . 71.32 109.278 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -72.01 114.62 10.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 74.55 109.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.454 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 61.8 mtp -88.18 144.71 26.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 74.35 111.077 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -41.49 147.58 0.41 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.517 1.135 . . . . 62.13 111.005 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -17.83 19.28 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.783 . . . . 72.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -72.88 -177.04 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.468 1.105 . . . . 74.45 109.63 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.36 174.49 5.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.24 110.32 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.7 mt -104.46 -82.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.113 . . . . 73.33 109.298 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.98 159.57 20.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.54 1.15 . . . . 74.32 111.007 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.61 -63.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.5 0.764 . . . . 75.44 109.287 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.52 -29.3 68.67 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.497 1.123 . . . . 74.32 109.276 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -68.52 156.61 53.18 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.464 1.103 . . . . 44.24 110.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.81 171.68 12.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 0.768 . . . . 71.54 110.311 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 293' ' ' MET . 37.2 tptt -118.78 165.11 14.43 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 73.33 109.341 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -143.88 124.6 14.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 72.53 110.279 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' A' ' 265' ' ' LEU . 10.3 mt -135.97 60.21 1.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 73.15 109.333 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.479 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 11.2 p-90 -72.48 134.68 45.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.514 1.134 . . . . 75.21 108.034 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.6 ' CE2' ' CD1' ' A' ' 312' ' ' LEU . 45.3 t80 -126.12 166.73 16.48 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.122 . . . . 74.13 111.028 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -137.91 157.16 73.72 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 74.43 110.972 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.95 -41.31 1.02 Allowed 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.99 -2.504 . . . . 73.45 111.038 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 172.93 143.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.51 109.993 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 4.4 mp -115.16 159.58 37.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.55 109.316 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 148.5 35.31 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 75.54 110.988 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -130.35 164.42 41.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 73.44 110.382 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 -177.73 21.36 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.019 -2.492 . . . . 74.14 111.006 0.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.573 HD21 ' CE2' ' A' ' 319' ' ' TYR . 1.8 mt -102.49 52.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.442 1.089 . . . . 74.22 109.308 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.4 p -76.08 127.19 32.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 75.0 109.988 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 317' ' ' SER . 28.7 t30 81.07 30.83 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 75.11 109.342 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.573 ' CE2' HD21 ' A' ' 316' ' ' LEU . 5.2 m-85 -109.56 167.55 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.44 111.035 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.527 ' O ' ' C ' ' A' ' 321' ' ' MET . 32.3 m -79.6 -59.75 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 64.45 110.425 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.601 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 0.6 OUTLIER 27.03 79.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.108 . . . . 74.41 110.971 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 279' ' ' PHE . 7.6 pttt -112.66 -170.66 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 72.54 109.325 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 49.4 t -136.89 138.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 72.14 109.305 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 278' ' ' THR . 0.4 OUTLIER -122.4 138.69 51.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.554 1.158 . . . . 75.01 109.271 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 324' ' ' VAL . 0.5 OUTLIER -76.82 -170.54 1.63 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.13 . . . . 74.23 109.284 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -78.99 4.32 14.66 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 73.35 110.267 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.04 -3.28 41.7 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 74.42 109.296 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 65.21 54.47 26.96 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.485 1.116 . . . . 74.14 110.998 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 9.9 pt-20 -157.04 121.86 4.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 0.77 . . . . 64.35 110.311 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 69.0 m -45.26 115.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.516 1.135 . . . . 71.54 110.406 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 36.5 pt -98.76 -41.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 73.31 109.297 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.467 ' C ' ' CG1' ' A' ' 333' ' ' VAL . 10.4 mt -131.48 168.45 17.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 74.51 109.286 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.467 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.38 122.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 74.1 109.336 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.421 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -72.45 121.53 8.17 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.131 . . . . 74.14 111.006 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.499 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -45.22 -26.71 0.53 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.461 0.742 . . . . 73.21 109.293 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 321' ' ' MET . 0.1 OUTLIER 47.83 76.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 62.14 108.312 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -90.3 -175.8 4.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 65.24 109.285 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.82 62.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.466 1.103 . . . . 65.33 109.302 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 15.4 m -171.08 150.2 3.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 74.32 109.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -60.38 -21.17 61.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 63.42 109.302 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -78.12 148.46 34.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.136 . . . . 74.15 110.289 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.601 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 57.1 mt -147.55 140.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.478 1.111 . . . . 74.22 109.309 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 250' ' ' LEU . 11.4 p -136.13 95.53 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 64.24 110.358 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 7.6 mp -49.97 153.63 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 73.22 109.311 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.499 ' HD3' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -128.51 -76.44 0.56 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 74.13 109.286 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 5.0 p 164.84 134.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.491 1.119 . . . . 73.11 110.057 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.443 1.76 . . . . 54.31 111.039 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 75.45 109.288 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.273 -0.64 . . . . 75.54 109.273 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.551 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -115.55 99.76 7.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 72.31 109.302 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.418 ' NE2' HD22 ' A' ' 249' ' ' LEU . 18.8 m170 -95.52 130.83 42.22 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 74.4 109.569 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 253' ' ' GLU . 69.6 t -124.71 166.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 73.42 109.302 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.451 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 27.8 tt0 -122.67 123.34 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 74.32 110.316 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.02 107.5 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 75.34 109.318 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -59.59 2.51 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 61.44 109.969 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 2.9 t-20 60.71 70.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.25 109.243 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -105.32 161.97 13.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.556 1.16 . . . . 63.34 110.293 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 259' ' ' ASN . 46.1 m-20 -41.15 -60.22 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.561 1.163 . . . . 73.41 109.293 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 258' ' ' ASP . 66.5 t30 -40.07 -64.34 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 62.33 109.353 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -178.6 -174.54 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 72.51 109.999 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.474 ' CD1' HD13 ' A' ' 312' ' ' LEU . 46.8 mt -76.19 153.97 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.491 1.119 . . . . 74.13 109.318 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -142.03 91.66 2.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 72.44 109.603 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.573 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 8.2 m-30 -98.84 133.99 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.475 1.11 . . . . 61.52 110.977 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.638 ' CG2' ' CE2' ' A' ' 266' ' ' TYR . 62.6 mt -127.93 121.2 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 73.51 109.294 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 304' ' ' LYS . 0.4 OUTLIER -107.3 119.67 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 74.41 109.32 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.638 ' CE2' ' CG2' ' A' ' 264' ' ' ILE . 5.1 m-85 -109.03 92.16 3.94 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.502 1.126 . . . . 73.23 111.027 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -54.45 95.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 70.02 109.282 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.7 28.18 7.74 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 75.11 109.343 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 61.3 p -87.52 -174.94 5.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.545 1.153 . . . . 72.13 110.388 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -88.69 -56.17 3.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.43 109.333 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 271' ' ' ILE . 0.1 OUTLIER -60.18 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.44 1.088 . . . . 71.13 109.342 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.409 ' N ' HG12 ' A' ' 271' ' ' ILE . 4.1 mp -124.77 123.21 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.493 1.121 . . . . 72.35 109.307 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 3.5 mm -40.94 137.75 1.42 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 74.31 109.306 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.03 -24.46 12.75 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.501 1.79 . . . . 72.2 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.42 169.17 31.97 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.501 1.126 . . . . 74.05 111.008 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.0 t30 63.44 36.76 11.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 0.754 . . . . 65.22 109.344 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.411 ' C ' ' OG1' ' A' ' 278' ' ' THR . 64.1 m -90.44 -176.5 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.448 1.093 . . . . 73.42 108.316 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.411 ' OG1' ' C ' ' A' ' 277' ' ' CYS . 1.6 m -153.77 129.02 9.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 71.31 110.381 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.2 179.21 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.505 1.128 . . . . 75.42 111.017 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -169.97 97.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.11 . . . . 74.23 110.308 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.625 ' CE1' ' CE2' ' A' ' 308' ' ' PHE . 4.4 p90 -120.65 121.66 38.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 71.11 111.02 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 m -101.84 143.54 31.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.564 1.165 . . . . 71.15 110.027 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 64.33 110.02 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.308 -0.627 . . . . 61.0 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -122.7 156.73 33.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 74.32 111.014 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 6.1 p -128.1 126.34 40.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.515 1.134 . . . . 72.21 110.025 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 5.5 mt -97.68 129.47 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.133 . . . . 74.51 109.306 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -67.28 121.07 14.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 73.04 109.285 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 98.7 mtp -89.06 140.2 29.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 72.23 111.003 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.472 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -40.7 144.23 0.56 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.486 1.116 . . . . 74.51 110.989 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -24.72 12.72 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.509 1.794 . . . . 72.13 111.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -63.66 163.91 10.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.525 1.141 . . . . 72.43 109.61 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -100.12 128.92 46.12 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 73.34 110.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 77.0 mt -57.63 -72.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.122 . . . . 75.1 109.345 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.02 172.15 24.3 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.497 1.123 . . . . 53.54 110.997 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 13.4 mt -60.39 -54.69 31.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 74.21 109.325 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 36.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 75.4 109.27 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -125.46 147.16 16.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.57 1.169 . . . . 72.2 111.006 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -119.74 170.66 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 0.774 . . . . 75.4 110.313 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.472 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 46.3 tptt -140.4 149.72 42.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 74.44 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 2.1 mt-10 -115.23 151.16 34.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 71.21 110.327 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 20.4 mt -152.25 69.24 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.483 1.114 . . . . 70.33 109.291 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.518 ' CE2' ' HB3' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -75.23 119.74 19.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 64.3 108.005 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.7 m-30 -113.46 142.13 46.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 73.42 110.998 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -128.59 160.37 63.08 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 74.53 111.017 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 311' ' ' SER . 18.4 Cg_endo -74.97 -36.2 2.67 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 121.027 -2.489 . . . . 75.31 110.979 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.5 p 162.14 127.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.534 1.146 . . . . 70.45 110.025 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.474 HD13 ' CD1' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -99.32 169.5 8.07 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.417 1.073 . . . . 73.01 109.301 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 143.54 29.22 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 74.01 110.991 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.478 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.7 OUTLIER -131.27 162.17 57.46 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.559 1.162 . . . . 74.3 110.377 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.0 167.98 78.83 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.027 -2.489 . . . . 74.31 111.021 -0.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 319' ' ' TYR . 3.7 mp -87.85 46.83 1.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 73.51 109.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 58.1 p -67.7 115.8 7.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 75.14 109.961 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 317' ' ' SER . 4.2 t30 83.42 39.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 75.31 109.277 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.516 ' CG ' ' HB3' ' A' ' 316' ' ' LEU . 5.6 m-85 -116.17 150.56 37.26 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.547 1.155 . . . . 75.24 111.003 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.476 ' CG2' ' HG3' ' A' ' 322' ' ' LYS . 87.7 m -57.57 -64.11 1.01 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 1.139 . . . . 65.51 110.378 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.465 ' HE2' ' CD2' ' A' ' 316' ' ' LEU . 0.5 OUTLIER 35.39 33.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 74.23 111.02 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.476 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 90.9 mttt -72.99 -176.53 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 75.23 109.334 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.6 t -142.88 138.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.441 1.088 . . . . 74.54 109.293 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 329' ' ' GLU . 0.0 OUTLIER -116.11 152.11 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 73.52 109.289 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' A' ' 331' ' ' ILE . 0.4 OUTLIER -91.83 -173.6 3.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 63.45 109.268 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -75.45 -0.87 21.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.491 1.119 . . . . 63.14 110.299 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.47 -10.11 33.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 74.13 109.258 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.04 48.06 16.88 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.447 1.092 . . . . 70.44 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.565 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 9.7 pt-20 -153.8 110.48 3.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 73.24 110.288 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.437 ' N ' HG12 ' A' ' 324' ' ' VAL . 12.2 m -38.53 125.57 1.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.534 1.146 . . . . 72.02 110.445 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.411 HD13 ' ND2' ' A' ' 325' ' ' ASN . 6.8 pt -100.58 -37.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 74.34 109.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 9.2 mt -134.23 165.56 24.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 74.15 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.47 HG13 ' CA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -145.67 118.77 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 75.51 109.309 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.419 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -74.86 135.92 19.84 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.494 1.121 . . . . 72.31 110.993 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -79.93 -29.43 39.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 0.741 . . . . 73.53 109.265 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.51 ' SG ' ' CD1' ' A' ' 342' ' ' ILE . 12.1 t 40.07 88.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 75.54 108.339 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -78.39 -161.05 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.447 1.092 . . . . 75.3 109.298 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -81.69 58.08 3.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.494 1.121 . . . . 63.53 109.322 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 57.7 m -172.15 166.13 6.07 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 63.2 110.007 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.58 -15.85 63.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 75.23 109.308 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.03 141.15 45.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 74.01 110.318 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.51 ' CD1' ' SG ' ' A' ' 336' ' ' CYS . 8.5 mt -148.2 116.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 75.24 109.286 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.403 HG22 ' CD2' ' A' ' 251' ' ' HIS . 9.6 p -119.65 113.65 21.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 73.34 110.446 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -67.69 145.9 54.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.464 1.102 . . . . 74.51 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -123.25 -44.66 2.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 73.21 109.284 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.1 t 153.96 156.14 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.23 110.02 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . 0.47 ' CA ' HG13 ' A' ' 333' ' ' VAL . 18.5 Cg_endo -74.99 -49.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.487 1.783 . . . . 70.1 111.038 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.551 1.157 . . . . 71.43 109.289 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.293 -0.632 . . . . 73.34 109.293 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.541 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -116.64 100.55 7.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.103 . . . . 73.02 109.282 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.438 ' CD2' HG21 ' A' ' 343' ' ' THR . 10.1 m80 -90.93 128.58 36.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.529 1.143 . . . . 75.54 109.603 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 265' ' ' LEU . 58.9 t -120.52 167.27 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 73.1 109.306 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.419 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.3 tp10 -128.06 135.24 49.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 63.51 110.325 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 314' ' ' THR . 89.6 t -109.61 109.49 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 75.3 109.305 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 m -79.73 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 74.04 110.023 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.458 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 0.1 OUTLIER 63.56 71.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.545 1.153 . . . . 73.4 109.288 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -91.13 147.34 23.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 71.22 110.305 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.99 -35.29 33.07 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.146 . . . . 75.54 109.271 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.73 -46.95 73.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 75.43 109.293 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 m -174.25 -173.4 0.78 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.137 . . . . 65.44 109.996 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 256' ' ' ASN . 10.2 mt -87.47 161.82 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 1.125 . . . . 73.33 109.329 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -159.91 101.43 1.45 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 75.25 109.605 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.45 ' CZ ' HD22 ' A' ' 261' ' ' LEU . 51.1 m-85 -110.89 129.17 55.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 75.32 110.95 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.568 HG23 ' CE1' ' A' ' 266' ' ' TYR . 48.0 mt -119.37 119.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 72.44 109.26 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.456 ' CD2' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -112.41 139.96 47.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 74.54 109.285 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.568 ' CE1' HG23 ' A' ' 264' ' ' ILE . 4.5 m-85 -126.97 114.9 18.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.442 1.089 . . . . 71.2 110.998 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.494 ' CG ' ' CG2' ' A' ' 298' ' ' ILE . 48.5 p-10 -69.19 77.06 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.143 . . . . 75.54 109.284 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.469 ' CE ' ' HA ' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -78.89 55.23 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 1.117 . . . . 75.22 109.304 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.9 p -125.45 -170.5 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 75.52 110.371 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -94.42 -52.79 4.18 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 1.127 . . . . 74.22 109.304 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.63 169.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 74.13 109.298 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 273' ' ' ILE . 3.8 mp -106.28 161.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 74.44 109.306 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 298' ' ' ILE . 3.6 mm -92.36 137.4 24.68 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.559 1.162 . . . . 75.03 109.294 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 -23.87 13.31 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.56 1.821 . . . . 71.43 110.976 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 74.05 161.72 7.8 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.53 1.144 . . . . 72.44 110.972 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 6.0 t30 81.69 22.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 0.777 . . . . 63.21 109.301 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.412 ' C ' ' OG1' ' A' ' 278' ' ' THR . 22.4 m -69.15 -178.23 1.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 71.52 108.3 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.7 m -153.81 106.5 2.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 74.5 110.415 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -60.53 173.09 0.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 73.21 111.038 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -168.43 92.21 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.107 . . . . 73.41 110.32 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 7.2 p90 -116.17 146.98 41.87 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.44 1.087 . . . . 73.43 110.977 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.419 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 82.9 p -72.57 -179.8 3.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 71.34 109.992 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 312' ' ' LEU . 1.9 m . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 72.01 109.99 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.311 -0.626 . . . . 74.34 109.311 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.423 ' CD2' ' CE1' ' A' ' 308' ' ' PHE . 5.8 t80 -134.33 144.72 48.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 72.24 111.011 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 m -114.17 121.93 45.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 75.12 110.006 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 308' ' ' PHE . 18.8 mt -101.86 128.56 54.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.52 1.138 . . . . 74.21 109.288 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.469 ' CD ' HG22 ' A' ' 278' ' ' THR . 0.0 OUTLIER -68.06 99.66 0.9 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 74.44 109.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.449 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 78.9 mtp -56.33 152.26 11.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 75.43 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . 0.547 ' CA ' ' NZ ' ' A' ' 304' ' ' LYS . . . -35.33 140.57 0.17 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.57 1.169 . . . . 64.02 111.025 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 294' ' ' GLY . 18.1 Cg_endo -75.03 -22.98 14.2 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.521 1.8 . . . . 70.22 110.996 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -76.17 172.66 12.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.12 . . . . 74.33 109.61 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -107.59 124.3 49.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.147 . . . . 73.44 110.302 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.494 ' CG2' ' CG ' ' A' ' 267' ' ' ASN . 15.0 mt -47.07 -67.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 73.23 109.301 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.58 159.56 32.9 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.486 1.116 . . . . 65.21 111.026 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 19.2 mt -43.23 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.477 0.751 . . . . 73.44 109.317 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.469 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 62.75 75.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 74.13 109.315 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 298' ' ' ILE . . . -135.07 173.46 21.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.453 1.096 . . . . 73.43 111.022 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.28 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 0.758 . . . . 72.41 110.293 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.547 ' NZ ' ' CA ' ' A' ' 294' ' ' GLY . 40.3 tptt -159.49 155.04 25.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 70.51 109.261 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . 0.425 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 5.4 mt-10 -130.25 139.96 50.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 73.33 110.294 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.517 HD11 ' CG ' ' A' ' 279' ' ' PHE . 16.0 mt -143.3 38.74 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.523 1.14 . . . . 73.54 109.285 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -49.55 148.3 2.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.959 -1.126 . . . . 75.04 107.959 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.532 ' CD1' HD11 ' A' ' 291' ' ' ILE . 12.5 t80 -147.43 168.18 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 74.13 111.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -141.12 161.18 54.77 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 75.53 111.013 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.98 -47.77 0.3 Allowed 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.007 -2.497 . . . . 74.11 111.018 -0.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.0 p 177.14 133.58 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 1.112 . . . . 73.44 109.951 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.453 ' CD1' HD12 ' A' ' 261' ' ' LEU . 5.6 mp -110.96 158.78 34.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 73.13 109.351 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 146.65 32.67 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.493 1.786 . . . . 75.51 110.988 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.482 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.7 OUTLIER -124.64 161.98 45.37 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 73.54 110.372 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.02 -178.85 24.69 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.01 -2.496 . . . . 73.23 110.995 0.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.511 HD22 ' CD2' ' A' ' 319' ' ' TYR . 1.7 mt -95.53 64.87 2.63 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.128 . . . . 73.13 109.284 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 32.4 t -81.16 123.08 28.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 63.23 110.006 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 317' ' ' SER . 44.0 t30 81.95 20.21 0.33 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 63.2 109.298 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.511 ' CD2' HD22 ' A' ' 316' ' ' LEU . 24.0 m-85 -101.99 114.05 27.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.562 1.164 . . . . 74.03 111.007 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.481 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -37.75 -51.18 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 61.45 110.377 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.489 ' HG2' ' CZ ' ' A' ' 279' ' ' PHE . 7.1 ttm 30.93 52.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 74.42 110.985 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.46 ' HD2' ' CG2' ' A' ' 320' ' ' THR . 33.0 mttt -81.08 -170.18 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.55 109.264 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.487 HG23 ' CE1' ' A' ' 279' ' ' PHE . 5.8 t -151.61 130.32 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.525 1.141 . . . . 75.52 109.338 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 16.1 m -108.1 179.02 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 74.34 109.309 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.61 -172.4 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 53.15 109.306 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.16 -4.8 15.02 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 74.2 110.264 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.18 -7.12 33.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 71.34 109.321 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.12 54.63 6.83 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.503 1.127 . . . . 74.32 110.999 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.442 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.72 130.24 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 0.773 . . . . 72.42 110.302 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.422 ' N ' HG13 ' A' ' 324' ' ' VAL . 4.9 m -62.19 122.74 16.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 73.32 110.421 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.502 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.3 pt -105.4 -34.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.474 1.109 . . . . 75.3 109.256 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.425 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 6.6 mt -130.16 164.19 25.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 74.51 109.336 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -146.19 132.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 75.35 109.293 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.41 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -92.51 114.15 4.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.436 1.085 . . . . 75.41 111.035 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.744 ' NZ ' ' H ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -42.79 -27.72 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 0.75 . . . . 75.14 109.263 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 46.31 70.46 0.38 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 61.42 108.256 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . 0.744 ' H ' ' NZ ' ' A' ' 335' ' ' LYS . . . -79.28 -171.46 2.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 63.12 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 61.82 2.93 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 75.24 109.271 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 18.5 t -173.11 156.29 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 75.13 110.019 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.98 -30.14 71.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 74.41 109.289 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.64 136.22 56.03 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 71.34 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.431 ' CD1' ' HE1' ' A' ' 321' ' ' MET . 49.1 mt -142.32 130.28 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 74.13 109.27 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.438 HG21 ' CD2' ' A' ' 251' ' ' HIS . 13.6 p -127.58 83.57 2.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 71.12 110.382 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.425 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 8.9 mp -38.52 136.29 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 71.12 109.33 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -70.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 72.22 109.321 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.81 147.79 0.34 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.576 1.173 . . . . 74.32 109.994 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . 0.459 ' HB3' ' CG1' ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.94 -55.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 74.23 111.024 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.562 1.164 . . . . 74.23 109.272 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.501 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.297 -0.631 . . . . 73.05 109.297 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 344' ' ' LEU . 0.6 OUTLIER -122.92 103.05 8.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 75.34 109.29 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.18 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 74.41 109.586 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.466 ' CG2' HD21 ' A' ' 265' ' ' LEU . 58.0 t -125.22 145.05 33.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 72.12 109.355 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.42 120.84 42.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.32 110.314 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.503 HG22 ' CE2' ' A' ' 263' ' ' PHE . 54.1 t -110.0 98.09 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 73.12 109.28 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.1 t -67.93 -70.77 0.24 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 75.45 110.024 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.483 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 0.2 OUTLIER 68.25 65.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 71.12 109.3 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -103.26 165.33 11.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 63.11 110.325 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 259' ' ' ASN . 0.7 OUTLIER -47.65 -57.16 5.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 71.33 109.324 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 258' ' ' ASP . 8.2 t-20 -40.12 -62.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 74.13 109.305 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.402 ' OG ' ' C ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER -174.12 -160.56 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.476 1.11 . . . . 74.14 109.999 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 312' ' ' LEU . 19.6 mt -93.68 -178.35 4.67 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.11 . . . . 72.3 109.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -177.01 104.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 73.3 109.549 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.518 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 59.1 m-85 -110.86 96.67 6.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.5 110.995 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.636 ' CG2' ' CE1' ' A' ' 266' ' ' TYR . 64.0 mt -91.86 104.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 61.41 109.289 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.466 HD21 ' CG2' ' A' ' 252' ' ' VAL . 0.6 OUTLIER -89.72 129.15 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 75.32 109.321 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.636 ' CE1' ' CG2' ' A' ' 264' ' ' ILE . 14.8 m-85 -117.35 102.92 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 61.25 110.987 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.456 ' CG ' ' CD1' ' A' ' 273' ' ' ILE . 53.4 t30 -59.3 106.97 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 64.43 109.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -100.94 -12.1 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 75.31 109.302 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.461 ' O ' ' CD1' ' A' ' 300' ' ' ILE . 12.8 p -72.77 164.52 26.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 72.4 110.381 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 271' ' ' ILE . 22.0 m120 -67.17 -60.13 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 64.22 109.318 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.554 ' CD1' ' C ' ' A' ' 271' ' ' ILE . 0.0 OUTLIER -38.84 158.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.53 1.144 . . . . 75.32 109.347 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.468 ' N ' HG12 ' A' ' 271' ' ' ILE . 2.1 mp -114.41 117.35 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 74.13 109.288 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . 0.456 ' CD1' ' CG ' ' A' ' 267' ' ' ASN . 1.4 mp -46.23 138.41 6.2 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 73.33 109.317 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.04 -30.15 7.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.469 1.773 . . . . 75.31 111.047 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 90.55 159.72 35.86 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.509 1.131 . . . . 50.22 111.019 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 4.2 t30 76.23 27.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 0.766 . . . . 63.41 109.307 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.466 ' SG ' ' CD1' ' A' ' 331' ' ' ILE . 29.0 m -71.05 -178.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 71.31 108.288 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.463 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.9 m -152.97 105.44 2.93 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 73.51 110.382 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.521 ' CG ' HD11 ' A' ' 306' ' ' LEU . 1.1 t80 -59.05 157.66 9.82 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 74.33 110.947 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -146.69 84.33 1.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.551 1.157 . . . . 73.54 110.252 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.632 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 22.8 p90 -119.64 135.34 54.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 73.2 110.985 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.489 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 1.1 m -105.92 177.42 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 74.34 109.988 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' SER . . . . . 0.435 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 4.8 p . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 72.43 109.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 289' ' ' PHE . 2.8 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.256 -0.646 . . . . 65.43 109.256 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.456 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 1.8 t80 -103.37 159.57 15.45 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 73.34 110.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -150.74 122.34 7.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 70.11 110.029 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 47.0 mt -121.99 128.83 75.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.44 109.256 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.13 107.16 5.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 73.3 109.324 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.17 147.48 49.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.157 . . . . 73.52 110.998 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -49.68 152.28 3.66 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.506 1.129 . . . . 52.41 111.022 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -29.26 8.39 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 72.15 111.029 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -52.66 137.34 31.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 65.04 109.599 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.22 147.03 29.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 72.13 110.307 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.443 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -82.87 -76.62 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 74.15 109.342 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 76.21 -174.95 53.05 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.464 1.103 . . . . 72.34 110.976 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 269' ' ' THR . 3.3 mm -64.43 137.6 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.5 0.765 . . . . 74.15 109.287 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.47 9.43 6.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 73.12 109.26 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.443 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -97.82 140.86 15.27 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.517 1.136 . . . . 72.03 110.987 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -110.42 -179.52 3.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 0.794 . . . . 71.23 110.289 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 265' ' ' LEU . 19.3 tptt -145.72 164.23 32.47 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 74.21 109.306 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.97 128.41 36.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 1.109 . . . . 72.32 110.291 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 12.3 mt -140.91 62.52 1.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 74.25 109.302 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -76.44 128.95 35.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 73.04 107.986 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.4 m-30 -115.79 178.55 4.27 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.5 111.052 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.495 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -159.29 157.04 26.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.5 110.992 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -35.14 3.02 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.998 -2.501 . . . . 75.52 111.021 0.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.0 p 169.04 139.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 71.23 109.999 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.473 ' CD1' HD11 ' A' ' 261' ' ' LEU . 5.1 mp -115.28 158.37 41.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 73.24 109.306 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.47 34.03 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.49 1.784 . . . . 73.45 111.002 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.32 162.24 49.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.439 1.087 . . . . 73.51 110.416 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.94 174.36 53.02 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.999 -2.5 . . . . 74.11 110.993 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.486 ' HB3' ' CD2' ' A' ' 319' ' ' TYR . 5.3 mp -88.99 65.61 7.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.51 109.277 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.1 p -84.42 139.44 32.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.448 1.092 . . . . 72.35 110.008 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.74 23.48 4.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.102 . . . . 71.44 109.282 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.489 ' CE2' ' O ' ' A' ' 282' ' ' SER . 3.2 m-85 -104.07 165.77 10.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.468 1.105 . . . . 73.11 111.027 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.486 ' O ' ' C ' ' A' ' 321' ' ' MET . 15.5 m -92.24 -49.47 6.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.44 110.37 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 320' ' ' THR . 1.7 ptp 30.13 63.35 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.33 111.028 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.462 ' HG2' ' CG1' ' A' ' 333' ' ' VAL . 42.8 mttt -91.26 -171.09 2.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 75.25 109.351 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . 0.45 ' CG2' HD23 ' A' ' 344' ' ' LEU . 2.2 t -150.26 132.2 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 72.1 109.296 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 9.0 m -118.29 179.62 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 73.25 109.276 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -108.4 -166.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 73.52 109.317 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.84 -10.42 37.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 74.43 110.265 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -107.38 19.57 20.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.136 . . . . 74.43 109.327 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 55.09 18.12 11.8 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 75.44 110.986 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.54 123.65 33.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.487 0.757 . . . . 71.45 110.276 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 324' ' ' VAL . 2.7 m -55.78 115.05 2.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 71.53 110.4 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.466 ' CD1' ' SG ' ' A' ' 277' ' ' CYS . 5.4 pt -97.88 -41.82 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 73.42 109.297 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 6.3 mt -138.34 162.57 34.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 70.13 109.322 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . 0.462 ' CG1' ' HG2' ' A' ' 322' ' ' LYS . 26.8 m -149.0 128.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 71.24 109.293 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -86.85 113.15 3.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.476 1.11 . . . . 72.42 111.012 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -50.04 -24.17 2.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 0.752 . . . . 74.53 109.32 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 335' ' ' LYS . 0.5 OUTLIER 66.23 162.88 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 73.3 108.283 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -173.98 -173.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.572 1.17 . . . . 71.42 109.269 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.55 56.52 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.14 109.306 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 341' ' ' GLU . 35.0 t -178.4 138.55 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 72.33 109.998 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -44.76 -27.01 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 73.31 109.315 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 339' ' ' SER . 6.9 mt-10 -63.97 117.27 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 74.51 110.323 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.441 ' CD1' ' HE2' ' A' ' 321' ' ' MET . 61.6 mt -141.62 122.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.433 1.083 . . . . 71.53 109.291 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 10.4 p -116.41 105.15 12.19 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 72.35 110.402 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.458 ' CD2' HD22 ' A' ' 250' ' ' LEU . 5.9 mp -58.56 142.62 48.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 75.12 109.264 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -77.29 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.541 1.151 . . . . 74.02 109.261 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.1 p -179.85 145.56 0.41 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 74.12 109.979 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -59.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.524 1.802 . . . . 70.14 110.987 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 73.21 109.329 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.304 -0.628 . . . . 64.32 109.304 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.471 HD21 ' CG2' ' A' ' 252' ' ' VAL . 0.6 OUTLIER -125.3 103.12 7.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 74.4 109.294 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.51 136.3 57.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 63.1 109.573 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.471 ' CG2' HD21 ' A' ' 250' ' ' LEU . 76.2 t -145.92 136.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 75.51 109.301 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.06 128.79 56.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 74.15 110.262 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.438 ' CG1' HG21 ' A' ' 314' ' ' THR . 14.2 t -105.47 105.45 18.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 72.02 109.291 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.76 -73.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 61.3 109.973 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 55.33 78.38 0.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 70.34 109.305 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.26 -166.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.544 1.152 . . . . 71.43 110.314 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.63 31.56 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 74.0 109.308 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -135.22 -45.16 0.7 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.481 1.113 . . . . 74.24 109.317 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 174.08 -174.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 50.4 110.009 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 312' ' ' LEU . 23.7 mt -93.24 167.65 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 73.43 109.288 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -163.81 100.25 0.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.24 109.608 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.19 101.55 10.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 73.1 110.992 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.603 ' O ' ' CE2' ' A' ' 266' ' ' TYR . 56.9 mt -97.52 103.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 75.04 109.263 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.501 ' CD1' ' CD1' ' A' ' 306' ' ' LEU . 0.4 OUTLIER -88.13 138.23 31.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.467 1.104 . . . . 74.23 109.301 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.603 ' CE2' ' O ' ' A' ' 264' ' ' ILE . 13.1 m-85 -125.66 101.06 6.71 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.504 1.128 . . . . 74.23 111.009 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.67 97.8 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 71.1 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.39 30.26 5.46 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.486 1.116 . . . . 75.12 109.319 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 36.0 p -85.59 -167.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.24 110.394 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -92.68 -52.3 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 75.15 109.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.47 173.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 75.41 109.257 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.15 137.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.501 1.126 . . . . 72.43 109.291 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.95 135.92 94.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.47 1.106 . . . . 73.45 109.3 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -22.79 14.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.797 . . . . 64.32 111.03 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 73.83 168.06 16.09 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.472 1.108 . . . . 64.44 111.02 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 1.7 t30 70.49 38.66 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 0.772 . . . . 71.14 109.271 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 52.6 m -83.29 -177.48 6.75 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 72.53 108.284 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.473 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.8 m -154.24 99.76 2.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 73.43 110.372 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.518 ' CG ' HD11 ' A' ' 306' ' ' LEU . 0.8 OUTLIER -55.4 162.64 1.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.492 1.12 . . . . 73.51 111.006 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -155.31 90.62 1.27 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.559 1.162 . . . . 74.22 110.328 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 279' ' ' PHE . 12.2 p90 -118.94 153.83 33.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 72.31 111.001 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.59 170.2 16.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 73.5 110.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.541 1.151 . . . . 74.41 110.032 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.3 -0.629 . . . . 73.31 109.3 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.09 133.7 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 73.43 110.979 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.4 p -110.7 121.86 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.476 1.11 . . . . 70.1 109.969 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.562 HD11 ' CD1' ' A' ' 308' ' ' PHE . 12.0 mt -103.54 132.13 50.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 72.44 109.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.63 106.16 6.07 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.452 1.095 . . . . 74.22 109.297 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.456 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 92.5 mtp -77.77 145.7 36.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 75.44 110.996 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.03 153.76 6.83 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.497 1.123 . . . . 72.35 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -30.58 7.01 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.433 1.754 . . . . 63.4 111.023 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -42.88 143.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 61.31 109.607 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -92.69 124.52 36.76 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 63.31 110.308 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.41 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 43.0 mt -62.02 -77.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.578 1.174 . . . . 71.35 109.309 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.32 -175.49 54.53 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.462 1.101 . . . . 65.11 111.008 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 300' ' ' ILE . 2.1 mm -66.68 133.86 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 74.52 109.305 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 12.1 mmtm 74.21 3.71 4.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 73.52 109.279 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.41 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -93.35 146.72 18.26 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.501 1.126 . . . . 75.3 111.006 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -113.63 -176.04 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 0.753 . . . . 73.12 110.282 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 265' ' ' LEU . 39.5 tptt -147.56 162.93 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.474 1.109 . . . . 74.52 109.295 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -136.0 118.92 16.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 74.2 110.305 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.518 HD11 ' CG ' ' A' ' 279' ' ' PHE . 20.1 mt -128.16 55.04 1.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.496 1.122 . . . . 73.35 109.308 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' TRP . . . . . 0.424 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 4.8 p90 -67.09 125.15 25.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.993 -1.114 . . . . 74.2 107.993 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.562 ' CD1' HD11 ' A' ' 291' ' ' ILE . 25.6 t80 -123.25 173.15 8.11 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.553 1.158 . . . . 74.32 111.042 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -150.55 161.72 29.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.509 1.131 . . . . 75.51 111.06 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -74.99 -43.15 0.72 Allowed 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.97 -2.513 . . . . 73.42 111.0 -0.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.5 p 179.59 158.4 0.67 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 75.15 109.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.453 ' CD1' HD13 ' A' ' 261' ' ' LEU . 1.1 mp -135.28 158.73 74.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 73.24 109.33 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 151.1 38.91 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.482 1.78 . . . . 72.42 110.996 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' THR . . . . . 0.481 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.8 OUTLIER -134.49 161.27 64.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.518 1.137 . . . . 71.34 110.453 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.91 -178.97 24.96 Favored 'Cis proline' 0 C--N 1.36 1.148 0 C-N-CA 121.002 -2.499 . . . . 75.41 111.038 -0.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.571 HD22 ' CD2' ' A' ' 319' ' ' TYR . 2.3 mt -101.27 57.39 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 72.52 109.318 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 6.1 p -81.4 127.7 33.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 64.54 109.989 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 317' ' ' SER . 30.8 t30 80.74 23.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 73.32 109.3 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 0.571 ' CD2' HD22 ' A' ' 316' ' ' LEU . 6.8 m-85 -101.92 176.46 5.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 74.23 110.985 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.504 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -93.21 -58.66 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 71.53 110.395 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.504 ' C ' ' O ' ' A' ' 320' ' ' THR . 2.2 ptp 28.3 61.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 73.42 110.991 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 28.4 mttp -91.29 179.12 5.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.151 . . . . 75.1 109.32 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.81 129.67 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 74.42 109.284 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.473 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 15.4 m -108.47 178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 75.05 109.317 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -110.84 -172.34 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.437 1.086 . . . . 71.51 109.281 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -68.23 -4.7 14.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.44 110.267 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -7.46 31.96 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 63.01 109.289 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.62 54.38 6.69 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 64.22 111.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.448 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -149.55 130.5 14.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 0.755 . . . . 75.44 110.313 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' THR . . . . . 0.425 ' N ' HG11 ' A' ' 324' ' ' VAL . 1.7 m -60.97 119.44 8.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 74.21 110.386 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.499 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.2 pt -97.19 -34.68 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 74.25 109.281 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.495 ' CD2' ' C ' ' A' ' 345' ' ' LYS . 4.8 mt -132.04 -171.46 2.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 73.52 109.341 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -175.89 114.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 65.54 109.241 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 336' ' ' CYS . . . -61.81 135.41 46.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.534 1.146 . . . . 72.25 111.011 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' LYS . . . . . 0.536 ' C ' ' SG ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -57.04 -19.54 19.41 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.582 0.813 . . . . 75.43 109.267 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.536 ' SG ' ' C ' ' A' ' 335' ' ' LYS . 0.8 OUTLIER 42.08 89.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 75.31 108.283 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.27 -175.32 2.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.53 109.324 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.31 61.86 2.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 72.51 109.288 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.82 142.78 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 64.5 109.961 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -52.18 -27.05 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 75.23 109.309 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.31 137.01 57.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.497 1.123 . . . . 72.12 110.293 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 53.8 mt -146.17 137.28 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.532 1.145 . . . . 74.12 109.305 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 24.2 p -138.05 99.51 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 74.43 110.414 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.78 132.27 45.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 74.13 109.265 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.504 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -112.72 -66.79 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 73.4 109.306 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 158.84 136.78 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 72.11 109.998 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -57.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.479 1.779 . . . . 74.22 111.002 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 73.15 109.317 -179.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.278 -0.638 . . . . 65.22 109.278 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.15 132.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.02 109.254 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -7.76 19.46 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.524 1.802 . . . . 74.42 110.978 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -42.48 134.38 3.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 75.25 109.325 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 252' ' ' VAL . 0.6 OUTLIER -121.23 103.15 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 64.53 109.259 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -61.38 134.37 56.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 74.33 109.618 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.467 ' CG2' HD21 ' A' ' 250' ' ' LEU . 89.9 t -142.36 164.95 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 72.32 109.295 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.418 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 4.1 tp10 -146.05 129.5 16.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 75.33 110.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.473 HG12 ' CG2' ' A' ' 314' ' ' THR . 89.0 t -102.82 118.28 49.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.538 1.148 . . . . 73.05 109.273 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 18.0 m -87.78 -65.56 1.0 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 64.13 110.019 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 58.36 63.5 1.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.472 1.108 . . . . 74.34 109.325 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.8 pt-20 -162.42 -175.01 4.29 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 74.43 110.321 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.67 24.21 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.552 1.158 . . . . 73.44 109.281 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 72.42 18.63 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 75.3 109.272 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 257' ' ' GLU . 4.2 m -165.28 -167.11 1.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 53.34 109.997 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 312' ' ' LEU . 9.4 mt -101.25 166.21 10.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.478 1.111 . . . . 74.11 109.321 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.458 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 0.3 OUTLIER -163.2 95.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 72.24 109.636 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.411 ' CZ ' HD12 ' A' ' 261' ' ' LEU . 97.4 m-85 -97.46 149.33 22.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 72.1 110.986 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.561 HG23 ' CE1' ' A' ' 266' ' ' TYR . 48.4 mt -142.24 112.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.53 1.144 . . . . 72.43 109.293 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 306' ' ' LEU . 0.0 OUTLIER -111.48 143.99 41.42 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.564 1.165 . . . . 64.05 109.306 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.561 ' CE1' HG23 ' A' ' 264' ' ' ILE . 2.1 m-85 -128.56 111.9 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.528 1.142 . . . . 75.21 110.979 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.484 ' OD1' ' CD1' ' A' ' 273' ' ' ILE . 26.2 t30 -60.47 101.34 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 75.45 109.292 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 300' ' ' ILE . 3.7 mmpt? -101.56 -19.17 15.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 75.13 109.333 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.6 p -48.0 175.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.484 1.115 . . . . 71.11 110.384 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -72.78 -57.39 4.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 73.4 109.307 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 271' ' ' ILE . 0.0 OUTLIER -69.3 166.8 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 64.14 109.303 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.48 131.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 75.12 109.262 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.484 ' CD1' ' OD1' ' A' ' 267' ' ' ASN . 1.3 mp -40.55 140.2 1.03 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.51 1.131 . . . . 71.12 109.298 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -34.87 3.55 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 63.51 110.999 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 106.2 159.38 22.27 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.488 1.117 . . . . 74.11 110.989 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 8.8 t30 69.18 23.6 6.32 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 0.778 . . . . 72.03 109.259 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.4 ' C ' ' OG1' ' A' ' 278' ' ' THR . 60.9 m -70.62 -179.15 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 62.32 108.274 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.456 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.9 m -153.96 136.26 14.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 74.11 110.4 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.559 ' CD2' HD11 ' A' ' 306' ' ' LEU . 1.5 t80 -89.54 179.03 6.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 74.24 110.98 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.461 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 11.2 tt0 -176.73 101.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.108 . . . . 72.15 110.316 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 1.3 p90 -116.26 147.81 41.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 74.41 111.006 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 53.2 p -100.67 -175.27 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 71.04 109.997 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.575 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 0.3 OUTLIER -178.45 -173.97 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 74.23 110.029 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 285' ' ' ILE . 17.8 pt20 -111.13 -52.77 2.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 72.33 110.309 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.508 ' CD1' ' C ' ' A' ' 285' ' ' ILE . 0.0 OUTLIER -62.38 -37.59 79.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 75.33 109.323 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 5.4 t -118.97 -176.0 3.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 60.54 110.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -108.32 -177.04 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 74.51 110.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 2.6 p -77.52 147.42 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.521 1.138 . . . . 73.32 109.255 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -152.88 142.95 22.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.42 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.411 ' OG ' ' CG2' ' A' ' 278' ' ' THR . 32.4 t -107.32 127.89 53.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 73.14 109.999 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.3 mt -101.04 137.22 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 73.31 109.287 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -77.47 113.0 14.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 73.53 109.317 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.442 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 63.0 mtp -84.13 165.51 18.41 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 72.31 110.973 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.441 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -64.47 151.42 50.51 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.473 1.108 . . . . 74.5 111.021 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.28 6.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.441 1.758 . . . . 71.52 110.961 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.56 ' CE1' ' OE1' ' A' ' 297' ' ' GLU . 57.6 t-80 -68.14 143.11 55.53 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 71.21 109.598 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.56 ' OE1' ' CE1' ' A' ' 296' ' ' HIS . 0.6 OUTLIER -65.38 179.36 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.135 . . . . 73.43 110.304 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 44.3 mt -105.77 -76.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 74.23 109.329 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 128.0 149.74 7.13 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.469 1.106 . . . . 65.41 111.056 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.494 ' O ' ' CE ' ' A' ' 268' ' ' LYS . 4.2 mt -46.75 -25.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.531 0.783 . . . . 73.52 109.342 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -115.6 -37.69 3.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 53.35 109.304 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -40.9 151.03 0.14 Allowed Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.571 1.169 . . . . 73.41 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.27 -177.49 3.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.512 0.772 . . . . 72.42 110.27 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.441 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 35.3 tptt -154.51 143.6 21.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.433 1.083 . . . . 72.43 109.301 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.54 ' HB2' ' CZ2' ' A' ' 307' ' ' TRP . 10.7 mt-10 -114.83 150.39 35.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 72.22 110.308 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.559 HD11 ' CD2' ' A' ' 279' ' ' PHE . 82.7 mt -141.15 62.58 1.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.113 . . . . 73.53 109.266 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.54 ' CZ2' ' HB2' ' A' ' 305' ' ' GLU . 0.9 OUTLIER -59.29 134.86 57.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.95 -1.13 . . . . 75.35 107.95 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.56 ' CE1' HD12 ' A' ' 312' ' ' LEU . 10.2 t80 -137.23 155.14 49.87 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 74.4 111.019 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.668 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -135.6 147.36 61.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 74.25 111.013 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -53.72 0.15 OUTLIER 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.005 -2.498 . . . . 64.24 111.007 -0.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 178.44 174.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 71.44 109.982 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.56 HD12 ' CE1' ' A' ' 308' ' ' PHE . 3.7 mp -138.82 158.42 70.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 74.53 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 145.25 31.06 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.487 1.783 . . . . 74.31 110.992 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.476 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.7 OUTLIER -123.02 162.54 38.61 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 71.44 110.404 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -175.45 16.03 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.015 -2.494 . . . . 75.34 111.023 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.571 HD21 ' CD2' ' A' ' 319' ' ' TYR . 1.8 mt -109.8 57.79 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 63.43 109.281 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.3 p -85.38 134.74 34.07 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 73.02 109.985 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 32.0 t30 83.19 2.63 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 73.43 109.319 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.575 ' CE2' ' HA ' ' A' ' 283' ' ' SER . 9.0 m-85 -81.13 -178.47 6.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 75.42 111.017 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.503 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -97.57 -58.28 2.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.32 110.373 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.61 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 1.0 OUTLIER 28.59 64.63 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 75.13 111.032 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.445 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 40.2 mttm -92.68 -172.57 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 73.43 109.299 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 41.9 t -141.84 130.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 74.14 109.304 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 5.6 m -109.52 176.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.081 . . . . 71.23 109.278 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 2.6 t30 -101.04 -165.56 1.22 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 71.23 109.322 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -70.1 -7.93 45.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 71.31 110.3 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -107.82 13.33 26.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.22 109.302 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 62.33 27.61 69.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.544 1.152 . . . . 70.22 110.99 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -102.83 127.19 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.464 0.743 . . . . 71.14 110.295 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 56.0 m -54.07 111.02 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.42 110.377 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 5.1 pt -94.33 -37.91 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.41 109.279 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.478 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 9.3 mt -139.36 176.18 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.472 1.107 . . . . 75.21 109.328 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.441 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -151.05 131.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.515 1.134 . . . . 61.32 109.323 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -83.76 130.2 9.6 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.504 1.128 . . . . 62.03 110.977 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.442 ' CE ' ' HA ' ' A' ' 342' ' ' ILE . 0.0 OUTLIER -61.08 -26.59 67.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.566 0.803 . . . . 74.24 109.297 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 316' ' ' LEU . 0.8 OUTLIER 48.23 76.62 0.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 53.45 108.305 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -88.27 -178.75 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 1.164 . . . . 64.53 109.316 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -75.91 62.44 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 71.2 109.288 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.7 m -173.59 150.68 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 74.03 110.024 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -58.9 -17.62 25.91 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 65.32 109.279 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -77.95 146.43 35.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.125 . . . . 74.22 110.289 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.61 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 65.9 mt -147.98 141.23 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 75.21 109.31 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.428 ' N ' HG21 ' A' ' 342' ' ' ILE . 8.7 p -138.77 97.81 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 73.24 110.396 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 8.5 mp -46.83 133.49 10.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.131 . . . . 72.42 109.329 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -98.06 -76.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 73.25 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 2.9 p 159.84 142.06 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 75.45 110.011 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -80.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.449 1.763 . . . . 72.52 110.955 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 75.31 109.286 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.296 -0.631 . . . . 73.51 109.296 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 52.96 87.73 0.13 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.142 . . . . 72.45 109.352 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 170.28 20.76 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.512 1.796 . . . . 71.44 111.017 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.431 ' CD1' ' N ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -172.16 157.72 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.524 1.14 . . . . 73.23 109.256 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.496 HD23 ' CD2' ' A' ' 344' ' ' LEU . 0.5 OUTLIER -114.43 102.21 9.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.502 1.126 . . . . 70.21 109.287 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.539 ' CE1' ' HG2' ' A' ' 341' ' ' GLU . 14.3 t60 -90.88 166.17 13.2 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.469 1.105 . . . . 75.32 109.558 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.447 ' H ' ' CD2' ' A' ' 251' ' ' HIS . 66.7 t -153.48 155.51 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 71.12 109.324 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -117.62 146.16 43.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.3 110.308 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.565 HG13 ' CE1' ' A' ' 263' ' ' PHE . 38.6 t -128.83 94.97 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 73.14 109.344 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.1 m -69.13 -63.34 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 73.31 110.027 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 312' ' ' LEU . 5.2 t-20 60.82 82.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.528 1.143 . . . . 74.23 109.307 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.29 166.5 13.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.502 1.126 . . . . 73.5 110.296 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 259' ' ' ASN . 23.8 t0 -42.69 -58.32 2.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.573 1.171 . . . . 75.03 109.31 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 258' ' ' ASP . 80.4 m-20 -40.06 -61.94 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 74.24 109.295 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 176.27 -173.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 74.23 109.992 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' CD1' HD12 ' A' ' 312' ' ' LEU . 19.6 mt -80.98 161.2 24.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 72.2 109.263 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.68 95.74 2.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 74.04 109.604 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.63 ' CD2' ' CE2' ' A' ' 308' ' ' PHE . 75.0 m-85 -103.6 112.02 24.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 75.3 110.965 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.495 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 73.8 mt -111.03 117.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 63.0 109.325 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.451 ' CD1' HD13 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -106.01 151.72 24.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 74.45 109.342 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.9 OUTLIER -138.11 117.58 12.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.484 1.115 . . . . 74.15 110.98 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.401 ' OD1' ' OG1' ' A' ' 269' ' ' THR . 17.1 t-20 -79.74 106.52 11.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 72.53 109.305 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -11.84 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 75.32 109.276 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.401 ' OG1' ' OD1' ' A' ' 267' ' ' ASN . 22.6 p -66.34 154.75 39.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.503 1.127 . . . . 74.03 110.368 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.55 -40.78 84.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.493 1.121 . . . . 75.31 109.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 9.1 pt -54.37 167.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.14 . . . . 75.21 109.299 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.54 157.74 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 75.21 109.275 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.476 ' CG2' ' HD2' ' A' ' 274' ' ' PRO . 1.2 mm -82.42 141.21 45.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.508 1.13 . . . . 75.43 109.29 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.476 ' HD2' ' CG2' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.01 -14.88 20.99 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.496 1.787 . . . . 62.42 111.0 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 84.62 151.21 13.09 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.52 1.137 . . . . 71.25 111.039 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.8 t30 70.27 50.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 0.767 . . . . 73.54 109.32 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.97 -179.72 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.52 1.137 . . . . 74.34 108.3 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.455 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 2.6 m -153.94 137.17 15.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.091 . . . . 75.24 110.347 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -85.85 176.98 7.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 71.4 110.978 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.454 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 55.4 tt0 -152.7 65.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 75.45 110.246 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 289' ' ' PHE . 9.9 p90 -96.14 130.47 43.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 75.41 110.957 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 17.9 p -121.79 -178.44 3.83 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 73.4 110.003 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.467 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 3.5 p -119.31 -5.71 10.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 72.32 109.991 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.438 ' C ' ' N ' ' A' ' 286' ' ' SER . 8.3 tp-100 -177.95 166.78 2.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.098 . . . . 75.34 110.279 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 286' ' ' SER . 7.9 pt -41.75 -28.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 74.34 109.342 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 284' ' ' GLN . 9.1 t -52.7 -173.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.14 . . . . 72.01 109.977 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -46.5 172.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 70.31 110.281 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.454 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 7.4 p -131.54 168.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 72.1 109.236 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.545 ' HB3' ' CE1' ' A' ' 281' ' ' PHE . 2.8 t80 -115.8 133.38 56.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 64.01 110.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.0 p -112.48 120.67 42.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.564 1.165 . . . . 74.52 109.988 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 12.5 mt -105.8 127.73 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 74.04 109.356 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -67.02 116.7 8.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 75.13 109.287 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 92.6 mtp -85.11 150.3 24.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 75.25 111.002 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -45.65 150.71 1.25 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 23.45 110.983 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -28.01 9.46 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.531 1.806 . . . . 74.4 110.954 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -65.1 143.3 57.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.083 . . . . 73.55 109.576 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.68 138.06 31.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.43 110.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.435 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -65.28 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.13 109.307 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.84 -155.35 18.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.518 1.136 . . . . 75.43 111.016 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.446 ' CG2' ' HD3' ' A' ' 301' ' ' LYS . 0.9 OUTLIER -86.93 133.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 0.79 . . . . 72.21 109.313 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 301' ' ' LYS . 0.3 OUTLIER 68.79 6.51 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 74.4 109.314 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.435 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -85.68 162.61 36.16 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.511 1.132 . . . . 72.22 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -131.47 174.82 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 0.767 . . . . 75.01 110.283 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -149.46 152.11 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.4 109.328 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.59 141.22 45.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.493 1.12 . . . . 62.53 110.307 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 12.3 mt -145.53 61.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 1.118 . . . . 75.25 109.32 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -79.27 121.61 25.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 73.4 107.98 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.8 m-30 -109.29 -174.13 2.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 65.34 111.043 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.9 OUTLIER -164.91 160.19 14.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 74.11 110.998 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.02 -36.29 2.64 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.005 -2.498 . . . . 71.44 111.022 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 2.9 p 169.74 131.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.107 . . . . 73.2 110.012 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.466 HD12 ' CD1' ' A' ' 261' ' ' LEU . 5.7 mp -111.59 158.94 34.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.15 . . . . 75.53 109.339 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 147.36 33.66 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.463 1.77 . . . . 74.32 110.973 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.497 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -123.91 164.43 29.3 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 73.2 110.4 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.497 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 -174.66 14.53 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.022 -2.491 . . . . 74.42 110.989 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.558 HD22 ' CE2' ' A' ' 319' ' ' TYR . 3.4 mt -102.36 60.12 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.44 109.294 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -82.91 131.81 35.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 73.3 110.047 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.4 t-20 76.66 21.97 1.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 74.0 109.322 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.558 ' CE2' HD22 ' A' ' 316' ' ' LEU . 4.0 m-85 -99.13 -170.06 1.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.22 111.001 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.46 ' CG2' ' HG3' ' A' ' 322' ' ' LYS . 28.2 m -107.81 -64.92 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.513 1.133 . . . . 75.2 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.586 ' SD ' ' CE1' ' A' ' 263' ' ' PHE . 2.8 mtm 34.09 35.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 74.12 110.998 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.46 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 27.9 mttm -75.98 169.82 17.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 72.21 109.284 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 74.8 t -119.1 133.71 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 73.23 109.275 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 278' ' ' THR . 8.9 m -118.23 172.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 63.15 109.284 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -96.06 -166.48 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 74.51 109.337 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -71.13 -5.72 33.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 71.41 110.338 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.46 12.09 26.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 1.137 . . . . 74.11 109.303 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.24 8.39 50.12 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.498 1.124 . . . . 75.41 111.047 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -78.9 129.95 35.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.757 . . . . 73.2 110.281 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.414 ' N ' HG12 ' A' ' 324' ' ' VAL . 4.1 m -62.97 108.08 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.43 110.38 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 2.7 pt -90.94 -43.68 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.511 1.132 . . . . 74.22 109.324 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 9.4 mt -136.1 168.45 19.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 74.41 109.292 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.451 ' CG1' ' HD3' ' A' ' 322' ' ' LYS . 1.2 m -151.75 131.71 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 71.55 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -85.34 121.04 5.5 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 72.4 111.008 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.467 ' CE ' ' HA ' ' A' ' 342' ' ' ILE . 0.0 OUTLIER -44.32 -26.93 0.37 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 0.753 . . . . 74.41 109.263 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.419 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.5 OUTLIER 45.68 71.72 0.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 75.32 108.296 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.437 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -84.77 -176.79 6.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 75.13 109.294 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.79 64.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.45 109.327 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.8 t -178.95 148.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.129 . . . . 73.23 109.967 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -57.65 -17.93 17.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 74.13 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.539 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 14.4 mt-10 -71.93 131.96 43.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.107 . . . . 75.5 110.271 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.571 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 45.4 mt -142.88 118.05 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.506 1.128 . . . . 74.2 109.286 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 18.5 p -117.57 87.28 2.68 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 75.24 110.39 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.496 ' CD2' HD23 ' A' ' 250' ' ' LEU . 8.5 mp -40.01 132.1 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 72.34 109.295 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.0 ptpt -117.72 -58.77 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.557 1.161 . . . . 73.11 109.265 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 158.98 158.19 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.32 110.007 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 -67.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.461 1.769 . . . . 74.33 110.969 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 72.22 109.323 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.308 -0.627 . . . . 75.11 109.308 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.93 101.37 0.57 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 54.24 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 269' ' ' THR . 18.2 Cg_endo -74.97 -0.8 10.4 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.476 1.777 . . . . 72.43 110.993 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.494 ' O ' ' CD2' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -60.58 151.88 27.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.451 1.094 . . . . 75.12 109.317 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.544 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -111.32 98.7 7.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.135 . . . . 71.3 109.293 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.521 ' CE1' ' HG2' ' A' ' 341' ' ' GLU . 20.3 t-80 -96.33 130.38 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 74.04 109.624 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.446 HG22 ' CD2' ' A' ' 265' ' ' LEU . 16.5 t -120.5 171.35 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 74.44 109.271 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -133.96 128.55 34.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 73.2 110.268 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.444 ' O ' ' ND2' ' A' ' 340' ' ' ASN . 4.5 t -105.72 112.56 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 74.43 109.318 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 53.2 109.994 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.459 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 3.1 t-20 60.48 67.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.528 1.143 . . . . 70.3 109.299 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.48 163.81 12.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 71.14 110.29 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.37 -44.74 68.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 73.14 109.303 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -55.11 -61.15 2.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 74.24 109.289 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 29.3 m -174.21 -176.7 1.17 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.437 1.086 . . . . 63.22 110.022 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.48 HD12 ' CD1' ' A' ' 312' ' ' LEU . 39.8 mt -77.5 171.05 15.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.12 . . . . 73.41 109.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -160.49 103.76 1.4 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 70.42 109.588 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.657 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 68.8 m-85 -109.3 90.51 3.32 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 74.53 111.008 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.568 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 54.3 mt -90.23 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 63.01 109.314 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.446 ' CD2' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -91.51 137.04 32.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.13 109.323 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' A' ' 264' ' ' ILE . 1.8 m-85 -120.65 110.41 16.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 74.42 111.014 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.415 ' ND2' HD13 ' A' ' 273' ' ' ILE . 12.3 t30 -68.38 96.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 71.22 109.319 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -101.09 28.3 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.22 109.29 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.454 ' CB ' ' HA ' ' A' ' 248' ' ' PRO . 4.5 p -102.9 143.48 32.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 74.34 110.419 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -44.29 -58.06 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.438 1.086 . . . . 71.12 109.306 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.7 pt -54.61 172.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 74.52 109.345 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.14 123.16 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.443 1.09 . . . . 75.51 109.306 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.415 HD13 ' ND2' ' A' ' 267' ' ' ASN . 1.7 mp -40.4 137.55 1.29 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 71.45 109.311 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -24.18 13.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.502 1.791 . . . . 70.23 111.007 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 89.37 162.81 38.79 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.501 1.126 . . . . 61.41 111.001 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.6 t30 69.26 34.24 3.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.754 . . . . 61.21 109.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 52.3 m -83.39 -179.22 7.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 71.44 108.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.0 m -151.85 132.58 14.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 74.32 110.41 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.54 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 0.9 OUTLIER -90.19 -178.63 5.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.429 1.08 . . . . 72.32 111.007 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.457 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 1.9 tt0 -171.68 89.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.135 . . . . 72.43 110.329 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.741 ' CZ ' ' CG ' ' A' ' 308' ' ' PHE . 22.7 p90 -116.89 128.58 55.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 74.21 111.046 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 36.7 p -95.54 165.24 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.137 . . . . 72.43 109.976 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.567 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.5 p -127.38 3.27 6.29 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.446 1.091 . . . . 74.13 110.021 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -178.55 177.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 74.32 110.303 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 1.1 pp -56.59 -20.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 75.4 109.285 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 10.9 m -55.61 -167.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 1.116 . . . . 75.14 109.965 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -75.4 -173.82 2.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.497 1.123 . . . . 73.14 110.3 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.457 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 13.9 p -136.22 170.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 73.55 109.319 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -134.89 145.46 48.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 75.41 111.016 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 60.2 p -104.3 129.76 52.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 71.45 110.011 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.48 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 2.0 mt -95.96 127.31 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 74.35 109.31 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.18 107.62 3.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.49 1.118 . . . . 72.34 109.257 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 85.5 mtp -78.11 158.61 29.06 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.577 1.173 . . . . 73.34 111.04 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -64.06 147.11 50.73 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.481 1.113 . . . . 74.4 111.025 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -29.66 7.97 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 72.51 110.952 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -54.12 152.58 5.87 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 72.54 109.594 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -85.35 154.31 21.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.45 110.299 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 86.4 mt -92.56 -79.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.122 . . . . 75.0 109.293 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.24 -177.1 21.42 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.547 1.154 . . . . 54.12 111.004 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 267' ' ' ASN . 8.9 mt -53.66 -86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.503 0.767 . . . . 74.01 109.268 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -23.8 66.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.147 . . . . 75.25 109.293 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -50.65 135.03 29.76 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.498 1.124 . . . . 62.52 111.023 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.54 176.81 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 0.766 . . . . 74.45 110.273 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.465 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 18.8 tptt -152.0 144.26 23.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 60.22 109.339 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -102.72 163.71 12.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 75.21 110.298 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 8.2 mt -161.27 73.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 74.32 109.277 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.25 127.38 32.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 74.34 107.988 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.741 ' CG ' ' CZ ' ' A' ' 281' ' ' PHE . 16.5 m-30 -114.15 38.49 3.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.113 . . . . 75.23 110.971 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.495 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 6.6 p90 -37.63 157.34 0.09 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 74.32 110.979 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -36.94 2.43 Favored 'Cis proline' 0 C--N 1.36 1.177 0 C-N-CA 120.99 -2.504 . . . . 70.23 111.052 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 37.0 p 176.13 144.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 65.13 109.987 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.48 ' CD1' HD12 ' A' ' 261' ' ' LEU . 3.7 mp -129.18 159.39 69.24 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 72.43 109.312 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 144.09 29.84 Favored 'Trans proline' 0 C--N 1.359 1.132 0 O-C-N 124.48 1.779 . . . . 74.44 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.488 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.16 162.58 47.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 73.52 110.378 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.1 Cg_endo -74.98 177.98 36.66 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.009 -2.496 . . . . 64.42 110.977 -0.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.458 ' CD1' ' HE2' ' A' ' 321' ' ' MET . 3.8 mt -92.85 64.4 4.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 75.2 109.276 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.7 t -83.97 135.77 34.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 74.35 109.963 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 72.12 10.86 6.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 71.44 109.303 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 282' ' ' SER . 4.8 m-30 -96.29 124.96 40.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 70.53 111.0 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -40.0 -61.48 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 72.42 110.384 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.548 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 3.9 ttm 31.19 68.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.459 1.099 . . . . 72.41 110.973 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 80.8 mttt -103.78 -171.29 1.91 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.094 . . . . 73.01 109.316 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.504 HG22 ' CE1' ' A' ' 279' ' ' PHE . 19.2 t -141.53 123.47 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 74.51 109.332 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.469 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 22.6 m -110.84 -172.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.464 1.103 . . . . 75.31 109.315 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -126.55 -171.92 2.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 74.51 109.268 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.51 -6.99 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 74.22 110.328 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -89.02 -14.82 35.58 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 73.11 109.292 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.61 1.66 89.07 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.484 1.115 . . . . 65.1 111.028 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.457 ' O ' ' ND2' ' A' ' 325' ' ' ASN . 14.0 pt-20 -94.54 153.22 18.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 0.79 . . . . 72.21 110.312 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.3 m -83.47 128.89 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 74.54 110.397 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.479 ' CG2' ' ND2' ' A' ' 325' ' ' ASN . 33.6 pt -103.64 -37.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.114 . . . . 75.14 109.28 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.476 ' C ' ' CG1' ' A' ' 333' ' ' VAL . 12.3 mt -134.14 168.77 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 73.23 109.291 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.476 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -152.79 122.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 72.04 109.336 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -77.53 119.53 5.32 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 71.22 110.987 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.461 ' CE ' ' HA ' ' A' ' 342' ' ' ILE . 0.0 OUTLIER -44.27 -27.0 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 0.783 . . . . 75.1 109.271 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 49.14 76.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 65.02 108.289 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -88.2 -178.68 5.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 65.12 109.276 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -76.04 61.15 1.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.477 1.111 . . . . 73.11 109.295 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 341' ' ' GLU . 4.2 m 179.43 141.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 61.52 110.019 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 13.9 m-20 -46.65 -26.13 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.151 . . . . 65.13 109.294 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.521 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 3.2 mt-10 -63.04 125.29 23.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 75.14 110.345 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.548 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 66.4 mt -141.65 123.38 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 71.13 109.345 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 15.2 p -126.25 87.84 2.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.132 . . . . 71.0 110.417 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 334' ' ' GLY . 10.3 mp -40.77 138.93 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.526 1.141 . . . . 74.13 109.299 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -112.57 -64.58 1.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 75.55 109.268 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 159.7 145.91 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 72.33 110.011 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -81.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.474 1.776 . . . . 74.42 111.049 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.471 ' CD2' ' C ' ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 74.54 109.261 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.315 -0.624 . . . . 72.21 109.315 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . 0.45 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 2.8 m-20 -79.73 153.08 75.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.12 . . . . 72.22 109.3 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -0.49 10.03 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.469 1.773 . . . . 73.54 110.999 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.486 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -39.88 141.8 0.4 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.145 . . . . 73.31 109.291 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.435 HD23 ' CG2' ' A' ' 252' ' ' VAL . 0.6 OUTLIER -128.51 103.34 7.06 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 72.01 109.304 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -66.56 139.68 57.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 71.11 109.605 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.435 ' CG2' HD23 ' A' ' 250' ' ' LEU . 60.2 t -144.33 167.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 75.35 109.303 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 254' ' ' VAL . 53.6 tt0 -122.93 154.49 38.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 74.41 110.281 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.466 ' CG1' HG21 ' A' ' 314' ' ' THR . 82.4 t -135.75 95.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.142 . . . . 70.0 109.307 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 2.5 t -69.1 -67.4 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 62.1 109.963 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.402 ' OD1' ' OG1' ' A' ' 314' ' ' THR . 5.0 t-20 60.91 64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 71.25 109.291 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -91.45 145.56 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 75.21 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.26 -34.16 4.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.517 1.136 . . . . 62.13 109.348 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -65.89 -52.03 53.6 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 74.41 109.261 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.9 m -171.14 -175.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 53.34 110.063 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.453 ' CD1' HD11 ' A' ' 312' ' ' LEU . 10.9 mt -88.12 176.38 7.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.446 1.091 . . . . 73.12 109.324 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.55 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 4.3 t-160 -176.2 103.51 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 75.02 109.618 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 93.8 m-85 -112.54 127.02 55.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 75.32 111.023 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.643 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 76.5 mt -119.42 116.83 52.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 71.22 109.272 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.25 130.01 50.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 64.45 109.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.643 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 1.3 m-85 -119.66 109.17 15.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.03 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 267' ' ' ASN . 14.5 t30 -69.81 75.51 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 70.04 109.301 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.97 52.85 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 72.43 109.322 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.5 p -127.58 -178.08 4.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 74.44 110.419 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.32 18.19 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 74.23 109.33 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.59 169.22 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 71.02 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.3 mt -121.11 137.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.512 1.132 . . . . 73.1 109.358 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.75 137.49 58.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 75.2 109.271 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -26.25 11.09 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.519 1.799 . . . . 73.21 111.007 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.443 ' O ' ' ND2' ' A' ' 276' ' ' ASN . . . 83.94 -157.38 33.79 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.527 1.142 . . . . 45.44 111.034 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 275' ' ' GLY . 0.2 OUTLIER 39.89 30.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.463 0.743 . . . . 64.33 109.269 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.433 ' N ' ' C ' ' A' ' 275' ' ' GLY . 18.0 m -87.04 -173.41 4.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.538 1.149 . . . . 74.5 108.304 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.474 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.5 m -152.93 126.37 8.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 75.42 110.356 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 1.7 t80 -79.99 172.66 13.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 75.22 110.984 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.45 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 2.3 tt0 -167.08 91.05 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.115 . . . . 63.13 110.312 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 32.8 p90 -111.7 120.98 43.85 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.476 1.11 . . . . 71.2 110.983 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.604 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 81.8 p -109.93 161.56 15.36 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 54.45 110.017 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.568 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 33.3 t -131.75 -63.52 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 53.31 109.986 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.83 171.34 7.58 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.57 1.169 . . . . 64.31 110.298 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 9.6 pt -72.76 -6.86 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 71.41 109.296 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.3 m -49.43 -71.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 74.43 110.005 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.27 176.32 3.94 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 75.35 110.302 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.45 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 8.8 p -123.98 168.26 16.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.535 1.147 . . . . 74.42 109.268 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -137.49 146.57 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 75.11 111.011 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 95.0 p -117.74 123.46 46.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 72.51 109.996 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.9 mt -101.77 126.94 55.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 73.01 109.259 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 122.69 18.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 74.31 109.321 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 97.2 mtp -84.45 148.94 26.3 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.096 . . . . 72.03 111.015 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.583 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -52.62 156.23 4.69 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 63.02 111.02 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -26.64 10.86 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.492 1.785 . . . . 72.31 110.985 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.563 ' CE1' ' HD3' ' A' ' 304' ' ' LYS . 28.4 p80 -52.82 -176.28 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 75.32 109.596 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.63 175.71 7.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 1.13 . . . . 73.31 110.289 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.441 HG23 ' CB ' ' A' ' 267' ' ' ASN . 3.9 mp -134.74 61.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.12 . . . . 75.02 109.321 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.71 -122.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.487 1.117 . . . . 62.42 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.402 ' C ' ' HG2' ' A' ' 301' ' ' LYS . 2.2 mt -98.73 138.11 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.513 0.772 . . . . 73.22 109.3 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.402 ' HG2' ' C ' ' A' ' 300' ' ' ILE . 1.1 mmmm 67.07 9.23 6.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 75.42 109.331 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -103.28 146.5 16.53 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.473 1.108 . . . . 74.43 110.986 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.02 -177.58 4.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 0.779 . . . . 64.51 110.302 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.583 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 57.0 tptt -149.38 150.11 31.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 72.14 109.28 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 10.3 mt-10 -110.36 160.07 16.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 71.03 110.307 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 13.6 mt -155.97 70.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 70.21 109.287 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.55 ' CD1' ' NE2' ' A' ' 262' ' ' HIS . 0.1 OUTLIER -74.97 129.29 37.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 75.13 108.02 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 12.8 m-30 -117.75 -172.02 2.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.45 1.094 . . . . 72.24 110.998 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.475 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.8 p90 -169.75 159.43 6.94 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 74.32 110.955 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.03 -36.17 2.68 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.046 -2.481 . . . . 73.35 110.994 0.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.2 p 170.25 131.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.538 1.149 . . . . 54.12 110.016 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.453 HD11 ' CD1' ' A' ' 261' ' ' LEU . 5.4 mp -114.79 158.81 39.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.32 109.355 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 145.73 31.95 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.491 1.785 . . . . 73.52 110.971 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.49 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -127.12 164.49 35.1 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 75.21 110.404 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.49 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.02 176.51 43.14 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.013 -2.495 . . . . 73.25 110.991 0.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.566 HD22 ' CE2' ' A' ' 319' ' ' TYR . 4.9 mt -92.16 66.41 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.549 1.156 . . . . 74.32 109.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 2.4 p -81.27 128.15 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 65.24 110.006 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.93 21.31 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 73.35 109.27 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.604 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.5 m-30 -103.7 134.13 47.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 74.43 110.982 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' A' ' 322' ' ' LYS . 60.4 m -45.91 -67.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 73.44 110.389 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.57 ' HG2' ' CE2' ' A' ' 279' ' ' PHE . 4.3 ttm 33.53 56.92 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.41 111.016 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 28.1 mttm -95.14 -166.38 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.13 109.303 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 12.7 t -145.02 126.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 72.13 109.304 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.474 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 11.8 m -109.69 -172.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 75.05 109.252 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -120.25 -170.85 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 64.51 109.304 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.42 -8.23 17.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 64.3 110.299 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 -8.76 35.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 75.12 109.278 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.59 -4.5 78.25 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.115 . . . . 63.23 111.026 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -80.84 140.48 35.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.484 0.755 . . . . 75.22 110.27 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 324' ' ' VAL . 7.7 m -66.53 122.89 18.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 73.04 110.388 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.8 pt -97.46 -41.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 64.21 109.263 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.473 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 6.1 mt -141.59 170.9 14.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 74.53 109.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.434 ' CG1' ' HD3' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.46 128.54 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 74.02 109.304 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -89.08 113.87 4.19 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.451 1.095 . . . . 74.04 110.977 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -26.79 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 0.788 . . . . 74.33 109.294 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.469 ' SG ' ' CE ' ' A' ' 321' ' ' MET . 0.1 OUTLIER 42.12 67.81 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 74.34 108.263 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -71.89 -172.93 0.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 71.3 109.314 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.29 57.95 2.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 74.34 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 50.4 m -168.28 141.87 3.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 73.21 110.009 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -45.56 -31.73 1.96 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 73.02 109.271 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -63.85 147.54 51.59 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 75.11 110.315 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.403 ' O ' ' O ' ' A' ' 250' ' ' LEU . 16.9 mt -150.05 141.26 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 75.33 109.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 62.6 p -140.89 107.53 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 72.35 110.397 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 10.6 mp -61.25 134.51 57.06 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 74.14 109.253 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 2.0 mtpt -104.55 -76.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 65.13 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.78 143.84 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.538 1.149 . . . . 73.12 110.025 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.493 1.786 . . . . 72.25 111.006 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.325 -0.46 0 O-C-N 124.465 1.103 . . . . 73.22 109.332 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 31.8 m120 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.299 -0.63 . . . . 71.43 109.299 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -159.48 77.26 2.96 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.548 1.155 . . . . 75.13 109.34 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 171.96 17.3 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.503 1.791 . . . . 75.52 110.954 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -168.66 -177.9 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 74.04 109.331 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.474 HD22 ' CD2' ' A' ' 344' ' ' LEU . 0.5 OUTLIER -97.6 101.5 13.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 74.12 109.311 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.52 ' CD2' ' OE1' ' A' ' 341' ' ' GLU . 0.5 OUTLIER -87.15 143.96 27.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.435 1.084 . . . . 70.41 109.602 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.488 ' N ' ' CD2' ' A' ' 251' ' ' HIS . 84.3 t -126.26 144.47 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.516 1.135 . . . . 75.21 109.314 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -119.39 121.58 39.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 62.23 110.283 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.38 107.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 72.15 109.263 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 72.6 m -68.43 -57.6 5.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 63.52 110.033 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 55.43 69.62 0.72 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.522 1.139 . . . . 74.44 109.311 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -114.63 161.73 17.7 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 75.53 110.3 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -42.21 -53.62 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 73.23 109.289 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -43.57 -64.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 75.32 109.284 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.8 m -179.61 -174.8 0.31 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 74.14 109.981 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.479 HD12 ' CD1' ' A' ' 312' ' ' LEU . 14.7 mt -78.14 169.29 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.487 1.117 . . . . 73.41 109.314 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -165.1 112.39 0.99 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.05 109.61 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -116.18 106.51 13.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 75.42 110.987 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.465 HG23 ' CE2' ' A' ' 266' ' ' TYR . 16.6 mt -99.55 103.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 73.53 109.331 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.488 ' CD2' ' CG2' ' A' ' 252' ' ' VAL . 0.2 OUTLIER -105.01 126.42 52.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 75.24 109.283 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.465 ' CE2' HG23 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -113.2 119.21 36.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 71.01 111.018 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 271' ' ' ILE . 25.4 t30 -80.71 95.52 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 61.42 109.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -88.68 -54.55 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.424 1.078 . . . . 72.31 109.294 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 1.7 t -100.48 173.83 6.38 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.08 . . . . 74.41 110.39 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 269' ' ' THR . 2.5 t-20 81.93 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 72.32 109.295 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.444 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 0.0 OUTLIER -81.62 -174.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 75.32 109.318 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.411 ' N ' HG12 ' A' ' 271' ' ' ILE . 21.9 mt -92.75 126.76 45.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.01 109.349 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.416 ' O ' ' CG ' ' A' ' 297' ' ' GLU . 1.4 mp -43.78 137.65 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.542 1.151 . . . . 75.2 109.309 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.97 -31.07 6.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.487 1.783 . . . . 74.41 111.0 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 102.14 154.2 25.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.48 1.112 . . . . 74.04 110.991 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 5.2 t30 74.49 32.63 0.91 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.466 0.745 . . . . 72.24 109.268 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 16.3 m -78.91 -176.66 5.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.159 . . . . 74.4 108.322 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 1.9 m -154.53 139.96 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 74.2 110.404 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.626 ' CD1' ' CD1' ' A' ' 306' ' ' LEU . 1.8 t80 -88.93 -177.26 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 73.24 110.991 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.426 ' HG2' ' CG2' ' A' ' 288' ' ' VAL . 22.2 tt0 -177.35 100.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.135 . . . . 73.23 110.281 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.7 p90 -123.62 146.59 48.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 71.43 110.988 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.602 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 92.0 p -77.99 162.25 26.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 74.32 110.033 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.435 ' CB ' HD22 ' A' ' 312' ' ' LEU . 72.3 p -148.87 -58.31 0.22 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.521 1.138 . . . . 62.43 110.046 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.428 ' C ' ' N ' ' A' ' 286' ' ' SER . 5.3 tp60 -142.62 169.08 18.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 73.45 110.31 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 286' ' ' SER . 3.0 tt -42.68 -28.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 72.21 109.328 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.428 ' N ' ' C ' ' A' ' 284' ' ' GLN . 1.7 m -50.65 -178.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.09 . . . . 65.32 109.954 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.61 134.36 37.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.54 110.268 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.426 ' CG2' ' HG2' ' A' ' 280' ' ' GLU . 14.5 p -48.48 169.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.143 . . . . 62.42 109.325 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -116.4 -175.96 2.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 72.52 110.961 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 278' ' ' THR . 3.6 t -163.49 123.58 2.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 42.41 109.967 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.425 HD11 ' CD1' ' A' ' 308' ' ' PHE . 10.9 mt -98.77 136.05 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.21 109.297 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 106.98 12.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 73.04 109.291 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.478 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.2 mtp -80.74 153.25 27.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 74.01 110.997 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.72 153.08 8.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.484 1.115 . . . . 72.25 110.999 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -18.84 18.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.438 1.757 . . . . 74.32 111.035 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -72.49 161.48 30.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 61.24 109.601 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 36.6 mt-10 -88.15 175.47 7.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 72.23 110.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 8.3 mt -98.3 -74.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.479 1.112 . . . . 73.34 109.258 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 121.0 159.76 10.85 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.119 . . . . 70.12 110.992 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 21.6 mt -58.61 -29.49 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 73.41 109.3 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -109.63 -34.95 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 73.11 109.255 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -46.81 168.79 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.496 1.123 . . . . 71.53 111.007 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -133.17 -178.44 4.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 72.13 110.299 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 38.1 tptt -137.5 156.74 47.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 74.23 109.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -133.57 100.83 4.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 72.42 110.304 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 279' ' ' PHE . 20.6 mt -97.74 30.74 2.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 75.45 109.3 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -43.09 126.88 4.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.34 107.989 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.472 ' CG ' ' N ' ' A' ' 309' ' ' PHE . 53.8 t80 -127.35 172.92 10.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 74.42 110.98 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -146.3 162.08 36.22 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 74.22 110.97 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.04 -53.8 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.001 -2.499 . . . . 74.02 111.006 0.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 14.5 p -175.29 146.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.102 . . . . 73.52 110.049 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.479 ' CD1' HD12 ' A' ' 261' ' ' LEU . 2.8 mp -123.63 159.19 56.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 73.15 109.299 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 145.84 31.73 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.533 1.807 . . . . 73.41 111.0 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.485 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -126.55 164.03 36.94 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 73.53 110.381 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 178.48 34.5 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.021 -2.491 . . . . 73.5 110.988 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.574 HD21 ' CE2' ' A' ' 319' ' ' TYR . 1.5 mt -104.91 61.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.543 1.152 . . . . 75.05 109.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.4 OUTLIER -86.52 138.08 32.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 75.2 110.034 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 82.89 -1.56 1.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 74.01 109.298 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.602 ' CD2' ' OG ' ' A' ' 282' ' ' SER . 10.5 m-85 -80.15 -172.87 3.67 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.105 . . . . 73.11 110.998 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.494 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -106.37 -58.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 74.52 110.36 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.511 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 0.8 OUTLIER 29.84 61.06 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 74.43 110.984 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.438 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 25.1 mttm -90.03 -172.46 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 72.53 109.284 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 90.6 t -141.46 125.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 75.02 109.273 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 278' ' ' THR . 7.0 m -109.38 172.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 75.25 109.274 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.471 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 12.6 t30 -101.53 -164.29 1.09 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 74.02 109.313 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -69.1 -7.49 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 65.44 110.287 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.03 11.73 25.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.11 109.28 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.12 67.78 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.541 1.15 . . . . 75.3 110.994 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 8.9 pt-20 -96.43 119.34 34.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 0.748 . . . . 75.44 110.295 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.407 ' N ' HG11 ' A' ' 324' ' ' VAL . 3.8 m -52.68 98.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 74.25 110.379 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.471 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 14.0 pt -77.51 -39.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.495 1.122 . . . . 74.31 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 11.6 mt -138.76 174.26 10.72 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.469 1.106 . . . . 71.22 109.28 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.57 118.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 75.4 109.278 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.459 ' CA ' HD13 ' A' ' 344' ' ' LEU . . . -68.7 127.41 22.7 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.495 1.122 . . . . 74.01 110.988 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.509 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -48.73 -27.18 2.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 75.33 109.33 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.0 83.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.11 108.297 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.485 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -101.11 -173.54 2.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 63.42 109.332 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.83 56.26 1.51 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 74.41 109.297 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 72.4 p -172.79 136.31 0.7 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.117 . . . . 74.52 110.002 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.401 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 29.7 m-20 -44.92 -33.42 1.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 64.51 109.316 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.52 ' OE1' ' CD2' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -62.66 139.26 58.64 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.479 1.112 . . . . 73.11 110.319 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.511 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 86.6 mt -144.96 120.67 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.527 1.142 . . . . 75.42 109.293 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.471 ' HB ' ' CD2' ' A' ' 249' ' ' LEU . 16.8 p -109.98 82.27 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 75.52 110.446 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.474 ' CD2' HD22 ' A' ' 250' ' ' LEU . 8.3 mp -39.45 147.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 1.135 . . . . 74.44 109.28 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -124.78 -87.35 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 74.32 109.312 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 40.3 p -176.19 137.97 0.49 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 64.44 109.977 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.545 1.813 . . . . 74.43 111.0 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 71.15 109.251 -179.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.299 -0.63 . . . . 71.54 109.299 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . 0.444 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 21.9 m-20 -139.77 154.08 70.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.44 109.328 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.457 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.9 0.35 8.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.458 1.767 . . . . 64.45 111.023 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.486 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -41.89 143.77 0.5 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.545 1.153 . . . . 72.4 109.3 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.539 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -122.08 100.31 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 1.109 . . . . 71.3 109.29 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -94.86 131.43 40.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 65.54 109.555 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 265' ' ' LEU . 17.2 t -112.09 163.16 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 74.01 109.31 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -123.31 122.45 38.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.113 . . . . 75.13 110.289 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 316' ' ' LEU . 47.2 t -101.75 110.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.533 1.146 . . . . 71.22 109.285 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 m -85.59 -55.54 3.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.34 109.981 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.445 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 2.4 t-20 60.53 73.14 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.122 . . . . 75.13 109.307 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 260' ' ' SER . 33.6 mm-40 -82.69 145.68 29.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.561 1.163 . . . . 73.24 110.303 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.85 -22.33 14.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 71.42 109.302 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -82.79 -41.48 19.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.557 1.161 . . . . 65.24 109.314 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 257' ' ' GLU . 12.3 m -173.4 -175.07 1.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 1.136 . . . . 74.25 110.032 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 312' ' ' LEU . 11.2 mt -87.02 178.93 6.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.533 1.145 . . . . 73.4 109.31 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -178.46 108.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 75.33 109.631 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 68.9 m-85 -110.6 110.65 21.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 54.33 110.995 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.52 HG21 ' CZ ' ' A' ' 266' ' ' TYR . 56.9 mt -103.26 109.34 26.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 62.43 109.287 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.482 ' HB3' ' CG2' ' A' ' 252' ' ' VAL . 0.0 OUTLIER -114.47 137.75 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.144 . . . . 74.44 109.258 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -120.9 127.08 51.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 71.33 110.967 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -84.35 93.29 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 73.23 109.312 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.38 18.54 12.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.153 . . . . 74.14 109.3 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.457 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 12.5 p -77.54 -172.6 2.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 64.43 110.388 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -87.06 -59.65 2.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 71.24 109.308 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.8 pt -58.86 157.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 73.44 109.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.44 130.33 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 71.42 109.289 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 6.0 mm -53.69 136.0 54.47 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.4 109.259 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -23.61 13.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.532 1.806 . . . . 74.13 110.986 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 86.52 170.91 47.37 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.517 1.136 . . . . 65.23 111.034 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . 0.404 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 58.1 t-20 66.8 45.09 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 0.767 . . . . 62.24 109.323 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.41 ' C ' ' OG1' ' A' ' 278' ' ' THR . 73.8 m -84.24 178.44 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.33 108.326 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.481 ' CG2' ' OG ' ' A' ' 290' ' ' SER . 1.8 m -154.74 98.86 2.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 73.43 110.339 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.521 ' CD1' HG23 ' A' ' 323' ' ' VAL . 1.2 t80 -54.31 -172.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.536 1.148 . . . . 75.24 110.996 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 322' ' ' LYS . 18.2 tt0 173.77 105.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 75.3 110.279 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -126.33 170.09 12.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 74.23 111.012 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.1 t -101.33 -172.82 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.15 . . . . 75.25 110.01 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.598 ' OG ' ' CE2' ' A' ' 319' ' ' TYR . 0.7 OUTLIER 50.83 62.72 2.56 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.156 . . . . 64.03 109.976 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.413 ' OE1' ' CB ' ' A' ' 289' ' ' PHE . 6.7 tt0 -106.36 170.12 8.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 71.11 110.292 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 19.1 tt -43.15 -34.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 73.41 109.306 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 48.0 m -127.14 -59.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.433 1.083 . . . . 74.53 109.992 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -164.68 169.37 16.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 75.21 110.342 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.6 p -40.29 139.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 75.23 109.275 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.413 ' CB ' ' OE1' ' A' ' 284' ' ' GLN . 5.0 t80 -153.28 155.52 36.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 74.1 110.955 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.481 ' OG ' ' CG2' ' A' ' 278' ' ' THR . 28.4 t -109.21 136.06 49.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 64.33 109.999 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.7 mt -103.47 133.72 46.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 75.04 109.312 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.38 112.47 9.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 72.32 109.261 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.47 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 84.8 mtp -92.9 135.49 34.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 74.35 111.008 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.61 147.55 0.08 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.486 1.116 . . . . 52.4 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.404 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.06 -24.13 13.02 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.508 1.794 . . . . 62.24 111.015 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -53.01 144.87 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.467 1.104 . . . . 74.33 109.579 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.02 150.28 33.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 74.33 110.332 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 61.3 mt -80.09 -75.39 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.455 1.097 . . . . 63.3 109.25 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.01 166.29 12.77 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.477 1.111 . . . . 51.42 110.981 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.47 -31.37 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.521 0.777 . . . . 75.2 109.305 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -110.72 -23.26 11.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.487 1.117 . . . . 75.11 109.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -58.78 157.86 20.61 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 53.33 111.002 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -120.3 -174.94 2.89 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.467 0.745 . . . . 75.33 110.309 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 293' ' ' MET . 6.3 tptp -147.66 154.69 40.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 75.2 109.256 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 4.1 mt-10 -123.52 135.7 54.17 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 74.41 110.328 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.585 ' O ' ' CE1' ' A' ' 308' ' ' PHE . 17.4 mt -136.38 60.0 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 74.51 109.268 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 3.3 p90 -70.86 131.1 43.26 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 74.41 107.993 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.8 m-30 -118.37 172.5 7.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.21 110.982 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.3 OUTLIER -148.91 145.69 20.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 75.02 111.026 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.96 -44.71 0.53 Allowed 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.043 -2.482 . . . . 74.24 110.987 0.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 24.1 p 177.63 172.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.516 1.135 . . . . 74.33 109.971 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -137.62 161.82 58.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 74.54 109.315 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 144.57 30.31 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.494 1.786 . . . . 74.11 111.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.494 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.9 OUTLIER -128.04 159.93 64.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 75.44 110.389 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.96 169.61 74.06 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.034 -2.486 . . . . 74.13 110.995 -0.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.457 ' CB ' ' HE2' ' A' ' 321' ' ' MET . 5.2 mp -80.34 63.67 4.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 74.52 109.288 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.3 p -83.63 133.57 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 75.53 109.978 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 70.11 27.57 4.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 74.41 109.286 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.598 ' CE2' ' OG ' ' A' ' 283' ' ' SER . 7.7 m-85 -101.31 176.59 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.539 1.149 . . . . 72.42 110.966 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.533 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.9 OUTLIER -109.34 -50.5 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 74.22 110.429 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.533 ' C ' ' O ' ' A' ' 320' ' ' THR . 3.9 ptp 26.6 61.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 75.33 111.015 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.442 ' C ' ' CG2' ' A' ' 323' ' ' VAL . 22.3 mttm -78.95 -173.43 3.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 71.53 109.299 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.521 HG23 ' CD1' ' A' ' 279' ' ' PHE . 3.4 t -151.73 125.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 75.14 109.315 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.475 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 26.6 m -113.9 -177.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 73.51 109.325 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.49 -161.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 72.01 109.301 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -74.21 -2.14 23.5 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.512 1.133 . . . . 72.32 110.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -101.77 0.55 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.21 109.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.8 8.33 47.3 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.542 1.151 . . . . 75.14 111.013 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 12.4 pt-20 -95.16 123.61 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 0.762 . . . . 71.12 110.272 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.475 ' CG2' HG13 ' A' ' 333' ' ' VAL . 14.6 m -55.93 113.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 65.43 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.3 pt -86.67 -38.3 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 75.14 109.279 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.491 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 11.1 mt -146.21 165.95 27.67 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 75.12 109.303 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.475 HG13 ' CG2' ' A' ' 330' ' ' THR . 1.1 m -150.29 124.34 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 70.12 109.32 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -64.0 125.99 33.36 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.533 1.146 . . . . 73.33 111.0 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -61.69 -27.61 68.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 0.754 . . . . 74.05 109.281 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 335' ' ' LYS . 0.5 OUTLIER 87.38 179.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 75.03 108.353 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 336' ' ' CYS . . . 163.89 157.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.099 . . . . 74.41 109.32 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.25 56.88 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.435 1.084 . . . . 71.43 109.352 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 m -178.93 179.68 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.107 . . . . 74.23 110.022 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.42 -10.03 59.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 73.32 109.282 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' HG13 ' A' ' 342' ' ' ILE . 1.1 mp0 -76.9 116.84 17.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 72.44 110.294 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.435 ' CD1' ' SD ' ' A' ' 321' ' ' MET . 93.1 mt -144.98 124.75 6.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 71.14 109.299 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 344' ' ' LEU . 11.7 p -125.16 96.56 4.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.108 . . . . 75.42 110.402 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.491 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 7.5 mp -39.41 139.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 75.12 109.32 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 346' ' ' SER . 1.9 ptmm? -109.93 -47.37 3.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 75.11 109.279 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.4 OUTLIER 156.32 154.43 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 74.22 109.966 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 -51.6 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 65.01 111.007 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 75.32 109.324 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.295 -0.631 . . . . 73.31 109.295 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -127.92 97.11 30.4 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 73.31 109.275 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 269' ' ' THR . 18.3 Cg_endo -74.99 -5.2 16.5 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.31 110.997 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.502 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -39.75 139.38 0.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.148 . . . . 72.14 109.309 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.545 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -119.88 103.28 9.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 74.01 109.3 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -81.81 123.62 28.95 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 61.31 109.58 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.47 ' CG2' HD21 ' A' ' 265' ' ' LEU . 80.2 t -122.29 165.05 18.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.31 109.324 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.425 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 27.7 tp10 -123.36 133.29 54.13 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.523 1.14 . . . . 63.43 110.312 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 60.5 t -109.3 108.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.495 1.122 . . . . 75.22 109.341 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 4.8 t -85.64 -61.86 1.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 72.3 110.012 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 57.01 63.37 1.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.446 1.092 . . . . 75.11 109.314 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -84.44 146.75 27.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 71.51 110.265 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -49.5 -25.67 2.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.452 1.095 . . . . 73.13 109.354 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -75.73 -48.69 20.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 75.33 109.294 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.2 p -172.62 -175.13 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 71.53 110.008 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 312' ' ' LEU . 11.6 mt -85.43 -178.24 6.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 65.52 109.314 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.41 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 5.3 t-160 -176.62 100.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 75.3 109.542 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.413 ' CZ ' HD21 ' A' ' 261' ' ' LEU . 89.1 m-85 -117.42 94.07 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 71.44 111.03 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.584 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 18.5 mt -86.97 128.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.493 1.121 . . . . 74.44 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.47 HD21 ' CG2' ' A' ' 252' ' ' VAL . 0.4 OUTLIER -110.48 137.25 48.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 74.41 109.297 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.584 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 9.5 m-85 -129.7 127.37 40.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.535 1.147 . . . . 75.43 111.024 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.428 ' CB ' HG22 ' A' ' 298' ' ' ILE . 22.5 t30 -82.67 102.58 11.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 74.54 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.93 19.81 19.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.479 1.112 . . . . 74.44 109.307 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.462 ' CG2' ' HA ' ' A' ' 248' ' ' PRO . 9.2 p -104.02 -165.48 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.485 1.116 . . . . 70.22 110.385 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.13 -51.31 5.65 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 72.42 109.335 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.9 pt -53.82 161.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 75.35 109.35 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 1.9 mp -117.67 111.17 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.453 1.095 . . . . 70.21 109.329 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.47 HG22 ' CD1' ' A' ' 298' ' ' ILE . 1.3 mp -53.82 139.78 51.13 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.15 109.258 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.414 ' HG2' ' ND2' ' A' ' 325' ' ' ASN . 18.2 Cg_endo -74.98 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 54.45 111.03 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 294' ' ' GLY . . . 89.72 -36.65 3.48 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 64.45 111.007 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -76.04 57.9 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 0.766 . . . . 72.45 109.311 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 324' ' ' VAL . 7.6 m -101.9 -175.09 2.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 75.41 108.302 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.487 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.6 m -152.92 97.34 2.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 75.44 110.363 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.517 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -56.04 171.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 74.03 110.982 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 69.3 tt0 -167.38 96.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 71.34 110.317 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.2 p90 -123.19 138.09 54.73 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.138 . . . . 74.22 110.982 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 88.5 p -99.46 -178.24 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 73.13 109.977 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 286' ' ' SER . 4.8 p -129.3 -167.6 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.427 1.079 . . . . 73.2 109.981 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -41.42 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 74.15 110.261 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 30.8 pt -130.92 11.43 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.14 . . . . 72.24 109.29 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.436 ' CB ' ' OG ' ' A' ' 283' ' ' SER . 0.6 OUTLIER -82.5 174.93 10.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 75.45 110.039 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.63 178.32 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.102 . . . . 64.33 110.27 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.46 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 1.6 p -113.4 161.06 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.108 . . . . 74.0 109.293 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.417 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 2.7 t80 -145.05 156.08 43.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.538 1.149 . . . . 73.33 110.981 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 3.3 m -117.34 130.13 56.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.22 110.011 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 11.9 mt -97.98 125.21 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.508 1.13 . . . . 74.33 109.241 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.12 99.58 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.554 1.159 . . . . 75.15 109.27 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.472 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 84.2 mtp -71.71 135.94 47.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 75.41 111.003 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.442 ' N ' ' HZ3' ' A' ' 304' ' ' LYS . . . -48.02 155.19 1.3 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 64.14 110.971 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.61 6.94 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.466 1.772 . . . . 73.12 110.993 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -49.49 116.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 75.34 109.585 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -62.62 151.25 38.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.112 . . . . 73.31 110.28 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.542 ' CG2' ' N ' ' A' ' 299' ' ' GLY . 13.5 mt -78.28 -88.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.483 1.114 . . . . 75.35 109.317 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.542 ' N ' ' CG2' ' A' ' 298' ' ' ILE . . . 89.34 -161.69 30.24 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.517 1.136 . . . . 73.44 110.989 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.469 ' CG2' ' HD3' ' A' ' 301' ' ' LYS . 8.3 mt -77.09 124.5 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.557 0.798 . . . . 74.42 109.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 301' ' ' LYS . 2.6 mptt 68.48 7.22 5.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.565 1.166 . . . . 74.02 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.478 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -91.87 53.38 2.96 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.566 1.166 . . . . 73.13 111.012 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 302' ' ' GLY . 6.3 pt20 -42.16 165.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.577 0.81 . . . . 64.12 110.321 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.442 ' HZ3' ' N ' ' A' ' 294' ' ' GLY . 38.8 tptt -131.67 150.55 52.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 73.42 109.308 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 mt-10 -115.02 114.15 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.513 1.133 . . . . 71.1 110.289 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.517 HD13 ' CG ' ' A' ' 279' ' ' PHE . 11.1 mt -114.61 48.65 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.497 1.123 . . . . 65.04 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.412 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 5.2 p-90 -59.1 141.77 53.22 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.23 108.024 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.566 ' CE1' HD13 ' A' ' 312' ' ' LEU . 5.1 t80 -139.78 165.77 26.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 73.43 111.013 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -145.72 158.12 50.24 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.23 110.973 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -45.87 0.42 Allowed 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.001 -2.499 . . . . 75.1 111.011 -0.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.7 p -176.69 164.32 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.147 . . . . 64.14 110.007 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.566 HD13 ' CE1' ' A' ' 308' ' ' PHE . 4.1 mt -137.04 158.51 72.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.548 1.155 . . . . 72.32 109.308 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 148.03 34.94 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.51 1.795 . . . . 74.12 111.057 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 1.0 OUTLIER -137.3 159.62 68.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 75.14 110.367 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.01 170.31 72.21 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 75.05 110.966 0.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 319' ' ' TYR . 3.2 mt -90.85 56.65 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 72.24 109.296 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.2 p -73.37 116.79 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 72.23 110.042 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 317' ' ' SER . 18.6 t-20 79.71 39.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 74.14 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.56 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.2 m-85 -115.83 143.89 44.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 73.21 111.025 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.518 ' O ' ' C ' ' A' ' 321' ' ' MET . 9.9 m -54.94 -61.54 2.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.522 1.139 . . . . 75.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 320' ' ' THR . 1.1 ptp 28.01 50.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.53 111.013 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.454 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 85.4 mttt -82.17 -179.95 7.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 74.12 109.33 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 279' ' ' PHE . 19.9 t -142.05 131.0 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 73.42 109.288 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.487 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 15.8 m -113.03 173.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 65.42 109.3 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 274' ' ' PRO . 0.3 OUTLIER -109.59 -168.98 1.4 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 73.13 109.289 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.2 -7.86 14.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.474 1.109 . . . . 72.24 110.322 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 327' ' ' ASP . 1.9 p30 -88.79 -12.38 42.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 75.43 109.263 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 80.74 -5.94 63.5 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.512 1.132 . . . . 74.14 111.017 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -90.6 143.94 26.24 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 0.742 . . . . 73.21 110.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.423 ' N ' HG11 ' A' ' 324' ' ' VAL . 27.7 m -58.86 130.99 49.61 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 1.102 . . . . 72.14 110.332 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 18.8 pt -112.7 -37.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 64.24 109.273 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.47 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 9.6 mt -139.7 168.42 19.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.33 109.298 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.1 m -151.81 127.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 74.55 109.332 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -76.24 147.81 35.07 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 72.11 110.971 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.444 ' NZ ' ' OG1' ' A' ' 343' ' ' THR . 0.1 OUTLIER -89.14 -35.96 15.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.512 0.772 . . . . 73.53 109.332 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 316' ' ' LEU . 0.3 OUTLIER 41.52 86.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 72.03 108.312 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -104.28 73.95 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.446 1.091 . . . . 72.25 109.324 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.8 t0 41.44 53.72 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.117 . . . . 75.13 109.3 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -160.6 123.79 3.39 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 74.12 109.986 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -41.2 -33.43 0.36 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.091 . . . . 70.2 109.308 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.68 146.38 46.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 73.21 110.3 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 4.3 mt -146.08 138.96 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 75.43 109.34 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.444 ' OG1' ' NZ ' ' A' ' 335' ' ' LYS . 16.6 p -132.44 84.85 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 72.3 110.405 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 9.8 mp -39.42 130.11 1.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 65.33 109.336 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 346' ' ' SER . 22.8 mttt -97.64 -74.01 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 71.44 109.292 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 2.7 p 159.9 146.92 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 73.12 109.989 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 -58.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.497 1.788 . . . . 74.41 110.966 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 73.52 109.316 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 246' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 72.32 109.313 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . 0.425 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 0.8 OUTLIER 60.31 160.23 0.11 Allowed Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.12 109.299 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.453 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.97 -3.27 13.67 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.562 1.822 . . . . 72.33 110.991 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -40.1 143.31 0.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.092 . . . . 72.04 109.29 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.471 HD23 ' CD2' ' A' ' 344' ' ' LEU . 0.5 OUTLIER -121.41 103.78 9.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 72.54 109.324 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.519 ' CE1' HG21 ' A' ' 343' ' ' THR . 8.2 m-70 -83.73 167.14 17.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 74.02 109.562 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.472 ' CG1' HD21 ' A' ' 265' ' ' LEU . 21.9 t -152.45 166.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 72.2 109.32 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -134.26 134.88 42.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 75.12 110.317 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 263' ' ' PHE . 56.9 t -119.74 101.7 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 75.23 109.253 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -54.37 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.496 1.123 . . . . 75.43 110.016 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.472 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 5.6 t-20 60.33 77.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.549 1.155 . . . . 63.11 109.339 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.28 152.09 35.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.532 1.145 . . . . 72.03 110.302 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -42.27 -47.26 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 72.33 109.315 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.49 -64.24 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.464 1.102 . . . . 73.05 109.301 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.2 m -173.42 -174.83 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 70.32 110.012 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.475 ' CD1' ' HG ' ' A' ' 312' ' ' LEU . 14.0 mt -86.76 150.98 23.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 74.31 109.29 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -137.45 108.0 6.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 74.23 109.628 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 82.7 m-85 -112.37 104.35 12.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.476 1.11 . . . . 74.55 111.039 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 266' ' ' TYR . 98.6 mt -105.03 111.62 35.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 73.43 109.271 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.473 HD13 ' CD1' ' A' ' 306' ' ' LEU . 0.4 OUTLIER -98.89 128.91 45.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 75.44 109.317 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.634 ' CE2' ' CG2' ' A' ' 264' ' ' ILE . 1.1 m-85 -116.86 106.57 13.6 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.504 1.128 . . . . 73.21 110.999 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -70.75 85.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 74.11 109.294 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -90.37 53.38 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 74.01 109.273 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 18.7 p -125.19 166.87 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 75.52 110.384 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -75.91 -49.62 17.31 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.556 1.16 . . . . 72.0 109.303 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 26.7 pt -51.63 -179.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.15 . . . . 75.14 109.341 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.3 126.71 73.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 75.23 109.267 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 5.8 mm -56.82 136.17 78.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 74.51 109.266 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.02 -24.12 13.1 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.503 1.791 . . . . 64.24 111.016 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.95 -163.63 51.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.511 1.132 . . . . 63.32 111.027 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 49.07 33.74 5.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 73.31 109.339 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 64.3 m -85.39 173.87 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 64.24 108.305 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.516 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.5 m -152.32 99.33 2.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 73.4 110.361 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.525 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.9 t80 -52.08 -179.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 72.4 111.016 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.97 100.24 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 72.44 110.245 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.692 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 17.0 p90 -115.02 152.27 32.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 72.15 111.032 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 t -87.41 179.19 6.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 74.44 110.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.601 ' OG ' ' CE2' ' A' ' 319' ' ' TYR . 1.4 m 59.42 70.98 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 70.02 110.006 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 289' ' ' PHE . 12.6 tt0 -112.75 170.11 8.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.147 . . . . 74.03 110.309 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.89 -28.91 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 65.45 109.297 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 30.9 t -120.91 -63.73 1.31 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.518 1.136 . . . . 72.42 109.976 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -168.82 168.15 10.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.494 1.122 . . . . 75.24 110.304 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.3 p -40.45 119.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 75.23 109.318 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.448 ' CB ' ' OE1' ' A' ' 284' ' ' GLN . 3.8 t80 -129.74 162.52 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.431 1.082 . . . . 75.13 111.044 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.504 ' OG ' ' CG2' ' A' ' 278' ' ' THR . 17.7 t -120.83 128.67 53.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 74.55 110.001 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 3.7 mt -93.55 130.56 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 73.41 109.341 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.429 ' HD2' ' CG2' ' A' ' 278' ' ' THR . 2.7 mptp? -71.96 113.09 8.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 74.53 109.294 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.402 ' CE ' ' HE2' ' A' ' 304' ' ' LYS . 92.4 mtp -79.87 162.75 24.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 73.34 110.993 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -67.09 155.31 52.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.133 . . . . 52.12 111.013 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -33.3 4.67 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.501 1.79 . . . . 64.11 110.991 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -46.14 144.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 75.14 109.626 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.55 126.76 41.06 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 64.2 110.301 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.409 HG21 ' N ' ' A' ' 303' ' ' GLN . 14.8 mt -64.18 -77.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.572 1.17 . . . . 65.41 109.328 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 79.47 -156.7 41.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.507 1.129 . . . . 75.53 111.017 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.446 ' C ' ' N ' ' A' ' 302' ' ' GLY . 2.0 mt -69.42 156.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.518 0.775 . . . . 73.14 109.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.28 30.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 73.41 109.308 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 300' ' ' ILE . . . -108.38 153.32 16.85 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.485 1.116 . . . . 75.01 111.018 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.409 ' N ' HG21 ' A' ' 298' ' ' ILE . 5.6 pt20 -126.23 -179.06 4.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 0.755 . . . . 73.03 110.289 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 265' ' ' LEU . 40.8 tptt -152.62 149.37 28.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 73.33 109.288 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.55 130.3 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 75.5 110.317 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 13.2 mt -139.38 61.64 1.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.123 . . . . 74.51 109.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.586 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 7.0 p90 -75.22 113.46 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 75.51 107.949 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.0 m-30 -102.01 173.62 6.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 73.34 111.013 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.473 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.1 p90 -158.93 159.1 29.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 74.32 110.946 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.98 -36.71 2.5 Favored 'Cis proline' 0 C--N 1.36 1.166 0 C-N-CA 121.045 -2.481 . . . . 72.5 110.963 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.4 p 167.52 150.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 74.5 109.968 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 281' ' ' PHE . 0.0 OUTLIER -123.21 172.93 4.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.472 1.108 . . . . 73.42 109.287 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.86 34.6 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.535 1.808 . . . . 75.22 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 1.1 p -133.08 159.45 72.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.508 1.13 . . . . 74.42 110.391 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.06 171.46 68.02 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.985 -2.506 . . . . 71.32 110.958 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.4 mt -89.07 62.33 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.46 1.1 . . . . 74.23 109.266 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 5.4 p -87.62 136.52 32.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.129 . . . . 71.22 110.029 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.6 OUTLIER 76.22 6.8 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 74.23 109.32 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.601 ' CE2' ' OG ' ' A' ' 283' ' ' SER . 8.6 m-85 -80.34 179.04 7.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 74.31 110.99 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.526 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.8 OUTLIER -105.72 -53.05 2.71 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 74.54 110.361 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.584 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 5.0 mtm 27.31 57.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 73.45 111.017 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -87.78 -168.81 2.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 73.22 109.317 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -148.91 137.65 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.14 . . . . 75.11 109.28 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.516 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 15.9 m -107.88 178.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 75.5 109.325 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.574 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.47 -172.43 2.03 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.495 1.122 . . . . 75.43 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.07 -3.67 14.09 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 74.13 110.345 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.02 -5.41 28.14 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.456 1.097 . . . . 73.11 109.291 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 70.3 58.94 5.67 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.474 1.109 . . . . 73.34 111.013 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -154.76 119.48 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.456 0.739 . . . . 74.4 110.276 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 324' ' ' VAL . 24.3 m -46.1 124.18 5.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 74.13 110.395 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.5 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 0.8 OUTLIER -105.53 -39.47 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 71.22 109.306 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.476 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 8.5 mt -130.47 167.79 18.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 73.04 109.284 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.452 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.2 m -151.9 132.18 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.15 109.259 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.43 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -85.44 122.1 5.86 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.511 1.132 . . . . 65.21 110.984 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.64 -26.82 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 74.52 109.302 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.43 ' N ' ' C ' ' A' ' 334' ' ' GLY . 1.2 m 50.42 63.2 2.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.116 . . . . 74.44 108.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -70.04 -179.56 1.96 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.489 1.118 . . . . 60.05 109.275 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -76.66 62.52 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 74.42 109.297 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 14.9 m -174.09 146.29 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.15 . . . . 75.24 109.999 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 79.0 m-20 -53.09 -21.19 4.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.435 1.084 . . . . 71.44 109.303 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.59 143.32 42.41 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 63.21 110.298 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.584 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 63.3 mt -147.55 139.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 72.52 109.31 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.519 HG21 ' CE1' ' A' ' 251' ' ' HIS . 11.8 p -133.58 94.73 3.35 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 75.52 110.427 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.471 ' CD2' HD23 ' A' ' 250' ' ' LEU . 5.4 mp -47.66 133.03 13.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 75.52 109.286 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.4 ptpt -117.88 -60.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 74.11 109.317 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.29 150.85 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 60.34 109.984 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -56.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.482 1.78 . . . . 71.32 111.047 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.45 109.336 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.315 -0.624 . . . . 73.24 109.315 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . 0.505 ' O ' ' CB ' ' A' ' 268' ' ' LYS . 13.5 m-20 -122.63 157.99 57.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 62.14 109.305 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.407 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.96 -1.21 10.92 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 70.31 111.055 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 247' ' ' ASP . 0.1 OUTLIER -71.78 158.41 36.15 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.529 1.143 . . . . 75.31 109.326 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.537 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.21 98.24 6.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 71.43 109.304 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.477 ' CE1' ' CD ' ' A' ' 341' ' ' GLU . 2.3 t-160 -96.63 130.23 43.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.472 1.107 . . . . 75.33 109.574 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 265' ' ' LEU . 3.6 t -116.06 171.16 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 71.3 109.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -134.76 121.99 21.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.519 1.137 . . . . 75.1 110.27 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.57 HG11 ' CE2' ' A' ' 263' ' ' PHE . 21.8 t -103.61 111.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 75.0 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -64.94 0.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 61.11 109.962 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.496 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 0.3 OUTLIER 66.97 67.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 72.43 109.312 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.09 169.08 11.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 75.22 110.298 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -73.52 -14.49 61.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.472 1.108 . . . . 71.14 109.318 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 260' ' ' SER . 1.8 p-10 -87.51 -45.37 10.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 75.35 109.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.473 ' N ' ' ND2' ' A' ' 259' ' ' ASN . 3.8 p -176.15 -177.31 0.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 70.33 110.004 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.468 ' CD1' HD13 ' A' ' 312' ' ' LEU . 16.8 mt -90.18 174.46 7.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.11 . . . . 74.11 109.255 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.405 ' NE2' ' HG2' ' A' ' 305' ' ' GLU . 4.2 t-160 -171.97 104.51 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.44 109.59 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.608 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 87.9 m-85 -107.05 91.68 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 75.32 110.993 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.512 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 48.9 mt -88.84 109.9 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.21 109.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 252' ' ' VAL . 0.1 OUTLIER -110.62 130.33 55.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 74.31 109.331 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.512 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 2.0 m-85 -114.99 136.74 52.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.496 1.123 . . . . 75.45 111.003 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 273' ' ' ILE . 9.2 p-10 -79.72 118.58 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 75.44 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 247' ' ' ASP . 0.0 OUTLIER -98.36 -11.53 22.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 71.42 109.309 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 17.5 p -72.1 175.67 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 63.42 110.345 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -88.52 -43.21 11.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 65.15 109.308 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.3 pt -53.15 175.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 74.31 109.299 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.12 134.42 62.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 72.33 109.319 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 267' ' ' ASN . 1.1 mp -57.59 139.18 81.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 74.12 109.313 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -30.96 6.61 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.474 1.776 . . . . 71.35 111.005 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 276' ' ' ASN . . . 86.76 -159.67 31.9 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.518 1.136 . . . . 75.34 110.981 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 275' ' ' GLY . 56.9 t-20 40.35 32.44 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 75.43 109.287 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.407 ' O ' ' OG1' ' A' ' 278' ' ' THR . 86.4 m -88.61 -176.77 5.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 74.2 108.298 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.466 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 33.1 m -157.4 119.94 3.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 75.23 110.428 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.427 ' CD1' ' CD1' ' A' ' 306' ' ' LEU . 3.1 t80 -65.79 173.36 2.92 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.457 1.098 . . . . 74.04 110.962 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.448 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 39.6 tt0 -155.99 79.61 0.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 73.14 110.339 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.56 151.07 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.12 . . . . 74.05 111.0 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 p -120.82 -177.25 3.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 71.14 110.015 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.483 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 26.5 p -111.26 -50.91 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.52 1.137 . . . . 72.34 110.018 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.439 ' C ' ' N ' ' A' ' 286' ' ' SER . 14.1 tt0 169.58 112.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 72.41 110.303 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 284' ' ' GLN . 2.2 pt 39.69 30.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 72.33 109.265 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.439 ' N ' ' C ' ' A' ' 284' ' ' GLN . 11.9 p -119.02 -173.76 2.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.519 1.137 . . . . 74.44 109.993 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.83 135.68 43.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.429 1.08 . . . . 74.42 110.293 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.448 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 2.4 p -85.72 151.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.508 1.13 . . . . 73.2 109.235 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.33 131.96 54.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 73.13 110.998 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 65.4 m -101.99 116.99 33.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 73.53 109.996 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.7 mt -98.63 125.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 72.13 109.302 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -67.61 117.77 9.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.437 1.086 . . . . 73.33 109.27 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.467 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 94.1 mtp -81.96 151.8 27.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 73.42 110.967 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.633 ' N ' ' HZ3' ' A' ' 304' ' ' LYS . . . -44.55 145.7 1.9 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.546 1.154 . . . . 52.1 110.981 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -25.97 11.41 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.534 1.807 . . . . 73.54 111.001 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -67.42 178.78 1.45 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.03 109.626 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 73.2 mt-10 -113.48 130.62 56.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 73.31 110.327 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 3.4 mt -44.08 -62.46 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 74.34 109.314 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 267' ' ' ASN . . . 111.21 -165.15 12.11 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 44.25 111.018 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 301' ' ' LYS . 9.7 mt -63.56 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.534 0.784 . . . . 71.53 109.343 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.475 ' N ' ' CG2' ' A' ' 300' ' ' ILE . 0.0 OUTLIER -89.22 14.6 10.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.32 109.278 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -62.25 178.47 5.06 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 71.33 111.0 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -141.24 176.79 8.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 0.766 . . . . 75.2 110.285 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.633 ' HZ3' ' N ' ' A' ' 294' ' ' GLY . 31.3 tptt -139.37 145.53 39.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.55 109.297 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.405 ' HG2' ' NE2' ' A' ' 262' ' ' HIS . 4.1 mt-10 -116.31 128.78 55.85 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.469 1.106 . . . . 74.14 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.59 ' O ' ' CE1' ' A' ' 308' ' ' PHE . 9.4 mt -132.14 56.9 1.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 72.22 109.312 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -70.94 123.6 22.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 71.15 107.985 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.7 m-30 -110.14 -166.48 1.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.431 1.082 . . . . 73.25 111.018 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.479 ' CD1' ' C ' ' A' ' 308' ' ' PHE . 1.2 p90 -172.09 160.51 4.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 65.44 111.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.01 -36.26 2.65 Favored 'Cis proline' 0 C--N 1.36 1.145 0 C-N-CA 121.003 -2.499 . . . . 70.42 110.998 0.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.2 p 169.63 130.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 74.14 110.029 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.468 HD13 ' CD1' ' A' ' 261' ' ' LEU . 5.6 mp -111.69 158.66 35.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 70.14 109.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 148.4 35.1 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.475 1.776 . . . . 73.24 110.954 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.496 ' CG2' ' OD1' ' A' ' 256' ' ' ASN . 0.3 OUTLIER -126.13 164.08 35.88 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 65.45 110.38 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.489 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -173.87 13.07 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 120.991 -2.504 . . . . 73.32 111.028 -0.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.564 HD22 ' CE2' ' A' ' 319' ' ' TYR . 2.4 mt -107.73 58.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.502 1.126 . . . . 74.11 109.241 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.415 ' CB ' ' HA ' ' A' ' 338' ' ' ASP . 0.9 OUTLIER -81.87 133.32 35.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 50.3 109.989 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 317' ' ' SER . 6.8 t-20 75.26 26.13 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.04 109.302 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.564 ' CE2' HD22 ' A' ' 316' ' ' LEU . 16.4 m-85 -101.33 -171.56 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 73.44 110.984 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.483 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -100.54 -64.28 1.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 65.24 110.391 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.598 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 1.8 mtm 30.54 70.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 73.43 110.975 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.461 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 91.4 mttt -100.93 -167.1 1.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.451 1.094 . . . . 73.21 109.317 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 11.7 t -151.94 127.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 71.15 109.284 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.466 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 22.2 m -107.34 177.32 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.434 1.084 . . . . 74.53 109.288 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.58 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -110.88 -172.32 2.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 73.53 109.289 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.77 -3.87 13.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 75.02 110.305 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.51 -7.78 30.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.55 109.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.12 54.09 6.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.508 1.13 . . . . 75.12 110.995 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.447 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.43 128.83 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 0.756 . . . . 74.12 110.271 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.432 ' N ' HG11 ' A' ' 324' ' ' VAL . 1.2 m -57.86 117.75 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 74.35 110.363 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.49 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.6 pt -96.39 -37.22 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 72.43 109.275 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.455 ' C ' ' CG1' ' A' ' 333' ' ' VAL . 7.0 mt -132.53 168.87 17.44 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 74.1 109.296 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.455 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.24 133.7 5.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 74.43 109.309 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.46 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -86.88 121.7 5.88 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.481 1.113 . . . . 73.13 110.998 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.466 ' CE ' ' HA ' ' A' ' 342' ' ' ILE . 0.0 OUTLIER -44.21 -27.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 0.768 . . . . 71.31 109.28 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 54.58 63.22 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.572 1.17 . . . . 75.23 108.306 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.435 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -71.35 -175.0 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 75.42 109.301 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 317' ' ' SER . 0.1 OUTLIER -81.53 53.38 2.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.2 109.282 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.1 t -169.1 142.26 2.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 63.51 109.997 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -47.04 -25.43 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.505 1.128 . . . . 75.32 109.281 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.477 ' CD ' ' CE1' ' A' ' 251' ' ' HIS . 14.0 mt-10 -69.35 140.45 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 73.1 110.295 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.598 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 67.0 mt -147.36 135.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 65.23 109.327 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.4 p -127.63 87.21 2.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 75.34 110.439 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -39.97 134.71 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.549 1.156 . . . . 71.41 109.287 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.505 ' O ' ' CB ' ' A' ' 346' ' ' SER . 3.5 mtpt -106.2 -74.86 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 75.35 109.305 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.32 136.27 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.31 109.995 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -70.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.525 1.803 . . . . 74.21 111.058 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.8 tp . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 73.14 109.307 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.265 -0.642 . . . . 74.4 109.265 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -117.12 86.54 20.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.123 . . . . 74.12 109.284 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.424 ' CB ' ' HA ' ' A' ' 269' ' ' THR . 18.2 Cg_endo -75.04 165.83 30.42 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.51 1.795 . . . . 75.44 110.994 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.409 ' HG ' ' C ' ' A' ' 248' ' ' PRO . 0.8 OUTLIER 179.84 155.44 0.58 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.485 1.116 . . . . 74.53 109.307 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.544 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -112.87 99.0 7.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 74.13 109.328 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 266' ' ' TYR . 2.4 m80 -93.08 131.38 38.16 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 73.13 109.582 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.47 ' CG1' HD22 ' A' ' 265' ' ' LEU . 95.0 t -119.8 167.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.447 1.092 . . . . 74.12 109.321 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.446 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 9.0 tt0 -130.97 120.16 23.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 70.13 110.259 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 340' ' ' ASN . 39.6 t -90.81 119.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 75.12 109.285 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.42 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.4 t -92.51 -63.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.477 1.11 . . . . 64.32 109.993 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.47 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 5.3 t-20 56.77 63.89 1.82 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.14 . . . . 65.32 109.272 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.94 163.64 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 73.01 110.278 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.4 -13.39 61.45 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 64.44 109.258 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.89 -39.11 10.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 73.14 109.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 m -174.98 -174.51 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 73.01 110.013 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.476 HD21 ' CZ ' ' A' ' 263' ' ' PHE . 9.8 mt -89.29 179.49 6.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.533 1.146 . . . . 73.05 109.323 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 1.7 t-160 -178.26 107.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 72.34 109.597 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 91.2 m-85 -121.88 101.17 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 75.12 111.013 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.407 ' CG2' ' O ' ' A' ' 304' ' ' LYS . 23.9 mt -90.04 132.73 33.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 72.02 109.297 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.47 HD22 ' CG1' ' A' ' 252' ' ' VAL . 0.2 OUTLIER -113.64 149.01 35.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 74.23 109.282 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.9 OUTLIER -128.04 115.66 18.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 72.42 111.016 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 298' ' ' ILE . 8.8 t-20 -73.97 78.82 1.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 1.088 . . . . 75.24 109.234 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -101.8 13.43 34.88 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 75.52 109.28 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.424 ' HA ' ' CB ' ' A' ' 248' ' ' PRO . 14.7 p -76.36 -166.15 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 75.45 110.398 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.99 -65.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 70.41 109.268 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -68.3 -178.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 75.01 109.343 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 273' ' ' ILE . 2.5 mp -122.32 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 71.21 109.263 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 272' ' ' ILE . 1.4 mp -40.7 139.47 1.15 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 74.05 109.308 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.417 ' HG2' ' ND2' ' A' ' 325' ' ' ASN . 18.2 Cg_endo -75.02 -33.17 4.76 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.513 1.796 . . . . 72.34 110.999 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 103.82 153.05 23.2 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 60.15 111.018 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 57.8 t30 71.86 26.85 2.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 0.768 . . . . 74.52 109.314 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.405 ' C ' ' OG1' ' A' ' 278' ' ' THR . 21.5 m -69.78 -179.17 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.553 1.158 . . . . 74.33 108.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 4.4 m -155.1 138.46 15.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 75.23 110.427 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.496 ' CG ' HD12 ' A' ' 306' ' ' LEU . 1.3 t80 -91.1 -173.58 3.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 70.34 111.032 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 178.03 102.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.21 110.277 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.665 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 1.2 p90 -128.44 128.95 45.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 75.1 110.979 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.478 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 0.8 OUTLIER -107.73 154.22 21.81 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.533 1.145 . . . . 64.41 110.014 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.546 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 10.5 p -125.84 4.14 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.536 1.147 . . . . 73.42 110.04 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -177.9 171.33 1.8 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 71.14 110.267 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.7 tt -66.38 -16.67 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 72.22 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 48.9 m -41.79 -77.2 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 70.34 109.989 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.87 -177.2 2.92 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 74.41 110.273 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.44 166.25 29.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.553 1.158 . . . . 73.12 109.317 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -135.99 138.55 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 73.12 110.992 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 96.8 p -110.59 125.85 53.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 61.12 109.983 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 11.4 mt -97.73 133.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 73.04 109.295 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.39 102.19 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 73.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.427 ' CE ' ' HE2' ' A' ' 304' ' ' LYS . 73.9 mtp -73.28 152.13 41.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 70.34 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -38.69 141.78 0.44 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.46 1.1 . . . . 65.01 110.959 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.06 -23.81 13.33 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.52 1.8 . . . . 73.44 110.952 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -73.43 175.94 6.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 73.14 109.624 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -94.85 155.15 16.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 71.55 110.291 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 66.3 mt -77.19 -83.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 74.15 109.322 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 126.66 141.01 5.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.51 1.131 . . . . 54.32 110.996 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 58.6 mt -40.57 -33.15 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 0.751 . . . . 75.55 109.292 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.15 -29.47 7.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 73.42 109.332 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -48.05 136.35 15.43 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.498 1.124 . . . . 72.2 111.002 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -89.65 -172.48 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 0.757 . . . . 73.54 110.297 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.427 ' HE2' ' CE ' ' A' ' 293' ' ' MET . 32.8 tptt -160.49 145.12 14.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 73.44 109.33 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -124.54 144.46 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.473 1.108 . . . . 73.14 110.296 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.601 ' O ' ' CE1' ' A' ' 308' ' ' PHE . 11.8 mt -144.13 61.18 1.36 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 74.23 109.299 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 132.29 46.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.53 107.989 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.1 m-30 -118.4 174.49 6.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 75.42 110.988 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -155.74 155.03 29.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.559 1.162 . . . . 65.03 111.001 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -37.14 2.35 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.03 -2.487 . . . . 74.42 111.003 -0.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.4 p 172.61 149.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 64.55 110.003 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.45 HD12 ' CD1' ' A' ' 261' ' ' LEU . 1.7 mp -128.78 157.97 73.74 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 73.31 109.285 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 148.5 35.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.465 1.771 . . . . 75.51 110.979 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.491 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.7 OUTLIER -134.51 161.96 60.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 71.21 110.395 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.0 Cg_endo -75.07 173.71 56.52 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.983 -2.507 . . . . 75.24 110.961 0.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.553 HD22 ' CE2' ' A' ' 319' ' ' TYR . 1.4 mt -95.07 64.02 2.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.528 1.143 . . . . 75.34 109.282 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 4.7 p -77.37 121.6 23.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 73.22 110.027 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 78.92 31.44 0.31 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 73.14 109.326 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.553 ' CE2' HD22 ' A' ' 316' ' ' LEU . 4.2 m-85 -112.14 141.14 46.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 63.45 110.997 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.3 m -51.89 -62.79 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 74.11 110.426 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.531 ' C ' ' O ' ' A' ' 320' ' ' THR . 0.9 OUTLIER 26.87 60.78 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 1.144 . . . . 74.11 111.012 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.466 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 49.0 mttm -97.44 -174.76 3.01 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 75.25 109.302 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.72 136.31 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 72.41 109.291 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' A' ' 278' ' ' THR . 4.4 m -116.66 -179.57 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 74.33 109.307 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.468 ' OD1' ' CG2' ' A' ' 331' ' ' ILE . 0.8 OUTLIER -105.03 -171.23 1.88 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 73.21 109.282 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.47 -9.27 24.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 71.44 110.312 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -99.08 -7.25 27.01 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 75.24 109.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.36 14.3 76.74 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.5 1.125 . . . . 70.01 111.033 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -92.94 132.78 36.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 0.744 . . . . 63.54 110.248 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 324' ' ' VAL . 16.6 m -61.39 130.87 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 73.23 110.417 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.468 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 19.8 pt -115.72 -39.24 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 73.23 109.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 9.9 mt -138.79 166.26 24.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 73.4 109.272 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' HD3' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.2 123.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 74.14 109.303 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -70.27 137.43 27.86 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.525 1.141 . . . . 44.42 111.042 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.502 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -74.11 -36.82 64.25 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.53 0.782 . . . . 72.54 109.244 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 335' ' ' LYS . 0.1 OUTLIER 40.9 87.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 1.16 . . . . 71.12 108.275 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.88 72.58 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 73.3 109.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.15 55.08 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.41 109.311 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.9 m -163.49 131.84 3.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 75.44 109.997 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.455 ' O ' ' CG2' ' A' ' 254' ' ' VAL . 8.5 m120 -46.9 -38.11 9.95 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 74.02 109.252 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.27 146.61 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 73.14 110.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 9.3 mt -146.26 121.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 63.13 109.301 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.554 HG23 ' CD2' ' A' ' 251' ' ' HIS . 14.5 p -115.33 79.17 1.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 74.33 110.382 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 334' ' ' GLY . 9.9 mp -38.82 149.87 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.1 . . . . 70.42 109.258 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -126.21 -55.01 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.14 109.343 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 157.41 154.81 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 74.32 110.001 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 348' ' ' LEU . 18.4 Cg_endo -74.96 -45.92 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.502 1.79 . . . . 74.23 111.018 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 347' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 63.33 109.305 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.255 -0.646 . . . . 70.23 109.255 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -133.49 146.2 59.6 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 64.4 109.3 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 0.45 8.87 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.488 1.783 . . . . 73.01 111.034 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.499 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -45.98 130.04 9.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 74.3 109.275 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.562 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -121.36 105.56 10.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.22 109.318 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.42 ' NE2' ' HG2' ' A' ' 341' ' ' GLU . 55.7 t-80 -73.17 124.19 25.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.01 109.628 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.531 ' CG1' ' CD2' ' A' ' 265' ' ' LEU . 56.6 t -118.49 168.69 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.553 1.158 . . . . 74.02 109.281 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 45.7 tp10 -129.8 146.88 51.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 75.45 110.27 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.76 103.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 62.42 109.308 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.2 m -76.15 -70.04 0.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 73.42 109.949 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.466 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 3.2 t-20 60.52 66.56 0.92 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.529 1.143 . . . . 45.55 109.324 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.3 pt-20 -166.21 -174.39 2.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 72.44 110.298 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 18.1 t0 67.05 15.14 10.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.24 109.327 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 9.3 t-20 82.24 19.66 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 73.15 109.284 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 257' ' ' GLU . 2.7 p -164.22 -175.39 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 72.55 109.999 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.466 ' CD2' ' HA ' ' A' ' 256' ' ' ASN . 13.6 mt -100.55 174.23 6.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.134 . . . . 73.31 109.286 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.2 117.72 0.3 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 72.0 109.583 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -129.18 117.84 21.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 74.34 110.993 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.632 ' CG2' ' CE2' ' A' ' 266' ' ' TYR . 86.1 mt -102.5 112.48 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 74.5 109.329 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.531 ' CD2' ' CG1' ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.06 123.8 42.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 72.14 109.306 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 264' ' ' ILE . 1.3 m-85 -112.58 140.25 47.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 73.43 111.019 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 271' ' ' ILE . 62.8 t-20 -91.16 88.66 7.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.12 . . . . 55.01 109.319 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -3.45 21.84 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 74.02 109.298 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 0.9 OUTLIER -56.66 -17.3 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 74.31 110.389 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 269' ' ' THR . 3.7 m120 83.75 43.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.44 109.327 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.508 ' CD1' ' OG1' ' A' ' 269' ' ' THR . 0.1 OUTLIER -152.03 177.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 71.14 109.303 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 271' ' ' ILE . 71.2 mt -106.62 130.64 58.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 65.14 109.309 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.434 HG12 ' ND2' ' A' ' 267' ' ' ASN . 3.4 mm -71.04 138.12 84.86 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 74.05 109.297 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.549 1.815 . . . . 71.41 110.982 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 76.47 179.38 47.08 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.504 1.127 . . . . 71.41 111.03 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 326' ' ' GLN . 50.8 t-20 62.79 31.42 16.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 0.763 . . . . 74.15 109.322 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.403 ' C ' ' OG1' ' A' ' 278' ' ' THR . 68.6 m -90.58 178.71 6.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.35 108.293 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.482 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.7 m -153.8 127.87 9.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 64.13 110.413 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.505 ' CG ' HD12 ' A' ' 306' ' ' LEU . 1.8 t80 -80.47 164.11 23.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 75.34 110.991 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -151.52 88.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.2 110.286 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.786 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 15.5 p90 -120.6 128.67 53.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 73.11 111.028 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.592 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 23.8 t -113.99 178.33 4.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.4 109.983 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.528 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 3.4 t -115.99 -36.05 4.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 61.14 109.973 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -136.5 173.92 11.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 74.15 110.329 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 285' ' ' ILE . 0.2 OUTLIER -50.16 -23.53 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 73.23 109.319 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 68.1 m -52.56 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.31 109.953 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.84 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.453 1.095 . . . . 74.01 110.276 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.63 169.08 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 74.42 109.295 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -116.4 139.42 50.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.537 1.148 . . . . 72.53 111.015 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 90.8 p -119.7 122.06 40.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 73.4 110.048 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 21.6 mt -103.44 129.25 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 74.54 109.335 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.429 ' CD ' HG21 ' A' ' 278' ' ' THR . 18.3 mmtp -71.24 115.99 11.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 74.32 109.298 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 81.6 mtp -78.27 164.31 25.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 75.43 111.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -66.53 147.73 50.05 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.519 1.137 . . . . 72.14 111.018 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -30.24 7.36 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.506 1.793 . . . . 73.32 110.966 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.93 138.3 58.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 74.4 109.617 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -73.44 141.19 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 72.2 110.307 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 27.0 mt -67.03 -81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 73.25 109.26 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 300' ' ' ILE . . . 109.59 156.63 16.71 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.508 1.13 . . . . 74.43 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 299' ' ' GLY . 54.2 mt -39.13 -72.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.522 0.778 . . . . 74.14 109.352 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -68.38 -28.08 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 71.23 109.298 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -50.13 158.44 1.65 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.498 1.124 . . . . 71.41 110.963 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -129.23 -174.24 3.22 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 0.762 . . . . 74.25 110.322 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -156.92 156.92 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 75.33 109.321 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -134.76 147.14 49.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 62.03 110.314 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 16.5 mt -144.82 64.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 73.21 109.294 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -73.17 134.63 44.46 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.977 -1.119 . . . . 74.23 107.977 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.786 ' CD2' ' CE2' ' A' ' 281' ' ' PHE . 7.3 m-85 -121.69 167.07 13.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 75.05 111.024 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -142.71 143.4 25.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.21 110.997 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.0 -54.0 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.027 -2.489 . . . . 75.21 110.969 0.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.99 109.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 50.33 110.023 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' A' ' 283' ' ' SER . 3.9 mp -70.69 158.09 88.7 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 72.32 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.06 33.4 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.476 1.777 . . . . 72.24 110.995 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.482 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.4 OUTLIER -118.02 163.76 23.13 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 65.24 110.427 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.97 -173.19 11.86 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.021 -2.491 . . . . 74.3 111.016 -0.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.642 ' O ' ' CD1' ' A' ' 319' ' ' TYR . 4.6 mp -102.71 11.31 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.553 1.158 . . . . 75.24 109.311 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -46.27 119.26 2.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 71.31 110.005 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 317' ' ' SER . 8.4 t-20 87.15 42.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 71.14 109.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.642 ' CD1' ' O ' ' A' ' 316' ' ' LEU . 3.7 m-85 -120.85 -171.16 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 74.21 111.014 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.563 ' O ' ' C ' ' A' ' 321' ' ' MET . 52.3 m -105.04 -55.85 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 74.51 110.365 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.563 ' C ' ' O ' ' A' ' 320' ' ' THR . 3.8 ptp 23.81 57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 75.41 110.977 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.473 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 84.1 mttt -91.89 176.97 6.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.472 1.108 . . . . 63.42 109.339 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.63 129.52 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 75.4 109.306 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.482 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 6.5 m -109.1 -172.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.086 . . . . 70.43 109.307 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.458 ' HB3' ' CG2' ' A' ' 331' ' ' ILE . 39.8 p30 -121.38 -170.27 2.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 72.2 109.301 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.423 ' HB2' ' ND2' ' A' ' 276' ' ' ASN . 2.0 pt20 -63.2 -10.95 17.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 73.34 110.258 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -94.56 -13.96 25.51 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.466 1.104 . . . . 75.55 109.284 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.25 80.27 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.57 1.169 . . . . 72.55 111.028 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.25 134.79 38.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.514 0.773 . . . . 74.2 110.262 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.457 ' CG2' HG12 ' A' ' 333' ' ' VAL . 10.3 m -61.87 115.1 3.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 64.51 110.439 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 325' ' ' ASN . 8.1 pt -88.97 -37.82 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.534 1.147 . . . . 72.35 109.304 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 9.4 mt -141.64 169.6 17.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.554 1.159 . . . . 75.34 109.283 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.457 HG12 ' CG2' ' A' ' 330' ' ' THR . 1.0 OUTLIER -148.47 136.13 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 74.31 109.296 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -92.51 118.8 5.66 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.466 1.104 . . . . 62.52 111.026 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.422 ' NZ ' ' CB ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -50.04 -26.86 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 0.759 . . . . 72.13 109.307 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.6 t 46.05 77.03 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 53.42 108.333 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.422 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -81.51 -172.2 3.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 75.03 109.321 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.414 ' HA ' ' CB ' ' A' ' 317' ' ' SER . 0.8 OUTLIER -80.56 58.01 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 74.32 109.271 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.85 162.7 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 75.01 109.96 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.94 -38.49 86.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.11 109.319 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.42 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -61.77 133.06 55.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.114 . . . . 75.52 110.305 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.463 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 86.0 mt -143.77 131.33 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 75.3 109.289 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 344' ' ' LEU . 49.3 p -129.56 94.91 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.419 1.074 . . . . 74.41 110.404 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 10.0 mp -39.72 152.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 61.14 109.276 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 5.7 ptpt -125.67 -60.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 73.12 109.311 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.2 p 159.38 151.35 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.125 . . . . 62.33 109.978 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -79.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.514 1.797 . . . . 73.24 110.993 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.451 ' CD2' ' C ' ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.512 1.133 . . . . 75.12 109.312 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.272 -0.64 . . . . 63.34 109.272 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.52 76.74 35.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 71.54 109.264 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 168.42 24.88 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.489 1.784 . . . . 74.41 111.02 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -175.45 178.01 1.71 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.426 1.079 . . . . 75.3 109.291 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 344' ' ' LEU . 0.7 OUTLIER -105.58 101.12 10.66 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 74.42 109.319 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -82.07 168.1 18.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 74.21 109.632 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 22.4 t -155.05 150.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 74.11 109.328 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -124.57 151.05 45.25 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 74.21 110.313 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.78 106.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 75.52 109.327 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.8 t -73.55 -62.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 64.14 109.963 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.422 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 3.1 t-20 60.89 63.41 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 73.32 109.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -95.62 158.98 15.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 1.124 . . . . 75.34 110.325 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -48.25 -49.03 34.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 71.31 109.29 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -51.47 -53.41 37.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 64.11 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.8 p 178.75 -174.69 0.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.511 1.132 . . . . 74.31 109.993 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.615 ' CD1' ' CD1' ' A' ' 312' ' ' LEU . 34.8 mt -77.65 178.76 7.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 64.44 109.308 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -171.22 108.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 73.53 109.577 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.814 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 79.3 m-85 -115.79 93.13 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 75.1 111.036 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.565 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 84.6 mt -87.31 103.39 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 74.42 109.273 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.18 132.82 44.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 73.5 109.288 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.565 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 1.1 m-85 -118.27 125.98 51.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.32 110.988 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -64.0 79.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 72.33 109.266 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 266' ' ' TYR . 1.1 mmpt? -90.91 40.55 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.519 1.137 . . . . 73.43 109.259 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.6 p -119.65 177.78 4.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 64.34 110.402 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -85.56 -12.49 51.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 72.11 109.283 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.2 pt -101.46 160.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 75.52 109.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 273' ' ' ILE . 3.8 mp -120.58 121.58 65.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 65.32 109.278 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 272' ' ' ILE . 1.0 OUTLIER -40.01 142.4 0.7 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 75.42 109.313 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -44.41 0.34 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.797 . . . . 62.34 111.023 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 123.19 149.33 7.8 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.523 1.139 . . . . 52.43 110.977 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.9 t30 67.35 73.86 0.32 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 0.743 . . . . 72.21 109.308 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 293' ' ' MET . 0.8 OUTLIER -119.91 -179.15 3.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 72.25 108.286 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.475 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 22.3 m -153.51 137.52 16.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.535 1.147 . . . . 75.03 110.393 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.655 ' CD1' ' CD1' ' A' ' 306' ' ' LEU . 2.6 t80 -86.04 -167.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 73.14 110.993 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 176.5 104.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.458 1.099 . . . . 73.21 110.287 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.589 ' CZ ' ' CG ' ' A' ' 308' ' ' PHE . 3.0 p90 -133.56 144.0 49.05 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 73.01 111.021 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 37.3 p -104.43 143.27 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 74.12 110.011 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 312' ' ' LEU . 0.7 OUTLIER -104.05 -42.68 5.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.461 1.101 . . . . 70.44 109.988 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.427 ' C ' ' N ' ' A' ' 286' ' ' SER . 6.2 tt0 -143.56 173.67 11.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.452 1.095 . . . . 75.35 110.31 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 13.1 pt -40.89 -29.67 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 75.02 109.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.427 ' N ' ' C ' ' A' ' 284' ' ' GLN . 71.7 p -47.89 175.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.3 110.036 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -64.59 -175.85 0.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 73.54 110.268 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 289' ' ' PHE . 3.3 p -121.43 166.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 75.35 109.337 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.435 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 5.7 t80 -134.83 149.14 50.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.438 1.086 . . . . 75.31 110.949 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.452 ' HB3' ' CG2' ' A' ' 278' ' ' THR . 11.0 m -109.31 127.14 54.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 72.25 110.0 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.423 HD13 ' CD1' ' A' ' 308' ' ' PHE . 8.2 mt -97.06 125.63 50.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 75.13 109.289 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -70.26 116.57 10.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 73.32 109.3 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.482 ' CE ' ' SG ' ' A' ' 277' ' ' CYS . 86.2 mtp -84.74 170.0 13.68 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.571 1.169 . . . . 74.33 111.018 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.558 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -64.01 143.02 47.06 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.484 1.115 . . . . 60.34 111.023 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -27.93 9.55 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.514 1.797 . . . . 73.43 111.013 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -71.34 155.76 40.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 74.24 109.607 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.38 169.39 17.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.53 1.143 . . . . 71.22 110.284 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 79.0 mt -99.22 -74.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 64.15 109.308 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.408 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 122.15 135.95 4.82 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.545 1.153 . . . . 53.21 110.986 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 4.0 mt -41.52 -28.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 0.781 . . . . 72.2 109.299 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.408 ' N ' ' C ' ' A' ' 299' ' ' GLY . 0.0 OUTLIER -108.08 -31.19 8.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 71.12 109.303 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -57.76 146.6 38.19 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.497 1.123 . . . . 64.51 110.998 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -173.91 2.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.427 0.722 . . . . 63.25 110.277 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.558 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 28.8 tptt -159.99 144.6 14.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 75.25 109.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -107.69 155.03 20.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 72.2 110.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.655 ' CD1' ' CD1' ' A' ' 279' ' ' PHE . 9.7 mt -149.06 60.34 1.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 75.14 109.268 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.37 133.08 55.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 75.32 107.957 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.814 ' CD2' ' CE1' ' A' ' 263' ' ' PHE . 17.9 m-30 -119.38 39.52 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.494 1.121 . . . . 73.3 110.96 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -36.44 148.03 0.18 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 74.24 111.007 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.03 -46.45 0.37 Allowed 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.959 -2.517 . . . . 74.23 111.002 0.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 34.2 p 176.27 162.11 0.36 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 71.55 109.984 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.615 ' CD1' ' CD1' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -132.87 164.78 41.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.401 1.063 . . . . 73.21 109.275 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 145.24 31.28 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.52 1.8 . . . . 65.3 111.017 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.473 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.21 163.09 44.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 74.33 110.353 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.03 174.91 50.27 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.963 -2.515 . . . . 75.02 111.006 0.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.636 ' O ' ' CD1' ' A' ' 319' ' ' TYR . 8.2 mt -89.63 12.55 16.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 74.44 109.278 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.1 t -46.56 118.52 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 72.12 110.023 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.0 t-20 88.58 41.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 74.2 109.327 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.636 ' CD1' ' O ' ' A' ' 316' ' ' LEU . 4.9 m-85 -122.86 -174.28 2.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.53 110.982 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.1 m -103.76 -56.71 2.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 73.4 110.45 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.542 ' C ' ' O ' ' A' ' 320' ' ' THR . 2.5 ptp 25.29 67.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.53 1.144 . . . . 75.41 110.993 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.473 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 38.9 mttt -104.35 -176.77 3.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 1.126 . . . . 72.01 109.26 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 279' ' ' PHE . 65.4 t -136.56 158.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.111 . . . . 70.25 109.314 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 278' ' ' THR . 16.0 m -137.35 171.85 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 75.14 109.283 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -104.24 -162.87 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 1.129 . . . . 71.34 109.293 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -72.27 -4.84 32.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.528 1.143 . . . . 74.41 110.337 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -102.44 0.56 34.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 72.02 109.278 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.47 1.87 58.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.496 1.123 . . . . 72.15 111.011 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -83.54 141.17 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 0.753 . . . . 75.12 110.307 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 43.1 m -65.74 124.17 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 74.23 110.397 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.7 pt -102.5 -38.35 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 73.54 109.256 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 12.5 mt -144.33 171.71 13.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 74.32 109.272 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.458 ' CG2' ' HG2' ' A' ' 322' ' ' LYS . 0.2 OUTLIER -161.29 125.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.14 109.349 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.433 ' CA ' ' CD1' ' A' ' 344' ' ' LEU . . . -77.22 119.2 5.29 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.525 1.141 . . . . 71.13 110.982 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -26.02 0.73 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.537 0.787 . . . . 62.22 109.28 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.401 ' N ' ' C ' ' A' ' 334' ' ' GLY . 5.7 t 46.03 85.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.168 . . . . 72.44 108.3 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -95.67 -171.08 2.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.456 1.098 . . . . 64.54 109.262 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 338' ' ' ASP . 0.0 OUTLIER -81.04 56.16 2.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 75.13 109.288 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 341' ' ' GLU . 15.2 m -168.27 136.92 2.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 70.0 110.0 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -46.11 -26.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 65.2 109.301 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 339' ' ' SER . 3.4 mt-10 -69.75 141.31 53.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.104 . . . . 74.21 110.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.402 ' CD1' ' SD ' ' A' ' 321' ' ' MET . 66.0 mt -147.24 139.34 18.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 74.12 109.314 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 10.1 p -135.37 99.17 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 64.31 110.417 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.485 ' CD2' HD23 ' A' ' 250' ' ' LEU . 6.5 mp -52.07 132.97 33.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 74.45 109.318 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.3 ptpt -118.7 -61.45 1.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 64.44 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.9 OUTLIER 159.53 149.05 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 74.52 110.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 348' ' ' LEU . 18.5 Cg_endo -74.97 -46.24 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.51 1.795 . . . . 74.14 111.043 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 347' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.496 1.123 . . . . 74.32 109.32 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.279 -0.637 . . . . 61.22 109.279 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 97.18 3.01 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 72.25 109.334 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.447 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.5 Cg_endo -75.01 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.528 1.804 . . . . 75.41 111.009 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.48 HD23 ' CE1' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -40.76 144.61 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 73.43 109.346 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.542 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.39 101.07 8.8 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.468 1.105 . . . . 74.51 109.266 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.48 ' CE1' HD23 ' A' ' 249' ' ' LEU . 41.8 m170 -94.47 131.12 40.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.15 109.621 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 265' ' ' LEU . 21.9 t -128.55 169.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.44 109.303 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -125.31 146.62 49.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 72.24 110.304 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.454 ' CG1' HG21 ' A' ' 314' ' ' THR . 38.9 t -130.58 95.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.24 109.312 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -56.84 6.54 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 1.148 . . . . 61.31 109.999 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 59.73 74.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 74.15 109.333 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' ASP . 8.5 pt-20 -108.64 156.24 19.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.44 110.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 257' ' ' GLU . 46.2 m-20 -40.33 -57.86 1.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 72.44 109.291 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -39.94 -65.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.15 109.347 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.79 -170.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.122 . . . . 73.13 109.965 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.465 HD13 ' CD1' ' A' ' 312' ' ' LEU . 13.5 mt -81.69 162.27 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 70.44 109.255 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.551 ' NE2' ' CD1' ' A' ' 264' ' ' ILE . 1.3 t-160 -148.66 103.0 3.35 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 72.21 109.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.443 ' CE1' HG23 ' A' ' 254' ' ' VAL . 84.4 m-85 -116.15 130.68 56.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 65.34 110.995 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.64 ' CG2' ' CE2' ' A' ' 266' ' ' TYR . 45.6 mt -131.81 105.21 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 75.33 109.289 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 304' ' ' LYS . 0.1 OUTLIER -95.82 128.12 42.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 74.41 109.272 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.64 ' CE2' ' CG2' ' A' ' 264' ' ' ILE . 3.5 m-85 -114.31 113.84 25.13 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 72.14 111.018 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -72.34 87.35 1.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.5 109.329 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.423 ' CE ' ' O ' ' A' ' 300' ' ' ILE . 3.1 mmpt? -96.22 31.28 2.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.24 109.328 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 6.6 p -102.56 143.73 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 75.42 110.376 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -47.35 -53.42 13.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 75.11 109.309 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 37.5 pt -62.25 177.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 75.42 109.34 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.1 mt -118.96 136.06 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 75.4 109.282 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.28 140.18 97.66 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.145 . . . . 74.1 109.323 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 -34.16 3.97 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.484 1.781 . . . . 71.21 110.948 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 87.11 177.39 48.95 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.462 1.101 . . . . 71.34 111.036 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.99 27.49 8.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 0.789 . . . . 74.14 109.274 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.417 ' C ' ' OG1' ' A' ' 278' ' ' THR . 6.2 m -75.19 -177.07 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 73.42 108.313 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.4 m -154.51 100.02 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 65.13 110.364 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.554 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 0.4 OUTLIER -54.76 170.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.23 111.019 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.451 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 70.8 tt0 -160.58 84.21 0.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 73.15 110.302 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 29.6 p90 -115.32 133.1 56.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 74.22 110.983 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 2.8 t -128.72 -172.08 2.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.544 1.153 . . . . 74.31 109.991 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.56 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 22.0 t -145.73 162.81 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 75.53 109.976 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -76.59 -5.19 46.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 75.11 110.274 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 6.1 pt -118.48 -43.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 70.3 109.3 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.8 m -96.26 178.14 5.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.518 1.136 . . . . 71.15 110.03 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -95.36 170.75 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 75.32 110.302 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.459 ' HA ' ' CB ' ' A' ' 282' ' ' SER . 7.7 p -71.8 163.51 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 72.0 109.306 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -147.34 134.74 20.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 74.4 111.048 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 8.2 p -115.73 117.3 29.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.428 1.08 . . . . 72.41 110.007 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.1 mt -106.47 128.46 61.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 74.24 109.317 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.8 108.85 4.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 72.23 109.287 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 90.0 mtp -75.02 139.55 42.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 72.45 111.02 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.72 144.49 0.17 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.478 1.111 . . . . 74.4 110.995 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -24.43 12.8 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.515 1.797 . . . . 74.42 111.005 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -75.35 141.55 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 71.44 109.637 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.75 -174.18 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 74.4 110.327 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 39.1 mt -110.93 -74.2 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 73.42 109.278 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 123.53 162.95 11.63 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.468 1.105 . . . . 53.34 111.005 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.423 ' O ' ' CE ' ' A' ' 268' ' ' LYS . 36.5 mt -62.09 -30.58 49.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.519 0.776 . . . . 74.3 109.273 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.408 ' HA ' ' NZ ' ' A' ' 268' ' ' LYS . 48.6 mmtt -110.77 -22.88 11.35 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 75.23 109.27 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -59.08 164.63 9.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.527 1.142 . . . . 75.21 111.03 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -131.73 -179.84 5.63 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.519 0.776 . . . . 73.42 110.295 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 25.2 tptt -143.6 144.66 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 75.31 109.337 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.555 ' HG2' ' CH2' ' A' ' 307' ' ' TRP . 8.8 mp0 -112.71 143.6 43.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 64.43 110.302 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 12.7 mt -140.83 62.34 1.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.55 109.304 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.555 ' CH2' ' HG2' ' A' ' 305' ' ' GLU . 1.5 m-90 -68.82 118.72 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.9 m-30 -111.97 168.57 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 74.22 111.023 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.8 OUTLIER -155.02 160.76 30.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 74.51 110.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.0 -40.19 1.27 Allowed 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.023 -2.491 . . . . 73.35 110.986 0.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.1 p 175.56 132.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 73.52 110.029 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.465 ' CD1' HD13 ' A' ' 261' ' ' LEU . 5.5 mp -113.5 158.23 39.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 70.03 109.282 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 147.06 33.54 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.497 1.788 . . . . 73.42 110.966 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.467 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.4 OUTLIER -131.92 163.52 49.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 73.53 110.349 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 175.73 46.54 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.967 -2.514 . . . . 64.22 111.021 -0.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.473 ' CD2' ' HE2' ' A' ' 321' ' ' MET . 5.3 mp -93.52 65.57 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.502 1.126 . . . . 74.52 109.294 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 125.37 29.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.494 1.121 . . . . 74.5 109.998 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 73.51 29.1 1.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.03 109.306 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.4 m-85 -110.49 134.22 52.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.548 1.155 . . . . 74.52 110.988 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.468 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -49.32 -64.72 0.72 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 73.45 110.398 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.554 ' HG2' ' CE2' ' A' ' 279' ' ' PHE . 4.3 ttm 31.87 42.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 75.53 110.98 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.466 ' CE ' HG21 ' A' ' 320' ' ' THR . 16.9 pttt -80.09 -160.33 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.565 1.166 . . . . 74.11 109.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.448 HG23 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -151.96 133.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.142 . . . . 64.04 109.324 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 22.1 m -112.33 177.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 71.54 109.303 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.59 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.73 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.538 1.149 . . . . 74.42 109.306 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -1.91 12.7 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.489 1.118 . . . . 71.14 110.341 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.42 -8.19 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 72.31 109.357 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.89 5.86 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.516 1.135 . . . . 65.12 110.987 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.425 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.4 OUTLIER -149.64 129.81 13.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 0.758 . . . . 74.41 110.326 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.43 ' N ' HG11 ' A' ' 324' ' ' VAL . 1.3 m -64.1 113.39 3.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 74.54 110.39 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.501 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 1.7 pt -91.22 -34.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 70.43 109.279 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.495 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 9.7 mt -138.1 165.53 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 72.44 109.285 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -153.57 121.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 73.15 109.303 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.434 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -70.11 126.82 17.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.506 1.129 . . . . 42.03 111.014 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.499 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -44.8 -26.56 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 0.788 . . . . 74.22 109.314 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.6 OUTLIER 47.09 65.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.53 108.285 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -77.09 -171.23 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 73.4 109.299 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 54.66 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.126 . . . . 73.42 109.267 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.2 m -169.62 163.09 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 65.12 110.033 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -65.93 -32.49 74.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.43 109.323 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.32 135.41 57.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.495 1.122 . . . . 74.21 110.339 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.468 ' CD1' ' HE1' ' A' ' 321' ' ' MET . 82.1 mt -143.62 120.78 5.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.33 109.297 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 344' ' ' LEU . 16.2 p -123.27 84.57 2.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.568 1.168 . . . . 74.43 110.422 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 8.2 mp -38.75 147.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 72.55 109.306 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -128.87 -48.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 74.21 109.354 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 155.22 147.36 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 75.42 110.004 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -70.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.528 1.804 . . . . 72.04 111.014 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 74.43 109.317 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.332 -0.618 . . . . 74.1 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 268' ' ' LYS . 1.4 m-20 -141.93 91.44 8.11 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.45 109.307 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.423 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.3 Cg_endo -75.01 -10.69 21.31 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.464 1.771 . . . . 74.01 110.966 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.488 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -39.82 141.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 74.14 109.29 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.406 ' CD2' HD21 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -129.78 105.15 7.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 75.02 109.274 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.497 ' O ' ' CG2' ' A' ' 252' ' ' VAL . 9.7 t-160 -71.24 163.63 27.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 75.55 109.616 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 251' ' ' HIS . 54.8 t -158.38 126.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 65.54 109.29 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -96.84 135.82 38.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.565 1.165 . . . . 70.3 110.296 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 340' ' ' ASN . 48.1 t -108.27 100.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 72.5 109.302 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -60.66 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.52 1.138 . . . . 75.24 109.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 0.1 OUTLIER 53.72 68.89 0.78 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 63.54 109.298 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.25 157.27 15.97 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.492 1.12 . . . . 71.52 110.301 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -52.06 -33.54 39.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 72.33 109.291 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -68.08 -50.96 51.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 72.41 109.363 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p 178.49 -178.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.466 1.104 . . . . 75.44 109.979 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.471 ' CD1' ' HG ' ' A' ' 312' ' ' LEU . 77.7 mt -76.07 178.56 6.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 72.4 109.279 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -176.44 86.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.116 . . . . 75.3 109.619 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 263' ' ' PHE . 4.8 m-30 -96.84 134.09 40.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 75.21 110.995 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.604 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 23.1 mt -127.88 109.62 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 73.44 109.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.468 ' CB ' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.52 129.31 45.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 72.34 109.305 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.653 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -104.19 113.12 26.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 74.35 110.953 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -68.5 72.91 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 72.24 109.248 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.8 mmtt -87.35 53.59 2.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.51 109.294 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 30.7 p -120.64 -176.38 3.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.521 1.138 . . . . 73.23 110.381 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.21 -59.42 2.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 72.45 109.315 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.404 HG12 ' N ' ' A' ' 272' ' ' ILE . 0.1 OUTLIER -78.06 -176.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 74.43 109.308 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.404 ' N ' HG12 ' A' ' 271' ' ' ILE . 2.3 mp -120.22 143.42 32.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.501 1.125 . . . . 63.41 109.29 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 1.4 mp -43.66 142.44 1.87 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.453 1.095 . . . . 74.23 109.335 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -38.15 1.71 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.439 1.757 . . . . 73.41 110.983 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 99.51 160.18 28.98 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.523 1.139 . . . . 74.43 111.007 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 8.1 t-20 81.7 17.34 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 0.749 . . . . 62.52 109.29 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 87.3 m -66.61 170.57 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 74.33 108.303 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.481 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.8 m -153.64 99.24 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.554 1.159 . . . . 72.23 110.405 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.524 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.9 OUTLIER -50.79 171.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.111 . . . . 71.41 111.035 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -172.99 99.4 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 73.22 110.299 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.0 p90 -122.9 141.98 51.29 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.57 1.168 . . . . 73.41 111.015 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 54.7 p -74.88 159.13 32.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 71.15 109.983 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 9.8 p -143.25 -161.55 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.148 . . . . 74.43 110.003 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 286' ' ' SER . 9.1 mt-30 -54.0 -172.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.551 1.157 . . . . 75.43 110.325 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 286' ' ' SER . 1.0 OUTLIER -42.09 -28.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 74.23 109.303 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.429 ' N ' ' C ' ' A' ' 284' ' ' GLN . 0.9 OUTLIER -48.22 175.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 73.41 109.992 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -92.68 149.52 21.27 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.129 . . . . 74.24 110.344 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 10.4 p -52.36 171.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 74.23 109.313 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -145.22 162.36 37.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 74.53 110.992 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.0 t -137.05 124.92 22.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.097 . . . . 74.53 109.983 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 12.5 mt -103.67 148.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.558 1.161 . . . . 73.13 109.295 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 292' ' ' LYS . 0.3 OUTLIER -79.86 123.71 28.0 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 61.51 109.284 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 37.5 mtp -92.77 15.0 15.59 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.561 1.163 . . . . 75.44 110.999 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.19 151.91 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.482 1.114 . . . . 64.2 110.963 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -16.44 20.13 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.53 1.805 . . . . 74.42 110.993 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -62.84 151.14 39.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 73.42 109.6 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -87.6 165.4 15.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.56 1.163 . . . . 71.41 110.319 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 2.7 mm -89.05 -95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 73.43 109.305 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 120.11 168.88 13.9 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.468 1.105 . . . . 74.14 111.013 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.42 ' CG2' ' HD3' ' A' ' 301' ' ' LYS . 15.5 mm -60.36 -43.05 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.507 0.769 . . . . 75.25 109.304 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.42 ' HD3' ' CG2' ' A' ' 300' ' ' ILE . 0.5 OUTLIER -108.94 -12.8 14.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 70.33 109.357 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -81.27 49.62 4.04 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 61.42 111.019 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.524 ' HG2' ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -41.89 164.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 0.784 . . . . 73.41 110.29 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.499 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 41.9 tptt -118.4 165.69 13.56 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.13 . . . . 72.1 109.315 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -134.86 144.96 47.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 72.24 110.346 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.524 HD13 ' CG ' ' A' ' 279' ' ' PHE . 45.3 mt -140.72 61.69 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.44 109.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -72.19 123.02 22.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.963 -1.125 . . . . 74.4 107.963 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 309' ' ' PHE . 57.0 t80 -119.24 172.09 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 74.4 111.001 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -147.24 162.66 31.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.148 . . . . 74.24 110.972 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.03 -46.13 0.4 Allowed 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.025 -2.49 . . . . 64.22 110.952 0.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 28.7 p 177.83 170.41 0.68 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.11 110.011 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.471 ' HG ' ' CD1' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -153.7 161.12 29.99 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.459 1.099 . . . . 73.2 109.288 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 312' ' ' LEU . 18.3 Cg_endo -74.96 144.09 29.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.509 1.794 . . . . 73.13 111.006 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.1 OUTLIER -126.06 165.45 27.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 75.32 110.356 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.04 -176.11 17.43 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.987 -2.505 . . . . 63.1 111.031 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.561 HD23 ' CD2' ' A' ' 319' ' ' TYR . 2.0 mt -98.21 61.42 1.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 75.3 109.311 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.9 p -74.62 119.9 19.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 74.52 110.034 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 317' ' ' SER . 45.3 t30 79.42 40.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.453 1.096 . . . . 71.03 109.338 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.561 ' CD2' HD23 ' A' ' 316' ' ' LEU . 24.3 m-85 -119.84 142.99 48.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 74.03 111.013 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.524 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.3 m -59.75 -56.76 17.76 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 74.42 110.383 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.524 ' C ' ' O ' ' A' ' 320' ' ' THR . 0.9 OUTLIER 26.93 58.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 74.2 110.953 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 29.6 mttm -94.86 -168.17 1.77 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 73.41 109.321 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.414 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 2.9 t -150.35 133.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 74.3 109.268 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.481 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 10.9 m -109.98 172.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 72.52 109.23 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -109.61 -163.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.494 1.121 . . . . 73.44 109.268 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.16 -12.86 22.1 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.133 . . . . 71.52 110.303 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.5 22.81 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 70.34 109.356 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.27 25.66 0.79 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.543 1.152 . . . . 74.23 111.012 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -106.78 128.66 54.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 0.76 . . . . 72.22 110.286 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 9.0 m -54.29 135.02 45.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.112 . . . . 75.41 110.413 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.4 pt -114.99 -42.09 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.136 . . . . 64.21 109.293 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 12.6 mt -136.42 171.25 14.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 70.0 109.273 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.443 HG13 ' CG ' ' A' ' 322' ' ' LYS . 14.6 m -153.31 141.24 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.41 109.336 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -84.97 136.89 14.95 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.489 1.118 . . . . 71.21 110.988 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.433 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -67.2 -38.56 85.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 0.749 . . . . 75.35 109.302 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.433 ' N ' ' HG2' ' A' ' 335' ' ' LYS . 0.1 OUTLIER 40.18 88.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.496 1.123 . . . . 70.5 108.299 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -116.81 81.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 72.44 109.28 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 338' ' ' ASP . 3.4 p-10 39.93 49.9 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.15 . . . . 75.31 109.258 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 26.9 m -157.21 136.67 12.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 74.45 109.997 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.486 ' O ' ' CG2' ' A' ' 254' ' ' VAL . 7.1 m120 -58.14 -36.82 73.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 75.11 109.326 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.19 134.41 48.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.549 1.156 . . . . 74.41 110.315 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 252' ' ' VAL . 4.8 mt -136.35 134.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 64.42 109.31 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 344' ' ' LEU . 39.3 p -125.27 86.38 2.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 65.44 110.363 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.406 HD21 ' CD2' ' A' ' 250' ' ' LEU . 7.2 mp -40.38 130.85 2.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 71.25 109.32 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.9 ptpt -117.54 -60.04 1.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.107 . . . . 65.3 109.292 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.47 157.28 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 75.24 110.012 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 -61.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.536 1.809 . . . . 73.05 110.999 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 74.13 109.282 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.331 -0.618 . . . . 73.52 109.331 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -143.64 74.76 16.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 74.13 109.325 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -0.21 9.66 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.517 1.798 . . . . 75.05 111.015 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.444 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -75.1 148.89 39.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 75.45 109.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.556 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -110.8 99.94 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.582 1.176 . . . . 73.15 109.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.412 ' NE2' ' HG2' ' A' ' 341' ' ' GLU . 2.4 t-160 -90.33 131.54 36.07 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 73.45 109.614 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 253' ' ' GLU . 79.7 t -121.08 164.64 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 75.02 109.306 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.434 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 17.4 tp10 -129.72 147.26 51.48 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 74.35 110.325 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.462 ' CG1' HG23 ' A' ' 314' ' ' THR . 61.6 t -121.19 106.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.145 . . . . 71.25 109.335 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 t -72.85 -61.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.12 110.002 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.45 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 5.9 t-20 53.42 57.03 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 62.35 109.287 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 260' ' ' SER . 5.0 pt-20 -161.15 -174.54 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 75.25 110.344 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 71.86 17.15 5.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 71.33 109.268 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 3.6 m-20 82.61 18.77 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 75.14 109.317 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 257' ' ' GLU . 0.0 OUTLIER -170.05 -170.07 0.94 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 54.03 109.983 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -98.87 165.72 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.546 1.154 . . . . 73.54 109.298 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.85 102.38 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 73.11 109.611 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.438 ' CE2' HG23 ' A' ' 254' ' ' VAL . 85.1 m-85 -107.73 142.15 38.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.535 1.147 . . . . 73.31 110.977 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.486 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 53.2 mt -132.84 124.25 50.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.528 1.142 . . . . 74.44 109.314 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -120.53 141.87 49.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 64.02 109.291 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 1.1 m-85 -127.78 140.52 52.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.516 1.135 . . . . 73.13 110.986 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 267' ' ' ASN . 46.7 p-10 -89.79 64.24 6.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 72.52 109.275 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.479 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -58.03 -15.96 11.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 74.1 109.284 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 268' ' ' LYS . 43.8 p -54.68 -166.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 74.25 110.39 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -99.15 -59.03 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 74.34 109.331 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 4.1 pt -60.29 152.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.463 1.102 . . . . 75.44 109.282 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.77 149.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 73.4 109.291 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 3.5 mm -67.18 139.13 94.91 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.127 . . . . 74.43 109.317 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -26.95 10.52 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.486 1.782 . . . . 73.11 110.973 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 81.36 -178.51 53.86 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.504 1.128 . . . . 55.4 111.047 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 57.16 49.48 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 0.76 . . . . 70.11 109.323 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.414 ' CB ' ' SD ' ' A' ' 293' ' ' MET . 12.2 m -94.73 178.97 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 61.23 108.325 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.0 OUTLIER -152.22 97.31 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 61.21 110.378 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.596 ' CG ' ' CD1' ' A' ' 306' ' ' LEU . 0.2 OUTLIER -53.79 159.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 74.55 110.969 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 321' ' ' MET . 13.3 tt0 -143.61 75.94 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 75.3 110.327 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -109.45 121.79 45.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.145 . . . . 73.12 110.962 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.558 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 3.7 p -109.19 179.61 4.11 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 73.14 109.981 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.568 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.4 p -119.84 -42.03 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 54.5 110.01 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.413 ' C ' ' N ' ' A' ' 286' ' ' SER . 6.3 tp-100 -148.25 166.43 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.43 110.299 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 286' ' ' SER . 4.2 tt -47.19 -25.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.49 1.119 . . . . 75.04 109.306 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.413 ' N ' ' C ' ' A' ' 284' ' ' GLN . 12.6 t -38.54 -76.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 64.33 109.971 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.95 174.24 15.28 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.139 . . . . 64.42 110.328 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 282' ' ' SER . 14.8 p -122.47 170.57 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 75.24 109.299 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -131.69 137.83 48.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 74.32 111.054 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 54.1 p -116.75 126.21 52.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.122 . . . . 73.41 109.987 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 8.5 mt -105.11 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 73.22 109.289 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.459 ' CD ' HG21 ' A' ' 278' ' ' THR . 8.7 mmtp -67.32 110.81 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.531 1.144 . . . . 71.15 109.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.459 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 93.0 mtp -81.76 134.79 35.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 74.24 111.006 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.68 145.52 0.13 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.515 1.135 . . . . 73.21 111.031 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -20.95 16.5 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.516 1.798 . . . . 73.42 111.013 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.74 129.14 38.77 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 73.21 109.577 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.09 153.16 30.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.124 . . . . 74.12 110.254 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.6 ' CG2' ' N ' ' A' ' 299' ' ' GLY . 3.2 mt -70.22 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 71.2 109.293 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.6 ' N ' ' CG2' ' A' ' 298' ' ' ILE . . . 108.69 -177.04 20.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.505 1.128 . . . . 71.1 111.004 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 299' ' ' GLY . 59.6 mt -38.24 -90.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 74.24 109.282 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -91.3 23.93 3.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.21 109.272 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -83.74 45.14 3.42 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 75.15 111.006 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 302' ' ' GLY . 1.4 pt20 -39.99 161.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 0.761 . . . . 73.52 110.283 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.506 ' HB2' ' CG1' ' A' ' 298' ' ' ILE . 30.5 tptt -121.92 152.35 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 72.44 109.281 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 11.9 mp0 -118.37 133.83 55.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 71.41 110.307 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.596 ' CD1' ' CG ' ' A' ' 279' ' ' PHE . 35.5 mt -126.35 55.57 1.49 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 74.23 109.303 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 138.34 55.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 75.34 107.999 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.552 ' CE2' HD13 ' A' ' 312' ' ' LEU . 37.2 t80 -134.64 166.59 22.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.14 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -138.99 148.09 56.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 74.34 111.028 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.01 -53.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.005 -2.498 . . . . 73.15 110.975 0.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 23.6 p -178.8 162.66 1.35 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.503 1.127 . . . . 63.53 109.971 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.552 HD13 ' CE2' ' A' ' 308' ' ' PHE . 1.0 OUTLIER -128.61 159.16 69.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.157 . . . . 74.01 109.292 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 145.07 31.03 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.483 1.781 . . . . 73.11 111.007 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.492 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.9 OUTLIER -125.81 160.27 57.24 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 74.33 110.395 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.9 170.35 71.98 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.032 -2.487 . . . . 75.53 111.057 -0.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.462 ' CD2' ' HE3' ' A' ' 321' ' ' MET . 5.7 mp -87.68 66.26 8.81 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.536 1.147 . . . . 75.4 109.28 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.6 p -81.78 127.31 32.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 1.145 . . . . 73.35 109.975 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.2 OUTLIER 76.66 21.47 1.27 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 74.43 109.262 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 283' ' ' SER . 3.3 m-85 -103.93 134.08 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.521 1.138 . . . . 73.43 111.039 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.461 ' O ' ' C ' ' A' ' 321' ' ' MET . 88.7 m -51.25 -60.54 3.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 62.4 110.42 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.47 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 3.5 ttm 33.08 40.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 74.25 110.996 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.455 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 36.1 mttt -72.81 -174.0 1.34 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 74.51 109.287 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 t -143.51 121.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 72.31 109.32 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 28.4 m -110.12 171.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 75.44 109.356 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.477 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 0.1 OUTLIER -109.17 -155.51 0.56 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 72.54 109.296 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -77.38 -4.0 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.56 1.163 . . . . 75.44 110.324 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -105.25 8.98 34.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 70.12 109.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.74 14.89 24.4 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.472 1.108 . . . . 72.24 110.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 7.3 pt-20 -95.83 116.39 28.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 71.04 110.279 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 1.8 m -50.83 96.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.45 110.386 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 3.1 pt -66.81 -36.87 78.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 74.21 109.312 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 346' ' ' SER . 12.6 mt -147.19 170.7 16.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 73.44 109.323 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.463 ' CG1' ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -147.17 119.3 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 75.45 109.291 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -71.45 125.09 11.42 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.543 1.152 . . . . 73.4 111.004 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.488 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -48.85 -26.44 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.563 0.802 . . . . 72.41 109.324 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 48.33 62.08 2.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 75.0 108.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.458 ' CB ' ' NZ ' ' A' ' 335' ' ' LYS . . . -73.39 -176.78 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 74.35 109.315 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.62 55.98 1.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 73.31 109.262 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.7 m -169.08 149.16 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 61.33 109.973 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . 0.418 ' N ' ' HB3' ' A' ' 315' ' ' PRO . 10.2 m-20 -55.31 -19.95 10.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 74.41 109.29 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.412 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 18.4 mt-10 -72.69 141.37 48.22 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 73.13 110.302 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.475 ' HA ' ' CE ' ' A' ' 335' ' ' LYS . 64.5 mt -146.84 120.84 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.13 . . . . 73.13 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 344' ' ' LEU . 15.4 p -123.94 85.44 2.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.451 1.095 . . . . 73.24 110.345 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 8.4 mp -39.31 152.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 75.41 109.31 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -129.87 -51.72 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 60.14 109.306 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 158.18 146.97 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 70.05 110.018 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . 0.463 ' HA ' ' CG1' ' A' ' 333' ' ' VAL . 18.1 Cg_endo -74.98 -50.71 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.502 1.791 . . . . 74.22 110.986 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.13 . . . . 74.24 109.308 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.329 -0.619 . . . . 73.41 109.329 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.93 147.7 52.1 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.479 1.112 . . . . 75.11 109.319 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -3.79 14.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.46 1.769 . . . . 74.34 111.009 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.495 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.71 132.53 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 72.22 109.332 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 343' ' ' THR . 0.5 OUTLIER -116.58 103.21 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.41 109.302 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -67.35 147.35 53.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 72.53 109.592 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 45.1 t -145.37 161.92 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 71.21 109.358 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -134.39 132.48 39.47 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.138 . . . . 73.52 110.296 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.462 ' CG1' HG22 ' A' ' 314' ' ' THR . 94.8 t -109.69 110.72 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 72.12 109.246 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.428 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.7 t -77.93 -67.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.13 . . . . 63.41 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.408 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 4.8 t-20 61.15 63.91 1.18 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.56 1.162 . . . . 71.21 109.287 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -88.86 148.61 23.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 72.41 110.291 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.04 -24.58 1.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.474 1.109 . . . . 75.21 109.322 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -76.18 -55.37 5.64 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 72.04 109.306 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.9 m -168.37 -175.02 2.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.529 1.143 . . . . 73.41 109.942 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 312' ' ' LEU . 13.1 mt -86.48 176.02 8.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.24 109.316 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 10.7 t-160 -174.71 107.93 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.54 109.573 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -112.13 118.56 35.7 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 75.45 111.032 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.505 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 13.7 mt -112.39 104.59 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 64.01 109.254 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.47 ' CD1' HD11 ' A' ' 306' ' ' LEU . 0.8 OUTLIER -101.4 129.79 47.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 75.34 109.319 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -102.54 119.05 38.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 72.25 110.983 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.486 ' OD1' ' CD1' ' A' ' 273' ' ' ILE . 34.9 t30 -65.71 75.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.132 . . . . 75.44 109.276 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.1 mmtt -92.07 64.63 4.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 74.2 109.305 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 72.5 p -142.67 160.43 40.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 74.21 110.406 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.48 -54.27 45.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 73.53 109.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.4 pt -69.8 163.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 73.42 109.292 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 17.9 mt -114.74 139.14 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 73.5 109.333 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.486 ' CD1' ' OD1' ' A' ' 267' ' ' ASN . 1.8 mp -54.68 137.23 63.25 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 75.4 109.296 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.2 Cg_endo -75.01 -26.34 10.99 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.494 1.787 . . . . 70.21 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.61 157.76 29.61 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.504 1.127 . . . . 72.23 111.011 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.5 t30 73.41 39.44 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 0.755 . . . . 75.44 109.277 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.45 -174.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 63.45 108.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.445 ' HB ' ' CG1' ' A' ' 324' ' ' VAL . 7.3 m -155.12 156.26 35.47 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.44 1.087 . . . . 63.42 110.384 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 322' ' ' LYS . 1.9 t80 -108.75 171.07 7.64 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 74.33 110.968 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -161.59 93.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 71.11 110.31 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.407 ' HZ ' ' CD1' ' A' ' 308' ' ' PHE . 13.9 p90 -113.6 133.91 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 74.42 110.991 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -94.4 -175.18 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 73.45 109.987 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.564 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 24.8 t -173.48 -169.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 64.34 110.017 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.98 -14.75 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.32 110.268 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 286' ' ' SER . 2.3 pt -63.44 -16.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 75.25 109.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 285' ' ' ILE . 0.5 OUTLIER 87.51 -59.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 71.41 109.974 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.52 170.29 10.91 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.118 . . . . 71.3 110.335 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 8.8 p -126.43 171.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 73.43 109.274 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -148.23 149.31 31.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.527 1.142 . . . . 74.4 110.965 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.9 p -118.43 128.09 54.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 73.54 109.984 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 17.7 mt -101.63 129.01 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.107 . . . . 71.32 109.278 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -72.01 114.62 10.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 74.55 109.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.454 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 61.8 mtp -88.18 144.71 26.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 74.35 111.077 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -41.49 147.58 0.41 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.517 1.135 . . . . 62.13 111.005 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -17.83 19.28 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.783 . . . . 72.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -72.88 -177.04 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.468 1.105 . . . . 74.45 109.63 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.36 174.49 5.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.24 110.32 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.7 mt -104.46 -82.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.113 . . . . 73.33 109.298 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.98 159.57 20.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.54 1.15 . . . . 74.32 111.007 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.61 -63.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.5 0.764 . . . . 75.44 109.287 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.52 -29.3 68.67 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.497 1.123 . . . . 74.32 109.276 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -68.52 156.61 53.18 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.464 1.103 . . . . 44.24 110.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.81 171.68 12.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 0.768 . . . . 71.54 110.311 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 293' ' ' MET . 37.2 tptt -118.78 165.11 14.43 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 73.33 109.341 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -143.88 124.6 14.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 72.53 110.279 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' A' ' 265' ' ' LEU . 10.3 mt -135.97 60.21 1.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 73.15 109.333 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.479 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 11.2 p-90 -72.48 134.68 45.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.514 1.134 . . . . 75.21 108.034 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.6 ' CE2' ' CD1' ' A' ' 312' ' ' LEU . 45.3 t80 -126.12 166.73 16.48 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.122 . . . . 74.13 111.028 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -137.91 157.16 73.72 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 74.43 110.972 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.95 -41.31 1.02 Allowed 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.99 -2.504 . . . . 73.45 111.038 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 172.93 143.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.51 109.993 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 4.4 mp -115.16 159.58 37.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.55 109.316 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 148.5 35.31 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 75.54 110.988 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -130.35 164.42 41.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 73.44 110.382 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 -177.73 21.36 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.019 -2.492 . . . . 74.14 111.006 0.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.573 HD21 ' CE2' ' A' ' 319' ' ' TYR . 1.8 mt -102.49 52.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.442 1.089 . . . . 74.22 109.308 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.4 p -76.08 127.19 32.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 75.0 109.988 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 317' ' ' SER . 28.7 t30 81.07 30.83 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 75.11 109.342 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.573 ' CE2' HD21 ' A' ' 316' ' ' LEU . 5.2 m-85 -109.56 167.55 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.44 111.035 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.527 ' O ' ' C ' ' A' ' 321' ' ' MET . 32.3 m -79.6 -59.75 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 64.45 110.425 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.601 ' CE ' ' CD1' ' A' ' 342' ' ' ILE . 0.6 OUTLIER 27.03 79.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.108 . . . . 74.41 110.971 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 279' ' ' PHE . 7.6 pttt -112.66 -170.66 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 72.54 109.325 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 49.4 t -136.89 138.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 72.14 109.305 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.445 ' CG1' ' HB ' ' A' ' 278' ' ' THR . 0.4 OUTLIER -122.4 138.69 51.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.554 1.158 . . . . 75.01 109.271 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 324' ' ' VAL . 0.5 OUTLIER -76.82 -170.54 1.63 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.13 . . . . 74.23 109.284 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -78.99 4.32 14.66 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 73.35 110.267 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.04 -3.28 41.7 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 74.42 109.296 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 65.21 54.47 26.96 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.485 1.116 . . . . 74.14 110.998 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 9.9 pt-20 -157.04 121.86 4.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 0.77 . . . . 64.35 110.311 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' THR . . . . . . . . . . . . . 69.0 m -45.26 115.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.516 1.135 . . . . 71.54 110.406 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 36.5 pt -98.76 -41.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 73.31 109.297 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.467 ' C ' ' CG1' ' A' ' 333' ' ' VAL . 10.4 mt -131.48 168.45 17.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 74.51 109.286 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.467 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.38 122.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 74.1 109.336 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.421 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -72.45 121.53 8.17 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.131 . . . . 74.14 111.006 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.499 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -45.22 -26.71 0.53 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.461 0.742 . . . . 73.21 109.293 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 321' ' ' MET . 0.1 OUTLIER 47.83 76.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 62.14 108.312 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -90.3 -175.8 4.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 65.24 109.285 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.82 62.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.466 1.103 . . . . 65.33 109.302 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 15.4 m -171.08 150.2 3.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 74.32 109.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -60.38 -21.17 61.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 63.42 109.302 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -78.12 148.46 34.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.136 . . . . 74.15 110.289 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.601 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 57.1 mt -147.55 140.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.478 1.111 . . . . 74.22 109.309 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 250' ' ' LEU . 11.4 p -136.13 95.53 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 64.24 110.358 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 7.6 mp -49.97 153.63 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 73.22 109.311 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.499 ' HD3' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -128.51 -76.44 0.56 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 74.13 109.286 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 5.0 p 164.84 134.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.491 1.119 . . . . 73.11 110.057 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.443 1.76 . . . . 54.31 111.039 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 75.45 109.288 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.261 -0.644 . . . . 73.31 109.261 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.42 104.46 1.84 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.148 . . . . 71.13 109.25 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.454 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.4 Cg_endo -75.02 -1.09 10.78 Favored 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 72.22 111.017 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -40.45 144.53 0.23 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 75.54 109.273 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.551 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -115.55 99.76 7.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 72.31 109.302 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.418 ' NE2' HD22 ' A' ' 249' ' ' LEU . 18.8 m170 -95.52 130.83 42.22 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 74.4 109.569 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 253' ' ' GLU . 69.6 t -124.71 166.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 73.42 109.302 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.451 ' N ' ' CG1' ' A' ' 252' ' ' VAL . 27.8 tt0 -122.67 123.34 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 74.32 110.316 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.02 107.5 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 75.34 109.318 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -59.59 2.51 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 61.44 109.969 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.426 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 2.9 t-20 60.71 70.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.25 109.243 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -105.32 161.97 13.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.556 1.16 . . . . 63.34 110.293 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 259' ' ' ASN . 46.1 m-20 -41.15 -60.22 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.561 1.163 . . . . 73.41 109.293 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 258' ' ' ASP . 66.5 t30 -40.07 -64.34 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 62.33 109.353 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -178.6 -174.54 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 72.51 109.999 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.474 ' CD1' HD13 ' A' ' 312' ' ' LEU . 46.8 mt -76.19 153.97 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.491 1.119 . . . . 74.13 109.318 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -142.03 91.66 2.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 72.44 109.603 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.573 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 8.2 m-30 -98.84 133.99 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.475 1.11 . . . . 61.52 110.977 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.638 ' CG2' ' CE2' ' A' ' 266' ' ' TYR . 62.6 mt -127.93 121.2 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 73.51 109.294 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 304' ' ' LYS . 0.4 OUTLIER -107.3 119.67 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 74.41 109.32 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.638 ' CE2' ' CG2' ' A' ' 264' ' ' ILE . 5.1 m-85 -109.03 92.16 3.94 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.502 1.126 . . . . 73.23 111.027 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -54.45 95.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 70.02 109.282 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.7 28.18 7.74 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 75.11 109.343 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 61.3 p -87.52 -174.94 5.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.545 1.153 . . . . 72.13 110.388 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -88.69 -56.17 3.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.43 109.333 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 271' ' ' ILE . 0.1 OUTLIER -60.18 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.44 1.088 . . . . 71.13 109.342 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.409 ' N ' HG12 ' A' ' 271' ' ' ILE . 4.1 mp -124.77 123.21 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.493 1.121 . . . . 72.35 109.307 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 3.5 mm -40.94 137.75 1.42 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 74.31 109.306 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.03 -24.46 12.75 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.501 1.79 . . . . 72.2 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.42 169.17 31.97 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.501 1.126 . . . . 74.05 111.008 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.0 t30 63.44 36.76 11.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 0.754 . . . . 65.22 109.344 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.411 ' C ' ' OG1' ' A' ' 278' ' ' THR . 64.1 m -90.44 -176.5 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.448 1.093 . . . . 73.42 108.316 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.411 ' OG1' ' C ' ' A' ' 277' ' ' CYS . 1.6 m -153.77 129.02 9.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 71.31 110.381 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.2 179.21 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.505 1.128 . . . . 75.42 111.017 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -169.97 97.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.11 . . . . 74.23 110.308 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.625 ' CE1' ' CE2' ' A' ' 308' ' ' PHE . 4.4 p90 -120.65 121.66 38.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 71.11 111.02 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 m -101.84 143.54 31.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.564 1.165 . . . . 71.15 110.027 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 56.6 m -121.65 -51.36 2.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 64.33 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -104.44 171.5 7.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 73.33 110.28 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.77 5.89 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.106 . . . . 74.23 109.322 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.2 m -69.99 -71.07 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.505 1.128 . . . . 73.42 109.989 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.66 174.84 12.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 70.31 110.247 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.05 154.16 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 61.0 109.308 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -122.7 156.73 33.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 74.32 111.014 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 6.1 p -128.1 126.34 40.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.515 1.134 . . . . 72.21 110.025 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 5.5 mt -97.68 129.47 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.133 . . . . 74.51 109.306 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -67.28 121.07 14.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 73.04 109.285 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 98.7 mtp -89.06 140.2 29.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 72.23 111.003 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.472 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -40.7 144.23 0.56 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.486 1.116 . . . . 74.51 110.989 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -24.72 12.72 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.509 1.794 . . . . 72.13 111.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -63.66 163.91 10.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.525 1.141 . . . . 72.43 109.61 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -100.12 128.92 46.12 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 73.34 110.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 77.0 mt -57.63 -72.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.122 . . . . 75.1 109.345 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.02 172.15 24.3 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.497 1.123 . . . . 53.54 110.997 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 13.4 mt -60.39 -54.69 31.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 74.21 109.325 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 36.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 75.4 109.27 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -125.46 147.16 16.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.57 1.169 . . . . 72.2 111.006 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -119.74 170.66 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 0.774 . . . . 75.4 110.313 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.472 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 46.3 tptt -140.4 149.72 42.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 74.44 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 2.1 mt-10 -115.23 151.16 34.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 71.21 110.327 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 20.4 mt -152.25 69.24 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.483 1.114 . . . . 70.33 109.291 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.518 ' CE2' ' HB3' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -75.23 119.74 19.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 64.3 108.005 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.7 m-30 -113.46 142.13 46.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 73.42 110.998 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -128.59 160.37 63.08 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 74.53 111.017 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 311' ' ' SER . 18.4 Cg_endo -74.97 -36.2 2.67 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 121.027 -2.489 . . . . 75.31 110.979 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.5 p 162.14 127.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.534 1.146 . . . . 70.45 110.025 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.474 HD13 ' CD1' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -99.32 169.5 8.07 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.417 1.073 . . . . 73.01 109.301 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 143.54 29.22 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 74.01 110.991 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.478 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.7 OUTLIER -131.27 162.17 57.46 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.559 1.162 . . . . 74.3 110.377 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.0 167.98 78.83 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.027 -2.489 . . . . 74.31 111.021 -0.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 319' ' ' TYR . 3.7 mp -87.85 46.83 1.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 73.51 109.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 58.1 p -67.7 115.8 7.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 75.14 109.961 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 317' ' ' SER . 4.2 t30 83.42 39.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 75.31 109.277 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.516 ' CG ' ' HB3' ' A' ' 316' ' ' LEU . 5.6 m-85 -116.17 150.56 37.26 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.547 1.155 . . . . 75.24 111.003 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.476 ' CG2' ' HG3' ' A' ' 322' ' ' LYS . 87.7 m -57.57 -64.11 1.01 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 1.139 . . . . 65.51 110.378 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.465 ' HE2' ' CD2' ' A' ' 316' ' ' LEU . 0.5 OUTLIER 35.39 33.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 74.23 111.02 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.476 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 90.9 mttt -72.99 -176.53 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 75.23 109.334 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 5.6 t -142.88 138.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.441 1.088 . . . . 74.54 109.293 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 329' ' ' GLU . 0.0 OUTLIER -116.11 152.11 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 73.52 109.289 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' A' ' 331' ' ' ILE . 0.4 OUTLIER -91.83 -173.6 3.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 63.45 109.268 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -75.45 -0.87 21.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.491 1.119 . . . . 63.14 110.299 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.47 -10.11 33.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 74.13 109.258 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.04 48.06 16.88 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.447 1.092 . . . . 70.44 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.565 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 9.7 pt-20 -153.8 110.48 3.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 73.24 110.288 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.437 ' N ' HG12 ' A' ' 324' ' ' VAL . 12.2 m -38.53 125.57 1.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.534 1.146 . . . . 72.02 110.445 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.411 HD13 ' ND2' ' A' ' 325' ' ' ASN . 6.8 pt -100.58 -37.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 74.34 109.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.476 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 9.2 mt -134.23 165.56 24.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 74.15 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.47 HG13 ' CA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -145.67 118.77 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 75.51 109.309 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.419 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -74.86 135.92 19.84 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.494 1.121 . . . . 72.31 110.993 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -79.93 -29.43 39.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 0.741 . . . . 73.53 109.265 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.51 ' SG ' ' CD1' ' A' ' 342' ' ' ILE . 12.1 t 40.07 88.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 75.54 108.339 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -78.39 -161.05 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.447 1.092 . . . . 75.3 109.298 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -81.69 58.08 3.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.494 1.121 . . . . 63.53 109.322 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 57.7 m -172.15 166.13 6.07 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 63.2 110.007 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.58 -15.85 63.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 75.23 109.308 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.03 141.15 45.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 74.01 110.318 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.51 ' CD1' ' SG ' ' A' ' 336' ' ' CYS . 8.5 mt -148.2 116.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 75.24 109.286 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.403 HG22 ' CD2' ' A' ' 251' ' ' HIS . 9.6 p -119.65 113.65 21.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 73.34 110.446 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -67.69 145.9 54.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.464 1.102 . . . . 74.51 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -123.25 -44.66 2.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 73.21 109.284 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.1 t 153.96 156.14 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.23 110.02 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . 0.47 ' CA ' HG13 ' A' ' 333' ' ' VAL . 18.5 Cg_endo -74.99 -49.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.487 1.783 . . . . 70.1 111.038 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.551 1.157 . . . . 71.43 109.289 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.2 p30 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.309 -0.626 . . . . 64.13 109.309 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . 0.445 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 1.3 m-20 -96.23 151.29 38.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.536 1.148 . . . . 73.13 109.318 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.448 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.3 Cg_endo -74.92 -0.04 9.45 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.504 1.792 . . . . 72.32 111.007 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.479 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -39.93 144.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.545 1.153 . . . . 73.34 109.293 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.541 ' CD1' ' C ' ' A' ' 250' ' ' LEU . 0.1 OUTLIER -116.64 100.55 7.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.103 . . . . 73.02 109.282 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.438 ' CD2' HG21 ' A' ' 343' ' ' THR . 10.1 m80 -90.93 128.58 36.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.529 1.143 . . . . 75.54 109.603 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 265' ' ' LEU . 58.9 t -120.52 167.27 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 73.1 109.306 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.419 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.3 tp10 -128.06 135.24 49.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 63.51 110.325 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 314' ' ' THR . 89.6 t -109.61 109.49 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 75.3 109.305 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 m -79.73 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 74.04 110.023 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.458 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 0.1 OUTLIER 63.56 71.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.545 1.153 . . . . 73.4 109.288 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -91.13 147.34 23.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 71.22 110.305 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.99 -35.29 33.07 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.146 . . . . 75.54 109.271 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.73 -46.95 73.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 75.43 109.293 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.5 m -174.25 -173.4 0.78 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.137 . . . . 65.44 109.996 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 256' ' ' ASN . 10.2 mt -87.47 161.82 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 1.125 . . . . 73.33 109.329 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -159.91 101.43 1.45 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 75.25 109.605 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.45 ' CZ ' HD22 ' A' ' 261' ' ' LEU . 51.1 m-85 -110.89 129.17 55.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 75.32 110.95 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.568 HG23 ' CE1' ' A' ' 266' ' ' TYR . 48.0 mt -119.37 119.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 72.44 109.26 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.456 ' CD2' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -112.41 139.96 47.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 74.54 109.285 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.568 ' CE1' HG23 ' A' ' 264' ' ' ILE . 4.5 m-85 -126.97 114.9 18.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.442 1.089 . . . . 71.2 110.998 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.494 ' CG ' ' CG2' ' A' ' 298' ' ' ILE . 48.5 p-10 -69.19 77.06 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.143 . . . . 75.54 109.284 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' CE ' ' HA ' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -78.89 55.23 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 1.117 . . . . 75.22 109.304 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 17.9 p -125.45 -170.5 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 75.52 110.371 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -94.42 -52.79 4.18 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 1.127 . . . . 74.22 109.304 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.63 169.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 74.13 109.298 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 273' ' ' ILE . 3.8 mp -106.28 161.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 74.44 109.306 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.448 HG13 ' CD1' ' A' ' 298' ' ' ILE . 3.6 mm -92.36 137.4 24.68 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.559 1.162 . . . . 75.03 109.294 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 -23.87 13.31 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.56 1.821 . . . . 71.43 110.976 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 74.05 161.72 7.8 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.53 1.144 . . . . 72.44 110.972 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 6.0 t30 81.69 22.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 0.777 . . . . 63.21 109.301 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.412 ' C ' ' OG1' ' A' ' 278' ' ' THR . 22.4 m -69.15 -178.23 1.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 71.52 108.3 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.7 m -153.81 106.5 2.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 74.5 110.415 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.517 ' CG ' HD11 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -60.53 173.09 0.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 73.21 111.038 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -168.43 92.21 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.107 . . . . 73.41 110.32 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 7.2 p90 -116.17 146.98 41.87 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.44 1.087 . . . . 73.43 110.977 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.419 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 82.9 p -72.57 -179.8 3.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 71.34 109.992 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 312' ' ' LEU . 1.9 m -156.67 175.77 13.61 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 72.01 109.99 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.445 ' C ' ' N ' ' A' ' 286' ' ' SER . 41.3 tt0 -98.48 139.4 34.28 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 72.12 110.288 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 284' ' ' GLN . 1.6 pt 39.31 30.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.125 . . . . 73.04 109.324 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.445 ' N ' ' C ' ' A' ' 284' ' ' GLN . 4.7 m -142.34 172.08 13.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 73.21 110.033 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.87 141.42 34.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 73.22 110.341 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 11.6 p -48.34 149.6 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 74.34 109.311 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.423 ' CD2' ' CE1' ' A' ' 308' ' ' PHE . 5.8 t80 -134.33 144.72 48.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 72.24 111.011 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 m -114.17 121.93 45.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 75.12 110.006 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 308' ' ' PHE . 18.8 mt -101.86 128.56 54.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.52 1.138 . . . . 74.21 109.288 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.469 ' CD ' HG22 ' A' ' 278' ' ' THR . 0.0 OUTLIER -68.06 99.66 0.9 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 74.44 109.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.449 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 78.9 mtp -56.33 152.26 11.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 75.43 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . 0.547 ' CA ' ' NZ ' ' A' ' 304' ' ' LYS . . . -35.33 140.57 0.17 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.57 1.169 . . . . 64.02 111.025 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 294' ' ' GLY . 18.1 Cg_endo -75.03 -22.98 14.2 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.521 1.8 . . . . 70.22 110.996 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -76.17 172.66 12.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.12 . . . . 74.33 109.61 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -107.59 124.3 49.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.147 . . . . 73.44 110.302 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.494 ' CG2' ' CG ' ' A' ' 267' ' ' ASN . 15.0 mt -47.07 -67.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 73.23 109.301 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.58 159.56 32.9 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.486 1.116 . . . . 65.21 111.026 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 19.2 mt -43.23 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.477 0.751 . . . . 73.44 109.317 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.469 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 62.75 75.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 74.13 109.315 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 298' ' ' ILE . . . -135.07 173.46 21.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.453 1.096 . . . . 73.43 111.022 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.28 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 0.758 . . . . 72.41 110.293 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.547 ' NZ ' ' CA ' ' A' ' 294' ' ' GLY . 40.3 tptt -159.49 155.04 25.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 70.51 109.261 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . 0.425 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 5.4 mt-10 -130.25 139.96 50.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 73.33 110.294 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.517 HD11 ' CG ' ' A' ' 279' ' ' PHE . 16.0 mt -143.3 38.74 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.523 1.14 . . . . 73.54 109.285 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -49.55 148.3 2.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.959 -1.126 . . . . 75.04 107.959 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.532 ' CD1' HD11 ' A' ' 291' ' ' ILE . 12.5 t80 -147.43 168.18 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 74.13 111.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -141.12 161.18 54.77 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 75.53 111.013 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.98 -47.77 0.3 Allowed 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.007 -2.497 . . . . 74.11 111.018 -0.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.0 p 177.14 133.58 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 1.112 . . . . 73.44 109.951 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.453 ' CD1' HD12 ' A' ' 261' ' ' LEU . 5.6 mp -110.96 158.78 34.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 73.13 109.351 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 146.65 32.67 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.493 1.786 . . . . 75.51 110.988 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.482 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.7 OUTLIER -124.64 161.98 45.37 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 73.54 110.372 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.02 -178.85 24.69 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.01 -2.496 . . . . 73.23 110.995 0.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.511 HD22 ' CD2' ' A' ' 319' ' ' TYR . 1.7 mt -95.53 64.87 2.63 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.128 . . . . 73.13 109.284 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 32.4 t -81.16 123.08 28.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 63.23 110.006 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 317' ' ' SER . 44.0 t30 81.95 20.21 0.33 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 63.2 109.298 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.511 ' CD2' HD22 ' A' ' 316' ' ' LEU . 24.0 m-85 -101.99 114.05 27.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.562 1.164 . . . . 74.03 111.007 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.481 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.0 OUTLIER -37.75 -51.18 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 61.45 110.377 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.489 ' HG2' ' CZ ' ' A' ' 279' ' ' PHE . 7.1 ttm 30.93 52.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 74.42 110.985 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.46 ' HD2' ' CG2' ' A' ' 320' ' ' THR . 33.0 mttt -81.08 -170.18 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.55 109.264 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.487 HG23 ' CE1' ' A' ' 279' ' ' PHE . 5.8 t -151.61 130.32 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.525 1.141 . . . . 75.52 109.338 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 16.1 m -108.1 179.02 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 74.34 109.309 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.61 -172.4 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 53.15 109.306 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.16 -4.8 15.02 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 74.2 110.264 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.18 -7.12 33.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 71.34 109.321 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.12 54.63 6.83 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.503 1.127 . . . . 74.32 110.999 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.442 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.72 130.24 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 0.773 . . . . 72.42 110.302 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.422 ' N ' HG13 ' A' ' 324' ' ' VAL . 4.9 m -62.19 122.74 16.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 73.32 110.421 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.502 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.3 pt -105.4 -34.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.474 1.109 . . . . 75.3 109.256 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.425 ' HB3' ' CD2' ' A' ' 344' ' ' LEU . 6.6 mt -130.16 164.19 25.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 74.51 109.336 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -146.19 132.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 75.35 109.293 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.41 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -92.51 114.15 4.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.436 1.085 . . . . 75.41 111.035 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.744 ' NZ ' ' H ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -42.79 -27.72 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 0.75 . . . . 75.14 109.263 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 46.31 70.46 0.38 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 61.42 108.256 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.744 ' H ' ' NZ ' ' A' ' 335' ' ' LYS . . . -79.28 -171.46 2.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 63.12 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 61.82 2.93 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 75.24 109.271 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 18.5 t -173.11 156.29 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 75.13 110.019 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.98 -30.14 71.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 74.41 109.289 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.64 136.22 56.03 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 71.34 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.431 ' CD1' ' HE1' ' A' ' 321' ' ' MET . 49.1 mt -142.32 130.28 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 74.13 109.27 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.438 HG21 ' CD2' ' A' ' 251' ' ' HIS . 13.6 p -127.58 83.57 2.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 71.12 110.382 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.425 ' CD2' ' HB3' ' A' ' 332' ' ' LEU . 8.9 mp -38.52 136.29 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 71.12 109.33 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -70.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 72.22 109.321 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.81 147.79 0.34 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.576 1.173 . . . . 74.32 109.994 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . 0.459 ' HB3' ' CG1' ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.94 -55.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 74.23 111.024 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.562 1.164 . . . . 74.23 109.272 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.281 -0.637 . . . . 73.32 109.281 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.07 90.31 0.25 Allowed Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 74.3 109.285 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -17.2 19.66 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.532 1.807 . . . . 72.24 110.992 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.501 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -51.41 137.3 23.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 73.05 109.297 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 344' ' ' LEU . 0.6 OUTLIER -122.92 103.05 8.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 75.34 109.29 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.18 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 74.41 109.586 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.466 ' CG2' HD21 ' A' ' 265' ' ' LEU . 58.0 t -125.22 145.05 33.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 72.12 109.355 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.42 120.84 42.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.32 110.314 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.503 HG22 ' CE2' ' A' ' 263' ' ' PHE . 54.1 t -110.0 98.09 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 73.12 109.28 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.1 t -67.93 -70.77 0.24 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 75.45 110.024 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.483 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 0.2 OUTLIER 68.25 65.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 71.12 109.3 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -103.26 165.33 11.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 63.11 110.325 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 259' ' ' ASN . 0.7 OUTLIER -47.65 -57.16 5.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 71.33 109.324 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 258' ' ' ASP . 8.2 t-20 -40.12 -62.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 74.13 109.305 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.402 ' OG ' ' C ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER -174.12 -160.56 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.476 1.11 . . . . 74.14 109.999 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 312' ' ' LEU . 19.6 mt -93.68 -178.35 4.67 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.11 . . . . 72.3 109.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -177.01 104.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 73.3 109.549 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.518 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 59.1 m-85 -110.86 96.67 6.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.5 110.995 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.636 ' CG2' ' CE1' ' A' ' 266' ' ' TYR . 64.0 mt -91.86 104.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 61.41 109.289 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.466 HD21 ' CG2' ' A' ' 252' ' ' VAL . 0.6 OUTLIER -89.72 129.15 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 75.32 109.321 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.636 ' CE1' ' CG2' ' A' ' 264' ' ' ILE . 14.8 m-85 -117.35 102.92 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 61.25 110.987 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.456 ' CG ' ' CD1' ' A' ' 273' ' ' ILE . 53.4 t30 -59.3 106.97 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 64.43 109.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -100.94 -12.1 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 75.31 109.302 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.461 ' O ' ' CD1' ' A' ' 300' ' ' ILE . 12.8 p -72.77 164.52 26.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 72.4 110.381 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 271' ' ' ILE . 22.0 m120 -67.17 -60.13 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 64.22 109.318 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.554 ' CD1' ' C ' ' A' ' 271' ' ' ILE . 0.0 OUTLIER -38.84 158.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.53 1.144 . . . . 75.32 109.347 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.468 ' N ' HG12 ' A' ' 271' ' ' ILE . 2.1 mp -114.41 117.35 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 74.13 109.288 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . 0.456 ' CD1' ' CG ' ' A' ' 267' ' ' ASN . 1.4 mp -46.23 138.41 6.2 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 73.33 109.317 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.04 -30.15 7.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.469 1.773 . . . . 75.31 111.047 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 90.55 159.72 35.86 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.509 1.131 . . . . 50.22 111.019 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 4.2 t30 76.23 27.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 0.766 . . . . 63.41 109.307 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.466 ' SG ' ' CD1' ' A' ' 331' ' ' ILE . 29.0 m -71.05 -178.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 71.31 108.288 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.463 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 1.9 m -152.97 105.44 2.93 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 73.51 110.382 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.521 ' CG ' HD11 ' A' ' 306' ' ' LEU . 1.1 t80 -59.05 157.66 9.82 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 74.33 110.947 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -146.69 84.33 1.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.551 1.157 . . . . 73.54 110.252 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.632 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 22.8 p90 -119.64 135.34 54.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 73.2 110.985 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.489 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 1.1 m -105.92 177.42 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 74.34 109.988 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' SER . . . . . 0.435 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 4.8 p -123.14 -42.73 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 72.43 109.979 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.412 ' C ' ' N ' ' A' ' 286' ' ' SER . 4.1 tt0 -145.82 179.05 7.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.452 1.095 . . . . 74.11 110.26 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 10.0 tt -43.06 -28.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 70.41 109.321 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 284' ' ' GLN . 57.8 m -51.26 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 65.11 110.004 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -55.5 -175.05 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.105 . . . . 74.54 110.315 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 289' ' ' PHE . 2.8 p -118.84 167.02 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 65.43 109.256 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.456 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 1.8 t80 -103.37 159.57 15.45 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 73.34 110.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -150.74 122.34 7.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 70.11 110.029 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 47.0 mt -121.99 128.83 75.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.44 109.256 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.13 107.16 5.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 73.3 109.324 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 87.4 mtp -70.17 147.48 49.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.157 . . . . 73.52 110.998 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -49.68 152.28 3.66 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.506 1.129 . . . . 52.41 111.022 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -29.26 8.39 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 72.15 111.029 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -52.66 137.34 31.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 65.04 109.599 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.22 147.03 29.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 72.13 110.307 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.443 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -82.87 -76.62 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 74.15 109.342 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 76.21 -174.95 53.05 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.464 1.103 . . . . 72.34 110.976 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 269' ' ' THR . 3.3 mm -64.43 137.6 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.5 0.765 . . . . 74.15 109.287 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.47 9.43 6.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 73.12 109.26 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.443 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -97.82 140.86 15.27 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.517 1.136 . . . . 72.03 110.987 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -110.42 -179.52 3.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 0.794 . . . . 71.23 110.289 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 265' ' ' LEU . 19.3 tptt -145.72 164.23 32.47 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 74.21 109.306 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.97 128.41 36.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 1.109 . . . . 72.32 110.291 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 12.3 mt -140.91 62.52 1.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 74.25 109.302 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -76.44 128.95 35.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 73.04 107.986 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.4 m-30 -115.79 178.55 4.27 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.5 111.052 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.495 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -159.29 157.04 26.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.5 110.992 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -35.14 3.02 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.998 -2.501 . . . . 75.52 111.021 0.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.0 p 169.04 139.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 71.23 109.999 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.473 ' CD1' HD11 ' A' ' 261' ' ' LEU . 5.1 mp -115.28 158.37 41.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 73.24 109.306 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.47 34.03 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.49 1.784 . . . . 73.45 111.002 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.32 162.24 49.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.439 1.087 . . . . 73.51 110.416 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.94 174.36 53.02 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.999 -2.5 . . . . 74.11 110.993 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.486 ' HB3' ' CD2' ' A' ' 319' ' ' TYR . 5.3 mp -88.99 65.61 7.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.51 109.277 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.1 p -84.42 139.44 32.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.448 1.092 . . . . 72.35 110.008 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.74 23.48 4.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.102 . . . . 71.44 109.282 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.489 ' CE2' ' O ' ' A' ' 282' ' ' SER . 3.2 m-85 -104.07 165.77 10.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.468 1.105 . . . . 73.11 111.027 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.486 ' O ' ' C ' ' A' ' 321' ' ' MET . 15.5 m -92.24 -49.47 6.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.44 110.37 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 320' ' ' THR . 1.7 ptp 30.13 63.35 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.33 111.028 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.462 ' HG2' ' CG1' ' A' ' 333' ' ' VAL . 42.8 mttt -91.26 -171.09 2.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 75.25 109.351 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . 0.45 ' CG2' HD23 ' A' ' 344' ' ' LEU . 2.2 t -150.26 132.2 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 72.1 109.296 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 9.0 m -118.29 179.62 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 73.25 109.276 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -108.4 -166.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 73.52 109.317 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.84 -10.42 37.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 74.43 110.265 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -107.38 19.57 20.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.136 . . . . 74.43 109.327 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 55.09 18.12 11.8 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 75.44 110.986 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.54 123.65 33.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.487 0.757 . . . . 71.45 110.276 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 324' ' ' VAL . 2.7 m -55.78 115.05 2.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 71.53 110.4 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.466 ' CD1' ' SG ' ' A' ' 277' ' ' CYS . 5.4 pt -97.88 -41.82 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 73.42 109.297 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 6.3 mt -138.34 162.57 34.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 70.13 109.322 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . 0.462 ' CG1' ' HG2' ' A' ' 322' ' ' LYS . 26.8 m -149.0 128.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 71.24 109.293 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -86.85 113.15 3.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.476 1.11 . . . . 72.42 111.012 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -50.04 -24.17 2.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 0.752 . . . . 74.53 109.32 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 335' ' ' LYS . 0.5 OUTLIER 66.23 162.88 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 73.3 108.283 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -173.98 -173.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.572 1.17 . . . . 71.42 109.269 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.55 56.52 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.14 109.306 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 341' ' ' GLU . 35.0 t -178.4 138.55 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 72.33 109.998 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -44.76 -27.01 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 73.31 109.315 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 339' ' ' SER . 6.9 mt-10 -63.97 117.27 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 74.51 110.323 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.441 ' CD1' ' HE2' ' A' ' 321' ' ' MET . 61.6 mt -141.62 122.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.433 1.083 . . . . 71.53 109.291 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 10.4 p -116.41 105.15 12.19 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 72.35 110.402 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.458 ' CD2' HD22 ' A' ' 250' ' ' LEU . 5.9 mp -58.56 142.62 48.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 75.12 109.264 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -77.29 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.541 1.151 . . . . 74.02 109.261 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.1 p -179.85 145.56 0.41 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 74.12 109.979 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -59.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.524 1.802 . . . . 70.14 110.987 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 73.21 109.329 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.638 . . . . 75.43 109.276 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.12 159.42 30.22 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 72.21 109.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 249' ' ' LEU . 18.3 Cg_endo -75.0 -14.1 21.23 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.466 1.771 . . . . 74.13 111.02 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.517 ' O ' ' CD2' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -39.93 146.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 64.32 109.304 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.471 HD21 ' CG2' ' A' ' 252' ' ' VAL . 0.6 OUTLIER -125.3 103.12 7.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 74.4 109.294 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.51 136.3 57.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 63.1 109.573 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.471 ' CG2' HD21 ' A' ' 250' ' ' LEU . 76.2 t -145.92 136.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 75.51 109.301 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.06 128.79 56.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 74.15 110.262 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.438 ' CG1' HG21 ' A' ' 314' ' ' THR . 14.2 t -105.47 105.45 18.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 72.02 109.291 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.76 -73.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 61.3 109.973 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 55.33 78.38 0.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 70.34 109.305 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.26 -166.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.544 1.152 . . . . 71.43 110.314 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.63 31.56 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 74.0 109.308 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -135.22 -45.16 0.7 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.481 1.113 . . . . 74.24 109.317 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 174.08 -174.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 50.4 110.009 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 312' ' ' LEU . 23.7 mt -93.24 167.65 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 73.43 109.288 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -163.81 100.25 0.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.24 109.608 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.19 101.55 10.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 73.1 110.992 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.603 ' O ' ' CE2' ' A' ' 266' ' ' TYR . 56.9 mt -97.52 103.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 75.04 109.263 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.501 ' CD1' ' CD1' ' A' ' 306' ' ' LEU . 0.4 OUTLIER -88.13 138.23 31.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.467 1.104 . . . . 74.23 109.301 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.603 ' CE2' ' O ' ' A' ' 264' ' ' ILE . 13.1 m-85 -125.66 101.06 6.71 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.504 1.128 . . . . 74.23 111.009 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.67 97.8 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 71.1 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.39 30.26 5.46 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.486 1.116 . . . . 75.12 109.319 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 36.0 p -85.59 -167.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.24 110.394 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -92.68 -52.3 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 75.15 109.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.47 173.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 75.41 109.257 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.15 137.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.501 1.126 . . . . 72.43 109.291 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 5.6 mm -61.95 135.92 94.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.47 1.106 . . . . 73.45 109.3 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -22.79 14.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.797 . . . . 64.32 111.03 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 73.83 168.06 16.09 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.472 1.108 . . . . 64.44 111.02 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 1.7 t30 70.49 38.66 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 0.772 . . . . 71.14 109.271 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 52.6 m -83.29 -177.48 6.75 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 72.53 108.284 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.473 ' HB ' ' CG2' ' A' ' 324' ' ' VAL . 2.8 m -154.24 99.76 2.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 73.43 110.372 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.518 ' CG ' HD11 ' A' ' 306' ' ' LEU . 0.8 OUTLIER -55.4 162.64 1.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.492 1.12 . . . . 73.51 111.006 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -155.31 90.62 1.27 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.559 1.162 . . . . 74.22 110.328 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 279' ' ' PHE . 12.2 p90 -118.94 153.83 33.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 72.31 111.001 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.59 170.2 16.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 73.5 110.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.3 p -149.77 -175.53 5.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.541 1.151 . . . . 74.41 110.032 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -66.89 -79.86 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.552 1.157 . . . . 62.33 110.285 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 18.7 tt -61.93 -46.47 96.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 74.44 109.29 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.75 154.03 34.45 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.576 1.173 . . . . 73.3 109.993 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -103.82 178.45 4.55 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 71.24 110.264 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.57 153.2 7.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 73.31 109.3 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.09 133.7 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 73.43 110.979 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.4 p -110.7 121.86 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.476 1.11 . . . . 70.1 109.969 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.562 HD11 ' CD1' ' A' ' 308' ' ' PHE . 12.0 mt -103.54 132.13 50.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 72.44 109.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.63 106.16 6.07 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.452 1.095 . . . . 74.22 109.297 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.456 ' HG2' ' CD2' ' A' ' 306' ' ' LEU . 92.5 mtp -77.77 145.7 36.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 75.44 110.996 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.03 153.76 6.83 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.497 1.123 . . . . 72.35 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -30.58 7.01 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.433 1.754 . . . . 63.4 111.023 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -42.88 143.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 61.31 109.607 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -92.69 124.52 36.76 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 63.31 110.308 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.41 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 43.0 mt -62.02 -77.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.578 1.174 . . . . 71.35 109.309 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.32 -175.49 54.53 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.462 1.101 . . . . 65.11 111.008 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 300' ' ' ILE . 2.1 mm -66.68 133.86 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 74.52 109.305 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 12.1 mmtm 74.21 3.71 4.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 73.52 109.279 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.41 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -93.35 146.72 18.26 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.501 1.126 . . . . 75.3 111.006 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -113.63 -176.04 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 0.753 . . . . 73.12 110.282 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 265' ' ' LEU . 39.5 tptt -147.56 162.93 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.474 1.109 . . . . 74.52 109.295 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -136.0 118.92 16.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 74.2 110.305 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.518 HD11 ' CG ' ' A' ' 279' ' ' PHE . 20.1 mt -128.16 55.04 1.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.496 1.122 . . . . 73.35 109.308 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' TRP . . . . . 0.424 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 4.8 p90 -67.09 125.15 25.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.993 -1.114 . . . . 74.2 107.993 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.562 ' CD1' HD11 ' A' ' 291' ' ' ILE . 25.6 t80 -123.25 173.15 8.11 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.553 1.158 . . . . 74.32 111.042 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -150.55 161.72 29.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.509 1.131 . . . . 75.51 111.06 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -74.99 -43.15 0.72 Allowed 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.97 -2.513 . . . . 73.42 111.0 -0.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.5 p 179.59 158.4 0.67 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 75.15 109.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.453 ' CD1' HD13 ' A' ' 261' ' ' LEU . 1.1 mp -135.28 158.73 74.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 73.24 109.33 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 151.1 38.91 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.482 1.78 . . . . 72.42 110.996 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' THR . . . . . 0.481 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.8 OUTLIER -134.49 161.27 64.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.518 1.137 . . . . 71.34 110.453 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.91 -178.97 24.96 Favored 'Cis proline' 0 C--N 1.36 1.148 0 C-N-CA 121.002 -2.499 . . . . 75.41 111.038 -0.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.571 HD22 ' CD2' ' A' ' 319' ' ' TYR . 2.3 mt -101.27 57.39 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 72.52 109.318 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 6.1 p -81.4 127.7 33.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 64.54 109.989 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 317' ' ' SER . 30.8 t30 80.74 23.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 73.32 109.3 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.571 ' CD2' HD22 ' A' ' 316' ' ' LEU . 6.8 m-85 -101.92 176.46 5.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 74.23 110.985 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.504 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.2 m -93.21 -58.66 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 71.53 110.395 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.504 ' C ' ' O ' ' A' ' 320' ' ' THR . 2.2 ptp 28.3 61.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 73.42 110.991 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 28.4 mttp -91.29 179.12 5.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.151 . . . . 75.1 109.32 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.81 129.67 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 74.42 109.284 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.473 ' CG2' ' HB ' ' A' ' 278' ' ' THR . 15.4 m -108.47 178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 75.05 109.317 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.582 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -110.84 -172.34 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.437 1.086 . . . . 71.51 109.281 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -68.23 -4.7 14.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.44 110.267 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -7.46 31.96 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 63.01 109.289 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.62 54.38 6.69 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 64.22 111.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.448 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -149.55 130.5 14.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 0.755 . . . . 75.44 110.313 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' THR . . . . . 0.425 ' N ' HG11 ' A' ' 324' ' ' VAL . 1.7 m -60.97 119.44 8.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 74.21 110.386 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.499 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.2 pt -97.19 -34.68 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 74.25 109.281 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.495 ' CD2' ' C ' ' A' ' 345' ' ' LYS . 4.8 mt -132.04 -171.46 2.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 73.52 109.341 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -175.89 114.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 65.54 109.241 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 336' ' ' CYS . . . -61.81 135.41 46.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.534 1.146 . . . . 72.25 111.011 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' LYS . . . . . 0.536 ' C ' ' SG ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -57.04 -19.54 19.41 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.582 0.813 . . . . 75.43 109.267 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.536 ' SG ' ' C ' ' A' ' 335' ' ' LYS . 0.8 OUTLIER 42.08 89.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 75.31 108.283 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.27 -175.32 2.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.53 109.324 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.31 61.86 2.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 72.51 109.288 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.82 142.78 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 64.5 109.961 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -52.18 -27.05 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 75.23 109.309 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.31 137.01 57.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.497 1.123 . . . . 72.12 110.293 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 53.8 mt -146.17 137.28 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.532 1.145 . . . . 74.12 109.305 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 24.2 p -138.05 99.51 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 74.43 110.414 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.78 132.27 45.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 74.13 109.265 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.504 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -112.72 -66.79 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 73.4 109.306 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 158.84 136.78 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 72.11 109.998 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -57.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.479 1.779 . . . . 74.22 111.002 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.4 tp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 73.15 109.317 -179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.325 -0.62 . . . . 75.25 109.325 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.23 103.15 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 64.530000000000001 109.259 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -61.38 134.37 56.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 71.439999999999998 109.618 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 253' ' ' GLU . 89.9 t -142.36 164.95 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 72.319999999999993 109.295 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.5 ' N ' HG12 ' A' ' 252' ' ' VAL . 4.1 tp10 -146.05 129.5 16.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 64.530000000000001 110.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.738 ' CG1' HG21 ' A' ' 314' ' ' THR . 89.0 t -102.82 118.28 49.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.538 1.148 . . . . 72.540000000000006 109.273 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 18.0 m -87.78 -65.56 1.0 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 53.340000000000003 110.019 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.865 ' HA ' HD23 ' A' ' 261' ' ' LEU . 7.6 t-20 58.36 63.5 1.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.472 1.108 . . . . 74.340000000000003 109.325 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.8 pt-20 -162.42 -175.01 4.29 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 74.430000000000007 110.321 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.67 24.21 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.552 1.158 . . . . 73.439999999999998 109.281 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 72.42 18.63 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 75.299999999999997 109.272 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 4.2 m -165.28 -167.11 1.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 34.439999999999998 109.997 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 256' ' ' ASN . 9.4 mt -101.25 166.21 10.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.478 1.111 . . . . 63.149999999999999 109.321 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' HIS . . . . . 0.458 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 0.3 OUTLIER -163.2 95.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 72.239999999999995 109.636 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.59 ' CE2' HD13 ' A' ' 261' ' ' LEU . 97.4 m-85 -97.46 149.33 22.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 70.340000000000003 110.986 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.807 HG22 ' CE1' ' A' ' 266' ' ' TYR . 48.4 mt -142.24 112.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.53 1.144 . . . . 71.140000000000001 109.293 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.617 HD11 HD12 ' A' ' 306' ' ' LEU . 0.0 OUTLIER -111.48 143.99 41.42 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.564 1.165 . . . . 64.049999999999997 109.306 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.807 ' CE1' HG22 ' A' ' 264' ' ' ILE . 2.1 m-85 -128.56 111.9 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.528 1.142 . . . . 75.209999999999994 110.979 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.758 ' HB2' HD13 ' A' ' 273' ' ' ILE . 26.2 t30 -60.47 101.34 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 75.450000000000003 109.292 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 300' ' ' ILE . 3.7 mmpt? -101.56 -19.17 15.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 54.439999999999998 109.333 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.6 p -48.0 175.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.484 1.115 . . . . 71.109999999999999 110.384 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -72.78 -57.39 4.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 62.130000000000003 109.307 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 271' ' ' ILE . 0.0 OUTLIER -69.3 166.8 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 63.43 109.303 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.48 131.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 65.409999999999997 109.262 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.758 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.3 mp -40.55 140.2 1.03 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.51 1.131 . . . . 52.329999999999998 109.298 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -34.87 3.55 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 62.229999999999997 110.999 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 106.2 159.38 22.27 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.488 1.117 . . . . 60.210000000000001 110.989 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 69.18 23.6 6.32 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 0.778 . . . . 71.530000000000001 109.259 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.4 ' C ' ' OG1' ' A' ' 278' ' ' THR . 60.9 m -70.62 -179.15 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 62.32 108.274 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.735 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -153.96 136.26 14.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 74.109999999999999 110.4 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.645 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.5 t80 -89.54 179.03 6.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 65.349999999999994 110.98 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.461 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 11.2 tt0 -176.73 101.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.108 . . . . 72.150000000000006 110.316 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 1.3 p90 -116.26 147.81 41.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 74.409999999999997 111.006 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 53.2 p -100.67 -175.27 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 62.039999999999999 109.997 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.558 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 71.340000000000003 110.029 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 2.6 p . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.255 -0.646 . . . . 73.239999999999995 109.255 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -152.88 142.95 22.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.030000000000001 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.627 ' OG ' HG22 ' A' ' 278' ' ' THR . 32.4 t -107.32 127.89 53.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 73.140000000000001 109.999 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.3 mt -101.04 137.22 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 72.409999999999997 109.287 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -77.47 113.0 14.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 73.530000000000001 109.317 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.924 ' HG2' HD21 ' A' ' 306' ' ' LEU . 63.0 mtp -84.13 165.51 18.41 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 72.310000000000002 110.973 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.454 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -64.47 151.42 50.51 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.473 1.108 . . . . 55.140000000000001 111.021 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.28 6.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.441 1.758 . . . . 61.299999999999997 110.961 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.56 ' CE1' ' OE1' ' A' ' 297' ' ' GLU . 57.6 t-80 -68.14 143.11 55.53 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 64.140000000000001 109.598 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.56 ' OE1' ' CE1' ' A' ' 296' ' ' HIS . 0.6 OUTLIER -65.38 179.36 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.135 . . . . 73.209999999999994 110.304 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.475 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 44.3 mt -105.77 -76.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 51.539999999999999 109.329 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 128.0 149.74 7.13 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.469 1.106 . . . . 30.43 111.056 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.494 ' O ' ' CE ' ' A' ' 268' ' ' LYS . 4.2 mt -46.75 -25.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.531 0.783 . . . . 73.150000000000006 109.342 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -115.6 -37.69 3.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 52.439999999999998 109.304 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.475 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -40.9 151.03 0.14 Allowed Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.571 1.169 . . . . 65.349999999999994 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.27 -177.49 3.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.512 0.772 . . . . 72.219999999999999 110.27 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.454 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 35.3 tptt -154.51 143.6 21.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.433 1.083 . . . . 72.120000000000005 109.301 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.54 ' HB2' ' CZ2' ' A' ' 307' ' ' TRP . 10.7 mt-10 -114.83 150.39 35.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 71.120000000000005 110.308 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.924 HD21 ' HG2' ' A' ' 293' ' ' MET . 82.7 mt -141.15 62.58 1.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.113 . . . . 73.530000000000001 109.266 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.54 ' CZ2' ' HB2' ' A' ' 305' ' ' GLU . 0.9 OUTLIER -59.29 134.86 57.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.95 -1.13 . . . . 71.140000000000001 107.95 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.622 ' CE1' HD11 ' A' ' 312' ' ' LEU . 10.2 t80 -137.23 155.14 49.87 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 74.400000000000006 111.019 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.668 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -135.6 147.36 61.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 74.25 111.013 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -53.72 0.15 OUTLIER 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.005 -2.498 . . . . 63.240000000000002 111.007 -0.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 178.44 174.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 71.439999999999998 109.982 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 261' ' ' LEU . 3.7 mp -138.82 158.42 70.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 74.530000000000001 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 145.25 31.06 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.487 1.783 . . . . 52.149999999999999 110.992 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.738 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -123.02 162.54 38.61 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 71.439999999999998 110.404 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -175.45 16.03 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.015 -2.494 . . . . 44.340000000000003 111.023 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.845 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.8 mt -109.8 57.79 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 63.43 109.281 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.3 p -85.38 134.74 34.07 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 70.510000000000005 109.985 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 32.0 t30 83.19 2.63 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 73.430000000000007 109.319 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.845 ' CE2' HD23 ' A' ' 316' ' ' LEU . 9.0 m-85 -81.13 -178.47 6.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 75.420000000000002 111.017 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.536 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -97.57 -58.28 2.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.319999999999993 110.373 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.777 ' SD ' HD13 ' A' ' 316' ' ' LEU . 1.0 OUTLIER 28.59 64.63 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 52.439999999999998 111.032 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.536 ' HG3' HG23 ' A' ' 320' ' ' THR . 40.2 mttm -92.68 -172.57 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 71.420000000000002 109.299 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.764 ' CG2' HD21 ' A' ' 344' ' ' LEU . 41.9 t -141.84 130.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 63.43 109.304 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 278' ' ' THR . 5.6 m -109.52 176.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.081 . . . . 64.329999999999998 109.278 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.453 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 2.6 t30 -101.04 -165.56 1.22 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 62.340000000000003 109.322 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -70.1 -7.93 45.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 54.130000000000003 110.3 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -107.82 13.33 26.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.219999999999999 109.302 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 62.33 27.61 69.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.544 1.152 . . . . 70.219999999999999 110.99 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 331' ' ' ILE . 6.7 pt-20 -102.83 127.19 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.464 0.743 . . . . 71.140000000000001 110.295 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.595 ' N ' HG12 ' A' ' 324' ' ' VAL . 56.0 m -54.07 111.02 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.420000000000002 110.377 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 329' ' ' GLU . 5.1 pt -94.33 -37.91 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.409999999999997 109.279 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.834 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.3 mt -139.36 176.18 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.472 1.107 . . . . 75.209999999999994 109.328 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.441 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -151.05 131.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.515 1.134 . . . . 51.420000000000002 109.323 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -83.76 130.2 9.6 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.504 1.128 . . . . 62.030000000000001 110.977 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.541 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -61.08 -26.59 67.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.566 0.803 . . . . 71.530000000000001 109.297 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 316' ' ' LEU . 0.8 OUTLIER 48.23 76.62 0.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 43.520000000000003 108.305 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.541 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -88.27 -178.75 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 1.164 . . . . 64.530000000000001 109.316 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -75.91 62.44 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 62.119999999999997 109.288 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.7 m -173.59 150.68 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 74.030000000000001 110.024 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -58.9 -17.62 25.91 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 54.049999999999997 109.279 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -77.95 146.43 35.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.125 . . . . 74.219999999999999 110.289 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.61 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 65.9 mt -147.98 141.23 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 44.119999999999997 109.31 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 343' ' ' THR . 8.7 p -138.77 97.81 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 54.229999999999997 110.396 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.5 mp -46.83 133.49 10.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.131 . . . . 63.130000000000003 109.329 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -98.06 -76.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.129999999999995 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.609 ' HA ' HD23 ' A' ' 332' ' ' LEU . 2.9 p 159.84 142.06 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 75.450000000000003 110.011 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -80.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.449 1.763 . . . . 72.519999999999996 110.955 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 53.329999999999998 109.286 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.683 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.256 -0.646 . . . . 73.230000000000004 109.256 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.858 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -114.43 102.21 9.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.502 1.126 . . . . 70.209999999999994 109.287 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.822 ' CD2' HG22 ' A' ' 343' ' ' THR . 65.0 t-80 -90.88 166.17 13.2 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.469 1.105 . . . . 75.319999999999993 109.558 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.762 HG21 HD23 ' A' ' 265' ' ' LEU . 66.7 t -153.48 155.51 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 51.539999999999999 109.324 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -117.62 146.16 43.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.299999999999997 110.308 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.673 HG22 ' CE1' ' A' ' 263' ' ' PHE . 38.6 t -128.83 94.97 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 72.329999999999998 109.344 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.1 m -69.13 -63.34 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 70.439999999999998 110.027 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.751 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.2 t-20 60.82 82.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.528 1.143 . . . . 74.230000000000004 109.307 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.29 166.5 13.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.502 1.126 . . . . 65.349999999999994 110.296 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 259' ' ' ASN . 23.8 t0 -42.69 -58.32 2.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.573 1.171 . . . . 75.030000000000001 109.31 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 258' ' ' ASP . 25.4 m120 -40.06 -61.94 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 71.219999999999999 109.295 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 176.27 -173.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 74.230000000000004 109.992 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 256' ' ' ASN . 19.6 mt -80.98 161.2 24.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 72.200000000000003 109.263 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.68 95.74 2.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 63.509999999999998 109.604 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.673 ' CE1' HG22 ' A' ' 254' ' ' VAL . 75.0 m-85 -103.6 112.02 24.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 75.299999999999997 110.965 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.78 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 73.8 mt -111.03 117.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 55.219999999999999 109.325 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.762 HD23 HG21 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -106.01 151.72 24.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 70.239999999999995 109.342 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.78 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -138.11 117.58 12.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.484 1.115 . . . . 74.150000000000006 110.98 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.645 ' ND2' HD11 ' A' ' 273' ' ' ILE . 17.1 t-20 -79.74 106.52 11.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 62.100000000000001 109.305 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -11.84 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 60.539999999999999 109.276 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.415 ' H ' HG23 ' A' ' 269' ' ' THR . 22.6 p -66.34 154.75 39.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.503 1.127 . . . . 73.219999999999999 110.368 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -67.55 -40.78 84.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.493 1.121 . . . . 75.310000000000002 109.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 9.1 pt -54.37 167.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.14 . . . . 71.420000000000002 109.299 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 272' ' ' ILE . 4.7 mp -121.54 157.74 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 73.319999999999993 109.275 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 273' ' ' ILE . 1.2 mm -82.42 141.21 45.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.508 1.13 . . . . 73.239999999999995 109.29 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.614 ' HD2' HG22 ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.01 -14.88 20.99 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.496 1.787 . . . . 53.119999999999997 111.0 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 84.62 151.21 13.09 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.52 1.137 . . . . 71.25 111.039 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.8 t30 70.27 50.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 0.767 . . . . 73.540000000000006 109.32 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.97 -179.72 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.52 1.137 . . . . 61.340000000000003 108.3 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.712 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.6 m -153.94 137.17 15.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.091 . . . . 72.310000000000002 110.347 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.69 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -85.85 176.98 7.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 71.400000000000006 110.978 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.6 ' CG ' HG21 ' A' ' 288' ' ' VAL . 55.4 tt0 -152.7 65.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 75.450000000000003 110.246 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 289' ' ' PHE . 9.9 p90 -96.14 130.47 43.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 75.230000000000004 110.957 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 17.9 p -121.79 -178.44 3.83 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 73.400000000000006 110.003 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.599 ' CB ' HD23 ' A' ' 312' ' ' LEU . 3.5 p . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 51.020000000000003 109.991 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.6 HG21 ' CG ' ' A' ' 280' ' ' GLU . 7.4 p . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.236 -0.653 . . . . 71.530000000000001 109.236 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.548 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.8 t80 -115.8 133.38 56.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 64.010000000000005 110.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.0 p -112.48 120.67 42.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.564 1.165 . . . . 63.32 109.988 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 12.5 mt -105.8 127.73 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 72.319999999999993 109.356 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -67.02 116.7 8.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 64.209999999999994 109.287 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.595 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.6 mtp -85.11 150.3 24.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.430000000000007 111.002 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -45.65 150.71 1.25 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 23.449999999999999 110.983 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -28.01 9.46 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.531 1.806 . . . . 74.209999999999994 110.954 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -65.1 143.3 57.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.083 . . . . 73.549999999999997 109.576 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.68 138.06 31.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 110.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.435 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -65.28 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.129999999999995 109.307 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.84 -155.35 18.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.518 1.136 . . . . 75.430000000000007 111.016 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.928 HG22 ' HD3' ' A' ' 301' ' ' LYS . 0.9 OUTLIER -86.93 133.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 0.79 . . . . 71.420000000000002 109.313 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.928 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.3 OUTLIER 68.79 6.51 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 71.129999999999995 109.314 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.435 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -85.68 162.61 36.16 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.511 1.132 . . . . 64.319999999999993 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 298' ' ' ILE . 4.5 pt20 -131.47 174.82 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 0.767 . . . . 75.010000000000005 110.283 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 38.5 tptt -149.46 152.11 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.230000000000004 109.328 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.59 141.22 45.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.493 1.12 . . . . 62.530000000000001 110.307 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.724 HD12 HD11 ' A' ' 265' ' ' LEU . 12.3 mt -145.53 61.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 1.118 . . . . 74.420000000000002 109.32 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -79.27 121.61 25.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 73.400000000000006 107.98 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.8 m-30 -109.29 -174.13 2.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 64.030000000000001 111.043 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.9 OUTLIER -164.91 160.19 14.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 74.109999999999999 110.998 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.02 -36.29 2.64 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.005 -2.498 . . . . 71.439999999999998 111.022 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 2.9 p 169.74 131.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.107 . . . . 73.200000000000003 110.012 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.599 HD23 ' CB ' ' A' ' 283' ' ' SER . 5.7 mp -111.59 158.94 34.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.15 . . . . 75.530000000000001 109.339 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 147.36 33.66 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.463 1.77 . . . . 74.319999999999993 110.973 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.604 HG21 HG12 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -123.91 164.43 29.3 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 61.109999999999999 110.4 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 -174.66 14.53 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.022 -2.491 . . . . 73.430000000000007 110.989 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.625 HD22 ' CE2' ' A' ' 319' ' ' TYR . 3.4 mt -102.36 60.12 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.409999999999997 109.294 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -82.91 131.81 35.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 73.299999999999997 110.047 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.4 t-20 76.66 21.97 1.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 72.340000000000003 109.322 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.625 ' CE2' HD22 ' A' ' 316' ' ' LEU . 4.0 m-85 -99.13 -170.06 1.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.219999999999999 111.001 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 322' ' ' LYS . 28.2 m -107.81 -64.92 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.513 1.133 . . . . 75.200000000000003 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.833 ' HE3' ' CD1' ' A' ' 342' ' ' ILE . 2.8 mtm 34.09 35.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 72.310000000000002 110.998 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.653 ' HG3' HG22 ' A' ' 320' ' ' THR . 27.9 mttm -75.98 169.82 17.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 62.299999999999997 109.284 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.591 HG23 HD21 ' A' ' 344' ' ' LEU . 74.8 t -119.1 133.71 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 72.450000000000003 109.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 278' ' ' THR . 8.9 m -118.23 172.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 63.149999999999999 109.284 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.407 ' ND2' ' H ' ' A' ' 326' ' ' GLN . 2.8 t30 -96.06 -166.48 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 74.510000000000005 109.337 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.407 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 3.3 pt20 -71.13 -5.72 33.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 65.420000000000002 110.338 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.46 12.09 26.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 1.137 . . . . 64.510000000000005 109.303 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.24 8.39 50.12 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.498 1.124 . . . . 43.229999999999997 111.047 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 6.5 pt-20 -78.9 129.95 35.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.757 . . . . 73.200000000000003 110.281 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.626 ' HA ' HG12 ' A' ' 324' ' ' VAL . 4.1 m -62.97 108.08 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.030000000000001 110.38 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 323' ' ' VAL . 2.7 pt -90.94 -43.68 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.511 1.132 . . . . 74.219999999999999 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.6 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.4 mt -136.1 168.45 19.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 71.439999999999998 109.292 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.483 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.2 m -151.75 131.71 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 71.549999999999997 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -85.34 121.04 5.5 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 71.209999999999994 111.008 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.695 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.32 -26.93 0.37 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 0.753 . . . . 74.409999999999997 109.263 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.419 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.5 OUTLIER 45.68 71.72 0.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 75.319999999999993 108.296 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.695 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -84.77 -176.79 6.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 73.530000000000001 109.294 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.79 64.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.450000000000003 109.327 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.8 t -178.95 148.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.967 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -57.65 -17.93 17.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 73.209999999999994 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.623 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 14.4 mt-10 -71.93 131.96 43.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.107 . . . . 74.540000000000006 110.271 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.833 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 45.4 mt -142.88 118.05 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.506 1.128 . . . . 71.049999999999997 109.286 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.822 HG22 ' CD2' ' A' ' 251' ' ' HIS . 18.5 p -117.57 87.28 2.68 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 62.450000000000003 110.39 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.858 HD22 ' CD2' ' A' ' 250' ' ' LEU . 8.5 mp -40.01 132.1 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 72.340000000000003 109.295 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.0 ptpt -117.72 -58.77 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.557 1.161 . . . . 71.439999999999998 109.265 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.536 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 158.98 158.19 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.32 110.007 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 -67.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.461 1.769 . . . . 74.329999999999998 110.969 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.559 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 72.219999999999999 109.323 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 1.001 HD23 ' O ' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.317 -0.623 . . . . 75.120000000000005 109.317 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -111.32 98.7 7.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.135 . . . . 71.299999999999997 109.293 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.607 ' CE1' ' HG2' ' A' ' 341' ' ' GLU . 4.3 t60 -96.33 130.38 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 73.319999999999993 109.624 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.661 HG21 HD23 ' A' ' 265' ' ' LEU . 16.5 t -120.5 171.35 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 74.239999999999995 109.271 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.52 ' N ' HG12 ' A' ' 252' ' ' VAL . 1.9 tp10 -133.96 128.55 34.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 70.140000000000001 110.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.597 ' CG1' HG21 ' A' ' 314' ' ' THR . 4.5 t -105.72 112.56 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 51.439999999999998 109.318 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 51.43 109.994 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.914 ' HA ' HD23 ' A' ' 261' ' ' LEU . 15.3 t30 60.48 67.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.528 1.143 . . . . 63.32 109.299 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.48 163.81 12.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 71.140000000000001 110.29 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.37 -44.74 68.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 71.129999999999995 109.303 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -55.11 -61.15 2.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 74.239999999999995 109.289 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 29.3 m -174.21 -176.7 1.17 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.437 1.086 . . . . 63.219999999999999 110.022 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.914 HD23 ' HA ' ' A' ' 256' ' ' ASN . 39.8 mt -77.5 171.05 15.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.12 . . . . 73.409999999999997 109.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -160.49 103.76 1.4 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 61.130000000000003 109.588 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.657 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 68.8 m-85 -109.3 90.51 3.32 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 74.530000000000001 111.008 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.78 HG22 ' CE2' ' A' ' 266' ' ' TYR . 54.3 mt -90.23 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 52.530000000000001 109.314 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.661 HD23 HG21 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -91.51 137.04 32.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.129999999999995 109.323 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.78 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.8 m-85 -120.65 110.41 16.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 64.209999999999994 111.014 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.417 ' ND2' HD13 ' A' ' 273' ' ' ILE . 12.3 t30 -68.38 96.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 53.530000000000001 109.319 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -101.09 28.3 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.219999999999999 109.29 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 4.5 p -102.9 143.48 32.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 64.340000000000003 110.419 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -44.29 -58.06 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.438 1.086 . . . . 71.120000000000005 109.306 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.7 pt -54.61 172.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 72.329999999999998 109.345 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.14 123.16 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.443 1.09 . . . . 72.219999999999999 109.306 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.417 HD13 ' ND2' ' A' ' 267' ' ' ASN . 1.7 mp -40.4 137.55 1.29 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 60.210000000000001 109.311 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.4 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.98 -24.18 13.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.502 1.791 . . . . 70.230000000000004 111.007 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 89.37 162.81 38.79 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.501 1.126 . . . . 33.310000000000002 111.001 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.6 t30 69.26 34.24 3.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.754 . . . . 61.210000000000001 109.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 52.3 m -83.39 -179.22 7.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 71.439999999999998 108.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.809 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.0 m -151.85 132.58 14.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 74.319999999999993 110.41 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.647 ' CE1' HG22 ' A' ' 323' ' ' VAL . 0.9 OUTLIER -90.19 -178.63 5.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.429 1.08 . . . . 63.210000000000001 111.007 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.589 ' HG3' HG21 ' A' ' 288' ' ' VAL . 1.9 tt0 -171.68 89.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.135 . . . . 72.430000000000007 110.329 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.763 ' HE1' HD12 ' A' ' 291' ' ' ILE . 22.7 p90 -116.89 128.58 55.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 74.209999999999994 111.046 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 36.7 p -95.54 165.24 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.137 . . . . 72.430000000000007 109.976 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.572 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.5 p . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.446 1.091 . . . . 74.129999999999995 110.021 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.589 HG21 ' HG3' ' A' ' 280' ' ' GLU . 13.9 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.319 -0.623 . . . . 71.420000000000002 109.319 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.521 ' N ' HG22 ' A' ' 288' ' ' VAL . 3.1 t80 -134.89 145.46 48.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 54.43 111.016 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.543 ' HB2' HG22 ' A' ' 278' ' ' THR . 60.2 p -104.3 129.76 52.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 110.011 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.763 HD12 ' HE1' ' A' ' 281' ' ' PHE . 2.0 mt -95.96 127.31 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 65.129999999999995 109.31 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.18 107.62 3.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.49 1.118 . . . . 71.239999999999995 109.257 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.486 ' HG2' HD21 ' A' ' 306' ' ' LEU . 85.5 mtp -78.11 158.61 29.06 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.577 1.173 . . . . 73.340000000000003 111.04 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -64.06 147.11 50.73 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.481 1.113 . . . . 74.400000000000006 111.025 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -29.66 7.97 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 72.510000000000005 110.952 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -54.12 152.58 5.87 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 65.129999999999995 109.594 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -85.35 154.31 21.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 71.120000000000005 110.299 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 86.4 mt -92.56 -79.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.122 . . . . 75.0 109.293 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.24 -177.1 21.42 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.547 1.154 . . . . 52.340000000000003 111.004 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.537 HG22 ' HD3' ' A' ' 301' ' ' LYS . 8.9 mt -53.66 -86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.503 0.767 . . . . 74.010000000000005 109.268 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.537 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.5 OUTLIER -61.82 -23.8 66.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.147 . . . . 73.409999999999997 109.293 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -50.65 135.03 29.76 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.498 1.124 . . . . 61.210000000000001 111.023 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.54 176.81 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 0.766 . . . . 74.450000000000003 110.273 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.506 ' O ' HD12 ' A' ' 265' ' ' LEU . 18.8 tptt -152.0 144.26 23.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 60.219999999999999 109.339 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -102.72 163.71 12.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 64.409999999999997 110.298 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 8.2 mt -161.27 73.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 74.319999999999993 109.277 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.25 127.38 32.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 74.340000000000003 107.988 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.741 ' CG ' ' CZ ' ' A' ' 281' ' ' PHE . 16.5 m-30 -114.15 38.49 3.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.113 . . . . 74.510000000000005 110.971 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.522 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 6.6 p90 -37.63 157.34 0.09 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 74.319999999999993 110.979 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -36.94 2.43 Favored 'Cis proline' 0 C--N 1.36 1.177 0 C-N-CA 120.99 -2.504 . . . . 50.009999999999998 111.052 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 37.0 p 176.13 144.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 65.129999999999995 109.987 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.805 ' HB2' HD11 ' A' ' 261' ' ' LEU . 3.7 mp -129.18 159.39 69.24 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 55.0 109.312 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 144.09 29.84 Favored 'Trans proline' 0 C--N 1.359 1.132 0 O-C-N 124.48 1.779 . . . . 74.409999999999997 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.597 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.6 OUTLIER -127.16 162.58 47.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 73.519999999999996 110.378 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.1 Cg_endo -74.98 177.98 36.66 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.009 -2.496 . . . . 54.329999999999998 110.977 -0.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.767 HD12 ' HE2' ' A' ' 321' ' ' MET . 3.8 mt -92.85 64.4 4.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 75.200000000000003 109.276 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.7 t -83.97 135.77 34.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 71.340000000000003 109.963 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.12 10.86 6.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 71.439999999999998 109.303 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 282' ' ' SER . 4.8 m-30 -96.29 124.96 40.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 61.130000000000003 111.0 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -40.0 -61.48 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 72.140000000000001 110.384 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.767 ' HE2' HD12 ' A' ' 316' ' ' LEU . 3.9 ttm 31.19 68.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.459 1.099 . . . . 72.409999999999997 110.973 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.548 ' HG3' HG23 ' A' ' 320' ' ' THR . 80.8 mttt -103.78 -171.29 1.91 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.094 . . . . 61.420000000000002 109.316 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.647 HG22 ' CE1' ' A' ' 279' ' ' PHE . 19.2 t -141.53 123.47 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 54.340000000000003 109.332 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 278' ' ' THR . 22.6 m -110.84 -172.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.464 1.103 . . . . 75.310000000000002 109.315 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.831 ' ND2' HG23 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -126.55 -171.92 2.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 74.0 109.268 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.51 -6.99 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 74.219999999999999 110.328 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -89.02 -14.82 35.58 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 64.219999999999999 109.292 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.61 1.66 89.07 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.484 1.115 . . . . 65.099999999999994 111.028 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.457 ' O ' ' ND2' ' A' ' 325' ' ' ASN . 14.0 pt-20 -94.54 153.22 18.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 0.79 . . . . 71.230000000000004 110.312 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.637 ' CA ' HG12 ' A' ' 324' ' ' VAL . 1.3 m -83.47 128.89 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 71.299999999999997 110.397 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.831 HG23 ' ND2' ' A' ' 325' ' ' ASN . 33.6 pt -103.64 -37.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.114 . . . . 74.030000000000001 109.28 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.854 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.3 mt -134.14 168.77 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 72.420000000000002 109.291 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.476 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -152.79 122.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 62.310000000000002 109.336 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -77.53 119.53 5.32 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 44.149999999999999 110.987 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.771 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.27 -27.0 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 0.783 . . . . 75.099999999999994 109.271 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 49.14 76.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 65.019999999999996 108.289 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.771 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -88.2 -178.68 5.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 60.530000000000001 109.276 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -76.04 61.15 1.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.477 1.111 . . . . 64.010000000000005 109.295 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 341' ' ' GLU . 4.2 m 179.43 141.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 61.520000000000003 110.019 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 13.9 m-20 -46.65 -26.13 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.151 . . . . 65.129999999999995 109.294 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 3.2 mt-10 -63.04 125.29 23.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 64.209999999999994 110.345 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.71 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 66.4 mt -141.65 123.38 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 54.219999999999999 109.345 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.42 HG22 ' ND1' ' A' ' 251' ' ' HIS . 15.2 p -126.25 87.84 2.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.132 . . . . 51.210000000000001 110.417 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.854 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.3 mp -40.77 138.93 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.526 1.141 . . . . 74.129999999999995 109.299 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -112.57 -64.58 1.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 75.549999999999997 109.268 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 159.7 145.91 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 72.329999999999998 110.011 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -81.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.474 1.776 . . . . 53.409999999999997 111.049 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.738 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 73.510000000000005 109.261 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.291 -0.633 . . . . 73.310000000000002 109.291 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.445 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -128.51 103.34 7.06 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 70.230000000000004 109.304 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -66.56 139.68 57.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 64.310000000000002 109.605 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 253' ' ' GLU . 60.2 t -144.33 167.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 72.140000000000001 109.303 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.535 ' N ' HG12 ' A' ' 252' ' ' VAL . 53.6 tt0 -122.93 154.49 38.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 74.409999999999997 110.281 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.773 ' CG1' HG21 ' A' ' 314' ' ' THR . 82.4 t -135.75 95.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.142 . . . . 65.109999999999999 109.307 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 2.5 t -69.1 -67.4 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 30.420000000000002 109.963 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.856 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.0 t-20 60.91 64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 71.25 109.291 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -91.45 145.56 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 75.209999999999994 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.26 -34.16 4.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.517 1.136 . . . . 62.130000000000003 109.348 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -65.89 -52.03 53.6 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 74.409999999999997 109.261 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.9 m -171.14 -175.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 53.340000000000003 110.063 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -88.12 176.38 7.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.446 1.091 . . . . 65.109999999999999 109.324 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' HIS . . . . . 0.55 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 4.3 t-160 -176.2 103.51 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.329999999999998 109.618 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 254' ' ' VAL . 93.8 m-85 -112.54 127.02 55.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 54.100000000000001 111.023 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.766 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 76.5 mt -119.42 116.83 52.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 62.450000000000003 109.272 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.675 HD11 HD12 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -103.25 130.01 50.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 64.450000000000003 109.319 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.766 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.3 m-85 -119.66 109.17 15.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.030000000000001 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.783 ' HB3' HG22 ' A' ' 298' ' ' ILE . 14.5 t30 -69.81 75.51 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 70.040000000000006 109.301 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.97 52.85 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 72.430000000000007 109.322 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.5 p -127.58 -178.08 4.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 74.439999999999998 110.419 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.32 18.19 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 74.019999999999996 109.33 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.59 169.22 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 71.019999999999996 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.3 mt -121.11 137.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.512 1.132 . . . . 73.099999999999994 109.358 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.75 137.49 58.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.271 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -26.25 11.09 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.519 1.799 . . . . 61.329999999999998 111.007 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.433 ' C ' ' N ' ' A' ' 277' ' ' CYS . . . 83.94 -157.38 33.79 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.527 1.142 . . . . 45.439999999999998 111.034 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 275' ' ' GLY . 0.2 OUTLIER 39.89 30.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.463 0.743 . . . . 64.329999999999998 109.269 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.433 ' N ' ' C ' ' A' ' 275' ' ' GLY . 18.0 m -87.04 -173.41 4.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.538 1.149 . . . . 74.5 108.304 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.805 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.5 m -152.93 126.37 8.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 53.530000000000001 110.356 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.627 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.7 t80 -79.99 172.66 13.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 75.219999999999999 110.984 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.505 ' HG3' HG21 ' A' ' 288' ' ' VAL . 2.3 tt0 -167.08 91.05 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.115 . . . . 61.350000000000001 110.312 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 32.8 p90 -111.7 120.98 43.85 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.476 1.11 . . . . 65.150000000000006 110.983 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.604 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 81.8 p -109.93 161.56 15.36 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 54.450000000000003 110.017 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.576 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 33.3 t . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 53.310000000000002 109.986 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 280' ' ' GLU . 8.8 p . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.268 -0.641 . . . . 42.43 109.268 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 288' ' ' VAL . 8.3 t80 -137.49 146.57 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 73.209999999999994 111.011 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 95.0 p -117.74 123.46 46.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 70.430000000000007 109.996 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.9 mt -101.77 126.94 55.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 72.319999999999993 109.259 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.429 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.1 OUTLIER -66.92 122.69 18.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 74.310000000000002 109.321 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 97.2 mtp -84.45 148.94 26.3 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.096 . . . . 62.219999999999999 111.015 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.708 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -52.62 156.23 4.69 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 63.020000000000003 111.02 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -26.64 10.86 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.492 1.785 . . . . 63.130000000000003 110.985 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.562 ' CE1' ' HD3' ' A' ' 304' ' ' LYS . 28.4 p80 -52.82 -176.28 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 75.319999999999993 109.596 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.63 175.71 7.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 1.13 . . . . 73.310000000000002 110.289 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.783 HG22 ' HB3' ' A' ' 267' ' ' ASN . 3.9 mp -134.74 61.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.12 . . . . 75.019999999999996 109.321 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.71 -122.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.487 1.117 . . . . 62.420000000000002 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.444 HG22 ' HG2' ' A' ' 301' ' ' LYS . 2.2 mt -98.73 138.11 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.513 0.772 . . . . 70.340000000000003 109.3 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.444 ' HG2' HG22 ' A' ' 300' ' ' ILE . 1.1 mmmm 67.07 9.23 6.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 109.331 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.599 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -103.28 146.5 16.53 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.473 1.108 . . . . 72.319999999999993 110.986 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.02 -177.58 4.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 0.779 . . . . 62.140000000000001 110.302 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.708 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 57.0 tptt -149.38 150.11 31.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 72.140000000000001 109.28 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 10.3 mt-10 -110.36 160.07 16.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 70.040000000000006 110.307 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.675 HD12 HD11 ' A' ' 265' ' ' LEU . 13.6 mt -155.97 70.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 70.209999999999994 109.287 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.55 ' CD1' ' NE2' ' A' ' 262' ' ' HIS . 0.1 OUTLIER -74.97 129.29 37.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 72.439999999999998 108.02 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 12.8 m-30 -117.75 -172.02 2.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.45 1.094 . . . . 65.519999999999996 110.998 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.509 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.8 p90 -169.75 159.43 6.94 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.439999999999998 110.955 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.03 -36.17 2.68 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.046 -2.481 . . . . 73.349999999999994 110.994 0.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.2 p 170.25 131.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.538 1.149 . . . . 44.539999999999999 110.016 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.4 mp -114.79 158.81 39.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.319999999999993 109.355 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 145.73 31.95 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.491 1.785 . . . . 73.519999999999996 110.971 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.773 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.2 OUTLIER -127.12 164.49 35.1 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 75.209999999999994 110.404 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.02 176.51 43.14 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.013 -2.495 . . . . 60.140000000000001 110.991 0.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.713 HD12 ' CE ' ' A' ' 321' ' ' MET . 4.9 mt -92.16 66.41 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.549 1.156 . . . . 73.450000000000003 109.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 2.4 p -81.27 128.15 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 61.32 110.006 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.93 21.31 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 73.349999999999994 109.27 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.604 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.5 m-30 -103.7 134.13 47.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 74.430000000000007 110.982 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 322' ' ' LYS . 60.4 m -45.91 -67.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 73.439999999999998 110.389 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.713 ' CE ' HD12 ' A' ' 316' ' ' LEU . 4.3 ttm 33.53 56.92 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.409999999999997 111.016 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.746 ' HZ2' ' HB ' ' A' ' 333' ' ' VAL . 28.1 mttm -95.14 -166.38 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.129999999999995 109.303 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.528 ' CG2' HD21 ' A' ' 344' ' ' LEU . 12.7 t -145.02 126.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 51.119999999999997 109.304 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 278' ' ' THR . 11.8 m -109.69 -172.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 75.049999999999997 109.252 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 331' ' ' ILE . 39.2 p30 -120.25 -170.85 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 64.510000000000005 109.304 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.42 -8.23 17.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 64.109999999999999 110.299 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 -8.76 35.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 75.120000000000005 109.278 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.59 -4.5 78.25 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.115 . . . . 63.229999999999997 111.026 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -80.84 140.48 35.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.484 0.755 . . . . 75.219999999999999 110.27 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.712 ' HA ' HG12 ' A' ' 324' ' ' VAL . 7.7 m -66.53 122.89 18.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 61.439999999999998 110.388 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.404 HG21 ' HB3' ' A' ' 325' ' ' ASN . 1.8 pt -97.46 -41.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 64.209999999999994 109.263 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.879 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.1 mt -141.59 170.9 14.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 71.400000000000006 109.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.746 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.46 128.54 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 73.510000000000005 109.304 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -89.08 113.87 4.19 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.451 1.095 . . . . 74.040000000000006 110.977 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -26.79 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 0.788 . . . . 74.329999999999998 109.294 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 342' ' ' ILE . 0.1 OUTLIER 42.12 67.81 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 74.209999999999994 108.263 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -71.89 -172.93 0.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 70.209999999999994 109.314 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.29 57.95 2.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 74.340000000000003 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 50.4 m -168.28 141.87 3.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 53.030000000000001 110.009 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -45.56 -31.73 1.96 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 73.019999999999996 109.271 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -63.85 147.54 51.59 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 75.109999999999999 110.315 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.495 HD13 ' SG ' ' A' ' 336' ' ' CYS . 16.9 mt -150.05 141.26 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 73.099999999999994 109.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 62.6 p -140.89 107.53 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 53.509999999999998 110.397 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.6 mp -61.25 134.51 57.06 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 63.530000000000001 109.253 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 2.0 mtpt -104.55 -76.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 64.510000000000005 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.724 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 159.78 143.84 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.538 1.149 . . . . 73.120000000000005 110.025 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.493 1.786 . . . . 72.25 111.006 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.325 -0.46 0 O-C-N 124.465 1.103 . . . . 71.349999999999994 109.332 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.84 HD22 ' HB ' ' A' ' 343' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.331 -0.618 . . . . 63.340000000000003 109.331 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.837 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -97.6 101.5 13.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 65.439999999999998 109.311 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.15 143.96 27.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.435 1.084 . . . . 70.409999999999997 109.602 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.911 HG21 HD23 ' A' ' 265' ' ' LEU . 84.3 t -126.26 144.47 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.516 1.135 . . . . 71.450000000000003 109.314 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -119.39 121.58 39.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 62.229999999999997 110.283 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.38 107.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 65.030000000000001 109.263 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 72.6 m -68.43 -57.6 5.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 63.520000000000003 110.033 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.693 ' HA ' HD23 ' A' ' 261' ' ' LEU . 6.4 t-20 55.43 69.62 0.72 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.522 1.139 . . . . 74.439999999999998 109.311 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -114.63 161.73 17.7 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 75.530000000000001 110.3 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -42.21 -53.62 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 73.230000000000004 109.289 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -43.57 -64.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 75.319999999999993 109.284 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.8 m -179.61 -174.8 0.31 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 74.140000000000001 109.981 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.717 HD13 ' HZ ' ' A' ' 263' ' ' PHE . 14.7 mt -78.14 169.29 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.487 1.117 . . . . 73.409999999999997 109.314 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -165.1 112.39 0.99 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.049999999999997 109.61 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.717 ' HZ ' HD13 ' A' ' 261' ' ' LEU . 6.4 m-85 -116.18 106.51 13.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 75.420000000000002 110.987 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.662 HG22 ' CE2' ' A' ' 266' ' ' TYR . 16.6 mt -99.55 103.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 73.530000000000001 109.331 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.911 HD23 HG21 ' A' ' 252' ' ' VAL . 0.2 OUTLIER -105.01 126.42 52.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 71.439999999999998 109.283 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.662 ' CE2' HG22 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -113.2 119.21 36.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 71.010000000000005 111.018 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 250' ' ' LEU . 25.4 t30 -80.71 95.52 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 61.420000000000002 109.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -88.68 -54.55 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.424 1.078 . . . . 72.310000000000002 109.294 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 1.7 t -100.48 173.83 6.38 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.08 . . . . 64.310000000000002 110.39 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 269' ' ' THR . 2.5 t-20 81.93 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 72.319999999999993 109.295 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.444 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 0.0 OUTLIER -81.62 -174.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 75.319999999999993 109.318 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.413 ' N ' HG12 ' A' ' 271' ' ' ILE . 21.9 mt -92.75 126.76 45.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.010000000000005 109.349 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 1.4 mp -43.78 137.65 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.542 1.151 . . . . 75.200000000000003 109.309 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.97 -31.07 6.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.487 1.783 . . . . 74.409999999999997 111.0 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 102.14 154.2 25.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.48 1.112 . . . . 74.040000000000006 110.991 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 5.2 t30 74.49 32.63 0.91 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.466 0.745 . . . . 71.219999999999999 109.268 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 16.3 m -78.91 -176.66 5.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.159 . . . . 74.400000000000006 108.322 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.589 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -154.53 139.96 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 71.109999999999999 110.404 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 1.007 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.8 t80 -88.93 -177.26 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 73.239999999999995 110.991 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.646 ' HG2' HG21 ' A' ' 288' ' ' VAL . 22.2 tt0 -177.35 100.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.135 . . . . 60.020000000000003 110.281 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 2.7 p90 -123.62 146.59 48.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 71.430000000000007 110.988 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.599 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 92.0 p -77.99 162.25 26.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 74.319999999999993 110.033 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.522 ' HB2' HD21 ' A' ' 312' ' ' LEU . 72.3 p . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.521 1.138 . . . . 54.0 110.046 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.646 HG21 ' HG2' ' A' ' 280' ' ' GLU . 14.5 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.325 -0.62 . . . . 62.420000000000002 109.325 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.518 ' N ' HG22 ' A' ' 288' ' ' VAL . 10.0 t80 -116.4 -175.96 2.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 72.519999999999996 110.961 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.49 ' OG ' HG22 ' A' ' 278' ' ' THR . 3.6 t -163.49 123.58 2.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 41.229999999999997 109.967 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.875 HD11 ' CD1' ' A' ' 308' ' ' PHE . 10.9 mt -98.77 136.05 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.209999999999994 109.297 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 106.98 12.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 73.040000000000006 109.291 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.716 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.2 mtp -80.74 153.25 27.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 74.010000000000005 110.997 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.72 153.08 8.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.484 1.115 . . . . 72.230000000000004 110.999 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -18.84 18.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.438 1.757 . . . . 74.319999999999993 111.035 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -72.49 161.48 30.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 51.210000000000001 109.601 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 36.6 mt-10 -88.15 175.47 7.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.340000000000003 110.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 299' ' ' GLY . 8.3 mt -98.3 -74.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.479 1.112 . . . . 73.340000000000003 109.258 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.524 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 121.0 159.76 10.85 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.119 . . . . 70.120000000000005 110.992 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.46 HG22 ' HD2' ' A' ' 301' ' ' LYS . 21.6 mt -58.61 -29.49 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 73.200000000000003 109.3 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.46 ' HD2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -109.63 -34.95 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 70.239999999999995 109.255 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -46.81 168.79 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.496 1.123 . . . . 71.530000000000001 111.007 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -133.17 -178.44 4.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 62.310000000000002 110.299 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 38.1 tptt -137.5 156.74 47.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 63.119999999999997 109.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -133.57 100.83 4.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 62.299999999999997 110.304 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 1.007 HD13 ' CG ' ' A' ' 279' ' ' PHE . 20.6 mt -97.74 30.74 2.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 65.349999999999994 109.3 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -43.09 126.88 4.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.340000000000003 107.989 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.875 ' CD1' HD11 ' A' ' 291' ' ' ILE . 53.8 t80 -127.35 172.92 10.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 74.420000000000002 110.98 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -146.3 162.08 36.22 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 74.219999999999999 110.97 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.04 -53.8 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.001 -2.499 . . . . 63.219999999999999 111.006 0.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 14.5 p -175.29 146.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.102 . . . . 73.519999999999996 110.049 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.617 ' HB2' HD11 ' A' ' 261' ' ' LEU . 2.8 mp -123.63 159.19 56.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 73.150000000000006 109.299 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 145.84 31.73 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.533 1.807 . . . . 73.409999999999997 111.0 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -126.55 164.03 36.94 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 63.240000000000002 110.381 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.506 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 178.48 34.5 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.021 -2.491 . . . . 73.5 110.988 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.792 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.5 mt -104.91 61.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.543 1.152 . . . . 72.409999999999997 109.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.4 OUTLIER -86.52 138.08 32.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 62.5 110.034 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 82.89 -1.56 1.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 73.109999999999999 109.298 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.792 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.5 m-85 -80.15 -172.87 3.67 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.105 . . . . 73.109999999999999 110.998 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.532 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -106.37 -58.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 74.519999999999996 110.36 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.746 ' SD ' HD13 ' A' ' 316' ' ' LEU . 0.8 OUTLIER 29.84 61.06 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 74.430000000000007 110.984 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' A' ' 320' ' ' THR . 25.1 mttm -90.03 -172.46 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 42.119999999999997 109.284 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 90.6 t -141.46 125.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 75.019999999999996 109.273 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.677 HG12 ' N ' ' A' ' 330' ' ' THR . 7.0 m -109.38 172.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 74.040000000000006 109.274 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.469 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 12.6 t30 -101.53 -164.29 1.09 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 74.019999999999996 109.313 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -69.1 -7.49 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 65.439999999999998 110.287 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.03 11.73 25.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.109999999999999 109.28 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.12 67.78 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.541 1.15 . . . . 75.299999999999997 110.994 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 331' ' ' ILE . 8.9 pt-20 -96.43 119.34 34.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 0.748 . . . . 65.530000000000001 110.295 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.677 ' N ' HG12 ' A' ' 324' ' ' VAL . 3.8 m -52.68 98.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 42.299999999999997 110.379 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.469 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 14.0 pt -77.51 -39.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.495 1.122 . . . . 73.420000000000002 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 344' ' ' LEU . 11.6 mt -138.76 174.26 10.72 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.469 1.106 . . . . 52.5 109.28 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.41 HG21 ' NZ ' ' A' ' 322' ' ' LYS . 0.1 OUTLIER -156.57 118.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 75.400000000000006 109.278 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -68.7 127.41 22.7 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.495 1.122 . . . . 73.129999999999995 110.988 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.78 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -48.73 -27.18 2.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 75.329999999999998 109.33 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.0 83.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.109999999999999 108.297 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.78 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -101.11 -173.54 2.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 23.149999999999999 109.332 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.83 56.26 1.51 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 74.409999999999997 109.297 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 72.4 p -172.79 136.31 0.7 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.117 . . . . 74.519999999999996 110.002 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.401 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 29.7 m-20 -44.92 -33.42 1.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 44.32 109.316 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.66 139.26 58.64 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.479 1.112 . . . . 70.129999999999995 110.319 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.511 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 86.6 mt -144.96 120.67 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.527 1.142 . . . . 70.510000000000005 109.293 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.84 ' HB ' HD22 ' A' ' 249' ' ' LEU . 16.8 p -109.98 82.27 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 51.5 110.446 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.837 HD22 ' CD2' ' A' ' 250' ' ' LEU . 8.3 mp -39.45 147.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 1.135 . . . . 72.310000000000002 109.28 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -124.78 -87.35 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 73.239999999999995 109.312 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 40.3 p -176.19 137.97 0.49 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 64.439999999999998 109.977 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.545 1.813 . . . . 74.430000000000007 111.0 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 348' ' ' LEU . 2.5 mm? . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 71.150000000000006 109.251 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.773 HD22 ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.3 -0.63 . . . . 64.430000000000007 109.3 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -122.08 100.31 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 1.109 . . . . 71.299999999999997 109.29 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.773 ' NE2' HD22 ' A' ' 249' ' ' LEU . 12.3 m170 -94.86 131.43 40.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 65.540000000000006 109.555 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.856 HG22 ' HB3' ' A' ' 265' ' ' LEU . 17.2 t -112.09 163.16 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 74.010000000000005 109.31 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.406 ' N ' HG12 ' A' ' 252' ' ' VAL . 1.3 tp10 -123.31 122.45 38.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.113 . . . . 75.129999999999995 110.289 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.75 110.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.533 1.146 . . . . 71.219999999999999 109.285 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 m -85.59 -55.54 3.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.340000000000003 109.981 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.953 ' HA ' HD23 ' A' ' 261' ' ' LEU . 11.1 t30 60.53 73.14 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.122 . . . . 75.129999999999995 109.307 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 260' ' ' SER . 33.6 mm-40 -82.69 145.68 29.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.561 1.163 . . . . 44.109999999999999 110.303 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.85 -22.33 14.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 71.420000000000002 109.302 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -82.79 -41.48 19.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.557 1.161 . . . . 60.450000000000003 109.314 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 257' ' ' GLU . 12.3 m -173.4 -175.07 1.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 1.136 . . . . 65.030000000000001 110.032 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.953 HD23 ' HA ' ' A' ' 256' ' ' ASN . 11.2 mt -87.02 178.93 6.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.533 1.145 . . . . 62.100000000000001 109.31 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -178.46 108.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 75.329999999999998 109.631 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 68.9 m-85 -110.6 110.65 21.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 54.329999999999998 110.995 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.686 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 56.9 mt -103.26 109.34 26.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 62.310000000000002 109.287 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.856 ' HB3' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -114.47 137.75 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.144 . . . . 64.329999999999998 109.258 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -120.9 127.08 51.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 71.329999999999998 110.967 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -84.35 93.29 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 63.140000000000001 109.312 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.38 18.54 12.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.153 . . . . 74.140000000000001 109.3 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 12.5 p -77.54 -172.6 2.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 63.329999999999998 110.388 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.558 ' O ' HD11 ' A' ' 300' ' ' ILE . 93.6 m-20 -87.06 -59.65 2.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 71.239999999999995 109.308 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.8 pt -58.86 157.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 73.319999999999993 109.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.44 130.33 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 71.420000000000002 109.289 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 273' ' ' ILE . 6.0 mm -53.69 136.0 54.47 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.400000000000006 109.259 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -23.61 13.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.532 1.806 . . . . 74.109999999999999 110.986 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 86.52 170.91 47.37 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.517 1.136 . . . . 65.230000000000004 111.034 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ASN . . . . . 0.478 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 58.1 t-20 66.8 45.09 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 0.767 . . . . 52.140000000000001 109.323 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.41 ' C ' ' OG1' ' A' ' 278' ' ' THR . 73.8 m -84.24 178.44 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.329999999999998 108.326 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.896 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.8 m -154.74 98.86 2.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 62.240000000000002 110.339 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.514 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.2 t80 -54.31 -172.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.536 1.148 . . . . 75.239999999999995 110.996 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 322' ' ' LYS . 18.2 tt0 173.77 105.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 64.140000000000001 110.279 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.611 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -126.33 170.09 12.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 74.230000000000004 111.012 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.1 t -101.33 -172.82 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.15 . . . . 61.439999999999998 110.01 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.922 ' O ' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.156 . . . . 52.109999999999999 109.976 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 281' ' ' PHE . 4.6 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.275 -0.639 . . . . 64.099999999999994 109.275 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -153.28 155.52 36.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 54.439999999999998 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.89 ' OG ' HG22 ' A' ' 278' ' ' THR . 28.4 t -109.21 136.06 49.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 64.329999999999998 109.999 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.7 mt -103.47 133.72 46.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 63.219999999999999 109.312 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -73.38 112.47 9.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.120000000000005 109.261 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.804 ' HG2' HD21 ' A' ' 306' ' ' LEU . 84.8 mtp -92.9 135.49 34.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 74.349999999999994 111.008 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.61 147.55 0.08 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.486 1.116 . . . . 52.399999999999999 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.478 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.06 -24.13 13.02 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.508 1.794 . . . . 62.240000000000002 111.015 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -53.01 144.87 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.467 1.104 . . . . 74.329999999999998 109.579 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.02 150.28 33.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 74.329999999999998 110.332 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 61.3 mt -80.09 -75.39 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.455 1.097 . . . . 63.299999999999997 109.25 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.01 166.29 12.77 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.477 1.111 . . . . 42.350000000000001 110.981 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.558 HD11 ' O ' ' A' ' 270' ' ' ASN . 18.8 mt -65.47 -31.37 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.521 0.777 . . . . 73.329999999999998 109.305 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -110.72 -23.26 11.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.487 1.117 . . . . 75.109999999999999 109.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -58.78 157.86 20.61 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 53.329999999999998 111.002 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -120.3 -174.94 2.89 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.467 0.745 . . . . 75.329999999999998 110.309 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' A' ' 293' ' ' MET . 6.3 tptp -147.66 154.69 40.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 73.129999999999995 109.256 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 4.1 mt-10 -123.52 135.7 54.17 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 72.530000000000001 110.328 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.804 HD21 ' HG2' ' A' ' 293' ' ' MET . 17.4 mt -136.38 60.0 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 64.239999999999995 109.268 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 3.3 p90 -70.86 131.1 43.26 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 74.409999999999997 107.993 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.8 m-30 -118.37 172.5 7.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.209999999999994 110.982 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.3 OUTLIER -148.91 145.69 20.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 75.019999999999996 111.026 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.96 -44.71 0.53 Allowed 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.043 -2.482 . . . . 74.239999999999995 110.987 0.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 24.1 p 177.63 172.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.516 1.135 . . . . 74.329999999999998 109.971 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 283' ' ' SER . 0.2 OUTLIER -137.62 161.82 58.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 72.150000000000006 109.315 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 144.57 30.31 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.494 1.786 . . . . 74.109999999999999 111.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.523 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.9 OUTLIER -128.04 159.93 64.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 53.340000000000003 110.389 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.96 169.61 74.06 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.034 -2.486 . . . . 74.129999999999995 110.995 -0.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.597 HD22 ' CE ' ' A' ' 321' ' ' MET . 5.2 mp -80.34 63.67 4.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 73.219999999999999 109.288 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.3 p -83.63 133.57 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.150000000000006 109.978 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 70.11 27.57 4.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 74.099999999999994 109.286 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.556 ' CE2' ' OG ' ' A' ' 283' ' ' SER . 7.7 m-85 -101.31 176.59 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.539 1.149 . . . . 63.310000000000002 110.966 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.533 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.9 OUTLIER -109.34 -50.5 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 74.219999999999999 110.429 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.81 ' SD ' HD13 ' A' ' 342' ' ' ILE . 3.9 ptp 26.6 61.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 60.229999999999997 111.015 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.773 ' HZ2' ' HB ' ' A' ' 333' ' ' VAL . 22.3 mttm -78.95 -173.43 3.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 71.530000000000001 109.299 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.4 t -151.73 125.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 71.319999999999993 109.315 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 278' ' ' THR . 26.6 m -113.9 -177.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 73.510000000000005 109.325 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.49 -161.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 72.010000000000005 109.301 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -74.21 -2.14 23.5 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.512 1.133 . . . . 72.319999999999993 110.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -101.77 0.55 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.210000000000001 109.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.8 8.33 47.3 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.542 1.151 . . . . 65.230000000000004 111.013 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 12.4 pt-20 -95.16 123.61 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 0.762 . . . . 63.530000000000001 110.272 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.772 ' HA ' HG12 ' A' ' 324' ' ' VAL . 14.6 m -55.93 113.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 64.200000000000003 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.3 pt -86.67 -38.3 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 109.279 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.9 ' HB3' HD23 ' A' ' 344' ' ' LEU . 11.1 mt -146.21 165.95 27.67 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 75.120000000000005 109.303 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.773 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.1 m -150.29 124.34 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 70.120000000000005 109.32 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -64.0 125.99 33.36 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.533 1.146 . . . . 73.329999999999998 111.0 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -61.69 -27.61 68.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 0.754 . . . . 71.030000000000001 109.281 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.69 ' O ' ' HB2' ' A' ' 337' ' ' ALA . 0.5 OUTLIER 87.38 179.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 75.030000000000001 108.353 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 336' ' ' CYS . . . 163.89 157.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.099 . . . . 74.409999999999997 109.32 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.25 56.88 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.435 1.084 . . . . 71.430000000000007 109.352 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 m -178.93 179.68 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.107 . . . . 53.119999999999997 110.022 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -79.42 -10.03 59.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 73.319999999999993 109.282 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' HG13 ' A' ' 342' ' ' ILE . 1.1 mp0 -76.9 116.84 17.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 72.439999999999998 110.294 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.81 HD13 ' SD ' ' A' ' 321' ' ' MET . 93.1 mt -144.98 124.75 6.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 71.140000000000001 109.299 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 344' ' ' LEU . 11.7 p -125.16 96.56 4.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.108 . . . . 75.420000000000002 110.402 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.5 mp -39.41 139.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 75.120000000000005 109.32 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 346' ' ' SER . 1.9 ptmm? -109.93 -47.37 3.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 60.299999999999997 109.279 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.4 OUTLIER 156.32 154.43 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 73.049999999999997 109.966 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.41 ' HA ' ' CG1' ' A' ' 333' ' ' VAL . 18.2 Cg_endo -74.96 -51.6 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 64.230000000000004 111.007 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.5 109.324 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.972 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.309 -0.626 . . . . 71.329999999999998 109.309 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -119.88 103.28 9.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 72.430000000000007 109.3 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -81.81 123.62 28.95 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 61.310000000000002 109.58 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 253' ' ' GLU . 80.2 t -122.29 165.05 18.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.310000000000002 109.324 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 252' ' ' VAL . 27.7 tp10 -123.36 133.29 54.13 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.523 1.14 . . . . 53.409999999999997 110.312 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 340' ' ' ASN . 60.5 t -109.3 108.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.495 1.122 . . . . 75.219999999999999 109.341 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 4.8 t -85.64 -61.86 1.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 72.299999999999997 110.012 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.876 ' HA ' HD23 ' A' ' 261' ' ' LEU . 4.4 t-20 57.01 63.37 1.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.446 1.092 . . . . 75.109999999999999 109.314 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -84.44 146.75 27.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 71.510000000000005 110.265 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -49.5 -25.67 2.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.452 1.095 . . . . 73.129999999999995 109.354 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -75.73 -48.69 20.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 72.230000000000004 109.294 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.2 p -172.62 -175.13 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 71.530000000000001 110.008 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 312' ' ' LEU . 11.6 mt -85.43 -178.24 6.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 65.219999999999999 109.314 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' HIS . . . . . 0.41 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 5.3 t-160 -176.62 100.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 75.299999999999997 109.542 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.783 ' HE2' HD13 ' A' ' 261' ' ' LEU . 89.1 m-85 -117.42 94.07 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 71.439999999999998 111.03 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.584 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 18.5 mt -86.97 128.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.493 1.121 . . . . 74.439999999999998 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 1.042 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -110.48 137.25 48.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 73.329999999999998 109.297 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.584 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 9.5 m-85 -129.7 127.37 40.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.535 1.147 . . . . 70.200000000000003 111.024 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.501 ' HB2' HD13 ' A' ' 273' ' ' ILE . 22.5 t30 -82.67 102.58 11.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 63.340000000000003 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.93 19.81 19.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.479 1.112 . . . . 74.439999999999998 109.307 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.2 p -104.02 -165.48 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.485 1.116 . . . . 70.219999999999999 110.385 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.13 -51.31 5.65 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 71.209999999999994 109.335 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.9 pt -53.82 161.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 74.409999999999997 109.35 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 1.9 mp -117.67 111.17 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.453 1.095 . . . . 42.43 109.329 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.9 HG21 HD12 ' A' ' 298' ' ' ILE . 1.3 mp -53.82 139.78 51.13 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.129999999999995 109.258 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.451 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.2 Cg_endo -74.98 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 54.450000000000003 111.03 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 294' ' ' GLY . . . 89.72 -36.65 3.48 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 64.450000000000003 111.007 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -76.04 57.9 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 0.766 . . . . 64.209999999999994 109.311 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 324' ' ' VAL . 7.6 m -101.9 -175.09 2.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 75.409999999999997 108.302 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.836 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.6 m -152.92 97.34 2.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 72.310000000000002 110.363 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 323' ' ' VAL . 0.6 OUTLIER -56.04 171.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 74.030000000000001 110.982 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 69.3 tt0 -167.38 96.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 71.340000000000003 110.317 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 2.2 p90 -123.19 138.09 54.73 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.138 . . . . 74.219999999999999 110.982 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 88.5 p -99.46 -178.24 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 65.209999999999994 109.977 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.427 1.079 . . . . 73.200000000000003 109.981 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.46 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 1.6 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.293 -0.632 . . . . 61.219999999999999 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.417 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 2.7 t80 -145.05 156.08 43.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.538 1.149 . . . . 73.329999999999998 110.981 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.701 ' HB3' HG22 ' A' ' 278' ' ' THR . 3.3 m -117.34 130.13 56.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.219999999999999 110.011 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 11.9 mt -97.98 125.21 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.508 1.13 . . . . 74.329999999999998 109.241 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.12 99.58 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.554 1.159 . . . . 75.150000000000006 109.27 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.866 ' HG2' HD21 ' A' ' 306' ' ' LEU . 84.2 mtp -71.71 135.94 47.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 72.0 111.003 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 275' ' ' GLY . . . -48.02 155.19 1.3 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 64.140000000000001 110.971 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.61 6.94 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.466 1.772 . . . . 64.530000000000001 110.993 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -49.49 116.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 74.329999999999998 109.585 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -62.62 151.25 38.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.112 . . . . 73.310000000000002 110.28 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.9 HD12 HG21 ' A' ' 273' ' ' ILE . 13.5 mt -78.28 -88.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.483 1.114 . . . . 72.409999999999997 109.317 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.792 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 89.34 -161.69 30.24 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.517 1.136 . . . . 64.310000000000002 110.989 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.501 HG23 ' HD3' ' A' ' 301' ' ' LYS . 8.3 mt -77.09 124.5 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.557 0.798 . . . . 74.420000000000002 109.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 300' ' ' ILE . 2.6 mptt 68.48 7.22 5.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.565 1.166 . . . . 64.549999999999997 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.895 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -91.87 53.38 2.96 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.566 1.166 . . . . 24.25 111.012 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 302' ' ' GLY . 6.3 pt20 -42.16 165.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.577 0.81 . . . . 51.340000000000003 110.321 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.483 ' HB2' HD11 ' A' ' 298' ' ' ILE . 38.8 tptt -131.67 150.55 52.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 73.420000000000002 109.308 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 mt-10 -115.02 114.15 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.513 1.133 . . . . 71.099999999999994 110.289 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 1.042 HD12 HD11 ' A' ' 265' ' ' LEU . 11.1 mt -114.61 48.65 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.497 1.123 . . . . 61.409999999999997 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.412 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 5.2 p-90 -59.1 141.77 53.22 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 72.0 108.024 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.699 ' CD1' HD12 ' A' ' 261' ' ' LEU . 5.1 t80 -139.78 165.77 26.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 73.430000000000007 111.013 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -145.72 158.12 50.24 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.230000000000004 110.973 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -45.87 0.42 Allowed 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.001 -2.499 . . . . 63.049999999999997 111.011 -0.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.7 p -176.69 164.32 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.147 . . . . 64.030000000000001 110.007 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.951 ' HB2' HD11 ' A' ' 261' ' ' LEU . 4.1 mt -137.04 158.51 72.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.548 1.155 . . . . 54.43 109.308 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 148.03 34.94 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.51 1.795 . . . . 74.120000000000005 111.057 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.544 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 1.0 OUTLIER -137.3 159.62 68.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 75.140000000000001 110.367 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.01 170.31 72.21 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 75.049999999999997 110.966 0.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.61 HD23 ' CE2' ' A' ' 319' ' ' TYR . 3.2 mt -90.85 56.65 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 64.209999999999994 109.296 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.2 p -73.37 116.79 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 72.219999999999999 110.042 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 317' ' ' SER . 18.6 t-20 79.71 39.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 62.009999999999998 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.61 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.2 m-85 -115.83 143.89 44.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 63.399999999999999 111.025 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.518 ' O ' ' C ' ' A' ' 321' ' ' MET . 9.9 m -54.94 -61.54 2.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.522 1.139 . . . . 75.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.59 ' HE3' HD13 ' A' ' 316' ' ' LEU . 1.1 ptp 28.01 50.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.530000000000001 111.013 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.452 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 85.4 mttt -82.17 -179.95 7.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 64.239999999999995 109.33 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.605 HG22 ' CD1' ' A' ' 279' ' ' PHE . 19.9 t -142.05 131.0 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 53.210000000000001 109.288 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 278' ' ' THR . 15.8 m -113.03 173.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 65.400000000000006 109.3 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.873 HD21 HG21 ' A' ' 331' ' ' ILE . 2.4 m-20 -109.59 -168.98 1.4 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 65.219999999999999 109.289 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.2 -7.86 14.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.474 1.109 . . . . 72.040000000000006 110.322 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ASP . . . . . 0.408 ' N ' ' OD2' ' A' ' 327' ' ' ASP . 1.9 p30 -88.79 -12.38 42.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 75.219999999999999 109.263 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 80.74 -5.94 63.5 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.512 1.132 . . . . 52.25 111.017 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -90.6 143.94 26.24 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 0.742 . . . . 70.140000000000001 110.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.715 ' HA ' HG12 ' A' ' 324' ' ' VAL . 27.7 m -58.86 130.99 49.61 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 1.102 . . . . 63.130000000000003 110.332 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.873 HG21 HD21 ' A' ' 325' ' ' ASN . 18.8 pt -112.7 -37.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 61.43 109.273 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.886 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.6 mt -139.7 168.42 19.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.230000000000004 109.298 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.1 m -151.81 127.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 74.549999999999997 109.332 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -76.24 147.81 35.07 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 72.109999999999999 110.971 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -89.14 -35.96 15.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.512 0.772 . . . . 71.109999999999999 109.332 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.515 ' H ' HG23 ' A' ' 342' ' ' ILE . 0.3 OUTLIER 41.52 86.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 72.030000000000001 108.312 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -104.28 73.95 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.446 1.091 . . . . 70.409999999999997 109.324 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.8 t0 41.44 53.72 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.117 . . . . 75.129999999999995 109.3 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -160.6 123.79 3.39 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 64.040000000000006 109.986 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 254' ' ' VAL . 4.7 m120 -41.2 -33.43 0.36 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.091 . . . . 70.200000000000003 109.308 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.68 146.38 46.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 72.319999999999993 110.3 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 336' ' ' CYS . 4.3 mt -146.08 138.96 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 75.430000000000007 109.34 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 249' ' ' LEU . 16.6 p -132.44 84.85 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 62.200000000000003 110.405 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.8 mp -39.42 130.11 1.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 65.329999999999998 109.336 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 346' ' ' SER . 22.8 mttt -97.64 -74.01 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 71.439999999999998 109.292 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 2.7 p 159.9 146.92 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.439999999999998 109.989 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 -58.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.497 1.788 . . . . 74.409999999999997 110.966 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.407 ' C ' HD13 ' A' ' 348' ' ' LEU . 1.5 tm? . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 63.329999999999998 109.316 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.29 -0.633 . . . . 54.109999999999999 109.29 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.799 HD22 HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -121.41 103.78 9.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 71.519999999999996 109.324 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.418 ' C ' HG23 ' A' ' 252' ' ' VAL . 8.2 m-70 -83.73 167.14 17.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 73.049999999999997 109.562 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 265' ' ' LEU . 21.9 t -152.45 166.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 63.310000000000002 109.32 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 252' ' ' VAL . 10.5 tp10 -134.26 134.88 42.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 54.329999999999998 110.317 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 263' ' ' PHE . 56.9 t -119.74 101.7 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 74.420000000000002 109.253 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -54.37 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.496 1.123 . . . . 75.430000000000007 110.016 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.641 ' HB2' HG21 ' A' ' 314' ' ' THR . 5.6 t-20 60.33 77.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.549 1.155 . . . . 53.329999999999998 109.339 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.28 152.09 35.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.532 1.145 . . . . 52.32 110.302 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -42.27 -47.26 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 72.329999999999998 109.315 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.49 -64.24 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.464 1.102 . . . . 63.299999999999997 109.301 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.2 m -173.42 -174.83 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 61.039999999999999 110.012 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' ' 256' ' ' ASN . 14.0 mt -86.76 150.98 23.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 74.310000000000002 109.29 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -137.45 108.0 6.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 72.519999999999996 109.628 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 82.7 m-85 -112.37 104.35 12.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.476 1.11 . . . . 74.549999999999997 111.039 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.782 HG22 ' CE2' ' A' ' 266' ' ' TYR . 98.6 mt -105.03 111.62 35.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 64.219999999999999 109.271 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.89 128.91 45.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 72.430000000000007 109.317 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.782 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -116.86 106.57 13.6 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.504 1.128 . . . . 73.209999999999994 110.999 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.526 ' HA ' HD12 ' A' ' 250' ' ' LEU . 57.9 t30 -70.75 85.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 64.120000000000005 109.294 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -90.37 53.38 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 74.010000000000005 109.273 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 18.7 p -125.19 166.87 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 75.519999999999996 110.384 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -75.91 -49.62 17.31 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.556 1.16 . . . . 72.0 109.303 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 26.7 pt -51.63 -179.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.15 . . . . 72.010000000000005 109.341 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.3 126.71 73.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 71.409999999999997 109.267 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' A' ' 273' ' ' ILE . 5.8 mm -56.82 136.17 78.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 72.409999999999997 109.266 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.02 -24.12 13.1 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.503 1.791 . . . . 64.239999999999995 111.016 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.95 -163.63 51.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.511 1.132 . . . . 63.32 111.027 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 49.07 33.74 5.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 45.210000000000001 109.339 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 64.3 m -85.39 173.87 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 44.340000000000003 108.305 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.892 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.5 m -152.32 99.33 2.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 64.329999999999998 110.361 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.9 t80 -52.08 -179.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 72.400000000000006 111.016 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.97 100.24 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 60.329999999999998 110.245 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.692 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 17.0 p90 -115.02 152.27 32.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 72.150000000000006 111.032 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 t -87.41 179.19 6.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 64.310000000000002 110.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' SER . . . . . 1.022 ' O ' HD22 ' A' ' 312' ' ' LEU . 1.4 m . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 62.119999999999997 110.006 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.318 -0.623 . . . . 60.350000000000001 109.318 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.74 162.52 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.431 1.082 . . . . 75.129999999999995 111.044 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.849 ' OG ' HG22 ' A' ' 278' ' ' THR . 17.7 t -120.83 128.67 53.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 71.530000000000001 110.001 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 3.7 mt -93.55 130.56 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.209999999999994 109.341 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.675 ' HA ' HG23 ' A' ' 278' ' ' THR . 2.7 mptp? -71.96 113.09 8.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 71.5 109.294 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.657 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.4 mtp -79.87 162.75 24.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 73.340000000000003 110.993 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -67.09 155.31 52.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.133 . . . . 52.119999999999997 111.013 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -33.3 4.67 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.501 1.79 . . . . 64.109999999999999 110.991 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -46.14 144.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 75.140000000000001 109.626 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.55 126.76 41.06 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 64.200000000000003 110.301 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 303' ' ' GLN . 14.8 mt -64.18 -77.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.572 1.17 . . . . 65.010000000000005 109.328 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 79.47 -156.7 41.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.507 1.129 . . . . 35.32 111.017 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.446 ' C ' ' N ' ' A' ' 302' ' ' GLY . 2.0 mt -69.42 156.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.518 0.775 . . . . 62.439999999999998 109.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.405 ' HD2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER 40.28 30.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 61.310000000000002 109.308 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 300' ' ' ILE . . . -108.38 153.32 16.85 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.485 1.116 . . . . 75.010000000000005 111.018 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.411 ' N ' HG23 ' A' ' 298' ' ' ILE . 5.6 pt20 -126.23 -179.06 4.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 0.755 . . . . 73.030000000000001 110.289 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 265' ' ' LEU . 40.8 tptt -152.62 149.37 28.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 71.219999999999999 109.288 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.55 130.3 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 71.040000000000006 110.317 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.842 HD12 HD11 ' A' ' 265' ' ' LEU . 13.2 mt -139.38 61.64 1.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.123 . . . . 73.439999999999998 109.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.586 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 7.0 p90 -75.22 113.46 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 75.510000000000005 107.949 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.0 m-30 -102.01 173.62 6.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 72.049999999999997 111.013 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.507 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.1 p90 -158.93 159.1 29.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 74.319999999999993 110.946 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.98 -36.71 2.5 Favored 'Cis proline' 0 C--N 1.36 1.166 0 C-N-CA 121.045 -2.481 . . . . 72.420000000000002 110.963 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.4 p 167.52 150.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 74.5 109.968 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.022 HD22 ' O ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -123.21 172.93 4.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.472 1.108 . . . . 73.420000000000002 109.287 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.86 34.6 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.535 1.808 . . . . 75.219999999999999 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 256' ' ' ASN . 1.1 p -133.08 159.45 72.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.508 1.13 . . . . 74.420000000000002 110.391 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.06 171.46 68.02 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.985 -2.506 . . . . 71.319999999999993 110.958 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.721 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.4 mt -89.07 62.33 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.46 1.1 . . . . 71.430000000000007 109.266 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 5.4 p -87.62 136.52 32.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.129 . . . . 33.049999999999997 110.029 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.6 OUTLIER 76.22 6.8 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 54.439999999999998 109.32 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.721 ' CE2' HD23 ' A' ' 316' ' ' LEU . 8.6 m-85 -80.34 179.04 7.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 74.310000000000002 110.99 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.526 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.8 OUTLIER -105.72 -53.05 2.71 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 74.540000000000006 110.361 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.685 ' CE ' HD13 ' A' ' 316' ' ' LEU . 5.0 mtm 27.31 57.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 73.450000000000003 111.017 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.559 ' HD3' HG21 ' A' ' 330' ' ' THR . 16.0 mttt -87.78 -168.81 2.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 53.340000000000003 109.317 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -148.91 137.65 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.14 . . . . 75.109999999999999 109.28 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 278' ' ' THR . 15.9 m -107.88 178.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 55.109999999999999 109.325 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.859 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -111.47 -172.43 2.03 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.495 1.122 . . . . 63.109999999999999 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.07 -3.67 14.09 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 74.129999999999995 110.345 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.02 -5.41 28.14 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.456 1.097 . . . . 73.109999999999999 109.291 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 70.3 58.94 5.67 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.474 1.109 . . . . 73.340000000000003 111.013 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.859 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.9 OUTLIER -154.76 119.48 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.456 0.739 . . . . 74.400000000000006 110.276 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.851 ' N ' HG12 ' A' ' 324' ' ' VAL . 24.3 m -46.1 124.18 5.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 72.329999999999998 110.395 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.711 HG22 ' ND2' ' A' ' 325' ' ' ASN . 0.8 OUTLIER -105.53 -39.47 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 63.549999999999997 109.306 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 344' ' ' LEU . 8.5 mt -130.47 167.79 18.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 73.040000000000006 109.284 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.452 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.2 m -151.9 132.18 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 60.420000000000002 109.259 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.737 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -85.44 122.1 5.86 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.511 1.132 . . . . 62.229999999999997 110.984 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.798 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.64 -26.82 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 70.239999999999995 109.302 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 342' ' ' ILE . 1.2 m 50.42 63.2 2.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.116 . . . . 74.0 108.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.798 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -70.04 -179.56 1.96 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.489 1.118 . . . . 60.049999999999997 109.275 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -76.66 62.52 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 74.420000000000002 109.297 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 14.9 m -174.09 146.29 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.15 . . . . 75.239999999999995 109.999 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 79.0 m-20 -53.09 -21.19 4.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.435 1.084 . . . . 71.439999999999998 109.303 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.59 143.32 42.41 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 63.210000000000001 110.298 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.584 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 63.3 mt -147.55 139.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 51.43 109.31 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 11.8 p -133.58 94.73 3.35 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.430000000000007 110.427 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.799 HD22 HD22 ' A' ' 250' ' ' LEU . 5.4 mp -47.66 133.03 13.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 74.519999999999996 109.286 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.4 ptpt -117.88 -60.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 74.109999999999999 109.317 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.29 150.85 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 54.439999999999998 109.984 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -56.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.482 1.78 . . . . 61.240000000000002 111.047 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.516 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.450000000000003 109.336 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 249' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.326 -0.62 . . . . 75.310000000000002 109.326 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.576 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.21 98.24 6.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 64.040000000000006 109.304 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.477 ' CE1' ' CD ' ' A' ' 341' ' ' GLU . 2.3 t-160 -96.63 130.23 43.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.472 1.107 . . . . 61.119999999999997 109.574 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 265' ' ' LEU . 3.6 t -116.06 171.16 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 71.299999999999997 109.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.528 ' H ' HG12 ' A' ' 252' ' ' VAL . 1.1 tp10 -134.76 121.99 21.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.519 1.137 . . . . 74.439999999999998 110.27 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 263' ' ' PHE . 21.8 t -103.61 111.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 54.240000000000002 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -64.94 0.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 61.109999999999999 109.962 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.906 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.3 OUTLIER 66.97 67.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 72.430000000000007 109.312 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.09 169.08 11.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 75.219999999999999 110.298 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -73.52 -14.49 61.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.472 1.108 . . . . 71.140000000000001 109.318 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 260' ' ' SER . 1.8 p-10 -87.51 -45.37 10.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 75.349999999999994 109.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.473 ' N ' ' ND2' ' A' ' 259' ' ' ASN . 3.8 p -176.15 -177.31 0.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 70.329999999999998 110.004 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 256' ' ' ASN . 16.8 mt -90.18 174.46 7.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.11 . . . . 73.200000000000003 109.255 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' HIS . . . . . 0.404 ' NE2' ' HG2' ' A' ' 305' ' ' GLU . 4.2 t-160 -171.97 104.51 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.439999999999998 109.59 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.608 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 87.9 m-85 -107.05 91.68 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 72.420000000000002 110.993 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.718 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 48.9 mt -88.84 109.9 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.209999999999994 109.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.715 HD21 HD12 ' A' ' 306' ' ' LEU . 0.1 OUTLIER -110.62 130.33 55.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 73.400000000000006 109.331 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.718 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 2.0 m-85 -114.99 136.74 52.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.496 1.123 . . . . 75.450000000000003 111.003 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 273' ' ' ILE . 9.2 p-10 -79.72 118.58 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 61.420000000000002 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -11.53 22.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 54.409999999999997 109.309 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.5 p -72.1 175.67 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 63.420000000000002 110.345 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -88.52 -43.21 11.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 65.150000000000006 109.308 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.3 pt -53.15 175.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 74.310000000000002 109.299 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.12 134.42 62.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 72.329999999999998 109.319 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.479 HG21 HD12 ' A' ' 298' ' ' ILE . 1.1 mp -57.59 139.18 81.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 109.313 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.402 ' HA ' ' OE1' ' A' ' 297' ' ' GLU . 18.3 Cg_endo -74.99 -30.96 6.61 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.474 1.776 . . . . 42.340000000000003 111.005 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 276' ' ' ASN . . . 86.76 -159.67 31.9 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.518 1.136 . . . . 61.210000000000001 110.981 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 275' ' ' GLY . 56.9 t-20 40.35 32.44 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 72.150000000000006 109.287 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 275' ' ' GLY . 86.4 m -88.61 -176.77 5.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 43.310000000000002 108.298 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.944 ' O ' HG22 ' A' ' 324' ' ' VAL . 33.1 m -157.4 119.94 3.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 73.319999999999993 110.428 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.571 ' CD1' HD13 ' A' ' 306' ' ' LEU . 3.1 t80 -65.79 173.36 2.92 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.457 1.098 . . . . 73.200000000000003 110.962 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.59 ' HG3' HG21 ' A' ' 288' ' ' VAL . 39.6 tt0 -155.99 79.61 0.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 64.120000000000005 110.339 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.56 151.07 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.12 . . . . 71.409999999999997 111.0 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 p -120.82 -177.25 3.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 71.140000000000001 110.015 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.583 ' CB ' HD23 ' A' ' 312' ' ' LEU . 26.5 p . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.52 1.137 . . . . 65.219999999999999 110.018 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.59 HG21 ' HG3' ' A' ' 280' ' ' GLU . 2.4 p . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 109.235 -0.654 . . . . 63.25 109.235 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.33 131.96 54.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 71.319999999999993 110.998 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 65.4 m -101.99 116.99 33.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 71.530000000000001 109.996 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.7 mt -98.63 125.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 72.129999999999995 109.302 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -67.61 117.77 9.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.437 1.086 . . . . 63.32 109.27 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.466 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 94.1 mtp -81.96 151.8 27.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 63.210000000000001 110.967 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.466 ' N ' ' NZ ' ' A' ' 304' ' ' LYS . . . -44.55 145.7 1.9 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.546 1.154 . . . . 41.009999999999998 110.981 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -25.97 11.41 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.534 1.807 . . . . 73.540000000000006 111.001 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -67.42 178.78 1.45 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.030000000000001 109.626 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 73.2 mt-10 -113.48 130.62 56.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 73.310000000000002 110.327 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 304' ' ' LYS . 3.4 mt -44.08 -62.46 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 71.319999999999993 109.314 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 267' ' ' ASN . . . 111.21 -165.15 12.11 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 34.420000000000002 111.018 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.711 HG22 ' N ' ' A' ' 301' ' ' LYS . 9.7 mt -63.56 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.534 0.784 . . . . 62.119999999999997 109.343 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.711 ' N ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -89.22 14.6 10.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.319999999999993 109.278 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.529 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -62.25 178.47 5.06 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 41.439999999999998 111.0 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 298' ' ' ILE . 2.5 pt20 -141.24 176.79 8.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 0.766 . . . . 75.200000000000003 110.285 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.583 ' HB2' HD11 ' A' ' 298' ' ' ILE . 31.3 tptt -139.37 145.53 39.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.549999999999997 109.297 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.404 ' HG2' ' NE2' ' A' ' 262' ' ' HIS . 4.1 mt-10 -116.31 128.78 55.85 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.469 1.106 . . . . 74.140000000000001 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.715 HD12 HD21 ' A' ' 265' ' ' LEU . 9.4 mt -132.14 56.9 1.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 64.400000000000006 109.312 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -70.94 123.6 22.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 64.010000000000005 107.985 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.7 m-30 -110.14 -166.48 1.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.431 1.082 . . . . 72.209999999999994 111.018 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.504 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.2 p90 -172.09 160.51 4.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 54.149999999999999 111.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.01 -36.26 2.65 Favored 'Cis proline' 0 C--N 1.36 1.145 0 C-N-CA 121.003 -2.499 . . . . 70.420000000000002 110.998 0.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.2 p 169.63 130.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 74.030000000000001 110.029 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.583 HD23 ' CB ' ' A' ' 283' ' ' SER . 5.6 mp -111.69 158.66 35.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 64.430000000000007 109.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 148.4 35.1 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.475 1.776 . . . . 61.310000000000002 110.954 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.665 HG23 ' OD1' ' A' ' 256' ' ' ASN . 0.3 OUTLIER -126.13 164.08 35.88 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 65.450000000000003 110.38 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -173.87 13.07 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 120.991 -2.504 . . . . 72.219999999999999 111.028 -0.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 1.021 HD13 ' SD ' ' A' ' 321' ' ' MET . 2.4 mt -107.73 58.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.502 1.126 . . . . 54.009999999999998 109.241 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.9 OUTLIER -81.87 133.32 35.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 44.43 109.989 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 317' ' ' SER . 6.8 t-20 75.26 26.13 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.040000000000006 109.302 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.825 ' CE2' HD23 ' A' ' 316' ' ' LEU . 16.4 m-85 -101.33 -171.56 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 73.439999999999998 110.984 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.543 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -100.54 -64.28 1.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 65.239999999999995 110.391 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . 1.021 ' SD ' HD13 ' A' ' 316' ' ' LEU . 1.8 mtm 30.54 70.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 54.5 110.975 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.543 ' HG3' HG23 ' A' ' 320' ' ' THR . 91.4 mttt -100.93 -167.1 1.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.451 1.094 . . . . 72.319999999999993 109.317 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 11.7 t -151.94 127.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 71.150000000000006 109.284 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 278' ' ' THR . 22.2 m -107.34 177.32 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.434 1.084 . . . . 74.530000000000001 109.288 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.833 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -110.88 -172.32 2.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 42.310000000000002 109.289 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.77 -3.87 13.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 74.400000000000006 110.305 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.51 -7.78 30.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.549999999999997 109.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.12 54.09 6.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.508 1.13 . . . . 75.120000000000005 110.995 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.833 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.43 128.83 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 0.756 . . . . 74.040000000000006 110.271 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.823 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.2 m -57.86 117.75 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 71.420000000000002 110.363 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.653 HG22 ' ND2' ' A' ' 325' ' ' ASN . 2.6 pt -96.39 -37.22 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 72.430000000000007 109.275 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.841 ' HB3' HD23 ' A' ' 344' ' ' LEU . 7.0 mt -132.53 168.87 17.44 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 74.099999999999994 109.296 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.455 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.24 133.7 5.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 64.340000000000003 109.309 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -86.88 121.7 5.88 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.481 1.113 . . . . 73.129999999999995 110.998 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.948 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.21 -27.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 0.768 . . . . 71.310000000000002 109.28 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 54.58 63.22 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.572 1.17 . . . . 73.519999999999996 108.306 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.948 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -71.35 -175.0 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 75.420000000000002 109.301 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 317' ' ' SER . 0.1 OUTLIER -81.53 53.38 2.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.200000000000003 109.282 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.1 t -169.1 142.26 2.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 63.509999999999998 109.997 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -47.04 -25.43 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.505 1.128 . . . . 75.319999999999993 109.281 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.477 ' CD ' ' CE1' ' A' ' 251' ' ' HIS . 14.0 mt-10 -69.35 140.45 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 72.129999999999995 110.295 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.598 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 67.0 mt -147.36 135.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 65.230000000000004 109.327 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.4 p -127.63 87.21 2.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 45.32 110.439 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.841 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -39.97 134.71 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.549 1.156 . . . . 71.409999999999997 109.287 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.505 ' O ' ' CB ' ' A' ' 346' ' ' SER . 3.5 mtpt -106.2 -74.86 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 75.349999999999994 109.305 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.619 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 159.32 136.27 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.25 109.995 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 346' ' ' SER . 18.3 Cg_endo -74.97 -70.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.525 1.803 . . . . 74.209999999999994 111.058 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.435 ' C ' HD12 ' A' ' 348' ' ' LEU . 1.8 tp . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 70.430000000000007 109.307 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.307 -0.627 . . . . 43.240000000000002 109.307 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.605 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -112.87 99.0 7.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 74.129999999999995 109.328 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.833 ' CD2' HG22 ' A' ' 343' ' ' THR . 2.4 m80 -93.08 131.38 38.16 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 73.129999999999995 109.582 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 253' ' ' GLU . 95.0 t -119.8 167.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.447 1.092 . . . . 74.120000000000005 109.321 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.527 ' N ' HG12 ' A' ' 252' ' ' VAL . 9.0 tt0 -130.97 120.16 23.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 70.129999999999995 110.259 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 340' ' ' ASN . 39.6 t -90.81 119.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 73.239999999999995 109.285 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.4 t -92.51 -63.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.477 1.11 . . . . 64.319999999999993 109.993 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.88 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.3 t-20 56.77 63.89 1.82 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.14 . . . . 65.030000000000001 109.272 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.94 163.64 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 72.439999999999998 110.278 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.4 -13.39 61.45 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 63.310000000000002 109.258 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.89 -39.11 10.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 73.140000000000001 109.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.4 m -174.98 -174.51 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 73.010000000000005 110.013 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 256' ' ' ASN . 9.8 mt -89.29 179.49 6.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.533 1.146 . . . . 73.049999999999997 109.323 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 1.7 t-160 -178.26 107.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 109.597 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.598 ' CE1' HD22 ' A' ' 261' ' ' LEU . 91.2 m-85 -121.88 101.17 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 111.013 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 304' ' ' LYS . 23.9 mt -90.04 132.73 33.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 63.200000000000003 109.297 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -113.64 149.01 35.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 72.420000000000002 109.282 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.9 OUTLIER -128.04 115.66 18.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 72.420000000000002 111.016 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.534 ' HB2' HD13 ' A' ' 273' ' ' ILE . 8.8 t-20 -73.97 78.82 1.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 1.088 . . . . 73.120000000000005 109.234 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -101.8 13.43 34.88 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 65.549999999999997 109.28 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.7 p -76.36 -166.15 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 54.130000000000003 110.398 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.99 -65.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 70.409999999999997 109.268 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 272' ' ' ILE . 0.0 OUTLIER -68.3 -178.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 75.010000000000005 109.343 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 271' ' ' ILE . 2.5 mp -122.32 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 53.240000000000002 109.263 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -40.7 139.47 1.15 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 71.140000000000001 109.308 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.417 ' HG2' ' ND2' ' A' ' 325' ' ' ASN . 18.2 Cg_endo -75.02 -33.17 4.76 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.513 1.796 . . . . 64.129999999999995 110.999 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 103.82 153.05 23.2 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 52.340000000000003 111.018 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ASN . . . . . 0.416 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 57.8 t30 71.86 26.85 2.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 0.768 . . . . 74.519999999999996 109.314 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.405 ' C ' ' OG1' ' A' ' 278' ' ' THR . 21.5 m -69.78 -179.17 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.553 1.158 . . . . 74.329999999999998 108.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 324' ' ' VAL . 4.4 m -155.1 138.46 15.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 71.420000000000002 110.427 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.52 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.3 t80 -91.1 -173.58 3.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 70.340000000000003 111.032 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 178.03 102.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.209999999999994 110.277 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.665 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 1.2 p90 -128.44 128.95 45.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 75.099999999999994 110.979 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.478 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 0.8 OUTLIER -107.73 154.22 21.81 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.533 1.145 . . . . 64.409999999999997 110.014 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.554 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 10.5 p . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.536 1.147 . . . . 50.450000000000003 110.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.317 -0.623 . . . . 64.040000000000006 109.317 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -135.99 138.55 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 73.120000000000005 110.992 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 96.8 p -110.59 125.85 53.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 61.119999999999997 109.983 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 11.4 mt -97.73 133.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 61.450000000000003 109.295 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.39 102.19 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 61.520000000000003 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.775 ' HG2' HD21 ' A' ' 306' ' ' LEU . 73.9 mtp -73.28 152.13 41.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 70.340000000000003 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -38.69 141.78 0.44 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.46 1.1 . . . . 65.010000000000005 110.959 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.416 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.3 Cg_endo -75.06 -23.81 13.33 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.52 1.8 . . . . 72.140000000000001 110.952 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -73.43 175.94 6.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 73.140000000000001 109.624 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -94.85 155.15 16.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 71.549999999999997 110.291 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.523 HG22 ' HB3' ' A' ' 267' ' ' ASN . 66.3 mt -77.19 -83.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.420000000000002 109.322 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 126.66 141.01 5.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.51 1.131 . . . . 52.409999999999997 110.996 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.764 HG22 ' HD3' ' A' ' 301' ' ' LYS . 58.6 mt -40.57 -33.15 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 0.751 . . . . 74.400000000000006 109.292 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.764 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -111.15 -29.47 7.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 61.030000000000001 109.332 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -48.05 136.35 15.43 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.498 1.124 . . . . 72.200000000000003 111.002 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -89.65 -172.48 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 0.757 . . . . 73.200000000000003 110.297 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 264' ' ' ILE . 32.8 tptt -160.49 145.12 14.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 64.319999999999993 109.33 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -124.54 144.46 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.473 1.108 . . . . 73.140000000000001 110.296 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 265' ' ' LEU . 11.8 mt -144.13 61.18 1.36 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 70.219999999999999 109.299 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 132.29 46.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.530000000000001 107.989 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.1 m-30 -118.4 174.49 6.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 75.420000000000002 110.988 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -155.74 155.03 29.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.559 1.162 . . . . 64.329999999999998 111.001 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -37.14 2.35 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.03 -2.487 . . . . 74.420000000000002 111.003 -0.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.4 p 172.61 149.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 64.549999999999997 110.003 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.729 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.7 mp -128.78 157.97 73.74 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 73.310000000000002 109.285 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 148.5 35.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.465 1.771 . . . . 75.510000000000005 110.979 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.642 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -134.51 161.96 60.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 71.209999999999994 110.395 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.0 Cg_endo -75.07 173.71 56.52 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.983 -2.507 . . . . 75.239999999999995 110.961 0.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.56 HD13 ' HE3' ' A' ' 321' ' ' MET . 1.4 mt -95.07 64.02 2.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.528 1.143 . . . . 75.340000000000003 109.282 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 4.7 p -77.37 121.6 23.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 73.219999999999999 110.027 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 78.92 31.44 0.31 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 71.540000000000006 109.326 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 283' ' ' SER . 4.2 m-85 -112.14 141.14 46.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 63.450000000000003 110.997 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.3 m -51.89 -62.79 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 63.43 110.426 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.56 ' HE3' HD13 ' A' ' 316' ' ' LEU . 0.9 OUTLIER 26.87 60.78 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 1.144 . . . . 45.439999999999998 111.012 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 320' ' ' THR . 49.0 mttm -97.44 -174.76 3.01 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 73.409999999999997 109.302 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.52 HG22 ' CD1' ' A' ' 279' ' ' PHE . 49.6 t -136.72 136.31 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 62.310000000000002 109.291 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.622 HG12 ' N ' ' A' ' 330' ' ' THR . 4.4 m -116.66 -179.57 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 74.329999999999998 109.307 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.829 ' OD1' HG21 ' A' ' 331' ' ' ILE . 0.8 OUTLIER -105.03 -171.23 1.88 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 73.209999999999994 109.282 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.47 -9.27 24.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 71.439999999999998 110.312 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -99.08 -7.25 27.01 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 75.239999999999995 109.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.36 14.3 76.74 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.5 1.125 . . . . 70.010000000000005 111.033 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.428 ' C ' HG12 ' A' ' 324' ' ' VAL . 3.4 pt-20 -92.94 132.78 36.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 0.744 . . . . 63.539999999999999 110.248 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.622 ' N ' HG12 ' A' ' 324' ' ' VAL . 16.6 m -61.39 130.87 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 64.129999999999995 110.417 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.829 HG21 ' OD1' ' A' ' 325' ' ' ASN . 19.8 pt -115.72 -39.24 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 109.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.725 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.9 mt -138.79 166.26 24.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 65.319999999999993 109.272 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.512 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.2 123.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 74.140000000000001 109.303 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -70.27 137.43 27.86 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.525 1.141 . . . . 44.420000000000002 111.042 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.503 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -74.11 -36.82 64.25 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.53 0.782 . . . . 71.200000000000003 109.244 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 335' ' ' LYS . 0.1 OUTLIER 40.9 87.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 1.16 . . . . 54.329999999999998 108.275 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.88 72.58 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 61.100000000000001 109.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.15 55.08 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.409999999999997 109.311 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.9 m -163.49 131.84 3.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 75.439999999999998 109.997 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.814 ' O ' HG23 ' A' ' 254' ' ' VAL . 8.5 m120 -46.9 -38.11 9.95 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 74.019999999999996 109.252 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.27 146.61 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 73.140000000000001 110.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.504 HD13 ' SD ' ' A' ' 321' ' ' MET . 9.3 mt -146.26 121.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 63.130000000000003 109.301 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.833 HG22 ' CD2' ' A' ' 251' ' ' HIS . 14.5 p -115.33 79.17 1.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 74.329999999999998 110.382 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.725 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.9 mp -38.82 149.87 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.1 . . . . 53.350000000000001 109.258 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -126.21 -55.01 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 109.343 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.625 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.1 p 157.41 154.81 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 62.399999999999999 110.001 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.421 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.96 -45.92 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.502 1.79 . . . . 74.230000000000004 111.018 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 347' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 62.509999999999998 109.305 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.275 -0.639 . . . . 74.299999999999997 109.275 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -121.36 105.56 10.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.219999999999999 109.318 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.464 ' N ' HD12 ' A' ' 250' ' ' LEU . 55.7 t-80 -73.17 124.19 25.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.010000000000005 109.628 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 1.142 HG13 HD23 ' A' ' 265' ' ' LEU . 56.6 t -118.49 168.69 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.553 1.158 . . . . 72.129999999999995 109.281 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.543 ' N ' HG12 ' A' ' 252' ' ' VAL . 45.7 tp10 -129.8 146.88 51.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 75.450000000000003 110.27 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.682 HG13 ' CE1' ' A' ' 263' ' ' PHE . 43.7 t -124.76 103.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 52.530000000000001 109.308 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.2 m -76.15 -70.04 0.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 73.420000000000002 109.949 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.967 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.2 t-20 60.52 66.56 0.92 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.529 1.143 . . . . 45.549999999999997 109.324 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.3 pt-20 -166.21 -174.39 2.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 71.209999999999994 110.298 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 18.1 t0 67.05 15.14 10.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.239999999999995 109.327 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 9.3 t-20 82.24 19.66 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 60.409999999999997 109.284 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 2.7 p -164.22 -175.39 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 62.140000000000001 109.999 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.6 mt -100.55 174.23 6.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.134 . . . . 63.420000000000002 109.286 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.2 117.72 0.3 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 72.0 109.583 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.682 ' CE1' HG13 ' A' ' 254' ' ' VAL . 80.9 m-85 -129.18 117.84 21.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 52.530000000000001 110.993 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.752 HG22 ' CE2' ' A' ' 266' ' ' TYR . 86.1 mt -102.5 112.48 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 64.109999999999999 109.329 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 1.142 HD23 HG13 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.06 123.8 42.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 72.140000000000001 109.306 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.752 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.3 m-85 -112.58 140.25 47.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 73.430000000000007 111.019 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.54 ' OD1' HD13 ' A' ' 271' ' ' ILE . 62.8 t-20 -91.16 88.66 7.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.12 . . . . 55.009999999999998 109.319 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -3.45 21.84 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 73.0 109.298 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 0.9 OUTLIER -56.66 -17.3 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 73.109999999999999 110.389 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 269' ' ' THR . 3.7 m120 83.75 43.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.439999999999998 109.327 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.54 HD13 ' OD1' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -152.03 177.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 71.140000000000001 109.303 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 271' ' ' ILE . 71.2 mt -106.62 130.64 58.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 63.109999999999999 109.309 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 298' ' ' ILE . 3.4 mm -71.04 138.12 84.86 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 51.43 109.297 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.1 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.549 1.815 . . . . 71.409999999999997 110.982 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 76.47 179.38 47.08 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.504 1.127 . . . . 71.409999999999997 111.03 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 326' ' ' GLN . 50.8 t-20 62.79 31.42 16.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 0.763 . . . . 74.150000000000006 109.322 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.403 ' C ' ' OG1' ' A' ' 278' ' ' THR . 68.6 m -90.58 178.71 6.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.349999999999994 108.293 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.7 m -153.8 127.87 9.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 64.129999999999995 110.413 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.469 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.8 t80 -80.47 164.11 23.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.219999999999999 110.991 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.417 ' CG ' HG21 ' A' ' 288' ' ' VAL . 28.3 tt0 -151.52 88.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.200000000000003 110.286 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.786 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 15.5 p90 -120.6 128.67 53.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 73.109999999999999 111.028 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.592 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 23.8 t -113.99 178.33 4.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.400000000000006 109.983 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.935 ' HB2' HD23 ' A' ' 312' ' ' LEU . 3.4 t . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 50.210000000000001 109.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.544 HG22 ' N ' ' A' ' 289' ' ' PHE . 8.2 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.295 -0.631 . . . . 71.530000000000001 109.295 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.544 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.5 t80 -116.4 139.42 50.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.537 1.148 . . . . 64.519999999999996 111.015 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 90.8 p -119.7 122.06 40.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 52.039999999999999 110.048 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 21.6 mt -103.44 129.25 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 72.519999999999996 109.335 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -71.24 115.99 11.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 73.439999999999998 109.298 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 81.6 mtp -78.27 164.31 25.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.219999999999999 111.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -66.53 147.73 50.05 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.519 1.137 . . . . 72.140000000000001 111.018 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -30.24 7.36 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.506 1.793 . . . . 73.319999999999993 110.966 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.93 138.3 58.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 74.400000000000006 109.617 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -73.44 141.19 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 72.200000000000003 110.307 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.653 HD12 HG13 ' A' ' 273' ' ' ILE . 27.0 mt -67.03 -81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 71.409999999999997 109.26 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 300' ' ' ILE . . . 109.59 156.63 16.71 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.508 1.13 . . . . 52.240000000000002 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.56 HG22 ' HD2' ' A' ' 301' ' ' LYS . 54.2 mt -39.13 -72.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.522 0.778 . . . . 74.120000000000005 109.352 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.56 ' HD2' HG22 ' A' ' 300' ' ' ILE . 13.5 mptt -68.38 -28.08 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 41.229999999999997 109.298 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -50.13 158.44 1.65 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.498 1.124 . . . . 63.439999999999998 110.963 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.414 ' N ' HG23 ' A' ' 298' ' ' ILE . 8.4 pt20 -129.23 -174.24 3.22 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 0.762 . . . . 74.25 110.322 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 24.6 tptt -156.92 156.92 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 53.219999999999999 109.321 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -134.76 147.14 49.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 62.030000000000001 110.314 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.997 HD12 HD11 ' A' ' 265' ' ' LEU . 16.5 mt -144.82 64.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 64.219999999999999 109.294 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -73.17 134.63 44.46 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.977 -1.119 . . . . 74.230000000000004 107.977 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.786 ' CD2' ' CE2' ' A' ' 281' ' ' PHE . 7.3 m-85 -121.69 167.07 13.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 73.129999999999995 111.024 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -142.71 143.4 25.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.209999999999994 110.997 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.0 -54.0 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.027 -2.489 . . . . 52.5 110.969 0.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.99 109.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 50.329999999999998 110.023 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 283' ' ' SER . 3.9 mp -70.69 158.09 88.7 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 62.539999999999999 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.06 33.4 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.476 1.777 . . . . 71.299999999999997 110.995 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.682 HG22 HD12 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -118.02 163.76 23.13 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 65.239999999999995 110.427 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.97 -173.19 11.86 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.021 -2.491 . . . . 63.240000000000002 111.016 -0.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.71 HD23 ' CD2' ' A' ' 319' ' ' TYR . 4.6 mp -102.71 11.31 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.553 1.158 . . . . 75.239999999999995 109.311 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -46.27 119.26 2.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 44.229999999999997 110.005 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 317' ' ' SER . 8.4 t-20 87.15 42.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 63.100000000000001 109.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.71 ' CD2' HD23 ' A' ' 316' ' ' LEU . 3.7 m-85 -120.85 -171.16 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 74.109999999999999 111.014 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 322' ' ' LYS . 52.3 m -105.04 -55.85 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 35.32 110.365 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.85 ' SD ' HD13 ' A' ' 342' ' ' ILE . 3.8 ptp 23.81 57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 63.020000000000003 110.977 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.569 ' HG3' HG22 ' A' ' 320' ' ' THR . 84.1 mttt -91.89 176.97 6.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.472 1.108 . . . . 62.299999999999997 109.339 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.437 HG22 ' HD1' ' A' ' 279' ' ' PHE . 17.3 t -133.63 129.52 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 75.400000000000006 109.306 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 278' ' ' THR . 6.5 m -109.1 -172.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.086 . . . . 61.130000000000003 109.307 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.638 ' HB3' HG21 ' A' ' 331' ' ' ILE . 39.8 p30 -121.38 -170.27 2.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 72.200000000000003 109.301 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.422 ' HB2' ' ND2' ' A' ' 276' ' ' ASN . 2.0 pt20 -63.2 -10.95 17.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 71.310000000000002 110.258 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -94.56 -13.96 25.51 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.466 1.104 . . . . 75.549999999999997 109.284 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.25 80.27 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.57 1.169 . . . . 72.549999999999997 111.028 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.25 134.79 38.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.514 0.773 . . . . 74.200000000000003 110.262 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.604 ' N ' HG12 ' A' ' 324' ' ' VAL . 10.3 m -61.87 115.1 3.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 64.510000000000005 110.439 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 325' ' ' ASN . 8.1 pt -88.97 -37.82 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.534 1.147 . . . . 72.349999999999994 109.304 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.905 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.4 mt -141.64 169.6 17.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.554 1.159 . . . . 71.430000000000007 109.283 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.461 HG12 ' CG2' ' A' ' 330' ' ' THR . 1.0 OUTLIER -148.47 136.13 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 74.310000000000002 109.296 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -92.51 118.8 5.66 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.466 1.104 . . . . 62.520000000000003 111.026 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.826 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -50.04 -26.86 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 0.759 . . . . 72.129999999999995 109.307 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.467 ' HG ' ' HB2' ' A' ' 319' ' ' TYR . 5.6 t 46.05 77.03 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 53.299999999999997 108.333 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.826 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -81.51 -172.2 3.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 53.140000000000001 109.321 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.56 58.01 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 74.319999999999993 109.271 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.85 162.7 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 44.439999999999998 109.96 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.94 -38.49 86.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.109999999999999 109.319 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.421 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -61.77 133.06 55.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.114 . . . . 73.140000000000001 110.305 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.85 HD13 ' SD ' ' A' ' 321' ' ' MET . 86.0 mt -143.77 131.33 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 75.299999999999997 109.289 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.453 ' HB ' HD23 ' A' ' 249' ' ' LEU . 49.3 p -129.56 94.91 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.419 1.074 . . . . 74.409999999999997 110.404 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.0 mp -39.72 152.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 52.420000000000002 109.276 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 5.7 ptpt -125.67 -60.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 64.120000000000005 109.311 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.504 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.2 p 159.38 151.35 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.125 . . . . 55.229999999999997 109.978 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -79.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.514 1.797 . . . . 71.239999999999995 110.993 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.714 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.512 1.133 . . . . 75.120000000000005 109.312 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.291 -0.633 . . . . 44.299999999999997 109.291 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.803 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.7 OUTLIER -105.58 101.12 10.66 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 74.420000000000002 109.319 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.534 ' ND1' HG22 ' A' ' 343' ' ' THR . 22.2 m-70 -82.07 168.1 18.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 74.209999999999994 109.632 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.681 ' CG2' HD23 ' A' ' 265' ' ' LEU . 22.4 t -155.05 150.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 73.150000000000006 109.328 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -124.57 151.05 45.25 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 73.519999999999996 110.313 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.78 106.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 60.420000000000002 109.327 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.8 t -73.55 -62.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 64.140000000000001 109.963 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.937 ' HA ' HD23 ' A' ' 261' ' ' LEU . 17.2 t30 60.89 63.41 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 71.450000000000003 109.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -95.62 158.98 15.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 1.124 . . . . 72.25 110.325 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -48.25 -49.03 34.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 71.310000000000002 109.29 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -51.47 -53.41 37.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 64.109999999999999 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.8 p 178.75 -174.69 0.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.511 1.132 . . . . 34.140000000000001 109.993 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 1.032 ' CD1' HD12 ' A' ' 312' ' ' LEU . 34.8 mt -77.65 178.76 7.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 62.32 109.308 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -171.22 108.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.010000000000005 109.577 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.814 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 79.3 m-85 -115.79 93.13 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 75.099999999999994 111.036 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.835 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 84.6 mt -87.31 103.39 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 74.420000000000002 109.273 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.18 132.82 44.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 72.430000000000007 109.288 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.835 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -118.27 125.98 51.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 110.988 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.483 ' HA ' HD12 ' A' ' 250' ' ' LEU . 32.9 t-20 -64.0 79.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 72.329999999999998 109.266 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 266' ' ' TYR . 1.1 mmpt? -90.91 40.55 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.519 1.137 . . . . 72.519999999999996 109.259 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.6 p -119.65 177.78 4.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 110.402 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -85.56 -12.49 51.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 72.109999999999999 109.283 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.2 pt -101.46 160.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 73.420000000000002 109.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 273' ' ' ILE . 3.8 mp -120.58 121.58 65.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 53.219999999999999 109.278 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.412 HD12 ' ND2' ' A' ' 267' ' ' ASN . 1.0 OUTLIER -40.01 142.4 0.7 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 53.350000000000001 109.313 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -74.97 -44.41 0.34 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.797 . . . . 44.43 111.023 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 123.19 149.33 7.8 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.523 1.139 . . . . 52.43 110.977 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.9 t30 67.35 73.86 0.32 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 0.743 . . . . 72.209999999999994 109.308 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 293' ' ' MET . 0.8 OUTLIER -119.91 -179.15 3.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 54.240000000000002 108.286 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 324' ' ' VAL . 22.3 m -153.51 137.52 16.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.535 1.147 . . . . 61.530000000000001 110.393 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.904 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.6 t80 -86.04 -167.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 73.140000000000001 110.993 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 176.5 104.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.458 1.099 . . . . 72.530000000000001 110.287 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.589 ' CZ ' ' CG ' ' A' ' 308' ' ' PHE . 3.0 p90 -133.56 144.0 49.05 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 72.340000000000003 111.021 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 37.3 p -104.43 143.27 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 74.120000000000005 110.011 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.699 ' OG ' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 O-C-N 124.461 1.101 . . . . 70.439999999999998 109.988 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 289' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.337 -0.616 . . . . 75.349999999999994 109.337 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.516 ' N ' HG22 ' A' ' 288' ' ' VAL . 5.7 t80 -134.83 149.14 50.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.438 1.086 . . . . 71.319999999999993 110.949 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.459 ' HB3' HG22 ' A' ' 278' ' ' THR . 11.0 m -109.31 127.14 54.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.109999999999999 110.0 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 278' ' ' THR . 8.2 mt -97.06 125.63 50.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 73.439999999999998 109.289 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -70.26 116.57 10.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 63.229999999999997 109.3 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.708 ' HG2' HD21 ' A' ' 306' ' ' LEU . 86.2 mtp -84.74 170.0 13.68 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.571 1.169 . . . . 74.329999999999998 111.018 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.595 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -64.01 143.02 47.06 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.484 1.115 . . . . 60.340000000000003 111.023 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -27.93 9.55 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.514 1.797 . . . . 72.510000000000005 111.013 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -71.34 155.76 40.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 74.239999999999995 109.607 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.38 169.39 17.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.53 1.143 . . . . 71.129999999999995 110.284 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 79.0 mt -99.22 -74.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.219999999999999 109.308 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.408 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 122.15 135.95 4.82 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.545 1.153 . . . . 53.210000000000001 110.986 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.411 HG22 ' CE ' ' A' ' 301' ' ' LYS . 4.0 mt -41.52 -28.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 0.781 . . . . 63.520000000000003 109.299 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.411 ' CE ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -108.08 -31.19 8.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 63.109999999999999 109.303 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -57.76 146.6 38.19 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.497 1.123 . . . . 64.510000000000005 110.998 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -173.91 2.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.427 0.722 . . . . 43.240000000000002 110.277 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.595 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 28.8 tptt -159.99 144.6 14.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 75.25 109.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -107.69 155.03 20.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 72.200000000000003 110.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.708 HD21 ' HG2' ' A' ' 293' ' ' MET . 9.7 mt -149.06 60.34 1.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 52.200000000000003 109.268 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.37 133.08 55.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 74.439999999999998 107.957 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.814 ' CD2' ' CE1' ' A' ' 263' ' ' PHE . 17.9 m-30 -119.38 39.52 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.494 1.121 . . . . 73.010000000000005 110.96 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.517 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -36.44 148.03 0.18 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 74.239999999999995 111.007 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.03 -46.45 0.37 Allowed 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.959 -2.517 . . . . 74.230000000000004 111.002 0.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 34.2 p 176.27 162.11 0.36 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 71.549999999999997 109.984 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -132.87 164.78 41.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.401 1.063 . . . . 73.209999999999994 109.275 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 145.24 31.28 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.52 1.8 . . . . 54.409999999999997 111.017 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.21 163.09 44.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 74.329999999999998 110.353 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.03 174.91 50.27 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.963 -2.515 . . . . 62.340000000000003 111.006 0.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.676 HD13 ' CE ' ' A' ' 321' ' ' MET . 8.2 mt -89.63 12.55 16.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 74.439999999999998 109.278 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.1 t -46.56 118.52 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 72.120000000000005 110.023 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.0 t-20 88.58 41.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 71.140000000000001 109.327 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.638 ' CE2' HD23 ' A' ' 316' ' ' LEU . 4.9 m-85 -122.86 -174.28 2.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.530000000000001 110.982 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.1 m -103.76 -56.71 2.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 71.109999999999999 110.45 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.76 ' SD ' HD13 ' A' ' 342' ' ' ILE . 2.5 ptp 25.29 67.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.53 1.144 . . . . 75.409999999999997 110.993 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.653 ' HG2' HG23 ' A' ' 333' ' ' VAL . 38.9 mttt -104.35 -176.77 3.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 1.126 . . . . 62.450000000000003 109.26 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.904 HG22 ' CD1' ' A' ' 279' ' ' PHE . 65.4 t -136.56 158.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.111 . . . . 43.030000000000001 109.314 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 278' ' ' THR . 16.0 m -137.35 171.85 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 75.140000000000001 109.283 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -104.24 -162.87 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 1.129 . . . . 70.120000000000005 109.293 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -72.27 -4.84 32.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.528 1.143 . . . . 74.409999999999997 110.337 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -102.44 0.56 34.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 72.019999999999996 109.278 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.47 1.87 58.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.496 1.123 . . . . 72.150000000000006 111.011 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -83.54 141.17 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 0.753 . . . . 73.420000000000002 110.307 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.673 HG22 ' HG3' ' A' ' 347' ' ' PRO . 43.1 m -65.74 124.17 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 73.340000000000003 110.397 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.7 pt -102.5 -38.35 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 73.540000000000006 109.256 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.616 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.5 mt -144.33 171.71 13.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 71.510000000000005 109.272 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.653 HG23 ' HG2' ' A' ' 322' ' ' LYS . 0.2 OUTLIER -161.29 125.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.140000000000001 109.349 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.749 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -77.22 119.2 5.29 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.525 1.141 . . . . 42.25 110.982 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -26.02 0.73 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.537 0.787 . . . . 62.219999999999999 109.28 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.412 ' HG ' ' C ' ' A' ' 316' ' ' LEU . 5.7 t 46.03 85.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.168 . . . . 72.439999999999998 108.3 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -95.67 -171.08 2.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.456 1.098 . . . . 64.540000000000006 109.262 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 338' ' ' ASP . 0.0 OUTLIER -81.04 56.16 2.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 75.129999999999995 109.288 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 339' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 341' ' ' GLU . 15.2 m -168.27 136.92 2.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 54.210000000000001 110.0 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -46.11 -26.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 65.200000000000003 109.301 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 339' ' ' SER . 3.4 mt-10 -69.75 141.31 53.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.104 . . . . 63.399999999999999 110.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.76 HD13 ' SD ' ' A' ' 321' ' ' MET . 66.0 mt -147.24 139.34 18.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 72.239999999999995 109.314 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.534 HG22 ' ND1' ' A' ' 251' ' ' HIS . 10.1 p -135.37 99.17 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 64.310000000000002 110.417 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.803 HD22 ' CD2' ' A' ' 250' ' ' LEU . 6.5 mp -52.07 132.97 33.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 74.420000000000002 109.318 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.3 ptpt -118.7 -61.45 1.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 64.340000000000003 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.9 OUTLIER 159.53 149.05 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 74.519999999999996 110.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.673 ' HG3' HG22 ' A' ' 330' ' ' THR . 18.5 Cg_endo -74.97 -46.24 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.51 1.795 . . . . 62.340000000000003 111.043 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 348' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.496 1.123 . . . . 72.420000000000002 109.32 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.714 HD22 ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.346 -0.613 . . . . 73.430000000000007 109.346 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.39 101.07 8.8 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.468 1.105 . . . . 74.510000000000005 109.266 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.714 ' NE2' HD22 ' A' ' 249' ' ' LEU . 41.8 m170 -94.47 131.12 40.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.150000000000006 109.621 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.613 HG21 HD23 ' A' ' 265' ' ' LEU . 21.9 t -128.55 169.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.310000000000002 109.303 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.513 ' N ' HG12 ' A' ' 252' ' ' VAL . 15.0 tp10 -125.31 146.62 49.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 72.239999999999995 110.304 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.685 HG22 ' CE1' ' A' ' 263' ' ' PHE . 38.9 t -130.58 95.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.239999999999995 109.312 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -56.84 6.54 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 1.148 . . . . 61.310000000000002 109.999 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.822 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.3 t-20 59.73 74.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 72.040000000000006 109.333 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' ASP . 8.5 pt-20 -108.64 156.24 19.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 110.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 257' ' ' GLU . 46.2 m-20 -40.33 -57.86 1.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 72.25 109.291 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -39.94 -65.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.150000000000006 109.347 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.79 -170.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.122 . . . . 73.129999999999995 109.965 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.5 mt -81.69 162.27 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 70.439999999999998 109.255 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' HIS . . . . . 0.551 ' NE2' ' CD1' ' A' ' 264' ' ' ILE . 1.3 t-160 -148.66 103.0 3.35 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 72.209999999999994 109.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.743 ' HE2' HD13 ' A' ' 261' ' ' LEU . 84.4 m-85 -116.15 130.68 56.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 65.340000000000003 110.995 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.824 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 45.6 mt -131.81 105.21 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 75.140000000000001 109.289 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 252' ' ' VAL . 0.1 OUTLIER -95.82 128.12 42.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.329999999999998 109.272 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.824 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 3.5 m-85 -114.31 113.84 25.13 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 72.140000000000001 111.018 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.65 ' CG ' HD13 ' A' ' 273' ' ' ILE . 26.6 t30 -72.34 87.35 1.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.25 109.329 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.645 ' HZ1' ' HA ' ' A' ' 301' ' ' LYS . 3.1 mmpt? -96.22 31.28 2.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.239999999999995 109.328 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 6.6 p -102.56 143.73 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 62.109999999999999 110.376 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.44 ' O ' HD11 ' A' ' 300' ' ' ILE . 23.9 m120 -47.35 -53.42 13.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 75.109999999999999 109.309 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 37.5 pt -62.25 177.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.34 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.1 mt -118.96 136.06 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 75.400000000000006 109.282 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.65 HD13 ' CG ' ' A' ' 267' ' ' ASN . 0.9 OUTLIER -63.28 140.18 97.66 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.145 . . . . 72.150000000000006 109.323 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 -34.16 3.97 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.484 1.781 . . . . 71.209999999999994 110.948 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 87.11 177.39 48.95 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.462 1.101 . . . . 71.340000000000003 111.036 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.99 27.49 8.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 0.789 . . . . 73.209999999999994 109.274 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.417 ' C ' ' OG1' ' A' ' 278' ' ' THR . 6.2 m -75.19 -177.07 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 73.420000000000002 108.313 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.921 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.4 m -154.51 100.02 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 65.129999999999995 110.364 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.555 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 0.4 OUTLIER -54.76 170.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.230000000000004 111.019 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.452 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 70.8 tt0 -160.58 84.21 0.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 73.150000000000006 110.302 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 29.6 p90 -115.32 133.1 56.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 74.219999999999999 110.983 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.699 ' HG ' ' N ' ' A' ' 288' ' ' VAL . 2.8 t -128.72 -172.08 2.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.544 1.153 . . . . 64.109999999999999 109.991 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 22.0 t . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 75.530000000000001 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.699 ' N ' ' HG ' ' A' ' 282' ' ' SER . 7.7 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.306 -0.627 . . . . 72.0 109.306 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 288' ' ' VAL . 1.2 t80 -147.34 134.74 20.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 74.400000000000006 111.048 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 8.2 p -115.73 117.3 29.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.428 1.08 . . . . 62.530000000000001 110.007 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.1 mt -106.47 128.46 61.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 73.209999999999994 109.317 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.8 108.85 4.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 71.319999999999993 109.287 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.55 ' HG2' HD21 ' A' ' 306' ' ' LEU . 90.0 mtp -75.02 139.55 42.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 72.239999999999995 111.02 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.72 144.49 0.17 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.478 1.111 . . . . 74.400000000000006 110.995 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -24.43 12.8 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.515 1.797 . . . . 71.549999999999997 111.005 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -75.35 141.55 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 71.150000000000006 109.637 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.75 -174.18 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 74.400000000000006 110.327 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 39.1 mt -110.93 -74.2 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 71.150000000000006 109.278 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 123.53 162.95 11.63 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.468 1.105 . . . . 42.43 111.005 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 270' ' ' ASN . 36.5 mt -62.09 -30.58 49.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.519 0.776 . . . . 64.209999999999994 109.273 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.645 ' HA ' ' HZ1' ' A' ' 268' ' ' LYS . 48.6 mmtt -110.77 -22.88 11.35 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 75.230000000000004 109.27 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -59.08 164.63 9.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.527 1.142 . . . . 75.209999999999994 111.03 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -131.73 -179.84 5.63 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.519 0.776 . . . . 73.420000000000002 110.295 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 25.2 tptt -143.6 144.66 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 75.310000000000002 109.337 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.556 ' HG2' ' CH2' ' A' ' 307' ' ' TRP . 8.8 mp0 -112.71 143.6 43.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 61.450000000000003 110.302 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 12.7 mt -140.83 62.34 1.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.209999999999994 109.304 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.556 ' CH2' ' HG2' ' A' ' 305' ' ' GLU . 1.5 m-90 -68.82 118.72 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.971 -1.122 . . . . 74.239999999999995 107.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.9 m-30 -111.97 168.57 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 111.023 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.492 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -155.02 160.76 30.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 74.299999999999997 110.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.0 -40.19 1.27 Allowed 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.023 -2.491 . . . . 71.450000000000003 110.986 0.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.1 p 175.56 132.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 52.130000000000003 110.029 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.499 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.5 mp -113.5 158.23 39.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 70.030000000000001 109.282 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 147.06 33.54 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.497 1.788 . . . . 54.399999999999999 110.966 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.851 HG22 HD12 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -131.92 163.52 49.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 73.530000000000001 110.349 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 175.73 46.54 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.967 -2.514 . . . . 64.219999999999999 111.021 -0.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.851 HD12 HG22 ' A' ' 314' ' ' THR . 5.3 mp -93.52 65.57 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.502 1.126 . . . . 71.129999999999995 109.294 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 125.37 29.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.494 1.121 . . . . 74.5 109.998 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 73.51 29.1 1.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.030000000000001 109.306 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.4 m-85 -110.49 134.22 52.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.548 1.155 . . . . 74.519999999999996 110.988 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.826 HG23 ' HD3' ' A' ' 322' ' ' LYS . 1.2 m -49.32 -64.72 0.72 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 73.400000000000006 110.398 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.653 ' HE1' ' CD1' ' A' ' 342' ' ' ILE . 4.3 ttm 31.87 42.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 75.530000000000001 110.98 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.826 ' HD3' HG23 ' A' ' 320' ' ' THR . 16.9 pttt -80.09 -160.33 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.565 1.166 . . . . 74.109999999999999 109.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -151.96 133.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.142 . . . . 64.040000000000006 109.324 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.921 HG22 ' O ' ' A' ' 278' ' ' THR . 22.1 m -112.33 177.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 71.540000000000006 109.303 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.847 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -111.73 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.538 1.149 . . . . 73.510000000000005 109.306 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -1.91 12.7 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.489 1.118 . . . . 64.239999999999995 110.341 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.42 -8.19 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 72.310000000000002 109.357 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.89 5.86 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.516 1.135 . . . . 65.120000000000005 110.987 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.847 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.4 OUTLIER -149.64 129.81 13.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 0.758 . . . . 61.219999999999999 110.326 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.759 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.3 m -64.1 113.39 3.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 74.540000000000006 110.39 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.651 ' CG2' ' ND2' ' A' ' 325' ' ' ASN . 1.7 pt -91.22 -34.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 70.430000000000007 109.279 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.949 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.7 mt -138.1 165.53 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 72.439999999999998 109.285 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -153.57 121.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 73.150000000000006 109.303 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.434 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -70.11 126.82 17.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.506 1.129 . . . . 25.219999999999999 111.014 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.499 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -44.8 -26.56 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 0.788 . . . . 74.219999999999999 109.314 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.6 OUTLIER 47.09 65.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.530000000000001 108.285 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -77.09 -171.23 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 73.400000000000006 109.299 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 54.66 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.126 . . . . 73.420000000000002 109.267 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.2 m -169.62 163.09 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 50.340000000000003 110.033 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -65.93 -32.49 74.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.430000000000007 109.323 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.32 135.41 57.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 110.339 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.653 ' CD1' ' HE1' ' A' ' 321' ' ' MET . 82.1 mt -143.62 120.78 5.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 70.150000000000006 109.297 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 251' ' ' HIS . 16.2 p -123.27 84.57 2.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.568 1.168 . . . . 65.140000000000001 110.422 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.949 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.2 mp -38.75 147.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 72.549999999999997 109.306 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -128.87 -48.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 72.0 109.354 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 155.22 147.36 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 73.420000000000002 110.004 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.4 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.3 Cg_endo -75.02 -70.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.528 1.804 . . . . 72.040000000000006 111.014 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.788 HD13 ' O ' ' A' ' 348' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 61.439999999999998 109.317 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.719 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.29 -0.633 . . . . 70.140000000000001 109.29 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.698 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -129.78 105.15 7.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 71.230000000000004 109.274 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.596 ' O ' HG23 ' A' ' 252' ' ' VAL . 9.7 t-160 -71.24 163.63 27.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 75.549999999999997 109.616 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.696 HG21 HD23 ' A' ' 265' ' ' LEU . 54.8 t -158.38 126.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 54.25 109.29 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -96.84 135.82 38.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.565 1.165 . . . . 70.299999999999997 110.296 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 340' ' ' ASN . 48.1 t -108.27 100.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 72.5 109.302 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -60.66 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.52 1.138 . . . . 71.400000000000006 109.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.949 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER 53.72 68.89 0.78 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 43.43 109.298 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.25 157.27 15.97 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.492 1.12 . . . . 64.420000000000002 110.301 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -52.06 -33.54 39.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 72.329999999999998 109.291 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -68.08 -50.96 51.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 72.409999999999997 109.363 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p 178.49 -178.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.466 1.104 . . . . 62.119999999999997 109.979 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.949 HD23 ' HA ' ' A' ' 256' ' ' ASN . 77.7 mt -76.07 178.56 6.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 60.240000000000002 109.279 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -176.44 86.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.116 . . . . 62.420000000000002 109.619 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.686 ' CZ ' HD13 ' A' ' 261' ' ' LEU . 4.8 m-30 -96.84 134.09 40.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 71.420000000000002 110.995 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.604 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 23.1 mt -127.88 109.62 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 73.439999999999998 109.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.52 129.31 45.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 55.43 109.305 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.653 ' N ' ' CD1' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -104.19 113.12 26.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 74.349999999999994 110.953 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.695 ' HB2' HD13 ' A' ' 273' ' ' ILE . 18.2 t30 -68.5 72.91 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 65.310000000000002 109.248 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.8 mmtt -87.35 53.59 2.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.510000000000005 109.294 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.485 ' O ' HD11 ' A' ' 300' ' ' ILE . 30.7 p -120.64 -176.38 3.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.521 1.138 . . . . 62.409999999999997 110.381 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.21 -59.42 2.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 44.420000000000002 109.315 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.693 ' C ' HD12 ' A' ' 272' ' ' ILE . 0.1 OUTLIER -78.06 -176.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 72.129999999999995 109.308 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.693 HD12 ' C ' ' A' ' 271' ' ' ILE . 2.3 mp -120.22 143.42 32.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.501 1.125 . . . . 63.409999999999997 109.29 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -43.66 142.44 1.87 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.453 1.095 . . . . 74.230000000000004 109.335 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -38.15 1.71 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.439 1.757 . . . . 72.239999999999995 110.983 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 99.51 160.18 28.98 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.523 1.139 . . . . 74.430000000000007 111.007 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 8.1 t-20 81.7 17.34 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 0.749 . . . . 62.520000000000003 109.29 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 87.3 m -66.61 170.57 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 108.303 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.873 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.8 m -153.64 99.24 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.554 1.159 . . . . 64.219999999999999 110.405 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.754 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.9 OUTLIER -50.79 171.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.111 . . . . 62.25 111.035 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -172.99 99.4 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 73.219999999999999 110.299 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 2.0 p90 -122.9 141.98 51.29 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.57 1.168 . . . . 73.409999999999997 111.015 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 54.7 p -74.88 159.13 32.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 71.150000000000006 109.983 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.148 . . . . 64.540000000000006 110.003 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.551 HG22 ' H ' ' A' ' 289' ' ' PHE . 10.4 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.313 -0.625 . . . . 74.230000000000004 109.313 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.551 ' H ' HG22 ' A' ' 288' ' ' VAL . 4.3 t80 -145.22 162.36 37.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 74.530000000000001 110.992 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.605 ' OG ' HG22 ' A' ' 278' ' ' THR . 4.0 t -137.05 124.92 22.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.097 . . . . 74.530000000000001 109.983 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.776 HD11 ' HD1' ' A' ' 308' ' ' PHE . 12.5 mt -103.67 148.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.558 1.161 . . . . 73.129999999999995 109.295 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.527 ' CD ' ' N ' ' A' ' 292' ' ' LYS . 0.3 OUTLIER -79.86 123.71 28.0 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 42.240000000000002 109.284 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.951 ' HG2' HD21 ' A' ' 306' ' ' LEU . 37.5 mtp -92.77 15.0 15.59 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.561 1.163 . . . . 64.5 110.999 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.19 151.91 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.482 1.114 . . . . 51.240000000000002 110.963 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.427 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.03 -16.44 20.13 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.53 1.805 . . . . 73.329999999999998 110.993 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -62.84 151.14 39.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 63.399999999999999 109.6 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.437 ' C ' HD13 ' A' ' 298' ' ' ILE . 4.4 mp0 -87.6 165.4 15.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.56 1.163 . . . . 65.150000000000006 110.319 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 302' ' ' GLY . 2.7 mm -89.05 -95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 73.109999999999999 109.305 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 120.11 168.88 13.9 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.468 1.105 . . . . 74.140000000000001 111.013 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.854 HG22 ' HD3' ' A' ' 301' ' ' LYS . 15.5 mm -60.36 -43.05 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.507 0.769 . . . . 71.200000000000003 109.304 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.854 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.5 OUTLIER -108.94 -12.8 14.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 60.539999999999999 109.357 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.7 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -81.27 49.62 4.04 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 61.420000000000002 111.019 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.524 ' HG2' ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -41.89 164.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 0.784 . . . . 70.049999999999997 110.29 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.5 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 41.9 tptt -118.4 165.69 13.56 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.13 . . . . 72.099999999999994 109.315 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -134.86 144.96 47.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 64.5 110.346 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.951 HD21 ' HG2' ' A' ' 293' ' ' MET . 45.3 mt -140.72 61.69 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 109.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -72.19 123.02 22.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.963 -1.125 . . . . 71.420000000000002 107.963 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.776 ' HD1' HD11 ' A' ' 291' ' ' ILE . 57.0 t80 -119.24 172.09 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 74.400000000000006 111.001 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -147.24 162.66 31.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.148 . . . . 74.239999999999995 110.972 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.03 -46.13 0.4 Allowed 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.025 -2.49 . . . . 34.329999999999998 110.952 0.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 28.7 p 177.83 170.41 0.68 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.109999999999999 110.011 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.949 ' HG ' HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -153.7 161.12 29.99 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.459 1.099 . . . . 63.229999999999997 109.288 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 312' ' ' LEU . 18.3 Cg_endo -74.96 144.09 29.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.509 1.794 . . . . 50.32 111.006 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.632 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -126.06 165.45 27.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 110.356 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.04 -176.11 17.43 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.987 -2.505 . . . . 62.409999999999997 111.031 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.575 HD13 ' HE3' ' A' ' 321' ' ' MET . 2.0 mt -98.21 61.42 1.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.150000000000006 109.311 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.9 p -74.62 119.9 19.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 74.519999999999996 110.034 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 317' ' ' SER . 45.3 t30 79.42 40.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.453 1.096 . . . . 61.32 109.338 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.436 ' CG ' ' HB3' ' A' ' 316' ' ' LEU . 24.3 m-85 -119.84 142.99 48.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 74.030000000000001 111.013 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.524 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.3 m -59.75 -56.76 17.76 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 71.030000000000001 110.383 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.575 ' HE3' HD13 ' A' ' 316' ' ' LEU . 0.9 OUTLIER 26.93 58.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 74.200000000000003 110.953 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.577 ' HD3' HG21 ' A' ' 330' ' ' THR . 29.6 mttm -94.86 -168.17 1.77 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 73.409999999999997 109.321 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.414 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 2.9 t -150.35 133.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 73.540000000000006 109.268 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 278' ' ' THR . 10.9 m -109.98 172.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 72.519999999999996 109.23 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -109.61 -163.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.494 1.121 . . . . 73.439999999999998 109.268 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.16 -12.86 22.1 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.133 . . . . 71.519999999999996 110.303 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.5 22.81 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 64.310000000000002 109.356 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.27 25.66 0.79 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.543 1.152 . . . . 74.230000000000004 111.012 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.493 ' C ' HG12 ' A' ' 324' ' ' VAL . 6.5 pt-20 -106.78 128.66 54.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 0.76 . . . . 71.230000000000004 110.286 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.797 ' N ' HG12 ' A' ' 324' ' ' VAL . 9.0 m -54.29 135.02 45.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.112 . . . . 75.409999999999997 110.413 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.4 pt -114.99 -42.09 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.136 . . . . 64.209999999999994 109.293 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.444 ' C ' HG13 ' A' ' 333' ' ' VAL . 12.6 mt -136.42 171.25 14.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 70.0 109.273 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.53 HG12 ' CG ' ' A' ' 322' ' ' LYS . 14.6 m -153.31 141.24 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.409999999999997 109.336 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -84.97 136.89 14.95 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.489 1.118 . . . . 71.209999999999994 110.988 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -67.2 -38.56 85.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 0.749 . . . . 75.349999999999994 109.302 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.494 ' H ' HG23 ' A' ' 342' ' ' ILE . 0.1 OUTLIER 40.18 88.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.496 1.123 . . . . 70.5 108.299 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -116.81 81.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 63.200000000000003 109.28 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 338' ' ' ASP . 3.4 p-10 39.93 49.9 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.15 . . . . 75.310000000000002 109.258 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 26.9 m -157.21 136.67 12.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 74.450000000000003 109.997 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.697 ' O ' HG23 ' A' ' 254' ' ' VAL . 7.1 m120 -58.14 -36.82 73.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 75.109999999999999 109.326 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.19 134.41 48.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.549 1.156 . . . . 73.319999999999993 110.315 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 336' ' ' CYS . 4.8 mt -136.35 134.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 33.240000000000002 109.31 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 344' ' ' LEU . 39.3 p -125.27 86.38 2.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 61.509999999999998 110.363 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' A' ' 250' ' ' LEU . 7.2 mp -40.38 130.85 2.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 71.25 109.32 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.9 ptpt -117.54 -60.04 1.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.107 . . . . 44.0 109.292 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.517 ' C ' HG22 ' A' ' 333' ' ' VAL . 1.5 m 159.47 157.28 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 53.219999999999999 110.012 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 -61.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.536 1.809 . . . . 72.430000000000007 110.999 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 74.129999999999995 109.282 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.296 -0.631 . . . . 72.030000000000001 109.296 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.603 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -110.8 99.94 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.582 1.176 . . . . 73.150000000000006 109.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.412 ' NE2' ' HG2' ' A' ' 341' ' ' GLU . 2.4 t-160 -90.33 131.54 36.07 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 71.150000000000006 109.614 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 265' ' ' LEU . 79.7 t -121.08 164.64 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 72.450000000000003 109.306 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.474 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.4 tp10 -129.72 147.26 51.48 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 63.32 110.325 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 263' ' ' PHE . 61.6 t -121.19 106.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.145 . . . . 71.25 109.335 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 t -72.85 -61.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.120000000000005 110.002 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.918 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.9 t-20 53.42 57.03 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 62.350000000000001 109.287 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 260' ' ' SER . 5.0 pt-20 -161.15 -174.54 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 74.439999999999998 110.344 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 71.86 17.15 5.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 63.340000000000003 109.268 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 3.6 m-20 82.61 18.77 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 75.140000000000001 109.317 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -170.05 -170.07 0.94 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 54.030000000000001 109.983 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.918 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -98.87 165.72 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.546 1.154 . . . . 72.439999999999998 109.298 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.85 102.38 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 73.109999999999999 109.611 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.779 ' CE2' HG22 ' A' ' 254' ' ' VAL . 85.1 m-85 -107.73 142.15 38.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.535 1.147 . . . . 73.310000000000002 110.977 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.686 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 53.2 mt -132.84 124.25 50.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.528 1.142 . . . . 74.439999999999998 109.314 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.814 ' N ' HD12 ' A' ' 265' ' ' LEU . 0.0 OUTLIER -120.53 141.87 49.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 61.43 109.291 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -127.78 140.52 52.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.516 1.135 . . . . 73.129999999999995 110.986 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.466 ' O ' ' CG ' ' A' ' 267' ' ' ASN . 46.7 p-10 -89.79 64.24 6.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 63.409999999999997 109.275 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.45 ' CE ' ' HA ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -58.03 -15.96 11.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 73.530000000000001 109.284 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 269' ' ' THR . 43.8 p -54.68 -166.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 60.32 110.39 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -99.15 -59.03 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 74.340000000000003 109.331 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 4.1 pt -60.29 152.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.463 1.102 . . . . 63.340000000000003 109.282 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.77 149.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 54.5 109.291 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 273' ' ' ILE . 3.5 mm -67.18 139.13 94.91 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.127 . . . . 53.409999999999997 109.317 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -26.95 10.52 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.486 1.782 . . . . 73.109999999999999 110.973 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 81.36 -178.51 53.86 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.504 1.128 . . . . 44.420000000000002 111.047 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 57.16 49.48 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 0.76 . . . . 63.100000000000001 109.323 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.414 ' CB ' ' SD ' ' A' ' 293' ' ' MET . 12.2 m -94.73 178.97 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 51.240000000000002 108.325 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.899 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.0 OUTLIER -152.22 97.31 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 61.210000000000001 110.378 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 1.002 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -53.79 159.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 74.549999999999997 110.969 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.664 ' HG3' HG21 ' A' ' 288' ' ' VAL . 13.3 tt0 -143.61 75.94 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 75.299999999999997 110.327 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 291' ' ' ILE . 35.0 p90 -109.45 121.79 45.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.145 . . . . 71.25 110.962 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 288' ' ' VAL . 3.7 p -109.19 179.61 4.11 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 73.140000000000001 109.981 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.569 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.4 p . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 51.420000000000002 110.01 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.664 HG21 ' HG3' ' A' ' 280' ' ' GLU . 14.8 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.299 -0.63 . . . . 75.239999999999995 109.299 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.522 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.6 t80 -131.69 137.83 48.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 74.319999999999993 111.054 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 54.1 p -116.75 126.21 52.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.122 . . . . 73.409999999999997 109.987 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 281' ' ' PHE . 8.5 mt -105.11 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 73.120000000000005 109.289 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.412 ' HD3' HG23 ' A' ' 278' ' ' THR . 8.7 mmtp -67.32 110.81 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.531 1.144 . . . . 51.030000000000001 109.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.92 ' HG2' HD21 ' A' ' 306' ' ' LEU . 93.0 mtp -81.76 134.79 35.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.209999999999994 111.006 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.68 145.52 0.13 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.515 1.135 . . . . 63.149999999999999 111.031 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -20.95 16.5 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.516 1.798 . . . . 62.43 111.013 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.74 129.14 38.77 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 109.577 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.09 153.16 30.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.124 . . . . 74.120000000000005 110.254 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.898 HG23 ' O ' ' A' ' 302' ' ' GLY . 3.2 mt -70.22 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 71.200000000000003 109.293 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.851 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 108.69 -177.04 20.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.505 1.128 . . . . 71.099999999999994 111.004 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 301' ' ' LYS . 59.6 mt -38.24 -90.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 74.239999999999995 109.282 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.618 ' N ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -91.3 23.93 3.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.209999999999994 109.272 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.898 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -83.74 45.14 3.42 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 74.200000000000003 111.006 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 302' ' ' GLY . 1.4 pt20 -39.99 161.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 0.761 . . . . 73.519999999999996 110.283 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 298' ' ' ILE . 30.5 tptt -121.92 152.35 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 72.439999999999998 109.281 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 11.9 mp0 -118.37 133.83 55.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 71.409999999999997 110.307 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 1.002 HD13 ' CG ' ' A' ' 279' ' ' PHE . 35.5 mt -126.35 55.57 1.49 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 64.109999999999999 109.303 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 138.34 55.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 75.340000000000003 107.999 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 309' ' ' PHE . 37.2 t80 -134.64 166.59 22.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.109999999999999 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.638 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -138.99 148.09 56.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 73.040000000000006 111.028 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.01 -53.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.005 -2.498 . . . . 73.150000000000006 110.975 0.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 23.6 p -178.8 162.66 1.35 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.503 1.127 . . . . 63.530000000000001 109.971 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.0 OUTLIER -128.61 159.16 69.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.157 . . . . 74.010000000000005 109.292 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 145.07 31.03 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.483 1.781 . . . . 61.32 111.007 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.85 HG22 HD12 ' A' ' 316' ' ' LEU . 0.9 OUTLIER -125.81 160.27 57.24 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 74.329999999999998 110.395 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.9 170.35 71.98 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.032 -2.487 . . . . 75.530000000000001 111.057 -0.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.85 HD12 HG22 ' A' ' 314' ' ' THR . 5.7 mp -87.68 66.26 8.81 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.536 1.147 . . . . 73.120000000000005 109.28 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.6 p -81.78 127.31 32.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 1.145 . . . . 73.349999999999994 109.975 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.2 OUTLIER 76.66 21.47 1.27 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 74.430000000000007 109.262 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.735 ' HD2' HD23 ' A' ' 316' ' ' LEU . 3.3 m-85 -103.93 134.08 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.521 1.138 . . . . 73.430000000000007 111.039 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.494 HG22 ' HG3' ' A' ' 322' ' ' LYS . 88.7 m -51.25 -60.54 3.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.399999999999999 110.42 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.71 ' HE2' HD22 ' A' ' 316' ' ' LEU . 3.5 ttm 33.08 40.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 61.140000000000001 110.996 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.501 ' HD3' HG21 ' A' ' 330' ' ' THR . 36.1 mttt -72.81 -174.0 1.34 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 71.25 109.287 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 t -143.51 121.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 72.310000000000002 109.32 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 278' ' ' THR . 28.4 m -110.12 171.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 75.439999999999998 109.356 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.477 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 0.1 OUTLIER -109.17 -155.51 0.56 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 72.219999999999999 109.296 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -77.38 -4.0 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.56 1.163 . . . . 75.439999999999998 110.324 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -105.25 8.98 34.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 65.25 109.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.74 14.89 24.4 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.472 1.108 . . . . 63.119999999999997 110.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 7.3 pt-20 -95.83 116.39 28.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 71.040000000000006 110.279 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.624 ' CA ' HG12 ' A' ' 324' ' ' VAL . 1.8 m -50.83 96.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 110.386 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 3.1 pt -66.81 -36.87 78.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 73.519999999999996 109.312 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.914 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.6 mt -147.19 170.7 16.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 70.519999999999996 109.323 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -147.17 119.3 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 75.040000000000006 109.291 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -71.45 125.09 11.42 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.543 1.152 . . . . 51.049999999999997 111.004 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.787 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -48.85 -26.44 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.563 0.802 . . . . 72.319999999999993 109.324 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 48.33 62.08 2.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 75.0 108.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.787 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -73.39 -176.78 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 74.349999999999994 109.315 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.62 55.98 1.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 61.310000000000002 109.262 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.7 m -169.08 149.16 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 55.310000000000002 109.973 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.418 ' N ' ' HB3' ' A' ' 315' ' ' PRO . 10.2 m-20 -55.31 -19.95 10.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 74.409999999999997 109.29 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.412 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 18.4 mt-10 -72.69 141.37 48.22 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.109999999999999 110.302 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.681 HD11 ' HE1' ' A' ' 321' ' ' MET . 64.5 mt -146.84 120.84 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.13 . . . . 73.129999999999995 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 344' ' ' LEU . 15.4 p -123.94 85.44 2.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.451 1.095 . . . . 70.510000000000005 110.345 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.914 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.4 mp -39.31 152.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 75.409999999999997 109.31 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -129.87 -51.72 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 52.100000000000001 109.306 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 158.18 146.97 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 70.049999999999997 110.018 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.664 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.1 Cg_endo -74.98 -50.71 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.502 1.791 . . . . 63.229999999999997 110.986 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.13 . . . . 70.340000000000003 109.308 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.914 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.332 -0.618 . . . . 64.439999999999998 109.332 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.545 HD22 HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -116.58 103.21 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 109.302 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -67.35 147.35 53.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 72.420000000000002 109.592 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.696 HG13 ' HG ' ' A' ' 265' ' ' LEU . 45.1 t -145.37 161.92 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 63.310000000000002 109.358 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.42 ' N ' HG12 ' A' ' 252' ' ' VAL . 11.2 tp10 -134.39 132.48 39.47 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.138 . . . . 71.109999999999999 110.296 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.593 ' CG1' HG21 ' A' ' 314' ' ' THR . 94.8 t -109.69 110.72 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 72.120000000000005 109.246 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.428 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.7 t -77.93 -67.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.13 . . . . 63.229999999999997 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.881 ' HA ' HD23 ' A' ' 261' ' ' LEU . 4.8 t-20 61.15 63.91 1.18 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.56 1.162 . . . . 71.209999999999994 109.287 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -88.86 148.61 23.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 65.120000000000005 110.291 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.04 -24.58 1.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.474 1.109 . . . . 75.209999999999994 109.322 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -76.18 -55.37 5.64 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 70.299999999999997 109.306 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.9 m -168.37 -175.02 2.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.529 1.143 . . . . 73.409999999999997 109.942 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.881 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.1 mt -86.48 176.02 8.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.239999999999995 109.316 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' HIS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 10.7 t-160 -174.71 107.93 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.540000000000006 109.573 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.406 ' HE1' HD13 ' A' ' 261' ' ' LEU . 88.0 m-85 -112.13 118.56 35.7 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 75.450000000000003 111.032 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.505 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 13.7 mt -112.39 104.59 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 52.229999999999997 109.254 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.696 ' HG ' HG13 ' A' ' 252' ' ' VAL . 0.8 OUTLIER -101.4 129.79 47.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 71.209999999999994 109.319 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.596 ' N ' ' CD1' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -102.54 119.05 38.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 61.32 110.983 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.486 ' OD1' ' CD1' ' A' ' 273' ' ' ILE . 34.9 t30 -65.71 75.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.132 . . . . 75.439999999999998 109.276 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.1 mmtt -92.07 64.63 4.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 64.230000000000004 109.305 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 72.5 p -142.67 160.43 40.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 71.120000000000005 110.406 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.48 -54.27 45.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 72.230000000000004 109.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.4 pt -69.8 163.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 73.420000000000002 109.292 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 17.9 mt -114.74 139.14 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 73.5 109.333 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.486 ' CD1' ' OD1' ' A' ' 267' ' ' ASN . 1.8 mp -54.68 137.23 63.25 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 75.400000000000006 109.296 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.2 Cg_endo -75.01 -26.34 10.99 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.494 1.787 . . . . 44.009999999999998 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.61 157.76 29.61 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.504 1.127 . . . . 72.230000000000004 111.011 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.5 t30 73.41 39.44 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 0.755 . . . . 75.439999999999998 109.277 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.45 -174.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 63.450000000000003 108.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 291' ' ' ILE . 7.3 m -155.12 156.26 35.47 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.44 1.087 . . . . 63.420000000000002 110.384 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.536 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.9 t80 -108.75 171.07 7.64 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 72.329999999999998 110.968 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.526 ' HG3' HG21 ' A' ' 288' ' ' VAL . 9.4 tt0 -161.59 93.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 71.109999999999999 110.31 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -113.6 133.91 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 74.420000000000002 110.991 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -94.4 -175.18 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 64.129999999999995 109.987 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.559 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 24.8 t . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 61.240000000000002 110.017 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.544 HG22 ' H ' ' A' ' 289' ' ' PHE . 8.8 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.274 -0.639 . . . . 70.239999999999995 109.274 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.544 ' H ' HG22 ' A' ' 288' ' ' VAL . 8.5 t80 -148.23 149.31 31.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.527 1.142 . . . . 73.230000000000004 110.965 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 279' ' ' PHE . 4.9 p -118.43 128.09 54.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 43.140000000000001 109.984 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 278' ' ' THR . 17.7 mt -101.63 129.01 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.107 . . . . 64.420000000000002 109.278 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -72.01 114.62 10.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 71.439999999999998 109.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.765 ' HG2' HD21 ' A' ' 306' ' ' LEU . 61.8 mtp -88.18 144.71 26.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 74.349999999999994 111.077 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -41.49 147.58 0.41 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.517 1.135 . . . . 62.130000000000003 111.005 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -17.83 19.28 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.783 . . . . 72.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.88 -177.04 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.468 1.105 . . . . 74.450000000000003 109.63 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.36 174.49 5.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.239999999999995 110.32 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.7 mt -104.46 -82.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.113 . . . . 60.409999999999997 109.298 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.98 159.57 20.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.54 1.15 . . . . 74.319999999999993 111.007 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.61 -63.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.5 0.764 . . . . 75.439999999999998 109.287 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.52 -29.3 68.67 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 109.276 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -68.52 156.61 53.18 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.464 1.103 . . . . 42.229999999999997 110.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.81 171.68 12.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 0.768 . . . . 71.540000000000006 110.311 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 293' ' ' MET . 37.2 tptt -118.78 165.11 14.43 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 73.329999999999998 109.341 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -143.88 124.6 14.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 72.530000000000001 110.279 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.765 HD21 ' HG2' ' A' ' 293' ' ' MET . 10.3 mt -135.97 60.21 1.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 64.030000000000001 109.333 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.479 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 11.2 p-90 -72.48 134.68 45.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.514 1.134 . . . . 75.209999999999994 108.034 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.816 ' CE2' HD11 ' A' ' 312' ' ' LEU . 45.3 t80 -126.12 166.73 16.48 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.122 . . . . 74.129999999999995 111.028 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -137.91 157.16 73.72 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 74.129999999999995 110.972 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.95 -41.31 1.02 Allowed 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.99 -2.504 . . . . 40.130000000000003 111.038 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 172.93 143.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.340000000000003 109.993 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.816 HD11 ' CE2' ' A' ' 308' ' ' PHE . 4.4 mp -115.16 159.58 37.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.549999999999997 109.316 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 148.5 35.31 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 75.540000000000006 110.988 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.593 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.2 OUTLIER -130.35 164.42 41.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 71.549999999999997 110.382 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 -177.73 21.36 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.019 -2.492 . . . . 74.140000000000001 111.006 0.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.984 HD13 ' SD ' ' A' ' 321' ' ' MET . 1.8 mt -102.49 52.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.442 1.089 . . . . 74.219999999999999 109.308 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.4 p -76.08 127.19 32.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 75.0 109.988 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 317' ' ' SER . 28.7 t30 81.07 30.83 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 74.120000000000005 109.342 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.806 ' CE2' HD23 ' A' ' 316' ' ' LEU . 5.2 m-85 -109.56 167.55 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.439999999999998 111.035 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.91 HG22 ' HG2' ' A' ' 322' ' ' LYS . 32.3 m -79.6 -59.75 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 64.400000000000006 110.425 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.984 ' SD ' HD13 ' A' ' 316' ' ' LEU . 0.6 OUTLIER 27.03 79.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.108 . . . . 73.409999999999997 110.971 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.91 ' HG2' HG22 ' A' ' 320' ' ' THR . 7.6 pttt -112.66 -170.66 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 72.540000000000006 109.325 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.589 ' CG2' HD21 ' A' ' 344' ' ' LEU . 49.4 t -136.89 138.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 61.020000000000003 109.305 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.737 HG23 ' H ' ' A' ' 329' ' ' GLU . 0.4 OUTLIER -122.4 138.69 51.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.554 1.158 . . . . 75.010000000000005 109.271 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.713 ' OD1' HD13 ' A' ' 331' ' ' ILE . 0.5 OUTLIER -76.82 -170.54 1.63 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.13 . . . . 64.200000000000003 109.284 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -78.99 4.32 14.66 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 53.109999999999999 110.267 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.04 -3.28 41.7 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 74.420000000000002 109.296 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 65.21 54.47 26.96 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.485 1.116 . . . . 61.329999999999998 110.998 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.737 ' H ' HG23 ' A' ' 324' ' ' VAL . 9.9 pt-20 -157.04 121.86 4.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 0.77 . . . . 64.349999999999994 110.311 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.414 HG21 ' HD3' ' A' ' 322' ' ' LYS . 69.0 m -45.26 115.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.516 1.135 . . . . 71.540000000000006 110.406 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.713 HD13 ' OD1' ' A' ' 325' ' ' ASN . 36.5 pt -98.76 -41.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 73.310000000000002 109.297 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.898 ' HB3' HD23 ' A' ' 344' ' ' LEU . 10.4 mt -131.48 168.45 17.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 73.230000000000004 109.286 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.467 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.38 122.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 74.099999999999994 109.336 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.421 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -72.45 121.53 8.17 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 111.006 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -45.22 -26.71 0.53 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.461 0.742 . . . . 73.209999999999994 109.293 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 321' ' ' MET . 0.1 OUTLIER 47.83 76.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 62.140000000000001 108.312 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -90.3 -175.8 4.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 63.210000000000001 109.285 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.82 62.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.466 1.103 . . . . 65.329999999999998 109.302 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 15.4 m -171.08 150.2 3.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 74.319999999999993 109.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 254' ' ' VAL . 18.9 m-20 -60.38 -21.17 61.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 63.420000000000002 109.302 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -78.12 148.46 34.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.136 . . . . 74.150000000000006 110.289 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.601 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 57.1 mt -147.55 140.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.478 1.111 . . . . 63.549999999999997 109.309 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 11.4 p -136.13 95.53 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 64.239999999999995 110.358 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.6 mp -49.97 153.63 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 64.109999999999999 109.311 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -128.51 -76.44 0.56 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 73.439999999999998 109.286 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 5.0 p 164.84 134.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.491 1.119 . . . . 62.420000000000002 110.057 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.443 1.76 . . . . 44.409999999999997 111.039 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 72.120000000000005 109.288 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.273 -0.64 . . . . 74.140000000000001 109.273 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.593 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -115.55 99.76 7.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 52.219999999999999 109.302 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.554 ' CD2' HG22 ' A' ' 343' ' ' THR . 18.8 m170 -95.52 130.83 42.22 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 74.400000000000006 109.569 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 253' ' ' GLU . 69.6 t -124.71 166.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 73.420000000000002 109.302 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.524 ' N ' HG12 ' A' ' 252' ' ' VAL . 27.8 tt0 -122.67 123.34 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 74.319999999999993 110.316 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.02 107.5 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 74.019999999999996 109.318 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -59.59 2.51 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 44.43 109.969 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.939 ' HA ' HD23 ' A' ' 261' ' ' LEU . 2.9 t-20 60.71 70.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.25 109.243 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -105.32 161.97 13.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.556 1.16 . . . . 63.340000000000003 110.293 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 259' ' ' ASN . 46.1 m-20 -41.15 -60.22 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.561 1.163 . . . . 73.409999999999997 109.293 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 258' ' ' ASP . 66.5 t30 -40.07 -64.34 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 62.329999999999998 109.353 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -178.6 -174.54 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 72.510000000000005 109.999 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.939 HD23 ' HA ' ' A' ' 256' ' ' ASN . 46.8 mt -76.19 153.97 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.491 1.119 . . . . 74.129999999999995 109.318 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -142.03 91.66 2.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 72.439999999999998 109.603 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.573 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 8.2 m-30 -98.84 133.99 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.475 1.11 . . . . 52.219999999999999 110.977 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.661 HG22 ' CE2' ' A' ' 266' ' ' TYR . 62.6 mt -127.93 121.2 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 73.510000000000005 109.294 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -107.3 119.67 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.540000000000006 109.32 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.661 ' CE2' HG22 ' A' ' 264' ' ' ILE . 5.1 m-85 -109.03 92.16 3.94 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.502 1.126 . . . . 63.140000000000001 111.027 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -54.45 95.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 70.019999999999996 109.282 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.7 28.18 7.74 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 62.310000000000002 109.343 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 61.3 p -87.52 -174.94 5.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.545 1.153 . . . . 72.129999999999995 110.388 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -88.69 -56.17 3.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.400000000000006 109.333 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.408 ' H ' HG23 ' A' ' 271' ' ' ILE . 0.1 OUTLIER -60.18 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.44 1.088 . . . . 71.129999999999995 109.342 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 271' ' ' ILE . 4.1 mp -124.77 123.21 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.493 1.121 . . . . 50.109999999999999 109.307 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 273' ' ' ILE . 3.5 mm -40.94 137.75 1.42 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 71.319999999999993 109.306 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.03 -24.46 12.75 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.501 1.79 . . . . 72.010000000000005 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.42 169.17 31.97 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.501 1.126 . . . . 74.049999999999997 111.008 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.0 t30 63.44 36.76 11.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 0.754 . . . . 65.219999999999999 109.344 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.411 ' C ' ' OG1' ' A' ' 278' ' ' THR . 64.1 m -90.44 -176.5 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.448 1.093 . . . . 73.420000000000002 108.316 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 324' ' ' VAL . 1.6 m -153.77 129.02 9.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 71.310000000000002 110.381 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.527 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.0 OUTLIER -80.2 179.21 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.505 1.128 . . . . 75.420000000000002 111.017 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -169.97 97.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.11 . . . . 64.239999999999995 110.308 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.625 ' CE1' ' CE2' ' A' ' 308' ' ' PHE . 4.4 p90 -120.65 121.66 38.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 71.109999999999999 111.02 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 m -101.84 143.54 31.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.564 1.165 . . . . 71.150000000000006 110.027 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 64.329999999999998 110.02 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.308 -0.627 . . . . 53.310000000000002 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -122.7 156.73 33.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 65.409999999999997 111.014 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 6.1 p -128.1 126.34 40.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.515 1.134 . . . . 72.209999999999994 110.025 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 5.5 mt -97.68 129.47 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.133 . . . . 72.530000000000001 109.306 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.421 ' HA ' HG23 ' A' ' 278' ' ' THR . 2.8 mptp? -67.28 121.07 14.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 65.200000000000003 109.285 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 98.7 mtp -89.06 140.2 29.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 41.310000000000002 111.003 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.553 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -40.7 144.23 0.56 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.486 1.116 . . . . 74.510000000000005 110.989 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -24.72 12.72 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.509 1.794 . . . . 72.129999999999995 111.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -63.66 163.91 10.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.525 1.141 . . . . 63.219999999999999 109.61 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -100.12 128.92 46.12 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 73.340000000000003 110.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 77.0 mt -57.63 -72.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.122 . . . . 71.310000000000002 109.345 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.02 172.15 24.3 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.497 1.123 . . . . 52.119999999999997 110.997 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 13.4 mt -60.39 -54.69 31.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 74.209999999999994 109.325 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 36.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 70.230000000000004 109.27 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -125.46 147.16 16.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.57 1.169 . . . . 72.200000000000003 111.006 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -119.74 170.66 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 0.774 . . . . 74.549999999999997 110.313 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.553 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 46.3 tptt -140.4 149.72 42.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 74.209999999999994 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 2.1 mt-10 -115.23 151.16 34.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 71.209999999999994 110.327 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.807 HD12 HD11 ' A' ' 265' ' ' LEU . 20.4 mt -152.25 69.24 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.483 1.114 . . . . 63.210000000000001 109.291 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.517 ' CE2' ' HB3' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -75.23 119.74 19.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 62.310000000000002 108.005 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.7 m-30 -113.46 142.13 46.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 73.420000000000002 110.998 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -128.59 160.37 63.08 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 74.530000000000001 111.017 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -36.2 2.67 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 121.027 -2.489 . . . . 75.310000000000002 110.979 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.5 p 162.14 127.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.534 1.146 . . . . 70.450000000000003 110.025 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.512 HD12 ' CD1' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -99.32 169.5 8.07 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.417 1.073 . . . . 71.510000000000005 109.301 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 143.54 29.22 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 63.539999999999999 110.991 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.601 HG22 HD12 ' A' ' 316' ' ' LEU . 0.7 OUTLIER -131.27 162.17 57.46 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.559 1.162 . . . . 73.439999999999998 110.377 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.0 167.98 78.83 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.027 -2.489 . . . . 64.120000000000005 111.021 -0.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.792 HD22 ' HE3' ' A' ' 321' ' ' MET . 3.7 mp -87.85 46.83 1.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 73.510000000000005 109.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 58.1 p -67.7 115.8 7.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 61.140000000000001 109.961 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 317' ' ' SER . 4.2 t30 83.42 39.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 71.239999999999995 109.277 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.676 ' CD2' HD23 ' A' ' 316' ' ' LEU . 5.6 m-85 -116.17 150.56 37.26 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.547 1.155 . . . . 74.430000000000007 111.003 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 322' ' ' LYS . 87.7 m -57.57 -64.11 1.01 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 1.139 . . . . 61.32 110.378 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.792 ' HE3' HD22 ' A' ' 316' ' ' LEU . 0.5 OUTLIER 35.39 33.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 74.230000000000004 111.02 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.519 ' HG3' HG22 ' A' ' 320' ' ' THR . 90.9 mttt -72.99 -176.53 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 75.230000000000004 109.334 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 279' ' ' PHE . 5.6 t -142.88 138.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.441 1.088 . . . . 54.420000000000002 109.293 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 278' ' ' THR . 0.0 OUTLIER -116.11 152.11 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 73.519999999999996 109.289 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.569 ' OD1' HD13 ' A' ' 331' ' ' ILE . 1.3 t30 -91.83 -173.6 3.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 63.450000000000003 109.268 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -75.45 -0.87 21.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.491 1.119 . . . . 63.140000000000001 110.299 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.47 -10.11 33.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 73.430000000000007 109.258 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.04 48.06 16.88 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.447 1.092 . . . . 42.299999999999997 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.565 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 9.7 pt-20 -153.8 110.48 3.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 70.439999999999998 110.288 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.433 ' N ' HG13 ' A' ' 324' ' ' VAL . 12.2 m -38.53 125.57 1.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.534 1.146 . . . . 63.439999999999998 110.445 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.569 HD13 ' OD1' ' A' ' 325' ' ' ASN . 6.8 pt -100.58 -37.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 74.340000000000003 109.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.943 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.2 mt -134.23 165.56 24.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 74.150000000000006 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -145.67 118.77 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 73.219999999999999 109.309 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -74.86 135.92 19.84 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.494 1.121 . . . . 72.310000000000002 110.993 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -79.93 -29.43 39.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 0.741 . . . . 73.430000000000007 109.265 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.583 ' H ' HG23 ' A' ' 342' ' ' ILE . 12.1 t 40.07 88.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 61.119999999999997 108.339 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -78.39 -161.05 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.447 1.092 . . . . 70.299999999999997 109.298 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -81.69 58.08 3.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.494 1.121 . . . . 63.530000000000001 109.322 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 57.7 m -172.15 166.13 6.07 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 43.340000000000003 110.007 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.58 -15.85 63.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 75.230000000000004 109.308 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.03 141.15 45.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 73.450000000000003 110.318 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.583 HG23 ' H ' ' A' ' 336' ' ' CYS . 8.5 mt -148.2 116.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 75.239999999999995 109.286 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.554 HG22 ' CD2' ' A' ' 251' ' ' HIS . 9.6 p -119.65 113.65 21.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 73.340000000000003 110.446 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.943 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -67.69 145.9 54.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.464 1.102 . . . . 74.510000000000005 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -123.25 -44.66 2.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 65.239999999999995 109.284 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.1 t 153.96 156.14 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.230000000000004 110.02 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.6 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.5 Cg_endo -74.99 -49.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.487 1.783 . . . . 64.219999999999999 111.038 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.551 1.157 . . . . 71.430000000000007 109.289 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.293 -0.632 . . . . 62.509999999999998 109.293 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.598 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -116.64 100.55 7.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.103 . . . . 70.5 109.282 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.571 ' CE1' HG22 ' A' ' 343' ' ' THR . 29.4 m-70 -90.93 128.58 36.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.529 1.143 . . . . 75.540000000000006 109.603 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 265' ' ' LEU . 58.9 t -120.52 167.27 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 52.109999999999999 109.306 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.3 tp10 -128.06 135.24 49.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 61.240000000000002 110.325 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.717 ' CG1' HG21 ' A' ' 314' ' ' THR . 89.6 t -109.61 109.49 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 61.409999999999997 109.305 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 m -79.73 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 74.040000000000006 110.023 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.908 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER 63.56 71.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.545 1.153 . . . . 72.310000000000002 109.288 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -91.13 147.34 23.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 64.439999999999998 110.305 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.99 -35.29 33.07 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.146 . . . . 75.540000000000006 109.271 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.73 -46.95 73.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 75.230000000000004 109.293 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 1.5 m -174.25 -173.4 0.78 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.137 . . . . 65.439999999999998 109.996 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.2 mt -87.47 161.82 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 1.125 . . . . 54.43 109.329 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -159.91 101.43 1.45 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 75.25 109.605 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.696 ' CZ ' HD13 ' A' ' 261' ' ' LEU . 51.1 m-85 -110.89 129.17 55.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 63.140000000000001 110.95 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.747 HG22 ' CE1' ' A' ' 266' ' ' TYR . 48.0 mt -119.37 119.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 72.439999999999998 109.26 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.713 ' HB3' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -112.41 139.96 47.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 74.540000000000006 109.285 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.747 ' CE1' HG22 ' A' ' 264' ' ' ILE . 4.5 m-85 -126.97 114.9 18.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.442 1.089 . . . . 71.200000000000003 110.998 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.494 ' CG ' ' CG2' ' A' ' 298' ' ' ILE . 48.5 p-10 -69.19 77.06 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.143 . . . . 64.109999999999999 109.284 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.479 ' CE ' ' HA ' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -78.89 55.23 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 1.117 . . . . 75.099999999999994 109.304 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.9 p -125.45 -170.5 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 71.239999999999995 110.371 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -94.42 -52.79 4.18 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 1.127 . . . . 71.010000000000005 109.304 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.63 169.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 51.109999999999999 109.298 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.531 ' N ' HD12 ' A' ' 272' ' ' ILE . 3.8 mp -106.28 161.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 74.439999999999998 109.306 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.895 HG13 HD12 ' A' ' 298' ' ' ILE . 3.6 mm -92.36 137.4 24.68 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.559 1.162 . . . . 65.109999999999999 109.294 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 -23.87 13.31 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.56 1.821 . . . . 60.539999999999999 110.976 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 74.05 161.72 7.8 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.53 1.144 . . . . 33.039999999999999 110.972 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 6.0 t30 81.69 22.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 0.777 . . . . 62.140000000000001 109.301 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.412 ' C ' ' OG1' ' A' ' 278' ' ' THR . 22.4 m -69.15 -178.23 1.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 71.519999999999996 108.3 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.904 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.7 m -153.81 106.5 2.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 74.5 110.415 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.88 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -60.53 173.09 0.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 63.130000000000003 111.038 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -168.43 92.21 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.107 . . . . 73.409999999999997 110.32 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 7.2 p90 -116.17 146.98 41.87 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.44 1.087 . . . . 64.200000000000003 110.977 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.407 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 82.9 p -72.57 -179.8 3.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 71.340000000000003 109.992 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 312' ' ' LEU . 1.9 m . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 51.439999999999998 109.99 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 281' ' ' PHE . 11.6 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.311 -0.626 . . . . 71.430000000000007 109.311 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.423 ' CD2' ' CE1' ' A' ' 308' ' ' PHE . 5.8 t80 -134.33 144.72 48.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 111.011 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 m -114.17 121.93 45.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 74.340000000000003 110.006 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.981 HD11 ' CD1' ' A' ' 308' ' ' PHE . 18.8 mt -101.86 128.56 54.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.52 1.138 . . . . 71.530000000000001 109.288 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.481 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.0 OUTLIER -68.06 99.66 0.9 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 109.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.772 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.9 mtp -56.33 152.26 11.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 51.439999999999998 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLY . . . . . 0.714 ' HA3' ' HZ2' ' A' ' 304' ' ' LYS . . . -35.33 140.57 0.17 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.57 1.169 . . . . 64.019999999999996 111.025 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 294' ' ' GLY . 18.1 Cg_endo -75.03 -22.98 14.2 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.521 1.8 . . . . 70.219999999999999 110.996 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -76.17 172.66 12.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.12 . . . . 52.130000000000003 109.61 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -107.59 124.3 49.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.147 . . . . 73.340000000000003 110.302 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.895 HD12 HG13 ' A' ' 273' ' ' ILE . 15.0 mt -47.07 -67.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 73.230000000000004 109.301 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.58 159.56 32.9 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.486 1.116 . . . . 65.209999999999994 111.026 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 19.2 mt -43.23 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.477 0.751 . . . . 73.140000000000001 109.317 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.479 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 62.75 75.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 63.219999999999999 109.315 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 298' ' ' ILE . . . -135.07 173.46 21.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.453 1.096 . . . . 73.430000000000007 111.022 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.28 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 0.758 . . . . 72.409999999999997 110.293 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.714 ' HZ2' ' HA3' ' A' ' 294' ' ' GLY . 40.3 tptt -159.49 155.04 25.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 70.510000000000005 109.261 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 5.4 mt-10 -130.25 139.96 50.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 51.109999999999999 110.294 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.88 HD13 ' CG ' ' A' ' 279' ' ' PHE . 16.0 mt -143.3 38.74 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.523 1.14 . . . . 73.439999999999998 109.285 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -49.55 148.3 2.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.959 -1.126 . . . . 75.040000000000006 107.959 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.981 ' CD1' HD11 ' A' ' 291' ' ' ILE . 12.5 t80 -147.43 168.18 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 73.409999999999997 111.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -141.12 161.18 54.77 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 61.43 111.013 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.98 -47.77 0.3 Allowed 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.007 -2.497 . . . . 74.109999999999999 111.018 -0.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.0 p 177.14 133.58 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 1.112 . . . . 71.340000000000003 109.951 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.6 mp -110.96 158.78 34.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 72.420000000000002 109.351 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 146.65 32.67 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.493 1.786 . . . . 75.510000000000005 110.988 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.717 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -124.64 161.98 45.37 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 73.540000000000006 110.372 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.02 -178.85 24.69 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.01 -2.496 . . . . 73.230000000000004 110.995 0.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.765 HD13 ' CE ' ' A' ' 321' ' ' MET . 1.7 mt -95.53 64.87 2.63 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.128 . . . . 64.150000000000006 109.284 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 32.4 t -81.16 123.08 28.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 53.43 110.006 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 317' ' ' SER . 44.0 t30 81.95 20.21 0.33 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 63.200000000000003 109.298 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.518 ' CD2' HD23 ' A' ' 316' ' ' LEU . 24.0 m-85 -101.99 114.05 27.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.562 1.164 . . . . 74.030000000000001 111.007 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.676 HG23 ' HD2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -37.75 -51.18 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 61.450000000000003 110.377 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.765 ' CE ' HD13 ' A' ' 316' ' ' LEU . 7.1 ttm 30.93 52.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 64.310000000000002 110.985 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.676 ' HD2' HG23 ' A' ' 320' ' ' THR . 33.0 mttt -81.08 -170.18 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.549999999999997 109.264 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 279' ' ' PHE . 5.8 t -151.61 130.32 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.525 1.141 . . . . 73.530000000000001 109.338 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 278' ' ' THR . 16.1 m -108.1 179.02 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.520000000000003 109.309 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.825 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -111.61 -172.4 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 41.049999999999997 109.306 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.16 -4.8 15.02 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 71.129999999999995 110.264 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.18 -7.12 33.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 71.340000000000003 109.321 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.12 54.63 6.83 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.503 1.127 . . . . 74.319999999999993 110.999 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.825 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.72 130.24 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 0.773 . . . . 72.420000000000002 110.302 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.854 ' N ' HG12 ' A' ' 324' ' ' VAL . 4.9 m -62.19 122.74 16.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 73.040000000000006 110.421 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.652 ' CG2' ' ND2' ' A' ' 325' ' ' ASN . 2.3 pt -105.4 -34.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.474 1.109 . . . . 75.299999999999997 109.256 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.884 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.6 mt -130.16 164.19 25.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 74.510000000000005 109.336 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -146.19 132.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 74.219999999999999 109.293 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.41 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -92.51 114.15 4.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.436 1.085 . . . . 72.239999999999995 111.035 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.763 ' NZ ' ' H ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -42.79 -27.72 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 0.75 . . . . 75.140000000000001 109.263 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 46.31 70.46 0.38 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 61.310000000000002 108.256 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . 0.763 ' H ' ' NZ ' ' A' ' 335' ' ' LYS . . . -79.28 -171.46 2.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 63.119999999999997 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 61.82 2.93 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 75.239999999999995 109.271 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 18.5 t -173.11 156.29 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 75.129999999999995 110.019 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.98 -30.14 71.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 60.43 109.289 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.64 136.22 56.03 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 63.240000000000002 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.62 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 49.1 mt -142.32 130.28 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 70.25 109.27 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.571 HG22 ' CE1' ' A' ' 251' ' ' HIS . 13.6 p -127.58 83.57 2.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 53.43 110.382 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.884 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.9 mp -38.52 136.29 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 64.109999999999999 109.33 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -70.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 63.539999999999999 109.321 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.81 147.79 0.34 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.576 1.173 . . . . 74.319999999999993 109.994 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.461 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.94 -55.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 74.230000000000004 111.024 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.562 1.164 . . . . 72.230000000000004 109.272 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.297 -0.631 . . . . 71.420000000000002 109.297 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 1.02 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -122.92 103.05 8.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 75.340000000000003 109.29 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.18 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 74.219999999999999 109.586 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.766 HG13 HD23 ' A' ' 265' ' ' LEU . 58.0 t -125.22 145.05 33.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 72.120000000000005 109.355 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.42 120.84 42.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.319999999999993 110.314 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.0 98.09 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 73.120000000000005 109.28 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.1 t -67.93 -70.77 0.24 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 75.450000000000003 110.024 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.894 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER 68.25 65.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 71.120000000000005 109.3 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -103.26 165.33 11.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 63.109999999999999 110.325 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 259' ' ' ASN . 0.7 OUTLIER -47.65 -57.16 5.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.324 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 258' ' ' ASP . 8.2 t-20 -40.12 -62.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 71.219999999999999 109.305 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -174.12 -160.56 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.476 1.11 . . . . 74.140000000000001 109.999 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.894 HD23 ' HA ' ' A' ' 256' ' ' ASN . 19.6 mt -93.68 -178.35 4.67 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.11 . . . . 72.299999999999997 109.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -177.01 104.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.450000000000003 109.549 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.518 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 59.1 m-85 -110.86 96.67 6.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 110.995 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.795 HG22 ' CE1' ' A' ' 266' ' ' TYR . 64.0 mt -91.86 104.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 61.140000000000001 109.289 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -89.72 129.15 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 75.319999999999993 109.321 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.795 ' CE1' HG22 ' A' ' 264' ' ' ILE . 14.8 m-85 -117.35 102.92 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 61.25 110.987 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.503 ' HB2' HD13 ' A' ' 273' ' ' ILE . 53.4 t30 -59.3 106.97 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 60.25 109.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -100.94 -12.1 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 75.310000000000002 109.302 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.461 ' O ' ' CD1' ' A' ' 300' ' ' ILE . 12.8 p -72.77 164.52 26.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 72.400000000000006 110.381 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.638 ' O ' HD11 ' A' ' 300' ' ' ILE . 22.0 m120 -67.17 -60.13 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 63.109999999999999 109.318 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.807 ' C ' HD13 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -38.84 158.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.53 1.144 . . . . 75.319999999999993 109.347 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.469 ' N ' HG12 ' A' ' 271' ' ' ILE . 2.1 mp -114.41 117.35 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 65.329999999999998 109.288 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -46.23 138.41 6.2 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 45.039999999999999 109.317 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.04 -30.15 7.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.469 1.773 . . . . 75.310000000000002 111.047 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 90.55 159.72 35.86 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.509 1.131 . . . . 44.310000000000002 111.019 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 1.9 t-20 76.23 27.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 0.766 . . . . 63.310000000000002 109.307 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.466 ' SG ' ' CD1' ' A' ' 331' ' ' ILE . 29.0 m -71.05 -178.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 108.288 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.843 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -152.97 105.44 2.93 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 73.510000000000005 110.382 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.522 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.1 t80 -59.05 157.66 9.82 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 74.329999999999998 110.947 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -146.69 84.33 1.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.551 1.157 . . . . 73.540000000000006 110.252 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.632 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 22.8 p90 -119.64 135.34 54.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 64.120000000000005 110.985 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.489 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 1.1 m -105.92 177.42 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 74.340000000000003 109.988 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' SER . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 319' ' ' TYR . 4.8 p . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 72.430000000000007 109.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 289' ' ' PHE . 2.8 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.256 -0.646 . . . . 63.210000000000001 109.256 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.533 ' N ' HG22 ' A' ' 288' ' ' VAL . 1.8 t80 -103.37 159.57 15.45 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 70.150000000000006 110.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -150.74 122.34 7.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 70.109999999999999 110.029 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 47.0 mt -121.99 128.83 75.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.439999999999998 109.256 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.588 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.5 OUTLIER -73.13 107.16 5.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 62.219999999999999 109.324 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.772 ' HG2' HD21 ' A' ' 306' ' ' LEU . 87.4 mtp -70.17 147.48 49.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.157 . . . . 61.210000000000001 110.998 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -49.68 152.28 3.66 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.506 1.129 . . . . 42.450000000000003 111.022 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -29.26 8.39 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 71.140000000000001 111.029 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -52.66 137.34 31.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 65.040000000000006 109.599 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.22 147.03 29.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 65.140000000000001 110.307 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.443 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -82.87 -76.62 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 74.150000000000006 109.342 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 76.21 -174.95 53.05 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.464 1.103 . . . . 71.230000000000004 110.976 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.638 HD11 ' O ' ' A' ' 270' ' ' ASN . 3.3 mm -64.43 137.6 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.5 0.765 . . . . 74.150000000000006 109.287 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.591 ' HG2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER 66.47 9.43 6.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 73.120000000000005 109.26 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.443 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -97.82 140.86 15.27 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.517 1.136 . . . . 53.210000000000001 110.987 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -110.42 -179.52 3.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 0.794 . . . . 64.329999999999998 110.289 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 264' ' ' ILE . 19.3 tptt -145.72 164.23 32.47 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 65.310000000000002 109.306 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.97 128.41 36.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 1.109 . . . . 61.229999999999997 110.291 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.961 HD12 HD11 ' A' ' 265' ' ' LEU . 12.3 mt -140.91 62.52 1.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 71.430000000000007 109.302 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -76.44 128.95 35.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 73.040000000000006 107.986 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.4 m-30 -115.79 178.55 4.27 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.5 111.052 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.516 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -159.29 157.04 26.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.5 110.992 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -35.14 3.02 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.998 -2.501 . . . . 63.350000000000001 111.021 0.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.0 p 169.04 139.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 71.230000000000004 109.999 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.1 mp -115.28 158.37 41.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 73.239999999999995 109.306 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.47 34.03 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.49 1.784 . . . . 73.450000000000003 111.002 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.725 HG22 HD12 ' A' ' 316' ' ' LEU . 0.6 OUTLIER -127.32 162.24 49.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.439 1.087 . . . . 73.510000000000005 110.416 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.94 174.36 53.02 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.999 -2.5 . . . . 74.109999999999999 110.993 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.725 HD12 HG22 ' A' ' 314' ' ' THR . 5.3 mp -88.99 65.61 7.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.049999999999997 109.277 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.1 p -84.42 139.44 32.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.448 1.092 . . . . 60.200000000000003 110.008 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.74 23.48 4.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.102 . . . . 63.0 109.282 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.701 ' CD2' HD23 ' A' ' 316' ' ' LEU . 3.2 m-85 -104.07 165.77 10.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.468 1.105 . . . . 63.039999999999999 111.027 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 322' ' ' LYS . 15.5 m -92.24 -49.47 6.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 110.37 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.878 ' SD ' HD13 ' A' ' 342' ' ' ILE . 1.7 ptp 30.13 63.35 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.329999999999998 111.028 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.594 ' HG2' HG12 ' A' ' 333' ' ' VAL . 42.8 mttt -91.26 -171.09 2.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 75.25 109.351 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.482 HG21 HD21 ' A' ' 344' ' ' LEU . 2.2 t -150.26 132.2 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 72.099999999999994 109.296 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 278' ' ' THR . 9.0 m -118.29 179.62 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 73.25 109.276 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -108.4 -166.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 73.519999999999996 109.317 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.84 -10.42 37.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 62.020000000000003 110.265 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -107.38 19.57 20.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 109.327 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 55.09 18.12 11.8 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 75.439999999999998 110.986 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 331' ' ' ILE . 10.6 pt-20 -89.54 123.65 33.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.487 0.757 . . . . 71.450000000000003 110.276 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.593 ' N ' HG12 ' A' ' 324' ' ' VAL . 2.7 m -55.78 115.05 2.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 63.420000000000002 110.4 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.466 ' CD1' ' SG ' ' A' ' 277' ' ' CYS . 5.4 pt -97.88 -41.82 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 62.030000000000001 109.297 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.806 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.3 mt -138.34 162.57 34.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 55.310000000000002 109.322 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.594 HG12 ' HG2' ' A' ' 322' ' ' LYS . 26.8 m -149.0 128.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 71.239999999999995 109.293 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -86.85 113.15 3.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.476 1.11 . . . . 72.420000000000002 111.012 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.415 ' O ' ' SG ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -50.04 -24.17 2.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 0.752 . . . . 62.530000000000001 109.32 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 335' ' ' LYS . 0.5 OUTLIER 66.23 162.88 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 65.439999999999998 108.283 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -173.98 -173.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.572 1.17 . . . . 71.420000000000002 109.269 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.55 56.52 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.140000000000001 109.306 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 341' ' ' GLU . 35.0 t -178.4 138.55 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 54.229999999999997 109.998 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -44.76 -27.01 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 63.530000000000001 109.315 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 339' ' ' SER . 6.9 mt-10 -63.97 117.27 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 74.510000000000005 110.323 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.878 HD13 ' SD ' ' A' ' 321' ' ' MET . 61.6 mt -141.62 122.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.433 1.083 . . . . 65.040000000000006 109.291 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 10.4 p -116.41 105.15 12.19 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 72.299999999999997 110.402 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 1.02 HD22 HD22 ' A' ' 250' ' ' LEU . 5.9 mp -58.56 142.62 48.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 72.030000000000001 109.264 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -77.29 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.541 1.151 . . . . 74.019999999999996 109.261 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.1 p -179.85 145.56 0.41 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 74.120000000000005 109.979 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -59.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.524 1.802 . . . . 70.140000000000001 110.987 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 348' ' ' LEU . 2.2 tm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 73.209999999999994 109.329 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 1.008 HD23 ' O ' ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.304 -0.628 . . . . 51.25 109.304 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.678 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -125.3 103.12 7.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 74.400000000000006 109.294 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.51 136.3 57.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 63.100000000000001 109.573 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.749 HG22 HD23 ' A' ' 265' ' ' LEU . 76.2 t -145.92 136.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 53.210000000000001 109.301 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.06 128.79 56.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 54.409999999999997 110.262 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.522 ' CG1' HG21 ' A' ' 314' ' ' THR . 14.2 t -105.47 105.45 18.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 70.450000000000003 109.291 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.76 -73.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 61.299999999999997 109.973 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.591 ' HA ' HD23 ' A' ' 261' ' ' LEU . 8.6 t-20 55.33 78.38 0.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 70.340000000000003 109.305 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.26 -166.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.544 1.152 . . . . 71.430000000000007 110.314 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.63 31.56 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 63.119999999999997 109.308 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -135.22 -45.16 0.7 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.481 1.113 . . . . 74.239999999999995 109.317 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 174.08 -174.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 32.210000000000001 110.009 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.863 HD11 ' HB2' ' A' ' 312' ' ' LEU . 23.7 mt -93.24 167.65 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 73.049999999999997 109.288 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -163.81 100.25 0.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.239999999999995 109.608 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.19 101.55 10.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 73.099999999999994 110.992 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.816 HG22 ' CE1' ' A' ' 266' ' ' TYR . 56.9 mt -97.52 103.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 75.040000000000006 109.263 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 1.056 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -88.13 138.23 31.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.467 1.104 . . . . 74.200000000000003 109.301 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.816 ' CE1' HG22 ' A' ' 264' ' ' ILE . 13.1 m-85 -125.66 101.06 6.71 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.504 1.128 . . . . 60.049999999999997 111.009 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.67 97.8 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 53.109999999999999 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.39 30.26 5.46 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.486 1.116 . . . . 71.420000000000002 109.319 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.581 ' O ' HD12 ' A' ' 300' ' ' ILE . 36.0 p -85.59 -167.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.239999999999995 110.394 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -92.68 -52.3 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 75.150000000000006 109.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.41 ' H ' HG23 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -65.47 173.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 62.549999999999997 109.257 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.15 137.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.501 1.126 . . . . 65.519999999999996 109.291 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ILE . . . . . 0.5 ' HA ' HD13 ' A' ' 273' ' ' ILE . 5.6 mm -61.95 135.92 94.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.47 1.106 . . . . 73.450000000000003 109.3 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -22.79 14.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.797 . . . . 42.200000000000003 111.03 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 73.83 168.06 16.09 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.472 1.108 . . . . 64.439999999999998 111.02 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 1.7 t30 70.49 38.66 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 0.772 . . . . 70.450000000000003 109.271 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 52.6 m -83.29 -177.48 6.75 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 70.219999999999999 108.284 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.864 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.8 m -154.24 99.76 2.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 73.430000000000007 110.372 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 323' ' ' VAL . 0.8 OUTLIER -55.4 162.64 1.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.492 1.12 . . . . 73.510000000000005 111.006 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -155.31 90.62 1.27 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.559 1.162 . . . . 74.219999999999999 110.328 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 279' ' ' PHE . 12.2 p90 -118.94 153.83 33.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 70.200000000000003 111.001 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.59 170.2 16.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 72.530000000000001 110.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.541 1.151 . . . . 74.409999999999997 110.032 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.3 -0.629 . . . . 60.409999999999997 109.3 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.09 133.7 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 73.430000000000007 110.979 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.4 p -110.7 121.86 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.476 1.11 . . . . 70.099999999999994 109.969 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.873 HD11 ' CD1' ' A' ' 308' ' ' PHE . 12.0 mt -103.54 132.13 50.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 65.439999999999998 109.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.63 106.16 6.07 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.452 1.095 . . . . 73.430000000000007 109.297 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.819 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.5 mtp -77.77 145.7 36.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 71.349999999999994 110.996 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.03 153.76 6.83 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.497 1.123 . . . . 60.340000000000003 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -30.58 7.01 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.433 1.754 . . . . 63.399999999999999 111.023 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -42.88 143.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 61.310000000000002 109.607 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -92.69 124.52 36.76 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 63.310000000000002 110.308 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.526 HG23 ' C ' ' A' ' 302' ' ' GLY . 43.0 mt -62.02 -77.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.578 1.174 . . . . 65.120000000000005 109.309 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.32 -175.49 54.53 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.462 1.101 . . . . 65.109999999999999 111.008 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 300' ' ' ILE . 2.1 mm -66.68 133.86 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 74.519999999999996 109.305 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.49 ' HG2' HG22 ' A' ' 300' ' ' ILE . 12.1 mmtm 74.21 3.71 4.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.040000000000006 109.279 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.526 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -93.35 146.72 18.26 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.501 1.126 . . . . 72.129999999999995 111.006 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -113.63 -176.04 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 0.753 . . . . 65.430000000000007 110.282 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 264' ' ' ILE . 39.5 tptt -147.56 162.93 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.474 1.109 . . . . 60.399999999999999 109.295 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -136.0 118.92 16.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 74.200000000000003 110.305 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 1.056 HD12 HD11 ' A' ' 265' ' ' LEU . 20.1 mt -128.16 55.04 1.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.496 1.122 . . . . 72.519999999999996 109.308 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' TRP . . . . . 0.424 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 4.8 p90 -67.09 125.15 25.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.993 -1.114 . . . . 74.200000000000003 107.993 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.873 ' CD1' HD11 ' A' ' 291' ' ' ILE . 25.6 t80 -123.25 173.15 8.11 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.553 1.158 . . . . 71.349999999999994 111.042 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -150.55 161.72 29.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.509 1.131 . . . . 75.510000000000005 111.06 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -74.99 -43.15 0.72 Allowed 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.97 -2.513 . . . . 73.420000000000002 111.0 -0.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.5 p 179.59 158.4 0.67 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 52.109999999999999 109.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.863 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.1 mp -135.28 158.73 74.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 70.329999999999998 109.33 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 151.1 38.91 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.482 1.78 . . . . 71.439999999999998 110.996 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' THR . . . . . 0.522 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.8 OUTLIER -134.49 161.27 64.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.518 1.137 . . . . 71.129999999999995 110.453 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.91 -178.97 24.96 Favored 'Cis proline' 0 C--N 1.36 1.148 0 C-N-CA 121.002 -2.499 . . . . 75.409999999999997 111.038 -0.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.756 HD23 ' CE2' ' A' ' 319' ' ' TYR . 2.3 mt -101.27 57.39 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.519999999999996 109.318 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 6.1 p -81.4 127.7 33.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 60.399999999999999 109.989 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 317' ' ' SER . 30.8 t30 80.74 23.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 73.299999999999997 109.3 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.756 ' CE2' HD23 ' A' ' 316' ' ' LEU . 6.8 m-85 -101.92 176.46 5.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 71.329999999999998 110.985 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.611 HG23 ' HZ3' ' A' ' 322' ' ' LYS . 1.2 m -93.21 -58.66 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 110.395 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.749 ' SD ' HD13 ' A' ' 342' ' ' ILE . 2.2 ptp 28.3 61.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 73.420000000000002 110.991 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' LYS . . . . . 0.611 ' HZ3' HG23 ' A' ' 320' ' ' THR . 28.4 mttp -91.29 179.12 5.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.151 . . . . 62.409999999999997 109.32 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.5 t -140.81 129.67 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 72.519999999999996 109.284 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.868 HG12 ' N ' ' A' ' 330' ' ' THR . 15.4 m -108.47 178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 70.019999999999996 109.317 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.839 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -110.84 -172.34 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.437 1.086 . . . . 71.510000000000005 109.281 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -68.23 -4.7 14.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.439999999999998 110.267 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -7.46 31.96 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 55.329999999999998 109.289 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.62 54.38 6.69 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 61.450000000000003 111.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.839 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.1 OUTLIER -149.55 130.5 14.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 0.755 . . . . 75.439999999999998 110.313 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 330' ' ' THR . . . . . 0.868 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.7 m -60.97 119.44 8.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 70.129999999999995 110.386 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.649 ' CG2' ' ND2' ' A' ' 325' ' ' ASN . 2.2 pt -97.19 -34.68 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 74.25 109.281 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 344' ' ' LEU . 4.8 mt -132.04 -171.46 2.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 73.519999999999996 109.341 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' VAL . . . . . 0.58 HG12 ' C ' ' A' ' 332' ' ' LEU . 0.1 OUTLIER -175.89 114.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 65.540000000000006 109.241 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.475 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -61.81 135.41 46.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.534 1.146 . . . . 62.240000000000002 111.011 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' LYS . . . . . 0.536 ' C ' ' SG ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -57.04 -19.54 19.41 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.582 0.813 . . . . 75.430000000000007 109.267 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.536 ' SG ' ' C ' ' A' ' 335' ' ' LYS . 0.8 OUTLIER 42.08 89.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 75.310000000000002 108.283 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.27 -175.32 2.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.530000000000001 109.324 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.31 61.86 2.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 64.409999999999997 109.288 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.82 142.78 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 62.200000000000003 109.961 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ASN . . . . . 0.453 ' O ' HG23 ' A' ' 254' ' ' VAL . 55.9 m-20 -52.18 -27.05 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 75.230000000000004 109.309 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.31 137.01 57.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.497 1.123 . . . . 72.120000000000005 110.293 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.749 HD13 ' SD ' ' A' ' 321' ' ' MET . 53.8 mt -146.17 137.28 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 109.305 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 24.2 p -138.05 99.51 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 73.230000000000004 110.414 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.2 mp -54.78 132.27 45.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 63.350000000000001 109.265 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.623 ' O ' HD21 ' A' ' 332' ' ' LEU . 0.1 OUTLIER -112.72 -66.79 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 72.209999999999994 109.306 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 346' ' ' SER . . . . . 0.682 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.1 p 158.84 136.78 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 53.210000000000001 109.998 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' PRO . . . . . 0.528 ' HB3' HG11 ' A' ' 333' ' ' VAL . 18.3 Cg_endo -75.04 -57.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.479 1.779 . . . . 74.209999999999994 111.002 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 348' ' ' LEU . 1.4 tp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 73.150000000000006 109.317 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.278 -0.638 . . . . 65.219999999999999 109.278 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.467 ' HB2' HD12 ' A' ' 249' ' ' LEU . 0.8 OUTLIER 65.15 132.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.019999999999996 109.254 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 269' ' ' THR . 18.2 Cg_endo -75.0 -7.76 19.46 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.524 1.802 . . . . 61.119999999999997 110.978 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -42.48 134.38 3.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 75.25 109.325 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.23 103.15 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 64.530000000000001 109.259 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -61.38 134.37 56.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 71.439999999999998 109.618 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 253' ' ' GLU . 89.9 t -142.36 164.95 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 72.319999999999993 109.295 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.5 ' N ' HG12 ' A' ' 252' ' ' VAL . 4.1 tp10 -146.05 129.5 16.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 64.530000000000001 110.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.738 ' CG1' HG21 ' A' ' 314' ' ' THR . 89.0 t -102.82 118.28 49.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.538 1.148 . . . . 72.540000000000006 109.273 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 18.0 m -87.78 -65.56 1.0 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 53.340000000000003 110.019 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.865 ' HA ' HD23 ' A' ' 261' ' ' LEU . 7.6 t-20 58.36 63.5 1.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.472 1.108 . . . . 74.340000000000003 109.325 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.8 pt-20 -162.42 -175.01 4.29 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 74.430000000000007 110.321 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.67 24.21 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.552 1.158 . . . . 73.439999999999998 109.281 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 72.42 18.63 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 75.299999999999997 109.272 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 4.2 m -165.28 -167.11 1.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 34.439999999999998 109.997 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 256' ' ' ASN . 9.4 mt -101.25 166.21 10.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.478 1.111 . . . . 63.149999999999999 109.321 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' HIS . . . . . 0.458 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 0.3 OUTLIER -163.2 95.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 72.239999999999995 109.636 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.59 ' CE2' HD13 ' A' ' 261' ' ' LEU . 97.4 m-85 -97.46 149.33 22.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 70.340000000000003 110.986 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.807 HG22 ' CE1' ' A' ' 266' ' ' TYR . 48.4 mt -142.24 112.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.53 1.144 . . . . 71.140000000000001 109.293 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.617 HD11 HD12 ' A' ' 306' ' ' LEU . 0.0 OUTLIER -111.48 143.99 41.42 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.564 1.165 . . . . 64.049999999999997 109.306 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.807 ' CE1' HG22 ' A' ' 264' ' ' ILE . 2.1 m-85 -128.56 111.9 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.528 1.142 . . . . 75.209999999999994 110.979 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.758 ' HB2' HD13 ' A' ' 273' ' ' ILE . 26.2 t30 -60.47 101.34 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 75.450000000000003 109.292 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 300' ' ' ILE . 3.7 mmpt? -101.56 -19.17 15.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 54.439999999999998 109.333 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 248' ' ' PRO . 60.6 p -48.0 175.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.484 1.115 . . . . 71.109999999999999 110.384 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -72.78 -57.39 4.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 62.130000000000003 109.307 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 271' ' ' ILE . 0.0 OUTLIER -69.3 166.8 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 63.43 109.303 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.48 131.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 65.409999999999997 109.262 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.758 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.3 mp -40.55 140.2 1.03 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.51 1.131 . . . . 52.329999999999998 109.298 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -34.87 3.55 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 62.229999999999997 110.999 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 106.2 159.38 22.27 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.488 1.117 . . . . 60.210000000000001 110.989 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 69.18 23.6 6.32 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 0.778 . . . . 71.530000000000001 109.259 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.4 ' C ' ' OG1' ' A' ' 278' ' ' THR . 60.9 m -70.62 -179.15 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 62.32 108.274 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.735 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -153.96 136.26 14.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 74.109999999999999 110.4 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.645 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.5 t80 -89.54 179.03 6.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 65.349999999999994 110.98 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.461 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 11.2 tt0 -176.73 101.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.108 . . . . 72.150000000000006 110.316 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 1.3 p90 -116.26 147.81 41.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 74.409999999999997 111.006 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 53.2 p -100.67 -175.27 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 62.039999999999999 109.997 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.558 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 0.3 OUTLIER -178.45 -173.97 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 71.340000000000003 110.029 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 285' ' ' ILE . 17.8 pt20 -111.13 -52.77 2.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 72.329999999999998 110.309 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 285' ' ' ILE . 0.0 OUTLIER -62.38 -37.59 79.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 75.329999999999998 109.323 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 5.4 t -118.97 -176.0 3.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 60.539999999999999 110.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -108.32 -177.04 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 74.510000000000005 110.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 2.6 p -77.52 147.42 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.521 1.138 . . . . 73.239999999999995 109.255 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -152.88 142.95 22.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.030000000000001 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.627 ' OG ' HG22 ' A' ' 278' ' ' THR . 32.4 t -107.32 127.89 53.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 73.140000000000001 109.999 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.3 mt -101.04 137.22 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 72.409999999999997 109.287 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -77.47 113.0 14.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 73.530000000000001 109.317 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.924 ' HG2' HD21 ' A' ' 306' ' ' LEU . 63.0 mtp -84.13 165.51 18.41 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 72.310000000000002 110.973 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.454 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -64.47 151.42 50.51 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.473 1.108 . . . . 55.140000000000001 111.021 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.28 6.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.441 1.758 . . . . 61.299999999999997 110.961 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.56 ' CE1' ' OE1' ' A' ' 297' ' ' GLU . 57.6 t-80 -68.14 143.11 55.53 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 64.140000000000001 109.598 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.56 ' OE1' ' CE1' ' A' ' 296' ' ' HIS . 0.6 OUTLIER -65.38 179.36 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.135 . . . . 73.209999999999994 110.304 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.475 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 44.3 mt -105.77 -76.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 51.539999999999999 109.329 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 128.0 149.74 7.13 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.469 1.106 . . . . 30.43 111.056 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.494 ' O ' ' CE ' ' A' ' 268' ' ' LYS . 4.2 mt -46.75 -25.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.531 0.783 . . . . 73.150000000000006 109.342 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -115.6 -37.69 3.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 52.439999999999998 109.304 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.475 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -40.9 151.03 0.14 Allowed Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.571 1.169 . . . . 65.349999999999994 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.27 -177.49 3.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.512 0.772 . . . . 72.219999999999999 110.27 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.454 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 35.3 tptt -154.51 143.6 21.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.433 1.083 . . . . 72.120000000000005 109.301 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.54 ' HB2' ' CZ2' ' A' ' 307' ' ' TRP . 10.7 mt-10 -114.83 150.39 35.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 71.120000000000005 110.308 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.924 HD21 ' HG2' ' A' ' 293' ' ' MET . 82.7 mt -141.15 62.58 1.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.113 . . . . 73.530000000000001 109.266 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.54 ' CZ2' ' HB2' ' A' ' 305' ' ' GLU . 0.9 OUTLIER -59.29 134.86 57.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.95 -1.13 . . . . 71.140000000000001 107.95 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.622 ' CE1' HD11 ' A' ' 312' ' ' LEU . 10.2 t80 -137.23 155.14 49.87 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 74.400000000000006 111.019 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.668 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -135.6 147.36 61.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 74.25 111.013 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -53.72 0.15 OUTLIER 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.005 -2.498 . . . . 63.240000000000002 111.007 -0.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 178.44 174.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 71.439999999999998 109.982 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 261' ' ' LEU . 3.7 mp -138.82 158.42 70.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 74.530000000000001 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 145.25 31.06 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.487 1.783 . . . . 52.149999999999999 110.992 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.738 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -123.02 162.54 38.61 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 71.439999999999998 110.404 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -175.45 16.03 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.015 -2.494 . . . . 44.340000000000003 111.023 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.845 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.8 mt -109.8 57.79 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 63.43 109.281 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.3 p -85.38 134.74 34.07 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 70.510000000000005 109.985 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 32.0 t30 83.19 2.63 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 73.430000000000007 109.319 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.845 ' CE2' HD23 ' A' ' 316' ' ' LEU . 9.0 m-85 -81.13 -178.47 6.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 75.420000000000002 111.017 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.536 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -97.57 -58.28 2.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.319999999999993 110.373 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.777 ' SD ' HD13 ' A' ' 316' ' ' LEU . 1.0 OUTLIER 28.59 64.63 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 52.439999999999998 111.032 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.536 ' HG3' HG23 ' A' ' 320' ' ' THR . 40.2 mttm -92.68 -172.57 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 71.420000000000002 109.299 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.764 ' CG2' HD21 ' A' ' 344' ' ' LEU . 41.9 t -141.84 130.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 63.43 109.304 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 278' ' ' THR . 5.6 m -109.52 176.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.081 . . . . 64.329999999999998 109.278 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.453 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 2.6 t30 -101.04 -165.56 1.22 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 62.340000000000003 109.322 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -70.1 -7.93 45.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 54.130000000000003 110.3 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -107.82 13.33 26.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.219999999999999 109.302 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 62.33 27.61 69.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.544 1.152 . . . . 70.219999999999999 110.99 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 331' ' ' ILE . 6.7 pt-20 -102.83 127.19 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.464 0.743 . . . . 71.140000000000001 110.295 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.595 ' N ' HG12 ' A' ' 324' ' ' VAL . 56.0 m -54.07 111.02 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.420000000000002 110.377 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 329' ' ' GLU . 5.1 pt -94.33 -37.91 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.409999999999997 109.279 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.834 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.3 mt -139.36 176.18 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.472 1.107 . . . . 75.209999999999994 109.328 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.441 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -151.05 131.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.515 1.134 . . . . 51.420000000000002 109.323 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -83.76 130.2 9.6 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.504 1.128 . . . . 62.030000000000001 110.977 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.541 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -61.08 -26.59 67.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.566 0.803 . . . . 71.530000000000001 109.297 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 316' ' ' LEU . 0.8 OUTLIER 48.23 76.62 0.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 43.520000000000003 108.305 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.541 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -88.27 -178.75 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 1.164 . . . . 64.530000000000001 109.316 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -75.91 62.44 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 62.119999999999997 109.288 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.7 m -173.59 150.68 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 74.030000000000001 110.024 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -58.9 -17.62 25.91 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 54.049999999999997 109.279 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -77.95 146.43 35.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.125 . . . . 74.219999999999999 110.289 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.61 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 65.9 mt -147.98 141.23 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 44.119999999999997 109.31 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 343' ' ' THR . 8.7 p -138.77 97.81 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 54.229999999999997 110.396 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.5 mp -46.83 133.49 10.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.131 . . . . 63.130000000000003 109.329 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -98.06 -76.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.129999999999995 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.609 ' HA ' HD23 ' A' ' 332' ' ' LEU . 2.9 p 159.84 142.06 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 75.450000000000003 110.011 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -80.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.449 1.763 . . . . 72.519999999999996 110.955 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 53.329999999999998 109.286 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.296 -0.631 . . . . 73.510000000000005 109.296 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 52.96 87.73 0.13 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.142 . . . . 72.450000000000003 109.352 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 170.28 20.76 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.512 1.796 . . . . 71.340000000000003 111.017 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.683 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -172.16 157.72 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.524 1.14 . . . . 73.230000000000004 109.256 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.858 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -114.43 102.21 9.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.502 1.126 . . . . 70.209999999999994 109.287 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.822 ' CD2' HG22 ' A' ' 343' ' ' THR . 65.0 t-80 -90.88 166.17 13.2 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.469 1.105 . . . . 75.319999999999993 109.558 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.762 HG21 HD23 ' A' ' 265' ' ' LEU . 66.7 t -153.48 155.51 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 51.539999999999999 109.324 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -117.62 146.16 43.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.299999999999997 110.308 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.673 HG22 ' CE1' ' A' ' 263' ' ' PHE . 38.6 t -128.83 94.97 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 72.329999999999998 109.344 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.1 m -69.13 -63.34 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 70.439999999999998 110.027 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.751 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.2 t-20 60.82 82.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.528 1.143 . . . . 74.230000000000004 109.307 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.29 166.5 13.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.502 1.126 . . . . 65.349999999999994 110.296 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 259' ' ' ASN . 23.8 t0 -42.69 -58.32 2.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.573 1.171 . . . . 75.030000000000001 109.31 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 258' ' ' ASP . 25.4 m120 -40.06 -61.94 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 71.219999999999999 109.295 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 176.27 -173.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 74.230000000000004 109.992 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 256' ' ' ASN . 19.6 mt -80.98 161.2 24.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 72.200000000000003 109.263 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.68 95.74 2.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 63.509999999999998 109.604 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.673 ' CE1' HG22 ' A' ' 254' ' ' VAL . 75.0 m-85 -103.6 112.02 24.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 75.299999999999997 110.965 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.78 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 73.8 mt -111.03 117.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 55.219999999999999 109.325 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.762 HD23 HG21 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -106.01 151.72 24.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 70.239999999999995 109.342 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.78 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -138.11 117.58 12.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.484 1.115 . . . . 74.150000000000006 110.98 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.645 ' ND2' HD11 ' A' ' 273' ' ' ILE . 17.1 t-20 -79.74 106.52 11.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 62.100000000000001 109.305 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -11.84 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 60.539999999999999 109.276 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.415 ' H ' HG23 ' A' ' 269' ' ' THR . 22.6 p -66.34 154.75 39.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.503 1.127 . . . . 73.219999999999999 110.368 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -67.55 -40.78 84.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.493 1.121 . . . . 75.310000000000002 109.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 9.1 pt -54.37 167.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.14 . . . . 71.420000000000002 109.299 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 272' ' ' ILE . 4.7 mp -121.54 157.74 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 73.319999999999993 109.275 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.701 HD13 ' N ' ' A' ' 273' ' ' ILE . 1.2 mm -82.42 141.21 45.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.508 1.13 . . . . 73.239999999999995 109.29 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.614 ' HD2' HG22 ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.01 -14.88 20.99 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.496 1.787 . . . . 53.119999999999997 111.0 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 84.62 151.21 13.09 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.52 1.137 . . . . 71.25 111.039 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.8 t30 70.27 50.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 0.767 . . . . 73.540000000000006 109.32 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.97 -179.72 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.52 1.137 . . . . 61.340000000000003 108.3 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.712 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.6 m -153.94 137.17 15.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.091 . . . . 72.310000000000002 110.347 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.69 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -85.85 176.98 7.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 71.400000000000006 110.978 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.6 ' CG ' HG21 ' A' ' 288' ' ' VAL . 55.4 tt0 -152.7 65.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 75.450000000000003 110.246 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 289' ' ' PHE . 9.9 p90 -96.14 130.47 43.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 75.230000000000004 110.957 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 17.9 p -121.79 -178.44 3.83 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 73.400000000000006 110.003 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.599 ' CB ' HD23 ' A' ' 312' ' ' LEU . 3.5 p -119.31 -5.71 10.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 51.020000000000003 109.991 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.689 ' OE1' HG23 ' A' ' 285' ' ' ILE . 8.3 tp-100 -177.95 166.78 2.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.098 . . . . 73.430000000000007 110.279 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.689 HG23 ' OE1' ' A' ' 284' ' ' GLN . 7.9 pt -41.75 -28.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 72.540000000000006 109.342 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 284' ' ' GLN . 9.1 t -52.7 -173.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.14 . . . . 71.340000000000003 109.977 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -46.5 172.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 70.310000000000002 110.281 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.6 HG21 ' CG ' ' A' ' 280' ' ' GLU . 7.4 p -131.54 168.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 71.530000000000001 109.236 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.548 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.8 t80 -115.8 133.38 56.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 64.010000000000005 110.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.0 p -112.48 120.67 42.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.564 1.165 . . . . 63.32 109.988 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 12.5 mt -105.8 127.73 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 72.319999999999993 109.356 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -67.02 116.7 8.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 64.209999999999994 109.287 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.595 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.6 mtp -85.11 150.3 24.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.430000000000007 111.002 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -45.65 150.71 1.25 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 23.449999999999999 110.983 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -28.01 9.46 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.531 1.806 . . . . 74.209999999999994 110.954 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -65.1 143.3 57.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.083 . . . . 73.549999999999997 109.576 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.68 138.06 31.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 110.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.435 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -65.28 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.129999999999995 109.307 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.84 -155.35 18.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.518 1.136 . . . . 75.430000000000007 111.016 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.928 HG22 ' HD3' ' A' ' 301' ' ' LYS . 0.9 OUTLIER -86.93 133.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 0.79 . . . . 71.420000000000002 109.313 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.928 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.3 OUTLIER 68.79 6.51 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 71.129999999999995 109.314 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.435 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -85.68 162.61 36.16 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.511 1.132 . . . . 64.319999999999993 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 298' ' ' ILE . 4.5 pt20 -131.47 174.82 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 0.767 . . . . 75.010000000000005 110.283 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 38.5 tptt -149.46 152.11 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.230000000000004 109.328 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.59 141.22 45.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.493 1.12 . . . . 62.530000000000001 110.307 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.724 HD12 HD11 ' A' ' 265' ' ' LEU . 12.3 mt -145.53 61.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 1.118 . . . . 74.420000000000002 109.32 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -79.27 121.61 25.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 73.400000000000006 107.98 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.8 m-30 -109.29 -174.13 2.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 64.030000000000001 111.043 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.9 OUTLIER -164.91 160.19 14.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 74.109999999999999 110.998 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.02 -36.29 2.64 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.005 -2.498 . . . . 71.439999999999998 111.022 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 2.9 p 169.74 131.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.107 . . . . 73.200000000000003 110.012 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.599 HD23 ' CB ' ' A' ' 283' ' ' SER . 5.7 mp -111.59 158.94 34.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.15 . . . . 75.530000000000001 109.339 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 147.36 33.66 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.463 1.77 . . . . 74.319999999999993 110.973 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.604 HG21 HG12 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -123.91 164.43 29.3 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 61.109999999999999 110.4 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 -174.66 14.53 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.022 -2.491 . . . . 73.430000000000007 110.989 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.625 HD22 ' CE2' ' A' ' 319' ' ' TYR . 3.4 mt -102.36 60.12 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.409999999999997 109.294 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -82.91 131.81 35.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 73.299999999999997 110.047 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.4 t-20 76.66 21.97 1.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 72.340000000000003 109.322 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.625 ' CE2' HD22 ' A' ' 316' ' ' LEU . 4.0 m-85 -99.13 -170.06 1.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.219999999999999 111.001 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 322' ' ' LYS . 28.2 m -107.81 -64.92 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.513 1.133 . . . . 75.200000000000003 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.833 ' HE3' ' CD1' ' A' ' 342' ' ' ILE . 2.8 mtm 34.09 35.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 72.310000000000002 110.998 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.653 ' HG3' HG22 ' A' ' 320' ' ' THR . 27.9 mttm -75.98 169.82 17.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 62.299999999999997 109.284 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.591 HG23 HD21 ' A' ' 344' ' ' LEU . 74.8 t -119.1 133.71 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 72.450000000000003 109.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 278' ' ' THR . 8.9 m -118.23 172.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 63.149999999999999 109.284 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.407 ' ND2' ' H ' ' A' ' 326' ' ' GLN . 2.8 t30 -96.06 -166.48 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 74.510000000000005 109.337 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.407 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 3.3 pt20 -71.13 -5.72 33.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 65.420000000000002 110.338 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.46 12.09 26.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 1.137 . . . . 64.510000000000005 109.303 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.24 8.39 50.12 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.498 1.124 . . . . 43.229999999999997 111.047 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 6.5 pt-20 -78.9 129.95 35.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.757 . . . . 73.200000000000003 110.281 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.626 ' HA ' HG12 ' A' ' 324' ' ' VAL . 4.1 m -62.97 108.08 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.030000000000001 110.38 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 323' ' ' VAL . 2.7 pt -90.94 -43.68 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.511 1.132 . . . . 74.219999999999999 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.6 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.4 mt -136.1 168.45 19.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 71.439999999999998 109.292 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.483 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.2 m -151.75 131.71 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 71.549999999999997 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -85.34 121.04 5.5 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 71.209999999999994 111.008 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.695 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.32 -26.93 0.37 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 0.753 . . . . 74.409999999999997 109.263 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.419 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.5 OUTLIER 45.68 71.72 0.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 75.319999999999993 108.296 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.695 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -84.77 -176.79 6.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 73.530000000000001 109.294 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.79 64.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.450000000000003 109.327 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.8 t -178.95 148.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.967 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -57.65 -17.93 17.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 73.209999999999994 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.623 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 14.4 mt-10 -71.93 131.96 43.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.107 . . . . 74.540000000000006 110.271 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.833 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 45.4 mt -142.88 118.05 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.506 1.128 . . . . 71.049999999999997 109.286 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.822 HG22 ' CD2' ' A' ' 251' ' ' HIS . 18.5 p -117.57 87.28 2.68 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 62.450000000000003 110.39 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.858 HD22 ' CD2' ' A' ' 250' ' ' LEU . 8.5 mp -40.01 132.1 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 72.340000000000003 109.295 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.0 ptpt -117.72 -58.77 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.557 1.161 . . . . 71.439999999999998 109.265 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.536 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 158.98 158.19 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.32 110.007 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 -67.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.461 1.769 . . . . 74.329999999999998 110.969 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.559 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 72.219999999999999 109.323 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.308 -0.627 . . . . 75.109999999999999 109.308 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.93 101.37 0.57 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 54.240000000000002 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.552 ' HA ' ' CB ' ' A' ' 269' ' ' THR . 18.2 Cg_endo -74.97 -0.8 10.4 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.476 1.777 . . . . 72.430000000000007 110.993 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 1.001 HD23 ' O ' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -60.58 151.88 27.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.451 1.094 . . . . 75.120000000000005 109.317 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -111.32 98.7 7.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.135 . . . . 71.299999999999997 109.293 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.607 ' CE1' ' HG2' ' A' ' 341' ' ' GLU . 4.3 t60 -96.33 130.38 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 73.319999999999993 109.624 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.661 HG21 HD23 ' A' ' 265' ' ' LEU . 16.5 t -120.5 171.35 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 74.239999999999995 109.271 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.52 ' N ' HG12 ' A' ' 252' ' ' VAL . 1.9 tp10 -133.96 128.55 34.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 70.140000000000001 110.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.597 ' CG1' HG21 ' A' ' 314' ' ' THR . 4.5 t -105.72 112.56 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 51.439999999999998 109.318 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 51.43 109.994 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.914 ' HA ' HD23 ' A' ' 261' ' ' LEU . 15.3 t30 60.48 67.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.528 1.143 . . . . 63.32 109.299 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.48 163.81 12.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 71.140000000000001 110.29 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.37 -44.74 68.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 71.129999999999995 109.303 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -55.11 -61.15 2.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 74.239999999999995 109.289 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 29.3 m -174.21 -176.7 1.17 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.437 1.086 . . . . 63.219999999999999 110.022 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.914 HD23 ' HA ' ' A' ' 256' ' ' ASN . 39.8 mt -77.5 171.05 15.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.12 . . . . 73.409999999999997 109.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -160.49 103.76 1.4 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 61.130000000000003 109.588 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.657 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 68.8 m-85 -109.3 90.51 3.32 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 74.530000000000001 111.008 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.78 HG22 ' CE2' ' A' ' 266' ' ' TYR . 54.3 mt -90.23 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 52.530000000000001 109.314 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.661 HD23 HG21 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -91.51 137.04 32.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.129999999999995 109.323 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.78 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.8 m-85 -120.65 110.41 16.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 64.209999999999994 111.014 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.417 ' ND2' HD13 ' A' ' 273' ' ' ILE . 12.3 t30 -68.38 96.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 53.530000000000001 109.319 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -101.09 28.3 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.219999999999999 109.29 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.552 ' CB ' ' HA ' ' A' ' 248' ' ' PRO . 4.5 p -102.9 143.48 32.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 64.340000000000003 110.419 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -44.29 -58.06 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.438 1.086 . . . . 71.120000000000005 109.306 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.7 pt -54.61 172.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 72.329999999999998 109.345 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.14 123.16 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.443 1.09 . . . . 72.219999999999999 109.306 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.417 HD13 ' ND2' ' A' ' 267' ' ' ASN . 1.7 mp -40.4 137.55 1.29 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 60.210000000000001 109.311 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.4 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.98 -24.18 13.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.502 1.791 . . . . 70.230000000000004 111.007 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 89.37 162.81 38.79 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.501 1.126 . . . . 33.310000000000002 111.001 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.6 t30 69.26 34.24 3.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.754 . . . . 61.210000000000001 109.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 52.3 m -83.39 -179.22 7.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 71.439999999999998 108.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.809 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.0 m -151.85 132.58 14.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 74.319999999999993 110.41 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.647 ' CE1' HG22 ' A' ' 323' ' ' VAL . 0.9 OUTLIER -90.19 -178.63 5.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.429 1.08 . . . . 63.210000000000001 111.007 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.589 ' HG3' HG21 ' A' ' 288' ' ' VAL . 1.9 tt0 -171.68 89.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.135 . . . . 72.430000000000007 110.329 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.763 ' HE1' HD12 ' A' ' 291' ' ' ILE . 22.7 p90 -116.89 128.58 55.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 74.209999999999994 111.046 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 36.7 p -95.54 165.24 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.137 . . . . 72.430000000000007 109.976 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.572 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.5 p -127.38 3.27 6.29 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.446 1.091 . . . . 74.129999999999995 110.021 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -178.55 177.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 74.319999999999993 110.303 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.629 ' C ' HD12 ' A' ' 285' ' ' ILE . 1.1 pp -56.59 -20.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 74.230000000000004 109.285 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 10.9 m -55.61 -167.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 1.116 . . . . 75.140000000000001 109.965 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -75.4 -173.82 2.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.497 1.123 . . . . 60.210000000000001 110.3 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.589 HG21 ' HG3' ' A' ' 280' ' ' GLU . 13.9 p -136.22 170.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 71.420000000000002 109.319 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.521 ' N ' HG22 ' A' ' 288' ' ' VAL . 3.1 t80 -134.89 145.46 48.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 54.43 111.016 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.543 ' HB2' HG22 ' A' ' 278' ' ' THR . 60.2 p -104.3 129.76 52.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 110.011 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.763 HD12 ' HE1' ' A' ' 281' ' ' PHE . 2.0 mt -95.96 127.31 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 65.129999999999995 109.31 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.18 107.62 3.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.49 1.118 . . . . 71.239999999999995 109.257 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.486 ' HG2' HD21 ' A' ' 306' ' ' LEU . 85.5 mtp -78.11 158.61 29.06 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.577 1.173 . . . . 73.340000000000003 111.04 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -64.06 147.11 50.73 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.481 1.113 . . . . 74.400000000000006 111.025 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -29.66 7.97 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 72.510000000000005 110.952 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -54.12 152.58 5.87 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 65.129999999999995 109.594 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -85.35 154.31 21.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 71.120000000000005 110.299 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 86.4 mt -92.56 -79.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.122 . . . . 75.0 109.293 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.24 -177.1 21.42 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.547 1.154 . . . . 52.340000000000003 111.004 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.537 HG22 ' HD3' ' A' ' 301' ' ' LYS . 8.9 mt -53.66 -86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.503 0.767 . . . . 74.010000000000005 109.268 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.537 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.5 OUTLIER -61.82 -23.8 66.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.147 . . . . 73.409999999999997 109.293 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -50.65 135.03 29.76 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.498 1.124 . . . . 61.210000000000001 111.023 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.54 176.81 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 0.766 . . . . 74.450000000000003 110.273 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.506 ' O ' HD12 ' A' ' 265' ' ' LEU . 18.8 tptt -152.0 144.26 23.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 60.219999999999999 109.339 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -102.72 163.71 12.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 64.409999999999997 110.298 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 8.2 mt -161.27 73.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 74.319999999999993 109.277 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.25 127.38 32.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 74.340000000000003 107.988 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.741 ' CG ' ' CZ ' ' A' ' 281' ' ' PHE . 16.5 m-30 -114.15 38.49 3.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.113 . . . . 74.510000000000005 110.971 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.522 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 6.6 p90 -37.63 157.34 0.09 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 74.319999999999993 110.979 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -36.94 2.43 Favored 'Cis proline' 0 C--N 1.36 1.177 0 C-N-CA 120.99 -2.504 . . . . 50.009999999999998 111.052 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 37.0 p 176.13 144.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 65.129999999999995 109.987 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.805 ' HB2' HD11 ' A' ' 261' ' ' LEU . 3.7 mp -129.18 159.39 69.24 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 55.0 109.312 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 144.09 29.84 Favored 'Trans proline' 0 C--N 1.359 1.132 0 O-C-N 124.48 1.779 . . . . 74.409999999999997 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.597 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.6 OUTLIER -127.16 162.58 47.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 73.519999999999996 110.378 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.1 Cg_endo -74.98 177.98 36.66 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.009 -2.496 . . . . 54.329999999999998 110.977 -0.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.767 HD12 ' HE2' ' A' ' 321' ' ' MET . 3.8 mt -92.85 64.4 4.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 75.200000000000003 109.276 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.7 t -83.97 135.77 34.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 71.340000000000003 109.963 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.12 10.86 6.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 71.439999999999998 109.303 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 282' ' ' SER . 4.8 m-30 -96.29 124.96 40.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 61.130000000000003 111.0 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -40.0 -61.48 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 72.140000000000001 110.384 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.767 ' HE2' HD12 ' A' ' 316' ' ' LEU . 3.9 ttm 31.19 68.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.459 1.099 . . . . 72.409999999999997 110.973 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.548 ' HG3' HG23 ' A' ' 320' ' ' THR . 80.8 mttt -103.78 -171.29 1.91 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.094 . . . . 61.420000000000002 109.316 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.647 HG22 ' CE1' ' A' ' 279' ' ' PHE . 19.2 t -141.53 123.47 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 54.340000000000003 109.332 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 278' ' ' THR . 22.6 m -110.84 -172.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.464 1.103 . . . . 75.310000000000002 109.315 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.831 ' ND2' HG23 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -126.55 -171.92 2.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 74.0 109.268 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.51 -6.99 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 74.219999999999999 110.328 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -89.02 -14.82 35.58 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 64.219999999999999 109.292 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.61 1.66 89.07 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.484 1.115 . . . . 65.099999999999994 111.028 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.457 ' O ' ' ND2' ' A' ' 325' ' ' ASN . 14.0 pt-20 -94.54 153.22 18.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 0.79 . . . . 71.230000000000004 110.312 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.637 ' CA ' HG12 ' A' ' 324' ' ' VAL . 1.3 m -83.47 128.89 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 71.299999999999997 110.397 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.831 HG23 ' ND2' ' A' ' 325' ' ' ASN . 33.6 pt -103.64 -37.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.114 . . . . 74.030000000000001 109.28 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.854 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.3 mt -134.14 168.77 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 72.420000000000002 109.291 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.476 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -152.79 122.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 62.310000000000002 109.336 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -77.53 119.53 5.32 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 44.149999999999999 110.987 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.771 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.27 -27.0 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 0.783 . . . . 75.099999999999994 109.271 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 49.14 76.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 65.019999999999996 108.289 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.771 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -88.2 -178.68 5.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 60.530000000000001 109.276 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -76.04 61.15 1.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.477 1.111 . . . . 64.010000000000005 109.295 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 341' ' ' GLU . 4.2 m 179.43 141.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 61.520000000000003 110.019 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 13.9 m-20 -46.65 -26.13 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.151 . . . . 65.129999999999995 109.294 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 3.2 mt-10 -63.04 125.29 23.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 64.209999999999994 110.345 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.71 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 66.4 mt -141.65 123.38 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 54.219999999999999 109.345 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.42 HG22 ' ND1' ' A' ' 251' ' ' HIS . 15.2 p -126.25 87.84 2.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.132 . . . . 51.210000000000001 110.417 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.854 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.3 mp -40.77 138.93 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.526 1.141 . . . . 74.129999999999995 109.299 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -112.57 -64.58 1.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 75.549999999999997 109.268 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 159.7 145.91 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 72.329999999999998 110.011 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -81.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.474 1.776 . . . . 53.409999999999997 111.049 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.738 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 73.510000000000005 109.261 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.315 -0.624 . . . . 64.439999999999998 109.315 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.45 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 2.8 m-20 -79.73 153.08 75.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.12 . . . . 72.219999999999999 109.3 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -0.49 10.03 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.469 1.773 . . . . 73.209999999999994 110.999 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -39.88 141.8 0.4 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.145 . . . . 73.310000000000002 109.291 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.445 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -128.51 103.34 7.06 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 70.230000000000004 109.304 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -66.56 139.68 57.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 64.310000000000002 109.605 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 253' ' ' GLU . 60.2 t -144.33 167.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 72.140000000000001 109.303 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.535 ' N ' HG12 ' A' ' 252' ' ' VAL . 53.6 tt0 -122.93 154.49 38.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 74.409999999999997 110.281 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.773 ' CG1' HG21 ' A' ' 314' ' ' THR . 82.4 t -135.75 95.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.142 . . . . 65.109999999999999 109.307 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 2.5 t -69.1 -67.4 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 30.420000000000002 109.963 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.856 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.0 t-20 60.91 64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 71.25 109.291 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -91.45 145.56 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 75.209999999999994 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.26 -34.16 4.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.517 1.136 . . . . 62.130000000000003 109.348 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -65.89 -52.03 53.6 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 74.409999999999997 109.261 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.9 m -171.14 -175.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 53.340000000000003 110.063 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -88.12 176.38 7.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.446 1.091 . . . . 65.109999999999999 109.324 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' HIS . . . . . 0.55 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 4.3 t-160 -176.2 103.51 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.329999999999998 109.618 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 254' ' ' VAL . 93.8 m-85 -112.54 127.02 55.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 54.100000000000001 111.023 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.766 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 76.5 mt -119.42 116.83 52.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 62.450000000000003 109.272 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.675 HD11 HD12 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -103.25 130.01 50.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 64.450000000000003 109.319 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.766 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.3 m-85 -119.66 109.17 15.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.030000000000001 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.783 ' HB3' HG22 ' A' ' 298' ' ' ILE . 14.5 t30 -69.81 75.51 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 70.040000000000006 109.301 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.97 52.85 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 72.430000000000007 109.322 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.5 p -127.58 -178.08 4.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 74.439999999999998 110.419 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.32 18.19 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 74.019999999999996 109.33 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.59 169.22 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 71.019999999999996 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.3 mt -121.11 137.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.512 1.132 . . . . 73.099999999999994 109.358 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.75 137.49 58.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.271 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -26.25 11.09 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.519 1.799 . . . . 61.329999999999998 111.007 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.433 ' C ' ' N ' ' A' ' 277' ' ' CYS . . . 83.94 -157.38 33.79 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.527 1.142 . . . . 45.439999999999998 111.034 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 275' ' ' GLY . 0.2 OUTLIER 39.89 30.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.463 0.743 . . . . 64.329999999999998 109.269 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.433 ' N ' ' C ' ' A' ' 275' ' ' GLY . 18.0 m -87.04 -173.41 4.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.538 1.149 . . . . 74.5 108.304 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.805 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.5 m -152.93 126.37 8.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 53.530000000000001 110.356 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.627 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.7 t80 -79.99 172.66 13.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 75.219999999999999 110.984 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.505 ' HG3' HG21 ' A' ' 288' ' ' VAL . 2.3 tt0 -167.08 91.05 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.115 . . . . 61.350000000000001 110.312 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 32.8 p90 -111.7 120.98 43.85 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.476 1.11 . . . . 65.150000000000006 110.983 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.604 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 81.8 p -109.93 161.56 15.36 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 54.450000000000003 110.017 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.576 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 33.3 t -131.75 -63.52 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 53.310000000000002 109.986 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.83 171.34 7.58 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.57 1.169 . . . . 64.310000000000002 110.298 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 9.6 pt -72.76 -6.86 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 62.439999999999998 109.296 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.3 m -49.43 -71.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 65.150000000000006 110.005 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.27 176.32 3.94 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 73.319999999999993 110.302 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 280' ' ' GLU . 8.8 p -123.98 168.26 16.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.535 1.147 . . . . 42.43 109.268 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 288' ' ' VAL . 8.3 t80 -137.49 146.57 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 73.209999999999994 111.011 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 95.0 p -117.74 123.46 46.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 70.430000000000007 109.996 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.9 mt -101.77 126.94 55.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 72.319999999999993 109.259 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.429 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.1 OUTLIER -66.92 122.69 18.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 74.310000000000002 109.321 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 97.2 mtp -84.45 148.94 26.3 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.096 . . . . 62.219999999999999 111.015 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.708 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -52.62 156.23 4.69 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 63.020000000000003 111.02 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -26.64 10.86 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.492 1.785 . . . . 63.130000000000003 110.985 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.562 ' CE1' ' HD3' ' A' ' 304' ' ' LYS . 28.4 p80 -52.82 -176.28 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 75.319999999999993 109.596 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.63 175.71 7.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 1.13 . . . . 73.310000000000002 110.289 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.783 HG22 ' HB3' ' A' ' 267' ' ' ASN . 3.9 mp -134.74 61.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.12 . . . . 75.019999999999996 109.321 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.71 -122.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.487 1.117 . . . . 62.420000000000002 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.444 HG22 ' HG2' ' A' ' 301' ' ' LYS . 2.2 mt -98.73 138.11 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.513 0.772 . . . . 70.340000000000003 109.3 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.444 ' HG2' HG22 ' A' ' 300' ' ' ILE . 1.1 mmmm 67.07 9.23 6.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 109.331 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.599 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -103.28 146.5 16.53 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.473 1.108 . . . . 72.319999999999993 110.986 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.02 -177.58 4.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 0.779 . . . . 62.140000000000001 110.302 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.708 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 57.0 tptt -149.38 150.11 31.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 72.140000000000001 109.28 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 10.3 mt-10 -110.36 160.07 16.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 70.040000000000006 110.307 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.675 HD12 HD11 ' A' ' 265' ' ' LEU . 13.6 mt -155.97 70.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 70.209999999999994 109.287 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.55 ' CD1' ' NE2' ' A' ' 262' ' ' HIS . 0.1 OUTLIER -74.97 129.29 37.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 72.439999999999998 108.02 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 12.8 m-30 -117.75 -172.02 2.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.45 1.094 . . . . 65.519999999999996 110.998 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.509 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.8 p90 -169.75 159.43 6.94 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.439999999999998 110.955 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.03 -36.17 2.68 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.046 -2.481 . . . . 73.349999999999994 110.994 0.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.2 p 170.25 131.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.538 1.149 . . . . 44.539999999999999 110.016 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.4 mp -114.79 158.81 39.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.319999999999993 109.355 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 145.73 31.95 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.491 1.785 . . . . 73.519999999999996 110.971 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.773 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.2 OUTLIER -127.12 164.49 35.1 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 75.209999999999994 110.404 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.02 176.51 43.14 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.013 -2.495 . . . . 60.140000000000001 110.991 0.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.713 HD12 ' CE ' ' A' ' 321' ' ' MET . 4.9 mt -92.16 66.41 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.549 1.156 . . . . 73.450000000000003 109.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 2.4 p -81.27 128.15 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 61.32 110.006 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.93 21.31 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 73.349999999999994 109.27 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.604 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.5 m-30 -103.7 134.13 47.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 74.430000000000007 110.982 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 322' ' ' LYS . 60.4 m -45.91 -67.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 73.439999999999998 110.389 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.713 ' CE ' HD12 ' A' ' 316' ' ' LEU . 4.3 ttm 33.53 56.92 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.409999999999997 111.016 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.746 ' HZ2' ' HB ' ' A' ' 333' ' ' VAL . 28.1 mttm -95.14 -166.38 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.129999999999995 109.303 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.528 ' CG2' HD21 ' A' ' 344' ' ' LEU . 12.7 t -145.02 126.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 51.119999999999997 109.304 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 278' ' ' THR . 11.8 m -109.69 -172.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 75.049999999999997 109.252 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 331' ' ' ILE . 39.2 p30 -120.25 -170.85 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 64.510000000000005 109.304 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.42 -8.23 17.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 64.109999999999999 110.299 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 -8.76 35.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 75.120000000000005 109.278 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.59 -4.5 78.25 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.115 . . . . 63.229999999999997 111.026 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -80.84 140.48 35.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.484 0.755 . . . . 75.219999999999999 110.27 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.712 ' HA ' HG12 ' A' ' 324' ' ' VAL . 7.7 m -66.53 122.89 18.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 61.439999999999998 110.388 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.404 HG21 ' HB3' ' A' ' 325' ' ' ASN . 1.8 pt -97.46 -41.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 64.209999999999994 109.263 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.879 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.1 mt -141.59 170.9 14.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 71.400000000000006 109.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.746 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.46 128.54 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 73.510000000000005 109.304 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -89.08 113.87 4.19 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.451 1.095 . . . . 74.040000000000006 110.977 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -26.79 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 0.788 . . . . 74.329999999999998 109.294 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 342' ' ' ILE . 0.1 OUTLIER 42.12 67.81 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 74.209999999999994 108.263 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -71.89 -172.93 0.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 70.209999999999994 109.314 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.29 57.95 2.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 74.340000000000003 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 50.4 m -168.28 141.87 3.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 53.030000000000001 110.009 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -45.56 -31.73 1.96 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 73.019999999999996 109.271 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -63.85 147.54 51.59 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 75.109999999999999 110.315 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.495 HD13 ' SG ' ' A' ' 336' ' ' CYS . 16.9 mt -150.05 141.26 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 73.099999999999994 109.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 62.6 p -140.89 107.53 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 53.509999999999998 110.397 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.6 mp -61.25 134.51 57.06 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 63.530000000000001 109.253 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 2.0 mtpt -104.55 -76.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 64.510000000000005 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.724 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 159.78 143.84 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.538 1.149 . . . . 73.120000000000005 110.025 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.493 1.786 . . . . 72.25 111.006 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.325 -0.46 0 O-C-N 124.465 1.103 . . . . 71.349999999999994 109.332 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 31.8 m120 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.299 -0.63 . . . . 64.409999999999997 109.299 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -159.48 77.26 2.96 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.548 1.155 . . . . 75.129999999999995 109.34 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 171.96 17.3 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.503 1.791 . . . . 73.209999999999994 110.954 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.84 HD22 ' HB ' ' A' ' 343' ' ' THR . 0.0 OUTLIER -168.66 -177.9 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 63.340000000000003 109.331 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.837 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -97.6 101.5 13.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 65.439999999999998 109.311 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.15 143.96 27.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.435 1.084 . . . . 70.409999999999997 109.602 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.911 HG21 HD23 ' A' ' 265' ' ' LEU . 84.3 t -126.26 144.47 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.516 1.135 . . . . 71.450000000000003 109.314 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -119.39 121.58 39.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 62.229999999999997 110.283 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.38 107.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 65.030000000000001 109.263 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 72.6 m -68.43 -57.6 5.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 63.520000000000003 110.033 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.693 ' HA ' HD23 ' A' ' 261' ' ' LEU . 6.4 t-20 55.43 69.62 0.72 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.522 1.139 . . . . 74.439999999999998 109.311 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -114.63 161.73 17.7 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 75.530000000000001 110.3 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -42.21 -53.62 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 73.230000000000004 109.289 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -43.57 -64.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 75.319999999999993 109.284 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.8 m -179.61 -174.8 0.31 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 74.140000000000001 109.981 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.717 HD13 ' HZ ' ' A' ' 263' ' ' PHE . 14.7 mt -78.14 169.29 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.487 1.117 . . . . 73.409999999999997 109.314 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -165.1 112.39 0.99 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.049999999999997 109.61 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.717 ' HZ ' HD13 ' A' ' 261' ' ' LEU . 6.4 m-85 -116.18 106.51 13.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 75.420000000000002 110.987 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.662 HG22 ' CE2' ' A' ' 266' ' ' TYR . 16.6 mt -99.55 103.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 73.530000000000001 109.331 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.911 HD23 HG21 ' A' ' 252' ' ' VAL . 0.2 OUTLIER -105.01 126.42 52.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 71.439999999999998 109.283 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.662 ' CE2' HG22 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -113.2 119.21 36.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 71.010000000000005 111.018 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 250' ' ' LEU . 25.4 t30 -80.71 95.52 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 61.420000000000002 109.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -88.68 -54.55 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.424 1.078 . . . . 72.310000000000002 109.294 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 1.7 t -100.48 173.83 6.38 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.08 . . . . 64.310000000000002 110.39 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 269' ' ' THR . 2.5 t-20 81.93 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 72.319999999999993 109.295 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.444 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 0.0 OUTLIER -81.62 -174.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 75.319999999999993 109.318 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.413 ' N ' HG12 ' A' ' 271' ' ' ILE . 21.9 mt -92.75 126.76 45.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.010000000000005 109.349 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 1.4 mp -43.78 137.65 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.542 1.151 . . . . 75.200000000000003 109.309 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.97 -31.07 6.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.487 1.783 . . . . 74.409999999999997 111.0 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 102.14 154.2 25.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.48 1.112 . . . . 74.040000000000006 110.991 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 5.2 t30 74.49 32.63 0.91 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.466 0.745 . . . . 71.219999999999999 109.268 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 16.3 m -78.91 -176.66 5.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.159 . . . . 74.400000000000006 108.322 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.589 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -154.53 139.96 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 71.109999999999999 110.404 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 1.007 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.8 t80 -88.93 -177.26 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 73.239999999999995 110.991 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.646 ' HG2' HG21 ' A' ' 288' ' ' VAL . 22.2 tt0 -177.35 100.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.135 . . . . 60.020000000000003 110.281 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 2.7 p90 -123.62 146.59 48.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 71.430000000000007 110.988 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.599 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 92.0 p -77.99 162.25 26.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 74.319999999999993 110.033 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.522 ' HB2' HD21 ' A' ' 312' ' ' LEU . 72.3 p -148.87 -58.31 0.22 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.521 1.138 . . . . 54.0 110.046 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.428 ' C ' ' N ' ' A' ' 286' ' ' SER . 5.3 tp60 -142.62 169.08 18.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 42.520000000000003 110.31 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 286' ' ' SER . 3.0 tt -42.68 -28.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 72.209999999999994 109.328 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.428 ' N ' ' C ' ' A' ' 284' ' ' GLN . 1.7 m -50.65 -178.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.09 . . . . 65.319999999999993 109.954 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.61 134.36 37.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.540000000000006 110.268 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.646 HG21 ' HG2' ' A' ' 280' ' ' GLU . 14.5 p -48.48 169.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.143 . . . . 62.420000000000002 109.325 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.518 ' N ' HG22 ' A' ' 288' ' ' VAL . 10.0 t80 -116.4 -175.96 2.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 72.519999999999996 110.961 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.49 ' OG ' HG22 ' A' ' 278' ' ' THR . 3.6 t -163.49 123.58 2.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 41.229999999999997 109.967 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.875 HD11 ' CD1' ' A' ' 308' ' ' PHE . 10.9 mt -98.77 136.05 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.209999999999994 109.297 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 106.98 12.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 73.040000000000006 109.291 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.716 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.2 mtp -80.74 153.25 27.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 74.010000000000005 110.997 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.72 153.08 8.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.484 1.115 . . . . 72.230000000000004 110.999 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -18.84 18.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.438 1.757 . . . . 74.319999999999993 111.035 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -72.49 161.48 30.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 51.210000000000001 109.601 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 36.6 mt-10 -88.15 175.47 7.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.340000000000003 110.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 299' ' ' GLY . 8.3 mt -98.3 -74.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.479 1.112 . . . . 73.340000000000003 109.258 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.524 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 121.0 159.76 10.85 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.119 . . . . 70.120000000000005 110.992 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.46 HG22 ' HD2' ' A' ' 301' ' ' LYS . 21.6 mt -58.61 -29.49 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 73.200000000000003 109.3 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.46 ' HD2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -109.63 -34.95 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 70.239999999999995 109.255 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -46.81 168.79 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.496 1.123 . . . . 71.530000000000001 111.007 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -133.17 -178.44 4.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 62.310000000000002 110.299 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 38.1 tptt -137.5 156.74 47.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 63.119999999999997 109.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -133.57 100.83 4.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 62.299999999999997 110.304 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 1.007 HD13 ' CG ' ' A' ' 279' ' ' PHE . 20.6 mt -97.74 30.74 2.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 65.349999999999994 109.3 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -43.09 126.88 4.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.340000000000003 107.989 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.875 ' CD1' HD11 ' A' ' 291' ' ' ILE . 53.8 t80 -127.35 172.92 10.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 74.420000000000002 110.98 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -146.3 162.08 36.22 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 74.219999999999999 110.97 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.04 -53.8 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.001 -2.499 . . . . 63.219999999999999 111.006 0.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 14.5 p -175.29 146.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.102 . . . . 73.519999999999996 110.049 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.617 ' HB2' HD11 ' A' ' 261' ' ' LEU . 2.8 mp -123.63 159.19 56.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 73.150000000000006 109.299 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 145.84 31.73 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.533 1.807 . . . . 73.409999999999997 111.0 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -126.55 164.03 36.94 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 63.240000000000002 110.381 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.506 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 178.48 34.5 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.021 -2.491 . . . . 73.5 110.988 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.792 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.5 mt -104.91 61.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.543 1.152 . . . . 72.409999999999997 109.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.4 OUTLIER -86.52 138.08 32.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 62.5 110.034 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 82.89 -1.56 1.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 73.109999999999999 109.298 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.792 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.5 m-85 -80.15 -172.87 3.67 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.105 . . . . 73.109999999999999 110.998 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.532 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -106.37 -58.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 74.519999999999996 110.36 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.746 ' SD ' HD13 ' A' ' 316' ' ' LEU . 0.8 OUTLIER 29.84 61.06 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 74.430000000000007 110.984 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' A' ' 320' ' ' THR . 25.1 mttm -90.03 -172.46 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 42.119999999999997 109.284 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 90.6 t -141.46 125.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 75.019999999999996 109.273 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.677 HG12 ' N ' ' A' ' 330' ' ' THR . 7.0 m -109.38 172.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 74.040000000000006 109.274 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.469 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 12.6 t30 -101.53 -164.29 1.09 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 74.019999999999996 109.313 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -69.1 -7.49 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 65.439999999999998 110.287 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.03 11.73 25.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.109999999999999 109.28 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.12 67.78 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.541 1.15 . . . . 75.299999999999997 110.994 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 331' ' ' ILE . 8.9 pt-20 -96.43 119.34 34.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 0.748 . . . . 65.530000000000001 110.295 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.677 ' N ' HG12 ' A' ' 324' ' ' VAL . 3.8 m -52.68 98.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 42.299999999999997 110.379 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.469 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 14.0 pt -77.51 -39.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.495 1.122 . . . . 73.420000000000002 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 344' ' ' LEU . 11.6 mt -138.76 174.26 10.72 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.469 1.106 . . . . 52.5 109.28 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.41 HG21 ' NZ ' ' A' ' 322' ' ' LYS . 0.1 OUTLIER -156.57 118.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 75.400000000000006 109.278 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -68.7 127.41 22.7 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.495 1.122 . . . . 73.129999999999995 110.988 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.78 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -48.73 -27.18 2.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 75.329999999999998 109.33 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.0 83.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.109999999999999 108.297 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.78 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -101.11 -173.54 2.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 23.149999999999999 109.332 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.83 56.26 1.51 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 74.409999999999997 109.297 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 72.4 p -172.79 136.31 0.7 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.117 . . . . 74.519999999999996 110.002 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.401 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 29.7 m-20 -44.92 -33.42 1.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 44.32 109.316 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.66 139.26 58.64 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.479 1.112 . . . . 70.129999999999995 110.319 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.511 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 86.6 mt -144.96 120.67 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.527 1.142 . . . . 70.510000000000005 109.293 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.84 ' HB ' HD22 ' A' ' 249' ' ' LEU . 16.8 p -109.98 82.27 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 51.5 110.446 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.837 HD22 ' CD2' ' A' ' 250' ' ' LEU . 8.3 mp -39.45 147.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 1.135 . . . . 72.310000000000002 109.28 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -124.78 -87.35 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 73.239999999999995 109.312 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 40.3 p -176.19 137.97 0.49 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 64.439999999999998 109.977 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.545 1.813 . . . . 74.430000000000007 111.0 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 348' ' ' LEU . 2.5 mm? . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 71.150000000000006 109.251 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.299 -0.63 . . . . 65.150000000000006 109.299 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.444 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 21.9 m-20 -139.77 154.08 70.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 109.328 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.685 ' O ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.9 0.35 8.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.458 1.767 . . . . 64.450000000000003 111.023 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.773 HD22 ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -41.89 143.77 0.5 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.545 1.153 . . . . 64.430000000000007 109.3 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -122.08 100.31 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 1.109 . . . . 71.299999999999997 109.29 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.773 ' NE2' HD22 ' A' ' 249' ' ' LEU . 12.3 m170 -94.86 131.43 40.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 65.540000000000006 109.555 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.856 HG22 ' HB3' ' A' ' 265' ' ' LEU . 17.2 t -112.09 163.16 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 74.010000000000005 109.31 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.406 ' N ' HG12 ' A' ' 252' ' ' VAL . 1.3 tp10 -123.31 122.45 38.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.113 . . . . 75.129999999999995 110.289 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.75 110.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.533 1.146 . . . . 71.219999999999999 109.285 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 m -85.59 -55.54 3.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.340000000000003 109.981 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.953 ' HA ' HD23 ' A' ' 261' ' ' LEU . 11.1 t30 60.53 73.14 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.122 . . . . 75.129999999999995 109.307 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 260' ' ' SER . 33.6 mm-40 -82.69 145.68 29.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.561 1.163 . . . . 44.109999999999999 110.303 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.85 -22.33 14.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 71.420000000000002 109.302 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -82.79 -41.48 19.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.557 1.161 . . . . 60.450000000000003 109.314 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 257' ' ' GLU . 12.3 m -173.4 -175.07 1.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 1.136 . . . . 65.030000000000001 110.032 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.953 HD23 ' HA ' ' A' ' 256' ' ' ASN . 11.2 mt -87.02 178.93 6.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.533 1.145 . . . . 62.100000000000001 109.31 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -178.46 108.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 75.329999999999998 109.631 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 68.9 m-85 -110.6 110.65 21.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 54.329999999999998 110.995 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.686 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 56.9 mt -103.26 109.34 26.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 62.310000000000002 109.287 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.856 ' HB3' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -114.47 137.75 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.144 . . . . 64.329999999999998 109.258 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -120.9 127.08 51.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 71.329999999999998 110.967 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -84.35 93.29 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 63.140000000000001 109.312 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.38 18.54 12.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.153 . . . . 74.140000000000001 109.3 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 248' ' ' PRO . 12.5 p -77.54 -172.6 2.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 63.329999999999998 110.388 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.558 ' O ' HD11 ' A' ' 300' ' ' ILE . 93.6 m-20 -87.06 -59.65 2.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 71.239999999999995 109.308 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.8 pt -58.86 157.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 73.319999999999993 109.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.44 130.33 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 71.420000000000002 109.289 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 273' ' ' ILE . 6.0 mm -53.69 136.0 54.47 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.400000000000006 109.259 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -23.61 13.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.532 1.806 . . . . 74.109999999999999 110.986 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 86.52 170.91 47.37 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.517 1.136 . . . . 65.230000000000004 111.034 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ASN . . . . . 0.478 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 58.1 t-20 66.8 45.09 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 0.767 . . . . 52.140000000000001 109.323 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.41 ' C ' ' OG1' ' A' ' 278' ' ' THR . 73.8 m -84.24 178.44 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.329999999999998 108.326 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.896 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.8 m -154.74 98.86 2.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 62.240000000000002 110.339 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.514 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.2 t80 -54.31 -172.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.536 1.148 . . . . 75.239999999999995 110.996 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 322' ' ' LYS . 18.2 tt0 173.77 105.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 64.140000000000001 110.279 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.611 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -126.33 170.09 12.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 74.230000000000004 111.012 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.1 t -101.33 -172.82 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.15 . . . . 61.439999999999998 110.01 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.922 ' O ' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER 50.83 62.72 2.56 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.156 . . . . 52.109999999999999 109.976 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.413 ' OE1' ' CB ' ' A' ' 289' ' ' PHE . 6.7 tt0 -106.36 170.12 8.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 44.299999999999997 110.292 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.531 HD12 ' HD3' ' A' ' 310' ' ' PRO . 19.1 tt -43.15 -34.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 73.409999999999997 109.306 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 48.0 m -127.14 -59.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.433 1.083 . . . . 74.530000000000001 109.992 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -164.68 169.37 16.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 75.209999999999994 110.342 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 281' ' ' PHE . 4.6 p -40.29 139.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 64.099999999999994 109.275 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.413 ' CB ' ' OE1' ' A' ' 284' ' ' GLN . 5.0 t80 -153.28 155.52 36.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 54.439999999999998 110.955 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.89 ' OG ' HG22 ' A' ' 278' ' ' THR . 28.4 t -109.21 136.06 49.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 64.329999999999998 109.999 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.7 mt -103.47 133.72 46.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 63.219999999999999 109.312 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -73.38 112.47 9.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.120000000000005 109.261 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.804 ' HG2' HD21 ' A' ' 306' ' ' LEU . 84.8 mtp -92.9 135.49 34.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 74.349999999999994 111.008 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.61 147.55 0.08 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.486 1.116 . . . . 52.399999999999999 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.478 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.06 -24.13 13.02 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.508 1.794 . . . . 62.240000000000002 111.015 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -53.01 144.87 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.467 1.104 . . . . 74.329999999999998 109.579 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.02 150.28 33.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 74.329999999999998 110.332 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 61.3 mt -80.09 -75.39 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.455 1.097 . . . . 63.299999999999997 109.25 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.01 166.29 12.77 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.477 1.111 . . . . 42.350000000000001 110.981 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.558 HD11 ' O ' ' A' ' 270' ' ' ASN . 18.8 mt -65.47 -31.37 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.521 0.777 . . . . 73.329999999999998 109.305 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -110.72 -23.26 11.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.487 1.117 . . . . 75.109999999999999 109.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -58.78 157.86 20.61 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 53.329999999999998 111.002 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -120.3 -174.94 2.89 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.467 0.745 . . . . 75.329999999999998 110.309 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' A' ' 293' ' ' MET . 6.3 tptp -147.66 154.69 40.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 73.129999999999995 109.256 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 4.1 mt-10 -123.52 135.7 54.17 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 72.530000000000001 110.328 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.804 HD21 ' HG2' ' A' ' 293' ' ' MET . 17.4 mt -136.38 60.0 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 64.239999999999995 109.268 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 3.3 p90 -70.86 131.1 43.26 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 74.409999999999997 107.993 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.8 m-30 -118.37 172.5 7.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.209999999999994 110.982 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.3 OUTLIER -148.91 145.69 20.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 75.019999999999996 111.026 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.531 ' HD3' HD12 ' A' ' 285' ' ' ILE . 18.2 Cg_endo -74.96 -44.71 0.53 Allowed 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.043 -2.482 . . . . 74.239999999999995 110.987 0.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 24.1 p 177.63 172.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.516 1.135 . . . . 74.329999999999998 109.971 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 283' ' ' SER . 0.2 OUTLIER -137.62 161.82 58.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 72.150000000000006 109.315 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 144.57 30.31 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.494 1.786 . . . . 74.109999999999999 111.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.523 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.9 OUTLIER -128.04 159.93 64.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 53.340000000000003 110.389 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.96 169.61 74.06 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.034 -2.486 . . . . 74.129999999999995 110.995 -0.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.597 HD22 ' CE ' ' A' ' 321' ' ' MET . 5.2 mp -80.34 63.67 4.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 73.219999999999999 109.288 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.3 p -83.63 133.57 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.150000000000006 109.978 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 70.11 27.57 4.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 74.099999999999994 109.286 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.556 ' CE2' ' OG ' ' A' ' 283' ' ' SER . 7.7 m-85 -101.31 176.59 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.539 1.149 . . . . 63.310000000000002 110.966 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.533 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.9 OUTLIER -109.34 -50.5 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 74.219999999999999 110.429 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.81 ' SD ' HD13 ' A' ' 342' ' ' ILE . 3.9 ptp 26.6 61.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 60.229999999999997 111.015 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.773 ' HZ2' ' HB ' ' A' ' 333' ' ' VAL . 22.3 mttm -78.95 -173.43 3.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 71.530000000000001 109.299 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.4 t -151.73 125.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 71.319999999999993 109.315 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 278' ' ' THR . 26.6 m -113.9 -177.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 73.510000000000005 109.325 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.49 -161.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 72.010000000000005 109.301 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -74.21 -2.14 23.5 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.512 1.133 . . . . 72.319999999999993 110.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -101.77 0.55 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.210000000000001 109.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.8 8.33 47.3 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.542 1.151 . . . . 65.230000000000004 111.013 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 12.4 pt-20 -95.16 123.61 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 0.762 . . . . 63.530000000000001 110.272 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.772 ' HA ' HG12 ' A' ' 324' ' ' VAL . 14.6 m -55.93 113.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 64.200000000000003 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.3 pt -86.67 -38.3 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 109.279 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.9 ' HB3' HD23 ' A' ' 344' ' ' LEU . 11.1 mt -146.21 165.95 27.67 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 75.120000000000005 109.303 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.773 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.1 m -150.29 124.34 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 70.120000000000005 109.32 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -64.0 125.99 33.36 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.533 1.146 . . . . 73.329999999999998 111.0 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -61.69 -27.61 68.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 0.754 . . . . 71.030000000000001 109.281 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.69 ' O ' ' HB2' ' A' ' 337' ' ' ALA . 0.5 OUTLIER 87.38 179.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 75.030000000000001 108.353 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 336' ' ' CYS . . . 163.89 157.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.099 . . . . 74.409999999999997 109.32 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.25 56.88 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.435 1.084 . . . . 71.430000000000007 109.352 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 m -178.93 179.68 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.107 . . . . 53.119999999999997 110.022 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -79.42 -10.03 59.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 73.319999999999993 109.282 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' HG13 ' A' ' 342' ' ' ILE . 1.1 mp0 -76.9 116.84 17.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 72.439999999999998 110.294 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.81 HD13 ' SD ' ' A' ' 321' ' ' MET . 93.1 mt -144.98 124.75 6.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 71.140000000000001 109.299 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 344' ' ' LEU . 11.7 p -125.16 96.56 4.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.108 . . . . 75.420000000000002 110.402 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.5 mp -39.41 139.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 75.120000000000005 109.32 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 346' ' ' SER . 1.9 ptmm? -109.93 -47.37 3.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 60.299999999999997 109.279 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.4 OUTLIER 156.32 154.43 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 73.049999999999997 109.966 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.41 ' HA ' ' CG1' ' A' ' 333' ' ' VAL . 18.2 Cg_endo -74.96 -51.6 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 64.230000000000004 111.007 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.5 109.324 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.528 ' N ' HD21 ' A' ' 246' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.295 -0.631 . . . . 73.310000000000002 109.295 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -127.92 97.11 30.4 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 72.430000000000007 109.275 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' A' ' 269' ' ' THR . 18.3 Cg_endo -74.99 -5.2 16.5 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.310000000000002 110.997 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.972 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -39.75 139.38 0.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.148 . . . . 71.329999999999998 109.309 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -119.88 103.28 9.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 72.430000000000007 109.3 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -81.81 123.62 28.95 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 61.310000000000002 109.58 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 253' ' ' GLU . 80.2 t -122.29 165.05 18.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.310000000000002 109.324 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 252' ' ' VAL . 27.7 tp10 -123.36 133.29 54.13 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.523 1.14 . . . . 53.409999999999997 110.312 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 340' ' ' ASN . 60.5 t -109.3 108.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.495 1.122 . . . . 75.219999999999999 109.341 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 4.8 t -85.64 -61.86 1.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 72.299999999999997 110.012 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.876 ' HA ' HD23 ' A' ' 261' ' ' LEU . 4.4 t-20 57.01 63.37 1.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.446 1.092 . . . . 75.109999999999999 109.314 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -84.44 146.75 27.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 71.510000000000005 110.265 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -49.5 -25.67 2.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.452 1.095 . . . . 73.129999999999995 109.354 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -75.73 -48.69 20.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 72.230000000000004 109.294 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.2 p -172.62 -175.13 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 71.530000000000001 110.008 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 312' ' ' LEU . 11.6 mt -85.43 -178.24 6.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 65.219999999999999 109.314 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' HIS . . . . . 0.41 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 5.3 t-160 -176.62 100.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 75.299999999999997 109.542 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.783 ' HE2' HD13 ' A' ' 261' ' ' LEU . 89.1 m-85 -117.42 94.07 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 71.439999999999998 111.03 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.584 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 18.5 mt -86.97 128.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.493 1.121 . . . . 74.439999999999998 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 1.042 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -110.48 137.25 48.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 73.329999999999998 109.297 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.584 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 9.5 m-85 -129.7 127.37 40.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.535 1.147 . . . . 70.200000000000003 111.024 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.501 ' HB2' HD13 ' A' ' 273' ' ' ILE . 22.5 t30 -82.67 102.58 11.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 63.340000000000003 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.93 19.81 19.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.479 1.112 . . . . 74.439999999999998 109.307 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.534 ' CG2' ' HA ' ' A' ' 248' ' ' PRO . 9.2 p -104.02 -165.48 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.485 1.116 . . . . 70.219999999999999 110.385 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.13 -51.31 5.65 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 71.209999999999994 109.335 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.9 pt -53.82 161.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 74.409999999999997 109.35 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 1.9 mp -117.67 111.17 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.453 1.095 . . . . 42.43 109.329 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.9 HG21 HD12 ' A' ' 298' ' ' ILE . 1.3 mp -53.82 139.78 51.13 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.129999999999995 109.258 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.451 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.2 Cg_endo -74.98 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 54.450000000000003 111.03 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 294' ' ' GLY . . . 89.72 -36.65 3.48 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 64.450000000000003 111.007 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -76.04 57.9 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 0.766 . . . . 64.209999999999994 109.311 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 324' ' ' VAL . 7.6 m -101.9 -175.09 2.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 75.409999999999997 108.302 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.836 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.6 m -152.92 97.34 2.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 72.310000000000002 110.363 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 323' ' ' VAL . 0.6 OUTLIER -56.04 171.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 74.030000000000001 110.982 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 69.3 tt0 -167.38 96.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 71.340000000000003 110.317 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 2.2 p90 -123.19 138.09 54.73 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.138 . . . . 74.219999999999999 110.982 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 88.5 p -99.46 -178.24 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 65.209999999999994 109.977 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 286' ' ' SER . 4.8 p -129.3 -167.6 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.427 1.079 . . . . 73.200000000000003 109.981 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.412 ' HG2' HG23 ' A' ' 285' ' ' ILE . 21.7 tt0 -41.42 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 43.149999999999999 110.261 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.412 HG23 ' HG2' ' A' ' 284' ' ' GLN . 30.8 pt -130.92 11.43 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.14 . . . . 72.239999999999995 109.29 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.436 ' CB ' ' OG ' ' A' ' 283' ' ' SER . 0.6 OUTLIER -82.5 174.93 10.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 75.209999999999994 110.039 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.63 178.32 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.102 . . . . 54.509999999999998 110.27 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.46 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 1.6 p -113.4 161.06 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.108 . . . . 61.219999999999999 109.293 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.417 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 2.7 t80 -145.05 156.08 43.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.538 1.149 . . . . 73.329999999999998 110.981 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.701 ' HB3' HG22 ' A' ' 278' ' ' THR . 3.3 m -117.34 130.13 56.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.219999999999999 110.011 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 11.9 mt -97.98 125.21 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.508 1.13 . . . . 74.329999999999998 109.241 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.12 99.58 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.554 1.159 . . . . 75.150000000000006 109.27 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.866 ' HG2' HD21 ' A' ' 306' ' ' LEU . 84.2 mtp -71.71 135.94 47.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 72.0 111.003 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 275' ' ' GLY . . . -48.02 155.19 1.3 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 64.140000000000001 110.971 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.61 6.94 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.466 1.772 . . . . 64.530000000000001 110.993 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -49.49 116.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 74.329999999999998 109.585 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -62.62 151.25 38.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.112 . . . . 73.310000000000002 110.28 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.9 HD12 HG21 ' A' ' 273' ' ' ILE . 13.5 mt -78.28 -88.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.483 1.114 . . . . 72.409999999999997 109.317 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.792 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 89.34 -161.69 30.24 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.517 1.136 . . . . 64.310000000000002 110.989 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.501 HG23 ' HD3' ' A' ' 301' ' ' LYS . 8.3 mt -77.09 124.5 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.557 0.798 . . . . 74.420000000000002 109.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 300' ' ' ILE . 2.6 mptt 68.48 7.22 5.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.565 1.166 . . . . 64.549999999999997 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.895 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -91.87 53.38 2.96 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.566 1.166 . . . . 24.25 111.012 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 302' ' ' GLY . 6.3 pt20 -42.16 165.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.577 0.81 . . . . 51.340000000000003 110.321 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.483 ' HB2' HD11 ' A' ' 298' ' ' ILE . 38.8 tptt -131.67 150.55 52.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 73.420000000000002 109.308 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 mt-10 -115.02 114.15 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.513 1.133 . . . . 71.099999999999994 110.289 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 1.042 HD12 HD11 ' A' ' 265' ' ' LEU . 11.1 mt -114.61 48.65 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.497 1.123 . . . . 61.409999999999997 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.412 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 5.2 p-90 -59.1 141.77 53.22 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 72.0 108.024 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.699 ' CD1' HD12 ' A' ' 261' ' ' LEU . 5.1 t80 -139.78 165.77 26.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 73.430000000000007 111.013 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -145.72 158.12 50.24 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.230000000000004 110.973 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -45.87 0.42 Allowed 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.001 -2.499 . . . . 63.049999999999997 111.011 -0.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.7 p -176.69 164.32 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.147 . . . . 64.030000000000001 110.007 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.951 ' HB2' HD11 ' A' ' 261' ' ' LEU . 4.1 mt -137.04 158.51 72.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.548 1.155 . . . . 54.43 109.308 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 148.03 34.94 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.51 1.795 . . . . 74.120000000000005 111.057 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.544 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 1.0 OUTLIER -137.3 159.62 68.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 75.140000000000001 110.367 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.01 170.31 72.21 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 75.049999999999997 110.966 0.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.61 HD23 ' CE2' ' A' ' 319' ' ' TYR . 3.2 mt -90.85 56.65 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 64.209999999999994 109.296 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.2 p -73.37 116.79 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 72.219999999999999 110.042 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 317' ' ' SER . 18.6 t-20 79.71 39.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 62.009999999999998 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.61 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.2 m-85 -115.83 143.89 44.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 63.399999999999999 111.025 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.518 ' O ' ' C ' ' A' ' 321' ' ' MET . 9.9 m -54.94 -61.54 2.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.522 1.139 . . . . 75.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.59 ' HE3' HD13 ' A' ' 316' ' ' LEU . 1.1 ptp 28.01 50.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.530000000000001 111.013 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.452 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 85.4 mttt -82.17 -179.95 7.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 64.239999999999995 109.33 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.605 HG22 ' CD1' ' A' ' 279' ' ' PHE . 19.9 t -142.05 131.0 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 53.210000000000001 109.288 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 278' ' ' THR . 15.8 m -113.03 173.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 65.400000000000006 109.3 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.873 HD21 HG21 ' A' ' 331' ' ' ILE . 2.4 m-20 -109.59 -168.98 1.4 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 65.219999999999999 109.289 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.2 -7.86 14.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.474 1.109 . . . . 72.040000000000006 110.322 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . 0.408 ' N ' ' OD2' ' A' ' 327' ' ' ASP . 1.9 p30 -88.79 -12.38 42.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 75.219999999999999 109.263 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 80.74 -5.94 63.5 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.512 1.132 . . . . 52.25 111.017 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -90.6 143.94 26.24 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 0.742 . . . . 70.140000000000001 110.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.715 ' HA ' HG12 ' A' ' 324' ' ' VAL . 27.7 m -58.86 130.99 49.61 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 1.102 . . . . 63.130000000000003 110.332 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.873 HG21 HD21 ' A' ' 325' ' ' ASN . 18.8 pt -112.7 -37.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 61.43 109.273 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.886 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.6 mt -139.7 168.42 19.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.230000000000004 109.298 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.1 m -151.81 127.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 74.549999999999997 109.332 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -76.24 147.81 35.07 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 72.109999999999999 110.971 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -89.14 -35.96 15.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.512 0.772 . . . . 71.109999999999999 109.332 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.515 ' H ' HG23 ' A' ' 342' ' ' ILE . 0.3 OUTLIER 41.52 86.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 72.030000000000001 108.312 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -104.28 73.95 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.446 1.091 . . . . 70.409999999999997 109.324 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.8 t0 41.44 53.72 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.117 . . . . 75.129999999999995 109.3 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -160.6 123.79 3.39 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 64.040000000000006 109.986 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 254' ' ' VAL . 4.7 m120 -41.2 -33.43 0.36 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.091 . . . . 70.200000000000003 109.308 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.68 146.38 46.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 72.319999999999993 110.3 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 336' ' ' CYS . 4.3 mt -146.08 138.96 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 75.430000000000007 109.34 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 249' ' ' LEU . 16.6 p -132.44 84.85 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 62.200000000000003 110.405 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.8 mp -39.42 130.11 1.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 65.329999999999998 109.336 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 346' ' ' SER . 22.8 mttt -97.64 -74.01 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 71.439999999999998 109.292 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 2.7 p 159.9 146.92 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.439999999999998 109.989 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 -58.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.497 1.788 . . . . 74.409999999999997 110.966 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.407 ' C ' HD13 ' A' ' 348' ' ' LEU . 1.5 tm? . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 63.329999999999998 109.316 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.611 ' N ' HD21 ' A' ' 246' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 43.109999999999999 109.313 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.425 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 0.8 OUTLIER 60.31 160.23 0.11 Allowed Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.120000000000005 109.299 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.453 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.97 -3.27 13.67 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.562 1.822 . . . . 70.340000000000003 110.991 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -40.1 143.31 0.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.092 . . . . 54.109999999999999 109.29 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.799 HD22 HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -121.41 103.78 9.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 71.519999999999996 109.324 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.418 ' C ' HG23 ' A' ' 252' ' ' VAL . 8.2 m-70 -83.73 167.14 17.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 73.049999999999997 109.562 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 265' ' ' LEU . 21.9 t -152.45 166.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 63.310000000000002 109.32 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 252' ' ' VAL . 10.5 tp10 -134.26 134.88 42.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 54.329999999999998 110.317 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 263' ' ' PHE . 56.9 t -119.74 101.7 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 74.420000000000002 109.253 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -54.37 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.496 1.123 . . . . 75.430000000000007 110.016 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.641 ' HB2' HG21 ' A' ' 314' ' ' THR . 5.6 t-20 60.33 77.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.549 1.155 . . . . 53.329999999999998 109.339 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.28 152.09 35.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.532 1.145 . . . . 52.32 110.302 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -42.27 -47.26 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 72.329999999999998 109.315 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.49 -64.24 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.464 1.102 . . . . 63.299999999999997 109.301 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.2 m -173.42 -174.83 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 61.039999999999999 110.012 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' ' 256' ' ' ASN . 14.0 mt -86.76 150.98 23.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 74.310000000000002 109.29 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -137.45 108.0 6.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 72.519999999999996 109.628 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 82.7 m-85 -112.37 104.35 12.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.476 1.11 . . . . 74.549999999999997 111.039 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.782 HG22 ' CE2' ' A' ' 266' ' ' TYR . 98.6 mt -105.03 111.62 35.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 64.219999999999999 109.271 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.89 128.91 45.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 72.430000000000007 109.317 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.782 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -116.86 106.57 13.6 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.504 1.128 . . . . 73.209999999999994 110.999 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.526 ' HA ' HD12 ' A' ' 250' ' ' LEU . 57.9 t30 -70.75 85.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 64.120000000000005 109.294 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -90.37 53.38 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 74.010000000000005 109.273 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 18.7 p -125.19 166.87 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 75.519999999999996 110.384 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -75.91 -49.62 17.31 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.556 1.16 . . . . 72.0 109.303 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 26.7 pt -51.63 -179.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.15 . . . . 72.010000000000005 109.341 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.3 126.71 73.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 71.409999999999997 109.267 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' A' ' 273' ' ' ILE . 5.8 mm -56.82 136.17 78.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 72.409999999999997 109.266 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.02 -24.12 13.1 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.503 1.791 . . . . 64.239999999999995 111.016 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.95 -163.63 51.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.511 1.132 . . . . 63.32 111.027 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 49.07 33.74 5.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 45.210000000000001 109.339 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 64.3 m -85.39 173.87 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 44.340000000000003 108.305 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.892 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.5 m -152.32 99.33 2.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 64.329999999999998 110.361 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.9 t80 -52.08 -179.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 72.400000000000006 111.016 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.97 100.24 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 60.329999999999998 110.245 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.692 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 17.0 p90 -115.02 152.27 32.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 72.150000000000006 111.032 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 t -87.41 179.19 6.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 64.310000000000002 110.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . 1.022 ' O ' HD22 ' A' ' 312' ' ' LEU . 1.4 m 59.42 70.98 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 62.119999999999997 110.006 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 289' ' ' PHE . 12.6 tt0 -112.75 170.11 8.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.147 . . . . 74.030000000000001 110.309 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.89 -28.91 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 65.450000000000003 109.297 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 30.9 t -120.91 -63.73 1.31 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.518 1.136 . . . . 72.420000000000002 109.976 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -168.82 168.15 10.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.494 1.122 . . . . 75.239999999999995 110.304 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.3 p -40.45 119.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 60.350000000000001 109.318 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.448 ' CB ' ' OE1' ' A' ' 284' ' ' GLN . 3.8 t80 -129.74 162.52 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.431 1.082 . . . . 75.129999999999995 111.044 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.849 ' OG ' HG22 ' A' ' 278' ' ' THR . 17.7 t -120.83 128.67 53.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 71.530000000000001 110.001 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 3.7 mt -93.55 130.56 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.209999999999994 109.341 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.675 ' HA ' HG23 ' A' ' 278' ' ' THR . 2.7 mptp? -71.96 113.09 8.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 71.5 109.294 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.657 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.4 mtp -79.87 162.75 24.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 73.340000000000003 110.993 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -67.09 155.31 52.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.133 . . . . 52.119999999999997 111.013 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -33.3 4.67 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.501 1.79 . . . . 64.109999999999999 110.991 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -46.14 144.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 75.140000000000001 109.626 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.55 126.76 41.06 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 64.200000000000003 110.301 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 303' ' ' GLN . 14.8 mt -64.18 -77.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.572 1.17 . . . . 65.010000000000005 109.328 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 79.47 -156.7 41.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.507 1.129 . . . . 35.32 111.017 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.446 ' C ' ' N ' ' A' ' 302' ' ' GLY . 2.0 mt -69.42 156.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.518 0.775 . . . . 62.439999999999998 109.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.405 ' HD2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER 40.28 30.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 61.310000000000002 109.308 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 300' ' ' ILE . . . -108.38 153.32 16.85 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.485 1.116 . . . . 75.010000000000005 111.018 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.411 ' N ' HG23 ' A' ' 298' ' ' ILE . 5.6 pt20 -126.23 -179.06 4.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 0.755 . . . . 73.030000000000001 110.289 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 265' ' ' LEU . 40.8 tptt -152.62 149.37 28.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 71.219999999999999 109.288 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.55 130.3 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 71.040000000000006 110.317 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.842 HD12 HD11 ' A' ' 265' ' ' LEU . 13.2 mt -139.38 61.64 1.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.123 . . . . 73.439999999999998 109.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.586 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 7.0 p90 -75.22 113.46 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 75.510000000000005 107.949 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.0 m-30 -102.01 173.62 6.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 72.049999999999997 111.013 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.507 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.1 p90 -158.93 159.1 29.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 74.319999999999993 110.946 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.98 -36.71 2.5 Favored 'Cis proline' 0 C--N 1.36 1.166 0 C-N-CA 121.045 -2.481 . . . . 72.420000000000002 110.963 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.4 p 167.52 150.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 74.5 109.968 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.022 HD22 ' O ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -123.21 172.93 4.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.472 1.108 . . . . 73.420000000000002 109.287 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.86 34.6 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.535 1.808 . . . . 75.219999999999999 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 256' ' ' ASN . 1.1 p -133.08 159.45 72.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.508 1.13 . . . . 74.420000000000002 110.391 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.06 171.46 68.02 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.985 -2.506 . . . . 71.319999999999993 110.958 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.721 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.4 mt -89.07 62.33 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.46 1.1 . . . . 71.430000000000007 109.266 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 5.4 p -87.62 136.52 32.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.129 . . . . 33.049999999999997 110.029 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.6 OUTLIER 76.22 6.8 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 54.439999999999998 109.32 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.721 ' CE2' HD23 ' A' ' 316' ' ' LEU . 8.6 m-85 -80.34 179.04 7.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 74.310000000000002 110.99 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.526 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.8 OUTLIER -105.72 -53.05 2.71 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 74.540000000000006 110.361 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.685 ' CE ' HD13 ' A' ' 316' ' ' LEU . 5.0 mtm 27.31 57.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 73.450000000000003 111.017 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.559 ' HD3' HG21 ' A' ' 330' ' ' THR . 16.0 mttt -87.78 -168.81 2.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 53.340000000000003 109.317 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -148.91 137.65 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.14 . . . . 75.109999999999999 109.28 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 278' ' ' THR . 15.9 m -107.88 178.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 55.109999999999999 109.325 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.859 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -111.47 -172.43 2.03 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.495 1.122 . . . . 63.109999999999999 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.07 -3.67 14.09 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 74.129999999999995 110.345 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.02 -5.41 28.14 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.456 1.097 . . . . 73.109999999999999 109.291 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 70.3 58.94 5.67 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.474 1.109 . . . . 73.340000000000003 111.013 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.859 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.9 OUTLIER -154.76 119.48 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.456 0.739 . . . . 74.400000000000006 110.276 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.851 ' N ' HG12 ' A' ' 324' ' ' VAL . 24.3 m -46.1 124.18 5.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 72.329999999999998 110.395 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.711 HG22 ' ND2' ' A' ' 325' ' ' ASN . 0.8 OUTLIER -105.53 -39.47 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 63.549999999999997 109.306 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 344' ' ' LEU . 8.5 mt -130.47 167.79 18.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 73.040000000000006 109.284 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.452 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.2 m -151.9 132.18 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 60.420000000000002 109.259 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.737 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -85.44 122.1 5.86 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.511 1.132 . . . . 62.229999999999997 110.984 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.798 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.64 -26.82 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 70.239999999999995 109.302 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 342' ' ' ILE . 1.2 m 50.42 63.2 2.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.116 . . . . 74.0 108.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.798 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -70.04 -179.56 1.96 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.489 1.118 . . . . 60.049999999999997 109.275 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -76.66 62.52 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 74.420000000000002 109.297 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 14.9 m -174.09 146.29 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.15 . . . . 75.239999999999995 109.999 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 79.0 m-20 -53.09 -21.19 4.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.435 1.084 . . . . 71.439999999999998 109.303 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.59 143.32 42.41 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 63.210000000000001 110.298 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.584 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 63.3 mt -147.55 139.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 51.43 109.31 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 11.8 p -133.58 94.73 3.35 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.430000000000007 110.427 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.799 HD22 HD22 ' A' ' 250' ' ' LEU . 5.4 mp -47.66 133.03 13.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 74.519999999999996 109.286 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.4 ptpt -117.88 -60.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 74.109999999999999 109.317 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.29 150.85 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 54.439999999999998 109.984 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -56.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.482 1.78 . . . . 61.240000000000002 111.047 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.516 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.450000000000003 109.336 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.315 -0.624 . . . . 70.120000000000005 109.315 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.505 ' O ' ' CB ' ' A' ' 268' ' ' LYS . 13.5 m-20 -122.63 157.99 57.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 62.140000000000001 109.305 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.727 ' O ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.96 -1.21 10.92 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 63.219999999999999 111.055 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.479 ' CD1' ' HB2' ' A' ' 247' ' ' ASP . 0.1 OUTLIER -71.78 158.41 36.15 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.529 1.143 . . . . 75.310000000000002 109.326 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.576 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.21 98.24 6.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 64.040000000000006 109.304 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.477 ' CE1' ' CD ' ' A' ' 341' ' ' GLU . 2.3 t-160 -96.63 130.23 43.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.472 1.107 . . . . 61.119999999999997 109.574 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 265' ' ' LEU . 3.6 t -116.06 171.16 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 71.299999999999997 109.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.528 ' H ' HG12 ' A' ' 252' ' ' VAL . 1.1 tp10 -134.76 121.99 21.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.519 1.137 . . . . 74.439999999999998 110.27 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 263' ' ' PHE . 21.8 t -103.61 111.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 54.240000000000002 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -64.94 0.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 61.109999999999999 109.962 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.906 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.3 OUTLIER 66.97 67.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 72.430000000000007 109.312 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.09 169.08 11.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 75.219999999999999 110.298 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -73.52 -14.49 61.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.472 1.108 . . . . 71.140000000000001 109.318 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 260' ' ' SER . 1.8 p-10 -87.51 -45.37 10.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 75.349999999999994 109.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.473 ' N ' ' ND2' ' A' ' 259' ' ' ASN . 3.8 p -176.15 -177.31 0.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 70.329999999999998 110.004 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 256' ' ' ASN . 16.8 mt -90.18 174.46 7.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.11 . . . . 73.200000000000003 109.255 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' HIS . . . . . 0.404 ' NE2' ' HG2' ' A' ' 305' ' ' GLU . 4.2 t-160 -171.97 104.51 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.439999999999998 109.59 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.608 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 87.9 m-85 -107.05 91.68 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 72.420000000000002 110.993 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.718 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 48.9 mt -88.84 109.9 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.209999999999994 109.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.715 HD21 HD12 ' A' ' 306' ' ' LEU . 0.1 OUTLIER -110.62 130.33 55.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 73.400000000000006 109.331 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.718 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 2.0 m-85 -114.99 136.74 52.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.496 1.123 . . . . 75.450000000000003 111.003 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 273' ' ' ILE . 9.2 p-10 -79.72 118.58 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 61.420000000000002 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 247' ' ' ASP . 0.0 OUTLIER -98.36 -11.53 22.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 54.409999999999997 109.309 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 248' ' ' PRO . 17.5 p -72.1 175.67 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 63.420000000000002 110.345 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -88.52 -43.21 11.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 65.150000000000006 109.308 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.3 pt -53.15 175.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 74.310000000000002 109.299 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.12 134.42 62.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 72.329999999999998 109.319 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.479 HG21 HD12 ' A' ' 298' ' ' ILE . 1.1 mp -57.59 139.18 81.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 109.313 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.402 ' HA ' ' OE1' ' A' ' 297' ' ' GLU . 18.3 Cg_endo -74.99 -30.96 6.61 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.474 1.776 . . . . 42.340000000000003 111.005 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 276' ' ' ASN . . . 86.76 -159.67 31.9 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.518 1.136 . . . . 61.210000000000001 110.981 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 275' ' ' GLY . 56.9 t-20 40.35 32.44 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 72.150000000000006 109.287 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 275' ' ' GLY . 86.4 m -88.61 -176.77 5.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 43.310000000000002 108.298 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.944 ' O ' HG22 ' A' ' 324' ' ' VAL . 33.1 m -157.4 119.94 3.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 73.319999999999993 110.428 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.571 ' CD1' HD13 ' A' ' 306' ' ' LEU . 3.1 t80 -65.79 173.36 2.92 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.457 1.098 . . . . 73.200000000000003 110.962 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.59 ' HG3' HG21 ' A' ' 288' ' ' VAL . 39.6 tt0 -155.99 79.61 0.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 64.120000000000005 110.339 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.56 151.07 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.12 . . . . 71.409999999999997 111.0 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 p -120.82 -177.25 3.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 71.140000000000001 110.015 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.583 ' CB ' HD23 ' A' ' 312' ' ' LEU . 26.5 p -111.26 -50.91 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.52 1.137 . . . . 65.219999999999999 110.018 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.439 ' C ' ' N ' ' A' ' 286' ' ' SER . 14.1 tt0 169.58 112.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 72.150000000000006 110.303 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 284' ' ' GLN . 2.2 pt 39.69 30.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 72.329999999999998 109.265 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.439 ' N ' ' C ' ' A' ' 284' ' ' GLN . 11.9 p -119.02 -173.76 2.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.519 1.137 . . . . 71.409999999999997 109.993 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.83 135.68 43.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.429 1.08 . . . . 74.420000000000002 110.293 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.59 HG21 ' HG3' ' A' ' 280' ' ' GLU . 2.4 p -85.72 151.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.508 1.13 . . . . 63.25 109.235 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.33 131.96 54.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 71.319999999999993 110.998 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 65.4 m -101.99 116.99 33.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 71.530000000000001 109.996 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.7 mt -98.63 125.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 72.129999999999995 109.302 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -67.61 117.77 9.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.437 1.086 . . . . 63.32 109.27 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.466 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 94.1 mtp -81.96 151.8 27.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 63.210000000000001 110.967 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.466 ' N ' ' NZ ' ' A' ' 304' ' ' LYS . . . -44.55 145.7 1.9 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.546 1.154 . . . . 41.009999999999998 110.981 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -25.97 11.41 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.534 1.807 . . . . 73.540000000000006 111.001 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -67.42 178.78 1.45 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.030000000000001 109.626 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 73.2 mt-10 -113.48 130.62 56.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 73.310000000000002 110.327 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 304' ' ' LYS . 3.4 mt -44.08 -62.46 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 71.319999999999993 109.314 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 267' ' ' ASN . . . 111.21 -165.15 12.11 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 34.420000000000002 111.018 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.711 HG22 ' N ' ' A' ' 301' ' ' LYS . 9.7 mt -63.56 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.534 0.784 . . . . 62.119999999999997 109.343 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.711 ' N ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -89.22 14.6 10.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.319999999999993 109.278 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.529 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -62.25 178.47 5.06 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 41.439999999999998 111.0 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 298' ' ' ILE . 2.5 pt20 -141.24 176.79 8.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 0.766 . . . . 75.200000000000003 110.285 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.583 ' HB2' HD11 ' A' ' 298' ' ' ILE . 31.3 tptt -139.37 145.53 39.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.549999999999997 109.297 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.404 ' HG2' ' NE2' ' A' ' 262' ' ' HIS . 4.1 mt-10 -116.31 128.78 55.85 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.469 1.106 . . . . 74.140000000000001 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.715 HD12 HD21 ' A' ' 265' ' ' LEU . 9.4 mt -132.14 56.9 1.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 64.400000000000006 109.312 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -70.94 123.6 22.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 64.010000000000005 107.985 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.7 m-30 -110.14 -166.48 1.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.431 1.082 . . . . 72.209999999999994 111.018 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.504 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.2 p90 -172.09 160.51 4.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 54.149999999999999 111.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.01 -36.26 2.65 Favored 'Cis proline' 0 C--N 1.36 1.145 0 C-N-CA 121.003 -2.499 . . . . 70.420000000000002 110.998 0.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.2 p 169.63 130.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 74.030000000000001 110.029 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.583 HD23 ' CB ' ' A' ' 283' ' ' SER . 5.6 mp -111.69 158.66 35.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 64.430000000000007 109.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 148.4 35.1 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.475 1.776 . . . . 61.310000000000002 110.954 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.665 HG23 ' OD1' ' A' ' 256' ' ' ASN . 0.3 OUTLIER -126.13 164.08 35.88 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 65.450000000000003 110.38 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -173.87 13.07 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 120.991 -2.504 . . . . 72.219999999999999 111.028 -0.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 1.021 HD13 ' SD ' ' A' ' 321' ' ' MET . 2.4 mt -107.73 58.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.502 1.126 . . . . 54.009999999999998 109.241 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.9 OUTLIER -81.87 133.32 35.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 44.43 109.989 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 317' ' ' SER . 6.8 t-20 75.26 26.13 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.040000000000006 109.302 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.825 ' CE2' HD23 ' A' ' 316' ' ' LEU . 16.4 m-85 -101.33 -171.56 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 73.439999999999998 110.984 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.543 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -100.54 -64.28 1.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 65.239999999999995 110.391 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . 1.021 ' SD ' HD13 ' A' ' 316' ' ' LEU . 1.8 mtm 30.54 70.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 54.5 110.975 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.543 ' HG3' HG23 ' A' ' 320' ' ' THR . 91.4 mttt -100.93 -167.1 1.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.451 1.094 . . . . 72.319999999999993 109.317 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 11.7 t -151.94 127.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 71.150000000000006 109.284 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 278' ' ' THR . 22.2 m -107.34 177.32 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.434 1.084 . . . . 74.530000000000001 109.288 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.833 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -110.88 -172.32 2.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 42.310000000000002 109.289 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.77 -3.87 13.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 74.400000000000006 110.305 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.51 -7.78 30.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.549999999999997 109.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.12 54.09 6.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.508 1.13 . . . . 75.120000000000005 110.995 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.833 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.43 128.83 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 0.756 . . . . 74.040000000000006 110.271 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.823 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.2 m -57.86 117.75 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 71.420000000000002 110.363 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.653 HG22 ' ND2' ' A' ' 325' ' ' ASN . 2.6 pt -96.39 -37.22 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 72.430000000000007 109.275 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.841 ' HB3' HD23 ' A' ' 344' ' ' LEU . 7.0 mt -132.53 168.87 17.44 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 74.099999999999994 109.296 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.455 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.24 133.7 5.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 64.340000000000003 109.309 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -86.88 121.7 5.88 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.481 1.113 . . . . 73.129999999999995 110.998 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.948 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.21 -27.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 0.768 . . . . 71.310000000000002 109.28 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 54.58 63.22 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.572 1.17 . . . . 73.519999999999996 108.306 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.948 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -71.35 -175.0 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 75.420000000000002 109.301 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 317' ' ' SER . 0.1 OUTLIER -81.53 53.38 2.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.200000000000003 109.282 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.1 t -169.1 142.26 2.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 63.509999999999998 109.997 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -47.04 -25.43 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.505 1.128 . . . . 75.319999999999993 109.281 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.477 ' CD ' ' CE1' ' A' ' 251' ' ' HIS . 14.0 mt-10 -69.35 140.45 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 72.129999999999995 110.295 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.598 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 67.0 mt -147.36 135.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 65.230000000000004 109.327 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.4 p -127.63 87.21 2.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 45.32 110.439 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.841 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -39.97 134.71 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.549 1.156 . . . . 71.409999999999997 109.287 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.505 ' O ' ' CB ' ' A' ' 346' ' ' SER . 3.5 mtpt -106.2 -74.86 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 75.349999999999994 109.305 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.619 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 159.32 136.27 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.25 109.995 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 346' ' ' SER . 18.3 Cg_endo -74.97 -70.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.525 1.803 . . . . 74.209999999999994 111.058 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.435 ' C ' HD12 ' A' ' 348' ' ' LEU . 1.8 tp . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 70.430000000000007 109.307 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.491 ' N ' HD21 ' A' ' 246' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.265 -0.642 . . . . 74.400000000000006 109.265 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -117.12 86.54 20.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.123 . . . . 74.120000000000005 109.284 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.459 ' CB ' ' HA ' ' A' ' 269' ' ' THR . 18.2 Cg_endo -75.04 165.83 30.42 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.51 1.795 . . . . 75.439999999999998 110.994 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.409 ' HG ' ' C ' ' A' ' 248' ' ' PRO . 0.8 OUTLIER 179.84 155.44 0.58 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.485 1.116 . . . . 43.240000000000002 109.307 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.605 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -112.87 99.0 7.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 74.129999999999995 109.328 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.833 ' CD2' HG22 ' A' ' 343' ' ' THR . 2.4 m80 -93.08 131.38 38.16 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 73.129999999999995 109.582 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 253' ' ' GLU . 95.0 t -119.8 167.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.447 1.092 . . . . 74.120000000000005 109.321 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.527 ' N ' HG12 ' A' ' 252' ' ' VAL . 9.0 tt0 -130.97 120.16 23.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 70.129999999999995 110.259 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 340' ' ' ASN . 39.6 t -90.81 119.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 73.239999999999995 109.285 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.4 t -92.51 -63.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.477 1.11 . . . . 64.319999999999993 109.993 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.88 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.3 t-20 56.77 63.89 1.82 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.14 . . . . 65.030000000000001 109.272 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.94 163.64 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 72.439999999999998 110.278 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.4 -13.39 61.45 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 63.310000000000002 109.258 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.89 -39.11 10.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 73.140000000000001 109.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.4 m -174.98 -174.51 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 73.010000000000005 110.013 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 256' ' ' ASN . 9.8 mt -89.29 179.49 6.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.533 1.146 . . . . 73.049999999999997 109.323 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 1.7 t-160 -178.26 107.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 109.597 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.598 ' CE1' HD22 ' A' ' 261' ' ' LEU . 91.2 m-85 -121.88 101.17 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 111.013 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 304' ' ' LYS . 23.9 mt -90.04 132.73 33.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 63.200000000000003 109.297 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -113.64 149.01 35.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 72.420000000000002 109.282 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.9 OUTLIER -128.04 115.66 18.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 72.420000000000002 111.016 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.534 ' HB2' HD13 ' A' ' 273' ' ' ILE . 8.8 t-20 -73.97 78.82 1.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 1.088 . . . . 73.120000000000005 109.234 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -101.8 13.43 34.88 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 65.549999999999997 109.28 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 248' ' ' PRO . 14.7 p -76.36 -166.15 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 54.130000000000003 110.398 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.99 -65.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 70.409999999999997 109.268 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 272' ' ' ILE . 0.0 OUTLIER -68.3 -178.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 75.010000000000005 109.343 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 271' ' ' ILE . 2.5 mp -122.32 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 53.240000000000002 109.263 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -40.7 139.47 1.15 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 71.140000000000001 109.308 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.417 ' HG2' ' ND2' ' A' ' 325' ' ' ASN . 18.2 Cg_endo -75.02 -33.17 4.76 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.513 1.796 . . . . 64.129999999999995 110.999 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 103.82 153.05 23.2 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 52.340000000000003 111.018 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ASN . . . . . 0.416 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 57.8 t30 71.86 26.85 2.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 0.768 . . . . 74.519999999999996 109.314 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.405 ' C ' ' OG1' ' A' ' 278' ' ' THR . 21.5 m -69.78 -179.17 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.553 1.158 . . . . 74.329999999999998 108.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 324' ' ' VAL . 4.4 m -155.1 138.46 15.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 71.420000000000002 110.427 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.52 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.3 t80 -91.1 -173.58 3.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 70.340000000000003 111.032 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 178.03 102.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.209999999999994 110.277 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.665 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 1.2 p90 -128.44 128.95 45.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 75.099999999999994 110.979 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.478 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 0.8 OUTLIER -107.73 154.22 21.81 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.533 1.145 . . . . 64.409999999999997 110.014 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.554 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 10.5 p -125.84 4.14 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.536 1.147 . . . . 50.450000000000003 110.04 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -177.9 171.33 1.8 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 65.340000000000003 110.267 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.7 tt -66.38 -16.67 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 71.030000000000001 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 48.9 m -41.79 -77.2 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 70.340000000000003 109.989 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.87 -177.2 2.92 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 73.400000000000006 110.273 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.44 166.25 29.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.553 1.158 . . . . 64.040000000000006 109.317 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -135.99 138.55 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 73.120000000000005 110.992 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 96.8 p -110.59 125.85 53.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 61.119999999999997 109.983 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 11.4 mt -97.73 133.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 61.450000000000003 109.295 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.39 102.19 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 61.520000000000003 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.775 ' HG2' HD21 ' A' ' 306' ' ' LEU . 73.9 mtp -73.28 152.13 41.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 70.340000000000003 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -38.69 141.78 0.44 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.46 1.1 . . . . 65.010000000000005 110.959 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.416 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.3 Cg_endo -75.06 -23.81 13.33 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.52 1.8 . . . . 72.140000000000001 110.952 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -73.43 175.94 6.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 73.140000000000001 109.624 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -94.85 155.15 16.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 71.549999999999997 110.291 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.523 HG22 ' HB3' ' A' ' 267' ' ' ASN . 66.3 mt -77.19 -83.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.420000000000002 109.322 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 126.66 141.01 5.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.51 1.131 . . . . 52.409999999999997 110.996 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.764 HG22 ' HD3' ' A' ' 301' ' ' LYS . 58.6 mt -40.57 -33.15 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 0.751 . . . . 74.400000000000006 109.292 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.764 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -111.15 -29.47 7.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 61.030000000000001 109.332 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -48.05 136.35 15.43 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.498 1.124 . . . . 72.200000000000003 111.002 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -89.65 -172.48 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 0.757 . . . . 73.200000000000003 110.297 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 264' ' ' ILE . 32.8 tptt -160.49 145.12 14.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 64.319999999999993 109.33 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -124.54 144.46 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.473 1.108 . . . . 73.140000000000001 110.296 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 265' ' ' LEU . 11.8 mt -144.13 61.18 1.36 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 70.219999999999999 109.299 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 132.29 46.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.530000000000001 107.989 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.1 m-30 -118.4 174.49 6.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 75.420000000000002 110.988 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -155.74 155.03 29.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.559 1.162 . . . . 64.329999999999998 111.001 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -37.14 2.35 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.03 -2.487 . . . . 74.420000000000002 111.003 -0.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.4 p 172.61 149.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 64.549999999999997 110.003 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.729 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.7 mp -128.78 157.97 73.74 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 73.310000000000002 109.285 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 148.5 35.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.465 1.771 . . . . 75.510000000000005 110.979 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.642 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -134.51 161.96 60.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 71.209999999999994 110.395 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.0 Cg_endo -75.07 173.71 56.52 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.983 -2.507 . . . . 75.239999999999995 110.961 0.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.56 HD13 ' HE3' ' A' ' 321' ' ' MET . 1.4 mt -95.07 64.02 2.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.528 1.143 . . . . 75.340000000000003 109.282 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 4.7 p -77.37 121.6 23.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 73.219999999999999 110.027 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 78.92 31.44 0.31 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 71.540000000000006 109.326 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 283' ' ' SER . 4.2 m-85 -112.14 141.14 46.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 63.450000000000003 110.997 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.3 m -51.89 -62.79 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 63.43 110.426 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.56 ' HE3' HD13 ' A' ' 316' ' ' LEU . 0.9 OUTLIER 26.87 60.78 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 1.144 . . . . 45.439999999999998 111.012 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 320' ' ' THR . 49.0 mttm -97.44 -174.76 3.01 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 73.409999999999997 109.302 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.52 HG22 ' CD1' ' A' ' 279' ' ' PHE . 49.6 t -136.72 136.31 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 62.310000000000002 109.291 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.622 HG12 ' N ' ' A' ' 330' ' ' THR . 4.4 m -116.66 -179.57 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 74.329999999999998 109.307 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.829 ' OD1' HG21 ' A' ' 331' ' ' ILE . 0.8 OUTLIER -105.03 -171.23 1.88 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 73.209999999999994 109.282 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.47 -9.27 24.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 71.439999999999998 110.312 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -99.08 -7.25 27.01 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 75.239999999999995 109.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.36 14.3 76.74 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.5 1.125 . . . . 70.010000000000005 111.033 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.428 ' C ' HG12 ' A' ' 324' ' ' VAL . 3.4 pt-20 -92.94 132.78 36.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 0.744 . . . . 63.539999999999999 110.248 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.622 ' N ' HG12 ' A' ' 324' ' ' VAL . 16.6 m -61.39 130.87 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 64.129999999999995 110.417 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.829 HG21 ' OD1' ' A' ' 325' ' ' ASN . 19.8 pt -115.72 -39.24 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 109.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.725 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.9 mt -138.79 166.26 24.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 65.319999999999993 109.272 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.512 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.2 123.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 74.140000000000001 109.303 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -70.27 137.43 27.86 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.525 1.141 . . . . 44.420000000000002 111.042 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.503 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -74.11 -36.82 64.25 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.53 0.782 . . . . 71.200000000000003 109.244 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 335' ' ' LYS . 0.1 OUTLIER 40.9 87.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 1.16 . . . . 54.329999999999998 108.275 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.88 72.58 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 61.100000000000001 109.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.15 55.08 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.409999999999997 109.311 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.9 m -163.49 131.84 3.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 75.439999999999998 109.997 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.814 ' O ' HG23 ' A' ' 254' ' ' VAL . 8.5 m120 -46.9 -38.11 9.95 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 74.019999999999996 109.252 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.27 146.61 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 73.140000000000001 110.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.504 HD13 ' SD ' ' A' ' 321' ' ' MET . 9.3 mt -146.26 121.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 63.130000000000003 109.301 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.833 HG22 ' CD2' ' A' ' 251' ' ' HIS . 14.5 p -115.33 79.17 1.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 74.329999999999998 110.382 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.725 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.9 mp -38.82 149.87 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.1 . . . . 53.350000000000001 109.258 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -126.21 -55.01 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 109.343 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.625 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.1 p 157.41 154.81 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 62.399999999999999 110.001 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.421 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.96 -45.92 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.502 1.79 . . . . 74.230000000000004 111.018 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 347' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 62.509999999999998 109.305 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.0 t30 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.255 -0.646 . . . . 63.140000000000001 109.255 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -133.49 146.2 59.6 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 64.400000000000006 109.3 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.492 ' C ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.95 0.45 8.87 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.488 1.783 . . . . 73.010000000000005 111.034 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -45.98 130.04 9.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 109.275 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -121.36 105.56 10.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.219999999999999 109.318 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.464 ' N ' HD12 ' A' ' 250' ' ' LEU . 55.7 t-80 -73.17 124.19 25.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.010000000000005 109.628 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 1.142 HG13 HD23 ' A' ' 265' ' ' LEU . 56.6 t -118.49 168.69 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.553 1.158 . . . . 72.129999999999995 109.281 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.543 ' N ' HG12 ' A' ' 252' ' ' VAL . 45.7 tp10 -129.8 146.88 51.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 75.450000000000003 110.27 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.682 HG13 ' CE1' ' A' ' 263' ' ' PHE . 43.7 t -124.76 103.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 52.530000000000001 109.308 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.2 m -76.15 -70.04 0.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 73.420000000000002 109.949 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.967 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.2 t-20 60.52 66.56 0.92 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.529 1.143 . . . . 45.549999999999997 109.324 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.3 pt-20 -166.21 -174.39 2.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 71.209999999999994 110.298 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 18.1 t0 67.05 15.14 10.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.239999999999995 109.327 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 9.3 t-20 82.24 19.66 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 60.409999999999997 109.284 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 2.7 p -164.22 -175.39 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 62.140000000000001 109.999 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.6 mt -100.55 174.23 6.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.134 . . . . 63.420000000000002 109.286 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.2 117.72 0.3 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 72.0 109.583 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.682 ' CE1' HG13 ' A' ' 254' ' ' VAL . 80.9 m-85 -129.18 117.84 21.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 52.530000000000001 110.993 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.752 HG22 ' CE2' ' A' ' 266' ' ' TYR . 86.1 mt -102.5 112.48 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 64.109999999999999 109.329 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 1.142 HD23 HG13 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.06 123.8 42.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 72.140000000000001 109.306 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.752 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.3 m-85 -112.58 140.25 47.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 73.430000000000007 111.019 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.54 ' OD1' HD13 ' A' ' 271' ' ' ILE . 62.8 t-20 -91.16 88.66 7.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.12 . . . . 55.009999999999998 109.319 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -3.45 21.84 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 73.0 109.298 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 0.9 OUTLIER -56.66 -17.3 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 73.109999999999999 110.389 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 269' ' ' THR . 3.7 m120 83.75 43.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.439999999999998 109.327 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.54 HD13 ' OD1' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -152.03 177.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 71.140000000000001 109.303 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 271' ' ' ILE . 71.2 mt -106.62 130.64 58.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 63.109999999999999 109.309 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 298' ' ' ILE . 3.4 mm -71.04 138.12 84.86 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 51.43 109.297 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.1 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.549 1.815 . . . . 71.409999999999997 110.982 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 76.47 179.38 47.08 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.504 1.127 . . . . 71.409999999999997 111.03 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 326' ' ' GLN . 50.8 t-20 62.79 31.42 16.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 0.763 . . . . 74.150000000000006 109.322 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.403 ' C ' ' OG1' ' A' ' 278' ' ' THR . 68.6 m -90.58 178.71 6.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.349999999999994 108.293 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.7 m -153.8 127.87 9.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 64.129999999999995 110.413 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.469 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.8 t80 -80.47 164.11 23.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.219999999999999 110.991 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.417 ' CG ' HG21 ' A' ' 288' ' ' VAL . 28.3 tt0 -151.52 88.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.200000000000003 110.286 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.786 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 15.5 p90 -120.6 128.67 53.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 73.109999999999999 111.028 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.592 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 23.8 t -113.99 178.33 4.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.400000000000006 109.983 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.935 ' HB2' HD23 ' A' ' 312' ' ' LEU . 3.4 t -115.99 -36.05 4.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 50.210000000000001 109.973 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -136.5 173.92 11.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 74.150000000000006 110.329 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.416 HG23 ' H ' ' A' ' 285' ' ' ILE . 0.2 OUTLIER -50.16 -23.53 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 73.230000000000004 109.319 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 68.1 m -52.56 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.310000000000002 109.953 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.84 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.453 1.095 . . . . 74.010000000000005 110.276 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.544 HG22 ' N ' ' A' ' 289' ' ' PHE . 8.2 p -136.63 169.08 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 71.530000000000001 109.295 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.544 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.5 t80 -116.4 139.42 50.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.537 1.148 . . . . 64.519999999999996 111.015 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 90.8 p -119.7 122.06 40.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 52.039999999999999 110.048 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 21.6 mt -103.44 129.25 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 72.519999999999996 109.335 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -71.24 115.99 11.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 73.439999999999998 109.298 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 81.6 mtp -78.27 164.31 25.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.219999999999999 111.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -66.53 147.73 50.05 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.519 1.137 . . . . 72.140000000000001 111.018 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -30.24 7.36 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.506 1.793 . . . . 73.319999999999993 110.966 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.93 138.3 58.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 74.400000000000006 109.617 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -73.44 141.19 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 72.200000000000003 110.307 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.653 HD12 HG13 ' A' ' 273' ' ' ILE . 27.0 mt -67.03 -81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 71.409999999999997 109.26 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 300' ' ' ILE . . . 109.59 156.63 16.71 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.508 1.13 . . . . 52.240000000000002 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.56 HG22 ' HD2' ' A' ' 301' ' ' LYS . 54.2 mt -39.13 -72.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.522 0.778 . . . . 74.120000000000005 109.352 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.56 ' HD2' HG22 ' A' ' 300' ' ' ILE . 13.5 mptt -68.38 -28.08 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 41.229999999999997 109.298 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -50.13 158.44 1.65 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.498 1.124 . . . . 63.439999999999998 110.963 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.414 ' N ' HG23 ' A' ' 298' ' ' ILE . 8.4 pt20 -129.23 -174.24 3.22 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 0.762 . . . . 74.25 110.322 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 24.6 tptt -156.92 156.92 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 53.219999999999999 109.321 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -134.76 147.14 49.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 62.030000000000001 110.314 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.997 HD12 HD11 ' A' ' 265' ' ' LEU . 16.5 mt -144.82 64.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 64.219999999999999 109.294 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -73.17 134.63 44.46 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.977 -1.119 . . . . 74.230000000000004 107.977 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.786 ' CD2' ' CE2' ' A' ' 281' ' ' PHE . 7.3 m-85 -121.69 167.07 13.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 73.129999999999995 111.024 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -142.71 143.4 25.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.209999999999994 110.997 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.0 -54.0 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.027 -2.489 . . . . 52.5 110.969 0.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.99 109.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 50.329999999999998 110.023 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 283' ' ' SER . 3.9 mp -70.69 158.09 88.7 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 62.539999999999999 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.06 33.4 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.476 1.777 . . . . 71.299999999999997 110.995 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.682 HG22 HD12 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -118.02 163.76 23.13 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 65.239999999999995 110.427 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.97 -173.19 11.86 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.021 -2.491 . . . . 63.240000000000002 111.016 -0.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.71 HD23 ' CD2' ' A' ' 319' ' ' TYR . 4.6 mp -102.71 11.31 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.553 1.158 . . . . 75.239999999999995 109.311 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -46.27 119.26 2.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 44.229999999999997 110.005 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 317' ' ' SER . 8.4 t-20 87.15 42.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 63.100000000000001 109.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.71 ' CD2' HD23 ' A' ' 316' ' ' LEU . 3.7 m-85 -120.85 -171.16 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 74.109999999999999 111.014 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 322' ' ' LYS . 52.3 m -105.04 -55.85 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 35.32 110.365 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.85 ' SD ' HD13 ' A' ' 342' ' ' ILE . 3.8 ptp 23.81 57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 63.020000000000003 110.977 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.569 ' HG3' HG22 ' A' ' 320' ' ' THR . 84.1 mttt -91.89 176.97 6.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.472 1.108 . . . . 62.299999999999997 109.339 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.437 HG22 ' HD1' ' A' ' 279' ' ' PHE . 17.3 t -133.63 129.52 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 75.400000000000006 109.306 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 278' ' ' THR . 6.5 m -109.1 -172.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.086 . . . . 61.130000000000003 109.307 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.638 ' HB3' HG21 ' A' ' 331' ' ' ILE . 39.8 p30 -121.38 -170.27 2.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 72.200000000000003 109.301 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.422 ' HB2' ' ND2' ' A' ' 276' ' ' ASN . 2.0 pt20 -63.2 -10.95 17.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 71.310000000000002 110.258 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -94.56 -13.96 25.51 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.466 1.104 . . . . 75.549999999999997 109.284 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.25 80.27 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.57 1.169 . . . . 72.549999999999997 111.028 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.25 134.79 38.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.514 0.773 . . . . 74.200000000000003 110.262 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.604 ' N ' HG12 ' A' ' 324' ' ' VAL . 10.3 m -61.87 115.1 3.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 64.510000000000005 110.439 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 325' ' ' ASN . 8.1 pt -88.97 -37.82 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.534 1.147 . . . . 72.349999999999994 109.304 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.905 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.4 mt -141.64 169.6 17.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.554 1.159 . . . . 71.430000000000007 109.283 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.461 HG12 ' CG2' ' A' ' 330' ' ' THR . 1.0 OUTLIER -148.47 136.13 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 74.310000000000002 109.296 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -92.51 118.8 5.66 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.466 1.104 . . . . 62.520000000000003 111.026 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.826 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -50.04 -26.86 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 0.759 . . . . 72.129999999999995 109.307 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.467 ' HG ' ' HB2' ' A' ' 319' ' ' TYR . 5.6 t 46.05 77.03 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 53.299999999999997 108.333 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.826 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -81.51 -172.2 3.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 53.140000000000001 109.321 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.56 58.01 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 74.319999999999993 109.271 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.85 162.7 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 44.439999999999998 109.96 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.94 -38.49 86.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.109999999999999 109.319 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.421 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -61.77 133.06 55.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.114 . . . . 73.140000000000001 110.305 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.85 HD13 ' SD ' ' A' ' 321' ' ' MET . 86.0 mt -143.77 131.33 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 75.299999999999997 109.289 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.453 ' HB ' HD23 ' A' ' 249' ' ' LEU . 49.3 p -129.56 94.91 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.419 1.074 . . . . 74.409999999999997 110.404 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.0 mp -39.72 152.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 52.420000000000002 109.276 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 5.7 ptpt -125.67 -60.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 64.120000000000005 109.311 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.504 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.2 p 159.38 151.35 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.125 . . . . 55.229999999999997 109.978 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -79.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.514 1.797 . . . . 71.239999999999995 110.993 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.714 ' C ' HD22 ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.512 1.133 . . . . 75.120000000000005 109.312 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.272 -0.64 . . . . 63.340000000000003 109.272 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.52 76.74 35.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 71.540000000000006 109.264 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 168.42 24.88 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.489 1.784 . . . . 74.409999999999997 111.02 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -175.45 178.01 1.71 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.426 1.079 . . . . 44.299999999999997 109.291 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.803 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.7 OUTLIER -105.58 101.12 10.66 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 74.420000000000002 109.319 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.534 ' ND1' HG22 ' A' ' 343' ' ' THR . 22.2 m-70 -82.07 168.1 18.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 74.209999999999994 109.632 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.681 ' CG2' HD23 ' A' ' 265' ' ' LEU . 22.4 t -155.05 150.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 73.150000000000006 109.328 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -124.57 151.05 45.25 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 73.519999999999996 110.313 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.78 106.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 60.420000000000002 109.327 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.8 t -73.55 -62.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 64.140000000000001 109.963 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.937 ' HA ' HD23 ' A' ' 261' ' ' LEU . 17.2 t30 60.89 63.41 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 71.450000000000003 109.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -95.62 158.98 15.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 1.124 . . . . 72.25 110.325 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -48.25 -49.03 34.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 71.310000000000002 109.29 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -51.47 -53.41 37.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 64.109999999999999 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.8 p 178.75 -174.69 0.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.511 1.132 . . . . 34.140000000000001 109.993 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 1.032 ' CD1' HD12 ' A' ' 312' ' ' LEU . 34.8 mt -77.65 178.76 7.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 62.32 109.308 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -171.22 108.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.010000000000005 109.577 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.814 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 79.3 m-85 -115.79 93.13 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 75.099999999999994 111.036 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.835 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 84.6 mt -87.31 103.39 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 74.420000000000002 109.273 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.18 132.82 44.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 72.430000000000007 109.288 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.835 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -118.27 125.98 51.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 110.988 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.483 ' HA ' HD12 ' A' ' 250' ' ' LEU . 32.9 t-20 -64.0 79.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 72.329999999999998 109.266 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 266' ' ' TYR . 1.1 mmpt? -90.91 40.55 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.519 1.137 . . . . 72.519999999999996 109.259 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.6 p -119.65 177.78 4.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 110.402 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -85.56 -12.49 51.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 72.109999999999999 109.283 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.2 pt -101.46 160.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 73.420000000000002 109.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 273' ' ' ILE . 3.8 mp -120.58 121.58 65.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 53.219999999999999 109.278 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.412 HD12 ' ND2' ' A' ' 267' ' ' ASN . 1.0 OUTLIER -40.01 142.4 0.7 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 53.350000000000001 109.313 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -74.97 -44.41 0.34 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.797 . . . . 44.43 111.023 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 123.19 149.33 7.8 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.523 1.139 . . . . 52.43 110.977 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.9 t30 67.35 73.86 0.32 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 0.743 . . . . 72.209999999999994 109.308 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 293' ' ' MET . 0.8 OUTLIER -119.91 -179.15 3.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 54.240000000000002 108.286 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 324' ' ' VAL . 22.3 m -153.51 137.52 16.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.535 1.147 . . . . 61.530000000000001 110.393 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.904 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.6 t80 -86.04 -167.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 73.140000000000001 110.993 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 176.5 104.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.458 1.099 . . . . 72.530000000000001 110.287 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.589 ' CZ ' ' CG ' ' A' ' 308' ' ' PHE . 3.0 p90 -133.56 144.0 49.05 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 72.340000000000003 111.021 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 37.3 p -104.43 143.27 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 74.120000000000005 110.011 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.699 ' OG ' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -104.05 -42.68 5.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.461 1.101 . . . . 70.439999999999998 109.988 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.427 ' C ' ' N ' ' A' ' 286' ' ' SER . 6.2 tt0 -143.56 173.67 11.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.452 1.095 . . . . 75.349999999999994 110.31 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 13.1 pt -40.89 -29.67 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 71.049999999999997 109.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.427 ' N ' ' C ' ' A' ' 284' ' ' GLN . 71.7 p -47.89 175.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.299999999999997 110.036 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -64.59 -175.85 0.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 73.540000000000006 110.268 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 289' ' ' PHE . 3.3 p -121.43 166.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 75.349999999999994 109.337 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.516 ' N ' HG22 ' A' ' 288' ' ' VAL . 5.7 t80 -134.83 149.14 50.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.438 1.086 . . . . 71.319999999999993 110.949 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.459 ' HB3' HG22 ' A' ' 278' ' ' THR . 11.0 m -109.31 127.14 54.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.109999999999999 110.0 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 278' ' ' THR . 8.2 mt -97.06 125.63 50.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 73.439999999999998 109.289 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -70.26 116.57 10.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 63.229999999999997 109.3 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.708 ' HG2' HD21 ' A' ' 306' ' ' LEU . 86.2 mtp -84.74 170.0 13.68 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.571 1.169 . . . . 74.329999999999998 111.018 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.595 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -64.01 143.02 47.06 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.484 1.115 . . . . 60.340000000000003 111.023 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -27.93 9.55 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.514 1.797 . . . . 72.510000000000005 111.013 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -71.34 155.76 40.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 74.239999999999995 109.607 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.38 169.39 17.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.53 1.143 . . . . 71.129999999999995 110.284 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 79.0 mt -99.22 -74.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.219999999999999 109.308 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.408 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 122.15 135.95 4.82 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.545 1.153 . . . . 53.210000000000001 110.986 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.411 HG22 ' CE ' ' A' ' 301' ' ' LYS . 4.0 mt -41.52 -28.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 0.781 . . . . 63.520000000000003 109.299 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.411 ' CE ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -108.08 -31.19 8.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 63.109999999999999 109.303 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -57.76 146.6 38.19 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.497 1.123 . . . . 64.510000000000005 110.998 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -173.91 2.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.427 0.722 . . . . 43.240000000000002 110.277 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.595 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 28.8 tptt -159.99 144.6 14.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 75.25 109.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -107.69 155.03 20.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 72.200000000000003 110.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.708 HD21 ' HG2' ' A' ' 293' ' ' MET . 9.7 mt -149.06 60.34 1.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 52.200000000000003 109.268 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.37 133.08 55.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 74.439999999999998 107.957 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.814 ' CD2' ' CE1' ' A' ' 263' ' ' PHE . 17.9 m-30 -119.38 39.52 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.494 1.121 . . . . 73.010000000000005 110.96 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.517 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -36.44 148.03 0.18 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 74.239999999999995 111.007 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.03 -46.45 0.37 Allowed 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.959 -2.517 . . . . 74.230000000000004 111.002 0.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 34.2 p 176.27 162.11 0.36 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 71.549999999999997 109.984 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -132.87 164.78 41.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.401 1.063 . . . . 73.209999999999994 109.275 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 145.24 31.28 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.52 1.8 . . . . 54.409999999999997 111.017 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.21 163.09 44.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 74.329999999999998 110.353 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.03 174.91 50.27 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.963 -2.515 . . . . 62.340000000000003 111.006 0.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.676 HD13 ' CE ' ' A' ' 321' ' ' MET . 8.2 mt -89.63 12.55 16.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 74.439999999999998 109.278 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.1 t -46.56 118.52 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 72.120000000000005 110.023 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.0 t-20 88.58 41.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 71.140000000000001 109.327 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.638 ' CE2' HD23 ' A' ' 316' ' ' LEU . 4.9 m-85 -122.86 -174.28 2.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.530000000000001 110.982 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.1 m -103.76 -56.71 2.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 71.109999999999999 110.45 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.76 ' SD ' HD13 ' A' ' 342' ' ' ILE . 2.5 ptp 25.29 67.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.53 1.144 . . . . 75.409999999999997 110.993 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.653 ' HG2' HG23 ' A' ' 333' ' ' VAL . 38.9 mttt -104.35 -176.77 3.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 1.126 . . . . 62.450000000000003 109.26 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.904 HG22 ' CD1' ' A' ' 279' ' ' PHE . 65.4 t -136.56 158.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.111 . . . . 43.030000000000001 109.314 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 278' ' ' THR . 16.0 m -137.35 171.85 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 75.140000000000001 109.283 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -104.24 -162.87 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 1.129 . . . . 70.120000000000005 109.293 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -72.27 -4.84 32.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.528 1.143 . . . . 74.409999999999997 110.337 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -102.44 0.56 34.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 72.019999999999996 109.278 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.47 1.87 58.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.496 1.123 . . . . 72.150000000000006 111.011 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -83.54 141.17 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 0.753 . . . . 73.420000000000002 110.307 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.673 HG22 ' HG3' ' A' ' 347' ' ' PRO . 43.1 m -65.74 124.17 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 73.340000000000003 110.397 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.7 pt -102.5 -38.35 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 73.540000000000006 109.256 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.616 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.5 mt -144.33 171.71 13.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 71.510000000000005 109.272 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.653 HG23 ' HG2' ' A' ' 322' ' ' LYS . 0.2 OUTLIER -161.29 125.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.140000000000001 109.349 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.749 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -77.22 119.2 5.29 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.525 1.141 . . . . 42.25 110.982 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -26.02 0.73 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.537 0.787 . . . . 62.219999999999999 109.28 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.412 ' HG ' ' C ' ' A' ' 316' ' ' LEU . 5.7 t 46.03 85.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.168 . . . . 72.439999999999998 108.3 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -95.67 -171.08 2.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.456 1.098 . . . . 64.540000000000006 109.262 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 338' ' ' ASP . 0.0 OUTLIER -81.04 56.16 2.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 75.129999999999995 109.288 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 339' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 341' ' ' GLU . 15.2 m -168.27 136.92 2.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 54.210000000000001 110.0 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -46.11 -26.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 65.200000000000003 109.301 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 339' ' ' SER . 3.4 mt-10 -69.75 141.31 53.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.104 . . . . 63.399999999999999 110.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.76 HD13 ' SD ' ' A' ' 321' ' ' MET . 66.0 mt -147.24 139.34 18.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 72.239999999999995 109.314 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.534 HG22 ' ND1' ' A' ' 251' ' ' HIS . 10.1 p -135.37 99.17 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 64.310000000000002 110.417 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.803 HD22 ' CD2' ' A' ' 250' ' ' LEU . 6.5 mp -52.07 132.97 33.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 74.420000000000002 109.318 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.3 ptpt -118.7 -61.45 1.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 64.340000000000003 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.9 OUTLIER 159.53 149.05 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 74.519999999999996 110.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.673 ' HG3' HG22 ' A' ' 330' ' ' THR . 18.5 Cg_endo -74.97 -46.24 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.51 1.795 . . . . 62.340000000000003 111.043 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 348' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.496 1.123 . . . . 72.420000000000002 109.32 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.0 t30 . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.279 -0.637 . . . . 60.200000000000003 109.279 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 97.18 3.01 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 71.239999999999995 109.334 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 269' ' ' THR . 18.5 Cg_endo -75.01 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.528 1.804 . . . . 54.530000000000001 111.009 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.714 HD22 ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -40.76 144.61 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 73.430000000000007 109.346 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.39 101.07 8.8 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.468 1.105 . . . . 74.510000000000005 109.266 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.714 ' NE2' HD22 ' A' ' 249' ' ' LEU . 41.8 m170 -94.47 131.12 40.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.150000000000006 109.621 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.613 HG21 HD23 ' A' ' 265' ' ' LEU . 21.9 t -128.55 169.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.310000000000002 109.303 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.513 ' N ' HG12 ' A' ' 252' ' ' VAL . 15.0 tp10 -125.31 146.62 49.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 72.239999999999995 110.304 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.685 HG22 ' CE1' ' A' ' 263' ' ' PHE . 38.9 t -130.58 95.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.239999999999995 109.312 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -56.84 6.54 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 1.148 . . . . 61.310000000000002 109.999 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.822 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.3 t-20 59.73 74.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 72.040000000000006 109.333 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' ASP . 8.5 pt-20 -108.64 156.24 19.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 110.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 257' ' ' GLU . 46.2 m-20 -40.33 -57.86 1.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 72.25 109.291 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -39.94 -65.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.150000000000006 109.347 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.79 -170.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.122 . . . . 73.129999999999995 109.965 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.5 mt -81.69 162.27 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 70.439999999999998 109.255 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' HIS . . . . . 0.551 ' NE2' ' CD1' ' A' ' 264' ' ' ILE . 1.3 t-160 -148.66 103.0 3.35 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 72.209999999999994 109.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.743 ' HE2' HD13 ' A' ' 261' ' ' LEU . 84.4 m-85 -116.15 130.68 56.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 65.340000000000003 110.995 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.824 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 45.6 mt -131.81 105.21 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 75.140000000000001 109.289 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 252' ' ' VAL . 0.1 OUTLIER -95.82 128.12 42.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.329999999999998 109.272 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.824 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 3.5 m-85 -114.31 113.84 25.13 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 72.140000000000001 111.018 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.65 ' CG ' HD13 ' A' ' 273' ' ' ILE . 26.6 t30 -72.34 87.35 1.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.25 109.329 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.645 ' HZ1' ' HA ' ' A' ' 301' ' ' LYS . 3.1 mmpt? -96.22 31.28 2.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.239999999999995 109.328 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 248' ' ' PRO . 6.6 p -102.56 143.73 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 62.109999999999999 110.376 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.44 ' O ' HD11 ' A' ' 300' ' ' ILE . 23.9 m120 -47.35 -53.42 13.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 75.109999999999999 109.309 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 37.5 pt -62.25 177.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.34 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.1 mt -118.96 136.06 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 75.400000000000006 109.282 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.65 HD13 ' CG ' ' A' ' 267' ' ' ASN . 0.9 OUTLIER -63.28 140.18 97.66 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.145 . . . . 72.150000000000006 109.323 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 -34.16 3.97 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.484 1.781 . . . . 71.209999999999994 110.948 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 87.11 177.39 48.95 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.462 1.101 . . . . 71.340000000000003 111.036 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.99 27.49 8.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 0.789 . . . . 73.209999999999994 109.274 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.417 ' C ' ' OG1' ' A' ' 278' ' ' THR . 6.2 m -75.19 -177.07 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 73.420000000000002 108.313 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.921 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.4 m -154.51 100.02 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 65.129999999999995 110.364 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.555 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 0.4 OUTLIER -54.76 170.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.230000000000004 111.019 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.452 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 70.8 tt0 -160.58 84.21 0.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 73.150000000000006 110.302 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 29.6 p90 -115.32 133.1 56.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 74.219999999999999 110.983 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 2.8 t -128.72 -172.08 2.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.544 1.153 . . . . 64.109999999999999 109.991 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 22.0 t -145.73 162.81 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 75.530000000000001 109.976 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -76.59 -5.19 46.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 75.109999999999999 110.274 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 6.1 pt -118.48 -43.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 70.299999999999997 109.3 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.8 m -96.26 178.14 5.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.518 1.136 . . . . 71.150000000000006 110.03 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -95.36 170.75 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 75.319999999999993 110.302 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.452 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 7.7 p -71.8 163.51 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 72.0 109.306 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 288' ' ' VAL . 1.2 t80 -147.34 134.74 20.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 74.400000000000006 111.048 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 8.2 p -115.73 117.3 29.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.428 1.08 . . . . 62.530000000000001 110.007 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.1 mt -106.47 128.46 61.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 73.209999999999994 109.317 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.8 108.85 4.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 71.319999999999993 109.287 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.55 ' HG2' HD21 ' A' ' 306' ' ' LEU . 90.0 mtp -75.02 139.55 42.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 72.239999999999995 111.02 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.72 144.49 0.17 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.478 1.111 . . . . 74.400000000000006 110.995 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -24.43 12.8 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.515 1.797 . . . . 71.549999999999997 111.005 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -75.35 141.55 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 71.150000000000006 109.637 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.75 -174.18 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 74.400000000000006 110.327 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 39.1 mt -110.93 -74.2 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 71.150000000000006 109.278 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 123.53 162.95 11.63 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.468 1.105 . . . . 42.43 111.005 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 270' ' ' ASN . 36.5 mt -62.09 -30.58 49.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.519 0.776 . . . . 64.209999999999994 109.273 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.645 ' HA ' ' HZ1' ' A' ' 268' ' ' LYS . 48.6 mmtt -110.77 -22.88 11.35 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 75.230000000000004 109.27 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -59.08 164.63 9.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.527 1.142 . . . . 75.209999999999994 111.03 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -131.73 -179.84 5.63 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.519 0.776 . . . . 73.420000000000002 110.295 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 25.2 tptt -143.6 144.66 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 75.310000000000002 109.337 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.556 ' HG2' ' CH2' ' A' ' 307' ' ' TRP . 8.8 mp0 -112.71 143.6 43.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 61.450000000000003 110.302 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 12.7 mt -140.83 62.34 1.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.209999999999994 109.304 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.556 ' CH2' ' HG2' ' A' ' 305' ' ' GLU . 1.5 m-90 -68.82 118.72 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.971 -1.122 . . . . 74.239999999999995 107.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.9 m-30 -111.97 168.57 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 111.023 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.492 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -155.02 160.76 30.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 74.299999999999997 110.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.0 -40.19 1.27 Allowed 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.023 -2.491 . . . . 71.450000000000003 110.986 0.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.1 p 175.56 132.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 52.130000000000003 110.029 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.499 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.5 mp -113.5 158.23 39.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 70.030000000000001 109.282 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 147.06 33.54 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.497 1.788 . . . . 54.399999999999999 110.966 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.851 HG22 HD12 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -131.92 163.52 49.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 73.530000000000001 110.349 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 175.73 46.54 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.967 -2.514 . . . . 64.219999999999999 111.021 -0.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.851 HD12 HG22 ' A' ' 314' ' ' THR . 5.3 mp -93.52 65.57 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.502 1.126 . . . . 71.129999999999995 109.294 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 125.37 29.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.494 1.121 . . . . 74.5 109.998 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 73.51 29.1 1.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.030000000000001 109.306 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.4 m-85 -110.49 134.22 52.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.548 1.155 . . . . 74.519999999999996 110.988 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.826 HG23 ' HD3' ' A' ' 322' ' ' LYS . 1.2 m -49.32 -64.72 0.72 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 73.400000000000006 110.398 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.653 ' HE1' ' CD1' ' A' ' 342' ' ' ILE . 4.3 ttm 31.87 42.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 75.530000000000001 110.98 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.826 ' HD3' HG23 ' A' ' 320' ' ' THR . 16.9 pttt -80.09 -160.33 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.565 1.166 . . . . 74.109999999999999 109.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -151.96 133.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.142 . . . . 64.040000000000006 109.324 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.921 HG22 ' O ' ' A' ' 278' ' ' THR . 22.1 m -112.33 177.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 71.540000000000006 109.303 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.847 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -111.73 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.538 1.149 . . . . 73.510000000000005 109.306 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -1.91 12.7 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.489 1.118 . . . . 64.239999999999995 110.341 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.42 -8.19 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 72.310000000000002 109.357 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.89 5.86 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.516 1.135 . . . . 65.120000000000005 110.987 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.847 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.4 OUTLIER -149.64 129.81 13.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 0.758 . . . . 61.219999999999999 110.326 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.759 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.3 m -64.1 113.39 3.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 74.540000000000006 110.39 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.651 ' CG2' ' ND2' ' A' ' 325' ' ' ASN . 1.7 pt -91.22 -34.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 70.430000000000007 109.279 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.949 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.7 mt -138.1 165.53 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 72.439999999999998 109.285 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -153.57 121.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 73.150000000000006 109.303 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.434 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -70.11 126.82 17.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.506 1.129 . . . . 25.219999999999999 111.014 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.499 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -44.8 -26.56 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 0.788 . . . . 74.219999999999999 109.314 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.6 OUTLIER 47.09 65.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.530000000000001 108.285 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -77.09 -171.23 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 73.400000000000006 109.299 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 54.66 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.126 . . . . 73.420000000000002 109.267 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.2 m -169.62 163.09 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 50.340000000000003 110.033 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -65.93 -32.49 74.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.430000000000007 109.323 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.32 135.41 57.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 110.339 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.653 ' CD1' ' HE1' ' A' ' 321' ' ' MET . 82.1 mt -143.62 120.78 5.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 70.150000000000006 109.297 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 251' ' ' HIS . 16.2 p -123.27 84.57 2.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.568 1.168 . . . . 65.140000000000001 110.422 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.949 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.2 mp -38.75 147.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 72.549999999999997 109.306 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -128.87 -48.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 72.0 109.354 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 155.22 147.36 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 73.420000000000002 110.004 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.4 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.3 Cg_endo -75.02 -70.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.528 1.804 . . . . 72.040000000000006 111.014 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.788 HD13 ' O ' ' A' ' 348' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 61.439999999999998 109.317 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 53.4 t30 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.332 -0.618 . . . . 71.420000000000002 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 268' ' ' LYS . 1.4 m-20 -141.93 91.44 8.11 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.450000000000003 109.307 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 269' ' ' THR . 18.3 Cg_endo -75.01 -10.69 21.31 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.464 1.771 . . . . 62.109999999999999 110.966 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.719 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -39.82 141.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 70.140000000000001 109.29 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.698 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -129.78 105.15 7.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 71.230000000000004 109.274 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.596 ' O ' HG23 ' A' ' 252' ' ' VAL . 9.7 t-160 -71.24 163.63 27.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 75.549999999999997 109.616 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.696 HG21 HD23 ' A' ' 265' ' ' LEU . 54.8 t -158.38 126.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 54.25 109.29 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -96.84 135.82 38.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.565 1.165 . . . . 70.299999999999997 110.296 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 340' ' ' ASN . 48.1 t -108.27 100.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 72.5 109.302 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -60.66 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.52 1.138 . . . . 71.400000000000006 109.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.949 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER 53.72 68.89 0.78 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 43.43 109.298 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.25 157.27 15.97 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.492 1.12 . . . . 64.420000000000002 110.301 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -52.06 -33.54 39.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 72.329999999999998 109.291 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -68.08 -50.96 51.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 72.409999999999997 109.363 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p 178.49 -178.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.466 1.104 . . . . 62.119999999999997 109.979 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.949 HD23 ' HA ' ' A' ' 256' ' ' ASN . 77.7 mt -76.07 178.56 6.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 60.240000000000002 109.279 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -176.44 86.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.116 . . . . 62.420000000000002 109.619 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.686 ' CZ ' HD13 ' A' ' 261' ' ' LEU . 4.8 m-30 -96.84 134.09 40.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 71.420000000000002 110.995 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.604 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 23.1 mt -127.88 109.62 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 73.439999999999998 109.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.52 129.31 45.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 55.43 109.305 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.653 ' N ' ' CD1' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -104.19 113.12 26.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 74.349999999999994 110.953 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.695 ' HB2' HD13 ' A' ' 273' ' ' ILE . 18.2 t30 -68.5 72.91 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 65.310000000000002 109.248 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.8 mmtt -87.35 53.59 2.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.510000000000005 109.294 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 248' ' ' PRO . 30.7 p -120.64 -176.38 3.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.521 1.138 . . . . 62.409999999999997 110.381 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.21 -59.42 2.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 44.420000000000002 109.315 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.693 ' C ' HD12 ' A' ' 272' ' ' ILE . 0.1 OUTLIER -78.06 -176.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 72.129999999999995 109.308 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.693 HD12 ' C ' ' A' ' 271' ' ' ILE . 2.3 mp -120.22 143.42 32.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.501 1.125 . . . . 63.409999999999997 109.29 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -43.66 142.44 1.87 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.453 1.095 . . . . 74.230000000000004 109.335 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -38.15 1.71 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.439 1.757 . . . . 72.239999999999995 110.983 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 99.51 160.18 28.98 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.523 1.139 . . . . 74.430000000000007 111.007 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 8.1 t-20 81.7 17.34 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 0.749 . . . . 62.520000000000003 109.29 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 87.3 m -66.61 170.57 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 108.303 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.873 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.8 m -153.64 99.24 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.554 1.159 . . . . 64.219999999999999 110.405 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.754 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.9 OUTLIER -50.79 171.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.111 . . . . 62.25 111.035 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -172.99 99.4 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 73.219999999999999 110.299 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 281' ' ' PHE . 2.0 p90 -122.9 141.98 51.29 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.57 1.168 . . . . 73.409999999999997 111.015 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 54.7 p -74.88 159.13 32.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 71.150000000000006 109.983 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 9.8 p -143.25 -161.55 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.148 . . . . 64.540000000000006 110.003 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 286' ' ' SER . 9.1 mt-30 -54.0 -172.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.551 1.157 . . . . 75.430000000000007 110.325 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 286' ' ' SER . 1.0 OUTLIER -42.09 -28.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 109.303 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.429 ' N ' ' C ' ' A' ' 284' ' ' GLN . 0.9 OUTLIER -48.22 175.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 109.992 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -92.68 149.52 21.27 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.129 . . . . 74.239999999999995 110.344 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.551 HG22 ' H ' ' A' ' 289' ' ' PHE . 10.4 p -52.36 171.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 74.230000000000004 109.313 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.551 ' H ' HG22 ' A' ' 288' ' ' VAL . 4.3 t80 -145.22 162.36 37.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 74.530000000000001 110.992 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.605 ' OG ' HG22 ' A' ' 278' ' ' THR . 4.0 t -137.05 124.92 22.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.097 . . . . 74.530000000000001 109.983 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.776 HD11 ' HD1' ' A' ' 308' ' ' PHE . 12.5 mt -103.67 148.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.558 1.161 . . . . 73.129999999999995 109.295 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.527 ' CD ' ' N ' ' A' ' 292' ' ' LYS . 0.3 OUTLIER -79.86 123.71 28.0 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 42.240000000000002 109.284 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.951 ' HG2' HD21 ' A' ' 306' ' ' LEU . 37.5 mtp -92.77 15.0 15.59 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.561 1.163 . . . . 64.5 110.999 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.19 151.91 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.482 1.114 . . . . 51.240000000000002 110.963 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.427 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.03 -16.44 20.13 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.53 1.805 . . . . 73.329999999999998 110.993 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -62.84 151.14 39.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 63.399999999999999 109.6 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.437 ' C ' HD13 ' A' ' 298' ' ' ILE . 4.4 mp0 -87.6 165.4 15.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.56 1.163 . . . . 65.150000000000006 110.319 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 302' ' ' GLY . 2.7 mm -89.05 -95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 73.109999999999999 109.305 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 120.11 168.88 13.9 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.468 1.105 . . . . 74.140000000000001 111.013 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.854 HG22 ' HD3' ' A' ' 301' ' ' LYS . 15.5 mm -60.36 -43.05 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.507 0.769 . . . . 71.200000000000003 109.304 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.854 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.5 OUTLIER -108.94 -12.8 14.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 60.539999999999999 109.357 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.7 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -81.27 49.62 4.04 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 61.420000000000002 111.019 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.524 ' HG2' ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -41.89 164.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 0.784 . . . . 70.049999999999997 110.29 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.5 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 41.9 tptt -118.4 165.69 13.56 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.13 . . . . 72.099999999999994 109.315 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -134.86 144.96 47.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 64.5 110.346 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.951 HD21 ' HG2' ' A' ' 293' ' ' MET . 45.3 mt -140.72 61.69 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 109.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -72.19 123.02 22.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.963 -1.125 . . . . 71.420000000000002 107.963 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.776 ' HD1' HD11 ' A' ' 291' ' ' ILE . 57.0 t80 -119.24 172.09 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 74.400000000000006 111.001 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -147.24 162.66 31.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.148 . . . . 74.239999999999995 110.972 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.03 -46.13 0.4 Allowed 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.025 -2.49 . . . . 34.329999999999998 110.952 0.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 28.7 p 177.83 170.41 0.68 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.109999999999999 110.011 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.949 ' HG ' HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -153.7 161.12 29.99 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.459 1.099 . . . . 63.229999999999997 109.288 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 312' ' ' LEU . 18.3 Cg_endo -74.96 144.09 29.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.509 1.794 . . . . 50.32 111.006 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.632 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -126.06 165.45 27.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 110.356 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.04 -176.11 17.43 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.987 -2.505 . . . . 62.409999999999997 111.031 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.575 HD13 ' HE3' ' A' ' 321' ' ' MET . 2.0 mt -98.21 61.42 1.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.150000000000006 109.311 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.9 p -74.62 119.9 19.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 74.519999999999996 110.034 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 317' ' ' SER . 45.3 t30 79.42 40.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.453 1.096 . . . . 61.32 109.338 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.436 ' CG ' ' HB3' ' A' ' 316' ' ' LEU . 24.3 m-85 -119.84 142.99 48.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 74.030000000000001 111.013 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.524 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.3 m -59.75 -56.76 17.76 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 71.030000000000001 110.383 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.575 ' HE3' HD13 ' A' ' 316' ' ' LEU . 0.9 OUTLIER 26.93 58.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 74.200000000000003 110.953 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.577 ' HD3' HG21 ' A' ' 330' ' ' THR . 29.6 mttm -94.86 -168.17 1.77 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 73.409999999999997 109.321 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.414 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 2.9 t -150.35 133.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 73.540000000000006 109.268 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 278' ' ' THR . 10.9 m -109.98 172.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 72.519999999999996 109.23 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -109.61 -163.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.494 1.121 . . . . 73.439999999999998 109.268 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.16 -12.86 22.1 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.133 . . . . 71.519999999999996 110.303 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.5 22.81 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 64.310000000000002 109.356 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.27 25.66 0.79 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.543 1.152 . . . . 74.230000000000004 111.012 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.493 ' C ' HG12 ' A' ' 324' ' ' VAL . 6.5 pt-20 -106.78 128.66 54.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 0.76 . . . . 71.230000000000004 110.286 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.797 ' N ' HG12 ' A' ' 324' ' ' VAL . 9.0 m -54.29 135.02 45.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.112 . . . . 75.409999999999997 110.413 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.4 pt -114.99 -42.09 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.136 . . . . 64.209999999999994 109.293 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.444 ' C ' HG13 ' A' ' 333' ' ' VAL . 12.6 mt -136.42 171.25 14.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 70.0 109.273 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.53 HG12 ' CG ' ' A' ' 322' ' ' LYS . 14.6 m -153.31 141.24 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.409999999999997 109.336 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -84.97 136.89 14.95 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.489 1.118 . . . . 71.209999999999994 110.988 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -67.2 -38.56 85.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 0.749 . . . . 75.349999999999994 109.302 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.494 ' H ' HG23 ' A' ' 342' ' ' ILE . 0.1 OUTLIER 40.18 88.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.496 1.123 . . . . 70.5 108.299 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -116.81 81.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 63.200000000000003 109.28 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 338' ' ' ASP . 3.4 p-10 39.93 49.9 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.15 . . . . 75.310000000000002 109.258 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 26.9 m -157.21 136.67 12.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 74.450000000000003 109.997 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.697 ' O ' HG23 ' A' ' 254' ' ' VAL . 7.1 m120 -58.14 -36.82 73.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 75.109999999999999 109.326 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.19 134.41 48.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.549 1.156 . . . . 73.319999999999993 110.315 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 336' ' ' CYS . 4.8 mt -136.35 134.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 33.240000000000002 109.31 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 344' ' ' LEU . 39.3 p -125.27 86.38 2.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 61.509999999999998 110.363 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' A' ' 250' ' ' LEU . 7.2 mp -40.38 130.85 2.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 71.25 109.32 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.9 ptpt -117.54 -60.04 1.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.107 . . . . 44.0 109.292 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.517 ' C ' HG22 ' A' ' 333' ' ' VAL . 1.5 m 159.47 157.28 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 53.219999999999999 110.012 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 -61.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.536 1.809 . . . . 72.430000000000007 110.999 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 74.129999999999995 109.282 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.331 -0.618 . . . . 63.109999999999999 109.331 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.515 ' HB3' HD11 ' A' ' 249' ' ' LEU . 6.3 m-20 -143.64 74.76 16.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 65.200000000000003 109.325 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.586 ' C ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.94 -0.21 9.66 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.517 1.798 . . . . 74.239999999999995 111.015 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -75.1 148.89 39.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 72.030000000000001 109.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.603 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -110.8 99.94 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.582 1.176 . . . . 73.150000000000006 109.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.412 ' NE2' ' HG2' ' A' ' 341' ' ' GLU . 2.4 t-160 -90.33 131.54 36.07 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 71.150000000000006 109.614 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 265' ' ' LEU . 79.7 t -121.08 164.64 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 72.450000000000003 109.306 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.474 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.4 tp10 -129.72 147.26 51.48 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 63.32 110.325 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 263' ' ' PHE . 61.6 t -121.19 106.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.145 . . . . 71.25 109.335 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 t -72.85 -61.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.120000000000005 110.002 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.918 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.9 t-20 53.42 57.03 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 62.350000000000001 109.287 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 260' ' ' SER . 5.0 pt-20 -161.15 -174.54 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 74.439999999999998 110.344 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 71.86 17.15 5.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 63.340000000000003 109.268 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 3.6 m-20 82.61 18.77 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 75.140000000000001 109.317 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -170.05 -170.07 0.94 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 54.030000000000001 109.983 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.918 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -98.87 165.72 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.546 1.154 . . . . 72.439999999999998 109.298 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.85 102.38 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 73.109999999999999 109.611 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.779 ' CE2' HG22 ' A' ' 254' ' ' VAL . 85.1 m-85 -107.73 142.15 38.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.535 1.147 . . . . 73.310000000000002 110.977 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.686 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 53.2 mt -132.84 124.25 50.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.528 1.142 . . . . 74.439999999999998 109.314 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.814 ' N ' HD12 ' A' ' 265' ' ' LEU . 0.0 OUTLIER -120.53 141.87 49.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 61.43 109.291 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -127.78 140.52 52.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.516 1.135 . . . . 73.129999999999995 110.986 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.466 ' O ' ' CG ' ' A' ' 267' ' ' ASN . 46.7 p-10 -89.79 64.24 6.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 63.409999999999997 109.275 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.45 ' CE ' ' HA ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -58.03 -15.96 11.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 73.530000000000001 109.284 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.586 HG22 ' C ' ' A' ' 248' ' ' PRO . 43.8 p -54.68 -166.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 60.32 110.39 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -99.15 -59.03 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 74.340000000000003 109.331 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 4.1 pt -60.29 152.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.463 1.102 . . . . 63.340000000000003 109.282 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.77 149.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 54.5 109.291 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 273' ' ' ILE . 3.5 mm -67.18 139.13 94.91 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.127 . . . . 53.409999999999997 109.317 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -26.95 10.52 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.486 1.782 . . . . 73.109999999999999 110.973 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 81.36 -178.51 53.86 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.504 1.128 . . . . 44.420000000000002 111.047 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 57.16 49.48 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 0.76 . . . . 63.100000000000001 109.323 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.414 ' CB ' ' SD ' ' A' ' 293' ' ' MET . 12.2 m -94.73 178.97 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 51.240000000000002 108.325 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.899 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.0 OUTLIER -152.22 97.31 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 61.210000000000001 110.378 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 1.002 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -53.79 159.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 74.549999999999997 110.969 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.664 ' HG3' HG21 ' A' ' 288' ' ' VAL . 13.3 tt0 -143.61 75.94 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 75.299999999999997 110.327 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 291' ' ' ILE . 35.0 p90 -109.45 121.79 45.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.145 . . . . 71.25 110.962 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 288' ' ' VAL . 3.7 p -109.19 179.61 4.11 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 73.140000000000001 109.981 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.569 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.4 p -119.84 -42.03 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 51.420000000000002 110.01 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.413 ' C ' ' N ' ' A' ' 286' ' ' SER . 6.3 tp-100 -148.25 166.43 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.430000000000007 110.299 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 286' ' ' SER . 4.2 tt -47.19 -25.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.49 1.119 . . . . 64.010000000000005 109.306 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.413 ' N ' ' C ' ' A' ' 284' ' ' GLN . 12.6 t -38.54 -76.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 64.329999999999998 109.971 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.95 174.24 15.28 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.139 . . . . 62.020000000000003 110.328 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.664 HG21 ' HG3' ' A' ' 280' ' ' GLU . 14.8 p -122.47 170.57 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 75.239999999999995 109.299 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.522 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.6 t80 -131.69 137.83 48.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 74.319999999999993 111.054 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 54.1 p -116.75 126.21 52.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.122 . . . . 73.409999999999997 109.987 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 281' ' ' PHE . 8.5 mt -105.11 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 73.120000000000005 109.289 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.412 ' HD3' HG23 ' A' ' 278' ' ' THR . 8.7 mmtp -67.32 110.81 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.531 1.144 . . . . 51.030000000000001 109.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.92 ' HG2' HD21 ' A' ' 306' ' ' LEU . 93.0 mtp -81.76 134.79 35.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.209999999999994 111.006 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.68 145.52 0.13 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.515 1.135 . . . . 63.149999999999999 111.031 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -20.95 16.5 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.516 1.798 . . . . 62.43 111.013 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.74 129.14 38.77 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 109.577 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.09 153.16 30.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.124 . . . . 74.120000000000005 110.254 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.898 HG23 ' O ' ' A' ' 302' ' ' GLY . 3.2 mt -70.22 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 71.200000000000003 109.293 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.851 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 108.69 -177.04 20.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.505 1.128 . . . . 71.099999999999994 111.004 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 301' ' ' LYS . 59.6 mt -38.24 -90.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 74.239999999999995 109.282 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.618 ' N ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -91.3 23.93 3.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.209999999999994 109.272 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.898 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -83.74 45.14 3.42 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 74.200000000000003 111.006 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 302' ' ' GLY . 1.4 pt20 -39.99 161.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 0.761 . . . . 73.519999999999996 110.283 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 298' ' ' ILE . 30.5 tptt -121.92 152.35 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 72.439999999999998 109.281 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 11.9 mp0 -118.37 133.83 55.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 71.409999999999997 110.307 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 1.002 HD13 ' CG ' ' A' ' 279' ' ' PHE . 35.5 mt -126.35 55.57 1.49 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 64.109999999999999 109.303 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 138.34 55.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 75.340000000000003 107.999 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 309' ' ' PHE . 37.2 t80 -134.64 166.59 22.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.109999999999999 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.638 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -138.99 148.09 56.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 73.040000000000006 111.028 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.01 -53.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.005 -2.498 . . . . 73.150000000000006 110.975 0.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 23.6 p -178.8 162.66 1.35 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.503 1.127 . . . . 63.530000000000001 109.971 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.0 OUTLIER -128.61 159.16 69.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.157 . . . . 74.010000000000005 109.292 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 145.07 31.03 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.483 1.781 . . . . 61.32 111.007 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.85 HG22 HD12 ' A' ' 316' ' ' LEU . 0.9 OUTLIER -125.81 160.27 57.24 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 74.329999999999998 110.395 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.9 170.35 71.98 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.032 -2.487 . . . . 75.530000000000001 111.057 -0.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.85 HD12 HG22 ' A' ' 314' ' ' THR . 5.7 mp -87.68 66.26 8.81 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.536 1.147 . . . . 73.120000000000005 109.28 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.6 p -81.78 127.31 32.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 1.145 . . . . 73.349999999999994 109.975 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.2 OUTLIER 76.66 21.47 1.27 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 74.430000000000007 109.262 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.735 ' HD2' HD23 ' A' ' 316' ' ' LEU . 3.3 m-85 -103.93 134.08 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.521 1.138 . . . . 73.430000000000007 111.039 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.494 HG22 ' HG3' ' A' ' 322' ' ' LYS . 88.7 m -51.25 -60.54 3.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.399999999999999 110.42 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.71 ' HE2' HD22 ' A' ' 316' ' ' LEU . 3.5 ttm 33.08 40.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 61.140000000000001 110.996 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.501 ' HD3' HG21 ' A' ' 330' ' ' THR . 36.1 mttt -72.81 -174.0 1.34 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 71.25 109.287 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 t -143.51 121.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 72.310000000000002 109.32 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 278' ' ' THR . 28.4 m -110.12 171.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 75.439999999999998 109.356 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.477 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 0.1 OUTLIER -109.17 -155.51 0.56 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 72.219999999999999 109.296 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -77.38 -4.0 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.56 1.163 . . . . 75.439999999999998 110.324 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -105.25 8.98 34.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 65.25 109.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.74 14.89 24.4 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.472 1.108 . . . . 63.119999999999997 110.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 7.3 pt-20 -95.83 116.39 28.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 71.040000000000006 110.279 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.624 ' CA ' HG12 ' A' ' 324' ' ' VAL . 1.8 m -50.83 96.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 110.386 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 3.1 pt -66.81 -36.87 78.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 73.519999999999996 109.312 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.914 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.6 mt -147.19 170.7 16.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 70.519999999999996 109.323 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -147.17 119.3 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 75.040000000000006 109.291 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -71.45 125.09 11.42 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.543 1.152 . . . . 51.049999999999997 111.004 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.787 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -48.85 -26.44 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.563 0.802 . . . . 72.319999999999993 109.324 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 48.33 62.08 2.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 75.0 108.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.787 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -73.39 -176.78 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 74.349999999999994 109.315 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.62 55.98 1.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 61.310000000000002 109.262 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.7 m -169.08 149.16 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 55.310000000000002 109.973 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.418 ' N ' ' HB3' ' A' ' 315' ' ' PRO . 10.2 m-20 -55.31 -19.95 10.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 74.409999999999997 109.29 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.412 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 18.4 mt-10 -72.69 141.37 48.22 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.109999999999999 110.302 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.681 HD11 ' HE1' ' A' ' 321' ' ' MET . 64.5 mt -146.84 120.84 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.13 . . . . 73.129999999999995 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 344' ' ' LEU . 15.4 p -123.94 85.44 2.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.451 1.095 . . . . 70.510000000000005 110.345 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.914 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.4 mp -39.31 152.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 75.409999999999997 109.31 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -129.87 -51.72 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 52.100000000000001 109.306 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 158.18 146.97 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 70.049999999999997 110.018 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.664 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.1 Cg_endo -74.98 -50.71 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.502 1.791 . . . . 63.229999999999997 110.986 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.13 . . . . 70.340000000000003 109.308 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.329 -0.619 . . . . 73.409999999999997 109.329 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.889 ' HB3' HD12 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -139.93 147.7 52.1 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.479 1.112 . . . . 75.109999999999999 109.319 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -3.79 14.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.46 1.769 . . . . 51.43 111.009 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.914 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.71 132.53 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 64.439999999999998 109.332 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.545 HD22 HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -116.58 103.21 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 109.302 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -67.35 147.35 53.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 72.420000000000002 109.592 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.696 HG13 ' HG ' ' A' ' 265' ' ' LEU . 45.1 t -145.37 161.92 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 63.310000000000002 109.358 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.42 ' N ' HG12 ' A' ' 252' ' ' VAL . 11.2 tp10 -134.39 132.48 39.47 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.138 . . . . 71.109999999999999 110.296 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.593 ' CG1' HG21 ' A' ' 314' ' ' THR . 94.8 t -109.69 110.72 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 72.120000000000005 109.246 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.428 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.7 t -77.93 -67.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.13 . . . . 63.229999999999997 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.881 ' HA ' HD23 ' A' ' 261' ' ' LEU . 4.8 t-20 61.15 63.91 1.18 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.56 1.162 . . . . 71.209999999999994 109.287 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -88.86 148.61 23.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 65.120000000000005 110.291 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.04 -24.58 1.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.474 1.109 . . . . 75.209999999999994 109.322 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -76.18 -55.37 5.64 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 70.299999999999997 109.306 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.9 m -168.37 -175.02 2.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.529 1.143 . . . . 73.409999999999997 109.942 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.881 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.1 mt -86.48 176.02 8.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.239999999999995 109.316 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' HIS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 10.7 t-160 -174.71 107.93 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.540000000000006 109.573 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.406 ' HE1' HD13 ' A' ' 261' ' ' LEU . 88.0 m-85 -112.13 118.56 35.7 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 75.450000000000003 111.032 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.505 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 13.7 mt -112.39 104.59 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 52.229999999999997 109.254 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.696 ' HG ' HG13 ' A' ' 252' ' ' VAL . 0.8 OUTLIER -101.4 129.79 47.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 71.209999999999994 109.319 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.596 ' N ' ' CD1' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -102.54 119.05 38.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 61.32 110.983 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.486 ' OD1' ' CD1' ' A' ' 273' ' ' ILE . 34.9 t30 -65.71 75.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.132 . . . . 75.439999999999998 109.276 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.1 mmtt -92.07 64.63 4.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 64.230000000000004 109.305 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 72.5 p -142.67 160.43 40.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 71.120000000000005 110.406 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.48 -54.27 45.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 72.230000000000004 109.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.4 pt -69.8 163.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 73.420000000000002 109.292 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 17.9 mt -114.74 139.14 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 73.5 109.333 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.486 ' CD1' ' OD1' ' A' ' 267' ' ' ASN . 1.8 mp -54.68 137.23 63.25 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 75.400000000000006 109.296 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.2 Cg_endo -75.01 -26.34 10.99 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.494 1.787 . . . . 44.009999999999998 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.61 157.76 29.61 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.504 1.127 . . . . 72.230000000000004 111.011 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.5 t30 73.41 39.44 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 0.755 . . . . 75.439999999999998 109.277 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.45 -174.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 63.450000000000003 108.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 291' ' ' ILE . 7.3 m -155.12 156.26 35.47 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.44 1.087 . . . . 63.420000000000002 110.384 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.536 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.9 t80 -108.75 171.07 7.64 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 72.329999999999998 110.968 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.526 ' HG3' HG21 ' A' ' 288' ' ' VAL . 9.4 tt0 -161.59 93.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 71.109999999999999 110.31 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -113.6 133.91 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 74.420000000000002 110.991 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -94.4 -175.18 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 64.129999999999995 109.987 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.559 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 24.8 t -173.48 -169.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 61.240000000000002 110.017 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.98 -14.75 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.319999999999993 110.268 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 286' ' ' SER . 2.3 pt -63.44 -16.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 75.25 109.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 285' ' ' ILE . 0.5 OUTLIER 87.51 -59.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 71.409999999999997 109.974 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.52 170.29 10.91 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.118 . . . . 71.299999999999997 110.335 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.544 HG22 ' H ' ' A' ' 289' ' ' PHE . 8.8 p -126.43 171.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 70.239999999999995 109.274 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.544 ' H ' HG22 ' A' ' 288' ' ' VAL . 8.5 t80 -148.23 149.31 31.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.527 1.142 . . . . 73.230000000000004 110.965 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 279' ' ' PHE . 4.9 p -118.43 128.09 54.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 43.140000000000001 109.984 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 278' ' ' THR . 17.7 mt -101.63 129.01 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.107 . . . . 64.420000000000002 109.278 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -72.01 114.62 10.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 71.439999999999998 109.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.765 ' HG2' HD21 ' A' ' 306' ' ' LEU . 61.8 mtp -88.18 144.71 26.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 74.349999999999994 111.077 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -41.49 147.58 0.41 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.517 1.135 . . . . 62.130000000000003 111.005 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -17.83 19.28 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.783 . . . . 72.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.88 -177.04 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.468 1.105 . . . . 74.450000000000003 109.63 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.36 174.49 5.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.239999999999995 110.32 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.7 mt -104.46 -82.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.113 . . . . 60.409999999999997 109.298 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.98 159.57 20.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.54 1.15 . . . . 74.319999999999993 111.007 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.61 -63.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.5 0.764 . . . . 75.439999999999998 109.287 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.52 -29.3 68.67 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 109.276 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -68.52 156.61 53.18 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.464 1.103 . . . . 42.229999999999997 110.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.81 171.68 12.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 0.768 . . . . 71.540000000000006 110.311 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 293' ' ' MET . 37.2 tptt -118.78 165.11 14.43 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 73.329999999999998 109.341 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -143.88 124.6 14.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 72.530000000000001 110.279 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.765 HD21 ' HG2' ' A' ' 293' ' ' MET . 10.3 mt -135.97 60.21 1.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 64.030000000000001 109.333 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.479 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 11.2 p-90 -72.48 134.68 45.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.514 1.134 . . . . 75.209999999999994 108.034 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.816 ' CE2' HD11 ' A' ' 312' ' ' LEU . 45.3 t80 -126.12 166.73 16.48 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.122 . . . . 74.129999999999995 111.028 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.647 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -137.91 157.16 73.72 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 74.129999999999995 110.972 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.95 -41.31 1.02 Allowed 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.99 -2.504 . . . . 40.130000000000003 111.038 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 172.93 143.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.340000000000003 109.993 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.816 HD11 ' CE2' ' A' ' 308' ' ' PHE . 4.4 mp -115.16 159.58 37.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.549999999999997 109.316 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 148.5 35.31 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 75.540000000000006 110.988 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.593 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.2 OUTLIER -130.35 164.42 41.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 71.549999999999997 110.382 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 -177.73 21.36 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.019 -2.492 . . . . 74.140000000000001 111.006 0.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.984 HD13 ' SD ' ' A' ' 321' ' ' MET . 1.8 mt -102.49 52.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.442 1.089 . . . . 74.219999999999999 109.308 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.4 p -76.08 127.19 32.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 75.0 109.988 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 317' ' ' SER . 28.7 t30 81.07 30.83 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 74.120000000000005 109.342 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.806 ' CE2' HD23 ' A' ' 316' ' ' LEU . 5.2 m-85 -109.56 167.55 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.439999999999998 111.035 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.91 HG22 ' HG2' ' A' ' 322' ' ' LYS . 32.3 m -79.6 -59.75 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 64.400000000000006 110.425 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.984 ' SD ' HD13 ' A' ' 316' ' ' LEU . 0.6 OUTLIER 27.03 79.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.108 . . . . 73.409999999999997 110.971 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.91 ' HG2' HG22 ' A' ' 320' ' ' THR . 7.6 pttt -112.66 -170.66 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 72.540000000000006 109.325 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.589 ' CG2' HD21 ' A' ' 344' ' ' LEU . 49.4 t -136.89 138.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 61.020000000000003 109.305 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.737 HG23 ' H ' ' A' ' 329' ' ' GLU . 0.4 OUTLIER -122.4 138.69 51.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.554 1.158 . . . . 75.010000000000005 109.271 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.713 ' OD1' HD13 ' A' ' 331' ' ' ILE . 0.5 OUTLIER -76.82 -170.54 1.63 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.13 . . . . 64.200000000000003 109.284 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -78.99 4.32 14.66 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 53.109999999999999 110.267 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.04 -3.28 41.7 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 74.420000000000002 109.296 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 65.21 54.47 26.96 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.485 1.116 . . . . 61.329999999999998 110.998 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.737 ' H ' HG23 ' A' ' 324' ' ' VAL . 9.9 pt-20 -157.04 121.86 4.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 0.77 . . . . 64.349999999999994 110.311 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.414 HG21 ' HD3' ' A' ' 322' ' ' LYS . 69.0 m -45.26 115.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.516 1.135 . . . . 71.540000000000006 110.406 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.713 HD13 ' OD1' ' A' ' 325' ' ' ASN . 36.5 pt -98.76 -41.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 73.310000000000002 109.297 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.898 ' HB3' HD23 ' A' ' 344' ' ' LEU . 10.4 mt -131.48 168.45 17.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 73.230000000000004 109.286 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.467 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.38 122.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 74.099999999999994 109.336 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.421 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -72.45 121.53 8.17 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.131 . . . . 74.140000000000001 111.006 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -45.22 -26.71 0.53 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.461 0.742 . . . . 73.209999999999994 109.293 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 321' ' ' MET . 0.1 OUTLIER 47.83 76.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 62.140000000000001 108.312 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -90.3 -175.8 4.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 63.210000000000001 109.285 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.82 62.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.466 1.103 . . . . 65.329999999999998 109.302 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 15.4 m -171.08 150.2 3.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 74.319999999999993 109.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 254' ' ' VAL . 18.9 m-20 -60.38 -21.17 61.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 63.420000000000002 109.302 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -78.12 148.46 34.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.136 . . . . 74.150000000000006 110.289 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.601 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 57.1 mt -147.55 140.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.478 1.111 . . . . 63.549999999999997 109.309 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 11.4 p -136.13 95.53 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 64.239999999999995 110.358 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.6 mp -49.97 153.63 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 64.109999999999999 109.311 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -128.51 -76.44 0.56 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 73.439999999999998 109.286 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 5.0 p 164.84 134.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.491 1.119 . . . . 62.420000000000002 110.057 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.443 1.76 . . . . 44.409999999999997 111.039 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 72.120000000000005 109.288 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.261 -0.644 . . . . 60.539999999999999 109.261 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.42 104.46 1.84 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.148 . . . . 71.129999999999995 109.25 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.756 ' HA ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -75.02 -1.09 10.78 Favored 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 43.409999999999997 111.017 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -40.45 144.53 0.23 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 74.140000000000001 109.273 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.593 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -115.55 99.76 7.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 52.219999999999999 109.302 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.554 ' CD2' HG22 ' A' ' 343' ' ' THR . 18.8 m170 -95.52 130.83 42.22 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 74.400000000000006 109.569 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 253' ' ' GLU . 69.6 t -124.71 166.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 73.420000000000002 109.302 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.524 ' N ' HG12 ' A' ' 252' ' ' VAL . 27.8 tt0 -122.67 123.34 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 74.319999999999993 110.316 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.02 107.5 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 74.019999999999996 109.318 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -59.59 2.51 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 44.43 109.969 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.939 ' HA ' HD23 ' A' ' 261' ' ' LEU . 2.9 t-20 60.71 70.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.25 109.243 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -105.32 161.97 13.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.556 1.16 . . . . 63.340000000000003 110.293 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 259' ' ' ASN . 46.1 m-20 -41.15 -60.22 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.561 1.163 . . . . 73.409999999999997 109.293 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 258' ' ' ASP . 66.5 t30 -40.07 -64.34 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 62.329999999999998 109.353 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -178.6 -174.54 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 72.510000000000005 109.999 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.939 HD23 ' HA ' ' A' ' 256' ' ' ASN . 46.8 mt -76.19 153.97 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.491 1.119 . . . . 74.129999999999995 109.318 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -142.03 91.66 2.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 72.439999999999998 109.603 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.573 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 8.2 m-30 -98.84 133.99 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.475 1.11 . . . . 52.219999999999999 110.977 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.661 HG22 ' CE2' ' A' ' 266' ' ' TYR . 62.6 mt -127.93 121.2 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 73.510000000000005 109.294 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -107.3 119.67 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.540000000000006 109.32 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.661 ' CE2' HG22 ' A' ' 264' ' ' ILE . 5.1 m-85 -109.03 92.16 3.94 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.502 1.126 . . . . 63.140000000000001 111.027 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -54.45 95.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 70.019999999999996 109.282 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.7 28.18 7.74 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 62.310000000000002 109.343 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.756 HG22 ' HA ' ' A' ' 248' ' ' PRO . 61.3 p -87.52 -174.94 5.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.545 1.153 . . . . 72.129999999999995 110.388 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -88.69 -56.17 3.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.400000000000006 109.333 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.408 ' H ' HG23 ' A' ' 271' ' ' ILE . 0.1 OUTLIER -60.18 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.44 1.088 . . . . 71.129999999999995 109.342 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 271' ' ' ILE . 4.1 mp -124.77 123.21 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.493 1.121 . . . . 50.109999999999999 109.307 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.443 ' HA ' HD13 ' A' ' 273' ' ' ILE . 3.5 mm -40.94 137.75 1.42 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 71.319999999999993 109.306 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.03 -24.46 12.75 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.501 1.79 . . . . 72.010000000000005 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.42 169.17 31.97 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.501 1.126 . . . . 74.049999999999997 111.008 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.0 t30 63.44 36.76 11.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 0.754 . . . . 65.219999999999999 109.344 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.411 ' C ' ' OG1' ' A' ' 278' ' ' THR . 64.1 m -90.44 -176.5 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.448 1.093 . . . . 73.420000000000002 108.316 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 324' ' ' VAL . 1.6 m -153.77 129.02 9.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 71.310000000000002 110.381 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.527 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.0 OUTLIER -80.2 179.21 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.505 1.128 . . . . 75.420000000000002 111.017 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -169.97 97.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.11 . . . . 64.239999999999995 110.308 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.625 ' CE1' ' CE2' ' A' ' 308' ' ' PHE . 4.4 p90 -120.65 121.66 38.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 71.109999999999999 111.02 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 m -101.84 143.54 31.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.564 1.165 . . . . 71.150000000000006 110.027 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 56.6 m -121.65 -51.36 2.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 64.329999999999998 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -104.44 171.5 7.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 72.010000000000005 110.28 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.77 5.89 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.106 . . . . 74.0 109.322 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.2 m -69.99 -71.07 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.505 1.128 . . . . 73.420000000000002 109.989 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.66 174.84 12.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 70.310000000000002 110.247 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.05 154.16 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 53.310000000000002 109.308 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -122.7 156.73 33.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 65.409999999999997 111.014 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 6.1 p -128.1 126.34 40.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.515 1.134 . . . . 72.209999999999994 110.025 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 5.5 mt -97.68 129.47 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.133 . . . . 72.530000000000001 109.306 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.421 ' HA ' HG23 ' A' ' 278' ' ' THR . 2.8 mptp? -67.28 121.07 14.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 65.200000000000003 109.285 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 98.7 mtp -89.06 140.2 29.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 41.310000000000002 111.003 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.553 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -40.7 144.23 0.56 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.486 1.116 . . . . 74.510000000000005 110.989 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -24.72 12.72 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.509 1.794 . . . . 72.129999999999995 111.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -63.66 163.91 10.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.525 1.141 . . . . 63.219999999999999 109.61 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -100.12 128.92 46.12 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 73.340000000000003 110.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 77.0 mt -57.63 -72.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.122 . . . . 71.310000000000002 109.345 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.02 172.15 24.3 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.497 1.123 . . . . 52.119999999999997 110.997 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 13.4 mt -60.39 -54.69 31.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 74.209999999999994 109.325 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 36.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 70.230000000000004 109.27 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -125.46 147.16 16.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.57 1.169 . . . . 72.200000000000003 111.006 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -119.74 170.66 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 0.774 . . . . 74.549999999999997 110.313 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.553 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 46.3 tptt -140.4 149.72 42.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 74.209999999999994 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 2.1 mt-10 -115.23 151.16 34.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 71.209999999999994 110.327 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.807 HD12 HD11 ' A' ' 265' ' ' LEU . 20.4 mt -152.25 69.24 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.483 1.114 . . . . 63.210000000000001 109.291 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.517 ' CE2' ' HB3' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -75.23 119.74 19.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 62.310000000000002 108.005 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.7 m-30 -113.46 142.13 46.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 73.420000000000002 110.998 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -128.59 160.37 63.08 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 74.530000000000001 111.017 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -36.2 2.67 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 121.027 -2.489 . . . . 75.310000000000002 110.979 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.5 p 162.14 127.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.534 1.146 . . . . 70.450000000000003 110.025 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.512 HD12 ' CD1' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -99.32 169.5 8.07 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.417 1.073 . . . . 71.510000000000005 109.301 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 143.54 29.22 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 63.539999999999999 110.991 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.601 HG22 HD12 ' A' ' 316' ' ' LEU . 0.7 OUTLIER -131.27 162.17 57.46 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.559 1.162 . . . . 73.439999999999998 110.377 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.0 167.98 78.83 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.027 -2.489 . . . . 64.120000000000005 111.021 -0.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.792 HD22 ' HE3' ' A' ' 321' ' ' MET . 3.7 mp -87.85 46.83 1.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 73.510000000000005 109.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 58.1 p -67.7 115.8 7.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 61.140000000000001 109.961 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 317' ' ' SER . 4.2 t30 83.42 39.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 71.239999999999995 109.277 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.676 ' CD2' HD23 ' A' ' 316' ' ' LEU . 5.6 m-85 -116.17 150.56 37.26 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.547 1.155 . . . . 74.430000000000007 111.003 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 322' ' ' LYS . 87.7 m -57.57 -64.11 1.01 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 1.139 . . . . 61.32 110.378 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.792 ' HE3' HD22 ' A' ' 316' ' ' LEU . 0.5 OUTLIER 35.39 33.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 74.230000000000004 111.02 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.519 ' HG3' HG22 ' A' ' 320' ' ' THR . 90.9 mttt -72.99 -176.53 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 75.230000000000004 109.334 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 279' ' ' PHE . 5.6 t -142.88 138.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.441 1.088 . . . . 54.420000000000002 109.293 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 278' ' ' THR . 0.0 OUTLIER -116.11 152.11 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 73.519999999999996 109.289 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.569 ' OD1' HD13 ' A' ' 331' ' ' ILE . 1.3 t30 -91.83 -173.6 3.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 63.450000000000003 109.268 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -75.45 -0.87 21.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.491 1.119 . . . . 63.140000000000001 110.299 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.47 -10.11 33.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 73.430000000000007 109.258 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.04 48.06 16.88 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.447 1.092 . . . . 42.299999999999997 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.565 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 9.7 pt-20 -153.8 110.48 3.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 70.439999999999998 110.288 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.433 ' N ' HG13 ' A' ' 324' ' ' VAL . 12.2 m -38.53 125.57 1.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.534 1.146 . . . . 63.439999999999998 110.445 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.569 HD13 ' OD1' ' A' ' 325' ' ' ASN . 6.8 pt -100.58 -37.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 74.340000000000003 109.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.943 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.2 mt -134.23 165.56 24.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 74.150000000000006 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -145.67 118.77 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 73.219999999999999 109.309 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -74.86 135.92 19.84 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.494 1.121 . . . . 72.310000000000002 110.993 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -79.93 -29.43 39.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 0.741 . . . . 73.430000000000007 109.265 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.583 ' H ' HG23 ' A' ' 342' ' ' ILE . 12.1 t 40.07 88.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 61.119999999999997 108.339 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -78.39 -161.05 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.447 1.092 . . . . 70.299999999999997 109.298 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -81.69 58.08 3.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.494 1.121 . . . . 63.530000000000001 109.322 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 57.7 m -172.15 166.13 6.07 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 43.340000000000003 110.007 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.58 -15.85 63.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 75.230000000000004 109.308 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.03 141.15 45.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 73.450000000000003 110.318 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.583 HG23 ' H ' ' A' ' 336' ' ' CYS . 8.5 mt -148.2 116.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 75.239999999999995 109.286 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.554 HG22 ' CD2' ' A' ' 251' ' ' HIS . 9.6 p -119.65 113.65 21.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 73.340000000000003 110.446 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.943 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -67.69 145.9 54.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.464 1.102 . . . . 74.510000000000005 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -123.25 -44.66 2.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 65.239999999999995 109.284 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.1 t 153.96 156.14 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.230000000000004 110.02 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.6 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.5 Cg_endo -74.99 -49.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.487 1.783 . . . . 64.219999999999999 111.038 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.551 1.157 . . . . 71.430000000000007 109.289 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 246' ' ' ASN . 1.3 p-10 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.309 -0.626 . . . . 64.129999999999995 109.309 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.444 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 1.3 m-20 -96.23 151.29 38.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.536 1.148 . . . . 73.129999999999995 109.318 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.671 ' O ' HG22 ' A' ' 269' ' ' THR . 18.3 Cg_endo -74.92 -0.04 9.45 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.504 1.792 . . . . 61.539999999999999 111.007 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -39.93 144.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.545 1.153 . . . . 62.509999999999998 109.293 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.598 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -116.64 100.55 7.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.103 . . . . 70.5 109.282 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.571 ' CE1' HG22 ' A' ' 343' ' ' THR . 29.4 m-70 -90.93 128.58 36.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.529 1.143 . . . . 75.540000000000006 109.603 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 265' ' ' LEU . 58.9 t -120.52 167.27 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 52.109999999999999 109.306 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.3 tp10 -128.06 135.24 49.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 61.240000000000002 110.325 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.717 ' CG1' HG21 ' A' ' 314' ' ' THR . 89.6 t -109.61 109.49 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 61.409999999999997 109.305 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 m -79.73 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 74.040000000000006 110.023 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.908 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER 63.56 71.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.545 1.153 . . . . 72.310000000000002 109.288 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -91.13 147.34 23.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 64.439999999999998 110.305 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.99 -35.29 33.07 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.146 . . . . 75.540000000000006 109.271 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.73 -46.95 73.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 75.230000000000004 109.293 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 1.5 m -174.25 -173.4 0.78 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.137 . . . . 65.439999999999998 109.996 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.2 mt -87.47 161.82 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 1.125 . . . . 54.43 109.329 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -159.91 101.43 1.45 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 75.25 109.605 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.696 ' CZ ' HD13 ' A' ' 261' ' ' LEU . 51.1 m-85 -110.89 129.17 55.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 63.140000000000001 110.95 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.747 HG22 ' CE1' ' A' ' 266' ' ' TYR . 48.0 mt -119.37 119.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 72.439999999999998 109.26 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.713 ' HB3' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -112.41 139.96 47.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 74.540000000000006 109.285 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.747 ' CE1' HG22 ' A' ' 264' ' ' ILE . 4.5 m-85 -126.97 114.9 18.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.442 1.089 . . . . 71.200000000000003 110.998 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.494 ' CG ' ' CG2' ' A' ' 298' ' ' ILE . 48.5 p-10 -69.19 77.06 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.143 . . . . 64.109999999999999 109.284 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.479 ' CE ' ' HA ' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -78.89 55.23 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 1.117 . . . . 75.099999999999994 109.304 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.671 HG22 ' O ' ' A' ' 248' ' ' PRO . 17.9 p -125.45 -170.5 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 71.239999999999995 110.371 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -94.42 -52.79 4.18 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 1.127 . . . . 71.010000000000005 109.304 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.63 169.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 51.109999999999999 109.298 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.531 ' N ' HD12 ' A' ' 272' ' ' ILE . 3.8 mp -106.28 161.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 74.439999999999998 109.306 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.895 HG13 HD12 ' A' ' 298' ' ' ILE . 3.6 mm -92.36 137.4 24.68 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.559 1.162 . . . . 65.109999999999999 109.294 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 -23.87 13.31 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.56 1.821 . . . . 60.539999999999999 110.976 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 74.05 161.72 7.8 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.53 1.144 . . . . 33.039999999999999 110.972 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 6.0 t30 81.69 22.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 0.777 . . . . 62.140000000000001 109.301 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.412 ' C ' ' OG1' ' A' ' 278' ' ' THR . 22.4 m -69.15 -178.23 1.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 71.519999999999996 108.3 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.904 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.7 m -153.81 106.5 2.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 74.5 110.415 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.88 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -60.53 173.09 0.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 63.130000000000003 111.038 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -168.43 92.21 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.107 . . . . 73.409999999999997 110.32 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 7.2 p90 -116.17 146.98 41.87 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.44 1.087 . . . . 64.200000000000003 110.977 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.407 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 82.9 p -72.57 -179.8 3.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 71.340000000000003 109.992 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 312' ' ' LEU . 1.9 m -156.67 175.77 13.61 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 51.439999999999998 109.99 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' A' ' 285' ' ' ILE . 41.3 tt0 -98.48 139.4 34.28 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 72.120000000000005 110.288 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.505 HG23 ' HG2' ' A' ' 284' ' ' GLN . 1.6 pt 39.31 30.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.125 . . . . 73.040000000000006 109.324 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.445 ' N ' ' C ' ' A' ' 284' ' ' GLN . 4.7 m -142.34 172.08 13.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 72.209999999999994 110.033 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.87 141.42 34.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 73.219999999999999 110.341 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 281' ' ' PHE . 11.6 p -48.34 149.6 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 71.430000000000007 109.311 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.423 ' CD2' ' CE1' ' A' ' 308' ' ' PHE . 5.8 t80 -134.33 144.72 48.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 111.011 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 m -114.17 121.93 45.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 74.340000000000003 110.006 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.981 HD11 ' CD1' ' A' ' 308' ' ' PHE . 18.8 mt -101.86 128.56 54.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.52 1.138 . . . . 71.530000000000001 109.288 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.481 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.0 OUTLIER -68.06 99.66 0.9 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 109.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.772 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.9 mtp -56.33 152.26 11.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 51.439999999999998 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLY . . . . . 0.714 ' HA3' ' HZ2' ' A' ' 304' ' ' LYS . . . -35.33 140.57 0.17 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.57 1.169 . . . . 64.019999999999996 111.025 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 294' ' ' GLY . 18.1 Cg_endo -75.03 -22.98 14.2 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.521 1.8 . . . . 70.219999999999999 110.996 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -76.17 172.66 12.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.12 . . . . 52.130000000000003 109.61 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -107.59 124.3 49.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.147 . . . . 73.340000000000003 110.302 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.895 HD12 HG13 ' A' ' 273' ' ' ILE . 15.0 mt -47.07 -67.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 73.230000000000004 109.301 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.58 159.56 32.9 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.486 1.116 . . . . 65.209999999999994 111.026 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 19.2 mt -43.23 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.477 0.751 . . . . 73.140000000000001 109.317 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.479 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 62.75 75.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 63.219999999999999 109.315 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 298' ' ' ILE . . . -135.07 173.46 21.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.453 1.096 . . . . 73.430000000000007 111.022 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.28 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 0.758 . . . . 72.409999999999997 110.293 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.714 ' HZ2' ' HA3' ' A' ' 294' ' ' GLY . 40.3 tptt -159.49 155.04 25.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 70.510000000000005 109.261 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 5.4 mt-10 -130.25 139.96 50.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 51.109999999999999 110.294 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.88 HD13 ' CG ' ' A' ' 279' ' ' PHE . 16.0 mt -143.3 38.74 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.523 1.14 . . . . 73.439999999999998 109.285 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -49.55 148.3 2.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.959 -1.126 . . . . 75.040000000000006 107.959 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.981 ' CD1' HD11 ' A' ' 291' ' ' ILE . 12.5 t80 -147.43 168.18 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 73.409999999999997 111.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -141.12 161.18 54.77 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 61.43 111.013 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.98 -47.77 0.3 Allowed 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.007 -2.497 . . . . 74.109999999999999 111.018 -0.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.0 p 177.14 133.58 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 1.112 . . . . 71.340000000000003 109.951 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.6 mp -110.96 158.78 34.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 72.420000000000002 109.351 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 146.65 32.67 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.493 1.786 . . . . 75.510000000000005 110.988 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.717 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -124.64 161.98 45.37 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 73.540000000000006 110.372 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.02 -178.85 24.69 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.01 -2.496 . . . . 73.230000000000004 110.995 0.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.765 HD13 ' CE ' ' A' ' 321' ' ' MET . 1.7 mt -95.53 64.87 2.63 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.128 . . . . 64.150000000000006 109.284 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 32.4 t -81.16 123.08 28.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 53.43 110.006 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 317' ' ' SER . 44.0 t30 81.95 20.21 0.33 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 63.200000000000003 109.298 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.518 ' CD2' HD23 ' A' ' 316' ' ' LEU . 24.0 m-85 -101.99 114.05 27.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.562 1.164 . . . . 74.030000000000001 111.007 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.676 HG23 ' HD2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -37.75 -51.18 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 61.450000000000003 110.377 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.765 ' CE ' HD13 ' A' ' 316' ' ' LEU . 7.1 ttm 30.93 52.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 64.310000000000002 110.985 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.676 ' HD2' HG23 ' A' ' 320' ' ' THR . 33.0 mttt -81.08 -170.18 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.549999999999997 109.264 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 279' ' ' PHE . 5.8 t -151.61 130.32 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.525 1.141 . . . . 73.530000000000001 109.338 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 278' ' ' THR . 16.1 m -108.1 179.02 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.520000000000003 109.309 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.825 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -111.61 -172.4 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 41.049999999999997 109.306 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.16 -4.8 15.02 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 71.129999999999995 110.264 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.18 -7.12 33.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 71.340000000000003 109.321 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.12 54.63 6.83 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.503 1.127 . . . . 74.319999999999993 110.999 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.825 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.72 130.24 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 0.773 . . . . 72.420000000000002 110.302 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.854 ' N ' HG12 ' A' ' 324' ' ' VAL . 4.9 m -62.19 122.74 16.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 73.040000000000006 110.421 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.652 ' CG2' ' ND2' ' A' ' 325' ' ' ASN . 2.3 pt -105.4 -34.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.474 1.109 . . . . 75.299999999999997 109.256 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.884 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.6 mt -130.16 164.19 25.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 74.510000000000005 109.336 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -146.19 132.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 74.219999999999999 109.293 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.41 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -92.51 114.15 4.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.436 1.085 . . . . 72.239999999999995 111.035 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.763 ' NZ ' ' H ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -42.79 -27.72 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 0.75 . . . . 75.140000000000001 109.263 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 46.31 70.46 0.38 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 61.310000000000002 108.256 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.763 ' H ' ' NZ ' ' A' ' 335' ' ' LYS . . . -79.28 -171.46 2.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 63.119999999999997 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 61.82 2.93 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 75.239999999999995 109.271 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 18.5 t -173.11 156.29 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 75.129999999999995 110.019 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.98 -30.14 71.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 60.43 109.289 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.64 136.22 56.03 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 63.240000000000002 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.62 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 49.1 mt -142.32 130.28 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 70.25 109.27 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.571 HG22 ' CE1' ' A' ' 251' ' ' HIS . 13.6 p -127.58 83.57 2.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 53.43 110.382 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.884 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.9 mp -38.52 136.29 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 64.109999999999999 109.33 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -70.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 63.539999999999999 109.321 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.81 147.79 0.34 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.576 1.173 . . . . 74.319999999999993 109.994 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.461 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.94 -55.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 74.230000000000004 111.024 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.562 1.164 . . . . 72.230000000000004 109.272 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.85 ' N ' HD22 ' A' ' 270' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.281 -0.637 . . . . 73.319999999999993 109.281 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ASP . . . . . 0.471 ' HB2' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -177.07 90.31 0.25 Allowed Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 74.299999999999997 109.285 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -17.2 19.66 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.532 1.807 . . . . 53.030000000000001 110.992 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -51.41 137.3 23.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 71.420000000000002 109.297 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 1.02 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -122.92 103.05 8.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 75.340000000000003 109.29 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.18 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 74.219999999999999 109.586 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.766 HG13 HD23 ' A' ' 265' ' ' LEU . 58.0 t -125.22 145.05 33.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 72.120000000000005 109.355 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.42 120.84 42.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.319999999999993 110.314 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.0 98.09 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 73.120000000000005 109.28 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.1 t -67.93 -70.77 0.24 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 75.450000000000003 110.024 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.894 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER 68.25 65.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 71.120000000000005 109.3 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -103.26 165.33 11.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 63.109999999999999 110.325 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 259' ' ' ASN . 0.7 OUTLIER -47.65 -57.16 5.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.324 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 258' ' ' ASP . 8.2 t-20 -40.12 -62.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 71.219999999999999 109.305 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -174.12 -160.56 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.476 1.11 . . . . 74.140000000000001 109.999 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.894 HD23 ' HA ' ' A' ' 256' ' ' ASN . 19.6 mt -93.68 -178.35 4.67 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.11 . . . . 72.299999999999997 109.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -177.01 104.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.450000000000003 109.549 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.518 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 59.1 m-85 -110.86 96.67 6.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.219999999999999 110.995 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.795 HG22 ' CE1' ' A' ' 266' ' ' TYR . 64.0 mt -91.86 104.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 61.140000000000001 109.289 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -89.72 129.15 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 75.319999999999993 109.321 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.795 ' CE1' HG22 ' A' ' 264' ' ' ILE . 14.8 m-85 -117.35 102.92 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 61.25 110.987 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.503 ' HB2' HD13 ' A' ' 273' ' ' ILE . 53.4 t30 -59.3 106.97 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 60.25 109.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -100.94 -12.1 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 75.310000000000002 109.302 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.461 ' O ' ' CD1' ' A' ' 300' ' ' ILE . 12.8 p -72.77 164.52 26.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 72.400000000000006 110.381 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.85 HD22 ' N ' ' A' ' 246' ' ' ASN . 32.9 m-80 -67.17 -60.13 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 63.109999999999999 109.318 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.807 ' C ' HD13 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -38.84 158.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.53 1.144 . . . . 75.319999999999993 109.347 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.469 ' N ' HG12 ' A' ' 271' ' ' ILE . 2.1 mp -114.41 117.35 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 65.329999999999998 109.288 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -46.23 138.41 6.2 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 45.039999999999999 109.317 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.04 -30.15 7.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.469 1.773 . . . . 75.310000000000002 111.047 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 90.55 159.72 35.86 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.509 1.131 . . . . 44.310000000000002 111.019 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 1.9 t-20 76.23 27.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 0.766 . . . . 63.310000000000002 109.307 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.466 ' SG ' ' CD1' ' A' ' 331' ' ' ILE . 29.0 m -71.05 -178.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 108.288 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.843 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -152.97 105.44 2.93 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 73.510000000000005 110.382 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.522 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.1 t80 -59.05 157.66 9.82 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 74.329999999999998 110.947 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -146.69 84.33 1.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.551 1.157 . . . . 73.540000000000006 110.252 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.632 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 22.8 p90 -119.64 135.34 54.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 64.120000000000005 110.985 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.489 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 1.1 m -105.92 177.42 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 74.340000000000003 109.988 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' SER . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 319' ' ' TYR . 4.8 p -123.14 -42.73 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 72.430000000000007 109.979 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLN . . . . . 0.412 ' C ' ' N ' ' A' ' 286' ' ' SER . 4.1 tt0 -145.82 179.05 7.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.452 1.095 . . . . 74.109999999999999 110.26 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 10.0 tt -43.06 -28.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 70.109999999999999 109.321 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 284' ' ' GLN . 57.8 m -51.26 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 65.109999999999999 110.004 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -55.5 -175.05 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.105 . . . . 74.540000000000006 110.315 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 289' ' ' PHE . 2.8 p -118.84 167.02 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 63.210000000000001 109.256 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.533 ' N ' HG22 ' A' ' 288' ' ' VAL . 1.8 t80 -103.37 159.57 15.45 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 70.150000000000006 110.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -150.74 122.34 7.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 70.109999999999999 110.029 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 47.0 mt -121.99 128.83 75.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.439999999999998 109.256 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.588 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.5 OUTLIER -73.13 107.16 5.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 62.219999999999999 109.324 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.772 ' HG2' HD21 ' A' ' 306' ' ' LEU . 87.4 mtp -70.17 147.48 49.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.157 . . . . 61.210000000000001 110.998 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -49.68 152.28 3.66 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.506 1.129 . . . . 42.450000000000003 111.022 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -29.26 8.39 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 71.140000000000001 111.029 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -52.66 137.34 31.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 65.040000000000006 109.599 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.22 147.03 29.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 65.140000000000001 110.307 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.443 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -82.87 -76.62 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 74.150000000000006 109.342 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 76.21 -174.95 53.05 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.464 1.103 . . . . 71.230000000000004 110.976 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.638 HD11 ' O ' ' A' ' 270' ' ' ASN . 3.3 mm -64.43 137.6 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.5 0.765 . . . . 74.150000000000006 109.287 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.591 ' HG2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER 66.47 9.43 6.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 73.120000000000005 109.26 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.443 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -97.82 140.86 15.27 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.517 1.136 . . . . 53.210000000000001 110.987 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -110.42 -179.52 3.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 0.794 . . . . 64.329999999999998 110.289 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 264' ' ' ILE . 19.3 tptt -145.72 164.23 32.47 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 65.310000000000002 109.306 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.97 128.41 36.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 1.109 . . . . 61.229999999999997 110.291 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.961 HD12 HD11 ' A' ' 265' ' ' LEU . 12.3 mt -140.91 62.52 1.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 71.430000000000007 109.302 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -76.44 128.95 35.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 73.040000000000006 107.986 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.4 m-30 -115.79 178.55 4.27 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.5 111.052 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.516 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -159.29 157.04 26.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.5 110.992 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -35.14 3.02 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.998 -2.501 . . . . 63.350000000000001 111.021 0.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.0 p 169.04 139.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 71.230000000000004 109.999 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.1 mp -115.28 158.37 41.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 73.239999999999995 109.306 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.47 34.03 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.49 1.784 . . . . 73.450000000000003 111.002 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.725 HG22 HD12 ' A' ' 316' ' ' LEU . 0.6 OUTLIER -127.32 162.24 49.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.439 1.087 . . . . 73.510000000000005 110.416 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.94 174.36 53.02 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.999 -2.5 . . . . 74.109999999999999 110.993 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.725 HD12 HG22 ' A' ' 314' ' ' THR . 5.3 mp -88.99 65.61 7.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.049999999999997 109.277 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.1 p -84.42 139.44 32.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.448 1.092 . . . . 60.200000000000003 110.008 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.74 23.48 4.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.102 . . . . 63.0 109.282 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.701 ' CD2' HD23 ' A' ' 316' ' ' LEU . 3.2 m-85 -104.07 165.77 10.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.468 1.105 . . . . 63.039999999999999 111.027 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 322' ' ' LYS . 15.5 m -92.24 -49.47 6.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.439999999999998 110.37 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.878 ' SD ' HD13 ' A' ' 342' ' ' ILE . 1.7 ptp 30.13 63.35 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.329999999999998 111.028 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.594 ' HG2' HG12 ' A' ' 333' ' ' VAL . 42.8 mttt -91.26 -171.09 2.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 75.25 109.351 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.482 HG21 HD21 ' A' ' 344' ' ' LEU . 2.2 t -150.26 132.2 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 72.099999999999994 109.296 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 278' ' ' THR . 9.0 m -118.29 179.62 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 73.25 109.276 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -108.4 -166.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 73.519999999999996 109.317 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.84 -10.42 37.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 62.020000000000003 110.265 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -107.38 19.57 20.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 109.327 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 55.09 18.12 11.8 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 75.439999999999998 110.986 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 331' ' ' ILE . 10.6 pt-20 -89.54 123.65 33.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.487 0.757 . . . . 71.450000000000003 110.276 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.593 ' N ' HG12 ' A' ' 324' ' ' VAL . 2.7 m -55.78 115.05 2.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 63.420000000000002 110.4 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.466 ' CD1' ' SG ' ' A' ' 277' ' ' CYS . 5.4 pt -97.88 -41.82 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 62.030000000000001 109.297 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.806 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.3 mt -138.34 162.57 34.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 55.310000000000002 109.322 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.594 HG12 ' HG2' ' A' ' 322' ' ' LYS . 26.8 m -149.0 128.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 71.239999999999995 109.293 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -86.85 113.15 3.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.476 1.11 . . . . 72.420000000000002 111.012 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.415 ' O ' ' SG ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -50.04 -24.17 2.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 0.752 . . . . 62.530000000000001 109.32 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 335' ' ' LYS . 0.5 OUTLIER 66.23 162.88 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 65.439999999999998 108.283 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -173.98 -173.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.572 1.17 . . . . 71.420000000000002 109.269 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.55 56.52 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.140000000000001 109.306 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 341' ' ' GLU . 35.0 t -178.4 138.55 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 54.229999999999997 109.998 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -44.76 -27.01 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 63.530000000000001 109.315 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 339' ' ' SER . 6.9 mt-10 -63.97 117.27 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 74.510000000000005 110.323 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.878 HD13 ' SD ' ' A' ' 321' ' ' MET . 61.6 mt -141.62 122.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.433 1.083 . . . . 65.040000000000006 109.291 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 10.4 p -116.41 105.15 12.19 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 72.299999999999997 110.402 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 1.02 HD22 HD22 ' A' ' 250' ' ' LEU . 5.9 mp -58.56 142.62 48.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 72.030000000000001 109.264 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -77.29 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.541 1.151 . . . . 74.019999999999996 109.261 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.1 p -179.85 145.56 0.41 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 74.120000000000005 109.979 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -59.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.524 1.802 . . . . 70.140000000000001 110.987 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 348' ' ' LEU . 2.2 tm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 73.209999999999994 109.329 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.638 . . . . 75.430000000000007 109.276 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.12 159.42 30.22 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 72.209999999999994 109.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 269' ' ' THR . 18.3 Cg_endo -75.0 -14.1 21.23 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.466 1.771 . . . . 74.129999999999995 111.02 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 1.008 HD23 ' O ' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -39.93 146.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 51.25 109.304 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.678 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -125.3 103.12 7.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 74.400000000000006 109.294 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.51 136.3 57.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 63.100000000000001 109.573 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.749 HG22 HD23 ' A' ' 265' ' ' LEU . 76.2 t -145.92 136.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 53.210000000000001 109.301 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.06 128.79 56.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 54.409999999999997 110.262 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.522 ' CG1' HG21 ' A' ' 314' ' ' THR . 14.2 t -105.47 105.45 18.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 70.450000000000003 109.291 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.76 -73.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 61.299999999999997 109.973 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.591 ' HA ' HD23 ' A' ' 261' ' ' LEU . 8.6 t-20 55.33 78.38 0.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 70.340000000000003 109.305 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.26 -166.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.544 1.152 . . . . 71.430000000000007 110.314 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.63 31.56 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 63.119999999999997 109.308 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -135.22 -45.16 0.7 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.481 1.113 . . . . 74.239999999999995 109.317 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 174.08 -174.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 32.210000000000001 110.009 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.863 HD11 ' HB2' ' A' ' 312' ' ' LEU . 23.7 mt -93.24 167.65 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 73.049999999999997 109.288 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -163.81 100.25 0.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.239999999999995 109.608 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.19 101.55 10.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 73.099999999999994 110.992 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.816 HG22 ' CE1' ' A' ' 266' ' ' TYR . 56.9 mt -97.52 103.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 75.040000000000006 109.263 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 1.056 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -88.13 138.23 31.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.467 1.104 . . . . 74.200000000000003 109.301 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.816 ' CE1' HG22 ' A' ' 264' ' ' ILE . 13.1 m-85 -125.66 101.06 6.71 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.504 1.128 . . . . 60.049999999999997 111.009 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.67 97.8 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 53.109999999999999 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.39 30.26 5.46 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.486 1.116 . . . . 71.420000000000002 109.319 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 248' ' ' PRO . 36.0 p -85.59 -167.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.239999999999995 110.394 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -92.68 -52.3 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 75.150000000000006 109.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.41 ' H ' HG23 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -65.47 173.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 62.549999999999997 109.257 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.15 137.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.501 1.126 . . . . 65.519999999999996 109.291 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ILE . . . . . 0.5 ' HA ' HD13 ' A' ' 273' ' ' ILE . 5.6 mm -61.95 135.92 94.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.47 1.106 . . . . 73.450000000000003 109.3 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -22.79 14.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.797 . . . . 42.200000000000003 111.03 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 73.83 168.06 16.09 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.472 1.108 . . . . 64.439999999999998 111.02 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 1.7 t30 70.49 38.66 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 0.772 . . . . 70.450000000000003 109.271 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 52.6 m -83.29 -177.48 6.75 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 70.219999999999999 108.284 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.864 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.8 m -154.24 99.76 2.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 73.430000000000007 110.372 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 323' ' ' VAL . 0.8 OUTLIER -55.4 162.64 1.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.492 1.12 . . . . 73.510000000000005 111.006 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -155.31 90.62 1.27 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.559 1.162 . . . . 74.219999999999999 110.328 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 279' ' ' PHE . 12.2 p90 -118.94 153.83 33.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 70.200000000000003 111.001 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.59 170.2 16.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 72.530000000000001 110.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.3 p -149.77 -175.53 5.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.541 1.151 . . . . 74.409999999999997 110.032 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -66.89 -79.86 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.552 1.157 . . . . 61.109999999999999 110.285 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 18.7 tt -61.93 -46.47 96.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 64.239999999999995 109.29 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.75 154.03 34.45 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.576 1.173 . . . . 54.210000000000001 109.993 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -103.82 178.45 4.55 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 64.209999999999994 110.264 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.57 153.2 7.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 60.409999999999997 109.3 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.09 133.7 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 73.430000000000007 110.979 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.4 p -110.7 121.86 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.476 1.11 . . . . 70.099999999999994 109.969 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.873 HD11 ' CD1' ' A' ' 308' ' ' PHE . 12.0 mt -103.54 132.13 50.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 65.439999999999998 109.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.63 106.16 6.07 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.452 1.095 . . . . 73.430000000000007 109.297 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.819 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.5 mtp -77.77 145.7 36.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 71.349999999999994 110.996 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.03 153.76 6.83 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.497 1.123 . . . . 60.340000000000003 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -30.58 7.01 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.433 1.754 . . . . 63.399999999999999 111.023 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -42.88 143.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 61.310000000000002 109.607 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -92.69 124.52 36.76 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 63.310000000000002 110.308 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.526 HG23 ' C ' ' A' ' 302' ' ' GLY . 43.0 mt -62.02 -77.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.578 1.174 . . . . 65.120000000000005 109.309 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.32 -175.49 54.53 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.462 1.101 . . . . 65.109999999999999 111.008 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 300' ' ' ILE . 2.1 mm -66.68 133.86 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 74.519999999999996 109.305 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.49 ' HG2' HG22 ' A' ' 300' ' ' ILE . 12.1 mmtm 74.21 3.71 4.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.040000000000006 109.279 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.526 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -93.35 146.72 18.26 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.501 1.126 . . . . 72.129999999999995 111.006 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -113.63 -176.04 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 0.753 . . . . 65.430000000000007 110.282 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 264' ' ' ILE . 39.5 tptt -147.56 162.93 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.474 1.109 . . . . 60.399999999999999 109.295 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -136.0 118.92 16.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 74.200000000000003 110.305 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 1.056 HD12 HD11 ' A' ' 265' ' ' LEU . 20.1 mt -128.16 55.04 1.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.496 1.122 . . . . 72.519999999999996 109.308 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' TRP . . . . . 0.424 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 4.8 p90 -67.09 125.15 25.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.993 -1.114 . . . . 74.200000000000003 107.993 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.873 ' CD1' HD11 ' A' ' 291' ' ' ILE . 25.6 t80 -123.25 173.15 8.11 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.553 1.158 . . . . 71.349999999999994 111.042 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -150.55 161.72 29.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.509 1.131 . . . . 75.510000000000005 111.06 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -74.99 -43.15 0.72 Allowed 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.97 -2.513 . . . . 73.420000000000002 111.0 -0.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.5 p 179.59 158.4 0.67 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 52.109999999999999 109.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.863 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.1 mp -135.28 158.73 74.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 70.329999999999998 109.33 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 151.1 38.91 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.482 1.78 . . . . 71.439999999999998 110.996 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' THR . . . . . 0.522 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.8 OUTLIER -134.49 161.27 64.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.518 1.137 . . . . 71.129999999999995 110.453 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.91 -178.97 24.96 Favored 'Cis proline' 0 C--N 1.36 1.148 0 C-N-CA 121.002 -2.499 . . . . 75.409999999999997 111.038 -0.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.756 HD23 ' CE2' ' A' ' 319' ' ' TYR . 2.3 mt -101.27 57.39 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.519999999999996 109.318 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 6.1 p -81.4 127.7 33.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 60.399999999999999 109.989 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 317' ' ' SER . 30.8 t30 80.74 23.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 73.299999999999997 109.3 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.756 ' CE2' HD23 ' A' ' 316' ' ' LEU . 6.8 m-85 -101.92 176.46 5.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 71.329999999999998 110.985 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.611 HG23 ' HZ3' ' A' ' 322' ' ' LYS . 1.2 m -93.21 -58.66 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 110.395 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.749 ' SD ' HD13 ' A' ' 342' ' ' ILE . 2.2 ptp 28.3 61.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 73.420000000000002 110.991 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.611 ' HZ3' HG23 ' A' ' 320' ' ' THR . 28.4 mttp -91.29 179.12 5.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.151 . . . . 62.409999999999997 109.32 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.5 t -140.81 129.67 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 72.519999999999996 109.284 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.868 HG12 ' N ' ' A' ' 330' ' ' THR . 15.4 m -108.47 178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 70.019999999999996 109.317 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.839 HD22 ' HG2' ' A' ' 329' ' ' GLU . 0.5 OUTLIER -110.84 -172.34 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.437 1.086 . . . . 71.510000000000005 109.281 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -68.23 -4.7 14.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.439999999999998 110.267 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -7.46 31.96 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 55.329999999999998 109.289 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.62 54.38 6.69 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 61.450000000000003 111.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.839 ' HG2' HD22 ' A' ' 325' ' ' ASN . 0.1 OUTLIER -149.55 130.5 14.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 0.755 . . . . 75.439999999999998 110.313 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 330' ' ' THR . . . . . 0.868 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.7 m -60.97 119.44 8.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 70.129999999999995 110.386 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.649 ' CG2' ' ND2' ' A' ' 325' ' ' ASN . 2.2 pt -97.19 -34.68 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 74.25 109.281 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 344' ' ' LEU . 4.8 mt -132.04 -171.46 2.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 73.519999999999996 109.341 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' VAL . . . . . 0.58 HG12 ' C ' ' A' ' 332' ' ' LEU . 0.1 OUTLIER -175.89 114.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 65.540000000000006 109.241 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.475 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -61.81 135.41 46.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.534 1.146 . . . . 62.240000000000002 111.011 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' LYS . . . . . 0.536 ' C ' ' SG ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -57.04 -19.54 19.41 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.582 0.813 . . . . 75.430000000000007 109.267 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.536 ' SG ' ' C ' ' A' ' 335' ' ' LYS . 0.8 OUTLIER 42.08 89.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 75.310000000000002 108.283 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.27 -175.32 2.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.530000000000001 109.324 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.31 61.86 2.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 64.409999999999997 109.288 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.82 142.78 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 62.200000000000003 109.961 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ASN . . . . . 0.453 ' O ' HG23 ' A' ' 254' ' ' VAL . 55.9 m-20 -52.18 -27.05 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 75.230000000000004 109.309 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.31 137.01 57.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.497 1.123 . . . . 72.120000000000005 110.293 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.749 HD13 ' SD ' ' A' ' 321' ' ' MET . 53.8 mt -146.17 137.28 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 109.305 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 24.2 p -138.05 99.51 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 73.230000000000004 110.414 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.2 mp -54.78 132.27 45.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 63.350000000000001 109.265 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.623 ' O ' HD21 ' A' ' 332' ' ' LEU . 0.1 OUTLIER -112.72 -66.79 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 72.209999999999994 109.306 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 346' ' ' SER . . . . . 0.682 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.1 p 158.84 136.78 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 53.210000000000001 109.998 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.528 ' HB3' HG11 ' A' ' 333' ' ' VAL . 18.3 Cg_endo -75.04 -57.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.479 1.779 . . . . 74.209999999999994 111.002 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 348' ' ' LEU . 1.4 tp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 73.150000000000006 109.317 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.325 -0.62 . . . . 75.25 109.325 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.23 103.15 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 64.53 109.259 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -61.38 134.37 56.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 71.44 109.618 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 253' ' ' GLU . 89.9 t -142.36 164.95 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 72.32 109.295 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.5 ' N ' HG12 ' A' ' 252' ' ' VAL . 4.1 tp10 -146.05 129.5 16.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 64.53 110.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.738 ' CG1' HG21 ' A' ' 314' ' ' THR . 89.0 t -102.82 118.28 49.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.538 1.148 . . . . 72.54 109.273 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 18.0 m -87.78 -65.56 1.0 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 53.34 110.019 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.865 ' HA ' HD23 ' A' ' 261' ' ' LEU . 7.6 t-20 58.36 63.5 1.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.472 1.108 . . . . 74.34 109.325 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.8 pt-20 -162.42 -175.01 4.29 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 74.43 110.321 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.67 24.21 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.552 1.158 . . . . 73.44 109.281 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 72.42 18.63 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 75.3 109.272 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 4.2 m -165.28 -167.11 1.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 34.44 109.997 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 256' ' ' ASN . 9.4 mt -101.25 166.21 10.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.478 1.111 . . . . 63.15 109.321 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . 0.458 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 0.3 OUTLIER -163.2 95.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 72.24 109.636 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.59 ' CE2' HD13 ' A' ' 261' ' ' LEU . 97.4 m-85 -97.46 149.33 22.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 70.34 110.986 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.807 HG22 ' CE1' ' A' ' 266' ' ' TYR . 48.4 mt -142.24 112.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.53 1.144 . . . . 71.14 109.293 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.617 HD11 HD12 ' A' ' 306' ' ' LEU . 0.0 OUTLIER -111.48 143.99 41.42 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.564 1.165 . . . . 64.05 109.306 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.807 ' CE1' HG22 ' A' ' 264' ' ' ILE . 2.1 m-85 -128.56 111.9 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.528 1.142 . . . . 75.21 110.979 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.758 ' HB2' HD13 ' A' ' 273' ' ' ILE . 26.2 t30 -60.47 101.34 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 75.45 109.292 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 300' ' ' ILE . 3.7 mmpt? -101.56 -19.17 15.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 54.44 109.333 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.6 p -48.0 175.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.484 1.115 . . . . 71.11 110.384 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -72.78 -57.39 4.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 62.13 109.307 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.473 ' O ' HD13 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -69.3 166.8 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 63.43 109.303 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.48 131.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 65.41 109.262 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.758 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.3 mp -40.55 140.2 1.03 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.51 1.131 . . . . 52.33 109.298 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -34.87 3.55 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 62.23 110.999 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 106.2 159.38 22.27 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.488 1.117 . . . . 60.21 110.989 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 8.8 t30 69.18 23.6 6.32 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 0.778 . . . . 71.53 109.259 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.4 ' C ' ' OG1' ' A' ' 278' ' ' THR . 60.9 m -70.62 -179.15 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 62.32 108.274 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.735 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -153.96 136.26 14.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 74.11 110.4 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.645 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.5 t80 -89.54 179.03 6.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 65.35 110.98 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.461 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 11.2 tt0 -176.73 101.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.108 . . . . 72.15 110.316 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 1.3 p90 -116.26 147.81 41.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 74.41 111.006 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 53.2 p -100.67 -175.27 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 62.04 109.997 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.558 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 71.34 110.029 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 2.6 p . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.255 -0.646 . . . . 73.24 109.255 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -152.88 142.95 22.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.03 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.627 ' OG ' HG22 ' A' ' 278' ' ' THR . 32.4 t -107.32 127.89 53.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 73.14 109.999 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.3 mt -101.04 137.22 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 72.41 109.287 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -77.47 113.0 14.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 73.53 109.317 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.924 ' HG2' HD21 ' A' ' 306' ' ' LEU . 63.0 mtp -84.13 165.51 18.41 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 72.31 110.973 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.454 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -64.47 151.42 50.51 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.473 1.108 . . . . 55.14 111.021 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.28 6.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.441 1.758 . . . . 61.3 110.961 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.56 ' CE1' ' OE1' ' A' ' 297' ' ' GLU . 57.6 t-80 -68.14 143.11 55.53 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 64.14 109.598 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.56 ' OE1' ' CE1' ' A' ' 296' ' ' HIS . 0.6 OUTLIER -65.38 179.36 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.135 . . . . 73.21 110.304 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 44.3 mt -105.77 -76.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 51.54 109.329 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 128.0 149.74 7.13 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.469 1.106 . . . . 30.43 111.056 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.494 ' O ' ' CE ' ' A' ' 268' ' ' LYS . 4.2 mt -46.75 -25.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.531 0.783 . . . . 73.15 109.342 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -115.6 -37.69 3.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 52.44 109.304 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -40.9 151.03 0.14 Allowed Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.571 1.169 . . . . 65.35 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.27 -177.49 3.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.512 0.772 . . . . 72.22 110.27 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.454 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 35.3 tptt -154.51 143.6 21.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.433 1.083 . . . . 72.12 109.301 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.54 ' HB2' ' CZ2' ' A' ' 307' ' ' TRP . 10.7 mt-10 -114.83 150.39 35.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 71.12 110.308 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.924 HD21 ' HG2' ' A' ' 293' ' ' MET . 82.7 mt -141.15 62.58 1.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.113 . . . . 73.53 109.266 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.54 ' CZ2' ' HB2' ' A' ' 305' ' ' GLU . 0.9 OUTLIER -59.29 134.86 57.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.95 -1.13 . . . . 71.14 107.95 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.622 ' CE1' HD11 ' A' ' 312' ' ' LEU . 10.2 t80 -137.23 155.14 49.87 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 74.4 111.019 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.668 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -135.6 147.36 61.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 74.25 111.013 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -53.72 0.15 OUTLIER 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.005 -2.498 . . . . 63.24 111.007 -0.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 178.44 174.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 71.44 109.982 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 261' ' ' LEU . 3.7 mp -138.82 158.42 70.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 74.53 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 145.25 31.06 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.487 1.783 . . . . 52.15 110.992 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.738 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -123.02 162.54 38.61 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 71.44 110.404 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -175.45 16.03 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.015 -2.494 . . . . 44.34 111.023 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.845 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.8 mt -109.8 57.79 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 63.43 109.281 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.3 p -85.38 134.74 34.07 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 70.51 109.985 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 32.0 t30 83.19 2.63 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 73.43 109.319 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.845 ' CE2' HD23 ' A' ' 316' ' ' LEU . 9.0 m-85 -81.13 -178.47 6.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 75.42 111.017 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.536 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -97.57 -58.28 2.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.32 110.373 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.777 ' SD ' HD13 ' A' ' 316' ' ' LEU . 1.0 OUTLIER 28.59 64.63 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 52.44 111.032 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.536 ' HG3' HG23 ' A' ' 320' ' ' THR . 40.2 mttm -92.68 -172.57 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 71.42 109.299 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.764 ' CG2' HD21 ' A' ' 344' ' ' LEU . 41.9 t -141.84 130.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 63.43 109.304 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 278' ' ' THR . 5.6 m -109.52 176.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.081 . . . . 64.33 109.278 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.453 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 2.6 t30 -101.04 -165.56 1.22 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 62.34 109.322 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -70.1 -7.93 45.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 54.13 110.3 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -107.82 13.33 26.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.22 109.302 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 62.33 27.61 69.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.544 1.152 . . . . 70.22 110.99 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 331' ' ' ILE . 6.7 pt-20 -102.83 127.19 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.464 0.743 . . . . 71.14 110.295 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.595 ' N ' HG12 ' A' ' 324' ' ' VAL . 56.0 m -54.07 111.02 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.42 110.377 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 329' ' ' GLU . 5.1 pt -94.33 -37.91 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.41 109.279 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.834 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.3 mt -139.36 176.18 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.472 1.107 . . . . 75.21 109.328 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.441 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -151.05 131.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.515 1.134 . . . . 51.42 109.323 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -83.76 130.2 9.6 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.504 1.128 . . . . 62.03 110.977 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.541 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -61.08 -26.59 67.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.566 0.803 . . . . 71.53 109.297 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 316' ' ' LEU . 0.8 OUTLIER 48.23 76.62 0.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 43.52 108.305 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.541 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -88.27 -178.75 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 1.164 . . . . 64.53 109.316 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -75.91 62.44 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 62.12 109.288 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.7 m -173.59 150.68 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 74.03 110.024 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -58.9 -17.62 25.91 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 54.05 109.279 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -77.95 146.43 35.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.125 . . . . 74.22 110.289 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.61 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 65.9 mt -147.98 141.23 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 44.12 109.31 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 343' ' ' THR . 8.7 p -138.77 97.81 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 54.23 110.396 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.5 mp -46.83 133.49 10.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.131 . . . . 63.13 109.329 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -98.06 -76.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.13 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.609 ' HA ' HD23 ' A' ' 332' ' ' LEU . 2.9 p 159.84 142.06 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 75.45 110.011 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -80.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.449 1.763 . . . . 72.52 110.955 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 53.33 109.286 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.256 -0.646 . . . . 73.23 109.256 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.858 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -114.43 102.21 9.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.502 1.126 . . . . 70.21 109.287 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.623 ' ND1' HG22 ' A' ' 343' ' ' THR . 14.3 t60 -90.88 166.17 13.2 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.469 1.105 . . . . 75.32 109.558 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.762 HG21 HD23 ' A' ' 265' ' ' LEU . 66.7 t -153.48 155.51 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 51.54 109.324 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -117.62 146.16 43.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.3 110.308 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.673 HG22 ' CE1' ' A' ' 263' ' ' PHE . 38.6 t -128.83 94.97 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 72.33 109.344 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.1 m -69.13 -63.34 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 70.44 110.027 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.751 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.2 t-20 60.82 82.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.528 1.143 . . . . 74.23 109.307 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.29 166.5 13.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.502 1.126 . . . . 65.35 110.296 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 259' ' ' ASN . 23.8 t0 -42.69 -58.32 2.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.573 1.171 . . . . 75.03 109.31 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 258' ' ' ASP . 80.4 m-20 -40.06 -61.94 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 71.22 109.295 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 176.27 -173.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 74.23 109.992 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 256' ' ' ASN . 19.6 mt -80.98 161.2 24.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 72.2 109.263 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.68 95.74 2.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 63.51 109.604 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.673 ' CE1' HG22 ' A' ' 254' ' ' VAL . 75.0 m-85 -103.6 112.02 24.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 75.3 110.965 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.78 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 73.8 mt -111.03 117.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 55.22 109.325 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.762 HD23 HG21 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -106.01 151.72 24.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 70.24 109.342 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.78 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -138.11 117.58 12.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.484 1.115 . . . . 74.15 110.98 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.645 ' ND2' HD11 ' A' ' 273' ' ' ILE . 17.1 t-20 -79.74 106.52 11.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 62.1 109.305 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -11.84 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 60.54 109.276 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.415 ' H ' HG23 ' A' ' 269' ' ' THR . 22.6 p -66.34 154.75 39.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.503 1.127 . . . . 73.22 110.368 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.55 -40.78 84.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.493 1.121 . . . . 75.31 109.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 9.1 pt -54.37 167.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.14 . . . . 71.42 109.299 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 272' ' ' ILE . 4.7 mp -121.54 157.74 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 73.32 109.275 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.701 ' N ' HD13 ' A' ' 273' ' ' ILE . 1.2 mm -82.42 141.21 45.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.508 1.13 . . . . 73.24 109.29 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.614 ' HD2' HG22 ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.01 -14.88 20.99 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.496 1.787 . . . . 53.12 111.0 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 84.62 151.21 13.09 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.52 1.137 . . . . 71.25 111.039 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.8 t30 70.27 50.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 0.767 . . . . 73.54 109.32 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.97 -179.72 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.52 1.137 . . . . 61.34 108.3 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.712 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.6 m -153.94 137.17 15.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.091 . . . . 72.31 110.347 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.69 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -85.85 176.98 7.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 71.4 110.978 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.6 ' CG ' HG21 ' A' ' 288' ' ' VAL . 55.4 tt0 -152.7 65.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 75.45 110.246 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 289' ' ' PHE . 9.9 p90 -96.14 130.47 43.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 75.23 110.957 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 17.9 p -121.79 -178.44 3.83 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 73.4 110.003 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.599 ' CB ' HD23 ' A' ' 312' ' ' LEU . 3.5 p . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 51.02 109.991 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.6 HG21 ' CG ' ' A' ' 280' ' ' GLU . 7.4 p . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.236 -0.653 . . . . 71.53 109.236 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.548 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.8 t80 -115.8 133.38 56.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 64.01 110.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.0 p -112.48 120.67 42.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.564 1.165 . . . . 63.32 109.988 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 12.5 mt -105.8 127.73 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 72.32 109.356 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -67.02 116.7 8.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 64.21 109.287 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.595 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.6 mtp -85.11 150.3 24.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.43 111.002 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -45.65 150.71 1.25 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 23.45 110.983 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -28.01 9.46 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.531 1.806 . . . . 74.21 110.954 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -65.1 143.3 57.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.083 . . . . 73.55 109.576 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.68 138.06 31.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.33 110.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.435 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -65.28 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.13 109.307 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.84 -155.35 18.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.518 1.136 . . . . 75.43 111.016 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.928 HG22 ' HD3' ' A' ' 301' ' ' LYS . 0.9 OUTLIER -86.93 133.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 0.79 . . . . 71.42 109.313 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.928 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.3 OUTLIER 68.79 6.51 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 71.13 109.314 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.435 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -85.68 162.61 36.16 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.511 1.132 . . . . 64.32 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 298' ' ' ILE . 4.5 pt20 -131.47 174.82 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 0.767 . . . . 75.01 110.283 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 38.5 tptt -149.46 152.11 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.23 109.328 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.59 141.22 45.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.493 1.12 . . . . 62.53 110.307 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.724 HD12 HD11 ' A' ' 265' ' ' LEU . 12.3 mt -145.53 61.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 1.118 . . . . 74.42 109.32 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -79.27 121.61 25.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 73.4 107.98 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.8 m-30 -109.29 -174.13 2.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 64.03 111.043 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.9 OUTLIER -164.91 160.19 14.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 74.11 110.998 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.02 -36.29 2.64 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.005 -2.498 . . . . 71.44 111.022 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 2.9 p 169.74 131.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.107 . . . . 73.2 110.012 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.599 HD23 ' CB ' ' A' ' 283' ' ' SER . 5.7 mp -111.59 158.94 34.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.15 . . . . 75.53 109.339 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 147.36 33.66 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.463 1.77 . . . . 74.32 110.973 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.604 HG21 HG12 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -123.91 164.43 29.3 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 61.11 110.4 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 -174.66 14.53 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.022 -2.491 . . . . 73.43 110.989 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.625 HD22 ' CE2' ' A' ' 319' ' ' TYR . 3.4 mt -102.36 60.12 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.41 109.294 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -82.91 131.81 35.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 73.3 110.047 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.4 t-20 76.66 21.97 1.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 72.34 109.322 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.625 ' CE2' HD22 ' A' ' 316' ' ' LEU . 4.0 m-85 -99.13 -170.06 1.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.22 111.001 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 322' ' ' LYS . 28.2 m -107.81 -64.92 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.513 1.133 . . . . 75.2 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.833 ' HE3' ' CD1' ' A' ' 342' ' ' ILE . 2.8 mtm 34.09 35.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 72.31 110.998 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.653 ' HG3' HG22 ' A' ' 320' ' ' THR . 27.9 mttm -75.98 169.82 17.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 62.3 109.284 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.591 HG23 HD21 ' A' ' 344' ' ' LEU . 74.8 t -119.1 133.71 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 72.45 109.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 278' ' ' THR . 8.9 m -118.23 172.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 63.15 109.284 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.407 ' ND2' ' H ' ' A' ' 326' ' ' GLN . 2.8 t30 -96.06 -166.48 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 74.51 109.337 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.407 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 3.3 pt20 -71.13 -5.72 33.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 65.42 110.338 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.46 12.09 26.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 1.137 . . . . 64.51 109.303 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.24 8.39 50.12 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.498 1.124 . . . . 43.23 111.047 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 6.5 pt-20 -78.9 129.95 35.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.757 . . . . 73.2 110.281 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.626 ' HA ' HG12 ' A' ' 324' ' ' VAL . 4.1 m -62.97 108.08 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.03 110.38 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 323' ' ' VAL . 2.7 pt -90.94 -43.68 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.511 1.132 . . . . 74.22 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.6 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.4 mt -136.1 168.45 19.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 71.44 109.292 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.483 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.2 m -151.75 131.71 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 71.55 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -85.34 121.04 5.5 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 71.21 111.008 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.695 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.32 -26.93 0.37 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 0.753 . . . . 74.41 109.263 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.419 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.5 OUTLIER 45.68 71.72 0.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 75.32 108.296 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.695 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -84.77 -176.79 6.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 73.53 109.294 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.79 64.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.45 109.327 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.8 t -178.95 148.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.129 . . . . 71.32 109.967 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -57.65 -17.93 17.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 73.21 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.54 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 14.4 mt-10 -71.93 131.96 43.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.107 . . . . 74.54 110.271 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.833 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 45.4 mt -142.88 118.05 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.506 1.128 . . . . 71.05 109.286 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.623 HG22 ' ND1' ' A' ' 251' ' ' HIS . 18.5 p -117.57 87.28 2.68 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 62.45 110.39 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.858 HD22 ' CD2' ' A' ' 250' ' ' LEU . 8.5 mp -40.01 132.1 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 72.34 109.295 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.0 ptpt -117.72 -58.77 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.557 1.161 . . . . 71.44 109.265 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.536 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 158.98 158.19 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.32 110.007 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 -67.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.461 1.769 . . . . 74.33 110.969 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.559 HD22 ' C ' ' A' ' 348' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 72.22 109.323 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 1.001 ' O ' HD23 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.317 -0.623 . . . . 75.12 109.317 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -111.32 98.7 7.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.135 . . . . 71.3 109.293 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.627 ' CD2' HG22 ' A' ' 343' ' ' THR . 20.3 t-80 -96.33 130.38 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 73.32 109.624 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.661 HG21 HD23 ' A' ' 265' ' ' LEU . 16.5 t -120.5 171.35 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 74.24 109.271 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.52 ' N ' HG12 ' A' ' 252' ' ' VAL . 1.9 tp10 -133.96 128.55 34.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 70.14 110.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.597 ' CG1' HG21 ' A' ' 314' ' ' THR . 4.5 t -105.72 112.56 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 51.44 109.318 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 51.43 109.994 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.914 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.1 t-20 60.48 67.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.528 1.143 . . . . 63.32 109.299 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.48 163.81 12.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 71.14 110.29 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.37 -44.74 68.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 71.13 109.303 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -55.11 -61.15 2.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 74.24 109.289 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 29.3 m -174.21 -176.7 1.17 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.437 1.086 . . . . 63.22 110.022 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.914 HD23 ' HA ' ' A' ' 256' ' ' ASN . 39.8 mt -77.5 171.05 15.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.12 . . . . 73.41 109.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -160.49 103.76 1.4 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 61.13 109.588 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.657 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 68.8 m-85 -109.3 90.51 3.32 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 74.53 111.008 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.78 HG22 ' CE2' ' A' ' 266' ' ' TYR . 54.3 mt -90.23 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 52.53 109.314 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.661 HD23 HG21 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -91.51 137.04 32.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.13 109.323 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.78 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.8 m-85 -120.65 110.41 16.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 64.21 111.014 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.417 ' ND2' HD13 ' A' ' 273' ' ' ILE . 12.3 t30 -68.38 96.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 53.53 109.319 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -101.09 28.3 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.22 109.29 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 4.5 p -102.9 143.48 32.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 64.34 110.419 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -44.29 -58.06 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.438 1.086 . . . . 71.12 109.306 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.7 pt -54.61 172.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 72.33 109.345 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.14 123.16 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.443 1.09 . . . . 72.22 109.306 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.417 HD13 ' ND2' ' A' ' 267' ' ' ASN . 1.7 mp -40.4 137.55 1.29 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 60.21 109.311 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.4 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.98 -24.18 13.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.502 1.791 . . . . 70.23 111.007 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 89.37 162.81 38.79 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.501 1.126 . . . . 33.31 111.001 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.6 t30 69.26 34.24 3.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.754 . . . . 61.21 109.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 52.3 m -83.39 -179.22 7.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 71.44 108.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.809 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.0 m -151.85 132.58 14.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 74.32 110.41 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.647 ' CE1' HG22 ' A' ' 323' ' ' VAL . 0.9 OUTLIER -90.19 -178.63 5.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.429 1.08 . . . . 63.21 111.007 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.589 ' HG3' HG21 ' A' ' 288' ' ' VAL . 1.9 tt0 -171.68 89.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.135 . . . . 72.43 110.329 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.763 ' HE1' HD12 ' A' ' 291' ' ' ILE . 22.7 p90 -116.89 128.58 55.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 74.21 111.046 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 36.7 p -95.54 165.24 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.137 . . . . 72.43 109.976 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.572 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.5 p . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.446 1.091 . . . . 74.13 110.021 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.589 HG21 ' HG3' ' A' ' 280' ' ' GLU . 13.9 p . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.319 -0.623 . . . . 71.42 109.319 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.521 ' N ' HG22 ' A' ' 288' ' ' VAL . 3.1 t80 -134.89 145.46 48.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 54.43 111.016 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.543 ' HB2' HG22 ' A' ' 278' ' ' THR . 60.2 p -104.3 129.76 52.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 71.45 110.011 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.763 HD12 ' HE1' ' A' ' 281' ' ' PHE . 2.0 mt -95.96 127.31 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 65.13 109.31 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.18 107.62 3.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.49 1.118 . . . . 71.24 109.257 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.486 ' HG2' HD21 ' A' ' 306' ' ' LEU . 85.5 mtp -78.11 158.61 29.06 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.577 1.173 . . . . 73.34 111.04 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -64.06 147.11 50.73 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.481 1.113 . . . . 74.4 111.025 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -29.66 7.97 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 72.51 110.952 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -54.12 152.58 5.87 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 65.13 109.594 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -85.35 154.31 21.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 71.12 110.299 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 86.4 mt -92.56 -79.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.122 . . . . 75.0 109.293 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.24 -177.1 21.42 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.547 1.154 . . . . 52.34 111.004 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.537 HG22 ' HD3' ' A' ' 301' ' ' LYS . 8.9 mt -53.66 -86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.503 0.767 . . . . 74.01 109.268 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.537 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.5 OUTLIER -61.82 -23.8 66.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.147 . . . . 73.41 109.293 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -50.65 135.03 29.76 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.498 1.124 . . . . 61.21 111.023 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.54 176.81 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 0.766 . . . . 74.45 110.273 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.506 ' O ' HD12 ' A' ' 265' ' ' LEU . 18.8 tptt -152.0 144.26 23.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 60.22 109.339 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -102.72 163.71 12.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 64.41 110.298 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 8.2 mt -161.27 73.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 74.32 109.277 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.25 127.38 32.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 74.34 107.988 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.741 ' CG ' ' CZ ' ' A' ' 281' ' ' PHE . 16.5 m-30 -114.15 38.49 3.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.113 . . . . 74.51 110.971 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.522 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 6.6 p90 -37.63 157.34 0.09 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 74.32 110.979 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -36.94 2.43 Favored 'Cis proline' 0 C--N 1.36 1.177 0 C-N-CA 120.99 -2.504 . . . . 50.01 111.052 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 37.0 p 176.13 144.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 65.13 109.987 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.805 ' HB2' HD11 ' A' ' 261' ' ' LEU . 3.7 mp -129.18 159.39 69.24 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 55.0 109.312 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 144.09 29.84 Favored 'Trans proline' 0 C--N 1.359 1.132 0 O-C-N 124.48 1.779 . . . . 74.41 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.597 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.6 OUTLIER -127.16 162.58 47.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 73.52 110.378 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.1 Cg_endo -74.98 177.98 36.66 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.009 -2.496 . . . . 54.33 110.977 -0.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.767 HD12 ' HE2' ' A' ' 321' ' ' MET . 3.8 mt -92.85 64.4 4.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 75.2 109.276 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.7 t -83.97 135.77 34.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 71.34 109.963 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 72.12 10.86 6.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 71.44 109.303 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 282' ' ' SER . 4.8 m-30 -96.29 124.96 40.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 61.13 111.0 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -40.0 -61.48 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 72.14 110.384 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.767 ' HE2' HD12 ' A' ' 316' ' ' LEU . 3.9 ttm 31.19 68.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.459 1.099 . . . . 72.41 110.973 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.548 ' HG3' HG23 ' A' ' 320' ' ' THR . 80.8 mttt -103.78 -171.29 1.91 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.094 . . . . 61.42 109.316 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.647 HG22 ' CE1' ' A' ' 279' ' ' PHE . 19.2 t -141.53 123.47 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 54.34 109.332 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 278' ' ' THR . 22.6 m -110.84 -172.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.464 1.103 . . . . 75.31 109.315 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.831 ' ND2' HG23 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -126.55 -171.92 2.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 74.0 109.268 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.51 -6.99 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 74.22 110.328 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -89.02 -14.82 35.58 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 64.22 109.292 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.61 1.66 89.07 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.484 1.115 . . . . 65.1 111.028 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.457 ' O ' ' ND2' ' A' ' 325' ' ' ASN . 14.0 pt-20 -94.54 153.22 18.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 0.79 . . . . 71.23 110.312 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.637 ' CA ' HG12 ' A' ' 324' ' ' VAL . 1.3 m -83.47 128.89 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 71.3 110.397 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.831 HG23 ' ND2' ' A' ' 325' ' ' ASN . 33.6 pt -103.64 -37.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.114 . . . . 74.03 109.28 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.854 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.3 mt -134.14 168.77 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 72.42 109.291 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.476 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -152.79 122.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 62.31 109.336 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -77.53 119.53 5.32 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 44.15 110.987 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.771 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.27 -27.0 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 0.783 . . . . 75.1 109.271 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 49.14 76.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 65.02 108.289 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.771 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -88.2 -178.68 5.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 60.53 109.276 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -76.04 61.15 1.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.477 1.111 . . . . 64.01 109.295 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 341' ' ' GLU . 4.2 m 179.43 141.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 61.52 110.019 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 13.9 m-20 -46.65 -26.13 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.151 . . . . 65.13 109.294 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.521 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 3.2 mt-10 -63.04 125.29 23.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 64.21 110.345 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.71 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 66.4 mt -141.65 123.38 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 54.22 109.345 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.627 HG22 ' CD2' ' A' ' 251' ' ' HIS . 15.2 p -126.25 87.84 2.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.132 . . . . 51.21 110.417 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.854 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.3 mp -40.77 138.93 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.526 1.141 . . . . 74.13 109.299 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -112.57 -64.58 1.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 75.55 109.268 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 159.7 145.91 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 72.33 110.011 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -81.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.474 1.776 . . . . 53.41 111.049 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 73.51 109.261 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.291 -0.633 . . . . 73.31 109.291 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.445 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -128.51 103.34 7.06 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 70.23 109.304 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -66.56 139.68 57.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 64.31 109.605 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 253' ' ' GLU . 60.2 t -144.33 167.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 72.14 109.303 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.535 ' N ' HG12 ' A' ' 252' ' ' VAL . 53.6 tt0 -122.93 154.49 38.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 74.41 110.281 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.773 ' CG1' HG21 ' A' ' 314' ' ' THR . 82.4 t -135.75 95.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.142 . . . . 65.11 109.307 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 2.5 t -69.1 -67.4 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 30.42 109.963 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.856 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.0 t-20 60.91 64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 71.25 109.291 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -91.45 145.56 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 75.21 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.26 -34.16 4.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.517 1.136 . . . . 62.13 109.348 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -65.89 -52.03 53.6 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 74.41 109.261 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.9 m -171.14 -175.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 53.34 110.063 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -88.12 176.38 7.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.446 1.091 . . . . 65.11 109.324 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . 0.55 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 4.3 t-160 -176.2 103.51 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.33 109.618 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 254' ' ' VAL . 93.8 m-85 -112.54 127.02 55.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 54.1 111.023 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.766 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 76.5 mt -119.42 116.83 52.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 62.45 109.272 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.675 HD11 HD12 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -103.25 130.01 50.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 64.45 109.319 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.766 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.3 m-85 -119.66 109.17 15.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.03 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.783 ' HB3' HG22 ' A' ' 298' ' ' ILE . 14.5 t30 -69.81 75.51 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 70.04 109.301 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.97 52.85 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 72.43 109.322 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.5 p -127.58 -178.08 4.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 74.44 110.419 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.32 18.19 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 74.02 109.33 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.59 169.22 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 71.02 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.3 mt -121.11 137.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.512 1.132 . . . . 73.1 109.358 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.75 137.49 58.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 75.2 109.271 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -26.25 11.09 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.519 1.799 . . . . 61.33 111.007 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.443 ' O ' ' ND2' ' A' ' 276' ' ' ASN . . . 83.94 -157.38 33.79 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.527 1.142 . . . . 45.44 111.034 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 275' ' ' GLY . 0.2 OUTLIER 39.89 30.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.463 0.743 . . . . 64.33 109.269 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.433 ' N ' ' C ' ' A' ' 275' ' ' GLY . 18.0 m -87.04 -173.41 4.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.538 1.149 . . . . 74.5 108.304 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.805 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.5 m -152.93 126.37 8.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 53.53 110.356 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.627 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.7 t80 -79.99 172.66 13.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 75.22 110.984 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.505 ' HG3' HG21 ' A' ' 288' ' ' VAL . 2.3 tt0 -167.08 91.05 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.115 . . . . 61.35 110.312 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 32.8 p90 -111.7 120.98 43.85 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.476 1.11 . . . . 65.15 110.983 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.604 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 81.8 p -109.93 161.56 15.36 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 54.45 110.017 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.576 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 33.3 t . . . . . 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 53.31 109.986 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 280' ' ' GLU . 8.8 p . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.268 -0.641 . . . . 42.43 109.268 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 288' ' ' VAL . 8.3 t80 -137.49 146.57 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 73.21 111.011 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 95.0 p -117.74 123.46 46.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 70.43 109.996 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.9 mt -101.77 126.94 55.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 72.32 109.259 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.429 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.1 OUTLIER -66.92 122.69 18.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 74.31 109.321 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 97.2 mtp -84.45 148.94 26.3 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.096 . . . . 62.22 111.015 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.708 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -52.62 156.23 4.69 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 63.02 111.02 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -26.64 10.86 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.492 1.785 . . . . 63.13 110.985 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.562 ' CE1' ' HD3' ' A' ' 304' ' ' LYS . 28.4 p80 -52.82 -176.28 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 75.32 109.596 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.63 175.71 7.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 1.13 . . . . 73.31 110.289 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.783 HG22 ' HB3' ' A' ' 267' ' ' ASN . 3.9 mp -134.74 61.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.12 . . . . 75.02 109.321 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.71 -122.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.487 1.117 . . . . 62.42 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.444 HG22 ' HG2' ' A' ' 301' ' ' LYS . 2.2 mt -98.73 138.11 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.513 0.772 . . . . 70.34 109.3 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.444 ' HG2' HG22 ' A' ' 300' ' ' ILE . 1.1 mmmm 67.07 9.23 6.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 75.42 109.331 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.599 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -103.28 146.5 16.53 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.473 1.108 . . . . 72.32 110.986 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.02 -177.58 4.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 0.779 . . . . 62.14 110.302 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.708 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 57.0 tptt -149.38 150.11 31.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 72.14 109.28 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 10.3 mt-10 -110.36 160.07 16.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 70.04 110.307 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.675 HD12 HD11 ' A' ' 265' ' ' LEU . 13.6 mt -155.97 70.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 70.21 109.287 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.55 ' CD1' ' NE2' ' A' ' 262' ' ' HIS . 0.1 OUTLIER -74.97 129.29 37.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 72.44 108.02 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 12.8 m-30 -117.75 -172.02 2.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.45 1.094 . . . . 65.52 110.998 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.509 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.8 p90 -169.75 159.43 6.94 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.44 110.955 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.03 -36.17 2.68 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.046 -2.481 . . . . 73.35 110.994 0.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.2 p 170.25 131.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.538 1.149 . . . . 44.54 110.016 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.4 mp -114.79 158.81 39.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.32 109.355 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 145.73 31.95 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.491 1.785 . . . . 73.52 110.971 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.773 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.2 OUTLIER -127.12 164.49 35.1 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 75.21 110.404 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.02 176.51 43.14 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.013 -2.495 . . . . 60.14 110.991 0.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.713 HD12 ' CE ' ' A' ' 321' ' ' MET . 4.9 mt -92.16 66.41 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.549 1.156 . . . . 73.45 109.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 2.4 p -81.27 128.15 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 61.32 110.006 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.93 21.31 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 73.35 109.27 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.604 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.5 m-30 -103.7 134.13 47.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 74.43 110.982 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 322' ' ' LYS . 60.4 m -45.91 -67.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 73.44 110.389 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.713 ' CE ' HD12 ' A' ' 316' ' ' LEU . 4.3 ttm 33.53 56.92 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.41 111.016 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.746 ' HZ2' ' HB ' ' A' ' 333' ' ' VAL . 28.1 mttm -95.14 -166.38 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.13 109.303 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.528 ' CG2' HD21 ' A' ' 344' ' ' LEU . 12.7 t -145.02 126.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 51.12 109.304 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 278' ' ' THR . 11.8 m -109.69 -172.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 75.05 109.252 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 331' ' ' ILE . 39.2 p30 -120.25 -170.85 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 64.51 109.304 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.42 -8.23 17.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 64.11 110.299 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 -8.76 35.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 75.12 109.278 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.59 -4.5 78.25 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.115 . . . . 63.23 111.026 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -80.84 140.48 35.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.484 0.755 . . . . 75.22 110.27 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.712 ' HA ' HG12 ' A' ' 324' ' ' VAL . 7.7 m -66.53 122.89 18.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 61.44 110.388 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.404 HG21 ' HB3' ' A' ' 325' ' ' ASN . 1.8 pt -97.46 -41.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 64.21 109.263 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.879 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.1 mt -141.59 170.9 14.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 71.4 109.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.746 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.46 128.54 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 73.51 109.304 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -89.08 113.87 4.19 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.451 1.095 . . . . 74.04 110.977 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -26.79 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 0.788 . . . . 74.33 109.294 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 342' ' ' ILE . 0.1 OUTLIER 42.12 67.81 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 74.21 108.263 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -71.89 -172.93 0.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 70.21 109.314 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.29 57.95 2.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 74.34 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 50.4 m -168.28 141.87 3.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 53.03 110.009 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -45.56 -31.73 1.96 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 73.02 109.271 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -63.85 147.54 51.59 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 75.11 110.315 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.495 HD13 ' SG ' ' A' ' 336' ' ' CYS . 16.9 mt -150.05 141.26 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 73.1 109.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 62.6 p -140.89 107.53 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 53.51 110.397 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.6 mp -61.25 134.51 57.06 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 63.53 109.253 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 2.0 mtpt -104.55 -76.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 64.51 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.724 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 159.78 143.84 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.538 1.149 . . . . 73.12 110.025 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.493 1.786 . . . . 72.25 111.006 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.325 -0.46 0 O-C-N 124.465 1.103 . . . . 71.35 109.332 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.84 HD22 ' HB ' ' A' ' 343' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.331 -0.618 . . . . 63.34 109.331 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.837 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -97.6 101.5 13.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 65.44 109.311 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.52 ' CD2' ' OE1' ' A' ' 341' ' ' GLU . 0.5 OUTLIER -87.15 143.96 27.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.435 1.084 . . . . 70.41 109.602 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.911 HG21 HD23 ' A' ' 265' ' ' LEU . 84.3 t -126.26 144.47 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.516 1.135 . . . . 71.45 109.314 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -119.39 121.58 39.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 62.23 110.283 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.38 107.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 65.03 109.263 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 72.6 m -68.43 -57.6 5.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 63.52 110.033 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.693 ' HA ' HD23 ' A' ' 261' ' ' LEU . 6.4 t-20 55.43 69.62 0.72 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.522 1.139 . . . . 74.44 109.311 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -114.63 161.73 17.7 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 75.53 110.3 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -42.21 -53.62 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 73.23 109.289 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -43.57 -64.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 75.32 109.284 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.8 m -179.61 -174.8 0.31 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 74.14 109.981 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.717 HD13 ' HZ ' ' A' ' 263' ' ' PHE . 14.7 mt -78.14 169.29 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.487 1.117 . . . . 73.41 109.314 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -165.1 112.39 0.99 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.05 109.61 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.717 ' HZ ' HD13 ' A' ' 261' ' ' LEU . 6.4 m-85 -116.18 106.51 13.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 75.42 110.987 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.662 HG22 ' CE2' ' A' ' 266' ' ' TYR . 16.6 mt -99.55 103.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 73.53 109.331 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.911 HD23 HG21 ' A' ' 252' ' ' VAL . 0.2 OUTLIER -105.01 126.42 52.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 71.44 109.283 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.662 ' CE2' HG22 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -113.2 119.21 36.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 71.01 111.018 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 250' ' ' LEU . 25.4 t30 -80.71 95.52 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 61.42 109.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -88.68 -54.55 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.424 1.078 . . . . 72.31 109.294 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 1.7 t -100.48 173.83 6.38 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.08 . . . . 64.31 110.39 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 269' ' ' THR . 2.5 t-20 81.93 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 72.32 109.295 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.444 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 0.0 OUTLIER -81.62 -174.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 75.32 109.318 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.413 ' N ' HG12 ' A' ' 271' ' ' ILE . 21.9 mt -92.75 126.76 45.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.01 109.349 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 1.4 mp -43.78 137.65 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.542 1.151 . . . . 75.2 109.309 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.97 -31.07 6.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.487 1.783 . . . . 74.41 111.0 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 102.14 154.2 25.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.48 1.112 . . . . 74.04 110.991 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 5.2 t30 74.49 32.63 0.91 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.466 0.745 . . . . 71.22 109.268 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 16.3 m -78.91 -176.66 5.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.159 . . . . 74.4 108.322 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.589 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -154.53 139.96 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 71.11 110.404 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 1.007 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.8 t80 -88.93 -177.26 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 73.24 110.991 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.646 ' HG2' HG21 ' A' ' 288' ' ' VAL . 22.2 tt0 -177.35 100.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.135 . . . . 60.02 110.281 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.7 p90 -123.62 146.59 48.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 71.43 110.988 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.599 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 92.0 p -77.99 162.25 26.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 74.32 110.033 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.522 ' HB2' HD21 ' A' ' 312' ' ' LEU . 72.3 p . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.521 1.138 . . . . 54.0 110.046 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.646 HG21 ' HG2' ' A' ' 280' ' ' GLU . 14.5 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.325 -0.62 . . . . 62.42 109.325 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.518 ' N ' HG22 ' A' ' 288' ' ' VAL . 10.0 t80 -116.4 -175.96 2.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 72.52 110.961 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.49 ' OG ' HG22 ' A' ' 278' ' ' THR . 3.6 t -163.49 123.58 2.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 41.23 109.967 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.875 HD11 ' CD1' ' A' ' 308' ' ' PHE . 10.9 mt -98.77 136.05 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.21 109.297 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 106.98 12.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 73.04 109.291 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.716 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.2 mtp -80.74 153.25 27.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 74.01 110.997 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.72 153.08 8.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.484 1.115 . . . . 72.23 110.999 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -18.84 18.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.438 1.757 . . . . 74.32 111.035 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -72.49 161.48 30.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 51.21 109.601 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 36.6 mt-10 -88.15 175.47 7.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.34 110.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 299' ' ' GLY . 8.3 mt -98.3 -74.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.479 1.112 . . . . 73.34 109.258 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.524 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 121.0 159.76 10.85 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.119 . . . . 70.12 110.992 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.46 HG22 ' HD2' ' A' ' 301' ' ' LYS . 21.6 mt -58.61 -29.49 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 73.2 109.3 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.46 ' HD2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -109.63 -34.95 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 70.24 109.255 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -46.81 168.79 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.496 1.123 . . . . 71.53 111.007 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -133.17 -178.44 4.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 62.31 110.299 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 38.1 tptt -137.5 156.74 47.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 63.12 109.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -133.57 100.83 4.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 62.3 110.304 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 1.007 HD13 ' CG ' ' A' ' 279' ' ' PHE . 20.6 mt -97.74 30.74 2.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 65.35 109.3 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -43.09 126.88 4.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.34 107.989 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.875 ' CD1' HD11 ' A' ' 291' ' ' ILE . 53.8 t80 -127.35 172.92 10.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 74.42 110.98 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -146.3 162.08 36.22 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 74.22 110.97 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.04 -53.8 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.001 -2.499 . . . . 63.22 111.006 0.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 14.5 p -175.29 146.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.102 . . . . 73.52 110.049 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.617 ' HB2' HD11 ' A' ' 261' ' ' LEU . 2.8 mp -123.63 159.19 56.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 73.15 109.299 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 145.84 31.73 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.533 1.807 . . . . 73.41 111.0 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -126.55 164.03 36.94 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 63.24 110.381 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.506 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 178.48 34.5 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.021 -2.491 . . . . 73.5 110.988 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.792 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.5 mt -104.91 61.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.543 1.152 . . . . 72.41 109.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.4 OUTLIER -86.52 138.08 32.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 62.5 110.034 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 82.89 -1.56 1.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 73.11 109.298 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.792 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.5 m-85 -80.15 -172.87 3.67 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.105 . . . . 73.11 110.998 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.532 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -106.37 -58.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 74.52 110.36 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.746 ' SD ' HD13 ' A' ' 316' ' ' LEU . 0.8 OUTLIER 29.84 61.06 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 74.43 110.984 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' A' ' 320' ' ' THR . 25.1 mttm -90.03 -172.46 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 42.12 109.284 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 90.6 t -141.46 125.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 75.02 109.273 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.677 HG12 ' N ' ' A' ' 330' ' ' THR . 7.0 m -109.38 172.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 74.04 109.274 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.469 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 12.6 t30 -101.53 -164.29 1.09 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 74.02 109.313 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -69.1 -7.49 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 65.44 110.287 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.03 11.73 25.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.11 109.28 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.12 67.78 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.541 1.15 . . . . 75.3 110.994 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 331' ' ' ILE . 8.9 pt-20 -96.43 119.34 34.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 0.748 . . . . 65.53 110.295 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.677 ' N ' HG12 ' A' ' 324' ' ' VAL . 3.8 m -52.68 98.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 42.3 110.379 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.469 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 14.0 pt -77.51 -39.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.495 1.122 . . . . 73.42 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 344' ' ' LEU . 11.6 mt -138.76 174.26 10.72 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.469 1.106 . . . . 52.5 109.28 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.41 HG21 ' NZ ' ' A' ' 322' ' ' LYS . 0.1 OUTLIER -156.57 118.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 75.4 109.278 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -68.7 127.41 22.7 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.495 1.122 . . . . 73.13 110.988 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.78 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -48.73 -27.18 2.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 75.33 109.33 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.0 83.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.11 108.297 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.78 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -101.11 -173.54 2.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 23.15 109.332 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.83 56.26 1.51 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 74.41 109.297 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 72.4 p -172.79 136.31 0.7 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.117 . . . . 74.52 110.002 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.401 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 29.7 m-20 -44.92 -33.42 1.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 44.32 109.316 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.52 ' OE1' ' CD2' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -62.66 139.26 58.64 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.479 1.112 . . . . 70.13 110.319 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.511 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 86.6 mt -144.96 120.67 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.527 1.142 . . . . 70.51 109.293 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.84 ' HB ' HD22 ' A' ' 249' ' ' LEU . 16.8 p -109.98 82.27 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 51.5 110.446 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.837 HD22 ' CD2' ' A' ' 250' ' ' LEU . 8.3 mp -39.45 147.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 1.135 . . . . 72.31 109.28 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -124.78 -87.35 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 73.24 109.312 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 40.3 p -176.19 137.97 0.49 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 64.44 109.977 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.545 1.813 . . . . 74.43 111.0 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 348' ' ' LEU . 2.5 mm? . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 71.15 109.251 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.773 HD22 ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.3 -0.63 . . . . 64.43 109.3 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -122.08 100.31 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 1.109 . . . . 71.3 109.29 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.773 ' NE2' HD22 ' A' ' 249' ' ' LEU . 12.3 m170 -94.86 131.43 40.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 65.54 109.555 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.856 HG22 ' HB3' ' A' ' 265' ' ' LEU . 17.2 t -112.09 163.16 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 74.01 109.31 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.406 ' N ' HG12 ' A' ' 252' ' ' VAL . 1.3 tp10 -123.31 122.45 38.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.113 . . . . 75.13 110.289 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.75 110.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.533 1.146 . . . . 71.22 109.285 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 m -85.59 -55.54 3.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.34 109.981 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.953 ' HA ' HD23 ' A' ' 261' ' ' LEU . 2.4 t-20 60.53 73.14 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.122 . . . . 75.13 109.307 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 260' ' ' SER . 33.6 mm-40 -82.69 145.68 29.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.561 1.163 . . . . 44.11 110.303 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.85 -22.33 14.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 71.42 109.302 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -82.79 -41.48 19.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.557 1.161 . . . . 60.45 109.314 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 257' ' ' GLU . 12.3 m -173.4 -175.07 1.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 1.136 . . . . 65.03 110.032 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.953 HD23 ' HA ' ' A' ' 256' ' ' ASN . 11.2 mt -87.02 178.93 6.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.533 1.145 . . . . 62.1 109.31 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -178.46 108.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 75.33 109.631 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 68.9 m-85 -110.6 110.65 21.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 54.33 110.995 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.686 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 56.9 mt -103.26 109.34 26.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 62.31 109.287 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.856 ' HB3' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -114.47 137.75 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.144 . . . . 64.33 109.258 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -120.9 127.08 51.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 71.33 110.967 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -84.35 93.29 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 63.14 109.312 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.38 18.54 12.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.153 . . . . 74.14 109.3 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 12.5 p -77.54 -172.6 2.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 63.33 110.388 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.558 ' O ' HD11 ' A' ' 300' ' ' ILE . 93.6 m-20 -87.06 -59.65 2.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 71.24 109.308 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.8 pt -58.86 157.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 73.32 109.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.44 130.33 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 71.42 109.289 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 273' ' ' ILE . 6.0 mm -53.69 136.0 54.47 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.4 109.259 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -23.61 13.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.532 1.806 . . . . 74.11 110.986 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 86.52 170.91 47.37 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.517 1.136 . . . . 65.23 111.034 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . 0.478 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 58.1 t-20 66.8 45.09 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 0.767 . . . . 52.14 109.323 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.41 ' C ' ' OG1' ' A' ' 278' ' ' THR . 73.8 m -84.24 178.44 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.33 108.326 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.896 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.8 m -154.74 98.86 2.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 62.24 110.339 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.514 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.2 t80 -54.31 -172.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.536 1.148 . . . . 75.24 110.996 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 322' ' ' LYS . 18.2 tt0 173.77 105.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 64.14 110.279 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -126.33 170.09 12.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 74.23 111.012 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.1 t -101.33 -172.82 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.15 . . . . 61.44 110.01 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.922 ' O ' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.156 . . . . 52.11 109.976 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 281' ' ' PHE . 4.6 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.275 -0.639 . . . . 64.1 109.275 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -153.28 155.52 36.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 54.44 110.955 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.89 ' OG ' HG22 ' A' ' 278' ' ' THR . 28.4 t -109.21 136.06 49.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 64.33 109.999 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.7 mt -103.47 133.72 46.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 63.22 109.312 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -73.38 112.47 9.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.12 109.261 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.804 ' HG2' HD21 ' A' ' 306' ' ' LEU . 84.8 mtp -92.9 135.49 34.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 74.35 111.008 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.61 147.55 0.08 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.486 1.116 . . . . 52.4 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.478 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.06 -24.13 13.02 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.508 1.794 . . . . 62.24 111.015 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -53.01 144.87 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.467 1.104 . . . . 74.33 109.579 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.02 150.28 33.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 74.33 110.332 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 61.3 mt -80.09 -75.39 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.455 1.097 . . . . 63.3 109.25 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.01 166.29 12.77 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.477 1.111 . . . . 42.35 110.981 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.558 HD11 ' O ' ' A' ' 270' ' ' ASN . 18.8 mt -65.47 -31.37 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.521 0.777 . . . . 73.33 109.305 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -110.72 -23.26 11.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.487 1.117 . . . . 75.11 109.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -58.78 157.86 20.61 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 53.33 111.002 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -120.3 -174.94 2.89 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.467 0.745 . . . . 75.33 110.309 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' A' ' 293' ' ' MET . 6.3 tptp -147.66 154.69 40.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 73.13 109.256 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 4.1 mt-10 -123.52 135.7 54.17 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 72.53 110.328 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.804 HD21 ' HG2' ' A' ' 293' ' ' MET . 17.4 mt -136.38 60.0 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 64.24 109.268 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 3.3 p90 -70.86 131.1 43.26 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 74.41 107.993 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.8 m-30 -118.37 172.5 7.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.21 110.982 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.3 OUTLIER -148.91 145.69 20.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 75.02 111.026 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.96 -44.71 0.53 Allowed 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.043 -2.482 . . . . 74.24 110.987 0.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 24.1 p 177.63 172.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.516 1.135 . . . . 74.33 109.971 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 283' ' ' SER . 0.2 OUTLIER -137.62 161.82 58.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 72.15 109.315 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 144.57 30.31 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.494 1.786 . . . . 74.11 111.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.523 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.9 OUTLIER -128.04 159.93 64.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 53.34 110.389 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.96 169.61 74.06 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.034 -2.486 . . . . 74.13 110.995 -0.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.597 HD22 ' CE ' ' A' ' 321' ' ' MET . 5.2 mp -80.34 63.67 4.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 73.22 109.288 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.3 p -83.63 133.57 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.15 109.978 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 70.11 27.57 4.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 74.1 109.286 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.556 ' CE2' ' OG ' ' A' ' 283' ' ' SER . 7.7 m-85 -101.31 176.59 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.539 1.149 . . . . 63.31 110.966 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.533 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.9 OUTLIER -109.34 -50.5 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 74.22 110.429 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.81 ' SD ' HD13 ' A' ' 342' ' ' ILE . 3.9 ptp 26.6 61.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 60.23 111.015 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.773 ' HZ2' ' HB ' ' A' ' 333' ' ' VAL . 22.3 mttm -78.95 -173.43 3.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 71.53 109.299 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.4 t -151.73 125.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 71.32 109.315 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 278' ' ' THR . 26.6 m -113.9 -177.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 73.51 109.325 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.49 -161.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 72.01 109.301 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -74.21 -2.14 23.5 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.512 1.133 . . . . 72.32 110.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -101.77 0.55 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.21 109.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.8 8.33 47.3 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.542 1.151 . . . . 65.23 111.013 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 12.4 pt-20 -95.16 123.61 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 0.762 . . . . 63.53 110.272 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.772 ' HA ' HG12 ' A' ' 324' ' ' VAL . 14.6 m -55.93 113.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 64.2 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.3 pt -86.67 -38.3 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 75.14 109.279 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.9 ' HB3' HD23 ' A' ' 344' ' ' LEU . 11.1 mt -146.21 165.95 27.67 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 75.12 109.303 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.773 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.1 m -150.29 124.34 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 70.12 109.32 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -64.0 125.99 33.36 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.533 1.146 . . . . 73.33 111.0 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -61.69 -27.61 68.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 0.754 . . . . 71.03 109.281 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.69 ' O ' ' HB2' ' A' ' 337' ' ' ALA . 0.5 OUTLIER 87.38 179.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 75.03 108.353 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 336' ' ' CYS . . . 163.89 157.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.099 . . . . 74.41 109.32 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.25 56.88 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.435 1.084 . . . . 71.43 109.352 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 m -178.93 179.68 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.107 . . . . 53.12 110.022 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.42 -10.03 59.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 73.32 109.282 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' HG13 ' A' ' 342' ' ' ILE . 1.1 mp0 -76.9 116.84 17.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 72.44 110.294 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.81 HD13 ' SD ' ' A' ' 321' ' ' MET . 93.1 mt -144.98 124.75 6.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 71.14 109.299 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 344' ' ' LEU . 11.7 p -125.16 96.56 4.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.108 . . . . 75.42 110.402 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.5 mp -39.41 139.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 75.12 109.32 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 346' ' ' SER . 1.9 ptmm? -109.93 -47.37 3.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 60.3 109.279 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.4 OUTLIER 156.32 154.43 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 73.05 109.966 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.41 ' HA ' ' CG1' ' A' ' 333' ' ' VAL . 18.2 Cg_endo -74.96 -51.6 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 64.23 111.007 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.5 109.324 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.972 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.309 -0.626 . . . . 71.33 109.309 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -119.88 103.28 9.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 72.43 109.3 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -81.81 123.62 28.95 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 61.31 109.58 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 253' ' ' GLU . 80.2 t -122.29 165.05 18.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.31 109.324 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 252' ' ' VAL . 27.7 tp10 -123.36 133.29 54.13 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.523 1.14 . . . . 53.41 110.312 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 340' ' ' ASN . 60.5 t -109.3 108.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.495 1.122 . . . . 75.22 109.341 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 4.8 t -85.64 -61.86 1.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 72.3 110.012 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.876 ' HA ' HD23 ' A' ' 261' ' ' LEU . 4.4 t-20 57.01 63.37 1.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.446 1.092 . . . . 75.11 109.314 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -84.44 146.75 27.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 71.51 110.265 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -49.5 -25.67 2.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.452 1.095 . . . . 73.13 109.354 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -75.73 -48.69 20.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 72.23 109.294 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.2 p -172.62 -175.13 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 71.53 110.008 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 312' ' ' LEU . 11.6 mt -85.43 -178.24 6.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 65.22 109.314 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . 0.41 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 5.3 t-160 -176.62 100.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 75.3 109.542 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.783 ' HE2' HD13 ' A' ' 261' ' ' LEU . 89.1 m-85 -117.42 94.07 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 71.44 111.03 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.584 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 18.5 mt -86.97 128.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.493 1.121 . . . . 74.44 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 1.042 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -110.48 137.25 48.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 73.33 109.297 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.584 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 9.5 m-85 -129.7 127.37 40.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.535 1.147 . . . . 70.2 111.024 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.501 ' HB2' HD13 ' A' ' 273' ' ' ILE . 22.5 t30 -82.67 102.58 11.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 63.34 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.93 19.81 19.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.479 1.112 . . . . 74.44 109.307 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.2 p -104.02 -165.48 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.485 1.116 . . . . 70.22 110.385 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.13 -51.31 5.65 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 71.21 109.335 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.9 pt -53.82 161.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 74.41 109.35 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 1.9 mp -117.67 111.17 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.453 1.095 . . . . 42.43 109.329 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.9 HG21 HD12 ' A' ' 298' ' ' ILE . 1.3 mp -53.82 139.78 51.13 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.13 109.258 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.451 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.2 Cg_endo -74.98 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 54.45 111.03 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 294' ' ' GLY . . . 89.72 -36.65 3.48 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 64.45 111.007 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -76.04 57.9 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 0.766 . . . . 64.21 109.311 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 324' ' ' VAL . 7.6 m -101.9 -175.09 2.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 75.41 108.302 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.836 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.6 m -152.92 97.34 2.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 72.31 110.363 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 323' ' ' VAL . 0.6 OUTLIER -56.04 171.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 74.03 110.982 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 69.3 tt0 -167.38 96.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 71.34 110.317 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.2 p90 -123.19 138.09 54.73 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.138 . . . . 74.22 110.982 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 88.5 p -99.46 -178.24 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 65.21 109.977 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.427 1.079 . . . . 73.2 109.981 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.46 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 1.6 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.293 -0.632 . . . . 61.22 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.417 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 2.7 t80 -145.05 156.08 43.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.538 1.149 . . . . 73.33 110.981 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.701 ' HB3' HG22 ' A' ' 278' ' ' THR . 3.3 m -117.34 130.13 56.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.22 110.011 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 11.9 mt -97.98 125.21 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.508 1.13 . . . . 74.33 109.241 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.12 99.58 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.554 1.159 . . . . 75.15 109.27 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.866 ' HG2' HD21 ' A' ' 306' ' ' LEU . 84.2 mtp -71.71 135.94 47.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 72.0 111.003 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 275' ' ' GLY . . . -48.02 155.19 1.3 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 64.14 110.971 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.61 6.94 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.466 1.772 . . . . 64.53 110.993 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -49.49 116.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 74.33 109.585 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -62.62 151.25 38.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.112 . . . . 73.31 110.28 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.9 HD12 HG21 ' A' ' 273' ' ' ILE . 13.5 mt -78.28 -88.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.483 1.114 . . . . 72.41 109.317 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.792 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 89.34 -161.69 30.24 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.517 1.136 . . . . 64.31 110.989 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.501 HG23 ' HD3' ' A' ' 301' ' ' LYS . 8.3 mt -77.09 124.5 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.557 0.798 . . . . 74.42 109.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 300' ' ' ILE . 2.6 mptt 68.48 7.22 5.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.565 1.166 . . . . 64.55 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.895 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -91.87 53.38 2.96 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.566 1.166 . . . . 24.25 111.012 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 302' ' ' GLY . 6.3 pt20 -42.16 165.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.577 0.81 . . . . 51.34 110.321 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.483 ' HB2' HD11 ' A' ' 298' ' ' ILE . 38.8 tptt -131.67 150.55 52.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 73.42 109.308 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 mt-10 -115.02 114.15 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.513 1.133 . . . . 71.1 110.289 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 1.042 HD12 HD11 ' A' ' 265' ' ' LEU . 11.1 mt -114.61 48.65 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.497 1.123 . . . . 61.41 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.412 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 5.2 p-90 -59.1 141.77 53.22 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 72.0 108.024 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.699 ' CD1' HD12 ' A' ' 261' ' ' LEU . 5.1 t80 -139.78 165.77 26.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 73.43 111.013 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -145.72 158.12 50.24 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.23 110.973 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -45.87 0.42 Allowed 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.001 -2.499 . . . . 63.05 111.011 -0.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.7 p -176.69 164.32 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.147 . . . . 64.03 110.007 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.951 ' HB2' HD11 ' A' ' 261' ' ' LEU . 4.1 mt -137.04 158.51 72.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.548 1.155 . . . . 54.43 109.308 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 148.03 34.94 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.51 1.795 . . . . 74.12 111.057 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.544 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 1.0 OUTLIER -137.3 159.62 68.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 75.14 110.367 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.01 170.31 72.21 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 75.05 110.966 0.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.61 HD23 ' CE2' ' A' ' 319' ' ' TYR . 3.2 mt -90.85 56.65 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 64.21 109.296 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.2 p -73.37 116.79 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 72.22 110.042 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 317' ' ' SER . 18.6 t-20 79.71 39.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 62.01 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.61 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.2 m-85 -115.83 143.89 44.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 63.4 111.025 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.518 ' O ' ' C ' ' A' ' 321' ' ' MET . 9.9 m -54.94 -61.54 2.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.522 1.139 . . . . 75.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.59 ' HE3' HD13 ' A' ' 316' ' ' LEU . 1.1 ptp 28.01 50.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.53 111.013 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.452 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 85.4 mttt -82.17 -179.95 7.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 64.24 109.33 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.605 HG22 ' CD1' ' A' ' 279' ' ' PHE . 19.9 t -142.05 131.0 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 53.21 109.288 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 278' ' ' THR . 15.8 m -113.03 173.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 65.4 109.3 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.638 ' OD1' HG21 ' A' ' 331' ' ' ILE . 0.3 OUTLIER -109.59 -168.98 1.4 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 65.22 109.289 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.2 -7.86 14.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.474 1.109 . . . . 72.04 110.322 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . 0.408 ' N ' ' OD2' ' A' ' 327' ' ' ASP . 1.9 p30 -88.79 -12.38 42.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 75.22 109.263 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 80.74 -5.94 63.5 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.512 1.132 . . . . 52.25 111.017 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -90.6 143.94 26.24 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 0.742 . . . . 70.14 110.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.715 ' HA ' HG12 ' A' ' 324' ' ' VAL . 27.7 m -58.86 130.99 49.61 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 1.102 . . . . 63.13 110.332 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.638 HG21 ' OD1' ' A' ' 325' ' ' ASN . 18.8 pt -112.7 -37.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 61.43 109.273 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.886 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.6 mt -139.7 168.42 19.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.23 109.298 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.1 m -151.81 127.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 74.55 109.332 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -76.24 147.81 35.07 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 72.11 110.971 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -89.14 -35.96 15.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.512 0.772 . . . . 71.11 109.332 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.515 ' H ' HG23 ' A' ' 342' ' ' ILE . 0.3 OUTLIER 41.52 86.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 72.03 108.312 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -104.28 73.95 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.446 1.091 . . . . 70.41 109.324 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.8 t0 41.44 53.72 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.117 . . . . 75.13 109.3 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -160.6 123.79 3.39 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 64.04 109.986 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 254' ' ' VAL . 4.7 m120 -41.2 -33.43 0.36 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.091 . . . . 70.2 109.308 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.68 146.38 46.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 72.32 110.3 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 336' ' ' CYS . 4.3 mt -146.08 138.96 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 75.43 109.34 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 249' ' ' LEU . 16.6 p -132.44 84.85 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 62.2 110.405 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.8 mp -39.42 130.11 1.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 65.33 109.336 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 346' ' ' SER . 22.8 mttt -97.64 -74.01 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 71.44 109.292 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 2.7 p 159.9 146.92 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.44 109.989 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 -58.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.497 1.788 . . . . 74.41 110.966 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.407 ' C ' HD13 ' A' ' 348' ' ' LEU . 1.5 tm? . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 63.33 109.316 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.29 -0.633 . . . . 54.11 109.29 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.799 HD22 HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -121.41 103.78 9.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 71.52 109.324 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.418 ' C ' HG23 ' A' ' 252' ' ' VAL . 8.2 m-70 -83.73 167.14 17.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 73.05 109.562 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 265' ' ' LEU . 21.9 t -152.45 166.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 63.31 109.32 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 252' ' ' VAL . 10.5 tp10 -134.26 134.88 42.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 54.33 110.317 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 263' ' ' PHE . 56.9 t -119.74 101.7 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 74.42 109.253 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -54.37 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.496 1.123 . . . . 75.43 110.016 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.641 ' HB2' HG21 ' A' ' 314' ' ' THR . 5.6 t-20 60.33 77.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.549 1.155 . . . . 53.33 109.339 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.28 152.09 35.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.532 1.145 . . . . 52.32 110.302 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -42.27 -47.26 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 72.33 109.315 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.49 -64.24 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.464 1.102 . . . . 63.3 109.301 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.2 m -173.42 -174.83 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 61.04 110.012 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' ' 256' ' ' ASN . 14.0 mt -86.76 150.98 23.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 74.31 109.29 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -137.45 108.0 6.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 72.52 109.628 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 82.7 m-85 -112.37 104.35 12.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.476 1.11 . . . . 74.55 111.039 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.782 HG22 ' CE2' ' A' ' 266' ' ' TYR . 98.6 mt -105.03 111.62 35.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 64.22 109.271 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.89 128.91 45.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 72.43 109.317 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.782 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -116.86 106.57 13.6 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.504 1.128 . . . . 73.21 110.999 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.526 ' HA ' HD12 ' A' ' 250' ' ' LEU . 57.9 t30 -70.75 85.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 64.12 109.294 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -90.37 53.38 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 74.01 109.273 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 18.7 p -125.19 166.87 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 75.52 110.384 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -75.91 -49.62 17.31 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.556 1.16 . . . . 72.0 109.303 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 26.7 pt -51.63 -179.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.15 . . . . 72.01 109.341 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.3 126.71 73.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 71.41 109.267 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 273' ' ' ILE . 5.8 mm -56.82 136.17 78.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 72.41 109.266 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.02 -24.12 13.1 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.503 1.791 . . . . 64.24 111.016 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.95 -163.63 51.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.511 1.132 . . . . 63.32 111.027 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 49.07 33.74 5.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 45.21 109.339 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 64.3 m -85.39 173.87 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 44.34 108.305 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.892 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.5 m -152.32 99.33 2.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 64.33 110.361 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.9 t80 -52.08 -179.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 72.4 111.016 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.97 100.24 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 60.33 110.245 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.692 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 17.0 p90 -115.02 152.27 32.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 72.15 111.032 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 t -87.41 179.19 6.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 64.31 110.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 1.022 ' O ' HD22 ' A' ' 312' ' ' LEU . 1.4 m . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 62.12 110.006 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.318 -0.623 . . . . 60.35 109.318 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -129.74 162.52 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.431 1.082 . . . . 75.13 111.044 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.849 ' OG ' HG22 ' A' ' 278' ' ' THR . 17.7 t -120.83 128.67 53.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 71.53 110.001 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 3.7 mt -93.55 130.56 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.21 109.341 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.675 ' HA ' HG23 ' A' ' 278' ' ' THR . 2.7 mptp? -71.96 113.09 8.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 71.5 109.294 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.657 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.4 mtp -79.87 162.75 24.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 73.34 110.993 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -67.09 155.31 52.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.133 . . . . 52.12 111.013 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -33.3 4.67 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.501 1.79 . . . . 64.11 110.991 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -46.14 144.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 75.14 109.626 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.55 126.76 41.06 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 64.2 110.301 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 303' ' ' GLN . 14.8 mt -64.18 -77.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.572 1.17 . . . . 65.01 109.328 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 79.47 -156.7 41.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.507 1.129 . . . . 35.32 111.017 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.446 ' C ' ' N ' ' A' ' 302' ' ' GLY . 2.0 mt -69.42 156.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.518 0.775 . . . . 62.44 109.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.405 ' HD2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER 40.28 30.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 61.31 109.308 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 300' ' ' ILE . . . -108.38 153.32 16.85 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.485 1.116 . . . . 75.01 111.018 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.411 ' N ' HG23 ' A' ' 298' ' ' ILE . 5.6 pt20 -126.23 -179.06 4.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 0.755 . . . . 73.03 110.289 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 265' ' ' LEU . 40.8 tptt -152.62 149.37 28.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 71.22 109.288 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.55 130.3 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 71.04 110.317 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.842 HD12 HD11 ' A' ' 265' ' ' LEU . 13.2 mt -139.38 61.64 1.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.123 . . . . 73.44 109.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.586 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 7.0 p90 -75.22 113.46 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 75.51 107.949 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.0 m-30 -102.01 173.62 6.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 72.05 111.013 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.507 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.1 p90 -158.93 159.1 29.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 74.32 110.946 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.98 -36.71 2.5 Favored 'Cis proline' 0 C--N 1.36 1.166 0 C-N-CA 121.045 -2.481 . . . . 72.42 110.963 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.4 p 167.52 150.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 74.5 109.968 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.022 HD22 ' O ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -123.21 172.93 4.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.472 1.108 . . . . 73.42 109.287 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.86 34.6 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.535 1.808 . . . . 75.22 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 256' ' ' ASN . 1.1 p -133.08 159.45 72.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.508 1.13 . . . . 74.42 110.391 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.06 171.46 68.02 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.985 -2.506 . . . . 71.32 110.958 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.721 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.4 mt -89.07 62.33 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.46 1.1 . . . . 71.43 109.266 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 5.4 p -87.62 136.52 32.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.129 . . . . 33.05 110.029 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.6 OUTLIER 76.22 6.8 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 54.44 109.32 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.721 ' CE2' HD23 ' A' ' 316' ' ' LEU . 8.6 m-85 -80.34 179.04 7.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 74.31 110.99 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.526 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.8 OUTLIER -105.72 -53.05 2.71 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 74.54 110.361 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.685 ' CE ' HD13 ' A' ' 316' ' ' LEU . 5.0 mtm 27.31 57.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 73.45 111.017 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.559 ' HD3' HG21 ' A' ' 330' ' ' THR . 16.0 mttt -87.78 -168.81 2.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 53.34 109.317 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -148.91 137.65 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.14 . . . . 75.11 109.28 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 278' ' ' THR . 15.9 m -107.88 178.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 55.11 109.325 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.592 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.47 -172.43 2.03 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.495 1.122 . . . . 63.11 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.07 -3.67 14.09 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 74.13 110.345 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.02 -5.41 28.14 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.456 1.097 . . . . 73.11 109.291 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 70.3 58.94 5.67 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.474 1.109 . . . . 73.34 111.013 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -154.76 119.48 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.456 0.739 . . . . 74.4 110.276 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.851 ' N ' HG12 ' A' ' 324' ' ' VAL . 24.3 m -46.1 124.18 5.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 72.33 110.395 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.566 HG22 ' OD1' ' A' ' 325' ' ' ASN . 0.8 OUTLIER -105.53 -39.47 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 63.55 109.306 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 344' ' ' LEU . 8.5 mt -130.47 167.79 18.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 73.04 109.284 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.452 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.2 m -151.9 132.18 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 60.42 109.259 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.737 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -85.44 122.1 5.86 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.511 1.132 . . . . 62.23 110.984 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.798 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.64 -26.82 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 70.24 109.302 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 342' ' ' ILE . 1.2 m 50.42 63.2 2.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.116 . . . . 74.0 108.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.798 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -70.04 -179.56 1.96 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.489 1.118 . . . . 60.05 109.275 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -76.66 62.52 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 74.42 109.297 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 14.9 m -174.09 146.29 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.15 . . . . 75.24 109.999 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 79.0 m-20 -53.09 -21.19 4.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.435 1.084 . . . . 71.44 109.303 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.59 143.32 42.41 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 63.21 110.298 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.584 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 63.3 mt -147.55 139.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 51.43 109.31 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 11.8 p -133.58 94.73 3.35 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.43 110.427 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.799 HD22 HD22 ' A' ' 250' ' ' LEU . 5.4 mp -47.66 133.03 13.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 74.52 109.286 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.4 ptpt -117.88 -60.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 74.11 109.317 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.29 150.85 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 54.44 109.984 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -56.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.482 1.78 . . . . 61.24 111.047 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 348' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.45 109.336 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.326 -0.62 . . . . 75.31 109.326 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.576 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.21 98.24 6.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 64.04 109.304 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.477 ' CE1' ' CD ' ' A' ' 341' ' ' GLU . 2.3 t-160 -96.63 130.23 43.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.472 1.107 . . . . 61.12 109.574 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 265' ' ' LEU . 3.6 t -116.06 171.16 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 71.3 109.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.528 ' H ' HG12 ' A' ' 252' ' ' VAL . 1.1 tp10 -134.76 121.99 21.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.519 1.137 . . . . 74.44 110.27 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 263' ' ' PHE . 21.8 t -103.61 111.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 54.24 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -64.94 0.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 61.11 109.962 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.906 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.3 OUTLIER 66.97 67.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 72.43 109.312 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.09 169.08 11.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 75.22 110.298 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -73.52 -14.49 61.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.472 1.108 . . . . 71.14 109.318 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 260' ' ' SER . 1.8 p-10 -87.51 -45.37 10.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 75.35 109.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.473 ' N ' ' ND2' ' A' ' 259' ' ' ASN . 3.8 p -176.15 -177.31 0.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 70.33 110.004 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 256' ' ' ASN . 16.8 mt -90.18 174.46 7.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.11 . . . . 73.2 109.255 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . 0.404 ' NE2' ' HG2' ' A' ' 305' ' ' GLU . 4.2 t-160 -171.97 104.51 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.44 109.59 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.608 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 87.9 m-85 -107.05 91.68 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 72.42 110.993 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.718 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 48.9 mt -88.84 109.9 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.21 109.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.715 HD21 HD12 ' A' ' 306' ' ' LEU . 0.1 OUTLIER -110.62 130.33 55.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 73.4 109.331 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.718 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 2.0 m-85 -114.99 136.74 52.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.496 1.123 . . . . 75.45 111.003 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 273' ' ' ILE . 9.2 p-10 -79.72 118.58 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 61.42 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -11.53 22.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 54.41 109.309 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.5 p -72.1 175.67 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 63.42 110.345 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -88.52 -43.21 11.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 65.15 109.308 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.3 pt -53.15 175.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 74.31 109.299 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.12 134.42 62.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 72.33 109.319 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.479 HG21 HD12 ' A' ' 298' ' ' ILE . 1.1 mp -57.59 139.18 81.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 74.12 109.313 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.402 ' HA ' ' OE1' ' A' ' 297' ' ' GLU . 18.3 Cg_endo -74.99 -30.96 6.61 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.474 1.776 . . . . 42.34 111.005 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 276' ' ' ASN . . . 86.76 -159.67 31.9 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.518 1.136 . . . . 61.21 110.981 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 275' ' ' GLY . 56.9 t-20 40.35 32.44 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 72.15 109.287 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 275' ' ' GLY . 86.4 m -88.61 -176.77 5.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 43.31 108.298 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.944 ' O ' HG22 ' A' ' 324' ' ' VAL . 33.1 m -157.4 119.94 3.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 73.32 110.428 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.571 ' CD1' HD13 ' A' ' 306' ' ' LEU . 3.1 t80 -65.79 173.36 2.92 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.457 1.098 . . . . 73.2 110.962 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.59 ' HG3' HG21 ' A' ' 288' ' ' VAL . 39.6 tt0 -155.99 79.61 0.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 64.12 110.339 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.56 151.07 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.12 . . . . 71.41 111.0 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 p -120.82 -177.25 3.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 71.14 110.015 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.583 ' CB ' HD23 ' A' ' 312' ' ' LEU . 26.5 p . . . . . 0 C--N 1.324 -0.514 0 O-C-N 124.52 1.137 . . . . 65.22 110.018 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.59 HG21 ' HG3' ' A' ' 280' ' ' GLU . 2.4 p . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 109.235 -0.654 . . . . 63.25 109.235 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.33 131.96 54.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 71.32 110.998 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 65.4 m -101.99 116.99 33.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 71.53 109.996 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.7 mt -98.63 125.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 72.13 109.302 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -67.61 117.77 9.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.437 1.086 . . . . 63.32 109.27 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.466 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 94.1 mtp -81.96 151.8 27.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 63.21 110.967 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.466 ' N ' ' NZ ' ' A' ' 304' ' ' LYS . . . -44.55 145.7 1.9 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.546 1.154 . . . . 41.01 110.981 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -25.97 11.41 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.534 1.807 . . . . 73.54 111.001 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -67.42 178.78 1.45 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.03 109.626 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 73.2 mt-10 -113.48 130.62 56.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 73.31 110.327 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 304' ' ' LYS . 3.4 mt -44.08 -62.46 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 71.32 109.314 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 267' ' ' ASN . . . 111.21 -165.15 12.11 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 34.42 111.018 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.711 HG22 ' N ' ' A' ' 301' ' ' LYS . 9.7 mt -63.56 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.534 0.784 . . . . 62.12 109.343 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.711 ' N ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -89.22 14.6 10.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.32 109.278 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.529 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -62.25 178.47 5.06 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 41.44 111.0 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 298' ' ' ILE . 2.5 pt20 -141.24 176.79 8.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 0.766 . . . . 75.2 110.285 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.583 ' HB2' HD11 ' A' ' 298' ' ' ILE . 31.3 tptt -139.37 145.53 39.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.55 109.297 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.404 ' HG2' ' NE2' ' A' ' 262' ' ' HIS . 4.1 mt-10 -116.31 128.78 55.85 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.469 1.106 . . . . 74.14 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.715 HD12 HD21 ' A' ' 265' ' ' LEU . 9.4 mt -132.14 56.9 1.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 64.4 109.312 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -70.94 123.6 22.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 64.01 107.985 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.7 m-30 -110.14 -166.48 1.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.431 1.082 . . . . 72.21 111.018 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.504 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.2 p90 -172.09 160.51 4.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 54.15 111.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.01 -36.26 2.65 Favored 'Cis proline' 0 C--N 1.36 1.145 0 C-N-CA 121.003 -2.499 . . . . 70.42 110.998 0.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.2 p 169.63 130.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 74.03 110.029 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.583 HD23 ' CB ' ' A' ' 283' ' ' SER . 5.6 mp -111.69 158.66 35.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 64.43 109.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 148.4 35.1 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.475 1.776 . . . . 61.31 110.954 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.665 HG23 ' OD1' ' A' ' 256' ' ' ASN . 0.3 OUTLIER -126.13 164.08 35.88 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 65.45 110.38 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -173.87 13.07 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 120.991 -2.504 . . . . 72.22 111.028 -0.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 1.021 HD13 ' SD ' ' A' ' 321' ' ' MET . 2.4 mt -107.73 58.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.502 1.126 . . . . 54.01 109.241 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.9 OUTLIER -81.87 133.32 35.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 44.43 109.989 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 317' ' ' SER . 6.8 t-20 75.26 26.13 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.04 109.302 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.825 ' CE2' HD23 ' A' ' 316' ' ' LEU . 16.4 m-85 -101.33 -171.56 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 73.44 110.984 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.543 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -100.54 -64.28 1.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 65.24 110.391 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 1.021 ' SD ' HD13 ' A' ' 316' ' ' LEU . 1.8 mtm 30.54 70.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 54.5 110.975 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.543 ' HG3' HG23 ' A' ' 320' ' ' THR . 91.4 mttt -100.93 -167.1 1.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.451 1.094 . . . . 72.32 109.317 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 11.7 t -151.94 127.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 71.15 109.284 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 278' ' ' THR . 22.2 m -107.34 177.32 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.434 1.084 . . . . 74.53 109.288 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -110.88 -172.32 2.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 42.31 109.289 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.77 -3.87 13.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 74.4 110.305 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.51 -7.78 30.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.55 109.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.12 54.09 6.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.508 1.13 . . . . 75.12 110.995 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.464 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.43 128.83 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 0.756 . . . . 74.04 110.271 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.823 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.2 m -57.86 117.75 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 71.42 110.363 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.503 HG22 ' OD1' ' A' ' 325' ' ' ASN . 2.6 pt -96.39 -37.22 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 72.43 109.275 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.841 ' HB3' HD23 ' A' ' 344' ' ' LEU . 7.0 mt -132.53 168.87 17.44 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 74.1 109.296 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.455 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.24 133.7 5.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 64.34 109.309 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -86.88 121.7 5.88 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.481 1.113 . . . . 73.13 110.998 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.948 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.21 -27.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 0.768 . . . . 71.31 109.28 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 54.58 63.22 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.572 1.17 . . . . 73.52 108.306 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.948 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -71.35 -175.0 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 75.42 109.301 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 317' ' ' SER . 0.1 OUTLIER -81.53 53.38 2.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.2 109.282 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.1 t -169.1 142.26 2.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 63.51 109.997 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -47.04 -25.43 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.505 1.128 . . . . 75.32 109.281 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.477 ' CD ' ' CE1' ' A' ' 251' ' ' HIS . 14.0 mt-10 -69.35 140.45 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 72.13 110.295 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.598 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 67.0 mt -147.36 135.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 65.23 109.327 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.4 p -127.63 87.21 2.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 45.32 110.439 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.841 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -39.97 134.71 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.549 1.156 . . . . 71.41 109.287 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.505 ' O ' ' CB ' ' A' ' 346' ' ' SER . 3.5 mtpt -106.2 -74.86 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 75.35 109.305 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.619 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 159.32 136.27 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.25 109.995 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 346' ' ' SER . 18.3 Cg_endo -74.97 -70.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.525 1.803 . . . . 74.21 111.058 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.435 ' C ' HD12 ' A' ' 348' ' ' LEU . 1.8 tp . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 70.43 109.307 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.307 -0.627 . . . . 43.24 109.307 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.605 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -112.87 99.0 7.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 74.13 109.328 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.833 ' CD2' HG22 ' A' ' 343' ' ' THR . 2.4 m80 -93.08 131.38 38.16 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 73.13 109.582 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 253' ' ' GLU . 95.0 t -119.8 167.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.447 1.092 . . . . 74.12 109.321 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.527 ' N ' HG12 ' A' ' 252' ' ' VAL . 9.0 tt0 -130.97 120.16 23.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 70.13 110.259 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 340' ' ' ASN . 39.6 t -90.81 119.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 73.24 109.285 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.4 t -92.51 -63.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.477 1.11 . . . . 64.32 109.993 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.88 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.3 t-20 56.77 63.89 1.82 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.14 . . . . 65.03 109.272 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.94 163.64 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 72.44 110.278 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.4 -13.39 61.45 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 63.31 109.258 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.89 -39.11 10.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 73.14 109.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.4 m -174.98 -174.51 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 73.01 110.013 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 256' ' ' ASN . 9.8 mt -89.29 179.49 6.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.533 1.146 . . . . 73.05 109.323 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 1.7 t-160 -178.26 107.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 72.34 109.597 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.598 ' CE1' HD22 ' A' ' 261' ' ' LEU . 91.2 m-85 -121.88 101.17 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 74.24 111.013 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 304' ' ' LYS . 23.9 mt -90.04 132.73 33.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 63.2 109.297 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -113.64 149.01 35.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 72.42 109.282 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.9 OUTLIER -128.04 115.66 18.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 72.42 111.016 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.534 ' HB2' HD13 ' A' ' 273' ' ' ILE . 8.8 t-20 -73.97 78.82 1.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 1.088 . . . . 73.12 109.234 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -101.8 13.43 34.88 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 65.55 109.28 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.7 p -76.36 -166.15 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 54.13 110.398 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.99 -65.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 70.41 109.268 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 272' ' ' ILE . 0.0 OUTLIER -68.3 -178.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 75.01 109.343 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 271' ' ' ILE . 2.5 mp -122.32 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 53.24 109.263 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -40.7 139.47 1.15 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 71.14 109.308 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.417 ' HG2' ' ND2' ' A' ' 325' ' ' ASN . 18.2 Cg_endo -75.02 -33.17 4.76 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.513 1.796 . . . . 64.13 110.999 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 103.82 153.05 23.2 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 52.34 111.018 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . 0.416 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 57.8 t30 71.86 26.85 2.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 0.768 . . . . 74.52 109.314 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.405 ' C ' ' OG1' ' A' ' 278' ' ' THR . 21.5 m -69.78 -179.17 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.553 1.158 . . . . 74.33 108.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 324' ' ' VAL . 4.4 m -155.1 138.46 15.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 71.42 110.427 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.52 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.3 t80 -91.1 -173.58 3.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 70.34 111.032 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 178.03 102.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.21 110.277 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.665 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 1.2 p90 -128.44 128.95 45.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 75.1 110.979 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.478 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 0.8 OUTLIER -107.73 154.22 21.81 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.533 1.145 . . . . 64.41 110.014 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.554 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 10.5 p . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.536 1.147 . . . . 50.45 110.04 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.317 -0.623 . . . . 64.04 109.317 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -135.99 138.55 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 73.12 110.992 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 96.8 p -110.59 125.85 53.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 61.12 109.983 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 11.4 mt -97.73 133.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 61.45 109.295 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.39 102.19 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 61.52 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.775 ' HG2' HD21 ' A' ' 306' ' ' LEU . 73.9 mtp -73.28 152.13 41.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 70.34 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -38.69 141.78 0.44 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.46 1.1 . . . . 65.01 110.959 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.416 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.3 Cg_endo -75.06 -23.81 13.33 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.52 1.8 . . . . 72.14 110.952 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -73.43 175.94 6.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 73.14 109.624 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -94.85 155.15 16.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 71.55 110.291 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.523 HG22 ' HB3' ' A' ' 267' ' ' ASN . 66.3 mt -77.19 -83.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.42 109.322 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 126.66 141.01 5.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.51 1.131 . . . . 52.41 110.996 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.764 HG22 ' HD3' ' A' ' 301' ' ' LYS . 58.6 mt -40.57 -33.15 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 0.751 . . . . 74.4 109.292 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.764 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -111.15 -29.47 7.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 61.03 109.332 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -48.05 136.35 15.43 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.498 1.124 . . . . 72.2 111.002 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.413 ' NE2' HG21 ' A' ' 264' ' ' ILE . 9.6 mt-30 -89.65 -172.48 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 0.757 . . . . 73.2 110.297 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 264' ' ' ILE . 32.8 tptt -160.49 145.12 14.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 64.32 109.33 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -124.54 144.46 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.473 1.108 . . . . 73.14 110.296 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 265' ' ' LEU . 11.8 mt -144.13 61.18 1.36 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 70.22 109.299 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 132.29 46.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.53 107.989 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.1 m-30 -118.4 174.49 6.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 75.42 110.988 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -155.74 155.03 29.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.559 1.162 . . . . 64.33 111.001 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -37.14 2.35 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.03 -2.487 . . . . 74.42 111.003 -0.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.4 p 172.61 149.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 64.55 110.003 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.729 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.7 mp -128.78 157.97 73.74 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 73.31 109.285 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 148.5 35.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.465 1.771 . . . . 75.51 110.979 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.642 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -134.51 161.96 60.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 71.21 110.395 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.0 Cg_endo -75.07 173.71 56.52 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.983 -2.507 . . . . 75.24 110.961 0.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.56 HD13 ' HE3' ' A' ' 321' ' ' MET . 1.4 mt -95.07 64.02 2.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.528 1.143 . . . . 75.34 109.282 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 4.7 p -77.37 121.6 23.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 73.22 110.027 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 78.92 31.44 0.31 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 71.54 109.326 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 283' ' ' SER . 4.2 m-85 -112.14 141.14 46.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 63.45 110.997 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.3 m -51.89 -62.79 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 63.43 110.426 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.56 ' HE3' HD13 ' A' ' 316' ' ' LEU . 0.9 OUTLIER 26.87 60.78 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 1.144 . . . . 45.44 111.012 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 320' ' ' THR . 49.0 mttm -97.44 -174.76 3.01 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 73.41 109.302 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.52 HG22 ' CD1' ' A' ' 279' ' ' PHE . 49.6 t -136.72 136.31 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 62.31 109.291 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.622 HG12 ' N ' ' A' ' 330' ' ' THR . 4.4 m -116.66 -179.57 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 74.33 109.307 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.829 ' OD1' HG21 ' A' ' 331' ' ' ILE . 0.8 OUTLIER -105.03 -171.23 1.88 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 73.21 109.282 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.47 -9.27 24.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 71.44 110.312 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -99.08 -7.25 27.01 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 75.24 109.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.36 14.3 76.74 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.5 1.125 . . . . 70.01 111.033 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.428 ' C ' HG12 ' A' ' 324' ' ' VAL . 3.4 pt-20 -92.94 132.78 36.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 0.744 . . . . 63.54 110.248 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.622 ' N ' HG12 ' A' ' 324' ' ' VAL . 16.6 m -61.39 130.87 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 64.13 110.417 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.829 HG21 ' OD1' ' A' ' 325' ' ' ASN . 19.8 pt -115.72 -39.24 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 73.23 109.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.725 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.9 mt -138.79 166.26 24.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 65.32 109.272 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.512 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.2 123.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 74.14 109.303 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -70.27 137.43 27.86 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.525 1.141 . . . . 44.42 111.042 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.503 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -74.11 -36.82 64.25 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.53 0.782 . . . . 71.2 109.244 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 335' ' ' LYS . 0.1 OUTLIER 40.9 87.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 1.16 . . . . 54.33 108.275 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.88 72.58 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 61.1 109.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.15 55.08 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.41 109.311 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.9 m -163.49 131.84 3.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 75.44 109.997 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.814 ' O ' HG23 ' A' ' 254' ' ' VAL . 8.5 m120 -46.9 -38.11 9.95 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 74.02 109.252 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.27 146.61 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 73.14 110.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.504 HD13 ' SD ' ' A' ' 321' ' ' MET . 9.3 mt -146.26 121.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 63.13 109.301 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.833 HG22 ' CD2' ' A' ' 251' ' ' HIS . 14.5 p -115.33 79.17 1.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 74.33 110.382 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.725 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.9 mp -38.82 149.87 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.1 . . . . 53.35 109.258 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -126.21 -55.01 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.14 109.343 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.625 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.1 p 157.41 154.81 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 62.4 110.001 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.421 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.96 -45.92 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.502 1.79 . . . . 74.23 111.018 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 347' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 62.51 109.305 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.275 -0.639 . . . . 74.3 109.275 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -121.36 105.56 10.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.22 109.318 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.464 ' N ' HD12 ' A' ' 250' ' ' LEU . 55.7 t-80 -73.17 124.19 25.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.01 109.628 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 1.142 HG13 HD23 ' A' ' 265' ' ' LEU . 56.6 t -118.49 168.69 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.553 1.158 . . . . 72.13 109.281 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.543 ' N ' HG12 ' A' ' 252' ' ' VAL . 45.7 tp10 -129.8 146.88 51.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 75.45 110.27 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.682 HG13 ' CE1' ' A' ' 263' ' ' PHE . 43.7 t -124.76 103.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 52.53 109.308 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.2 m -76.15 -70.04 0.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 73.42 109.949 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.967 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.2 t-20 60.52 66.56 0.92 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.529 1.143 . . . . 45.55 109.324 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.3 pt-20 -166.21 -174.39 2.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 71.21 110.298 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 18.1 t0 67.05 15.14 10.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.24 109.327 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 9.3 t-20 82.24 19.66 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 60.41 109.284 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 2.7 p -164.22 -175.39 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 62.14 109.999 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.6 mt -100.55 174.23 6.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.134 . . . . 63.42 109.286 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.2 117.72 0.3 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 72.0 109.583 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.682 ' CE1' HG13 ' A' ' 254' ' ' VAL . 80.9 m-85 -129.18 117.84 21.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 52.53 110.993 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.752 HG22 ' CE2' ' A' ' 266' ' ' TYR . 86.1 mt -102.5 112.48 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 64.11 109.329 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 1.142 HD23 HG13 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.06 123.8 42.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 72.14 109.306 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.752 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.3 m-85 -112.58 140.25 47.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 73.43 111.019 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.54 ' OD1' HD13 ' A' ' 271' ' ' ILE . 62.8 t-20 -91.16 88.66 7.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.12 . . . . 55.01 109.319 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -3.45 21.84 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 73.0 109.298 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 0.9 OUTLIER -56.66 -17.3 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 73.11 110.389 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 269' ' ' THR . 3.7 m120 83.75 43.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.44 109.327 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.54 HD13 ' OD1' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -152.03 177.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 71.14 109.303 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 271' ' ' ILE . 71.2 mt -106.62 130.64 58.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 63.11 109.309 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 298' ' ' ILE . 3.4 mm -71.04 138.12 84.86 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 51.43 109.297 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.1 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.549 1.815 . . . . 71.41 110.982 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 76.47 179.38 47.08 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.504 1.127 . . . . 71.41 111.03 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 326' ' ' GLN . 50.8 t-20 62.79 31.42 16.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 0.763 . . . . 74.15 109.322 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.403 ' C ' ' OG1' ' A' ' 278' ' ' THR . 68.6 m -90.58 178.71 6.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.35 108.293 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.7 m -153.8 127.87 9.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 64.13 110.413 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.469 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.8 t80 -80.47 164.11 23.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.22 110.991 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.417 ' CG ' HG21 ' A' ' 288' ' ' VAL . 28.3 tt0 -151.52 88.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.2 110.286 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.786 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 15.5 p90 -120.6 128.67 53.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 73.11 111.028 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.592 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 23.8 t -113.99 178.33 4.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.4 109.983 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.935 ' HB2' HD23 ' A' ' 312' ' ' LEU . 3.4 t . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 50.21 109.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.544 HG22 ' N ' ' A' ' 289' ' ' PHE . 8.2 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.295 -0.631 . . . . 71.53 109.295 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.544 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.5 t80 -116.4 139.42 50.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.537 1.148 . . . . 64.52 111.015 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 90.8 p -119.7 122.06 40.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 52.04 110.048 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 21.6 mt -103.44 129.25 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 72.52 109.335 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -71.24 115.99 11.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 73.44 109.298 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 81.6 mtp -78.27 164.31 25.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.22 111.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -66.53 147.73 50.05 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.519 1.137 . . . . 72.14 111.018 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -30.24 7.36 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.506 1.793 . . . . 73.32 110.966 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.93 138.3 58.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 74.4 109.617 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -73.44 141.19 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 72.2 110.307 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.653 HD12 HG13 ' A' ' 273' ' ' ILE . 27.0 mt -67.03 -81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 71.41 109.26 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 300' ' ' ILE . . . 109.59 156.63 16.71 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.508 1.13 . . . . 52.24 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.56 HG22 ' HD2' ' A' ' 301' ' ' LYS . 54.2 mt -39.13 -72.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.522 0.778 . . . . 74.12 109.352 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.56 ' HD2' HG22 ' A' ' 300' ' ' ILE . 13.5 mptt -68.38 -28.08 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 41.23 109.298 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -50.13 158.44 1.65 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.498 1.124 . . . . 63.44 110.963 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.414 ' N ' HG23 ' A' ' 298' ' ' ILE . 8.4 pt20 -129.23 -174.24 3.22 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 0.762 . . . . 74.25 110.322 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 24.6 tptt -156.92 156.92 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 53.22 109.321 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -134.76 147.14 49.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 62.03 110.314 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.997 HD12 HD11 ' A' ' 265' ' ' LEU . 16.5 mt -144.82 64.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 64.22 109.294 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -73.17 134.63 44.46 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.977 -1.119 . . . . 74.23 107.977 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.786 ' CD2' ' CE2' ' A' ' 281' ' ' PHE . 7.3 m-85 -121.69 167.07 13.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 73.13 111.024 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -142.71 143.4 25.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.21 110.997 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.0 -54.0 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.027 -2.489 . . . . 52.5 110.969 0.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.99 109.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 50.33 110.023 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 283' ' ' SER . 3.9 mp -70.69 158.09 88.7 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 62.54 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.06 33.4 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.476 1.777 . . . . 71.3 110.995 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.682 HG22 HD12 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -118.02 163.76 23.13 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 65.24 110.427 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.97 -173.19 11.86 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.021 -2.491 . . . . 63.24 111.016 -0.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.71 HD23 ' CD2' ' A' ' 319' ' ' TYR . 4.6 mp -102.71 11.31 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.553 1.158 . . . . 75.24 109.311 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -46.27 119.26 2.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 44.23 110.005 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 317' ' ' SER . 8.4 t-20 87.15 42.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 63.1 109.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.71 ' CD2' HD23 ' A' ' 316' ' ' LEU . 3.7 m-85 -120.85 -171.16 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 74.11 111.014 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 322' ' ' LYS . 52.3 m -105.04 -55.85 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 35.32 110.365 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.85 ' SD ' HD13 ' A' ' 342' ' ' ILE . 3.8 ptp 23.81 57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 63.02 110.977 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.569 ' HG3' HG22 ' A' ' 320' ' ' THR . 84.1 mttt -91.89 176.97 6.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.472 1.108 . . . . 62.3 109.339 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.437 HG22 ' HD1' ' A' ' 279' ' ' PHE . 17.3 t -133.63 129.52 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 75.4 109.306 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 278' ' ' THR . 6.5 m -109.1 -172.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.086 . . . . 61.13 109.307 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.638 ' HB3' HG21 ' A' ' 331' ' ' ILE . 39.8 p30 -121.38 -170.27 2.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 72.2 109.301 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.422 ' HB2' ' ND2' ' A' ' 276' ' ' ASN . 2.0 pt20 -63.2 -10.95 17.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 71.31 110.258 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -94.56 -13.96 25.51 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.466 1.104 . . . . 75.55 109.284 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.25 80.27 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.57 1.169 . . . . 72.55 111.028 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.25 134.79 38.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.514 0.773 . . . . 74.2 110.262 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.604 ' N ' HG12 ' A' ' 324' ' ' VAL . 10.3 m -61.87 115.1 3.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 64.51 110.439 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 325' ' ' ASN . 8.1 pt -88.97 -37.82 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.534 1.147 . . . . 72.35 109.304 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.905 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.4 mt -141.64 169.6 17.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.554 1.159 . . . . 71.43 109.283 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.461 HG12 ' CG2' ' A' ' 330' ' ' THR . 1.0 OUTLIER -148.47 136.13 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 74.31 109.296 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -92.51 118.8 5.66 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.466 1.104 . . . . 62.52 111.026 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.826 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -50.04 -26.86 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 0.759 . . . . 72.13 109.307 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.467 ' HG ' ' HB2' ' A' ' 319' ' ' TYR . 5.6 t 46.05 77.03 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 53.3 108.333 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.826 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -81.51 -172.2 3.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 53.14 109.321 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.56 58.01 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 74.32 109.271 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.85 162.7 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 44.44 109.96 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.94 -38.49 86.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.11 109.319 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.421 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -61.77 133.06 55.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.114 . . . . 73.14 110.305 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.85 HD13 ' SD ' ' A' ' 321' ' ' MET . 86.0 mt -143.77 131.33 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 75.3 109.289 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.453 ' HB ' HD23 ' A' ' 249' ' ' LEU . 49.3 p -129.56 94.91 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.419 1.074 . . . . 74.41 110.404 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.0 mp -39.72 152.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 52.42 109.276 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 5.7 ptpt -125.67 -60.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 64.12 109.311 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.504 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.2 p 159.38 151.35 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.125 . . . . 55.23 109.978 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -79.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.514 1.797 . . . . 71.24 110.993 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.714 HD22 ' C ' ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.512 1.133 . . . . 75.12 109.312 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.291 -0.633 . . . . 44.3 109.291 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.803 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.7 OUTLIER -105.58 101.12 10.66 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 74.42 109.319 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.729 ' CD2' HG22 ' A' ' 343' ' ' THR . 8.1 m80 -82.07 168.1 18.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 74.21 109.632 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.681 ' CG2' HD23 ' A' ' 265' ' ' LEU . 22.4 t -155.05 150.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 73.15 109.328 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -124.57 151.05 45.25 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 73.52 110.313 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.78 106.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 60.42 109.327 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.8 t -73.55 -62.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 64.14 109.963 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.937 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.1 t-20 60.89 63.41 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 71.45 109.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -95.62 158.98 15.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 1.124 . . . . 72.25 110.325 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -48.25 -49.03 34.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 71.31 109.29 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -51.47 -53.41 37.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 64.11 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.8 p 178.75 -174.69 0.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.511 1.132 . . . . 34.14 109.993 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 1.032 ' CD1' HD12 ' A' ' 312' ' ' LEU . 34.8 mt -77.65 178.76 7.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 62.32 109.308 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -171.22 108.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.01 109.577 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.814 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 79.3 m-85 -115.79 93.13 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 75.1 111.036 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.835 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 84.6 mt -87.31 103.39 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 74.42 109.273 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.18 132.82 44.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 72.43 109.288 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.835 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -118.27 125.98 51.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.32 110.988 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.483 ' HA ' HD12 ' A' ' 250' ' ' LEU . 32.9 t-20 -64.0 79.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 72.33 109.266 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 266' ' ' TYR . 1.1 mmpt? -90.91 40.55 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.519 1.137 . . . . 72.52 109.259 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.6 p -119.65 177.78 4.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.23 110.402 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -85.56 -12.49 51.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 72.11 109.283 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.2 pt -101.46 160.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 73.42 109.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 273' ' ' ILE . 3.8 mp -120.58 121.58 65.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 53.22 109.278 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.412 HD12 ' ND2' ' A' ' 267' ' ' ASN . 1.0 OUTLIER -40.01 142.4 0.7 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 53.35 109.313 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -74.97 -44.41 0.34 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.797 . . . . 44.43 111.023 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 123.19 149.33 7.8 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.523 1.139 . . . . 52.43 110.977 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.9 t30 67.35 73.86 0.32 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 0.743 . . . . 72.21 109.308 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 293' ' ' MET . 0.8 OUTLIER -119.91 -179.15 3.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 54.24 108.286 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 324' ' ' VAL . 22.3 m -153.51 137.52 16.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.535 1.147 . . . . 61.53 110.393 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.904 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.6 t80 -86.04 -167.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 73.14 110.993 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 176.5 104.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.458 1.099 . . . . 72.53 110.287 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.589 ' CZ ' ' CG ' ' A' ' 308' ' ' PHE . 3.0 p90 -133.56 144.0 49.05 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 72.34 111.021 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 37.3 p -104.43 143.27 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 74.12 110.011 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.699 ' OG ' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 O-C-N 124.461 1.101 . . . . 70.44 109.988 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 289' ' ' PHE . 3.3 p . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.337 -0.616 . . . . 75.35 109.337 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.516 ' N ' HG22 ' A' ' 288' ' ' VAL . 5.7 t80 -134.83 149.14 50.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.438 1.086 . . . . 71.32 110.949 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.459 ' HB3' HG22 ' A' ' 278' ' ' THR . 11.0 m -109.31 127.14 54.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.11 110.0 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 278' ' ' THR . 8.2 mt -97.06 125.63 50.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 73.44 109.289 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -70.26 116.57 10.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 63.23 109.3 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.708 ' HG2' HD21 ' A' ' 306' ' ' LEU . 86.2 mtp -84.74 170.0 13.68 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.571 1.169 . . . . 74.33 111.018 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.595 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -64.01 143.02 47.06 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.484 1.115 . . . . 60.34 111.023 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -27.93 9.55 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.514 1.797 . . . . 72.51 111.013 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -71.34 155.76 40.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 74.24 109.607 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.38 169.39 17.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.53 1.143 . . . . 71.13 110.284 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 79.0 mt -99.22 -74.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.22 109.308 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.408 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 122.15 135.95 4.82 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.545 1.153 . . . . 53.21 110.986 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.411 HG22 ' CE ' ' A' ' 301' ' ' LYS . 4.0 mt -41.52 -28.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 0.781 . . . . 63.52 109.299 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.411 ' CE ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -108.08 -31.19 8.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 63.11 109.303 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -57.76 146.6 38.19 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.497 1.123 . . . . 64.51 110.998 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -173.91 2.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.427 0.722 . . . . 43.24 110.277 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.595 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 28.8 tptt -159.99 144.6 14.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 75.25 109.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -107.69 155.03 20.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 72.2 110.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.708 HD21 ' HG2' ' A' ' 293' ' ' MET . 9.7 mt -149.06 60.34 1.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 52.2 109.268 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.37 133.08 55.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 74.44 107.957 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.814 ' CD2' ' CE1' ' A' ' 263' ' ' PHE . 17.9 m-30 -119.38 39.52 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.494 1.121 . . . . 73.01 110.96 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.517 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -36.44 148.03 0.18 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 74.24 111.007 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.03 -46.45 0.37 Allowed 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.959 -2.517 . . . . 74.23 111.002 0.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 34.2 p 176.27 162.11 0.36 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 71.55 109.984 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -132.87 164.78 41.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.401 1.063 . . . . 73.21 109.275 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 145.24 31.28 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.52 1.8 . . . . 54.41 111.017 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.21 163.09 44.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 74.33 110.353 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.03 174.91 50.27 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.963 -2.515 . . . . 62.34 111.006 0.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.676 HD13 ' CE ' ' A' ' 321' ' ' MET . 8.2 mt -89.63 12.55 16.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 74.44 109.278 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.1 t -46.56 118.52 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 72.12 110.023 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.0 t-20 88.58 41.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 71.14 109.327 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.638 ' CE2' HD23 ' A' ' 316' ' ' LEU . 4.9 m-85 -122.86 -174.28 2.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.53 110.982 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.1 m -103.76 -56.71 2.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 71.11 110.45 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.76 ' SD ' HD13 ' A' ' 342' ' ' ILE . 2.5 ptp 25.29 67.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.53 1.144 . . . . 75.41 110.993 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.653 ' HG2' HG23 ' A' ' 333' ' ' VAL . 38.9 mttt -104.35 -176.77 3.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 1.126 . . . . 62.45 109.26 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.904 HG22 ' CD1' ' A' ' 279' ' ' PHE . 65.4 t -136.56 158.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.111 . . . . 43.03 109.314 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 278' ' ' THR . 16.0 m -137.35 171.85 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 75.14 109.283 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -104.24 -162.87 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 1.129 . . . . 70.12 109.293 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -72.27 -4.84 32.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.528 1.143 . . . . 74.41 110.337 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -102.44 0.56 34.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 72.02 109.278 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.47 1.87 58.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.496 1.123 . . . . 72.15 111.011 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -83.54 141.17 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 0.753 . . . . 73.42 110.307 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.673 HG22 ' HG3' ' A' ' 347' ' ' PRO . 43.1 m -65.74 124.17 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 73.34 110.397 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.7 pt -102.5 -38.35 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 73.54 109.256 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.616 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.5 mt -144.33 171.71 13.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 71.51 109.272 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.653 HG23 ' HG2' ' A' ' 322' ' ' LYS . 0.2 OUTLIER -161.29 125.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.14 109.349 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.749 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -77.22 119.2 5.29 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.525 1.141 . . . . 42.25 110.982 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -26.02 0.73 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.537 0.787 . . . . 62.22 109.28 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.412 ' HG ' ' C ' ' A' ' 316' ' ' LEU . 5.7 t 46.03 85.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.168 . . . . 72.44 108.3 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -95.67 -171.08 2.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.456 1.098 . . . . 64.54 109.262 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 338' ' ' ASP . 0.0 OUTLIER -81.04 56.16 2.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 75.13 109.288 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 341' ' ' GLU . 15.2 m -168.27 136.92 2.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 54.21 110.0 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -46.11 -26.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 65.2 109.301 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 339' ' ' SER . 3.4 mt-10 -69.75 141.31 53.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.104 . . . . 63.4 110.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.76 HD13 ' SD ' ' A' ' 321' ' ' MET . 66.0 mt -147.24 139.34 18.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 72.24 109.314 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.729 HG22 ' CD2' ' A' ' 251' ' ' HIS . 10.1 p -135.37 99.17 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 64.31 110.417 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.803 HD22 ' CD2' ' A' ' 250' ' ' LEU . 6.5 mp -52.07 132.97 33.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 74.42 109.318 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.3 ptpt -118.7 -61.45 1.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 64.34 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.9 OUTLIER 159.53 149.05 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 74.52 110.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.673 ' HG3' HG22 ' A' ' 330' ' ' THR . 18.5 Cg_endo -74.97 -46.24 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.51 1.795 . . . . 62.34 111.043 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 348' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.496 1.123 . . . . 72.42 109.32 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.714 HD22 ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.346 -0.613 . . . . 73.43 109.346 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.39 101.07 8.8 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.468 1.105 . . . . 74.51 109.266 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.714 ' NE2' HD22 ' A' ' 249' ' ' LEU . 41.8 m170 -94.47 131.12 40.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.15 109.621 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.613 HG21 HD23 ' A' ' 265' ' ' LEU . 21.9 t -128.55 169.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.31 109.303 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.513 ' N ' HG12 ' A' ' 252' ' ' VAL . 15.0 tp10 -125.31 146.62 49.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 72.24 110.304 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.685 HG22 ' CE1' ' A' ' 263' ' ' PHE . 38.9 t -130.58 95.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.24 109.312 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -56.84 6.54 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 1.148 . . . . 61.31 109.999 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.822 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.3 t-20 59.73 74.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 72.04 109.333 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' ASP . 8.5 pt-20 -108.64 156.24 19.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.44 110.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 257' ' ' GLU . 46.2 m-20 -40.33 -57.86 1.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 72.25 109.291 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -39.94 -65.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.15 109.347 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.79 -170.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.122 . . . . 73.13 109.965 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.5 mt -81.69 162.27 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 70.44 109.255 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . 0.551 ' NE2' ' CD1' ' A' ' 264' ' ' ILE . 1.3 t-160 -148.66 103.0 3.35 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 72.21 109.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.743 ' HE2' HD13 ' A' ' 261' ' ' LEU . 84.4 m-85 -116.15 130.68 56.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 65.34 110.995 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.824 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 45.6 mt -131.81 105.21 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 75.14 109.289 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 252' ' ' VAL . 0.1 OUTLIER -95.82 128.12 42.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.33 109.272 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.824 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 3.5 m-85 -114.31 113.84 25.13 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 72.14 111.018 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.65 ' CG ' HD13 ' A' ' 273' ' ' ILE . 26.6 t30 -72.34 87.35 1.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.25 109.329 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.645 ' HZ1' ' HA ' ' A' ' 301' ' ' LYS . 3.1 mmpt? -96.22 31.28 2.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.24 109.328 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 6.6 p -102.56 143.73 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 62.11 110.376 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.44 ' O ' HD11 ' A' ' 300' ' ' ILE . 23.9 m120 -47.35 -53.42 13.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 75.11 109.309 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 37.5 pt -62.25 177.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.15 109.34 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.1 mt -118.96 136.06 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 75.4 109.282 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.65 HD13 ' CG ' ' A' ' 267' ' ' ASN . 0.9 OUTLIER -63.28 140.18 97.66 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.145 . . . . 72.15 109.323 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 -34.16 3.97 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.484 1.781 . . . . 71.21 110.948 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 87.11 177.39 48.95 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.462 1.101 . . . . 71.34 111.036 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.99 27.49 8.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 0.789 . . . . 73.21 109.274 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.417 ' C ' ' OG1' ' A' ' 278' ' ' THR . 6.2 m -75.19 -177.07 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 73.42 108.313 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.921 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.4 m -154.51 100.02 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 65.13 110.364 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.555 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 0.4 OUTLIER -54.76 170.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.23 111.019 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.452 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 70.8 tt0 -160.58 84.21 0.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 73.15 110.302 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 29.6 p90 -115.32 133.1 56.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 74.22 110.983 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.699 ' HG ' ' N ' ' A' ' 288' ' ' VAL . 2.8 t -128.72 -172.08 2.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.544 1.153 . . . . 64.11 109.991 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 22.0 t . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 75.53 109.976 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.699 ' N ' ' HG ' ' A' ' 282' ' ' SER . 7.7 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.306 -0.627 . . . . 72.0 109.306 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 288' ' ' VAL . 1.2 t80 -147.34 134.74 20.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 74.4 111.048 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 8.2 p -115.73 117.3 29.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.428 1.08 . . . . 62.53 110.007 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.1 mt -106.47 128.46 61.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 73.21 109.317 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.8 108.85 4.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 71.32 109.287 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.55 ' HG2' HD21 ' A' ' 306' ' ' LEU . 90.0 mtp -75.02 139.55 42.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 72.24 111.02 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.72 144.49 0.17 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.478 1.111 . . . . 74.4 110.995 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -24.43 12.8 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.515 1.797 . . . . 71.55 111.005 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -75.35 141.55 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 71.15 109.637 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.75 -174.18 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 74.4 110.327 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 39.1 mt -110.93 -74.2 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 71.15 109.278 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 123.53 162.95 11.63 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.468 1.105 . . . . 42.43 111.005 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 270' ' ' ASN . 36.5 mt -62.09 -30.58 49.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.519 0.776 . . . . 64.21 109.273 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.645 ' HA ' ' HZ1' ' A' ' 268' ' ' LYS . 48.6 mmtt -110.77 -22.88 11.35 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 75.23 109.27 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -59.08 164.63 9.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.527 1.142 . . . . 75.21 111.03 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -131.73 -179.84 5.63 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.519 0.776 . . . . 73.42 110.295 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 25.2 tptt -143.6 144.66 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 75.31 109.337 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.556 ' HG2' ' CH2' ' A' ' 307' ' ' TRP . 8.8 mp0 -112.71 143.6 43.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 61.45 110.302 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 12.7 mt -140.83 62.34 1.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.21 109.304 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.556 ' CH2' ' HG2' ' A' ' 305' ' ' GLU . 1.5 m-90 -68.82 118.72 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.9 m-30 -111.97 168.57 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 73.45 111.023 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.492 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -155.02 160.76 30.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 74.3 110.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.0 -40.19 1.27 Allowed 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.023 -2.491 . . . . 71.45 110.986 0.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.1 p 175.56 132.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 52.13 110.029 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.499 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.5 mp -113.5 158.23 39.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 70.03 109.282 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 147.06 33.54 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.497 1.788 . . . . 54.4 110.966 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.851 HG22 HD12 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -131.92 163.52 49.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 73.53 110.349 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 175.73 46.54 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.967 -2.514 . . . . 64.22 111.021 -0.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.851 HD12 HG22 ' A' ' 314' ' ' THR . 5.3 mp -93.52 65.57 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.502 1.126 . . . . 71.13 109.294 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 125.37 29.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.494 1.121 . . . . 74.5 109.998 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 73.51 29.1 1.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.03 109.306 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.4 m-85 -110.49 134.22 52.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.548 1.155 . . . . 74.52 110.988 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.826 HG23 ' HD3' ' A' ' 322' ' ' LYS . 1.2 m -49.32 -64.72 0.72 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 73.4 110.398 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.653 ' HE1' ' CD1' ' A' ' 342' ' ' ILE . 4.3 ttm 31.87 42.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 75.53 110.98 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.826 ' HD3' HG23 ' A' ' 320' ' ' THR . 16.9 pttt -80.09 -160.33 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.565 1.166 . . . . 74.11 109.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -151.96 133.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.142 . . . . 64.04 109.324 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.921 HG22 ' O ' ' A' ' 278' ' ' THR . 22.1 m -112.33 177.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 71.54 109.303 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.607 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.73 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.538 1.149 . . . . 73.51 109.306 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -1.91 12.7 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.489 1.118 . . . . 64.24 110.341 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.42 -8.19 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 72.31 109.357 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.89 5.86 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.516 1.135 . . . . 65.12 110.987 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.439 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.4 OUTLIER -149.64 129.81 13.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 0.758 . . . . 61.22 110.326 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.759 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.3 m -64.1 113.39 3.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 74.54 110.39 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.501 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 1.7 pt -91.22 -34.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 70.43 109.279 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.949 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.7 mt -138.1 165.53 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 72.44 109.285 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -153.57 121.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 73.15 109.303 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.434 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -70.11 126.82 17.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.506 1.129 . . . . 25.22 111.014 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.499 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -44.8 -26.56 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 0.788 . . . . 74.22 109.314 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.6 OUTLIER 47.09 65.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.53 108.285 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -77.09 -171.23 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 73.4 109.299 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 54.66 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.126 . . . . 73.42 109.267 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.2 m -169.62 163.09 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 50.34 110.033 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -65.93 -32.49 74.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.43 109.323 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.32 135.41 57.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.495 1.122 . . . . 73.41 110.339 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.653 ' CD1' ' HE1' ' A' ' 321' ' ' MET . 82.1 mt -143.62 120.78 5.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 70.15 109.297 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 251' ' ' HIS . 16.2 p -123.27 84.57 2.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.568 1.168 . . . . 65.14 110.422 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.949 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.2 mp -38.75 147.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 72.55 109.306 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -128.87 -48.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 72.0 109.354 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 155.22 147.36 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 73.42 110.004 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.4 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.3 Cg_endo -75.02 -70.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.528 1.804 . . . . 72.04 111.014 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.788 HD13 ' O ' ' A' ' 348' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 61.44 109.317 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.719 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.29 -0.633 . . . . 70.14 109.29 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.698 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -129.78 105.15 7.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 71.23 109.274 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.596 ' O ' HG23 ' A' ' 252' ' ' VAL . 9.7 t-160 -71.24 163.63 27.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 75.55 109.616 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.696 HG21 HD23 ' A' ' 265' ' ' LEU . 54.8 t -158.38 126.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 54.25 109.29 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -96.84 135.82 38.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.565 1.165 . . . . 70.3 110.296 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 340' ' ' ASN . 48.1 t -108.27 100.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 72.5 109.302 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -60.66 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.52 1.138 . . . . 71.4 109.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.949 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER 53.72 68.89 0.78 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 43.43 109.298 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.25 157.27 15.97 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.492 1.12 . . . . 64.42 110.301 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -52.06 -33.54 39.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 72.33 109.291 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -68.08 -50.96 51.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 72.41 109.363 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p 178.49 -178.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.466 1.104 . . . . 62.12 109.979 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.949 HD23 ' HA ' ' A' ' 256' ' ' ASN . 77.7 mt -76.07 178.56 6.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 60.24 109.279 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -176.44 86.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.116 . . . . 62.42 109.619 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.686 ' CZ ' HD13 ' A' ' 261' ' ' LEU . 4.8 m-30 -96.84 134.09 40.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 71.42 110.995 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.604 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 23.1 mt -127.88 109.62 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 73.44 109.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.52 129.31 45.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 55.43 109.305 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.653 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -104.19 113.12 26.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 74.35 110.953 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.695 ' HB2' HD13 ' A' ' 273' ' ' ILE . 18.2 t30 -68.5 72.91 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 65.31 109.248 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.8 mmtt -87.35 53.59 2.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.51 109.294 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.485 ' O ' HD11 ' A' ' 300' ' ' ILE . 30.7 p -120.64 -176.38 3.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.521 1.138 . . . . 62.41 110.381 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.21 -59.42 2.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 44.42 109.315 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.693 ' C ' HD12 ' A' ' 272' ' ' ILE . 0.1 OUTLIER -78.06 -176.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 72.13 109.308 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.693 HD12 ' C ' ' A' ' 271' ' ' ILE . 2.3 mp -120.22 143.42 32.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.501 1.125 . . . . 63.41 109.29 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -43.66 142.44 1.87 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.453 1.095 . . . . 74.23 109.335 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -38.15 1.71 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.439 1.757 . . . . 72.24 110.983 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 99.51 160.18 28.98 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.523 1.139 . . . . 74.43 111.007 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 8.1 t-20 81.7 17.34 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 0.749 . . . . 62.52 109.29 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 87.3 m -66.61 170.57 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 74.33 108.303 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.873 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.8 m -153.64 99.24 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.554 1.159 . . . . 64.22 110.405 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.754 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.9 OUTLIER -50.79 171.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.111 . . . . 62.25 111.035 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -172.99 99.4 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 73.22 110.299 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.0 p90 -122.9 141.98 51.29 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.57 1.168 . . . . 73.41 111.015 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 54.7 p -74.88 159.13 32.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 71.15 109.983 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.148 . . . . 64.54 110.003 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.551 HG22 ' H ' ' A' ' 289' ' ' PHE . 10.4 p . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.313 -0.625 . . . . 74.23 109.313 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.551 ' H ' HG22 ' A' ' 288' ' ' VAL . 4.3 t80 -145.22 162.36 37.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 74.53 110.992 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.605 ' OG ' HG22 ' A' ' 278' ' ' THR . 4.0 t -137.05 124.92 22.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.097 . . . . 74.53 109.983 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.776 HD11 ' HD1' ' A' ' 308' ' ' PHE . 12.5 mt -103.67 148.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.558 1.161 . . . . 73.13 109.295 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 292' ' ' LYS . 0.3 OUTLIER -79.86 123.71 28.0 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 42.24 109.284 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.951 ' HG2' HD21 ' A' ' 306' ' ' LEU . 37.5 mtp -92.77 15.0 15.59 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.561 1.163 . . . . 64.5 110.999 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.19 151.91 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.482 1.114 . . . . 51.24 110.963 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.427 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.03 -16.44 20.13 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.53 1.805 . . . . 73.33 110.993 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -62.84 151.14 39.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 63.4 109.6 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.437 ' C ' HD13 ' A' ' 298' ' ' ILE . 4.4 mp0 -87.6 165.4 15.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.56 1.163 . . . . 65.15 110.319 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 302' ' ' GLY . 2.7 mm -89.05 -95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 73.11 109.305 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 120.11 168.88 13.9 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.468 1.105 . . . . 74.14 111.013 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.854 HG22 ' HD3' ' A' ' 301' ' ' LYS . 15.5 mm -60.36 -43.05 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.507 0.769 . . . . 71.2 109.304 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.854 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.5 OUTLIER -108.94 -12.8 14.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 60.54 109.357 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.7 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -81.27 49.62 4.04 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 61.42 111.019 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.524 ' HG2' ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -41.89 164.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 0.784 . . . . 70.05 110.29 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.5 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 41.9 tptt -118.4 165.69 13.56 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.13 . . . . 72.1 109.315 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -134.86 144.96 47.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 64.5 110.346 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.951 HD21 ' HG2' ' A' ' 293' ' ' MET . 45.3 mt -140.72 61.69 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.14 109.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -72.19 123.02 22.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.963 -1.125 . . . . 71.42 107.963 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.776 ' HD1' HD11 ' A' ' 291' ' ' ILE . 57.0 t80 -119.24 172.09 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 74.4 111.001 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -147.24 162.66 31.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.148 . . . . 74.24 110.972 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.03 -46.13 0.4 Allowed 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.025 -2.49 . . . . 34.33 110.952 0.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 28.7 p 177.83 170.41 0.68 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.11 110.011 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.949 ' HG ' HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -153.7 161.12 29.99 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.459 1.099 . . . . 63.23 109.288 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 312' ' ' LEU . 18.3 Cg_endo -74.96 144.09 29.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.509 1.794 . . . . 50.32 111.006 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.632 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -126.06 165.45 27.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 73.22 110.356 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.04 -176.11 17.43 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.987 -2.505 . . . . 62.41 111.031 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.575 HD13 ' HE3' ' A' ' 321' ' ' MET . 2.0 mt -98.21 61.42 1.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.15 109.311 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.9 p -74.62 119.9 19.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 74.52 110.034 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 317' ' ' SER . 45.3 t30 79.42 40.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.453 1.096 . . . . 61.32 109.338 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.436 ' CG ' ' HB3' ' A' ' 316' ' ' LEU . 24.3 m-85 -119.84 142.99 48.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 74.03 111.013 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.524 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.3 m -59.75 -56.76 17.76 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 71.03 110.383 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.575 ' HE3' HD13 ' A' ' 316' ' ' LEU . 0.9 OUTLIER 26.93 58.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 74.2 110.953 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.577 ' HD3' HG21 ' A' ' 330' ' ' THR . 29.6 mttm -94.86 -168.17 1.77 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 73.41 109.321 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.414 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 2.9 t -150.35 133.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 73.54 109.268 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 278' ' ' THR . 10.9 m -109.98 172.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 72.52 109.23 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -109.61 -163.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.494 1.121 . . . . 73.44 109.268 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.16 -12.86 22.1 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.133 . . . . 71.52 110.303 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.5 22.81 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 64.31 109.356 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.27 25.66 0.79 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.543 1.152 . . . . 74.23 111.012 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.493 ' C ' HG12 ' A' ' 324' ' ' VAL . 6.5 pt-20 -106.78 128.66 54.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 0.76 . . . . 71.23 110.286 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.797 ' N ' HG12 ' A' ' 324' ' ' VAL . 9.0 m -54.29 135.02 45.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.112 . . . . 75.41 110.413 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.4 pt -114.99 -42.09 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.136 . . . . 64.21 109.293 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.444 ' C ' HG13 ' A' ' 333' ' ' VAL . 12.6 mt -136.42 171.25 14.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 70.0 109.273 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.53 HG12 ' CG ' ' A' ' 322' ' ' LYS . 14.6 m -153.31 141.24 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.41 109.336 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -84.97 136.89 14.95 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.489 1.118 . . . . 71.21 110.988 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -67.2 -38.56 85.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 0.749 . . . . 75.35 109.302 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.494 ' H ' HG23 ' A' ' 342' ' ' ILE . 0.1 OUTLIER 40.18 88.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.496 1.123 . . . . 70.5 108.299 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -116.81 81.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 63.2 109.28 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 338' ' ' ASP . 3.4 p-10 39.93 49.9 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.15 . . . . 75.31 109.258 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 26.9 m -157.21 136.67 12.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 74.45 109.997 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.697 ' O ' HG23 ' A' ' 254' ' ' VAL . 7.1 m120 -58.14 -36.82 73.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 75.11 109.326 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.19 134.41 48.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.549 1.156 . . . . 73.32 110.315 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 336' ' ' CYS . 4.8 mt -136.35 134.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 33.24 109.31 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 344' ' ' LEU . 39.3 p -125.27 86.38 2.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 61.51 110.363 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' A' ' 250' ' ' LEU . 7.2 mp -40.38 130.85 2.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 71.25 109.32 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.9 ptpt -117.54 -60.04 1.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.107 . . . . 44.0 109.292 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.517 ' C ' HG22 ' A' ' 333' ' ' VAL . 1.5 m 159.47 157.28 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 53.22 110.012 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 -61.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.536 1.809 . . . . 72.43 110.999 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 74.13 109.282 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.296 -0.631 . . . . 72.03 109.296 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.603 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -110.8 99.94 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.582 1.176 . . . . 73.15 109.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.412 ' NE2' ' HG2' ' A' ' 341' ' ' GLU . 2.4 t-160 -90.33 131.54 36.07 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 71.15 109.614 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 265' ' ' LEU . 79.7 t -121.08 164.64 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 72.45 109.306 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.474 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.4 tp10 -129.72 147.26 51.48 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 63.32 110.325 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 263' ' ' PHE . 61.6 t -121.19 106.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.145 . . . . 71.25 109.335 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 t -72.85 -61.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.12 110.002 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.918 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.9 t-20 53.42 57.03 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 62.35 109.287 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 260' ' ' SER . 5.0 pt-20 -161.15 -174.54 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 74.44 110.344 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 71.86 17.15 5.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 63.34 109.268 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 3.6 m-20 82.61 18.77 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 75.14 109.317 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -170.05 -170.07 0.94 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 54.03 109.983 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.918 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -98.87 165.72 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.546 1.154 . . . . 72.44 109.298 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.85 102.38 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 73.11 109.611 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.779 ' CE2' HG22 ' A' ' 254' ' ' VAL . 85.1 m-85 -107.73 142.15 38.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.535 1.147 . . . . 73.31 110.977 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.686 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 53.2 mt -132.84 124.25 50.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.528 1.142 . . . . 74.44 109.314 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -120.53 141.87 49.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 61.43 109.291 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -127.78 140.52 52.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.516 1.135 . . . . 73.13 110.986 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 267' ' ' ASN . 46.7 p-10 -89.79 64.24 6.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 63.41 109.275 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -58.03 -15.96 11.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 73.53 109.284 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 269' ' ' THR . 43.8 p -54.68 -166.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 60.32 110.39 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -99.15 -59.03 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 74.34 109.331 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 4.1 pt -60.29 152.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.463 1.102 . . . . 63.34 109.282 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.77 149.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 54.5 109.291 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 273' ' ' ILE . 3.5 mm -67.18 139.13 94.91 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.127 . . . . 53.41 109.317 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -26.95 10.52 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.486 1.782 . . . . 73.11 110.973 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 81.36 -178.51 53.86 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.504 1.128 . . . . 44.42 111.047 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 57.16 49.48 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 0.76 . . . . 63.1 109.323 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.414 ' CB ' ' SD ' ' A' ' 293' ' ' MET . 12.2 m -94.73 178.97 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 51.24 108.325 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.899 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.0 OUTLIER -152.22 97.31 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 61.21 110.378 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 1.002 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -53.79 159.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 74.55 110.969 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.664 ' HG3' HG21 ' A' ' 288' ' ' VAL . 13.3 tt0 -143.61 75.94 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 75.3 110.327 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 291' ' ' ILE . 35.0 p90 -109.45 121.79 45.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.145 . . . . 71.25 110.962 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 288' ' ' VAL . 3.7 p -109.19 179.61 4.11 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 73.14 109.981 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.569 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.4 p . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 51.42 110.01 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.664 HG21 ' HG3' ' A' ' 280' ' ' GLU . 14.8 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.299 -0.63 . . . . 75.24 109.299 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.522 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.6 t80 -131.69 137.83 48.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 74.32 111.054 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 54.1 p -116.75 126.21 52.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.122 . . . . 73.41 109.987 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 281' ' ' PHE . 8.5 mt -105.11 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 73.12 109.289 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.412 ' HD3' HG23 ' A' ' 278' ' ' THR . 8.7 mmtp -67.32 110.81 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.531 1.144 . . . . 51.03 109.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.92 ' HG2' HD21 ' A' ' 306' ' ' LEU . 93.0 mtp -81.76 134.79 35.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.21 111.006 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.68 145.52 0.13 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.515 1.135 . . . . 63.15 111.031 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -20.95 16.5 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.516 1.798 . . . . 62.43 111.013 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.74 129.14 38.77 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 73.21 109.577 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.09 153.16 30.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.124 . . . . 74.12 110.254 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.898 HG23 ' O ' ' A' ' 302' ' ' GLY . 3.2 mt -70.22 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 71.2 109.293 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.851 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 108.69 -177.04 20.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.505 1.128 . . . . 71.1 111.004 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 301' ' ' LYS . 59.6 mt -38.24 -90.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 74.24 109.282 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.618 ' N ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -91.3 23.93 3.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.21 109.272 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.898 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -83.74 45.14 3.42 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 74.2 111.006 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 302' ' ' GLY . 1.4 pt20 -39.99 161.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 0.761 . . . . 73.52 110.283 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 298' ' ' ILE . 30.5 tptt -121.92 152.35 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 72.44 109.281 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 11.9 mp0 -118.37 133.83 55.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 71.41 110.307 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 1.002 HD13 ' CG ' ' A' ' 279' ' ' PHE . 35.5 mt -126.35 55.57 1.49 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 64.11 109.303 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 138.34 55.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 75.34 107.999 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 309' ' ' PHE . 37.2 t80 -134.64 166.59 22.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.11 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -138.99 148.09 56.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 73.04 111.028 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.01 -53.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.005 -2.498 . . . . 73.15 110.975 0.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 23.6 p -178.8 162.66 1.35 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.503 1.127 . . . . 63.53 109.971 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.0 OUTLIER -128.61 159.16 69.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.157 . . . . 74.01 109.292 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 145.07 31.03 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.483 1.781 . . . . 61.32 111.007 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.85 HG22 HD12 ' A' ' 316' ' ' LEU . 0.9 OUTLIER -125.81 160.27 57.24 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 74.33 110.395 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.9 170.35 71.98 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.032 -2.487 . . . . 75.53 111.057 -0.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.85 HD12 HG22 ' A' ' 314' ' ' THR . 5.7 mp -87.68 66.26 8.81 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.536 1.147 . . . . 73.12 109.28 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.6 p -81.78 127.31 32.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 1.145 . . . . 73.35 109.975 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.2 OUTLIER 76.66 21.47 1.27 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 74.43 109.262 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.735 ' HD2' HD23 ' A' ' 316' ' ' LEU . 3.3 m-85 -103.93 134.08 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.521 1.138 . . . . 73.43 111.039 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.494 HG22 ' HG3' ' A' ' 322' ' ' LYS . 88.7 m -51.25 -60.54 3.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.4 110.42 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.71 ' HE2' HD22 ' A' ' 316' ' ' LEU . 3.5 ttm 33.08 40.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 61.14 110.996 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.501 ' HD3' HG21 ' A' ' 330' ' ' THR . 36.1 mttt -72.81 -174.0 1.34 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 71.25 109.287 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 t -143.51 121.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 72.31 109.32 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 278' ' ' THR . 28.4 m -110.12 171.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 75.44 109.356 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.477 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 0.1 OUTLIER -109.17 -155.51 0.56 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 72.22 109.296 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -77.38 -4.0 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.56 1.163 . . . . 75.44 110.324 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -105.25 8.98 34.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 65.25 109.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.74 14.89 24.4 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.472 1.108 . . . . 63.12 110.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 7.3 pt-20 -95.83 116.39 28.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 71.04 110.279 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.624 ' CA ' HG12 ' A' ' 324' ' ' VAL . 1.8 m -50.83 96.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.14 110.386 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 3.1 pt -66.81 -36.87 78.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 73.52 109.312 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.914 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.6 mt -147.19 170.7 16.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 70.52 109.323 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -147.17 119.3 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 75.04 109.291 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -71.45 125.09 11.42 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.543 1.152 . . . . 51.05 111.004 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.787 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -48.85 -26.44 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.563 0.802 . . . . 72.32 109.324 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 48.33 62.08 2.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 75.0 108.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.787 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -73.39 -176.78 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 74.35 109.315 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.62 55.98 1.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 61.31 109.262 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.7 m -169.08 149.16 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 55.31 109.973 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.418 ' N ' ' HB3' ' A' ' 315' ' ' PRO . 10.2 m-20 -55.31 -19.95 10.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 74.41 109.29 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.412 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 18.4 mt-10 -72.69 141.37 48.22 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.11 110.302 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.681 HD11 ' HE1' ' A' ' 321' ' ' MET . 64.5 mt -146.84 120.84 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.13 . . . . 73.13 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 344' ' ' LEU . 15.4 p -123.94 85.44 2.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.451 1.095 . . . . 70.51 110.345 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.914 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.4 mp -39.31 152.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 75.41 109.31 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -129.87 -51.72 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 52.1 109.306 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 158.18 146.97 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 70.05 110.018 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.664 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.1 Cg_endo -74.98 -50.71 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.502 1.791 . . . . 63.23 110.986 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.13 . . . . 70.34 109.308 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.914 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.332 -0.618 . . . . 64.44 109.332 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.545 HD22 HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -116.58 103.21 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.41 109.302 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -67.35 147.35 53.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 72.42 109.592 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.696 HG13 ' HG ' ' A' ' 265' ' ' LEU . 45.1 t -145.37 161.92 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 63.31 109.358 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.42 ' N ' HG12 ' A' ' 252' ' ' VAL . 11.2 tp10 -134.39 132.48 39.47 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.138 . . . . 71.11 110.296 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.593 ' CG1' HG21 ' A' ' 314' ' ' THR . 94.8 t -109.69 110.72 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 72.12 109.246 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.428 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.7 t -77.93 -67.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.13 . . . . 63.23 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.881 ' HA ' HD23 ' A' ' 261' ' ' LEU . 4.8 t-20 61.15 63.91 1.18 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.56 1.162 . . . . 71.21 109.287 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -88.86 148.61 23.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 65.12 110.291 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.04 -24.58 1.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.474 1.109 . . . . 75.21 109.322 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -76.18 -55.37 5.64 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 70.3 109.306 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.9 m -168.37 -175.02 2.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.529 1.143 . . . . 73.41 109.942 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.881 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.1 mt -86.48 176.02 8.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.24 109.316 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 10.7 t-160 -174.71 107.93 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.54 109.573 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.406 ' HE1' HD13 ' A' ' 261' ' ' LEU . 88.0 m-85 -112.13 118.56 35.7 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 75.45 111.032 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.505 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 13.7 mt -112.39 104.59 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 52.23 109.254 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.696 ' HG ' HG13 ' A' ' 252' ' ' VAL . 0.8 OUTLIER -101.4 129.79 47.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 71.21 109.319 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -102.54 119.05 38.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 61.32 110.983 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.486 ' OD1' ' CD1' ' A' ' 273' ' ' ILE . 34.9 t30 -65.71 75.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.132 . . . . 75.44 109.276 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.1 mmtt -92.07 64.63 4.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 64.23 109.305 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 72.5 p -142.67 160.43 40.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 71.12 110.406 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.48 -54.27 45.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 72.23 109.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.4 pt -69.8 163.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 73.42 109.292 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 17.9 mt -114.74 139.14 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 73.5 109.333 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.486 ' CD1' ' OD1' ' A' ' 267' ' ' ASN . 1.8 mp -54.68 137.23 63.25 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 75.4 109.296 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.2 Cg_endo -75.01 -26.34 10.99 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.494 1.787 . . . . 44.01 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.61 157.76 29.61 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.504 1.127 . . . . 72.23 111.011 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.5 t30 73.41 39.44 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 0.755 . . . . 75.44 109.277 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.45 -174.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 63.45 108.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 291' ' ' ILE . 7.3 m -155.12 156.26 35.47 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.44 1.087 . . . . 63.42 110.384 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.536 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.9 t80 -108.75 171.07 7.64 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 72.33 110.968 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.526 ' HG3' HG21 ' A' ' 288' ' ' VAL . 9.4 tt0 -161.59 93.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 71.11 110.31 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -113.6 133.91 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 74.42 110.991 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -94.4 -175.18 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 64.13 109.987 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.559 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 24.8 t . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 61.24 110.017 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.544 HG22 ' H ' ' A' ' 289' ' ' PHE . 8.8 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.274 -0.639 . . . . 70.24 109.274 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.544 ' H ' HG22 ' A' ' 288' ' ' VAL . 8.5 t80 -148.23 149.31 31.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.527 1.142 . . . . 73.23 110.965 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 279' ' ' PHE . 4.9 p -118.43 128.09 54.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 43.14 109.984 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 278' ' ' THR . 17.7 mt -101.63 129.01 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.107 . . . . 64.42 109.278 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -72.01 114.62 10.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 71.44 109.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.765 ' HG2' HD21 ' A' ' 306' ' ' LEU . 61.8 mtp -88.18 144.71 26.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 74.35 111.077 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -41.49 147.58 0.41 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.517 1.135 . . . . 62.13 111.005 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -17.83 19.28 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.783 . . . . 72.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -72.88 -177.04 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.468 1.105 . . . . 74.45 109.63 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.36 174.49 5.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.24 110.32 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.7 mt -104.46 -82.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.113 . . . . 60.41 109.298 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.98 159.57 20.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.54 1.15 . . . . 74.32 111.007 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.61 -63.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.5 0.764 . . . . 75.44 109.287 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.52 -29.3 68.67 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.497 1.123 . . . . 74.32 109.276 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -68.52 156.61 53.18 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.464 1.103 . . . . 42.23 110.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.81 171.68 12.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 0.768 . . . . 71.54 110.311 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 293' ' ' MET . 37.2 tptt -118.78 165.11 14.43 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 73.33 109.341 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -143.88 124.6 14.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 72.53 110.279 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.765 HD21 ' HG2' ' A' ' 293' ' ' MET . 10.3 mt -135.97 60.21 1.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 64.03 109.333 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.479 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 11.2 p-90 -72.48 134.68 45.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.514 1.134 . . . . 75.21 108.034 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.816 ' CE2' HD11 ' A' ' 312' ' ' LEU . 45.3 t80 -126.12 166.73 16.48 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.122 . . . . 74.13 111.028 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -137.91 157.16 73.72 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 74.13 110.972 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.95 -41.31 1.02 Allowed 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.99 -2.504 . . . . 40.13 111.038 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 172.93 143.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.34 109.993 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.816 HD11 ' CE2' ' A' ' 308' ' ' PHE . 4.4 mp -115.16 159.58 37.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.55 109.316 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 148.5 35.31 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 75.54 110.988 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.593 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.2 OUTLIER -130.35 164.42 41.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 71.55 110.382 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 -177.73 21.36 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.019 -2.492 . . . . 74.14 111.006 0.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.984 HD13 ' SD ' ' A' ' 321' ' ' MET . 1.8 mt -102.49 52.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.442 1.089 . . . . 74.22 109.308 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.4 p -76.08 127.19 32.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 75.0 109.988 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 317' ' ' SER . 28.7 t30 81.07 30.83 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 74.12 109.342 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.806 ' CE2' HD23 ' A' ' 316' ' ' LEU . 5.2 m-85 -109.56 167.55 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.44 111.035 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.91 HG22 ' HG2' ' A' ' 322' ' ' LYS . 32.3 m -79.6 -59.75 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 64.4 110.425 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.984 ' SD ' HD13 ' A' ' 316' ' ' LEU . 0.6 OUTLIER 27.03 79.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.108 . . . . 73.41 110.971 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.91 ' HG2' HG22 ' A' ' 320' ' ' THR . 7.6 pttt -112.66 -170.66 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 72.54 109.325 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.589 ' CG2' HD21 ' A' ' 344' ' ' LEU . 49.4 t -136.89 138.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 61.02 109.305 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.737 HG23 ' H ' ' A' ' 329' ' ' GLU . 0.4 OUTLIER -122.4 138.69 51.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.554 1.158 . . . . 75.01 109.271 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.713 ' OD1' HD13 ' A' ' 331' ' ' ILE . 0.5 OUTLIER -76.82 -170.54 1.63 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.13 . . . . 64.2 109.284 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -78.99 4.32 14.66 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 53.11 110.267 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.04 -3.28 41.7 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 74.42 109.296 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 65.21 54.47 26.96 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.485 1.116 . . . . 61.33 110.998 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.737 ' H ' HG23 ' A' ' 324' ' ' VAL . 9.9 pt-20 -157.04 121.86 4.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 0.77 . . . . 64.35 110.311 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.414 HG21 ' HD3' ' A' ' 322' ' ' LYS . 69.0 m -45.26 115.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.516 1.135 . . . . 71.54 110.406 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.713 HD13 ' OD1' ' A' ' 325' ' ' ASN . 36.5 pt -98.76 -41.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 73.31 109.297 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.898 ' HB3' HD23 ' A' ' 344' ' ' LEU . 10.4 mt -131.48 168.45 17.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 73.23 109.286 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.467 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.38 122.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 74.1 109.336 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.421 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -72.45 121.53 8.17 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.131 . . . . 74.14 111.006 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -45.22 -26.71 0.53 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.461 0.742 . . . . 73.21 109.293 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 321' ' ' MET . 0.1 OUTLIER 47.83 76.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 62.14 108.312 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -90.3 -175.8 4.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 63.21 109.285 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.82 62.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.466 1.103 . . . . 65.33 109.302 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 15.4 m -171.08 150.2 3.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 74.32 109.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 254' ' ' VAL . 18.9 m-20 -60.38 -21.17 61.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 63.42 109.302 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -78.12 148.46 34.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.136 . . . . 74.15 110.289 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.601 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 57.1 mt -147.55 140.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.478 1.111 . . . . 63.55 109.309 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 11.4 p -136.13 95.53 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 64.24 110.358 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.6 mp -49.97 153.63 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 64.11 109.311 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -128.51 -76.44 0.56 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 73.44 109.286 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 5.0 p 164.84 134.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.491 1.119 . . . . 62.42 110.057 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.443 1.76 . . . . 44.41 111.039 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 72.12 109.288 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.273 -0.64 . . . . 74.14 109.273 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.593 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -115.55 99.76 7.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 52.22 109.302 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.554 ' CD2' HG22 ' A' ' 343' ' ' THR . 18.8 m170 -95.52 130.83 42.22 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 74.4 109.569 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 253' ' ' GLU . 69.6 t -124.71 166.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 73.42 109.302 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.524 ' N ' HG12 ' A' ' 252' ' ' VAL . 27.8 tt0 -122.67 123.34 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 74.32 110.316 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.02 107.5 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 74.02 109.318 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -59.59 2.51 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 44.43 109.969 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.939 ' HA ' HD23 ' A' ' 261' ' ' LEU . 2.9 t-20 60.71 70.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.25 109.243 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -105.32 161.97 13.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.556 1.16 . . . . 63.34 110.293 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 259' ' ' ASN . 46.1 m-20 -41.15 -60.22 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.561 1.163 . . . . 73.41 109.293 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 258' ' ' ASP . 66.5 t30 -40.07 -64.34 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 62.33 109.353 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -178.6 -174.54 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 72.51 109.999 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.939 HD23 ' HA ' ' A' ' 256' ' ' ASN . 46.8 mt -76.19 153.97 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.491 1.119 . . . . 74.13 109.318 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -142.03 91.66 2.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 72.44 109.603 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.573 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 8.2 m-30 -98.84 133.99 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.475 1.11 . . . . 52.22 110.977 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.661 HG22 ' CE2' ' A' ' 266' ' ' TYR . 62.6 mt -127.93 121.2 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 73.51 109.294 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -107.3 119.67 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.54 109.32 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.661 ' CE2' HG22 ' A' ' 264' ' ' ILE . 5.1 m-85 -109.03 92.16 3.94 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.502 1.126 . . . . 63.14 111.027 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -54.45 95.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 70.02 109.282 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.7 28.18 7.74 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 62.31 109.343 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 61.3 p -87.52 -174.94 5.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.545 1.153 . . . . 72.13 110.388 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -88.69 -56.17 3.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.4 109.333 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.408 ' H ' HG23 ' A' ' 271' ' ' ILE . 0.1 OUTLIER -60.18 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.44 1.088 . . . . 71.13 109.342 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 271' ' ' ILE . 4.1 mp -124.77 123.21 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.493 1.121 . . . . 50.11 109.307 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 273' ' ' ILE . 3.5 mm -40.94 137.75 1.42 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 71.32 109.306 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.03 -24.46 12.75 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.501 1.79 . . . . 72.01 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.42 169.17 31.97 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.501 1.126 . . . . 74.05 111.008 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.0 t30 63.44 36.76 11.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 0.754 . . . . 65.22 109.344 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.411 ' C ' ' OG1' ' A' ' 278' ' ' THR . 64.1 m -90.44 -176.5 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.448 1.093 . . . . 73.42 108.316 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 324' ' ' VAL . 1.6 m -153.77 129.02 9.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 71.31 110.381 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.527 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.0 OUTLIER -80.2 179.21 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.505 1.128 . . . . 75.42 111.017 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -169.97 97.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.11 . . . . 64.24 110.308 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.625 ' CE1' ' CE2' ' A' ' 308' ' ' PHE . 4.4 p90 -120.65 121.66 38.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 71.11 111.02 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 m -101.84 143.54 31.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.564 1.165 . . . . 71.15 110.027 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 64.33 110.02 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.308 -0.627 . . . . 53.31 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -122.7 156.73 33.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 65.41 111.014 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 6.1 p -128.1 126.34 40.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.515 1.134 . . . . 72.21 110.025 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 5.5 mt -97.68 129.47 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.133 . . . . 72.53 109.306 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.421 ' HA ' HG23 ' A' ' 278' ' ' THR . 2.8 mptp? -67.28 121.07 14.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 65.2 109.285 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 98.7 mtp -89.06 140.2 29.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 41.31 111.003 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.553 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -40.7 144.23 0.56 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.486 1.116 . . . . 74.51 110.989 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -24.72 12.72 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.509 1.794 . . . . 72.13 111.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -63.66 163.91 10.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.525 1.141 . . . . 63.22 109.61 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -100.12 128.92 46.12 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 73.34 110.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 77.0 mt -57.63 -72.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.122 . . . . 71.31 109.345 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.02 172.15 24.3 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.497 1.123 . . . . 52.12 110.997 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 13.4 mt -60.39 -54.69 31.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 74.21 109.325 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 36.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 70.23 109.27 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -125.46 147.16 16.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.57 1.169 . . . . 72.2 111.006 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -119.74 170.66 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 0.774 . . . . 74.55 110.313 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.553 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 46.3 tptt -140.4 149.72 42.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 74.21 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 2.1 mt-10 -115.23 151.16 34.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 71.21 110.327 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.807 HD12 HD11 ' A' ' 265' ' ' LEU . 20.4 mt -152.25 69.24 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.483 1.114 . . . . 63.21 109.291 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.517 ' CE2' ' HB3' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -75.23 119.74 19.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 62.31 108.005 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.7 m-30 -113.46 142.13 46.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 73.42 110.998 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -128.59 160.37 63.08 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 74.53 111.017 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -36.2 2.67 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 121.027 -2.489 . . . . 75.31 110.979 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.5 p 162.14 127.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.534 1.146 . . . . 70.45 110.025 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.512 HD12 ' CD1' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -99.32 169.5 8.07 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.417 1.073 . . . . 71.51 109.301 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 143.54 29.22 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 63.54 110.991 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.601 HG22 HD12 ' A' ' 316' ' ' LEU . 0.7 OUTLIER -131.27 162.17 57.46 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.559 1.162 . . . . 73.44 110.377 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.0 167.98 78.83 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.027 -2.489 . . . . 64.12 111.021 -0.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.792 HD22 ' HE3' ' A' ' 321' ' ' MET . 3.7 mp -87.85 46.83 1.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 73.51 109.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 58.1 p -67.7 115.8 7.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 61.14 109.961 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 317' ' ' SER . 4.2 t30 83.42 39.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 71.24 109.277 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.676 ' CD2' HD23 ' A' ' 316' ' ' LEU . 5.6 m-85 -116.17 150.56 37.26 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.547 1.155 . . . . 74.43 111.003 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 322' ' ' LYS . 87.7 m -57.57 -64.11 1.01 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 1.139 . . . . 61.32 110.378 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.792 ' HE3' HD22 ' A' ' 316' ' ' LEU . 0.5 OUTLIER 35.39 33.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 74.23 111.02 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.519 ' HG3' HG22 ' A' ' 320' ' ' THR . 90.9 mttt -72.99 -176.53 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 75.23 109.334 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 279' ' ' PHE . 5.6 t -142.88 138.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.441 1.088 . . . . 54.42 109.293 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 278' ' ' THR . 0.0 OUTLIER -116.11 152.11 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 73.52 109.289 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.727 ' ND2' HD13 ' A' ' 331' ' ' ILE . 0.4 OUTLIER -91.83 -173.6 3.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 63.45 109.268 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -75.45 -0.87 21.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.491 1.119 . . . . 63.14 110.299 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.47 -10.11 33.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 73.43 109.258 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.04 48.06 16.88 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.447 1.092 . . . . 42.3 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.565 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 9.7 pt-20 -153.8 110.48 3.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 70.44 110.288 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.433 ' N ' HG13 ' A' ' 324' ' ' VAL . 12.2 m -38.53 125.57 1.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.534 1.146 . . . . 63.44 110.445 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.727 HD13 ' ND2' ' A' ' 325' ' ' ASN . 6.8 pt -100.58 -37.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 74.34 109.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.943 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.2 mt -134.23 165.56 24.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 74.15 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -145.67 118.77 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 73.22 109.309 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -74.86 135.92 19.84 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.494 1.121 . . . . 72.31 110.993 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -79.93 -29.43 39.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 0.741 . . . . 73.43 109.265 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.583 ' H ' HG23 ' A' ' 342' ' ' ILE . 12.1 t 40.07 88.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 61.12 108.339 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -78.39 -161.05 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.447 1.092 . . . . 70.3 109.298 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -81.69 58.08 3.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.494 1.121 . . . . 63.53 109.322 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 57.7 m -172.15 166.13 6.07 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 43.34 110.007 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.58 -15.85 63.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 75.23 109.308 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.03 141.15 45.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 73.45 110.318 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.583 HG23 ' H ' ' A' ' 336' ' ' CYS . 8.5 mt -148.2 116.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 75.24 109.286 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.554 HG22 ' CD2' ' A' ' 251' ' ' HIS . 9.6 p -119.65 113.65 21.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 73.34 110.446 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.943 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -67.69 145.9 54.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.464 1.102 . . . . 74.51 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -123.25 -44.66 2.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 65.24 109.284 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.1 t 153.96 156.14 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.23 110.02 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.6 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.5 Cg_endo -74.99 -49.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.487 1.783 . . . . 64.22 111.038 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.551 1.157 . . . . 71.43 109.289 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.293 -0.632 . . . . 62.51 109.293 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.598 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -116.64 100.55 7.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.103 . . . . 70.5 109.282 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.63 ' CD2' HG22 ' A' ' 343' ' ' THR . 10.1 m80 -90.93 128.58 36.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.529 1.143 . . . . 75.54 109.603 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 265' ' ' LEU . 58.9 t -120.52 167.27 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 52.11 109.306 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.3 tp10 -128.06 135.24 49.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 61.24 110.325 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.717 ' CG1' HG21 ' A' ' 314' ' ' THR . 89.6 t -109.61 109.49 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 61.41 109.305 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 m -79.73 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 74.04 110.023 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.908 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER 63.56 71.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.545 1.153 . . . . 72.31 109.288 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -91.13 147.34 23.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 64.44 110.305 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.99 -35.29 33.07 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.146 . . . . 75.54 109.271 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.73 -46.95 73.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 75.23 109.293 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 1.5 m -174.25 -173.4 0.78 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.137 . . . . 65.44 109.996 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.2 mt -87.47 161.82 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 1.125 . . . . 54.43 109.329 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -159.91 101.43 1.45 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 75.25 109.605 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.696 ' CZ ' HD13 ' A' ' 261' ' ' LEU . 51.1 m-85 -110.89 129.17 55.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 63.14 110.95 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.747 HG22 ' CE1' ' A' ' 266' ' ' TYR . 48.0 mt -119.37 119.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 72.44 109.26 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.713 ' HB3' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -112.41 139.96 47.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 74.54 109.285 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.747 ' CE1' HG22 ' A' ' 264' ' ' ILE . 4.5 m-85 -126.97 114.9 18.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.442 1.089 . . . . 71.2 110.998 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.494 ' CG ' ' CG2' ' A' ' 298' ' ' ILE . 48.5 p-10 -69.19 77.06 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.143 . . . . 64.11 109.284 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.479 ' CE ' ' HA ' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -78.89 55.23 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 1.117 . . . . 75.1 109.304 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.9 p -125.45 -170.5 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 71.24 110.371 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -94.42 -52.79 4.18 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 1.127 . . . . 71.01 109.304 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.63 169.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 51.11 109.298 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 272' ' ' ILE . 3.8 mp -106.28 161.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 74.44 109.306 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.895 HG13 HD12 ' A' ' 298' ' ' ILE . 3.6 mm -92.36 137.4 24.68 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.559 1.162 . . . . 65.11 109.294 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 -23.87 13.31 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.56 1.821 . . . . 60.54 110.976 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 74.05 161.72 7.8 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.53 1.144 . . . . 33.04 110.972 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 6.0 t30 81.69 22.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 0.777 . . . . 62.14 109.301 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.412 ' C ' ' OG1' ' A' ' 278' ' ' THR . 22.4 m -69.15 -178.23 1.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 71.52 108.3 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.904 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.7 m -153.81 106.5 2.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 74.5 110.415 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.88 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -60.53 173.09 0.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 63.13 111.038 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -168.43 92.21 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.107 . . . . 73.41 110.32 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 7.2 p90 -116.17 146.98 41.87 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.44 1.087 . . . . 64.2 110.977 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.407 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 82.9 p -72.57 -179.8 3.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 71.34 109.992 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 312' ' ' LEU . 1.9 m . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 51.44 109.99 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 281' ' ' PHE . 11.6 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.311 -0.626 . . . . 71.43 109.311 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.423 ' CD2' ' CE1' ' A' ' 308' ' ' PHE . 5.8 t80 -134.33 144.72 48.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 72.24 111.011 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 m -114.17 121.93 45.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 74.34 110.006 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.981 HD11 ' CD1' ' A' ' 308' ' ' PHE . 18.8 mt -101.86 128.56 54.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.52 1.138 . . . . 71.53 109.288 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.481 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.0 OUTLIER -68.06 99.66 0.9 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 74.44 109.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.772 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.9 mtp -56.33 152.26 11.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 51.44 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . 0.714 ' HA3' ' HZ2' ' A' ' 304' ' ' LYS . . . -35.33 140.57 0.17 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.57 1.169 . . . . 64.02 111.025 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 294' ' ' GLY . 18.1 Cg_endo -75.03 -22.98 14.2 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.521 1.8 . . . . 70.22 110.996 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -76.17 172.66 12.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.12 . . . . 52.13 109.61 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -107.59 124.3 49.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.147 . . . . 73.34 110.302 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.895 HD12 HG13 ' A' ' 273' ' ' ILE . 15.0 mt -47.07 -67.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 73.23 109.301 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.58 159.56 32.9 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.486 1.116 . . . . 65.21 111.026 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 19.2 mt -43.23 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.477 0.751 . . . . 73.14 109.317 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.479 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 62.75 75.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 63.22 109.315 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 298' ' ' ILE . . . -135.07 173.46 21.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.453 1.096 . . . . 73.43 111.022 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.28 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 0.758 . . . . 72.41 110.293 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.714 ' HZ2' ' HA3' ' A' ' 294' ' ' GLY . 40.3 tptt -159.49 155.04 25.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 70.51 109.261 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 5.4 mt-10 -130.25 139.96 50.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 51.11 110.294 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.88 HD13 ' CG ' ' A' ' 279' ' ' PHE . 16.0 mt -143.3 38.74 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.523 1.14 . . . . 73.44 109.285 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -49.55 148.3 2.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.959 -1.126 . . . . 75.04 107.959 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.981 ' CD1' HD11 ' A' ' 291' ' ' ILE . 12.5 t80 -147.43 168.18 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 73.41 111.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -141.12 161.18 54.77 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 61.43 111.013 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.98 -47.77 0.3 Allowed 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.007 -2.497 . . . . 74.11 111.018 -0.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.0 p 177.14 133.58 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 1.112 . . . . 71.34 109.951 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.6 mp -110.96 158.78 34.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 72.42 109.351 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 146.65 32.67 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.493 1.786 . . . . 75.51 110.988 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.717 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -124.64 161.98 45.37 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 73.54 110.372 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.02 -178.85 24.69 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.01 -2.496 . . . . 73.23 110.995 0.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.765 HD13 ' CE ' ' A' ' 321' ' ' MET . 1.7 mt -95.53 64.87 2.63 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.128 . . . . 64.15 109.284 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 32.4 t -81.16 123.08 28.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 53.43 110.006 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 317' ' ' SER . 44.0 t30 81.95 20.21 0.33 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 63.2 109.298 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.518 ' CD2' HD23 ' A' ' 316' ' ' LEU . 24.0 m-85 -101.99 114.05 27.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.562 1.164 . . . . 74.03 111.007 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.676 HG23 ' HD2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -37.75 -51.18 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 61.45 110.377 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.765 ' CE ' HD13 ' A' ' 316' ' ' LEU . 7.1 ttm 30.93 52.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 64.31 110.985 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.676 ' HD2' HG23 ' A' ' 320' ' ' THR . 33.0 mttt -81.08 -170.18 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.55 109.264 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 279' ' ' PHE . 5.8 t -151.61 130.32 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.525 1.141 . . . . 73.53 109.338 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 278' ' ' THR . 16.1 m -108.1 179.02 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.52 109.309 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.61 -172.4 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 41.05 109.306 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.16 -4.8 15.02 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 71.13 110.264 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.18 -7.12 33.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 71.34 109.321 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.12 54.63 6.83 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.503 1.127 . . . . 74.32 110.999 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.555 ' C ' HG12 ' A' ' 324' ' ' VAL . 0.3 OUTLIER -149.72 130.24 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 0.773 . . . . 72.42 110.302 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.854 ' N ' HG12 ' A' ' 324' ' ' VAL . 4.9 m -62.19 122.74 16.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 73.04 110.421 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.502 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.3 pt -105.4 -34.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.474 1.109 . . . . 75.3 109.256 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.884 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.6 mt -130.16 164.19 25.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 74.51 109.336 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -146.19 132.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 74.22 109.293 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.41 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -92.51 114.15 4.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.436 1.085 . . . . 72.24 111.035 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.763 ' NZ ' ' H ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -42.79 -27.72 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 0.75 . . . . 75.14 109.263 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 46.31 70.46 0.38 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 61.31 108.256 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . 0.763 ' H ' ' NZ ' ' A' ' 335' ' ' LYS . . . -79.28 -171.46 2.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 63.12 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 61.82 2.93 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 75.24 109.271 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 18.5 t -173.11 156.29 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 75.13 110.019 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.98 -30.14 71.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 60.43 109.289 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.64 136.22 56.03 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 63.24 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.62 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 49.1 mt -142.32 130.28 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 70.25 109.27 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.63 HG22 ' CD2' ' A' ' 251' ' ' HIS . 13.6 p -127.58 83.57 2.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 53.43 110.382 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.884 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.9 mp -38.52 136.29 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 64.11 109.33 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -70.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 63.54 109.321 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.81 147.79 0.34 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.576 1.173 . . . . 74.32 109.994 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.461 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.94 -55.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 74.23 111.024 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.562 1.164 . . . . 72.23 109.272 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.297 -0.631 . . . . 71.42 109.297 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 1.02 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -122.92 103.05 8.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 75.34 109.29 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.18 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 74.22 109.586 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.766 HG13 HD23 ' A' ' 265' ' ' LEU . 58.0 t -125.22 145.05 33.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 72.12 109.355 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.42 120.84 42.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.32 110.314 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.0 98.09 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 73.12 109.28 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.1 t -67.93 -70.77 0.24 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 75.45 110.024 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.894 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER 68.25 65.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 71.12 109.3 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -103.26 165.33 11.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 63.11 110.325 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 259' ' ' ASN . 0.7 OUTLIER -47.65 -57.16 5.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 71.33 109.324 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 258' ' ' ASP . 8.2 t-20 -40.12 -62.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 71.22 109.305 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -174.12 -160.56 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.476 1.11 . . . . 74.14 109.999 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.894 HD23 ' HA ' ' A' ' 256' ' ' ASN . 19.6 mt -93.68 -178.35 4.67 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.11 . . . . 72.3 109.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -177.01 104.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.45 109.549 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.518 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 59.1 m-85 -110.86 96.67 6.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.22 110.995 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.795 HG22 ' CE1' ' A' ' 266' ' ' TYR . 64.0 mt -91.86 104.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 61.14 109.289 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -89.72 129.15 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 75.32 109.321 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.795 ' CE1' HG22 ' A' ' 264' ' ' ILE . 14.8 m-85 -117.35 102.92 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 61.25 110.987 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.503 ' HB2' HD13 ' A' ' 273' ' ' ILE . 53.4 t30 -59.3 106.97 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 60.25 109.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -100.94 -12.1 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 75.31 109.302 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.461 ' O ' ' CD1' ' A' ' 300' ' ' ILE . 12.8 p -72.77 164.52 26.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 72.4 110.381 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.638 ' O ' HD11 ' A' ' 300' ' ' ILE . 22.0 m120 -67.17 -60.13 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 63.11 109.318 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.807 HD13 ' C ' ' A' ' 271' ' ' ILE . 0.0 OUTLIER -38.84 158.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.53 1.144 . . . . 75.32 109.347 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.469 ' N ' HG12 ' A' ' 271' ' ' ILE . 2.1 mp -114.41 117.35 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 65.33 109.288 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -46.23 138.41 6.2 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 45.04 109.317 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.04 -30.15 7.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.469 1.773 . . . . 75.31 111.047 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 90.55 159.72 35.86 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.509 1.131 . . . . 44.31 111.019 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 4.2 t30 76.23 27.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 0.766 . . . . 63.31 109.307 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.466 ' SG ' ' CD1' ' A' ' 331' ' ' ILE . 29.0 m -71.05 -178.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 71.31 108.288 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.843 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -152.97 105.44 2.93 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 73.51 110.382 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.522 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.1 t80 -59.05 157.66 9.82 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 74.33 110.947 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -146.69 84.33 1.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.551 1.157 . . . . 73.54 110.252 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.632 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 22.8 p90 -119.64 135.34 54.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 64.12 110.985 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.489 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 1.1 m -105.92 177.42 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 74.34 109.988 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 319' ' ' TYR . 4.8 p . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 72.43 109.979 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 289' ' ' PHE . 2.8 p . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.256 -0.646 . . . . 63.21 109.256 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.533 ' N ' HG22 ' A' ' 288' ' ' VAL . 1.8 t80 -103.37 159.57 15.45 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 70.15 110.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -150.74 122.34 7.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 70.11 110.029 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 47.0 mt -121.99 128.83 75.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.44 109.256 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.588 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.5 OUTLIER -73.13 107.16 5.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 62.22 109.324 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.772 ' HG2' HD21 ' A' ' 306' ' ' LEU . 87.4 mtp -70.17 147.48 49.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.157 . . . . 61.21 110.998 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -49.68 152.28 3.66 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.506 1.129 . . . . 42.45 111.022 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -29.26 8.39 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 71.14 111.029 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -52.66 137.34 31.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 65.04 109.599 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.22 147.03 29.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 65.14 110.307 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.443 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -82.87 -76.62 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 74.15 109.342 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 76.21 -174.95 53.05 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.464 1.103 . . . . 71.23 110.976 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.638 HD11 ' O ' ' A' ' 270' ' ' ASN . 3.3 mm -64.43 137.6 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.5 0.765 . . . . 74.15 109.287 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.591 ' HG2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER 66.47 9.43 6.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 73.12 109.26 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.443 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -97.82 140.86 15.27 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.517 1.136 . . . . 53.21 110.987 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -110.42 -179.52 3.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 0.794 . . . . 64.33 110.289 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 264' ' ' ILE . 19.3 tptt -145.72 164.23 32.47 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 65.31 109.306 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.97 128.41 36.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 1.109 . . . . 61.23 110.291 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.961 HD12 HD11 ' A' ' 265' ' ' LEU . 12.3 mt -140.91 62.52 1.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 71.43 109.302 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -76.44 128.95 35.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 73.04 107.986 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.4 m-30 -115.79 178.55 4.27 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.5 111.052 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.516 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -159.29 157.04 26.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.5 110.992 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -35.14 3.02 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.998 -2.501 . . . . 63.35 111.021 0.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.0 p 169.04 139.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 71.23 109.999 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.1 mp -115.28 158.37 41.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 73.24 109.306 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.47 34.03 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.49 1.784 . . . . 73.45 111.002 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.725 HG22 HD12 ' A' ' 316' ' ' LEU . 0.6 OUTLIER -127.32 162.24 49.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.439 1.087 . . . . 73.51 110.416 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.94 174.36 53.02 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.999 -2.5 . . . . 74.11 110.993 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.725 HD12 HG22 ' A' ' 314' ' ' THR . 5.3 mp -88.99 65.61 7.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.05 109.277 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.1 p -84.42 139.44 32.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.448 1.092 . . . . 60.2 110.008 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.74 23.48 4.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.102 . . . . 63.0 109.282 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.701 ' CD2' HD23 ' A' ' 316' ' ' LEU . 3.2 m-85 -104.07 165.77 10.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.468 1.105 . . . . 63.04 111.027 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 322' ' ' LYS . 15.5 m -92.24 -49.47 6.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.44 110.37 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.878 ' SD ' HD13 ' A' ' 342' ' ' ILE . 1.7 ptp 30.13 63.35 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.33 111.028 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.594 ' HG2' HG12 ' A' ' 333' ' ' VAL . 42.8 mttt -91.26 -171.09 2.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 75.25 109.351 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.482 HG21 HD21 ' A' ' 344' ' ' LEU . 2.2 t -150.26 132.2 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 72.1 109.296 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 278' ' ' THR . 9.0 m -118.29 179.62 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 73.25 109.276 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -108.4 -166.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 73.52 109.317 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.84 -10.42 37.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 62.02 110.265 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -107.38 19.57 20.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.136 . . . . 74.43 109.327 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 55.09 18.12 11.8 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 75.44 110.986 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 331' ' ' ILE . 10.6 pt-20 -89.54 123.65 33.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.487 0.757 . . . . 71.45 110.276 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.593 ' N ' HG12 ' A' ' 324' ' ' VAL . 2.7 m -55.78 115.05 2.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 63.42 110.4 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.466 ' CD1' ' SG ' ' A' ' 277' ' ' CYS . 5.4 pt -97.88 -41.82 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 62.03 109.297 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.806 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.3 mt -138.34 162.57 34.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 55.31 109.322 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.594 HG12 ' HG2' ' A' ' 322' ' ' LYS . 26.8 m -149.0 128.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 71.24 109.293 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -86.85 113.15 3.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.476 1.11 . . . . 72.42 111.012 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.415 ' O ' ' SG ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -50.04 -24.17 2.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 0.752 . . . . 62.53 109.32 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 335' ' ' LYS . 0.5 OUTLIER 66.23 162.88 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 65.44 108.283 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -173.98 -173.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.572 1.17 . . . . 71.42 109.269 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.55 56.52 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.14 109.306 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 341' ' ' GLU . 35.0 t -178.4 138.55 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 54.23 109.998 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -44.76 -27.01 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 63.53 109.315 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 339' ' ' SER . 6.9 mt-10 -63.97 117.27 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 74.51 110.323 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.878 HD13 ' SD ' ' A' ' 321' ' ' MET . 61.6 mt -141.62 122.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.433 1.083 . . . . 65.04 109.291 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 10.4 p -116.41 105.15 12.19 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 72.3 110.402 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 1.02 HD22 HD22 ' A' ' 250' ' ' LEU . 5.9 mp -58.56 142.62 48.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 72.03 109.264 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -77.29 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.541 1.151 . . . . 74.02 109.261 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.1 p -179.85 145.56 0.41 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 74.12 109.979 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -59.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.524 1.802 . . . . 70.14 110.987 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 348' ' ' LEU . 2.2 tm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 73.21 109.329 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 1.008 ' O ' HD23 ' A' ' 249' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.304 -0.628 . . . . 51.25 109.304 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.678 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -125.3 103.12 7.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 74.4 109.294 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.51 136.3 57.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 63.1 109.573 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.749 HG22 HD23 ' A' ' 265' ' ' LEU . 76.2 t -145.92 136.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 53.21 109.301 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.06 128.79 56.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 54.41 110.262 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.522 ' CG1' HG21 ' A' ' 314' ' ' THR . 14.2 t -105.47 105.45 18.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 70.45 109.291 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.76 -73.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 61.3 109.973 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.591 ' HA ' HD23 ' A' ' 261' ' ' LEU . 8.6 t-20 55.33 78.38 0.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 70.34 109.305 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.26 -166.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.544 1.152 . . . . 71.43 110.314 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.63 31.56 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 63.12 109.308 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -135.22 -45.16 0.7 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.481 1.113 . . . . 74.24 109.317 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 174.08 -174.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 32.21 110.009 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.863 HD11 ' HB2' ' A' ' 312' ' ' LEU . 23.7 mt -93.24 167.65 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 73.05 109.288 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -163.81 100.25 0.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.24 109.608 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.19 101.55 10.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 73.1 110.992 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.816 HG22 ' CE1' ' A' ' 266' ' ' TYR . 56.9 mt -97.52 103.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 75.04 109.263 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 1.056 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -88.13 138.23 31.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.467 1.104 . . . . 74.2 109.301 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.816 ' CE1' HG22 ' A' ' 264' ' ' ILE . 13.1 m-85 -125.66 101.06 6.71 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.504 1.128 . . . . 60.05 111.009 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.67 97.8 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 53.11 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.39 30.26 5.46 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.486 1.116 . . . . 71.42 109.319 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.581 ' O ' HD12 ' A' ' 300' ' ' ILE . 36.0 p -85.59 -167.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.24 110.394 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -92.68 -52.3 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 75.15 109.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.41 ' H ' HG23 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -65.47 173.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 62.55 109.257 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.15 137.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.501 1.126 . . . . 65.52 109.291 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 273' ' ' ILE . 5.6 mm -61.95 135.92 94.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.47 1.106 . . . . 73.45 109.3 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -22.79 14.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.797 . . . . 42.2 111.03 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 73.83 168.06 16.09 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.472 1.108 . . . . 64.44 111.02 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 1.7 t30 70.49 38.66 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 0.772 . . . . 70.45 109.271 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 52.6 m -83.29 -177.48 6.75 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 70.22 108.284 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.864 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.8 m -154.24 99.76 2.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 73.43 110.372 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 323' ' ' VAL . 0.8 OUTLIER -55.4 162.64 1.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.492 1.12 . . . . 73.51 111.006 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -155.31 90.62 1.27 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.559 1.162 . . . . 74.22 110.328 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 279' ' ' PHE . 12.2 p90 -118.94 153.83 33.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 70.2 111.001 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.59 170.2 16.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 72.53 110.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.541 1.151 . . . . 74.41 110.032 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.3 -0.629 . . . . 60.41 109.3 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.09 133.7 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 73.43 110.979 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.4 p -110.7 121.86 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.476 1.11 . . . . 70.1 109.969 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.873 HD11 ' CD1' ' A' ' 308' ' ' PHE . 12.0 mt -103.54 132.13 50.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 65.44 109.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.63 106.16 6.07 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.452 1.095 . . . . 73.43 109.297 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.819 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.5 mtp -77.77 145.7 36.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 71.35 110.996 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.03 153.76 6.83 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.497 1.123 . . . . 60.34 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -30.58 7.01 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.433 1.754 . . . . 63.4 111.023 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -42.88 143.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 61.31 109.607 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -92.69 124.52 36.76 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 63.31 110.308 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.526 HG23 ' C ' ' A' ' 302' ' ' GLY . 43.0 mt -62.02 -77.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.578 1.174 . . . . 65.12 109.309 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.32 -175.49 54.53 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.462 1.101 . . . . 65.11 111.008 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.681 ' N ' HD13 ' A' ' 300' ' ' ILE . 2.1 mm -66.68 133.86 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 74.52 109.305 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.49 ' HG2' HG22 ' A' ' 300' ' ' ILE . 12.1 mmtm 74.21 3.71 4.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.04 109.279 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.526 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -93.35 146.72 18.26 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.501 1.126 . . . . 72.13 111.006 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -113.63 -176.04 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 0.753 . . . . 65.43 110.282 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 264' ' ' ILE . 39.5 tptt -147.56 162.93 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.474 1.109 . . . . 60.4 109.295 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -136.0 118.92 16.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 74.2 110.305 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 1.056 HD12 HD11 ' A' ' 265' ' ' LEU . 20.1 mt -128.16 55.04 1.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.496 1.122 . . . . 72.52 109.308 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' TRP . . . . . 0.424 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 4.8 p90 -67.09 125.15 25.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.993 -1.114 . . . . 74.2 107.993 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.873 ' CD1' HD11 ' A' ' 291' ' ' ILE . 25.6 t80 -123.25 173.15 8.11 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.553 1.158 . . . . 71.35 111.042 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -150.55 161.72 29.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.509 1.131 . . . . 75.51 111.06 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -74.99 -43.15 0.72 Allowed 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.97 -2.513 . . . . 73.42 111.0 -0.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.5 p 179.59 158.4 0.67 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 52.11 109.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.863 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.1 mp -135.28 158.73 74.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 70.33 109.33 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 151.1 38.91 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.482 1.78 . . . . 71.44 110.996 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' THR . . . . . 0.522 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.8 OUTLIER -134.49 161.27 64.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.518 1.137 . . . . 71.13 110.453 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.91 -178.97 24.96 Favored 'Cis proline' 0 C--N 1.36 1.148 0 C-N-CA 121.002 -2.499 . . . . 75.41 111.038 -0.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.756 HD23 ' CE2' ' A' ' 319' ' ' TYR . 2.3 mt -101.27 57.39 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.52 109.318 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 6.1 p -81.4 127.7 33.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 60.4 109.989 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 317' ' ' SER . 30.8 t30 80.74 23.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 73.3 109.3 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.756 ' CE2' HD23 ' A' ' 316' ' ' LEU . 6.8 m-85 -101.92 176.46 5.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 71.33 110.985 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.611 HG23 ' HZ3' ' A' ' 322' ' ' LYS . 1.2 m -93.21 -58.66 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 71.22 110.395 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.749 ' SD ' HD13 ' A' ' 342' ' ' ILE . 2.2 ptp 28.3 61.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 73.42 110.991 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' LYS . . . . . 0.611 ' HZ3' HG23 ' A' ' 320' ' ' THR . 28.4 mttp -91.29 179.12 5.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.151 . . . . 62.41 109.32 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.5 t -140.81 129.67 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 72.52 109.284 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.868 HG12 ' N ' ' A' ' 330' ' ' THR . 15.4 m -108.47 178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 70.02 109.317 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -110.84 -172.34 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.437 1.086 . . . . 71.51 109.281 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -68.23 -4.7 14.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.44 110.267 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -7.46 31.96 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 55.33 109.289 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.62 54.38 6.69 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 61.45 111.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.571 ' C ' HG12 ' A' ' 324' ' ' VAL . 0.1 OUTLIER -149.55 130.5 14.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 0.755 . . . . 75.44 110.313 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' THR . . . . . 0.868 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.7 m -60.97 119.44 8.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 70.13 110.386 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.499 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.2 pt -97.19 -34.68 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 74.25 109.281 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 344' ' ' LEU . 4.8 mt -132.04 -171.46 2.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 73.52 109.341 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' VAL . . . . . 0.58 HG12 ' C ' ' A' ' 332' ' ' LEU . 0.1 OUTLIER -175.89 114.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 65.54 109.241 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.475 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -61.81 135.41 46.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.534 1.146 . . . . 62.24 111.011 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' LYS . . . . . 0.536 ' C ' ' SG ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -57.04 -19.54 19.41 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.582 0.813 . . . . 75.43 109.267 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.536 ' SG ' ' C ' ' A' ' 335' ' ' LYS . 0.8 OUTLIER 42.08 89.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 75.31 108.283 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.27 -175.32 2.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.53 109.324 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.31 61.86 2.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 64.41 109.288 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.82 142.78 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 62.2 109.961 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ASN . . . . . 0.453 ' O ' HG23 ' A' ' 254' ' ' VAL . 55.9 m-20 -52.18 -27.05 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 75.23 109.309 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.31 137.01 57.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.497 1.123 . . . . 72.12 110.293 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.749 HD13 ' SD ' ' A' ' 321' ' ' MET . 53.8 mt -146.17 137.28 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.532 1.145 . . . . 74.12 109.305 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 24.2 p -138.05 99.51 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 73.23 110.414 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.2 mp -54.78 132.27 45.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 63.35 109.265 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.623 ' O ' HD21 ' A' ' 332' ' ' LEU . 0.1 OUTLIER -112.72 -66.79 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 72.21 109.306 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' SER . . . . . 0.682 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.1 p 158.84 136.78 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 53.21 109.998 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' PRO . . . . . 0.528 ' HB3' HG11 ' A' ' 333' ' ' VAL . 18.3 Cg_endo -75.04 -57.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.479 1.779 . . . . 74.21 111.002 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 348' ' ' LEU . 1.4 tp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 73.15 109.317 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.278 -0.638 . . . . 65.22 109.278 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.467 ' HB2' HD12 ' A' ' 249' ' ' LEU . 0.8 OUTLIER 65.15 132.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.02 109.254 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 269' ' ' THR . 18.2 Cg_endo -75.0 -7.76 19.46 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.524 1.802 . . . . 61.12 110.978 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -42.48 134.38 3.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 75.25 109.325 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -121.23 103.15 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.525 1.141 . . . . 64.53 109.259 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -61.38 134.37 56.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 71.44 109.618 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 253' ' ' GLU . 89.9 t -142.36 164.95 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 72.32 109.295 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.5 ' N ' HG12 ' A' ' 252' ' ' VAL . 4.1 tp10 -146.05 129.5 16.87 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 64.53 110.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.738 ' CG1' HG21 ' A' ' 314' ' ' THR . 89.0 t -102.82 118.28 49.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.538 1.148 . . . . 72.54 109.273 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 18.0 m -87.78 -65.56 1.0 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.448 1.092 . . . . 53.34 110.019 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.865 ' HA ' HD23 ' A' ' 261' ' ' LEU . 7.6 t-20 58.36 63.5 1.71 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.472 1.108 . . . . 74.34 109.325 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.8 pt-20 -162.42 -175.01 4.29 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.429 1.081 . . . . 74.43 110.321 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.67 24.21 5.55 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.552 1.158 . . . . 73.44 109.281 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 72.42 18.63 4.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 75.3 109.272 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 4.2 m -165.28 -167.11 1.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 34.44 109.997 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 256' ' ' ASN . 9.4 mt -101.25 166.21 10.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.478 1.111 . . . . 63.15 109.321 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.458 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 0.3 OUTLIER -163.2 95.28 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 72.24 109.636 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.59 ' CE2' HD13 ' A' ' 261' ' ' LEU . 97.4 m-85 -97.46 149.33 22.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 70.34 110.986 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.807 HG22 ' CE1' ' A' ' 266' ' ' TYR . 48.4 mt -142.24 112.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.53 1.144 . . . . 71.14 109.293 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.617 HD11 HD12 ' A' ' 306' ' ' LEU . 0.0 OUTLIER -111.48 143.99 41.42 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.564 1.165 . . . . 64.05 109.306 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.807 ' CE1' HG22 ' A' ' 264' ' ' ILE . 2.1 m-85 -128.56 111.9 13.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.528 1.142 . . . . 75.21 110.979 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.758 ' HB2' HD13 ' A' ' 273' ' ' ILE . 26.2 t30 -60.47 101.34 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.138 . . . . 75.45 109.292 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 300' ' ' ILE . 3.7 mmpt? -101.56 -19.17 15.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 54.44 109.333 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.401 HG22 ' O ' ' A' ' 248' ' ' PRO . 60.6 p -48.0 175.16 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.484 1.115 . . . . 71.11 110.384 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -72.78 -57.39 4.12 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.516 1.135 . . . . 62.13 109.307 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.473 ' O ' HD13 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -69.3 166.8 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 63.43 109.303 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.48 131.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 65.41 109.262 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.758 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.3 mp -40.55 140.2 1.03 Allowed Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.51 1.131 . . . . 52.33 109.298 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -34.87 3.55 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 62.23 110.999 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 106.2 159.38 22.27 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.488 1.117 . . . . 60.21 110.989 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 8.8 t30 69.18 23.6 6.32 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 0.778 . . . . 71.53 109.259 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.4 ' C ' ' OG1' ' A' ' 278' ' ' THR . 60.9 m -70.62 -179.15 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 62.32 108.274 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.735 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -153.96 136.26 14.91 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 74.11 110.4 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.645 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.5 t80 -89.54 179.03 6.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 65.35 110.98 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.461 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 11.2 tt0 -176.73 101.61 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.472 1.108 . . . . 72.15 110.316 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 1.3 p90 -116.26 147.81 41.12 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 74.41 111.006 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 53.2 p -100.67 -175.27 2.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 62.04 109.997 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.558 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 0.3 OUTLIER -178.45 -173.97 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.54 1.15 . . . . 71.34 110.029 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 285' ' ' ILE . 17.8 pt20 -111.13 -52.77 2.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 72.33 110.309 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 285' ' ' ILE . 0.0 OUTLIER -62.38 -37.59 79.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 75.33 109.323 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 5.4 t -118.97 -176.0 3.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 60.54 110.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -108.32 -177.04 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 74.51 110.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 2.6 p -77.52 147.42 7.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.521 1.138 . . . . 73.24 109.255 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -152.88 142.95 22.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 72.03 111.005 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.627 ' OG ' HG22 ' A' ' 278' ' ' THR . 32.4 t -107.32 127.89 53.96 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.507 1.129 . . . . 73.14 109.999 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 9.3 mt -101.04 137.22 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 72.41 109.287 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 mmtm -77.47 113.0 14.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.46 1.1 . . . . 73.53 109.317 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.924 ' HG2' HD21 ' A' ' 306' ' ' LEU . 63.0 mtp -84.13 165.51 18.41 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 72.31 110.973 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.454 ' H ' ' NZ ' ' A' ' 304' ' ' LYS . . . -64.47 151.42 50.51 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.473 1.108 . . . . 55.14 111.021 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -31.28 6.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.441 1.758 . . . . 61.3 110.961 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.56 ' CE1' ' OE1' ' A' ' 297' ' ' GLU . 57.6 t-80 -68.14 143.11 55.53 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 64.14 109.598 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.56 ' OE1' ' CE1' ' A' ' 296' ' ' HIS . 0.6 OUTLIER -65.38 179.36 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.135 . . . . 73.21 110.304 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 44.3 mt -105.77 -76.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 51.54 109.329 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.412 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 128.0 149.74 7.13 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.469 1.106 . . . . 30.43 111.056 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.494 ' O ' ' CE ' ' A' ' 268' ' ' LYS . 4.2 mt -46.75 -25.53 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.531 0.783 . . . . 73.15 109.342 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 299' ' ' GLY . 0.2 OUTLIER -115.6 -37.69 3.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 52.44 109.304 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -40.9 151.03 0.14 Allowed Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.571 1.169 . . . . 65.35 110.948 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.27 -177.49 3.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.512 0.772 . . . . 72.22 110.27 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.454 ' NZ ' ' H ' ' A' ' 294' ' ' GLY . 35.3 tptt -154.51 143.6 21.11 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.433 1.083 . . . . 72.12 109.301 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.54 ' HB2' ' CZ2' ' A' ' 307' ' ' TRP . 10.7 mt-10 -114.83 150.39 35.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 71.12 110.308 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.924 HD21 ' HG2' ' A' ' 293' ' ' MET . 82.7 mt -141.15 62.58 1.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.113 . . . . 73.53 109.266 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.54 ' CZ2' ' HB2' ' A' ' 305' ' ' GLU . 0.9 OUTLIER -59.29 134.86 57.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.95 -1.13 . . . . 71.14 107.95 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.622 ' CE1' HD11 ' A' ' 312' ' ' LEU . 10.2 t80 -137.23 155.14 49.87 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 74.4 111.019 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.668 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -135.6 147.36 61.22 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 74.25 111.013 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -53.72 0.15 OUTLIER 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.005 -2.498 . . . . 63.24 111.007 -0.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 178.44 174.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 71.44 109.982 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 261' ' ' LEU . 3.7 mp -138.82 158.42 70.01 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 74.53 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 145.25 31.06 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.487 1.783 . . . . 52.15 110.992 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.738 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -123.02 162.54 38.61 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.491 1.119 . . . . 71.44 110.404 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -175.45 16.03 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 121.015 -2.494 . . . . 44.34 111.023 -0.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.845 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.8 mt -109.8 57.79 0.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 63.43 109.281 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.3 p -85.38 134.74 34.07 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 70.51 109.985 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 32.0 t30 83.19 2.63 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 73.43 109.319 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.845 ' CE2' HD23 ' A' ' 316' ' ' LEU . 9.0 m-85 -81.13 -178.47 6.92 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 75.42 111.017 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.536 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -97.57 -58.28 2.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 71.32 110.373 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.777 ' SD ' HD13 ' A' ' 316' ' ' LEU . 1.0 OUTLIER 28.59 64.63 0.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 52.44 111.032 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.536 ' HG3' HG23 ' A' ' 320' ' ' THR . 40.2 mttm -92.68 -172.57 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 71.42 109.299 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.764 ' CG2' HD21 ' A' ' 344' ' ' LEU . 41.9 t -141.84 130.49 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 63.43 109.304 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 278' ' ' THR . 5.6 m -109.52 176.11 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.081 . . . . 64.33 109.278 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.453 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 2.6 t30 -101.04 -165.56 1.22 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 62.34 109.322 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -70.1 -7.93 45.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 54.13 110.3 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -107.82 13.33 26.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.22 109.302 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 62.33 27.61 69.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.544 1.152 . . . . 70.22 110.99 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 331' ' ' ILE . 6.7 pt-20 -102.83 127.19 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.464 0.743 . . . . 71.14 110.295 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.595 ' N ' HG12 ' A' ' 324' ' ' VAL . 56.0 m -54.07 111.02 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 1.14 . . . . 72.42 110.377 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 329' ' ' GLU . 5.1 pt -94.33 -37.91 8.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.41 109.279 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.834 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.3 mt -139.36 176.18 8.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.472 1.107 . . . . 75.21 109.328 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.441 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -151.05 131.07 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.515 1.134 . . . . 51.42 109.323 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -83.76 130.2 9.6 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.504 1.128 . . . . 62.03 110.977 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.541 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -61.08 -26.59 67.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.566 0.803 . . . . 71.53 109.297 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 316' ' ' LEU . 0.8 OUTLIER 48.23 76.62 0.11 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.45 1.094 . . . . 43.52 108.305 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.541 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -88.27 -178.75 5.99 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.563 1.164 . . . . 64.53 109.316 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -75.91 62.44 1.59 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 62.12 109.288 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.7 m -173.59 150.68 1.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 74.03 110.024 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -58.9 -17.62 25.91 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.512 1.132 . . . . 54.05 109.279 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -77.95 146.43 35.5 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.125 . . . . 74.22 110.289 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.61 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 65.9 mt -147.98 141.23 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 44.12 109.31 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' OG1' ' A' ' 343' ' ' THR . 8.7 p -138.77 97.81 3.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.518 1.136 . . . . 54.23 110.396 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.834 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.5 mp -46.83 133.49 10.8 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.131 . . . . 63.13 109.329 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -98.06 -76.84 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.479 1.112 . . . . 72.13 109.308 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.609 ' HA ' HD23 ' A' ' 332' ' ' LEU . 2.9 p 159.84 142.06 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 75.45 110.011 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 -80.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.449 1.763 . . . . 72.52 110.955 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 53.33 109.286 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 109.296 -0.631 . . . . 73.51 109.296 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 52.96 87.73 0.13 Allowed Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.526 1.142 . . . . 72.45 109.352 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 170.28 20.76 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.512 1.796 . . . . 71.34 111.017 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -172.16 157.72 4.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.524 1.14 . . . . 73.23 109.256 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.858 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -114.43 102.21 9.87 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.502 1.126 . . . . 70.21 109.287 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.623 ' ND1' HG22 ' A' ' 343' ' ' THR . 14.3 t60 -90.88 166.17 13.2 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.469 1.105 . . . . 75.32 109.558 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.762 HG21 HD23 ' A' ' 265' ' ' LEU . 66.7 t -153.48 155.51 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 51.54 109.324 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -117.62 146.16 43.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.3 110.308 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.673 HG22 ' CE1' ' A' ' 263' ' ' PHE . 38.6 t -128.83 94.97 2.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.525 1.14 . . . . 72.33 109.344 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.1 m -69.13 -63.34 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.542 1.151 . . . . 70.44 110.027 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.751 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.2 t-20 60.82 82.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.528 1.143 . . . . 74.23 109.307 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -121.29 166.5 13.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.502 1.126 . . . . 65.35 110.296 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 259' ' ' ASN . 23.8 t0 -42.69 -58.32 2.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.573 1.171 . . . . 75.03 109.31 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 258' ' ' ASP . 80.4 m-20 -40.06 -61.94 0.8 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 71.22 109.295 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 176.27 -173.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 74.23 109.992 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.751 HD23 ' HA ' ' A' ' 256' ' ' ASN . 19.6 mt -80.98 161.2 24.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.529 1.143 . . . . 72.2 109.263 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -152.68 95.74 2.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.532 1.145 . . . . 63.51 109.604 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.673 ' CE1' HG22 ' A' ' 254' ' ' VAL . 75.0 m-85 -103.6 112.02 24.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 75.3 110.965 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.78 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 73.8 mt -111.03 117.81 55.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 55.22 109.325 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.762 HD23 HG21 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -106.01 151.72 24.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 70.24 109.342 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.78 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 0.9 OUTLIER -138.11 117.58 12.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.484 1.115 . . . . 74.15 110.98 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.645 ' ND2' HD11 ' A' ' 273' ' ' ILE . 17.1 t-20 -79.74 106.52 11.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 62.1 109.305 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.65 -11.84 21.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.529 1.143 . . . . 60.54 109.276 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.415 ' H ' HG23 ' A' ' 269' ' ' THR . 22.6 p -66.34 154.75 39.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.503 1.127 . . . . 73.22 110.368 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -67.55 -40.78 84.96 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.493 1.121 . . . . 75.31 109.302 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 9.1 pt -54.37 167.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.14 . . . . 71.42 109.299 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 272' ' ' ILE . 4.7 mp -121.54 157.74 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 73.32 109.275 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.701 ' N ' HD13 ' A' ' 273' ' ' ILE . 1.2 mm -82.42 141.21 45.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.508 1.13 . . . . 73.24 109.29 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.614 ' HD2' HG22 ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.01 -14.88 20.99 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.496 1.787 . . . . 53.12 111.0 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 84.62 151.21 13.09 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.52 1.137 . . . . 71.25 111.039 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.8 t30 70.27 50.73 0.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 0.767 . . . . 73.54 109.32 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.97 -179.72 5.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.52 1.137 . . . . 61.34 108.3 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.712 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.6 m -153.94 137.17 15.67 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.446 1.091 . . . . 72.31 110.347 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.69 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -85.85 176.98 7.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 71.4 110.978 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.6 ' CG ' HG21 ' A' ' 288' ' ' VAL . 55.4 tt0 -152.7 65.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 75.45 110.246 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 289' ' ' PHE . 9.9 p90 -96.14 130.47 43.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 75.23 110.957 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.454 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 17.9 p -121.79 -178.44 3.83 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 73.4 110.003 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.599 ' CB ' HD23 ' A' ' 312' ' ' LEU . 3.5 p -119.31 -5.71 10.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 51.02 109.991 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.689 ' OE1' HG23 ' A' ' 285' ' ' ILE . 8.3 tp-100 -177.95 166.78 2.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.098 . . . . 73.43 110.279 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.689 HG23 ' OE1' ' A' ' 284' ' ' GLN . 7.9 pt -41.75 -28.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 72.54 109.342 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 284' ' ' GLN . 9.1 t -52.7 -173.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.14 . . . . 71.34 109.977 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -46.5 172.78 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 70.31 110.281 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.6 HG21 ' CG ' ' A' ' 280' ' ' GLU . 7.4 p -131.54 168.18 24.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 71.53 109.236 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.548 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.8 t80 -115.8 133.38 56.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 64.01 110.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 5.0 p -112.48 120.67 42.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.564 1.165 . . . . 63.32 109.988 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 12.5 mt -105.8 127.73 60.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 72.32 109.356 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -67.02 116.7 8.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 64.21 109.287 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.595 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.6 mtp -85.11 150.3 24.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.43 111.002 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -45.65 150.71 1.25 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.489 1.118 . . . . 23.45 110.983 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -28.01 9.46 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.531 1.806 . . . . 74.21 110.954 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 53.3 m170 -65.1 143.3 57.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.083 . . . . 73.55 109.576 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.68 138.06 31.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.33 110.309 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.435 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -65.28 -79.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.13 109.307 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.84 -155.35 18.78 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.518 1.136 . . . . 75.43 111.016 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.928 HG22 ' HD3' ' A' ' 301' ' ' LYS . 0.9 OUTLIER -86.93 133.86 28.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 0.79 . . . . 71.42 109.313 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.928 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.3 OUTLIER 68.79 6.51 5.58 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.538 1.149 . . . . 71.13 109.314 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.435 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -85.68 162.61 36.16 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.511 1.132 . . . . 64.32 110.999 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 298' ' ' ILE . 4.5 pt20 -131.47 174.82 9.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 0.767 . . . . 75.01 110.283 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 38.5 tptt -149.46 152.11 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.23 109.328 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -111.59 141.22 45.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.493 1.12 . . . . 62.53 110.307 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.724 HD12 HD11 ' A' ' 265' ' ' LEU . 12.3 mt -145.53 61.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.489 1.118 . . . . 74.42 109.32 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -79.27 121.61 25.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 73.4 107.98 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.682 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.8 m-30 -109.29 -174.13 2.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 64.03 111.043 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.502 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.9 OUTLIER -164.91 160.19 14.99 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 74.11 110.998 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.02 -36.29 2.64 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.005 -2.498 . . . . 71.44 111.022 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 2.9 p 169.74 131.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.107 . . . . 73.2 110.012 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.599 HD23 ' CB ' ' A' ' 283' ' ' SER . 5.7 mp -111.59 158.94 34.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.15 . . . . 75.53 109.339 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 147.36 33.66 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.463 1.77 . . . . 74.32 110.973 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.604 HG21 HG12 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -123.91 164.43 29.3 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 61.11 110.4 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 -174.66 14.53 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.022 -2.491 . . . . 73.43 110.989 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.625 HD22 ' CE2' ' A' ' 319' ' ' TYR . 3.4 mt -102.36 60.12 0.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.41 109.294 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -82.91 131.81 35.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 73.3 110.047 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.4 t-20 76.66 21.97 1.22 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 72.34 109.322 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.625 ' CE2' HD22 ' A' ' 316' ' ' LEU . 4.0 m-85 -99.13 -170.06 1.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 75.22 111.001 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.653 HG22 ' HG3' ' A' ' 322' ' ' LYS . 28.2 m -107.81 -64.92 1.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.513 1.133 . . . . 75.2 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.833 ' HE3' ' CD1' ' A' ' 342' ' ' ILE . 2.8 mtm 34.09 35.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 72.31 110.998 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.653 ' HG3' HG22 ' A' ' 320' ' ' THR . 27.9 mttm -75.98 169.82 17.44 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 62.3 109.284 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.591 HG23 HD21 ' A' ' 344' ' ' LEU . 74.8 t -119.1 133.71 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 72.45 109.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 278' ' ' THR . 8.9 m -118.23 172.43 5.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.111 . . . . 63.15 109.284 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.407 ' ND2' ' H ' ' A' ' 326' ' ' GLN . 2.8 t30 -96.06 -166.48 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 74.51 109.337 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.407 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 3.3 pt20 -71.13 -5.72 33.85 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.519 1.137 . . . . 65.42 110.338 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.46 12.09 26.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.52 1.137 . . . . 64.51 109.303 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 67.24 8.39 50.12 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.498 1.124 . . . . 43.23 111.047 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 6.5 pt-20 -78.9 129.95 35.09 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.757 . . . . 73.2 110.281 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.626 ' HA ' HG12 ' A' ' 324' ' ' VAL . 4.1 m -62.97 108.08 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.03 110.38 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 323' ' ' VAL . 2.7 pt -90.94 -43.68 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.511 1.132 . . . . 74.22 109.324 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.6 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.4 mt -136.1 168.45 19.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 71.44 109.292 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.483 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.2 m -151.75 131.71 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 71.55 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -85.34 121.04 5.5 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.502 1.126 . . . . 71.21 111.008 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.695 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.32 -26.93 0.37 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 0.753 . . . . 74.41 109.263 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.419 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.5 OUTLIER 45.68 71.72 0.26 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 75.32 108.296 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.695 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -84.77 -176.79 6.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.119 . . . . 73.53 109.294 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.79 64.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.45 109.327 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.8 t -178.95 148.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.129 . . . . 71.32 109.967 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -57.65 -17.93 17.45 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 73.21 109.265 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.54 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 14.4 mt-10 -71.93 131.96 43.69 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.107 . . . . 74.54 110.271 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.833 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 45.4 mt -142.88 118.05 4.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.506 1.128 . . . . 71.05 109.286 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.623 HG22 ' ND1' ' A' ' 251' ' ' HIS . 18.5 p -117.57 87.28 2.68 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.481 1.113 . . . . 62.45 110.39 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.858 HD22 ' CD2' ' A' ' 250' ' ' LEU . 8.5 mp -40.01 132.1 1.87 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.492 1.12 . . . . 72.34 109.295 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.0 ptpt -117.72 -58.77 1.99 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.557 1.161 . . . . 71.44 109.265 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.536 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 158.98 158.19 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 63.32 110.007 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 -67.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.461 1.769 . . . . 74.33 110.969 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.559 HD22 ' C ' ' A' ' 348' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.519 1.137 . . . . 72.22 109.323 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.308 -0.627 . . . . 75.11 109.308 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.93 101.37 0.57 Allowed Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 54.24 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.552 ' HA ' ' CB ' ' A' ' 269' ' ' THR . 18.2 Cg_endo -74.97 -0.8 10.4 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.476 1.777 . . . . 72.43 110.993 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 1.001 ' O ' HD23 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -60.58 151.88 27.66 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.451 1.094 . . . . 75.12 109.317 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -111.32 98.7 7.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.515 1.135 . . . . 71.3 109.293 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.627 ' CD2' HG22 ' A' ' 343' ' ' THR . 20.3 t-80 -96.33 130.38 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.496 1.123 . . . . 73.32 109.624 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.661 HG21 HD23 ' A' ' 265' ' ' LEU . 16.5 t -120.5 171.35 9.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.47 1.106 . . . . 74.24 109.271 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.52 ' N ' HG12 ' A' ' 252' ' ' VAL . 1.9 tp10 -133.96 128.55 34.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 70.14 110.268 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.597 ' CG1' HG21 ' A' ' 314' ' ' THR . 4.5 t -105.72 112.56 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.484 1.115 . . . . 51.44 109.318 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.22 -56.73 4.14 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.527 1.142 . . . . 51.43 109.994 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.914 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.1 t-20 60.48 67.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.528 1.143 . . . . 63.32 109.299 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.48 163.81 12.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 71.14 110.29 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.37 -44.74 68.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.439 1.087 . . . . 71.13 109.303 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -55.11 -61.15 2.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 74.24 109.289 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 29.3 m -174.21 -176.7 1.17 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.437 1.086 . . . . 63.22 110.022 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.914 HD23 ' HA ' ' A' ' 256' ' ' ASN . 39.8 mt -77.5 171.05 15.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.491 1.12 . . . . 73.41 109.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -160.49 103.76 1.4 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 61.13 109.588 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.657 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 68.8 m-85 -109.3 90.51 3.32 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.518 1.136 . . . . 74.53 111.008 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.78 HG22 ' CE2' ' A' ' 266' ' ' TYR . 54.3 mt -90.23 97.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 52.53 109.314 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.661 HD23 HG21 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -91.51 137.04 32.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.13 109.323 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.78 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.8 m-85 -120.65 110.41 16.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.516 1.135 . . . . 64.21 111.014 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.417 ' ND2' HD13 ' A' ' 273' ' ' ILE . 12.3 t30 -68.38 96.6 0.68 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.489 1.118 . . . . 53.53 109.319 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -101.09 28.3 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.521 1.138 . . . . 74.22 109.29 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.552 ' CB ' ' HA ' ' A' ' 248' ' ' PRO . 4.5 p -102.9 143.48 32.43 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.514 1.134 . . . . 64.34 110.419 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -44.29 -58.06 3.12 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.438 1.086 . . . . 71.12 109.306 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 14.7 pt -54.61 172.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 72.33 109.345 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.14 123.16 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.443 1.09 . . . . 72.22 109.306 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.417 HD13 ' ND2' ' A' ' 267' ' ' ASN . 1.7 mp -40.4 137.55 1.29 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 60.21 109.311 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.4 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.98 -24.18 13.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.502 1.791 . . . . 70.23 111.007 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 89.37 162.81 38.79 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.501 1.126 . . . . 33.31 111.001 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 2.6 t30 69.26 34.24 3.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.754 . . . . 61.21 109.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 52.3 m -83.39 -179.22 7.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 71.44 108.308 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.809 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.0 m -151.85 132.58 14.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 74.32 110.41 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.647 ' CE1' HG22 ' A' ' 323' ' ' VAL . 0.9 OUTLIER -90.19 -178.63 5.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.429 1.08 . . . . 63.21 111.007 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.589 ' HG3' HG21 ' A' ' 288' ' ' VAL . 1.9 tt0 -171.68 89.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.135 . . . . 72.43 110.329 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.763 ' HE1' HD12 ' A' ' 291' ' ' ILE . 22.7 p90 -116.89 128.58 55.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 74.21 111.046 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 36.7 p -95.54 165.24 12.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.137 . . . . 72.43 109.976 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.572 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.5 p -127.38 3.27 6.29 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.446 1.091 . . . . 74.13 110.021 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -178.55 177.05 0.95 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 74.32 110.303 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.629 HD12 ' C ' ' A' ' 285' ' ' ILE . 1.1 pp -56.59 -20.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.517 1.136 . . . . 74.23 109.285 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 10.9 m -55.61 -167.1 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 1.116 . . . . 75.14 109.965 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -75.4 -173.82 2.22 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.497 1.123 . . . . 60.21 110.3 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.589 HG21 ' HG3' ' A' ' 280' ' ' GLU . 13.9 p -136.22 170.91 17.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 71.42 109.319 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.521 ' N ' HG22 ' A' ' 288' ' ' VAL . 3.1 t80 -134.89 145.46 48.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 54.43 111.016 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.543 ' HB2' HG22 ' A' ' 278' ' ' THR . 60.2 p -104.3 129.76 52.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.534 1.146 . . . . 71.45 110.011 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.763 HD12 ' HE1' ' A' ' 281' ' ' PHE . 2.0 mt -95.96 127.31 48.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 65.13 109.31 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.18 107.62 3.77 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.49 1.118 . . . . 71.24 109.257 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.486 ' HG2' HD21 ' A' ' 306' ' ' LEU . 85.5 mtp -78.11 158.61 29.06 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.577 1.173 . . . . 73.34 111.04 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -64.06 147.11 50.73 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.481 1.113 . . . . 74.4 111.025 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -29.66 7.97 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 72.51 110.952 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -54.12 152.58 5.87 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 65.13 109.594 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -85.35 154.31 21.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 71.12 110.299 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 86.4 mt -92.56 -79.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.122 . . . . 75.0 109.293 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.24 -177.1 21.42 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.547 1.154 . . . . 52.34 111.004 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.537 HG22 ' HD3' ' A' ' 301' ' ' LYS . 8.9 mt -53.66 -86.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.503 0.767 . . . . 74.01 109.268 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.537 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.5 OUTLIER -61.82 -23.8 66.48 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.147 . . . . 73.41 109.293 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.487 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -50.65 135.03 29.76 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.498 1.124 . . . . 61.21 111.023 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.54 176.81 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 0.766 . . . . 74.45 110.273 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.506 ' O ' HD12 ' A' ' 265' ' ' LEU . 18.8 tptt -152.0 144.26 23.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 60.22 109.339 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -102.72 163.71 12.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.102 . . . . 64.41 110.298 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.577 ' HB3' ' CE1' ' A' ' 308' ' ' PHE . 8.2 mt -161.27 73.79 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 74.32 109.277 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.25 127.38 32.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.139 . . . . 74.34 107.988 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.741 ' CG ' ' CZ ' ' A' ' 281' ' ' PHE . 16.5 m-30 -114.15 38.49 3.01 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.48 1.113 . . . . 74.51 110.971 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.522 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 6.6 p90 -37.63 157.34 0.09 OUTLIER Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 74.32 110.979 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.5 Cg_endo -74.97 -36.94 2.43 Favored 'Cis proline' 0 C--N 1.36 1.177 0 C-N-CA 120.99 -2.504 . . . . 50.01 111.052 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 37.0 p 176.13 144.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 65.13 109.987 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.805 ' HB2' HD11 ' A' ' 261' ' ' LEU . 3.7 mp -129.18 159.39 69.24 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 55.0 109.312 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 144.09 29.84 Favored 'Trans proline' 0 C--N 1.359 1.132 0 O-C-N 124.48 1.779 . . . . 74.41 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.597 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.6 OUTLIER -127.16 162.58 47.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.45 1.093 . . . . 73.52 110.378 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.1 Cg_endo -74.98 177.98 36.66 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.009 -2.496 . . . . 54.33 110.977 -0.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.767 HD12 ' HE2' ' A' ' 321' ' ' MET . 3.8 mt -92.85 64.4 4.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 75.2 109.276 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.7 t -83.97 135.77 34.33 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 71.34 109.963 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 72.12 10.86 6.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.534 1.146 . . . . 71.44 109.303 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 282' ' ' SER . 4.8 m-30 -96.29 124.96 40.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 61.13 111.0 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -40.0 -61.48 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 1.102 . . . . 72.14 110.384 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.767 ' HE2' HD12 ' A' ' 316' ' ' LEU . 3.9 ttm 31.19 68.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.459 1.099 . . . . 72.41 110.973 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.548 ' HG3' HG23 ' A' ' 320' ' ' THR . 80.8 mttt -103.78 -171.29 1.91 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.451 1.094 . . . . 61.42 109.316 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.647 HG22 ' CE1' ' A' ' 279' ' ' PHE . 19.2 t -141.53 123.47 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 54.34 109.332 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 278' ' ' THR . 22.6 m -110.84 -172.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.464 1.103 . . . . 75.31 109.315 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.831 ' ND2' HG23 ' A' ' 331' ' ' ILE . 0.0 OUTLIER -126.55 -171.92 2.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 74.0 109.268 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -64.51 -6.99 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 74.22 110.328 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -89.02 -14.82 35.58 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 64.22 109.292 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.61 1.66 89.07 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.484 1.115 . . . . 65.1 111.028 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.457 ' O ' ' ND2' ' A' ' 325' ' ' ASN . 14.0 pt-20 -94.54 153.22 18.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 0.79 . . . . 71.23 110.312 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.637 ' CA ' HG12 ' A' ' 324' ' ' VAL . 1.3 m -83.47 128.89 34.87 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 71.3 110.397 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.831 HG23 ' ND2' ' A' ' 325' ' ' ASN . 33.6 pt -103.64 -37.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.114 . . . . 74.03 109.28 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.854 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.3 mt -134.14 168.77 18.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.114 . . . . 72.42 109.291 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.476 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 0.9 OUTLIER -152.79 122.0 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 62.31 109.336 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -77.53 119.53 5.32 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 44.15 110.987 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.771 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.27 -27.0 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.532 0.783 . . . . 75.1 109.271 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 49.14 76.0 0.14 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 65.02 108.289 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.771 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -88.2 -178.68 5.99 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.532 1.145 . . . . 60.53 109.276 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -76.04 61.15 1.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.477 1.111 . . . . 64.01 109.295 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 341' ' ' GLU . 4.2 m 179.43 141.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 61.52 110.019 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 13.9 m-20 -46.65 -26.13 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.151 . . . . 65.13 109.294 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.521 ' HG2' ' CE1' ' A' ' 251' ' ' HIS . 3.2 mt-10 -63.04 125.29 23.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.531 1.145 . . . . 64.21 110.345 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.71 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 66.4 mt -141.65 123.38 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.124 . . . . 54.22 109.345 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.627 HG22 ' CD2' ' A' ' 251' ' ' HIS . 15.2 p -126.25 87.84 2.74 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.132 . . . . 51.21 110.417 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.854 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.3 mp -40.77 138.93 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.526 1.141 . . . . 74.13 109.299 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.1 OUTLIER -112.57 -64.58 1.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.492 1.12 . . . . 75.55 109.268 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 159.7 145.91 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.532 1.145 . . . . 72.33 110.011 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -81.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.474 1.776 . . . . 53.41 111.049 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 73.51 109.261 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.315 -0.624 . . . . 64.44 109.315 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.45 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 2.8 m-20 -79.73 153.08 75.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.12 . . . . 72.22 109.3 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -0.49 10.03 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.469 1.773 . . . . 73.21 110.999 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -39.88 141.8 0.4 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.145 . . . . 73.31 109.291 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.445 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -128.51 103.34 7.06 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.5 1.125 . . . . 70.23 109.304 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -66.56 139.68 57.93 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 64.31 109.605 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 253' ' ' GLU . 60.2 t -144.33 167.84 11.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 72.14 109.303 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.535 ' N ' HG12 ' A' ' 252' ' ' VAL . 53.6 tt0 -122.93 154.49 38.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 74.41 110.281 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.773 ' CG1' HG21 ' A' ' 314' ' ' THR . 82.4 t -135.75 95.16 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.526 1.142 . . . . 65.11 109.307 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 2.5 t -69.1 -67.4 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 30.42 109.963 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.856 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.0 t-20 60.91 64.94 1.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 71.25 109.291 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -91.45 145.56 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 75.21 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -46.26 -34.16 4.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.517 1.136 . . . . 62.13 109.348 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -65.89 -52.03 53.6 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.569 1.168 . . . . 74.41 109.261 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.9 m -171.14 -175.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 53.34 110.063 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -88.12 176.38 7.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.446 1.091 . . . . 65.11 109.324 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.55 ' NE2' ' CD1' ' A' ' 307' ' ' TRP . 4.3 t-160 -176.2 103.51 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.33 109.618 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 254' ' ' VAL . 93.8 m-85 -112.54 127.02 55.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 54.1 111.023 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.766 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 76.5 mt -119.42 116.83 52.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.159 . . . . 62.45 109.272 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.675 HD11 HD12 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -103.25 130.01 50.37 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.491 1.119 . . . . 64.45 109.319 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.766 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.3 m-85 -119.66 109.17 15.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.03 111.022 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.783 ' HB3' HG22 ' A' ' 298' ' ' ILE . 14.5 t30 -69.81 75.51 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 70.04 109.301 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.97 52.85 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.12 . . . . 72.43 109.322 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.5 p -127.58 -178.08 4.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 74.44 110.419 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.32 18.19 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 74.02 109.33 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.59 169.22 7.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.477 1.111 . . . . 71.02 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.3 mt -121.11 137.94 53.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.512 1.132 . . . . 73.1 109.358 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.75 137.49 58.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 75.2 109.271 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -26.25 11.09 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.519 1.799 . . . . 61.33 111.007 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.443 ' O ' ' ND2' ' A' ' 276' ' ' ASN . . . 83.94 -157.38 33.79 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.527 1.142 . . . . 45.44 111.034 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 275' ' ' GLY . 0.2 OUTLIER 39.89 30.9 0.07 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.463 0.743 . . . . 64.33 109.269 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.433 ' N ' ' C ' ' A' ' 275' ' ' GLY . 18.0 m -87.04 -173.41 4.43 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.538 1.149 . . . . 74.5 108.304 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.805 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.5 m -152.93 126.37 8.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 1.112 . . . . 53.53 110.356 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.627 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.7 t80 -79.99 172.66 13.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.481 1.113 . . . . 75.22 110.984 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.505 ' HG3' HG21 ' A' ' 288' ' ' VAL . 2.3 tt0 -167.08 91.05 0.39 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.483 1.115 . . . . 61.35 110.312 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.418 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 32.8 p90 -111.7 120.98 43.85 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.476 1.11 . . . . 65.15 110.983 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.604 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 81.8 p -109.93 161.56 15.36 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.107 . . . . 54.45 110.017 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.576 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 33.3 t -131.75 -63.52 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 53.31 109.986 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.83 171.34 7.58 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.57 1.169 . . . . 64.31 110.298 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 9.6 pt -72.76 -6.86 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.112 . . . . 62.44 109.296 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 20.3 m -49.43 -71.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 65.15 110.005 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.27 176.32 3.94 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.486 1.116 . . . . 73.32 110.302 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 280' ' ' GLU . 8.8 p -123.98 168.26 16.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.535 1.147 . . . . 42.43 109.268 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.447 ' H ' HG22 ' A' ' 288' ' ' VAL . 8.3 t80 -137.49 146.57 44.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 73.21 111.011 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 95.0 p -117.74 123.46 46.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 70.43 109.996 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.9 mt -101.77 126.94 55.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.522 1.139 . . . . 72.32 109.259 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.429 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.1 OUTLIER -66.92 122.69 18.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.48 1.113 . . . . 74.31 109.321 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 97.2 mtp -84.45 148.94 26.3 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.096 . . . . 62.22 111.015 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.708 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -52.62 156.23 4.69 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 63.02 111.02 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -26.64 10.86 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.492 1.785 . . . . 63.13 110.985 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.562 ' CE1' ' HD3' ' A' ' 304' ' ' LYS . 28.4 p80 -52.82 -176.28 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 75.32 109.596 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -124.63 175.71 7.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.509 1.13 . . . . 73.31 110.289 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.783 HG22 ' HB3' ' A' ' 267' ' ' ASN . 3.9 mp -134.74 61.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.12 . . . . 75.02 109.321 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.71 -122.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.487 1.117 . . . . 62.42 110.981 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.444 HG22 ' HG2' ' A' ' 301' ' ' LYS . 2.2 mt -98.73 138.11 24.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.513 0.772 . . . . 70.34 109.3 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.444 ' HG2' HG22 ' A' ' 300' ' ' ILE . 1.1 mmmm 67.07 9.23 6.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 75.42 109.331 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.599 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -103.28 146.5 16.53 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.473 1.108 . . . . 72.32 110.986 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.02 -177.58 4.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.525 0.779 . . . . 62.14 110.302 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.708 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 57.0 tptt -149.38 150.11 31.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 72.14 109.28 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 10.3 mt-10 -110.36 160.07 16.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 70.04 110.307 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.675 HD12 HD11 ' A' ' 265' ' ' LEU . 13.6 mt -155.97 70.62 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.486 1.116 . . . . 70.21 109.287 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.55 ' CD1' ' NE2' ' A' ' 262' ' ' HIS . 0.1 OUTLIER -74.97 129.29 37.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 72.44 108.02 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.66 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 12.8 m-30 -117.75 -172.02 2.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.45 1.094 . . . . 65.52 110.998 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.509 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.8 p90 -169.75 159.43 6.94 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.557 1.161 . . . . 64.44 110.955 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.03 -36.17 2.68 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.046 -2.481 . . . . 73.35 110.994 0.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.2 p 170.25 131.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.538 1.149 . . . . 44.54 110.016 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.561 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.4 mp -114.79 158.81 39.52 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.32 109.355 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 145.73 31.95 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.491 1.785 . . . . 73.52 110.971 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.773 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.2 OUTLIER -127.12 164.49 35.1 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.501 1.126 . . . . 75.21 110.404 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.522 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.02 176.51 43.14 Favored 'Cis proline' 0 C--N 1.359 1.113 0 C-N-CA 121.013 -2.495 . . . . 60.14 110.991 0.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.713 HD12 ' CE ' ' A' ' 321' ' ' MET . 4.9 mt -92.16 66.41 4.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.549 1.156 . . . . 73.45 109.292 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 2.4 p -81.27 128.15 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 61.32 110.006 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.93 21.31 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 73.35 109.27 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.604 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.5 m-30 -103.7 134.13 47.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 74.43 110.982 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 322' ' ' LYS . 60.4 m -45.91 -67.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 73.44 110.389 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.713 ' CE ' HD12 ' A' ' 316' ' ' LEU . 4.3 ttm 33.53 56.92 0.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 73.41 111.016 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.746 ' HZ2' ' HB ' ' A' ' 333' ' ' VAL . 28.1 mttm -95.14 -166.38 1.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 74.13 109.303 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.528 ' CG2' HD21 ' A' ' 344' ' ' LEU . 12.7 t -145.02 126.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 51.12 109.304 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 278' ' ' THR . 11.8 m -109.69 -172.13 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 75.05 109.252 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 331' ' ' ILE . 39.2 p30 -120.25 -170.85 2.05 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.495 1.122 . . . . 64.51 109.304 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -65.42 -8.23 17.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.506 1.129 . . . . 64.11 110.299 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -95.21 -8.76 35.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 75.12 109.278 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.59 -4.5 78.25 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.115 . . . . 63.23 111.026 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -80.84 140.48 35.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.484 0.755 . . . . 75.22 110.27 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.712 ' HA ' HG12 ' A' ' 324' ' ' VAL . 7.7 m -66.53 122.89 18.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.483 1.114 . . . . 61.44 110.388 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.404 HG21 ' HB3' ' A' ' 325' ' ' ASN . 1.8 pt -97.46 -41.25 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 64.21 109.263 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.879 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.1 mt -141.59 170.9 14.85 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 71.4 109.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.746 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.46 128.54 5.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 73.51 109.304 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -89.08 113.87 4.19 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.451 1.095 . . . . 74.04 110.977 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.41 -26.79 0.37 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 0.788 . . . . 74.33 109.294 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 342' ' ' ILE . 0.1 OUTLIER 42.12 67.81 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 74.21 108.263 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -71.89 -172.93 0.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.533 1.146 . . . . 70.21 109.314 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.29 57.95 2.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 74.34 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 50.4 m -168.28 141.87 3.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 53.03 110.009 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -45.56 -31.73 1.96 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.463 1.102 . . . . 73.02 109.271 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -63.85 147.54 51.59 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 75.11 110.315 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.495 HD13 ' SG ' ' A' ' 336' ' ' CYS . 16.9 mt -150.05 141.26 16.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 73.1 109.319 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 62.6 p -140.89 107.53 5.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.484 1.115 . . . . 53.51 110.397 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.879 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.6 mp -61.25 134.51 57.06 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 63.53 109.253 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 2.0 mtpt -104.55 -76.19 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 64.51 109.284 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.724 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 159.78 143.84 0.01 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.538 1.149 . . . . 73.12 110.025 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.493 1.786 . . . . 72.25 111.006 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.325 -0.46 0 O-C-N 124.465 1.103 . . . . 71.35 109.332 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 31.8 m120 . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.299 -0.63 . . . . 64.41 109.299 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -159.48 77.26 2.96 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.548 1.155 . . . . 75.13 109.34 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 171.96 17.3 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.503 1.791 . . . . 73.21 110.954 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.84 HD22 ' HB ' ' A' ' 343' ' ' THR . 0.0 OUTLIER -168.66 -177.9 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.471 1.107 . . . . 63.34 109.331 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.837 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -97.6 101.5 13.03 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.134 . . . . 65.44 109.311 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.52 ' CD2' ' OE1' ' A' ' 341' ' ' GLU . 0.5 OUTLIER -87.15 143.96 27.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.435 1.084 . . . . 70.41 109.602 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.911 HG21 HD23 ' A' ' 265' ' ' LEU . 84.3 t -126.26 144.47 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.516 1.135 . . . . 71.45 109.314 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -119.39 121.58 39.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.505 1.128 . . . . 62.23 110.283 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.38 107.38 21.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 65.03 109.263 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 72.6 m -68.43 -57.6 5.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 63.52 110.033 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.693 ' HA ' HD23 ' A' ' 261' ' ' LEU . 6.4 t-20 55.43 69.62 0.72 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.522 1.139 . . . . 74.44 109.311 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -114.63 161.73 17.7 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.572 1.17 . . . . 75.53 110.3 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -42.21 -53.62 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 73.23 109.289 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -43.57 -64.23 0.69 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.468 1.105 . . . . 75.32 109.284 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.8 m -179.61 -174.8 0.31 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 74.14 109.981 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.717 HD13 ' HZ ' ' A' ' 263' ' ' PHE . 14.7 mt -78.14 169.29 18.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.487 1.117 . . . . 73.41 109.314 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -165.1 112.39 0.99 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 75.05 109.61 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.717 ' HZ ' HD13 ' A' ' 261' ' ' LEU . 6.4 m-85 -116.18 106.51 13.78 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.473 1.108 . . . . 75.42 110.987 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.662 HG22 ' CE2' ' A' ' 266' ' ' TYR . 16.6 mt -99.55 103.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 73.53 109.331 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.911 HD23 HG21 ' A' ' 252' ' ' VAL . 0.2 OUTLIER -105.01 126.42 52.04 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.53 1.144 . . . . 71.44 109.283 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.662 ' CE2' HG22 ' A' ' 264' ' ' ILE . 0.8 OUTLIER -113.2 119.21 36.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 71.01 111.018 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 250' ' ' LEU . 25.4 t30 -80.71 95.52 6.64 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.138 . . . . 61.42 109.313 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -88.68 -54.55 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.424 1.078 . . . . 72.31 109.294 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.5 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 1.7 t -100.48 173.83 6.38 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.429 1.08 . . . . 64.31 110.39 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 269' ' ' THR . 2.5 t-20 81.93 -171.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 72.32 109.295 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.444 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 0.0 OUTLIER -81.62 -174.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.486 1.116 . . . . 75.32 109.318 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.413 ' N ' HG12 ' A' ' 271' ' ' ILE . 21.9 mt -92.75 126.76 45.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.01 109.349 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 274' ' ' PRO . 1.4 mp -43.78 137.65 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.542 1.151 . . . . 75.2 109.309 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.97 -31.07 6.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.487 1.783 . . . . 74.41 111.0 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 102.14 154.2 25.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.48 1.112 . . . . 74.04 110.991 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 5.2 t30 74.49 32.63 0.91 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.466 0.745 . . . . 71.22 109.268 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 16.3 m -78.91 -176.66 5.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.555 1.159 . . . . 74.4 108.322 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.589 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -154.53 139.96 17.76 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 71.11 110.404 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 1.007 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.8 t80 -88.93 -177.26 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.534 1.146 . . . . 73.24 110.991 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.646 ' HG2' HG21 ' A' ' 288' ' ' VAL . 22.2 tt0 -177.35 100.52 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.517 1.135 . . . . 60.02 110.281 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.7 p90 -123.62 146.59 48.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.154 . . . . 71.43 110.988 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.599 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 92.0 p -77.99 162.25 26.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 74.32 110.033 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.522 ' HB2' HD21 ' A' ' 312' ' ' LEU . 72.3 p -148.87 -58.31 0.22 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.521 1.138 . . . . 54.0 110.046 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.428 ' C ' ' N ' ' A' ' 286' ' ' SER . 5.3 tp60 -142.62 169.08 18.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 42.52 110.31 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.402 ' O ' ' O ' ' A' ' 286' ' ' SER . 3.0 tt -42.68 -28.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.463 1.102 . . . . 72.21 109.328 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.428 ' N ' ' C ' ' A' ' 284' ' ' GLN . 1.7 m -50.65 -178.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.09 . . . . 65.32 109.954 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.61 134.36 37.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.54 110.268 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.646 HG21 ' HG2' ' A' ' 280' ' ' GLU . 14.5 p -48.48 169.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.143 . . . . 62.42 109.325 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.518 ' N ' HG22 ' A' ' 288' ' ' VAL . 10.0 t80 -116.4 -175.96 2.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 72.52 110.961 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.49 ' OG ' HG22 ' A' ' 278' ' ' THR . 3.6 t -163.49 123.58 2.19 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.135 . . . . 41.23 109.967 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.875 HD11 ' CD1' ' A' ' 308' ' ' PHE . 10.9 mt -98.77 136.05 31.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.21 109.297 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 106.98 12.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 73.04 109.291 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.716 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.2 mtp -80.74 153.25 27.92 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.536 1.148 . . . . 74.01 110.997 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.72 153.08 8.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.484 1.115 . . . . 72.23 110.999 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.97 -18.84 18.47 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.438 1.757 . . . . 74.32 111.035 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -72.49 161.48 30.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 51.21 109.601 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 36.6 mt-10 -88.15 175.47 7.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.34 110.344 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 299' ' ' GLY . 8.3 mt -98.3 -74.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.479 1.112 . . . . 73.34 109.258 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.524 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 121.0 159.76 10.85 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.119 . . . . 70.12 110.992 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.46 HG22 ' HD2' ' A' ' 301' ' ' LYS . 21.6 mt -58.61 -29.49 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.525 0.779 . . . . 73.2 109.3 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.46 ' HD2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -109.63 -34.95 6.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.115 . . . . 70.24 109.255 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -46.81 168.79 0.05 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.496 1.123 . . . . 71.53 111.007 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -133.17 -178.44 4.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 62.31 110.299 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.469 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 38.1 tptt -137.5 156.74 47.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 63.12 109.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -133.57 100.83 4.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 62.3 110.304 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 1.007 HD13 ' CG ' ' A' ' 279' ' ' PHE . 20.6 mt -97.74 30.74 2.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.49 1.119 . . . . 65.35 109.3 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -43.09 126.88 4.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.509 1.131 . . . . 74.34 107.989 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.875 ' CD1' HD11 ' A' ' 291' ' ' ILE . 53.8 t80 -127.35 172.92 10.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 74.42 110.98 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -146.3 162.08 36.22 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 74.22 110.97 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.04 -53.8 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.001 -2.499 . . . . 63.22 111.006 0.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 14.5 p -175.29 146.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.464 1.102 . . . . 73.52 110.049 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.617 ' HB2' HD11 ' A' ' 261' ' ' LEU . 2.8 mp -123.63 159.19 56.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.532 1.145 . . . . 73.15 109.299 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 145.84 31.73 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.533 1.807 . . . . 73.41 111.0 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -126.55 164.03 36.94 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 63.24 110.381 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.506 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.0 178.48 34.5 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.021 -2.491 . . . . 73.5 110.988 0.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.792 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.5 mt -104.91 61.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.543 1.152 . . . . 72.41 109.322 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.4 OUTLIER -86.52 138.08 32.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.527 1.142 . . . . 62.5 110.034 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 82.89 -1.56 1.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 73.11 109.298 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.792 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.5 m-85 -80.15 -172.87 3.67 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.105 . . . . 73.11 110.998 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.532 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -106.37 -58.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.561 1.163 . . . . 74.52 110.36 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.746 ' SD ' HD13 ' A' ' 316' ' ' LEU . 0.8 OUTLIER 29.84 61.06 0.18 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 74.43 110.984 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.532 ' HG3' HG23 ' A' ' 320' ' ' THR . 25.1 mttm -90.03 -172.46 3.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 1.114 . . . . 42.12 109.284 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 90.6 t -141.46 125.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.468 1.105 . . . . 75.02 109.273 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.677 HG12 ' N ' ' A' ' 330' ' ' THR . 7.0 m -109.38 172.4 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.51 1.131 . . . . 74.04 109.274 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.469 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 12.6 t30 -101.53 -164.29 1.09 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 74.02 109.313 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -69.1 -7.49 36.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 65.44 110.287 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.03 11.73 25.63 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.505 1.128 . . . . 73.11 109.28 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.12 67.78 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.541 1.15 . . . . 75.3 110.994 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 331' ' ' ILE . 8.9 pt-20 -96.43 119.34 34.73 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 0.748 . . . . 65.53 110.295 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.677 ' N ' HG12 ' A' ' 324' ' ' VAL . 3.8 m -52.68 98.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.454 1.096 . . . . 42.3 110.379 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.469 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 14.0 pt -77.51 -39.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.495 1.122 . . . . 73.42 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.665 ' HB3' HD23 ' A' ' 344' ' ' LEU . 11.6 mt -138.76 174.26 10.72 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.469 1.106 . . . . 52.5 109.28 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.41 HG21 ' NZ ' ' A' ' 322' ' ' LYS . 0.1 OUTLIER -156.57 118.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 75.4 109.278 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.695 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -68.7 127.41 22.7 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.495 1.122 . . . . 73.13 110.988 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.78 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -48.73 -27.18 2.74 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 0.764 . . . . 75.33 109.33 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.0 83.35 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.11 108.297 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.78 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -101.11 -173.54 2.4 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.497 1.123 . . . . 23.15 109.332 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.83 56.26 1.51 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 74.41 109.297 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 72.4 p -172.79 136.31 0.7 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.117 . . . . 74.52 110.002 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.401 ' OD1' ' CG2' ' A' ' 314' ' ' THR . 29.7 m-20 -44.92 -33.42 1.98 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 44.32 109.316 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.52 ' OE1' ' CD2' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -62.66 139.26 58.64 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.479 1.112 . . . . 70.13 110.319 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.511 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 86.6 mt -144.96 120.67 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.527 1.142 . . . . 70.51 109.293 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.84 ' HB ' HD22 ' A' ' 249' ' ' LEU . 16.8 p -109.98 82.27 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.166 . . . . 51.5 110.446 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.837 HD22 ' CD2' ' A' ' 250' ' ' LEU . 8.3 mp -39.45 147.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 1.135 . . . . 72.31 109.28 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.509 ' CE ' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -124.78 -87.35 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.481 1.113 . . . . 73.24 109.312 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 40.3 p -176.19 137.97 0.49 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 64.44 109.977 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -75.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.545 1.813 . . . . 74.43 111.0 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 348' ' ' LEU . 2.5 mm? . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 71.15 109.251 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 40.4 p-10 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.299 -0.63 . . . . 65.15 109.299 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.444 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 21.9 m-20 -139.77 154.08 70.59 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.44 109.328 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.685 ' O ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.9 0.35 8.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.458 1.767 . . . . 64.45 111.023 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.773 HD22 ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -41.89 143.77 0.5 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.545 1.153 . . . . 64.43 109.3 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -122.08 100.31 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.474 1.109 . . . . 71.3 109.29 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.773 ' NE2' HD22 ' A' ' 249' ' ' LEU . 12.3 m170 -94.86 131.43 40.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 65.54 109.555 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.856 HG22 ' HB3' ' A' ' 265' ' ' LEU . 17.2 t -112.09 163.16 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 74.01 109.31 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.406 ' N ' HG12 ' A' ' 252' ' ' VAL . 1.3 tp10 -123.31 122.45 38.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.113 . . . . 75.13 110.289 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.75 110.44 28.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.533 1.146 . . . . 71.22 109.285 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 32.6 m -85.59 -55.54 3.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 75.34 109.981 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.953 ' HA ' HD23 ' A' ' 261' ' ' LEU . 2.4 t-20 60.53 73.14 0.49 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.496 1.122 . . . . 75.13 109.307 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 260' ' ' SER . 33.6 mm-40 -82.69 145.68 29.48 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.561 1.163 . . . . 44.11 110.303 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.85 -22.33 14.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 71.42 109.302 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -82.79 -41.48 19.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.557 1.161 . . . . 60.45 109.314 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 257' ' ' GLU . 12.3 m -173.4 -175.07 1.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.518 1.136 . . . . 65.03 110.032 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.953 HD23 ' HA ' ' A' ' 256' ' ' ASN . 11.2 mt -87.02 178.93 6.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.533 1.145 . . . . 62.1 109.31 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -178.46 108.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.49 1.119 . . . . 75.33 109.631 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 68.9 m-85 -110.6 110.65 21.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 54.33 110.995 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.686 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 56.9 mt -103.26 109.34 26.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 62.31 109.287 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.856 ' HB3' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -114.47 137.75 51.46 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.144 . . . . 64.33 109.258 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 0.4 OUTLIER -120.9 127.08 51.53 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 71.33 110.967 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -84.35 93.29 8.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 63.14 109.312 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -95.38 18.54 12.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.153 . . . . 74.14 109.3 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 248' ' ' PRO . 12.5 p -77.54 -172.6 2.61 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 63.33 110.388 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.558 ' O ' HD11 ' A' ' 300' ' ' ILE . 93.6 m-20 -87.06 -59.65 2.2 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.517 1.136 . . . . 71.24 109.308 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 8.8 pt -58.86 157.67 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 73.32 109.29 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 35.8 mt -101.44 130.33 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 71.42 109.289 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 273' ' ' ILE . 6.0 mm -53.69 136.0 54.47 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 74.4 109.259 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -23.61 13.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.532 1.806 . . . . 74.11 110.986 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 86.52 170.91 47.37 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.517 1.136 . . . . 65.23 111.034 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . 0.478 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 58.1 t-20 66.8 45.09 1.97 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 0.767 . . . . 52.14 109.323 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.41 ' C ' ' OG1' ' A' ' 278' ' ' THR . 73.8 m -84.24 178.44 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.53 1.144 . . . . 73.33 108.326 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.896 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.8 m -154.74 98.86 2.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 62.24 110.339 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.514 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.2 t80 -54.31 -172.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.536 1.148 . . . . 75.24 110.996 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 322' ' ' LYS . 18.2 tt0 173.77 105.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.529 1.143 . . . . 64.14 110.279 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 0.3 OUTLIER -126.33 170.09 12.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 74.23 111.012 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.1 t -101.33 -172.82 2.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.541 1.15 . . . . 61.44 110.01 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.922 ' O ' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER 50.83 62.72 2.56 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.55 1.156 . . . . 52.11 109.976 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.413 ' OE1' ' CB ' ' A' ' 289' ' ' PHE . 6.7 tt0 -106.36 170.12 8.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 44.3 110.292 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.531 HD12 ' HD3' ' A' ' 310' ' ' PRO . 19.1 tt -43.15 -34.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 73.41 109.306 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 48.0 m -127.14 -59.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.433 1.083 . . . . 74.53 109.992 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -164.68 169.37 16.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.127 . . . . 75.21 110.342 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 281' ' ' PHE . 4.6 p -40.29 139.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 64.1 109.275 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.413 ' CB ' ' OE1' ' A' ' 284' ' ' GLN . 5.0 t80 -153.28 155.52 36.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 54.44 110.955 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.89 ' OG ' HG22 ' A' ' 278' ' ' THR . 28.4 t -109.21 136.06 49.3 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.493 1.12 . . . . 64.33 109.999 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.7 mt -103.47 133.72 46.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 63.22 109.312 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -73.38 112.47 9.48 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.12 109.261 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.804 ' HG2' HD21 ' A' ' 306' ' ' LEU . 84.8 mtp -92.9 135.49 34.09 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 74.35 111.008 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.61 147.55 0.08 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.486 1.116 . . . . 52.4 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.478 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.06 -24.13 13.02 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.508 1.794 . . . . 62.24 111.015 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -53.01 144.87 14.1 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.467 1.104 . . . . 74.33 109.579 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.02 150.28 33.88 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.444 1.09 . . . . 74.33 110.332 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 61.3 mt -80.09 -75.39 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.455 1.097 . . . . 63.3 109.25 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.01 166.29 12.77 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 124.477 1.111 . . . . 42.35 110.981 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.558 HD11 ' O ' ' A' ' 270' ' ' ASN . 18.8 mt -65.47 -31.37 53.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.521 0.777 . . . . 73.33 109.305 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -110.72 -23.26 11.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.487 1.117 . . . . 75.11 109.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -58.78 157.86 20.61 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 53.33 111.002 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -120.3 -174.94 2.89 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.467 0.745 . . . . 75.33 110.309 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' A' ' 293' ' ' MET . 6.3 tptp -147.66 154.69 40.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.127 . . . . 73.13 109.256 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.412 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 4.1 mt-10 -123.52 135.7 54.17 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 72.53 110.328 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.804 HD21 ' HG2' ' A' ' 293' ' ' MET . 17.4 mt -136.38 60.0 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.52 1.137 . . . . 64.24 109.268 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.418 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 3.3 p90 -70.86 131.1 43.26 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.533 1.146 . . . . 74.41 107.993 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.711 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.8 m-30 -118.37 172.5 7.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 74.21 110.982 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.3 OUTLIER -148.91 145.69 20.16 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 75.02 111.026 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.531 ' HD3' HD12 ' A' ' 285' ' ' ILE . 18.2 Cg_endo -74.96 -44.71 0.53 Allowed 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.043 -2.482 . . . . 74.24 110.987 0.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 24.1 p 177.63 172.49 0.58 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.516 1.135 . . . . 74.33 109.971 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 283' ' ' SER . 0.2 OUTLIER -137.62 161.82 58.22 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 72.15 109.315 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 144.57 30.31 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.494 1.786 . . . . 74.11 111.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.523 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.9 OUTLIER -128.04 159.93 64.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.465 1.103 . . . . 53.34 110.389 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.96 169.61 74.06 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 121.034 -2.486 . . . . 74.13 110.995 -0.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.597 HD22 ' CE ' ' A' ' 321' ' ' MET . 5.2 mp -80.34 63.67 4.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 73.22 109.288 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.3 p -83.63 133.57 34.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.491 1.12 . . . . 73.15 109.978 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 70.11 27.57 4.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 74.1 109.286 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.556 ' CE2' ' OG ' ' A' ' 283' ' ' SER . 7.7 m-85 -101.31 176.59 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.539 1.149 . . . . 63.31 110.966 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.533 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.9 OUTLIER -109.34 -50.5 2.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.513 1.133 . . . . 74.22 110.429 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.81 ' SD ' HD13 ' A' ' 342' ' ' ILE . 3.9 ptp 26.6 61.51 0.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 60.23 111.015 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.773 ' HZ2' ' HB ' ' A' ' 333' ' ' VAL . 22.3 mttm -78.95 -173.43 3.54 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.465 1.103 . . . . 71.53 109.299 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.514 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.4 t -151.73 125.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 71.32 109.315 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 278' ' ' THR . 26.6 m -113.9 -177.01 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 73.51 109.325 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.49 -161.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 72.01 109.301 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -74.21 -2.14 23.5 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.512 1.133 . . . . 72.32 110.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -101.77 0.55 36.04 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.21 109.28 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 66.8 8.33 47.3 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.542 1.151 . . . . 65.23 111.013 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 329' ' ' GLU . 12.4 pt-20 -95.16 123.61 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.496 0.762 . . . . 63.53 110.272 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.772 ' HA ' HG12 ' A' ' 324' ' ' VAL . 14.6 m -55.93 113.7 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 64.2 110.383 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 1.3 pt -86.67 -38.3 12.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 75.14 109.279 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.9 ' HB3' HD23 ' A' ' 344' ' ' LEU . 11.1 mt -146.21 165.95 27.67 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 75.12 109.303 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.773 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.1 m -150.29 124.34 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 70.12 109.32 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.474 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -64.0 125.99 33.36 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.533 1.146 . . . . 73.33 111.0 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -61.69 -27.61 68.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 0.754 . . . . 71.03 109.281 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.69 ' O ' ' HB2' ' A' ' 337' ' ' ALA . 0.5 OUTLIER 87.38 179.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 75.03 108.353 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 336' ' ' CYS . . . 163.89 157.89 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.459 1.099 . . . . 74.41 109.32 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.25 56.88 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.435 1.084 . . . . 71.43 109.352 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.6 m -178.93 179.68 0.67 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.47 1.107 . . . . 53.12 110.022 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.42 -10.03 59.72 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.133 . . . . 73.32 109.282 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.41 ' C ' HG13 ' A' ' 342' ' ' ILE . 1.1 mp0 -76.9 116.84 17.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 72.44 110.294 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.81 HD13 ' SD ' ' A' ' 321' ' ' MET . 93.1 mt -144.98 124.75 6.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.467 1.105 . . . . 71.14 109.299 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 344' ' ' LEU . 11.7 p -125.16 96.56 4.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.472 1.108 . . . . 75.42 110.402 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.5 mp -39.41 139.14 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.512 1.132 . . . . 75.12 109.32 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 346' ' ' SER . 1.9 ptmm? -109.93 -47.37 3.34 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 1.093 . . . . 60.3 109.279 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.4 OUTLIER 156.32 154.43 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 73.05 109.966 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.41 ' HA ' ' CG1' ' A' ' 333' ' ' VAL . 18.2 Cg_endo -74.96 -51.6 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.498 1.789 . . . . 64.23 111.007 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 72.5 109.324 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.295 -0.631 . . . . 73.31 109.295 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -127.92 97.11 30.4 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 72.43 109.275 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' A' ' 269' ' ' THR . 18.3 Cg_endo -74.99 -5.2 16.5 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.513 1.796 . . . . 74.31 110.997 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.972 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -39.75 139.38 0.63 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.148 . . . . 71.33 109.309 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.667 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -119.88 103.28 9.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 72.43 109.3 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -81.81 123.62 28.95 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.474 1.109 . . . . 61.31 109.58 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 253' ' ' GLU . 80.2 t -122.29 165.05 18.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.516 1.135 . . . . 75.31 109.324 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 252' ' ' VAL . 27.7 tp10 -123.36 133.29 54.13 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.523 1.14 . . . . 53.41 110.312 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 340' ' ' ASN . 60.5 t -109.3 108.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.495 1.122 . . . . 75.22 109.341 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 4.8 t -85.64 -61.86 1.66 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 72.3 110.012 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.876 ' HA ' HD23 ' A' ' 261' ' ' LEU . 4.4 t-20 57.01 63.37 1.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.446 1.092 . . . . 75.11 109.314 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -84.44 146.75 27.47 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 71.51 110.265 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -49.5 -25.67 2.84 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.452 1.095 . . . . 73.13 109.354 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -75.73 -48.69 20.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 72.23 109.294 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.2 p -172.62 -175.13 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 71.53 110.008 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.951 HD11 ' HB2' ' A' ' 312' ' ' LEU . 11.6 mt -85.43 -178.24 6.66 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.502 1.126 . . . . 65.22 109.314 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.41 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 5.3 t-160 -176.62 100.62 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 75.3 109.542 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.783 ' HE2' HD13 ' A' ' 261' ' ' LEU . 89.1 m-85 -117.42 94.07 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 71.44 111.03 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.584 ' CG2' ' CZ ' ' A' ' 266' ' ' TYR . 18.5 mt -86.97 128.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.493 1.121 . . . . 74.44 109.302 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 1.042 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -110.48 137.25 48.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 73.33 109.297 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.584 ' CZ ' ' CG2' ' A' ' 264' ' ' ILE . 9.5 m-85 -129.7 127.37 40.34 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.535 1.147 . . . . 70.2 111.024 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.501 ' HB2' HD13 ' A' ' 273' ' ' ILE . 22.5 t30 -82.67 102.58 11.58 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.46 1.1 . . . . 63.34 109.304 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.93 19.81 19.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.479 1.112 . . . . 74.44 109.307 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.534 ' CG2' ' HA ' ' A' ' 248' ' ' PRO . 9.2 p -104.02 -165.48 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.485 1.116 . . . . 70.22 110.385 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.13 -51.31 5.65 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 71.21 109.335 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.9 pt -53.82 161.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.127 . . . . 74.41 109.35 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 1.9 mp -117.67 111.17 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.453 1.095 . . . . 42.43 109.329 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.9 HG21 HD12 ' A' ' 298' ' ' ILE . 1.3 mp -53.82 139.78 51.13 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.13 109.258 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.451 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.2 Cg_endo -74.98 -25.21 12.13 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 54.45 111.03 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 294' ' ' GLY . . . 89.72 -36.65 3.48 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.481 1.113 . . . . 64.45 111.007 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -76.04 57.9 1.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 0.766 . . . . 64.21 109.311 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 324' ' ' VAL . 7.6 m -101.9 -175.09 2.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 75.41 108.302 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.836 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.6 m -152.92 97.34 2.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.505 1.128 . . . . 72.31 110.363 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.605 ' CD1' HG22 ' A' ' 323' ' ' VAL . 0.6 OUTLIER -56.04 171.12 0.27 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 74.03 110.982 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.46 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 69.3 tt0 -167.38 96.63 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 71.34 110.317 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.2 p90 -123.19 138.09 54.73 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.138 . . . . 74.22 110.982 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 88.5 p -99.46 -178.24 3.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 65.21 109.977 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 286' ' ' SER . 4.8 p -129.3 -167.6 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.427 1.079 . . . . 73.2 109.981 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.412 ' HG2' HG23 ' A' ' 285' ' ' ILE . 21.7 tt0 -41.42 -78.8 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 43.15 110.261 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.412 HG23 ' HG2' ' A' ' 284' ' ' GLN . 30.8 pt -130.92 11.43 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.523 1.14 . . . . 72.24 109.29 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.436 ' CB ' ' OG ' ' A' ' 283' ' ' SER . 0.6 OUTLIER -82.5 174.93 10.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 75.21 110.039 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.63 178.32 6.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.102 . . . . 54.51 110.27 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.46 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 1.6 p -113.4 161.06 12.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.474 1.108 . . . . 61.22 109.293 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.417 ' N ' ' CG2' ' A' ' 288' ' ' VAL . 2.7 t80 -145.05 156.08 43.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.538 1.149 . . . . 73.33 110.981 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.701 ' HB3' HG22 ' A' ' 278' ' ' THR . 3.3 m -117.34 130.13 56.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 74.22 110.011 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 11.9 mt -97.98 125.21 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.508 1.13 . . . . 74.33 109.241 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.12 99.58 1.5 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.554 1.159 . . . . 75.15 109.27 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.866 ' HG2' HD21 ' A' ' 306' ' ' LEU . 84.2 mtp -71.71 135.94 47.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.48 1.113 . . . . 72.0 111.003 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 275' ' ' GLY . . . -48.02 155.19 1.3 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 64.14 110.971 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -30.61 6.94 Favored 'Trans proline' 0 C--N 1.361 1.211 0 O-C-N 124.466 1.772 . . . . 64.53 110.993 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -49.49 116.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 74.33 109.585 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -62.62 151.25 38.54 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.112 . . . . 73.31 110.28 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.9 HD12 HG21 ' A' ' 273' ' ' ILE . 13.5 mt -78.28 -88.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.483 1.114 . . . . 72.41 109.317 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.792 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 89.34 -161.69 30.24 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.517 1.136 . . . . 64.31 110.989 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.501 HG23 ' HD3' ' A' ' 301' ' ' LYS . 8.3 mt -77.09 124.5 35.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.557 0.798 . . . . 74.42 109.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 300' ' ' ILE . 2.6 mptt 68.48 7.22 5.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.565 1.166 . . . . 64.55 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.895 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -91.87 53.38 2.96 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.566 1.166 . . . . 24.25 111.012 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 302' ' ' GLY . 6.3 pt20 -42.16 165.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.577 0.81 . . . . 51.34 110.321 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.483 ' HB2' HD11 ' A' ' 298' ' ' ILE . 38.8 tptt -131.67 150.55 52.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 1.117 . . . . 73.42 109.308 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 8.1 mt-10 -115.02 114.15 25.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.513 1.133 . . . . 71.1 110.289 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 1.042 HD12 HD11 ' A' ' 265' ' ' LEU . 11.1 mt -114.61 48.65 1.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.497 1.123 . . . . 61.41 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.412 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 5.2 p-90 -59.1 141.77 53.22 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 72.0 108.024 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.699 ' CD1' HD12 ' A' ' 261' ' ' LEU . 5.1 t80 -139.78 165.77 26.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 73.43 111.013 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -145.72 158.12 50.24 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.23 110.973 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -45.87 0.42 Allowed 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.001 -2.499 . . . . 63.05 111.011 -0.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.7 p -176.69 164.32 2.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.147 . . . . 64.03 110.007 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.951 ' HB2' HD11 ' A' ' 261' ' ' LEU . 4.1 mt -137.04 158.51 72.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.548 1.155 . . . . 54.43 109.308 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 148.03 34.94 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.51 1.795 . . . . 74.12 111.057 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.544 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 1.0 OUTLIER -137.3 159.62 68.86 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.466 1.104 . . . . 75.14 110.367 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.01 170.31 72.21 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.003 -2.499 . . . . 75.05 110.966 0.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.61 HD23 ' CE2' ' A' ' 319' ' ' TYR . 3.2 mt -90.85 56.65 3.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 64.21 109.296 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.2 p -73.37 116.79 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 72.22 110.042 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 317' ' ' SER . 18.6 t-20 79.71 39.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 62.01 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.61 ' CE2' HD23 ' A' ' 316' ' ' LEU . 10.2 m-85 -115.83 143.89 44.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 1.105 . . . . 63.4 111.025 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.518 ' O ' ' C ' ' A' ' 321' ' ' MET . 9.9 m -54.94 -61.54 2.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.522 1.139 . . . . 75.0 110.41 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.59 ' HE3' HD13 ' A' ' 316' ' ' LEU . 1.1 ptp 28.01 50.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.53 111.013 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.452 ' HG3' ' CG2' ' A' ' 320' ' ' THR . 85.4 mttt -82.17 -179.95 7.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.538 1.149 . . . . 64.24 109.33 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.605 HG22 ' CD1' ' A' ' 279' ' ' PHE . 19.9 t -142.05 131.0 22.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 53.21 109.288 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 278' ' ' THR . 15.8 m -113.03 173.66 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 65.4 109.3 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.638 ' OD1' HG21 ' A' ' 331' ' ' ILE . 0.3 OUTLIER -109.59 -168.98 1.4 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 65.22 109.289 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.2 -7.86 14.75 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.474 1.109 . . . . 72.04 110.322 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . 0.408 ' N ' ' OD2' ' A' ' 327' ' ' ASP . 1.9 p30 -88.79 -12.38 42.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 75.22 109.263 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 80.74 -5.94 63.5 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.512 1.132 . . . . 52.25 111.017 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -90.6 143.94 26.24 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 0.742 . . . . 70.14 110.291 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.715 ' HA ' HG12 ' A' ' 324' ' ' VAL . 27.7 m -58.86 130.99 49.61 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.463 1.102 . . . . 63.13 110.332 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.638 HG21 ' OD1' ' A' ' 325' ' ' ASN . 18.8 pt -112.7 -37.99 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 61.43 109.273 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.886 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.6 mt -139.7 168.42 19.86 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.23 109.298 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.453 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.1 m -151.81 127.51 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.518 1.136 . . . . 74.55 109.332 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -76.24 147.81 35.07 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 72.11 110.971 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -89.14 -35.96 15.97 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.512 0.772 . . . . 71.11 109.332 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.515 ' H ' HG23 ' A' ' 342' ' ' ILE . 0.3 OUTLIER 41.52 86.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.106 . . . . 72.03 108.312 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -104.28 73.95 1.15 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.446 1.091 . . . . 70.41 109.324 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 3.8 t0 41.44 53.72 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.117 . . . . 75.13 109.3 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.4 t -160.6 123.79 3.39 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 64.04 109.986 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 254' ' ' VAL . 4.7 m120 -41.2 -33.43 0.36 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.091 . . . . 70.2 109.308 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -72.68 146.38 46.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.464 1.103 . . . . 72.32 110.3 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 336' ' ' CYS . 4.3 mt -146.08 138.96 20.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 75.43 109.34 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 249' ' ' LEU . 16.6 p -132.44 84.85 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.464 1.102 . . . . 62.2 110.405 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.8 mp -39.42 130.11 1.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 65.33 109.336 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 346' ' ' SER . 22.8 mttt -97.64 -74.01 0.59 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 71.44 109.292 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 2.7 p 159.9 146.92 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.44 109.989 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 -58.32 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.497 1.788 . . . . 74.41 110.966 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.407 ' C ' HD13 ' A' ' 348' ' ' LEU . 1.5 tm? . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.484 1.115 . . . . 63.33 109.316 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 246' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.313 -0.625 . . . . 43.11 109.313 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.425 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 0.8 OUTLIER 60.31 160.23 0.11 Allowed Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.12 109.299 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.453 ' O ' ' CG2' ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.97 -3.27 13.67 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.562 1.822 . . . . 70.34 110.991 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.692 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -40.1 143.31 0.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.448 1.092 . . . . 54.11 109.29 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.799 HD22 HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -121.41 103.78 9.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 71.52 109.324 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.418 ' C ' HG23 ' A' ' 252' ' ' VAL . 8.2 m-70 -83.73 167.14 17.45 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 73.05 109.562 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 265' ' ' LEU . 21.9 t -152.45 166.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 63.31 109.32 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.457 ' N ' HG12 ' A' ' 252' ' ' VAL . 10.5 tp10 -134.26 134.88 42.44 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 54.33 110.317 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 263' ' ' PHE . 56.9 t -119.74 101.7 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.462 1.101 . . . . 74.42 109.253 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -54.37 38.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.496 1.123 . . . . 75.43 110.016 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.641 ' HB2' HG21 ' A' ' 314' ' ' THR . 5.6 t-20 60.33 77.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.549 1.155 . . . . 53.33 109.339 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.28 152.09 35.59 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.532 1.145 . . . . 52.32 110.302 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -42.27 -47.26 4.75 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.554 1.159 . . . . 72.33 109.315 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -46.49 -64.24 0.81 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.464 1.102 . . . . 63.3 109.301 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.2 m -173.42 -174.83 1.06 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 61.04 110.012 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.579 HD23 ' HA ' ' A' ' 256' ' ' ASN . 14.0 mt -86.76 150.98 23.77 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 74.31 109.29 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -137.45 108.0 6.55 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 72.52 109.628 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 82.7 m-85 -112.37 104.35 12.49 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.476 1.11 . . . . 74.55 111.039 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.782 HG22 ' CE2' ' A' ' 266' ' ' TYR . 98.6 mt -105.03 111.62 35.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 64.22 109.271 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.89 128.91 45.2 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 72.43 109.317 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.782 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -116.86 106.57 13.6 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.504 1.128 . . . . 73.21 110.999 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.526 ' HA ' HD12 ' A' ' 250' ' ' LEU . 57.9 t30 -70.75 85.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.529 1.143 . . . . 64.12 109.294 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -90.37 53.38 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 74.01 109.273 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 248' ' ' PRO . 18.7 p -125.19 166.87 15.68 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 75.52 110.384 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -75.91 -49.62 17.31 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.556 1.16 . . . . 72.0 109.303 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 26.7 pt -51.63 -179.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.15 . . . . 72.01 109.341 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.3 126.71 73.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 71.41 109.267 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 273' ' ' ILE . 5.8 mm -56.82 136.17 78.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 72.41 109.266 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.02 -24.12 13.1 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.503 1.791 . . . . 64.24 111.016 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.95 -163.63 51.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.511 1.132 . . . . 63.32 111.027 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 49.07 33.74 5.07 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 45.21 109.339 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 64.3 m -85.39 173.87 9.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.532 1.145 . . . . 44.34 108.305 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.892 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.5 m -152.32 99.33 2.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 64.33 110.361 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.567 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.9 t80 -52.08 -179.11 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.464 1.103 . . . . 72.4 111.016 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -175.97 100.24 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.43 1.081 . . . . 60.33 110.245 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.692 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 17.0 p90 -115.02 152.27 32.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.519 1.137 . . . . 72.15 111.032 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 t -87.41 179.19 6.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 64.31 110.008 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 1.022 ' O ' HD22 ' A' ' 312' ' ' LEU . 1.4 m 59.42 70.98 0.6 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.454 1.096 . . . . 62.12 110.006 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 289' ' ' PHE . 12.6 tt0 -112.75 170.11 8.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.147 . . . . 74.03 110.309 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 1.3 tp -57.89 -28.91 34.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 65.45 109.297 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 30.9 t -120.91 -63.73 1.31 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.518 1.136 . . . . 72.42 109.976 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -168.82 168.15 10.64 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.494 1.122 . . . . 75.24 110.304 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.3 p -40.45 119.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 60.35 109.318 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.448 ' CB ' ' OE1' ' A' ' 284' ' ' GLN . 3.8 t80 -129.74 162.52 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.431 1.082 . . . . 75.13 111.044 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.849 ' OG ' HG22 ' A' ' 278' ' ' THR . 17.7 t -120.83 128.67 53.07 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.099 . . . . 71.53 110.001 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 3.7 mt -93.55 130.56 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.498 1.124 . . . . 72.21 109.341 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.675 ' HA ' HG23 ' A' ' 278' ' ' THR . 2.7 mptp? -71.96 113.09 8.62 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 71.5 109.294 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.657 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.4 mtp -79.87 162.75 24.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.534 1.146 . . . . 73.34 110.993 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -67.09 155.31 52.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.512 1.133 . . . . 52.12 111.013 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -33.3 4.67 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.501 1.79 . . . . 64.11 110.991 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -46.14 144.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.531 1.144 . . . . 75.14 109.626 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -95.55 126.76 41.06 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 64.2 110.301 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 303' ' ' GLN . 14.8 mt -64.18 -77.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.572 1.17 . . . . 65.01 109.328 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 79.47 -156.7 41.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.507 1.129 . . . . 35.32 111.017 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.446 ' C ' ' N ' ' A' ' 302' ' ' GLY . 2.0 mt -69.42 156.24 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.518 0.775 . . . . 62.44 109.282 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.405 ' HD2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER 40.28 30.07 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 61.31 109.308 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 300' ' ' ILE . . . -108.38 153.32 16.85 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.485 1.116 . . . . 75.01 111.018 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.411 ' N ' HG23 ' A' ' 298' ' ' ILE . 5.6 pt20 -126.23 -179.06 4.55 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 0.755 . . . . 73.03 110.289 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 265' ' ' LEU . 40.8 tptt -152.62 149.37 28.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 71.22 109.288 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.55 130.3 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 71.04 110.317 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.842 HD12 HD11 ' A' ' 265' ' ' LEU . 13.2 mt -139.38 61.64 1.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.123 . . . . 73.44 109.299 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.586 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 7.0 p90 -75.22 113.46 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 75.51 107.949 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.0 m-30 -102.01 173.62 6.3 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.485 1.116 . . . . 72.05 111.013 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.507 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.1 p90 -158.93 159.1 29.5 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 74.32 110.946 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -74.98 -36.71 2.5 Favored 'Cis proline' 0 C--N 1.36 1.166 0 C-N-CA 121.045 -2.481 . . . . 72.42 110.963 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.4 p 167.52 150.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 74.5 109.968 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.022 HD22 ' O ' ' A' ' 283' ' ' SER . 0.0 OUTLIER -123.21 172.93 4.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.472 1.108 . . . . 73.42 109.287 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.86 34.6 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.535 1.808 . . . . 75.22 110.978 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 256' ' ' ASN . 1.1 p -133.08 159.45 72.6 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.508 1.13 . . . . 74.42 110.391 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.544 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.2 Cg_endo -75.06 171.46 68.02 Favored 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.985 -2.506 . . . . 71.32 110.958 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.721 HD23 ' CE2' ' A' ' 319' ' ' TYR . 1.4 mt -89.07 62.33 6.21 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.46 1.1 . . . . 71.43 109.266 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 5.4 p -87.62 136.52 32.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.506 1.129 . . . . 33.05 110.029 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.6 OUTLIER 76.22 6.8 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.527 1.142 . . . . 54.44 109.32 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.721 ' CE2' HD23 ' A' ' 316' ' ' LEU . 8.6 m-85 -80.34 179.04 7.89 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 74.31 110.99 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.526 ' O ' ' C ' ' A' ' 321' ' ' MET . 0.8 OUTLIER -105.72 -53.05 2.71 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.522 1.139 . . . . 74.54 110.361 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.685 ' CE ' HD13 ' A' ' 316' ' ' LEU . 5.0 mtm 27.31 57.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 73.45 111.017 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.559 ' HD3' HG21 ' A' ' 330' ' ' THR . 16.0 mttt -87.78 -168.81 2.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 53.34 109.317 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.567 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -148.91 137.65 15.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.523 1.14 . . . . 75.11 109.28 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 278' ' ' THR . 15.9 m -107.88 178.82 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 55.11 109.325 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.592 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.47 -172.43 2.03 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.495 1.122 . . . . 63.11 109.327 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.07 -3.67 14.09 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 74.13 110.345 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.02 -5.41 28.14 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.456 1.097 . . . . 73.11 109.291 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 70.3 58.94 5.67 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.474 1.109 . . . . 73.34 111.013 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -154.76 119.48 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.456 0.739 . . . . 74.4 110.276 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.851 ' N ' HG12 ' A' ' 324' ' ' VAL . 24.3 m -46.1 124.18 5.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 72.33 110.395 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.566 HG22 ' OD1' ' A' ' 325' ' ' ASN . 0.8 OUTLIER -105.53 -39.47 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 63.55 109.306 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 344' ' ' LEU . 8.5 mt -130.47 167.79 18.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 73.04 109.284 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.452 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.2 m -151.9 132.18 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 60.42 109.259 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.737 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -85.44 122.1 5.86 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.511 1.132 . . . . 62.23 110.984 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.798 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.64 -26.82 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 70.24 109.302 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 342' ' ' ILE . 1.2 m 50.42 63.2 2.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.116 . . . . 74.0 108.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.798 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -70.04 -179.56 1.96 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.489 1.118 . . . . 60.05 109.275 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -76.66 62.52 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.47 1.106 . . . . 74.42 109.297 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 14.9 m -174.09 146.29 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.539 1.15 . . . . 75.24 109.999 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 254' ' ' VAL . 79.0 m-20 -53.09 -21.19 4.42 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.435 1.084 . . . . 71.44 109.303 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.59 143.32 42.41 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 63.21 110.298 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.584 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 63.3 mt -147.55 139.52 18.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 51.43 109.31 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 11.8 p -133.58 94.73 3.35 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.43 110.427 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.799 HD22 HD22 ' A' ' 250' ' ' LEU . 5.4 mp -47.66 133.03 13.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 74.52 109.286 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.4 ptpt -117.88 -60.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.527 1.142 . . . . 74.11 109.317 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.503 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.5 m 159.29 150.85 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 54.44 109.984 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.94 -56.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.482 1.78 . . . . 61.24 111.047 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 348' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 73.45 109.336 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.315 -0.624 . . . . 70.12 109.315 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.505 ' O ' ' CB ' ' A' ' 268' ' ' LYS . 13.5 m-20 -122.63 157.99 57.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 62.14 109.305 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.727 ' O ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.96 -1.21 10.92 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.51 1.795 . . . . 63.22 111.055 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.479 ' CD1' ' HB2' ' A' ' 247' ' ' ASP . 0.1 OUTLIER -71.78 158.41 36.15 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.529 1.143 . . . . 75.31 109.326 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.576 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.21 98.24 6.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.558 1.161 . . . . 64.04 109.304 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.477 ' CE1' ' CD ' ' A' ' 341' ' ' GLU . 2.3 t-160 -96.63 130.23 43.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.472 1.107 . . . . 61.12 109.574 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 265' ' ' LEU . 3.6 t -116.06 171.16 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 71.3 109.296 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.528 ' H ' HG12 ' A' ' 252' ' ' VAL . 1.1 tp10 -134.76 121.99 21.51 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.519 1.137 . . . . 74.44 110.27 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 263' ' ' PHE . 21.8 t -103.61 111.87 34.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.115 . . . . 54.24 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -64.94 0.97 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.459 1.099 . . . . 61.11 109.962 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.906 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.3 OUTLIER 66.97 67.12 0.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 72.43 109.312 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.09 169.08 11.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.531 1.144 . . . . 75.22 110.298 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -73.52 -14.49 61.23 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.472 1.108 . . . . 71.14 109.318 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 260' ' ' SER . 1.8 p-10 -87.51 -45.37 10.54 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 75.35 109.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.473 ' N ' ' ND2' ' A' ' 259' ' ' ASN . 3.8 p -176.15 -177.31 0.88 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.123 . . . . 70.33 110.004 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 256' ' ' ASN . 16.8 mt -90.18 174.46 7.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.477 1.11 . . . . 73.2 109.255 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.404 ' NE2' ' HG2' ' A' ' 305' ' ' GLU . 4.2 t-160 -171.97 104.51 0.18 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.495 1.122 . . . . 64.44 109.59 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.608 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 87.9 m-85 -107.05 91.68 3.76 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 72.42 110.993 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.718 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 48.9 mt -88.84 109.9 20.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.21 109.336 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.715 HD21 HD12 ' A' ' 306' ' ' LEU . 0.1 OUTLIER -110.62 130.33 55.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 73.4 109.331 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.718 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 2.0 m-85 -114.99 136.74 52.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.496 1.123 . . . . 75.45 111.003 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 273' ' ' ILE . 9.2 p-10 -79.72 118.58 21.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.121 . . . . 61.42 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 247' ' ' ASP . 0.0 OUTLIER -98.36 -11.53 22.39 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.547 1.154 . . . . 54.41 109.309 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 248' ' ' PRO . 17.5 p -72.1 175.67 5.78 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 63.42 110.345 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -88.52 -43.21 11.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 65.15 109.308 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.3 pt -53.15 175.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 74.31 109.299 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 11.8 mt -119.12 134.42 62.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.445 1.091 . . . . 72.33 109.319 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.479 HG21 HD12 ' A' ' 298' ' ' ILE . 1.1 mp -57.59 139.18 81.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.474 1.109 . . . . 74.12 109.313 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.402 ' HA ' ' OE1' ' A' ' 297' ' ' GLU . 18.3 Cg_endo -74.99 -30.96 6.61 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.474 1.776 . . . . 42.34 111.005 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 276' ' ' ASN . . . 86.76 -159.67 31.9 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.518 1.136 . . . . 61.21 110.981 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 275' ' ' GLY . 56.9 t-20 40.35 32.44 0.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 72.15 109.287 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 275' ' ' GLY . 86.4 m -88.61 -176.77 5.39 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 43.31 108.298 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.944 ' O ' HG22 ' A' ' 324' ' ' VAL . 33.1 m -157.4 119.94 3.89 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 73.32 110.428 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.571 ' CD1' HD13 ' A' ' 306' ' ' LEU . 3.1 t80 -65.79 173.36 2.92 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.457 1.098 . . . . 73.2 110.962 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.59 ' HG3' HG21 ' A' ' 288' ' ' VAL . 39.6 tt0 -155.99 79.61 0.99 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 64.12 110.339 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.56 151.07 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.12 . . . . 71.41 111.0 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.1 p -120.82 -177.25 3.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 71.14 110.015 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.583 ' CB ' HD23 ' A' ' 312' ' ' LEU . 26.5 p -111.26 -50.91 2.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.52 1.137 . . . . 65.22 110.018 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.439 ' C ' ' N ' ' A' ' 286' ' ' SER . 14.1 tt0 169.58 112.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 72.15 110.303 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 284' ' ' GLN . 2.2 pt 39.69 30.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.535 1.147 . . . . 72.33 109.265 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.439 ' N ' ' C ' ' A' ' 284' ' ' GLN . 11.9 p -119.02 -173.76 2.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.519 1.137 . . . . 71.41 109.993 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.83 135.68 43.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.429 1.08 . . . . 74.42 110.293 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.59 HG21 ' HG3' ' A' ' 280' ' ' GLU . 2.4 p -85.72 151.68 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.508 1.13 . . . . 63.25 109.235 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.33 131.96 54.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.534 1.146 . . . . 71.32 110.998 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 65.4 m -101.99 116.99 33.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.531 1.144 . . . . 71.53 109.996 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 13.7 mt -98.63 125.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 72.13 109.302 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -67.61 117.77 9.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.437 1.086 . . . . 63.32 109.27 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.466 ' HB3' ' CE ' ' A' ' 304' ' ' LYS . 94.1 mtp -81.96 151.8 27.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 63.21 110.967 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.466 ' N ' ' NZ ' ' A' ' 304' ' ' LYS . . . -44.55 145.7 1.9 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.546 1.154 . . . . 41.01 110.981 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 -25.97 11.41 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.534 1.807 . . . . 73.54 111.001 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -67.42 178.78 1.45 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.03 109.626 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 273' ' ' ILE . 73.2 mt-10 -113.48 130.62 56.29 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 73.31 110.327 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 304' ' ' LYS . 3.4 mt -44.08 -62.46 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 71.32 109.314 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.459 ' O ' ' ND2' ' A' ' 267' ' ' ASN . . . 111.21 -165.15 12.11 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.505 1.128 . . . . 34.42 111.018 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.711 HG22 ' N ' ' A' ' 301' ' ' LYS . 9.7 mt -63.56 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.534 0.784 . . . . 62.12 109.343 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.711 ' N ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -89.22 14.6 10.57 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.32 109.278 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.529 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -62.25 178.47 5.06 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.521 1.138 . . . . 41.44 111.0 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.416 ' N ' HG23 ' A' ' 298' ' ' ILE . 2.5 pt20 -141.24 176.79 8.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 0.766 . . . . 75.2 110.285 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.583 ' HB2' HD11 ' A' ' 298' ' ' ILE . 31.3 tptt -139.37 145.53 39.1 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.55 109.297 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.404 ' HG2' ' NE2' ' A' ' 262' ' ' HIS . 4.1 mt-10 -116.31 128.78 55.85 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.469 1.106 . . . . 74.14 110.271 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.715 HD12 HD21 ' A' ' 265' ' ' LEU . 9.4 mt -132.14 56.9 1.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.464 1.102 . . . . 64.4 109.312 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -70.94 123.6 22.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 64.01 107.985 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.689 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 8.7 m-30 -110.14 -166.48 1.09 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.431 1.082 . . . . 72.21 111.018 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.504 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 1.2 p90 -172.09 160.51 4.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 54.15 111.006 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -75.01 -36.26 2.65 Favored 'Cis proline' 0 C--N 1.36 1.145 0 C-N-CA 121.003 -2.499 . . . . 70.42 110.998 0.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.2 p 169.63 130.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 1.113 . . . . 74.03 110.029 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.583 HD23 ' CB ' ' A' ' 283' ' ' SER . 5.6 mp -111.69 158.66 35.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 64.43 109.319 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 148.4 35.1 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.475 1.776 . . . . 61.31 110.954 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.665 HG23 ' OD1' ' A' ' 256' ' ' ASN . 0.3 OUTLIER -126.13 164.08 35.88 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 65.45 110.38 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.512 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.95 -173.87 13.07 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 120.991 -2.504 . . . . 72.22 111.028 -0.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 1.021 HD13 ' SD ' ' A' ' 321' ' ' MET . 2.4 mt -107.73 58.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.502 1.126 . . . . 54.01 109.241 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.9 OUTLIER -81.87 133.32 35.31 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 44.43 109.989 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 317' ' ' SER . 6.8 t-20 75.26 26.13 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 1.112 . . . . 73.04 109.302 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.825 ' CE2' HD23 ' A' ' 316' ' ' LEU . 16.4 m-85 -101.33 -171.56 2.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.489 1.118 . . . . 73.44 110.984 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.543 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.2 m -100.54 -64.28 1.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.149 . . . . 65.24 110.391 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 1.021 ' SD ' HD13 ' A' ' 316' ' ' LEU . 1.8 mtm 30.54 70.67 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.465 1.103 . . . . 54.5 110.975 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.543 ' HG3' HG23 ' A' ' 320' ' ' THR . 91.4 mttt -100.93 -167.1 1.38 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.451 1.094 . . . . 72.32 109.317 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 11.7 t -151.94 127.6 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 71.15 109.284 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 278' ' ' THR . 22.2 m -107.34 177.32 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.434 1.084 . . . . 74.53 109.288 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -110.88 -172.32 2.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 42.31 109.289 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -68.77 -3.87 13.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 74.4 110.305 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.51 -7.78 30.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.55 109.288 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.12 54.09 6.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.508 1.13 . . . . 75.12 110.995 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.464 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.3 OUTLIER -149.43 128.83 12.98 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 0.756 . . . . 74.04 110.271 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.823 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.2 m -57.86 117.75 4.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 71.42 110.363 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.503 HG22 ' OD1' ' A' ' 325' ' ' ASN . 2.6 pt -96.39 -37.22 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 72.43 109.275 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.841 ' HB3' HD23 ' A' ' 344' ' ' LEU . 7.0 mt -132.53 168.87 17.44 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 74.1 109.296 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.455 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.24 133.7 5.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 64.34 109.309 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.461 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -86.88 121.7 5.88 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.481 1.113 . . . . 73.13 110.998 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.948 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -44.21 -27.14 0.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 0.768 . . . . 71.31 109.28 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.422 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 54.58 63.22 2.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.572 1.17 . . . . 73.52 108.306 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.948 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -71.35 -175.0 1.14 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 75.42 109.301 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . 0.401 ' HA ' ' CB ' ' A' ' 317' ' ' SER . 0.1 OUTLIER -81.53 53.38 2.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.2 109.282 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.1 t -169.1 142.26 2.77 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.561 1.163 . . . . 63.51 109.997 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -47.04 -25.43 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.505 1.128 . . . . 75.32 109.281 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.477 ' CD ' ' CE1' ' A' ' 251' ' ' HIS . 14.0 mt-10 -69.35 140.45 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 72.13 110.295 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.598 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 67.0 mt -147.36 135.05 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.126 . . . . 65.23 109.327 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.4 p -127.63 87.21 2.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 45.32 110.439 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.841 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -39.97 134.71 1.44 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.549 1.156 . . . . 71.41 109.287 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.505 ' O ' ' CB ' ' A' ' 346' ' ' SER . 3.5 mtpt -106.2 -74.86 0.64 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.476 1.11 . . . . 75.35 109.305 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.619 ' HA ' HD23 ' A' ' 332' ' ' LEU . 1.5 m 159.32 136.27 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.455 1.097 . . . . 73.25 109.995 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 346' ' ' SER . 18.3 Cg_endo -74.97 -70.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.525 1.803 . . . . 74.21 111.058 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.435 ' C ' HD12 ' A' ' 348' ' ' LEU . 1.8 tp . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 70.43 109.307 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.265 -0.642 . . . . 74.4 109.265 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -117.12 86.54 20.78 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.123 . . . . 74.12 109.284 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.459 ' CB ' ' HA ' ' A' ' 269' ' ' THR . 18.2 Cg_endo -75.04 165.83 30.42 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.51 1.795 . . . . 75.44 110.994 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.409 ' HG ' ' C ' ' A' ' 248' ' ' PRO . 0.8 OUTLIER 179.84 155.44 0.58 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.485 1.116 . . . . 43.24 109.307 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.605 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -112.87 99.0 7.55 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 74.13 109.328 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.833 ' CD2' HG22 ' A' ' 343' ' ' THR . 2.4 m80 -93.08 131.38 38.16 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.514 1.134 . . . . 73.13 109.582 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 253' ' ' GLU . 95.0 t -119.8 167.14 13.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.447 1.092 . . . . 74.12 109.321 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.527 ' N ' HG12 ' A' ' 252' ' ' VAL . 9.0 tt0 -130.97 120.16 23.11 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 70.13 110.259 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 340' ' ' ASN . 39.6 t -90.81 119.89 38.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 73.24 109.285 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.4 t -92.51 -63.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.477 1.11 . . . . 64.32 109.993 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.88 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.3 t-20 56.77 63.89 1.82 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.14 . . . . 65.03 109.272 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -78.94 163.64 25.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 72.44 110.278 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.4 -13.39 61.45 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 63.31 109.258 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -93.89 -39.11 10.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 1.126 . . . . 73.14 109.273 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 3.4 m -174.98 -174.51 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 73.01 110.013 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.88 HD23 ' HA ' ' A' ' 256' ' ' ASN . 9.8 mt -89.29 179.49 6.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.533 1.146 . . . . 73.05 109.323 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 1.7 t-160 -178.26 107.38 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 72.34 109.597 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.598 ' CE1' HD22 ' A' ' 261' ' ' LEU . 91.2 m-85 -121.88 101.17 7.4 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 74.24 111.013 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 304' ' ' LYS . 23.9 mt -90.04 132.73 33.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 63.2 109.297 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -113.64 149.01 35.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 72.42 109.282 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.9 OUTLIER -128.04 115.66 18.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.539 1.15 . . . . 72.42 111.016 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.534 ' HB2' HD13 ' A' ' 273' ' ' ILE . 8.8 t-20 -73.97 78.82 1.67 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 1.088 . . . . 73.12 109.234 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -101.8 13.43 34.88 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.511 1.132 . . . . 65.55 109.28 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 248' ' ' PRO . 14.7 p -76.36 -166.15 0.59 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.5 1.125 . . . . 54.13 110.398 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -82.99 -65.4 1.01 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 70.41 109.268 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 272' ' ' ILE . 0.0 OUTLIER -68.3 -178.72 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 75.01 109.343 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 271' ' ' ILE . 2.5 mp -122.32 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 53.24 109.263 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -40.7 139.47 1.15 Allowed Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.493 1.121 . . . . 71.14 109.308 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.417 ' HG2' ' ND2' ' A' ' 325' ' ' ASN . 18.2 Cg_endo -75.02 -33.17 4.76 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.513 1.796 . . . . 64.13 110.999 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 103.82 153.05 23.2 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.489 1.118 . . . . 52.34 111.018 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . 0.416 ' N ' ' HA ' ' A' ' 295' ' ' PRO . 57.8 t30 71.86 26.85 2.9 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 0.768 . . . . 74.52 109.314 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.405 ' C ' ' OG1' ' A' ' 278' ' ' THR . 21.5 m -69.78 -179.17 1.71 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.553 1.158 . . . . 74.33 108.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 324' ' ' VAL . 4.4 m -155.1 138.46 15.81 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.438 1.086 . . . . 71.42 110.427 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.52 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.3 t80 -91.1 -173.58 3.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.486 1.116 . . . . 70.34 111.032 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 178.03 102.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.124 . . . . 74.21 110.277 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.665 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 1.2 p90 -128.44 128.95 45.4 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 1.126 . . . . 75.1 110.979 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.478 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 0.8 OUTLIER -107.73 154.22 21.81 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.533 1.145 . . . . 64.41 110.014 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.554 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 10.5 p -125.84 4.14 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.536 1.147 . . . . 50.45 110.04 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -177.9 171.33 1.8 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.474 1.109 . . . . 65.34 110.267 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.7 tt -66.38 -16.67 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 71.03 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 48.9 m -41.79 -77.2 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 70.34 109.989 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -168.87 -177.2 2.92 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 73.4 110.273 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.44 166.25 29.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.553 1.158 . . . . 64.04 109.317 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -135.99 138.55 42.37 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 73.12 110.992 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 96.8 p -110.59 125.85 53.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.539 1.149 . . . . 61.12 109.983 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 11.4 mt -97.73 133.4 39.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.475 1.109 . . . . 61.45 109.295 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.39 102.19 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 61.52 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.775 ' HG2' HD21 ' A' ' 306' ' ' LEU . 73.9 mtp -73.28 152.13 41.09 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 70.34 111.002 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -38.69 141.78 0.44 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.46 1.1 . . . . 65.01 110.959 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.416 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.3 Cg_endo -75.06 -23.81 13.33 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.52 1.8 . . . . 72.14 110.952 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -73.43 175.94 6.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 73.14 109.624 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -94.85 155.15 16.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 71.55 110.291 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.523 HG22 ' HB3' ' A' ' 267' ' ' ASN . 66.3 mt -77.19 -83.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.42 109.322 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 126.66 141.01 5.36 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.51 1.131 . . . . 52.41 110.996 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.764 HG22 ' HD3' ' A' ' 301' ' ' LYS . 58.6 mt -40.57 -33.15 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 0.751 . . . . 74.4 109.292 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.764 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -111.15 -29.47 7.85 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 61.03 109.332 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -48.05 136.35 15.43 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.498 1.124 . . . . 72.2 111.002 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.413 ' NE2' HG21 ' A' ' 264' ' ' ILE . 9.6 mt-30 -89.65 -172.48 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.487 0.757 . . . . 73.2 110.297 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.698 ' O ' HG23 ' A' ' 264' ' ' ILE . 32.8 tptt -160.49 145.12 14.33 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 64.32 109.33 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -124.54 144.46 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.473 1.108 . . . . 73.14 110.296 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 265' ' ' LEU . 11.8 mt -144.13 61.18 1.36 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 70.22 109.299 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -68.69 132.29 46.61 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.53 107.989 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.681 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 10.1 m-30 -118.4 174.49 6.21 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 75.42 110.988 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -155.74 155.03 29.03 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.559 1.162 . . . . 64.33 111.001 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -37.14 2.35 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.03 -2.487 . . . . 74.42 111.003 -0.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.4 p 172.61 149.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 64.55 110.003 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.729 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.7 mp -128.78 157.97 73.74 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.457 1.098 . . . . 73.31 109.285 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.05 148.5 35.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.465 1.771 . . . . 75.51 110.979 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.642 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -134.51 161.96 60.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.518 1.136 . . . . 71.21 110.395 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.0 Cg_endo -75.07 173.71 56.52 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.983 -2.507 . . . . 75.24 110.961 0.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.56 HD13 ' HE3' ' A' ' 321' ' ' MET . 1.4 mt -95.07 64.02 2.73 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.528 1.143 . . . . 75.34 109.282 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 4.7 p -77.37 121.6 23.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.453 1.096 . . . . 73.22 110.027 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.1 OUTLIER 78.92 31.44 0.31 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 71.54 109.326 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 283' ' ' SER . 4.2 m-85 -112.14 141.14 46.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 63.45 110.997 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.546 HG23 ' HG3' ' A' ' 322' ' ' LYS . 1.3 m -51.89 -62.79 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 63.43 110.426 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.56 ' HE3' HD13 ' A' ' 316' ' ' LEU . 0.9 OUTLIER 26.87 60.78 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 1.144 . . . . 45.44 111.012 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 320' ' ' THR . 49.0 mttm -97.44 -174.76 3.01 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.116 . . . . 73.41 109.302 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.52 HG22 ' CD1' ' A' ' 279' ' ' PHE . 49.6 t -136.72 136.31 48.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.496 1.122 . . . . 62.31 109.291 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.622 HG12 ' N ' ' A' ' 330' ' ' THR . 4.4 m -116.66 -179.57 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 74.33 109.307 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.829 ' OD1' HG21 ' A' ' 331' ' ' ILE . 0.8 OUTLIER -105.03 -171.23 1.88 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 73.21 109.282 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.47 -9.27 24.31 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.553 1.158 . . . . 71.44 110.312 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -99.08 -7.25 27.01 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 75.24 109.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 82.36 14.3 76.74 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.5 1.125 . . . . 70.01 111.033 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.428 ' C ' HG12 ' A' ' 324' ' ' VAL . 3.4 pt-20 -92.94 132.78 36.75 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 0.744 . . . . 63.54 110.248 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.622 ' N ' HG12 ' A' ' 324' ' ' VAL . 16.6 m -61.39 130.87 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 64.13 110.417 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.829 HG21 ' OD1' ' A' ' 325' ' ' ASN . 19.8 pt -115.72 -39.24 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.49 1.119 . . . . 73.23 109.32 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.725 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.9 mt -138.79 166.26 24.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.488 1.118 . . . . 65.32 109.272 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.512 ' HB ' ' HZ2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -147.2 123.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 74.14 109.303 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.47 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -70.27 137.43 27.86 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.525 1.141 . . . . 44.42 111.042 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.503 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -74.11 -36.82 64.25 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.53 0.782 . . . . 71.2 109.244 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 335' ' ' LYS . 0.1 OUTLIER 40.9 87.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.555 1.16 . . . . 54.33 108.275 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.88 72.58 0.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 61.1 109.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.15 55.08 4.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.41 109.311 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 73.9 m -163.49 131.84 3.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 75.44 109.997 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.814 ' O ' HG23 ' A' ' 254' ' ' VAL . 8.5 m120 -46.9 -38.11 9.95 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 74.02 109.252 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.27 146.61 54.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 73.14 110.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.504 HD13 ' SD ' ' A' ' 321' ' ' MET . 9.3 mt -146.26 121.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 63.13 109.301 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.833 HG22 ' CD2' ' A' ' 251' ' ' HIS . 14.5 p -115.33 79.17 1.25 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 74.33 110.382 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.725 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.9 mp -38.82 149.87 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.1 . . . . 53.35 109.258 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -126.21 -55.01 1.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.14 109.343 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.625 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.1 p 157.41 154.81 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 62.4 110.001 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.421 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.96 -45.92 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.502 1.79 . . . . 74.23 111.018 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 347' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.487 1.117 . . . . 62.51 109.305 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.255 -0.646 . . . . 63.14 109.255 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -133.49 146.2 59.6 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.482 1.114 . . . . 64.4 109.3 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.492 ' C ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.95 0.45 8.87 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.488 1.783 . . . . 73.01 111.034 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.883 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -45.98 130.04 9.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 74.3 109.275 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -121.36 105.56 10.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 73.22 109.318 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.464 ' N ' HD12 ' A' ' 250' ' ' LEU . 55.7 t-80 -73.17 124.19 25.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.01 109.628 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 1.142 HG13 HD23 ' A' ' 265' ' ' LEU . 56.6 t -118.49 168.69 10.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.553 1.158 . . . . 72.13 109.281 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.543 ' N ' HG12 ' A' ' 252' ' ' VAL . 45.7 tp10 -129.8 146.88 51.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.486 1.116 . . . . 75.45 110.27 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.682 HG13 ' CE1' ' A' ' 263' ' ' PHE . 43.7 t -124.76 103.29 12.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 52.53 109.308 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.2 m -76.15 -70.04 0.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 73.42 109.949 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.967 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.2 t-20 60.52 66.56 0.92 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.529 1.143 . . . . 45.55 109.324 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 260' ' ' SER . 4.3 pt-20 -166.21 -174.39 2.91 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.498 1.124 . . . . 71.21 110.298 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 18.1 t0 67.05 15.14 10.06 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 71.24 109.327 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 9.3 t-20 82.24 19.66 0.31 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 60.41 109.284 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 2.7 p -164.22 -175.39 3.94 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 62.14 109.999 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.6 mt -100.55 174.23 6.18 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 1.134 . . . . 63.42 109.286 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -173.2 117.72 0.3 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 1.107 . . . . 72.0 109.583 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.682 ' CE1' HG13 ' A' ' 254' ' ' VAL . 80.9 m-85 -129.18 117.84 21.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 52.53 110.993 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.752 HG22 ' CE2' ' A' ' 266' ' ' TYR . 86.1 mt -102.5 112.48 35.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 64.11 109.329 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 1.142 HD23 HG13 ' A' ' 252' ' ' VAL . 0.4 OUTLIER -98.06 123.8 42.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 72.14 109.306 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.752 ' CE2' HG22 ' A' ' 264' ' ' ILE . 1.3 m-85 -112.58 140.25 47.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 73.43 111.019 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.54 ' OD1' HD13 ' A' ' 271' ' ' ILE . 62.8 t-20 -91.16 88.66 7.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.12 . . . . 55.01 109.319 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -3.45 21.84 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 73.0 109.298 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 270' ' ' ASN . 0.9 OUTLIER -56.66 -17.3 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 73.11 110.389 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 269' ' ' THR . 3.7 m120 83.75 43.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.44 109.327 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.54 HD13 ' OD1' ' A' ' 267' ' ' ASN . 0.1 OUTLIER -152.03 177.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 71.14 109.303 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.442 ' N ' HG12 ' A' ' 271' ' ' ILE . 71.2 mt -106.62 130.64 58.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 63.11 109.309 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.653 HG13 HD12 ' A' ' 298' ' ' ILE . 3.4 mm -71.04 138.12 84.86 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.119 . . . . 51.43 109.297 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.1 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.549 1.815 . . . . 71.41 110.982 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 76.47 179.38 47.08 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.504 1.127 . . . . 71.41 111.03 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 326' ' ' GLN . 50.8 t-20 62.79 31.42 16.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 0.763 . . . . 74.15 109.322 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.403 ' C ' ' OG1' ' A' ' 278' ' ' THR . 68.6 m -90.58 178.71 6.02 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.35 108.293 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.7 m -153.8 127.87 9.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 64.13 110.413 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.469 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.8 t80 -80.47 164.11 23.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 74.22 110.991 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.417 ' CG ' HG21 ' A' ' 288' ' ' VAL . 28.3 tt0 -151.52 88.51 1.43 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.511 1.132 . . . . 74.2 110.286 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.786 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 15.5 p90 -120.6 128.67 53.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 73.11 111.028 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.592 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 23.8 t -113.99 178.33 4.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.4 109.983 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.935 ' HB2' HD23 ' A' ' 312' ' ' LEU . 3.4 t -115.99 -36.05 4.24 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.507 1.13 . . . . 50.21 109.973 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -136.5 173.92 11.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 74.15 110.329 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.416 HG23 ' H ' ' A' ' 285' ' ' ILE . 0.2 OUTLIER -50.16 -23.53 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.537 1.148 . . . . 73.23 109.319 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 68.1 m -52.56 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.31 109.953 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.84 -174.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.453 1.095 . . . . 74.01 110.276 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.544 HG22 ' N ' ' A' ' 289' ' ' PHE . 8.2 p -136.63 169.08 20.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 71.53 109.295 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.544 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.5 t80 -116.4 139.42 50.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.537 1.148 . . . . 64.52 111.015 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 90.8 p -119.7 122.06 40.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 52.04 110.048 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 21.6 mt -103.44 129.25 55.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 72.52 109.335 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -71.24 115.99 11.03 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 73.44 109.298 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 81.6 mtp -78.27 164.31 25.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 73.22 111.01 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -66.53 147.73 50.05 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.519 1.137 . . . . 72.14 111.018 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -30.24 7.36 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.506 1.793 . . . . 73.32 110.966 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.93 138.3 58.41 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 74.4 109.617 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 18.7 pm0 -73.44 141.19 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 72.2 110.307 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.653 HD12 HG13 ' A' ' 273' ' ' ILE . 27.0 mt -67.03 -81.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 71.41 109.26 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 300' ' ' ILE . . . 109.59 156.63 16.71 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.508 1.13 . . . . 52.24 111.006 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.56 HG22 ' HD2' ' A' ' 301' ' ' LYS . 54.2 mt -39.13 -72.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.522 0.778 . . . . 74.12 109.352 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.56 ' HD2' HG22 ' A' ' 300' ' ' ILE . 13.5 mptt -68.38 -28.08 66.79 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.511 1.132 . . . . 41.23 109.298 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -50.13 158.44 1.65 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.498 1.124 . . . . 63.44 110.963 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.414 ' N ' HG23 ' A' ' 298' ' ' ILE . 8.4 pt20 -129.23 -174.24 3.22 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.495 0.762 . . . . 74.25 110.322 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 264' ' ' ILE . 24.6 tptt -156.92 156.92 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 53.22 109.321 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -134.76 147.14 49.95 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 62.03 110.314 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.997 HD12 HD11 ' A' ' 265' ' ' LEU . 16.5 mt -144.82 64.61 1.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.474 1.109 . . . . 64.22 109.294 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 14.4 p90 -73.17 134.63 44.46 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.977 -1.119 . . . . 74.23 107.977 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.786 ' CD2' ' CE2' ' A' ' 281' ' ' PHE . 7.3 m-85 -121.69 167.07 13.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.49 1.119 . . . . 73.13 111.024 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -142.71 143.4 25.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 74.21 110.997 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.53 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.0 -54.0 0.15 OUTLIER 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 121.027 -2.489 . . . . 52.5 110.969 0.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.99 109.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 50.33 110.023 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 283' ' ' SER . 3.9 mp -70.69 158.09 88.7 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 62.54 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 147.06 33.4 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.476 1.777 . . . . 71.3 110.995 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.682 HG22 HD12 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -118.02 163.76 23.13 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 65.24 110.427 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -74.97 -173.19 11.86 Favored 'Cis proline' 0 C--N 1.36 1.163 0 C-N-CA 121.021 -2.491 . . . . 63.24 111.016 -0.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.71 HD23 ' CD2' ' A' ' 319' ' ' TYR . 4.6 mp -102.71 11.31 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.553 1.158 . . . . 75.24 109.311 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 0.7 OUTLIER -46.27 119.26 2.25 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.128 . . . . 44.23 110.005 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 317' ' ' SER . 8.4 t-20 87.15 42.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 63.1 109.303 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.71 ' CD2' HD23 ' A' ' 316' ' ' LEU . 3.7 m-85 -120.85 -171.16 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.123 . . . . 74.11 111.014 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 322' ' ' LYS . 52.3 m -105.04 -55.85 2.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.508 1.13 . . . . 35.32 110.365 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.85 ' SD ' HD13 ' A' ' 342' ' ' ILE . 3.8 ptp 23.81 57.84 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 63.02 110.977 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.569 ' HG3' HG22 ' A' ' 320' ' ' THR . 84.1 mttt -91.89 176.97 6.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.472 1.108 . . . . 62.3 109.339 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.437 HG22 ' HD1' ' A' ' 279' ' ' PHE . 17.3 t -133.63 129.52 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 75.4 109.306 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 278' ' ' THR . 6.5 m -109.1 -172.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.438 1.086 . . . . 61.13 109.307 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.638 ' HB3' HG21 ' A' ' 331' ' ' ILE . 39.8 p30 -121.38 -170.27 2.0 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 72.2 109.301 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.422 ' HB2' ' ND2' ' A' ' 276' ' ' ASN . 2.0 pt20 -63.2 -10.95 17.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.467 1.104 . . . . 71.31 110.258 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -94.56 -13.96 25.51 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.466 1.104 . . . . 75.55 109.284 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 89.24 -8.25 80.27 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.57 1.169 . . . . 72.55 111.028 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -77.25 134.79 38.48 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.514 0.773 . . . . 74.2 110.262 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.604 ' N ' HG12 ' A' ' 324' ' ' VAL . 10.3 m -61.87 115.1 3.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.529 1.143 . . . . 64.51 110.439 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 325' ' ' ASN . 8.1 pt -88.97 -37.82 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.534 1.147 . . . . 72.35 109.304 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.905 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.4 mt -141.64 169.6 17.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.554 1.159 . . . . 71.43 109.283 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.461 HG12 ' CG2' ' A' ' 330' ' ' THR . 1.0 OUTLIER -148.47 136.13 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 74.31 109.296 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -92.51 118.8 5.66 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.466 1.104 . . . . 62.52 111.026 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.826 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -50.04 -26.86 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 0.759 . . . . 72.13 109.307 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.467 ' HG ' ' HB2' ' A' ' 319' ' ' TYR . 5.6 t 46.05 77.03 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 53.3 108.333 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.826 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -81.51 -172.2 3.71 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 53.14 109.321 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.56 58.01 3.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 74.32 109.271 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.85 162.7 9.52 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 44.44 109.96 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -66.94 -38.49 86.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.5 1.125 . . . . 72.11 109.319 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.421 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -61.77 133.06 55.06 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.482 1.114 . . . . 73.14 110.305 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.85 HD13 ' SD ' ' A' ' 321' ' ' MET . 86.0 mt -143.77 131.33 17.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 75.3 109.289 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.453 ' HB ' HD23 ' A' ' 249' ' ' LEU . 49.3 p -129.56 94.91 3.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.419 1.074 . . . . 74.41 110.404 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 332' ' ' LEU . 10.0 mp -39.72 152.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 52.42 109.276 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 346' ' ' SER . 5.7 ptpt -125.67 -60.79 1.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 64.12 109.311 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.504 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.2 p 159.38 151.35 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.499 1.125 . . . . 55.23 109.978 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -79.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.514 1.797 . . . . 71.24 110.993 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.714 HD22 ' C ' ' A' ' 348' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.512 1.133 . . . . 75.12 109.312 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.272 -0.64 . . . . 63.34 109.272 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.52 76.74 35.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 71.54 109.264 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 168.42 24.88 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.489 1.784 . . . . 74.41 111.02 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 249' ' ' LEU . 0.3 OUTLIER -175.45 178.01 1.71 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.426 1.079 . . . . 44.3 109.291 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.803 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.7 OUTLIER -105.58 101.12 10.66 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.121 . . . . 74.42 109.319 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.729 ' CD2' HG22 ' A' ' 343' ' ' THR . 8.1 m80 -82.07 168.1 18.12 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 74.21 109.632 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.681 ' CG2' HD23 ' A' ' 265' ' ' LEU . 22.4 t -155.05 150.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.476 1.11 . . . . 73.15 109.328 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -124.57 151.05 45.25 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.466 1.104 . . . . 73.52 110.313 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 94.2 t -122.78 106.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.482 1.114 . . . . 60.42 109.327 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.8 t -73.55 -62.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 64.14 109.963 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.937 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.1 t-20 60.89 63.41 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 71.45 109.297 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -95.62 158.98 15.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 1.124 . . . . 72.25 110.325 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -48.25 -49.03 34.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.51 1.131 . . . . 71.31 109.29 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -51.47 -53.41 37.55 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.484 1.115 . . . . 64.11 109.314 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.8 p 178.75 -174.69 0.18 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.511 1.132 . . . . 34.14 109.993 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 1.032 ' CD1' HD12 ' A' ' 312' ' ' LEU . 34.8 mt -77.65 178.76 7.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 62.32 109.308 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -171.22 108.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.01 109.577 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.814 ' CE1' ' CD2' ' A' ' 308' ' ' PHE . 79.3 m-85 -115.79 93.13 4.13 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 75.1 111.036 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.835 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 84.6 mt -87.31 103.39 13.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 74.42 109.273 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.681 HD23 ' CG2' ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.18 132.82 44.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 72.43 109.288 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.835 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -118.27 125.98 51.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 74.32 110.988 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.483 ' HA ' HD12 ' A' ' 250' ' ' LEU . 32.9 t-20 -64.0 79.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 72.33 109.266 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 266' ' ' TYR . 1.1 mmpt? -90.91 40.55 1.03 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.519 1.137 . . . . 72.52 109.259 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.6 p -119.65 177.78 4.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.23 110.402 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -85.56 -12.49 51.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 72.11 109.283 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 15.2 pt -101.46 160.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 73.42 109.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 273' ' ' ILE . 3.8 mp -120.58 121.58 65.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 53.22 109.278 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.412 HD12 ' ND2' ' A' ' 267' ' ' ASN . 1.0 OUTLIER -40.01 142.4 0.7 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 53.35 109.313 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -74.97 -44.41 0.34 Allowed 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.513 1.797 . . . . 44.43 111.023 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 123.19 149.33 7.8 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.523 1.139 . . . . 52.43 110.977 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.9 t30 67.35 73.86 0.32 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 0.743 . . . . 72.21 109.308 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 293' ' ' MET . 0.8 OUTLIER -119.91 -179.15 3.82 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.504 1.127 . . . . 54.24 108.286 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 324' ' ' VAL . 22.3 m -153.51 137.52 16.36 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.535 1.147 . . . . 61.53 110.393 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.904 ' CD1' HG22 ' A' ' 323' ' ' VAL . 2.6 t80 -86.04 -167.16 1.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 73.14 110.993 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 176.5 104.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.458 1.099 . . . . 72.53 110.287 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.589 ' CZ ' ' CG ' ' A' ' 308' ' ' PHE . 3.0 p90 -133.56 144.0 49.05 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.51 1.131 . . . . 72.34 111.021 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 37.3 p -104.43 143.27 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.105 . . . . 74.12 110.011 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.699 ' OG ' HD22 ' A' ' 312' ' ' LEU . 0.7 OUTLIER -104.05 -42.68 5.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.461 1.101 . . . . 70.44 109.988 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.427 ' C ' ' N ' ' A' ' 286' ' ' SER . 6.2 tt0 -143.56 173.67 11.45 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.452 1.095 . . . . 75.35 110.31 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 13.1 pt -40.89 -29.67 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 71.05 109.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.427 ' N ' ' C ' ' A' ' 284' ' ' GLN . 71.7 p -47.89 175.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.3 110.036 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -64.59 -175.85 0.21 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 73.54 110.268 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 289' ' ' PHE . 3.3 p -121.43 166.07 16.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 75.35 109.337 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.516 ' N ' HG22 ' A' ' 288' ' ' VAL . 5.7 t80 -134.83 149.14 50.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.438 1.086 . . . . 71.32 110.949 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.459 ' HB3' HG22 ' A' ' 278' ' ' THR . 11.0 m -109.31 127.14 54.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.11 110.0 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 278' ' ' THR . 8.2 mt -97.06 125.63 50.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 73.44 109.289 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 292' ' ' LYS . 0.0 OUTLIER -70.26 116.57 10.77 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.452 1.095 . . . . 63.23 109.3 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.708 ' HG2' HD21 ' A' ' 306' ' ' LEU . 86.2 mtp -84.74 170.0 13.68 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.571 1.169 . . . . 74.33 111.018 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.595 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -64.01 143.02 47.06 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.484 1.115 . . . . 60.34 111.023 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -27.93 9.55 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.514 1.797 . . . . 72.51 111.013 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -71.34 155.76 40.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 74.24 109.607 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.38 169.39 17.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.53 1.143 . . . . 71.13 110.284 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 302' ' ' GLY . 79.0 mt -99.22 -74.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.53 1.144 . . . . 63.22 109.308 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.408 ' C ' ' N ' ' A' ' 301' ' ' LYS . . . 122.15 135.95 4.82 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.545 1.153 . . . . 53.21 110.986 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.411 HG22 ' CE ' ' A' ' 301' ' ' LYS . 4.0 mt -41.52 -28.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 0.781 . . . . 63.52 109.299 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.411 ' CE ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -108.08 -31.19 8.04 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 63.11 109.303 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.498 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -57.76 146.6 38.19 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.497 1.123 . . . . 64.51 110.998 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -173.91 2.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.427 0.722 . . . . 43.24 110.277 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.595 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 28.8 tptt -159.99 144.6 14.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 75.25 109.278 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -107.69 155.03 20.63 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 72.2 110.333 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.708 HD21 ' HG2' ' A' ' 293' ' ' MET . 9.7 mt -149.06 60.34 1.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 52.2 109.268 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.37 133.08 55.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 74.44 107.957 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.814 ' CD2' ' CE1' ' A' ' 263' ' ' PHE . 17.9 m-30 -119.38 39.52 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.494 1.121 . . . . 73.01 110.96 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.517 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -36.44 148.03 0.18 Allowed Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 74.24 111.007 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.03 -46.45 0.37 Allowed 'Cis proline' 0 C--N 1.36 1.174 0 C-N-CA 120.959 -2.517 . . . . 74.23 111.002 0.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 34.2 p 176.27 162.11 0.36 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.125 . . . . 71.55 109.984 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -132.87 164.78 41.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.401 1.063 . . . . 73.21 109.275 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 145.24 31.28 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.52 1.8 . . . . 54.41 111.017 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 315' ' ' PRO . 0.6 OUTLIER -127.21 163.09 44.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 74.33 110.353 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.03 174.91 50.27 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 120.963 -2.515 . . . . 62.34 111.006 0.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.676 HD13 ' CE ' ' A' ' 321' ' ' MET . 8.2 mt -89.63 12.55 16.49 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 74.44 109.278 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.582 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.1 t -46.56 118.52 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 72.12 110.023 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 317' ' ' SER . 2.0 t-20 88.58 41.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.129 . . . . 71.14 109.327 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.638 ' CE2' HD23 ' A' ' 316' ' ' LEU . 4.9 m-85 -122.86 -174.28 2.89 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 72.53 110.982 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.542 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.1 m -103.76 -56.71 2.16 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.464 1.103 . . . . 71.11 110.45 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.76 ' SD ' HD13 ' A' ' 342' ' ' ILE . 2.5 ptp 25.29 67.45 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.53 1.144 . . . . 75.41 110.993 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.653 ' HG2' HG23 ' A' ' 333' ' ' VAL . 38.9 mttt -104.35 -176.77 3.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.502 1.126 . . . . 62.45 109.26 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.904 HG22 ' CD1' ' A' ' 279' ' ' PHE . 65.4 t -136.56 158.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.111 . . . . 43.03 109.314 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 278' ' ' THR . 16.0 m -137.35 171.85 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 75.14 109.283 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -104.24 -162.87 0.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.507 1.129 . . . . 70.12 109.293 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -72.27 -4.84 32.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.528 1.143 . . . . 74.41 110.337 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -102.44 0.56 34.01 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.483 1.115 . . . . 72.02 109.278 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.47 1.87 58.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.496 1.123 . . . . 72.15 111.011 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -83.54 141.17 31.8 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 0.753 . . . . 73.42 110.307 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.673 HG22 ' HG3' ' A' ' 347' ' ' PRO . 43.1 m -65.74 124.17 21.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 73.34 110.397 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 24.7 pt -102.5 -38.35 5.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 73.54 109.256 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.616 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.5 mt -144.33 171.71 13.95 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 71.51 109.272 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.653 HG23 ' HG2' ' A' ' 322' ' ' LYS . 0.2 OUTLIER -161.29 125.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.14 109.349 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.749 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -77.22 119.2 5.29 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.525 1.141 . . . . 42.25 110.982 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -26.02 0.73 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.537 0.787 . . . . 62.22 109.28 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.412 ' HG ' ' C ' ' A' ' 316' ' ' LEU . 5.7 t 46.03 85.41 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.168 . . . . 72.44 108.3 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -95.67 -171.08 2.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.456 1.098 . . . . 64.54 109.262 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 338' ' ' ASP . 0.0 OUTLIER -81.04 56.16 2.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 75.13 109.288 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 341' ' ' GLU . 15.2 m -168.27 136.92 2.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 54.21 110.0 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -46.11 -26.58 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.513 1.133 . . . . 65.2 109.301 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 339' ' ' SER . 3.4 mt-10 -69.75 141.31 53.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.467 1.104 . . . . 63.4 110.279 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.76 HD13 ' SD ' ' A' ' 321' ' ' MET . 66.0 mt -147.24 139.34 18.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.453 1.096 . . . . 72.24 109.314 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.729 HG22 ' CD2' ' A' ' 251' ' ' HIS . 10.1 p -135.37 99.17 4.15 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.496 1.123 . . . . 64.31 110.417 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.803 HD22 ' CD2' ' A' ' 250' ' ' LEU . 6.5 mp -52.07 132.97 33.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 74.42 109.318 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.3 ptpt -118.7 -61.45 1.65 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 64.34 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 0.9 OUTLIER 159.53 149.05 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 74.52 110.001 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.673 ' HG3' HG22 ' A' ' 330' ' ' THR . 18.5 Cg_endo -74.97 -46.24 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.51 1.795 . . . . 62.34 111.043 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 348' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.442 0 O-C-N 124.496 1.123 . . . . 72.42 109.32 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.279 -0.637 . . . . 60.2 109.279 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.17 97.18 3.01 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.128 . . . . 71.24 109.334 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.547 ' O ' HG22 ' A' ' 269' ' ' THR . 18.5 Cg_endo -75.01 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.528 1.804 . . . . 54.53 111.009 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.714 HD22 ' NE2' ' A' ' 251' ' ' HIS . 0.2 OUTLIER -40.76 144.61 0.25 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 73.43 109.346 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -114.39 101.07 8.8 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.468 1.105 . . . . 74.51 109.266 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.714 ' NE2' HD22 ' A' ' 249' ' ' LEU . 41.8 m170 -94.47 131.12 40.5 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.522 1.139 . . . . 72.15 109.621 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.613 HG21 HD23 ' A' ' 265' ' ' LEU . 21.9 t -128.55 169.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.31 109.303 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.513 ' N ' HG12 ' A' ' 252' ' ' VAL . 15.0 tp10 -125.31 146.62 49.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.5 1.125 . . . . 72.24 110.304 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.685 HG22 ' CE1' ' A' ' 263' ' ' PHE . 38.9 t -130.58 95.47 2.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 73.24 109.312 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -56.84 6.54 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 1.148 . . . . 61.31 109.999 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.822 ' HA ' HD23 ' A' ' 261' ' ' LEU . 3.3 t-20 59.73 74.82 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 72.04 109.333 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 258' ' ' ASP . 8.5 pt-20 -108.64 156.24 19.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.53 1.144 . . . . 74.44 110.252 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 257' ' ' GLU . 46.2 m-20 -40.33 -57.86 1.66 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 72.25 109.291 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -39.94 -65.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 74.15 109.347 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.79 -170.37 0.77 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.122 . . . . 73.13 109.965 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.5 mt -81.69 162.27 23.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.478 1.111 . . . . 70.44 109.255 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.551 ' NE2' ' CD1' ' A' ' 264' ' ' ILE . 1.3 t-160 -148.66 103.0 3.35 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 72.21 109.587 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.743 ' HE2' HD13 ' A' ' 261' ' ' LEU . 84.4 m-85 -116.15 130.68 56.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 65.34 110.995 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.824 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 45.6 mt -131.81 105.21 9.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.488 1.118 . . . . 75.14 109.289 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 252' ' ' VAL . 0.1 OUTLIER -95.82 128.12 42.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.33 109.272 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.824 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 3.5 m-85 -114.31 113.84 25.13 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 72.14 111.018 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.65 ' CG ' HD13 ' A' ' 273' ' ' ILE . 26.6 t30 -72.34 87.35 1.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.25 109.329 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.645 ' HZ1' ' HA ' ' A' ' 301' ' ' LYS . 3.1 mmpt? -96.22 31.28 2.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 72.24 109.328 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 248' ' ' PRO . 6.6 p -102.56 143.73 31.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 62.11 110.376 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.44 ' O ' HD11 ' A' ' 300' ' ' ILE . 23.9 m120 -47.35 -53.42 13.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.12 . . . . 75.11 109.309 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 37.5 pt -62.25 177.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 74.15 109.34 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 26.1 mt -118.96 136.06 57.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 75.4 109.282 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.65 HD13 ' CG ' ' A' ' 267' ' ' ASN . 0.9 OUTLIER -63.28 140.18 97.66 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.145 . . . . 72.15 109.323 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 -34.16 3.97 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.484 1.781 . . . . 71.21 110.948 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 87.11 177.39 48.95 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.462 1.101 . . . . 71.34 111.036 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 4.2 t30 66.99 27.49 8.78 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 0.789 . . . . 73.21 109.274 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.417 ' C ' ' OG1' ' A' ' 278' ' ' THR . 6.2 m -75.19 -177.07 3.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 1.138 . . . . 73.42 108.313 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.921 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.4 m -154.51 100.02 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 65.13 110.364 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.555 ' CE2' ' HG2' ' A' ' 321' ' ' MET . 0.4 OUTLIER -54.76 170.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 74.23 111.019 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.452 ' HG3' ' CG2' ' A' ' 288' ' ' VAL . 70.8 tt0 -160.58 84.21 0.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.479 1.112 . . . . 73.15 110.302 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 29.6 p90 -115.32 133.1 56.35 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 74.22 110.983 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.598 ' O ' ' CD2' ' A' ' 319' ' ' TYR . 2.8 t -128.72 -172.08 2.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.544 1.153 . . . . 64.11 109.991 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 22.0 t -145.73 162.81 36.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.142 . . . . 75.53 109.976 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -76.59 -5.19 46.68 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 75.11 110.274 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 6.1 pt -118.48 -43.35 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 70.3 109.3 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.8 m -96.26 178.14 5.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.518 1.136 . . . . 71.15 110.03 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -95.36 170.75 9.15 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 75.32 110.302 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.452 ' CG2' ' HG3' ' A' ' 280' ' ' GLU . 7.7 p -71.8 163.51 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 72.0 109.306 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 288' ' ' VAL . 1.2 t80 -147.34 134.74 20.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.433 1.083 . . . . 74.4 111.048 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 8.2 p -115.73 117.3 29.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.428 1.08 . . . . 62.53 110.007 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 10.1 mt -106.47 128.46 61.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.483 1.115 . . . . 73.21 109.317 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.8 108.85 4.66 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 71.32 109.287 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.55 ' HG2' HD21 ' A' ' 306' ' ' LEU . 90.0 mtp -75.02 139.55 42.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 72.24 111.02 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.72 144.49 0.17 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.478 1.111 . . . . 74.4 110.995 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -24.43 12.8 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.515 1.797 . . . . 71.55 111.005 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -75.35 141.55 43.3 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 71.15 109.637 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -62.75 -174.18 0.06 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 74.4 110.327 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 39.1 mt -110.93 -74.2 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 71.15 109.278 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 123.53 162.95 11.63 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.468 1.105 . . . . 42.43 111.005 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 270' ' ' ASN . 36.5 mt -62.09 -30.58 49.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.519 0.776 . . . . 64.21 109.273 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.645 ' HA ' ' HZ1' ' A' ' 268' ' ' LYS . 48.6 mmtt -110.77 -22.88 11.35 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 75.23 109.27 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -59.08 164.63 9.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.527 1.142 . . . . 75.21 111.03 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -131.73 -179.84 5.63 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.519 0.776 . . . . 73.42 110.295 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 25.2 tptt -143.6 144.66 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 75.31 109.337 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.556 ' HG2' ' CH2' ' A' ' 307' ' ' TRP . 8.8 mp0 -112.71 143.6 43.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 61.45 110.302 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 12.7 mt -140.83 62.34 1.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.21 109.304 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.556 ' CH2' ' HG2' ' A' ' 305' ' ' GLU . 1.5 m-90 -68.82 118.72 12.13 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.9 m-30 -111.97 168.57 9.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.497 1.123 . . . . 73.45 111.023 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.492 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -155.02 160.76 30.62 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.543 1.152 . . . . 74.3 110.997 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -75.0 -40.19 1.27 Allowed 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.023 -2.491 . . . . 71.45 110.986 0.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.1 p 175.56 132.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 52.13 110.029 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.499 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.5 mp -113.5 158.23 39.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 70.03 109.282 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 147.06 33.54 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.497 1.788 . . . . 54.4 110.966 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.851 HG22 HD12 ' A' ' 316' ' ' LEU . 0.4 OUTLIER -131.92 163.52 49.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 73.53 110.349 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 175.73 46.54 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.967 -2.514 . . . . 64.22 111.021 -0.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.851 HD12 HG22 ' A' ' 314' ' ' THR . 5.3 mp -93.52 65.57 3.76 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.502 1.126 . . . . 71.13 109.294 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.24 125.37 29.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.494 1.121 . . . . 74.5 109.998 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 73.51 29.1 1.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.03 109.306 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 282' ' ' SER . 3.4 m-85 -110.49 134.22 52.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.548 1.155 . . . . 74.52 110.988 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.826 HG23 ' HD3' ' A' ' 322' ' ' LYS . 1.2 m -49.32 -64.72 0.72 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 73.4 110.398 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.653 ' HE1' ' CD1' ' A' ' 342' ' ' ILE . 4.3 ttm 31.87 42.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 75.53 110.98 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.826 ' HD3' HG23 ' A' ' 320' ' ' THR . 16.9 pttt -80.09 -160.33 0.28 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.565 1.166 . . . . 74.11 109.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.444 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.6 t -151.96 133.47 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.528 1.142 . . . . 64.04 109.324 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.921 HG22 ' O ' ' A' ' 278' ' ' THR . 22.1 m -112.33 177.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 71.54 109.303 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.607 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.73 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.538 1.149 . . . . 73.51 109.306 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -1.91 12.7 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.489 1.118 . . . . 64.24 110.341 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -98.42 -8.19 27.32 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 72.31 109.357 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.42 54.89 5.86 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.516 1.135 . . . . 65.12 110.987 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.439 ' H ' ' ND2' ' A' ' 325' ' ' ASN . 0.4 OUTLIER -149.64 129.81 13.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 0.758 . . . . 61.22 110.326 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.759 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.3 m -64.1 113.39 3.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 74.54 110.39 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.501 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 1.7 pt -91.22 -34.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 70.43 109.279 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.949 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.7 mt -138.1 165.53 26.39 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 72.44 109.285 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -153.57 121.98 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 73.15 109.303 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.434 ' HA3' ' CG2' ' A' ' 342' ' ' ILE . . . -70.11 126.82 17.22 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.506 1.129 . . . . 25.22 111.014 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.499 ' HB3' ' CE ' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -44.8 -26.56 0.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.539 0.788 . . . . 74.22 109.314 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.6 OUTLIER 47.09 65.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.514 1.134 . . . . 74.53 108.285 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.479 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -77.09 -171.23 1.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 73.4 109.299 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.48 54.66 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.126 . . . . 73.42 109.267 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 3.2 m -169.62 163.09 10.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 50.34 110.033 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -65.93 -32.49 74.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 73.43 109.323 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.32 135.41 57.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.495 1.122 . . . . 73.41 110.339 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.653 ' CD1' ' HE1' ' A' ' 321' ' ' MET . 82.1 mt -143.62 120.78 5.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 70.15 109.297 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 251' ' ' HIS . 16.2 p -123.27 84.57 2.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.568 1.168 . . . . 65.14 110.422 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.949 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.2 mp -38.75 147.53 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.53 1.144 . . . . 72.55 109.306 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -128.87 -48.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 72.0 109.354 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 155.22 147.36 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 73.42 110.004 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.4 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.3 Cg_endo -75.02 -70.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.528 1.804 . . . . 72.04 111.014 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.788 HD13 ' O ' ' A' ' 348' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.479 1.112 . . . . 61.44 109.317 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.332 -0.618 . . . . 71.42 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 268' ' ' LYS . 1.4 m-20 -141.93 91.44 8.11 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.45 109.307 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 269' ' ' THR . 18.3 Cg_endo -75.01 -10.69 21.31 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.464 1.771 . . . . 62.11 110.966 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.719 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -39.82 141.87 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 70.14 109.29 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.698 ' CD2' HD22 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -129.78 105.15 7.83 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 71.23 109.274 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.596 ' O ' HG23 ' A' ' 252' ' ' VAL . 9.7 t-160 -71.24 163.63 27.26 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.489 1.118 . . . . 75.55 109.616 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.696 HG21 HD23 ' A' ' 265' ' ' LEU . 54.8 t -158.38 126.31 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 54.25 109.29 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -96.84 135.82 38.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.565 1.165 . . . . 70.3 110.296 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 340' ' ' ASN . 48.1 t -108.27 100.17 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 72.5 109.302 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.72 -60.66 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.52 1.138 . . . . 71.4 109.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.949 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER 53.72 68.89 0.78 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.493 1.121 . . . . 43.43 109.298 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.25 157.27 15.97 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.492 1.12 . . . . 64.42 110.301 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -52.06 -33.54 39.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.523 1.139 . . . . 72.33 109.291 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -68.08 -50.96 51.78 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 72.41 109.363 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 p 178.49 -178.3 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.466 1.104 . . . . 62.12 109.979 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.949 HD23 ' HA ' ' A' ' 256' ' ' ASN . 77.7 mt -76.07 178.56 6.25 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.501 1.126 . . . . 60.24 109.279 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -176.44 86.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.116 . . . . 62.42 109.619 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.686 ' CZ ' HD13 ' A' ' 261' ' ' LEU . 4.8 m-30 -96.84 134.09 40.6 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.47 1.106 . . . . 71.42 110.995 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.604 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 23.1 mt -127.88 109.62 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 73.44 109.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -99.52 129.31 45.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 55.43 109.305 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.653 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -104.19 113.12 26.46 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.533 1.145 . . . . 74.35 110.953 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.695 ' HB2' HD13 ' A' ' 273' ' ' ILE . 18.2 t30 -68.5 72.91 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.126 . . . . 65.31 109.248 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.8 mmtt -87.35 53.59 2.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.117 . . . . 70.51 109.294 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 248' ' ' PRO . 30.7 p -120.64 -176.38 3.23 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.521 1.138 . . . . 62.41 110.381 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -74.21 -59.42 2.73 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.126 . . . . 44.42 109.315 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.693 ' C ' HD12 ' A' ' 272' ' ' ILE . 0.1 OUTLIER -78.06 -176.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 72.13 109.308 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.693 HD12 ' C ' ' A' ' 271' ' ' ILE . 2.3 mp -120.22 143.42 32.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.501 1.125 . . . . 63.41 109.29 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -43.66 142.44 1.87 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.453 1.095 . . . . 74.23 109.335 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -38.15 1.71 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.439 1.757 . . . . 72.24 110.983 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 99.51 160.18 28.98 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.523 1.139 . . . . 74.43 111.007 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 8.1 t-20 81.7 17.34 0.44 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.473 0.749 . . . . 62.52 109.29 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 87.3 m -66.61 170.57 6.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 74.33 108.303 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.873 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.8 m -153.64 99.24 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.554 1.159 . . . . 64.22 110.405 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.754 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.9 OUTLIER -50.79 171.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.477 1.111 . . . . 62.25 111.035 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -172.99 99.4 0.13 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 73.22 110.299 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 281' ' ' PHE . 2.0 p90 -122.9 141.98 51.29 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.57 1.168 . . . . 73.41 111.015 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 54.7 p -74.88 159.13 32.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.464 1.103 . . . . 71.15 109.983 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 9.8 p -143.25 -161.55 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 1.148 . . . . 64.54 110.003 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.429 ' C ' ' N ' ' A' ' 286' ' ' SER . 9.1 mt-30 -54.0 -172.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.551 1.157 . . . . 75.43 110.325 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 286' ' ' SER . 1.0 OUTLIER -42.09 -28.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 74.23 109.303 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.429 ' N ' ' C ' ' A' ' 284' ' ' GLN . 0.9 OUTLIER -48.22 175.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 73.41 109.992 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -92.68 149.52 21.27 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.506 1.129 . . . . 74.24 110.344 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.551 HG22 ' H ' ' A' ' 289' ' ' PHE . 10.4 p -52.36 171.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 74.23 109.313 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.551 ' H ' HG22 ' A' ' 288' ' ' VAL . 4.3 t80 -145.22 162.36 37.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 74.53 110.992 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.605 ' OG ' HG22 ' A' ' 278' ' ' THR . 4.0 t -137.05 124.92 22.59 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.456 1.097 . . . . 74.53 109.983 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.776 HD11 ' HD1' ' A' ' 308' ' ' PHE . 12.5 mt -103.67 148.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.558 1.161 . . . . 73.13 109.295 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 292' ' ' LYS . 0.3 OUTLIER -79.86 123.71 28.0 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 42.24 109.284 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.951 ' HG2' HD21 ' A' ' 306' ' ' LEU . 37.5 mtp -92.77 15.0 15.59 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.561 1.163 . . . . 64.5 110.999 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.19 151.91 0.01 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.482 1.114 . . . . 51.24 110.963 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.427 ' HA ' ' N ' ' A' ' 276' ' ' ASN . 18.2 Cg_endo -75.03 -16.44 20.13 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.53 1.805 . . . . 73.33 110.993 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -62.84 151.14 39.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 63.4 109.6 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.437 ' C ' HD13 ' A' ' 298' ' ' ILE . 4.4 mp0 -87.6 165.4 15.48 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.56 1.163 . . . . 65.15 110.319 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 302' ' ' GLY . 2.7 mm -89.05 -95.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 73.11 109.305 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 120.11 168.88 13.9 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.468 1.105 . . . . 74.14 111.013 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.854 HG22 ' HD3' ' A' ' 301' ' ' LYS . 15.5 mm -60.36 -43.05 92.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.507 0.769 . . . . 71.2 109.304 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.854 ' HD3' HG22 ' A' ' 300' ' ' ILE . 0.5 OUTLIER -108.94 -12.8 14.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 60.54 109.357 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.7 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -81.27 49.62 4.04 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.514 1.134 . . . . 61.42 111.019 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.524 ' HG2' ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -41.89 164.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 0.784 . . . . 70.05 110.29 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.5 ' HB2' ' CD1' ' A' ' 298' ' ' ILE . 41.9 tptt -118.4 165.69 13.56 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.13 . . . . 72.1 109.315 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -134.86 144.96 47.85 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.104 . . . . 64.5 110.346 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.951 HD21 ' HG2' ' A' ' 293' ' ' MET . 45.3 mt -140.72 61.69 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.511 1.132 . . . . 74.14 109.301 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 5.3 p90 -72.19 123.02 22.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.963 -1.125 . . . . 71.42 107.963 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.776 ' HD1' HD11 ' A' ' 291' ' ' ILE . 57.0 t80 -119.24 172.09 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 74.4 111.001 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -147.24 162.66 31.74 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.148 . . . . 74.24 110.972 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.03 -46.13 0.4 Allowed 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.025 -2.49 . . . . 34.33 110.952 0.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 28.7 p 177.83 170.41 0.68 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.11 110.011 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.949 ' HG ' HD11 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -153.7 161.12 29.99 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.459 1.099 . . . . 63.23 109.288 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 312' ' ' LEU . 18.3 Cg_endo -74.96 144.09 29.97 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.509 1.794 . . . . 50.32 111.006 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.632 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -126.06 165.45 27.33 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 73.22 110.356 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -75.04 -176.11 17.43 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.987 -2.505 . . . . 62.41 111.031 0.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.575 HD13 ' HE3' ' A' ' 321' ' ' MET . 2.0 mt -98.21 61.42 1.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.15 109.311 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 2.9 p -74.62 119.9 19.44 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.513 1.133 . . . . 74.52 110.034 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 317' ' ' SER . 45.3 t30 79.42 40.32 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.453 1.096 . . . . 61.32 109.338 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.436 ' CG ' ' HB3' ' A' ' 316' ' ' LEU . 24.3 m-85 -119.84 142.99 48.13 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 74.03 111.013 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.524 ' O ' ' C ' ' A' ' 321' ' ' MET . 1.3 m -59.75 -56.76 17.76 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 71.03 110.383 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.575 ' HE3' HD13 ' A' ' 316' ' ' LEU . 0.9 OUTLIER 26.93 58.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 74.2 110.953 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.577 ' HD3' HG21 ' A' ' 330' ' ' THR . 29.6 mttm -94.86 -168.17 1.77 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.502 1.126 . . . . 73.41 109.321 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.414 ' CG2' ' C ' ' A' ' 322' ' ' LYS . 2.9 t -150.35 133.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 73.54 109.268 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 278' ' ' THR . 10.9 m -109.98 172.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 72.52 109.23 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -109.61 -163.1 0.84 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.494 1.121 . . . . 73.44 109.268 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -62.16 -12.86 22.1 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.133 . . . . 71.52 110.303 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.5 22.81 13.63 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 64.31 109.356 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 44.27 25.66 0.79 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.543 1.152 . . . . 74.23 111.012 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.493 ' C ' HG12 ' A' ' 324' ' ' VAL . 6.5 pt-20 -106.78 128.66 54.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 0.76 . . . . 71.23 110.286 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.797 ' N ' HG12 ' A' ' 324' ' ' VAL . 9.0 m -54.29 135.02 45.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.112 . . . . 75.41 110.413 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.4 pt -114.99 -42.09 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.136 . . . . 64.21 109.293 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.444 ' C ' HG13 ' A' ' 333' ' ' VAL . 12.6 mt -136.42 171.25 14.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 70.0 109.273 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.53 HG12 ' CG ' ' A' ' 322' ' ' LYS . 14.6 m -153.31 141.24 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.49 1.119 . . . . 73.41 109.336 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.482 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -84.97 136.89 14.95 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.489 1.118 . . . . 71.21 110.988 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -67.2 -38.56 85.53 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.473 0.749 . . . . 75.35 109.302 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.494 ' H ' HG23 ' A' ' 342' ' ' ILE . 0.1 OUTLIER 40.18 88.72 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.496 1.123 . . . . 70.5 108.299 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -116.81 81.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 63.2 109.28 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 338' ' ' ASP . 3.4 p-10 39.93 49.9 2.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.15 . . . . 75.31 109.258 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 26.9 m -157.21 136.67 12.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.45 1.093 . . . . 74.45 109.997 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.697 ' O ' HG23 ' A' ' 254' ' ' VAL . 7.1 m120 -58.14 -36.82 73.53 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 75.11 109.326 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.19 134.41 48.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.549 1.156 . . . . 73.32 110.315 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 336' ' ' CYS . 4.8 mt -136.35 134.35 49.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.49 1.119 . . . . 33.24 109.31 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 344' ' ' LEU . 39.3 p -125.27 86.38 2.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 61.51 110.363 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' A' ' 250' ' ' LEU . 7.2 mp -40.38 130.85 2.26 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 71.25 109.32 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 346' ' ' SER . 6.9 ptpt -117.54 -60.04 1.86 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.107 . . . . 44.0 109.292 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.517 ' C ' HG22 ' A' ' 333' ' ' VAL . 1.5 m 159.47 157.28 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 53.22 110.012 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 -61.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.536 1.809 . . . . 72.43 110.999 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 13.2 tp . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.462 1.101 . . . . 74.13 109.282 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 109.331 -0.618 . . . . 63.11 109.331 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.515 ' HB3' HD11 ' A' ' 249' ' ' LEU . 6.3 m-20 -143.64 74.76 16.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.462 1.101 . . . . 65.2 109.325 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.586 ' C ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -74.94 -0.21 9.66 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.517 1.798 . . . . 74.24 111.015 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -75.1 148.89 39.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 72.03 109.296 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.603 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -110.8 99.94 8.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.582 1.176 . . . . 73.15 109.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.412 ' NE2' ' HG2' ' A' ' 341' ' ' GLU . 2.4 t-160 -90.33 131.54 36.07 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 71.15 109.614 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 265' ' ' LEU . 79.7 t -121.08 164.64 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.487 1.117 . . . . 72.45 109.306 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.474 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.4 tp10 -129.72 147.26 51.48 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 63.32 110.325 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 263' ' ' PHE . 61.6 t -121.19 106.87 19.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.533 1.145 . . . . 71.25 109.335 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 t -72.85 -61.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.12 110.002 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.918 ' HA ' HD23 ' A' ' 261' ' ' LEU . 5.9 t-20 53.42 57.03 6.58 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.115 . . . . 62.35 109.287 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 260' ' ' SER . 5.0 pt-20 -161.15 -174.54 4.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 74.44 110.344 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 259' ' ' ASN . 0.8 OUTLIER 71.86 17.15 5.4 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 63.34 109.268 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 258' ' ' ASP . 3.6 m-20 82.61 18.77 0.29 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.478 1.111 . . . . 75.14 109.317 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 0.0 OUTLIER -170.05 -170.07 0.94 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 54.03 109.983 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.918 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.9 mt -98.87 165.72 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.546 1.154 . . . . 72.44 109.298 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.85 102.38 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 73.11 109.611 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.779 ' CE2' HG22 ' A' ' 254' ' ' VAL . 85.1 m-85 -107.73 142.15 38.17 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.535 1.147 . . . . 73.31 110.977 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.686 HG22 ' CZ ' ' A' ' 266' ' ' TYR . 53.2 mt -132.84 124.25 50.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.528 1.142 . . . . 74.44 109.314 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.814 HD12 ' N ' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -120.53 141.87 49.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 61.43 109.291 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 264' ' ' ILE . 1.1 m-85 -127.78 140.52 52.0 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.516 1.135 . . . . 73.13 110.986 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 267' ' ' ASN . 46.7 p-10 -89.79 64.24 6.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 63.41 109.275 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -58.03 -15.96 11.04 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 73.53 109.284 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.586 HG22 ' C ' ' A' ' 248' ' ' PRO . 43.8 p -54.68 -166.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 60.32 110.39 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -99.15 -59.03 1.8 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.478 1.111 . . . . 74.34 109.331 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 4.1 pt -60.29 152.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.463 1.102 . . . . 63.34 109.282 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 4.2 mt -83.77 149.05 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 54.5 109.291 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 273' ' ' ILE . 3.5 mm -67.18 139.13 94.91 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.502 1.127 . . . . 53.41 109.317 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 273' ' ' ILE . 18.4 Cg_endo -74.95 -26.95 10.52 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.486 1.782 . . . . 73.11 110.973 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 81.36 -178.51 53.86 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.504 1.128 . . . . 44.42 111.047 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 57.16 49.48 13.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.491 0.76 . . . . 63.1 109.323 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.414 ' CB ' ' SD ' ' A' ' 293' ' ' MET . 12.2 m -94.73 178.97 5.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.49 1.119 . . . . 51.24 108.325 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.899 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.0 OUTLIER -152.22 97.31 2.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 61.21 110.378 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 1.002 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -53.79 159.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.466 1.104 . . . . 74.55 110.969 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.664 ' HG3' HG21 ' A' ' 288' ' ' VAL . 13.3 tt0 -143.61 75.94 1.49 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.469 1.106 . . . . 75.3 110.327 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 291' ' ' ILE . 35.0 p90 -109.45 121.79 45.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.533 1.145 . . . . 71.25 110.962 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 288' ' ' VAL . 3.7 p -109.19 179.61 4.11 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 73.14 109.981 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.569 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 1.4 p -119.84 -42.03 2.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 1.146 . . . . 51.42 110.01 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.413 ' C ' ' N ' ' A' ' 286' ' ' SER . 6.3 tp-100 -148.25 166.43 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.43 110.299 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 286' ' ' SER . 4.2 tt -47.19 -25.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.49 1.119 . . . . 64.01 109.306 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.413 ' N ' ' C ' ' A' ' 284' ' ' GLN . 12.6 t -38.54 -76.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 64.33 109.971 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.95 174.24 15.28 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.523 1.139 . . . . 62.02 110.328 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.664 HG21 ' HG3' ' A' ' 280' ' ' GLU . 14.8 p -122.47 170.57 12.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 75.24 109.299 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.522 ' N ' HG22 ' A' ' 288' ' ' VAL . 2.6 t80 -131.69 137.83 48.45 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 74.32 111.054 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 54.1 p -116.75 126.21 52.79 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.122 . . . . 73.41 109.987 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 281' ' ' PHE . 8.5 mt -105.11 125.7 60.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.541 1.151 . . . . 73.12 109.289 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.412 ' HD3' HG23 ' A' ' 278' ' ' THR . 8.7 mmtp -67.32 110.81 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.531 1.144 . . . . 51.03 109.278 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.92 ' HG2' HD21 ' A' ' 306' ' ' LEU . 93.0 mtp -81.76 134.79 35.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 73.21 111.006 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -37.68 145.52 0.13 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.515 1.135 . . . . 63.15 111.031 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 -20.95 16.5 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.516 1.798 . . . . 62.43 111.013 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.74 129.14 38.77 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 73.21 109.577 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.09 153.16 30.72 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.124 . . . . 74.12 110.254 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.898 HG23 ' O ' ' A' ' 302' ' ' GLY . 3.2 mt -70.22 -86.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 71.2 109.293 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.851 ' N ' HG22 ' A' ' 298' ' ' ILE . . . 108.69 -177.04 20.39 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.505 1.128 . . . . 71.1 111.004 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 301' ' ' LYS . 59.6 mt -38.24 -90.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.487 0.757 . . . . 74.24 109.282 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.618 ' N ' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER -91.3 23.93 3.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 73.21 109.272 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.898 ' O ' HG23 ' A' ' 298' ' ' ILE . . . -83.74 45.14 3.42 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.503 1.127 . . . . 74.2 111.006 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 302' ' ' GLY . 1.4 pt20 -39.99 161.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 0.761 . . . . 73.52 110.283 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 298' ' ' ILE . 30.5 tptt -121.92 152.35 39.75 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.449 1.093 . . . . 72.44 109.281 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.436 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 11.9 mp0 -118.37 133.83 55.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.542 1.151 . . . . 71.41 110.307 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 1.002 HD13 ' CG ' ' A' ' 279' ' ' PHE . 35.5 mt -126.35 55.57 1.49 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 64.11 109.303 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 138.34 55.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 75.34 107.999 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 309' ' ' PHE . 37.2 t80 -134.64 166.59 22.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.11 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -138.99 148.09 56.38 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 73.04 111.028 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.2 Cg_endo -75.01 -53.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.005 -2.498 . . . . 73.15 110.975 0.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 23.6 p -178.8 162.66 1.35 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.503 1.127 . . . . 63.53 109.971 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.0 OUTLIER -128.61 159.16 69.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.157 . . . . 74.01 109.292 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 145.07 31.03 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.483 1.781 . . . . 61.32 111.007 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.85 HG22 HD12 ' A' ' 316' ' ' LEU . 0.9 OUTLIER -125.81 160.27 57.24 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.465 1.103 . . . . 74.33 110.395 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.9 170.35 71.98 Favored 'Cis proline' 0 C--N 1.36 1.143 0 C-N-CA 121.032 -2.487 . . . . 75.53 111.057 -0.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.85 HD12 HG22 ' A' ' 314' ' ' THR . 5.7 mp -87.68 66.26 8.81 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.536 1.147 . . . . 73.12 109.28 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.432 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 3.6 p -81.78 127.31 32.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 1.145 . . . . 73.35 109.975 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 317' ' ' SER . 0.2 OUTLIER 76.66 21.47 1.27 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 74.43 109.262 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.735 ' HD2' HD23 ' A' ' 316' ' ' LEU . 3.3 m-85 -103.93 134.08 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.521 1.138 . . . . 73.43 111.039 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.494 HG22 ' HG3' ' A' ' 322' ' ' LYS . 88.7 m -51.25 -60.54 3.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 52.4 110.42 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.71 ' HE2' HD22 ' A' ' 316' ' ' LEU . 3.5 ttm 33.08 40.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 61.14 110.996 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.501 ' HD3' HG21 ' A' ' 330' ' ' THR . 36.1 mttt -72.81 -174.0 1.34 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.523 1.139 . . . . 71.25 109.287 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . . . . . . . . . 17.5 t -143.51 121.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 72.31 109.32 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 278' ' ' THR . 28.4 m -110.12 171.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.508 1.13 . . . . 75.44 109.356 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.477 ' HB2' ' CG2' ' A' ' 331' ' ' ILE . 0.1 OUTLIER -109.17 -155.51 0.56 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.463 1.102 . . . . 72.22 109.296 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -77.38 -4.0 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.56 1.163 . . . . 75.44 110.324 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -105.25 8.98 34.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 65.25 109.318 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 58.74 14.89 24.4 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.472 1.108 . . . . 63.12 110.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 7.3 pt-20 -95.83 116.39 28.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.498 0.763 . . . . 71.04 110.279 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.624 ' CA ' HG12 ' A' ' 324' ' ' VAL . 1.8 m -50.83 96.42 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.51 1.131 . . . . 74.14 110.386 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 325' ' ' ASN . 3.1 pt -66.81 -36.87 78.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.449 1.093 . . . . 73.52 109.312 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.914 ' HB3' HD23 ' A' ' 344' ' ' LEU . 12.6 mt -147.19 170.7 16.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.468 1.105 . . . . 70.52 109.323 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.2 OUTLIER -147.17 119.3 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.098 . . . . 75.04 109.291 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 344' ' ' LEU . . . -71.45 125.09 11.42 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.543 1.152 . . . . 51.05 111.004 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.787 ' HZ2' ' HB2' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -48.85 -26.44 2.43 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.563 0.802 . . . . 72.32 109.324 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 48.33 62.08 2.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 75.0 108.311 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.787 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -73.39 -176.78 2.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.55 1.156 . . . . 74.35 109.315 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.62 55.98 1.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 61.31 109.262 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 4.7 m -169.08 149.16 4.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 55.31 109.973 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.418 ' N ' ' HB3' ' A' ' 315' ' ' PRO . 10.2 m-20 -55.31 -19.95 10.05 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 74.41 109.29 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.412 ' HG2' ' NE2' ' A' ' 251' ' ' HIS . 18.4 mt-10 -72.69 141.37 48.22 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.459 1.099 . . . . 72.11 110.302 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.681 HD11 ' HE1' ' A' ' 321' ' ' MET . 64.5 mt -146.84 120.84 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.13 . . . . 73.13 109.307 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 344' ' ' LEU . 15.4 p -123.94 85.44 2.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.451 1.095 . . . . 70.51 110.345 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.914 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.4 mp -39.31 152.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.521 1.138 . . . . 75.41 109.31 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -129.87 -51.72 1.14 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 52.1 109.306 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 3.1 p 158.18 146.97 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 70.05 110.018 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.664 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.1 Cg_endo -74.98 -50.71 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.502 1.791 . . . . 63.23 110.986 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 1.6 tp . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.509 1.13 . . . . 70.34 109.308 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.329 -0.619 . . . . 73.41 109.329 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.889 ' HB3' HD12 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -139.93 147.7 52.1 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.479 1.112 . . . . 75.11 109.319 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -3.79 14.45 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.46 1.769 . . . . 51.43 111.009 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.914 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.71 132.53 49.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.15 . . . . 64.44 109.332 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.545 HD22 HD22 ' A' ' 344' ' ' LEU . 0.5 OUTLIER -116.58 103.21 10.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.136 . . . . 74.41 109.302 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -67.35 147.35 53.05 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.479 1.112 . . . . 72.42 109.592 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.696 HG13 ' HG ' ' A' ' 265' ' ' LEU . 45.1 t -145.37 161.92 12.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 63.31 109.358 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.42 ' N ' HG12 ' A' ' 252' ' ' VAL . 11.2 tp10 -134.39 132.48 39.47 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.138 . . . . 71.11 110.296 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.593 ' CG1' HG21 ' A' ' 314' ' ' THR . 94.8 t -109.69 110.72 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 72.12 109.246 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.428 ' CB ' ' HB3' ' A' ' 262' ' ' HIS . 5.7 t -77.93 -67.41 0.73 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.13 . . . . 63.23 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.881 ' HA ' HD23 ' A' ' 261' ' ' LEU . 4.8 t-20 61.15 63.91 1.18 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.56 1.162 . . . . 71.21 109.287 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -88.86 148.61 23.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 65.12 110.291 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.04 -24.58 1.62 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.474 1.109 . . . . 75.21 109.322 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -76.18 -55.37 5.64 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.457 1.098 . . . . 70.3 109.306 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.9 m -168.37 -175.02 2.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.529 1.143 . . . . 73.41 109.942 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.881 HD23 ' HA ' ' A' ' 256' ' ' ASN . 13.1 mt -86.48 176.02 8.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 71.24 109.316 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 255' ' ' SER . 10.7 t-160 -174.71 107.93 0.11 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.54 109.573 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.406 ' HE1' HD13 ' A' ' 261' ' ' LEU . 88.0 m-85 -112.13 118.56 35.7 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 75.45 111.032 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.505 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 13.7 mt -112.39 104.59 17.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 52.23 109.254 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.696 ' HG ' HG13 ' A' ' 252' ' ' VAL . 0.8 OUTLIER -101.4 129.79 47.48 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.152 . . . . 71.21 109.319 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -102.54 119.05 38.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 61.32 110.983 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.486 ' OD1' ' CD1' ' A' ' 273' ' ' ILE . 34.9 t30 -65.71 75.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.132 . . . . 75.44 109.276 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 266' ' ' TYR . 17.1 mmtt -92.07 64.63 4.63 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 64.23 109.305 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 72.5 p -142.67 160.43 40.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.506 1.129 . . . . 71.12 110.406 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -61.48 -54.27 45.56 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.143 . . . . 72.23 109.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.4 pt -69.8 163.02 3.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.122 . . . . 73.42 109.292 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 17.9 mt -114.74 139.14 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 73.5 109.333 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.486 ' CD1' ' OD1' ' A' ' 267' ' ' ASN . 1.8 mp -54.68 137.23 63.25 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 75.4 109.296 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.2 Cg_endo -75.01 -26.34 10.99 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.494 1.787 . . . . 44.01 110.958 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 98.61 157.76 29.61 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.504 1.127 . . . . 72.23 111.011 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.5 t30 73.41 39.44 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.483 0.755 . . . . 75.44 109.277 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . . . . . . . . . 97.7 m -91.45 -174.91 4.06 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 63.45 108.285 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 291' ' ' ILE . 7.3 m -155.12 156.26 35.47 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.44 1.087 . . . . 63.42 110.384 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.536 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.9 t80 -108.75 171.07 7.64 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 72.33 110.968 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.526 ' HG3' HG21 ' A' ' 288' ' ' VAL . 9.4 tt0 -161.59 93.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 71.11 110.31 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -113.6 133.91 55.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 74.42 110.991 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 47.7 t -94.4 -175.18 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 64.13 109.987 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.559 ' HA ' ' CE2' ' A' ' 319' ' ' TYR . 24.8 t -173.48 -169.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 61.24 110.017 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.98 -14.75 62.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.32 110.268 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 286' ' ' SER . 2.3 pt -63.44 -16.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.521 1.138 . . . . 75.25 109.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 285' ' ' ILE . 0.5 OUTLIER 87.51 -59.25 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.538 1.149 . . . . 71.41 109.974 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.52 170.29 10.91 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.49 1.118 . . . . 71.3 110.335 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.544 HG22 ' H ' ' A' ' 289' ' ' PHE . 8.8 p -126.43 171.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 70.24 109.274 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.544 ' H ' HG22 ' A' ' 288' ' ' VAL . 8.5 t80 -148.23 149.31 31.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.527 1.142 . . . . 73.23 110.965 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 279' ' ' PHE . 4.9 p -118.43 128.09 54.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.531 1.144 . . . . 43.14 109.984 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 278' ' ' THR . 17.7 mt -101.63 129.01 53.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.472 1.107 . . . . 64.42 109.278 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -72.01 114.62 10.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.12 . . . . 71.44 109.332 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.765 ' HG2' HD21 ' A' ' 306' ' ' LEU . 61.8 mtp -88.18 144.71 26.31 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 74.35 111.077 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -41.49 147.58 0.41 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.517 1.135 . . . . 62.13 111.005 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -17.83 19.28 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.783 . . . . 72.0 110.99 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -72.88 -177.04 2.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.468 1.105 . . . . 74.45 109.63 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -104.36 174.49 5.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.24 110.32 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 33.7 mt -104.46 -82.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.113 . . . . 60.41 109.298 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.98 159.57 20.4 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.54 1.15 . . . . 74.32 111.007 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 17.9 mt -50.61 -63.38 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.5 0.764 . . . . 75.44 109.287 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -67.52 -29.3 68.67 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.497 1.123 . . . . 74.32 109.276 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -68.52 156.61 53.18 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.464 1.103 . . . . 42.23 110.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.81 171.68 12.02 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 0.768 . . . . 71.54 110.311 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 293' ' ' MET . 37.2 tptt -118.78 165.11 14.43 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 73.33 109.341 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -143.88 124.6 14.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 72.53 110.279 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.765 HD21 ' HG2' ' A' ' 293' ' ' MET . 10.3 mt -135.97 60.21 1.69 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 64.03 109.333 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.479 ' O ' ' CE3' ' A' ' 307' ' ' TRP . 11.2 p-90 -72.48 134.68 45.43 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.514 1.134 . . . . 75.21 108.034 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.816 ' CE2' HD11 ' A' ' 312' ' ' LEU . 45.3 t80 -126.12 166.73 16.48 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.496 1.122 . . . . 74.13 111.028 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.1 OUTLIER -137.91 157.16 73.72 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.533 1.146 . . . . 74.13 110.972 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.95 -41.31 1.02 Allowed 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.99 -2.504 . . . . 40.13 111.038 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.1 p 172.93 143.52 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.34 109.993 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.816 HD11 ' CE2' ' A' ' 308' ' ' PHE . 4.4 mp -115.16 159.58 37.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.561 1.163 . . . . 74.55 109.316 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 148.5 35.31 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.533 1.807 . . . . 75.54 110.988 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.593 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.2 OUTLIER -130.35 164.42 41.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 71.55 110.382 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.513 ' HA ' ' CB ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.98 -177.73 21.36 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.019 -2.492 . . . . 74.14 111.006 0.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.984 HD13 ' SD ' ' A' ' 321' ' ' MET . 1.8 mt -102.49 52.69 0.8 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.442 1.089 . . . . 74.22 109.308 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 1.4 p -76.08 127.19 32.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 75.0 109.988 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 317' ' ' SER . 28.7 t30 81.07 30.83 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 74.12 109.342 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.806 ' CE2' HD23 ' A' ' 316' ' ' LEU . 5.2 m-85 -109.56 167.55 10.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.44 111.035 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.91 HG22 ' HG2' ' A' ' 322' ' ' LYS . 32.3 m -79.6 -59.75 2.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.543 1.152 . . . . 64.4 110.425 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.984 ' SD ' HD13 ' A' ' 316' ' ' LEU . 0.6 OUTLIER 27.03 79.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.472 1.108 . . . . 73.41 110.971 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.91 ' HG2' HG22 ' A' ' 320' ' ' THR . 7.6 pttt -112.66 -170.66 1.71 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 72.54 109.325 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.589 ' CG2' HD21 ' A' ' 344' ' ' LEU . 49.4 t -136.89 138.81 45.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 61.02 109.305 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.737 HG23 ' H ' ' A' ' 329' ' ' GLU . 0.4 OUTLIER -122.4 138.69 51.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.554 1.158 . . . . 75.01 109.271 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.713 ' OD1' HD13 ' A' ' 331' ' ' ILE . 0.5 OUTLIER -76.82 -170.54 1.63 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.507 1.13 . . . . 64.2 109.284 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -78.99 4.32 14.66 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.514 1.134 . . . . 53.11 110.267 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.04 -3.28 41.7 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.527 1.142 . . . . 74.42 109.296 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 65.21 54.47 26.96 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.485 1.116 . . . . 61.33 110.998 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.737 ' H ' HG23 ' A' ' 324' ' ' VAL . 9.9 pt-20 -157.04 121.86 4.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 0.77 . . . . 64.35 110.311 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.414 HG21 ' HD3' ' A' ' 322' ' ' LYS . 69.0 m -45.26 115.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.516 1.135 . . . . 71.54 110.406 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.713 HD13 ' OD1' ' A' ' 325' ' ' ASN . 36.5 pt -98.76 -41.36 10.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 73.31 109.297 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.898 ' HB3' HD23 ' A' ' 344' ' ' LEU . 10.4 mt -131.48 168.45 17.62 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 73.23 109.286 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.467 ' CG1' ' C ' ' A' ' 332' ' ' LEU . 1.0 OUTLIER -152.38 122.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.47 1.106 . . . . 74.1 109.336 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.421 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -72.45 121.53 8.17 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.51 1.131 . . . . 74.14 111.006 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -45.22 -26.71 0.53 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.461 0.742 . . . . 73.21 109.293 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.482 ' SG ' ' CE ' ' A' ' 321' ' ' MET . 0.1 OUTLIER 47.83 76.04 0.12 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 62.14 108.312 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -90.3 -175.8 4.62 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.147 . . . . 63.21 109.285 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.82 62.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.466 1.103 . . . . 65.33 109.302 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 15.4 m -171.08 150.2 3.01 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.478 1.111 . . . . 74.32 109.996 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 254' ' ' VAL . 18.9 m-20 -60.38 -21.17 61.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 63.42 109.302 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -78.12 148.46 34.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.517 1.136 . . . . 74.15 110.289 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.601 ' CD1' ' CE ' ' A' ' 321' ' ' MET . 57.1 mt -147.55 140.63 19.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.478 1.111 . . . . 63.55 109.309 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 11.4 p -136.13 95.53 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.127 . . . . 64.24 110.358 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.898 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.6 mp -49.97 153.63 1.3 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 64.11 109.311 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 335' ' ' LYS . 0.0 OUTLIER -128.51 -76.44 0.56 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.489 1.118 . . . . 73.44 109.286 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 5.0 p 164.84 134.84 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.491 1.119 . . . . 62.42 110.057 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 -70.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.443 1.76 . . . . 44.41 111.039 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 72.12 109.288 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.261 -0.644 . . . . 60.54 109.261 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.42 104.46 1.84 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.148 . . . . 71.13 109.25 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.756 ' HA ' HG22 ' A' ' 269' ' ' THR . 18.4 Cg_endo -75.02 -1.09 10.78 Favored 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 43.41 111.017 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -40.45 144.53 0.23 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.475 1.109 . . . . 74.14 109.273 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.593 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -115.55 99.76 7.58 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.493 1.121 . . . . 52.22 109.302 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.554 ' CD2' HG22 ' A' ' 343' ' ' THR . 18.8 m170 -95.52 130.83 42.22 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 74.4 109.569 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 253' ' ' GLU . 69.6 t -124.71 166.77 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.504 1.128 . . . . 73.42 109.302 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.524 ' N ' HG12 ' A' ' 252' ' ' VAL . 27.8 tt0 -122.67 123.34 40.92 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.539 1.149 . . . . 74.32 110.316 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 57.5 t -105.02 107.5 22.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 74.02 109.318 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.09 -59.59 2.51 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 44.43 109.969 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.939 ' HA ' HD23 ' A' ' 261' ' ' LEU . 2.9 t-20 60.71 70.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.488 1.118 . . . . 75.25 109.243 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -105.32 161.97 13.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.556 1.16 . . . . 63.34 110.293 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 259' ' ' ASN . 46.1 m-20 -41.15 -60.22 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.561 1.163 . . . . 73.41 109.293 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 258' ' ' ASP . 66.5 t30 -40.07 -64.34 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 1.134 . . . . 62.33 109.353 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -178.6 -174.54 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 72.51 109.999 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.939 HD23 ' HA ' ' A' ' 256' ' ' ASN . 46.8 mt -76.19 153.97 35.71 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.491 1.119 . . . . 74.13 109.318 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -142.03 91.66 2.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.528 1.143 . . . . 72.44 109.603 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.573 ' CE2' ' CD2' ' A' ' 308' ' ' PHE . 8.2 m-30 -98.84 133.99 42.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.475 1.11 . . . . 52.22 110.977 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.661 HG22 ' CE2' ' A' ' 266' ' ' TYR . 62.6 mt -127.93 121.2 55.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 73.51 109.294 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -107.3 119.67 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.5 1.125 . . . . 73.54 109.32 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.661 ' CE2' HG22 ' A' ' 264' ' ' ILE . 5.1 m-85 -109.03 92.16 3.94 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.502 1.126 . . . . 63.14 111.027 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -54.45 95.6 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.501 1.126 . . . . 70.02 109.282 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.7 28.18 7.74 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 62.31 109.343 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.756 HG22 ' HA ' ' A' ' 248' ' ' PRO . 61.3 p -87.52 -174.94 5.03 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.545 1.153 . . . . 72.13 110.388 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -88.69 -56.17 3.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 73.4 109.333 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.408 ' H ' HG23 ' A' ' 271' ' ' ILE . 0.1 OUTLIER -60.18 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.44 1.088 . . . . 71.13 109.342 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 271' ' ' ILE . 4.1 mp -124.77 123.21 65.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.493 1.121 . . . . 50.11 109.307 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 273' ' ' ILE . 3.5 mm -40.94 137.75 1.42 Allowed Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 71.32 109.306 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.4 Cg_endo -75.03 -24.46 12.75 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.501 1.79 . . . . 72.01 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 77.42 169.17 31.97 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.501 1.126 . . . . 74.05 111.008 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 60.0 t30 63.44 36.76 11.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 0.754 . . . . 65.22 109.344 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.411 ' C ' ' OG1' ' A' ' 278' ' ' THR . 64.1 m -90.44 -176.5 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.448 1.093 . . . . 73.42 108.316 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 324' ' ' VAL . 1.6 m -153.77 129.02 9.73 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.513 1.133 . . . . 71.31 110.381 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.527 ' CD1' HG22 ' A' ' 323' ' ' VAL . 1.0 OUTLIER -80.2 179.21 7.77 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.505 1.128 . . . . 75.42 111.017 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -169.97 97.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.11 . . . . 64.24 110.308 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.625 ' CE1' ' CE2' ' A' ' 308' ' ' PHE . 4.4 p90 -120.65 121.66 38.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.575 1.172 . . . . 71.11 111.02 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 m -101.84 143.54 31.61 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.564 1.165 . . . . 71.15 110.027 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 56.6 m -121.65 -51.36 2.05 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 64.33 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -104.44 171.5 7.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 72.01 110.28 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.77 5.89 2.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.469 1.106 . . . . 74.0 109.322 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.2 m -69.99 -71.07 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.505 1.128 . . . . 73.42 109.989 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.66 174.84 12.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 70.31 110.247 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.05 154.16 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 53.31 109.308 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -122.7 156.73 33.79 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.482 1.114 . . . . 65.41 111.014 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 6.1 p -128.1 126.34 40.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.515 1.134 . . . . 72.21 110.025 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 5.5 mt -97.68 129.47 47.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.512 1.133 . . . . 72.53 109.306 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.421 ' HA ' HG23 ' A' ' 278' ' ' THR . 2.8 mptp? -67.28 121.07 14.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 65.2 109.285 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 98.7 mtp -89.06 140.2 29.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.535 1.147 . . . . 41.31 111.003 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.553 ' H ' ' HZ1' ' A' ' 304' ' ' LYS . . . -40.7 144.23 0.56 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.486 1.116 . . . . 74.51 110.989 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -24.72 12.72 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.509 1.794 . . . . 72.13 111.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -63.66 163.91 10.6 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.525 1.141 . . . . 63.22 109.61 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -100.12 128.92 46.12 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 73.34 110.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 304' ' ' LYS . 77.0 mt -57.63 -72.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.122 . . . . 71.31 109.345 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.02 172.15 24.3 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.497 1.123 . . . . 52.12 110.997 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 13.4 mt -60.39 -54.69 31.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.49 0.759 . . . . 74.21 109.325 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 36.99 1.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 70.23 109.27 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 298' ' ' ILE . . . -125.46 147.16 16.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.57 1.169 . . . . 72.2 111.006 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -119.74 170.66 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.515 0.774 . . . . 74.55 110.313 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.553 ' HZ1' ' H ' ' A' ' 294' ' ' GLY . 46.3 tptt -140.4 149.72 42.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.546 1.154 . . . . 74.21 109.314 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 307' ' ' TRP . 2.1 mt-10 -115.23 151.16 34.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.116 . . . . 71.21 110.327 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.807 HD12 HD11 ' A' ' 265' ' ' LEU . 20.4 mt -152.25 69.24 0.88 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.483 1.114 . . . . 63.21 109.291 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.517 ' CE2' ' HB3' ' A' ' 305' ' ' GLU . 0.0 OUTLIER -75.23 119.74 19.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 62.31 108.005 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.69 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 15.7 m-30 -113.46 142.13 46.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 73.42 110.998 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -128.59 160.37 63.08 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 74.53 111.017 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.97 -36.2 2.67 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 121.027 -2.489 . . . . 75.31 110.979 -0.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 310' ' ' PRO . 1.5 p 162.14 127.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.534 1.146 . . . . 70.45 110.025 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.512 HD12 ' CD1' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -99.32 169.5 8.07 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.417 1.073 . . . . 71.51 109.301 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 143.54 29.22 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 63.54 110.991 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.601 HG22 HD12 ' A' ' 316' ' ' LEU . 0.7 OUTLIER -131.27 162.17 57.46 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.559 1.162 . . . . 73.44 110.377 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.0 167.98 78.83 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 121.027 -2.489 . . . . 64.12 111.021 -0.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.792 HD22 ' HE3' ' A' ' 321' ' ' MET . 3.7 mp -87.85 46.83 1.42 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 73.51 109.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 58.1 p -67.7 115.8 7.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.498 1.124 . . . . 61.14 109.961 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 317' ' ' SER . 4.2 t30 83.42 39.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 71.24 109.277 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.676 ' CD2' HD23 ' A' ' 316' ' ' LEU . 5.6 m-85 -116.17 150.56 37.26 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.547 1.155 . . . . 74.43 111.003 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 322' ' ' LYS . 87.7 m -57.57 -64.11 1.01 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 1.139 . . . . 61.32 110.378 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.792 ' HE3' HD22 ' A' ' 316' ' ' LEU . 0.5 OUTLIER 35.39 33.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 74.23 111.02 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.519 ' HG3' HG22 ' A' ' 320' ' ' THR . 90.9 mttt -72.99 -176.53 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 75.23 109.334 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 279' ' ' PHE . 5.6 t -142.88 138.05 27.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.441 1.088 . . . . 54.42 109.293 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 278' ' ' THR . 0.0 OUTLIER -116.11 152.11 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.144 . . . . 73.52 109.289 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.727 ' ND2' HD13 ' A' ' 331' ' ' ILE . 0.4 OUTLIER -91.83 -173.6 3.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 63.45 109.268 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -75.45 -0.87 21.56 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.491 1.119 . . . . 63.14 110.299 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.47 -10.11 33.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 73.43 109.258 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 74.04 48.06 16.88 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.447 1.092 . . . . 42.3 110.98 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.565 ' CG ' ' O ' ' A' ' 329' ' ' GLU . 9.7 pt-20 -153.8 110.48 3.36 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 70.44 110.288 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.433 ' N ' HG13 ' A' ' 324' ' ' VAL . 12.2 m -38.53 125.57 1.39 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.534 1.146 . . . . 63.44 110.445 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.727 HD13 ' ND2' ' A' ' 325' ' ' ASN . 6.8 pt -100.58 -37.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 74.34 109.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.943 ' HB3' HD23 ' A' ' 344' ' ' LEU . 9.2 mt -134.23 165.56 24.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 74.15 109.303 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.6 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -145.67 118.77 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.437 1.086 . . . . 73.22 109.309 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -74.86 135.92 19.84 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.494 1.121 . . . . 72.31 110.993 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 345' ' ' LYS . 0.0 OUTLIER -79.93 -29.43 39.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.46 0.741 . . . . 73.43 109.265 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.583 ' H ' HG23 ' A' ' 342' ' ' ILE . 12.1 t 40.07 88.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.549 1.155 . . . . 61.12 108.339 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 335' ' ' LYS . . . -78.39 -161.05 0.24 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.447 1.092 . . . . 70.3 109.298 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -81.69 58.08 3.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.494 1.121 . . . . 63.53 109.322 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 57.7 m -172.15 166.13 6.07 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 43.34 110.007 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -65.58 -15.85 63.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 75.23 109.308 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -74.03 141.15 45.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.538 1.149 . . . . 73.45 110.318 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.583 HG23 ' H ' ' A' ' 336' ' ' CYS . 8.5 mt -148.2 116.05 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 75.24 109.286 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.554 HG22 ' CD2' ' A' ' 251' ' ' HIS . 9.6 p -119.65 113.65 21.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.471 1.107 . . . . 73.34 110.446 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.943 HD23 ' HB3' ' A' ' 332' ' ' LEU . 7.8 mp -67.69 145.9 54.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.464 1.102 . . . . 74.51 109.28 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 346' ' ' SER . 0.0 OUTLIER -123.25 -44.66 2.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.541 1.151 . . . . 65.24 109.284 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 345' ' ' LYS . 1.1 t 153.96 156.14 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 74.23 110.02 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.6 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.5 Cg_endo -74.99 -49.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.487 1.783 . . . . 64.22 111.038 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.551 1.157 . . . . 71.43 109.289 179.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.2 p30 . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.309 -0.626 . . . . 64.13 109.309 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.444 ' CB ' ' HG ' ' A' ' 249' ' ' LEU . 1.3 m-20 -96.23 151.29 38.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.536 1.148 . . . . 73.13 109.318 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.671 ' O ' HG22 ' A' ' 269' ' ' THR . 18.3 Cg_endo -74.92 -0.04 9.45 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.504 1.792 . . . . 61.54 111.007 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -39.93 144.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.545 1.153 . . . . 62.51 109.293 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.598 ' C ' HD12 ' A' ' 250' ' ' LEU . 0.1 OUTLIER -116.64 100.55 7.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.103 . . . . 70.5 109.282 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.63 ' CD2' HG22 ' A' ' 343' ' ' THR . 10.1 m80 -90.93 128.58 36.83 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.529 1.143 . . . . 75.54 109.603 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 265' ' ' LEU . 58.9 t -120.52 167.27 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 52.11 109.306 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 252' ' ' VAL . 17.3 tp10 -128.06 135.24 49.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 61.24 110.325 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.717 ' CG1' HG21 ' A' ' 314' ' ' THR . 89.6 t -109.61 109.49 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 61.41 109.305 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.1 m -79.73 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 74.04 110.023 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.908 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.1 OUTLIER 63.56 71.39 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.545 1.153 . . . . 72.31 109.288 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -91.13 147.34 23.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 64.44 110.305 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.99 -35.29 33.07 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.146 . . . . 75.54 109.271 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -66.73 -46.95 73.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 75.23 109.293 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 1.5 m -174.25 -173.4 0.78 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.137 . . . . 65.44 109.996 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.908 HD23 ' HA ' ' A' ' 256' ' ' ASN . 10.2 mt -87.47 161.82 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 1.125 . . . . 54.43 109.329 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -159.91 101.43 1.45 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 75.25 109.605 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.696 ' CZ ' HD13 ' A' ' 261' ' ' LEU . 51.1 m-85 -110.89 129.17 55.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 63.14 110.95 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.747 HG22 ' CE1' ' A' ' 266' ' ' TYR . 48.0 mt -119.37 119.3 60.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 72.44 109.26 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.713 ' HB3' HG22 ' A' ' 252' ' ' VAL . 0.0 OUTLIER -112.41 139.96 47.54 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 74.54 109.285 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.747 ' CE1' HG22 ' A' ' 264' ' ' ILE . 4.5 m-85 -126.97 114.9 18.44 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.442 1.089 . . . . 71.2 110.998 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.494 ' CG ' ' CG2' ' A' ' 298' ' ' ILE . 48.5 p-10 -69.19 77.06 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.143 . . . . 64.11 109.284 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.479 ' CE ' ' HA ' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -78.89 55.23 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.487 1.117 . . . . 75.1 109.304 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.671 HG22 ' O ' ' A' ' 248' ' ' PRO . 17.9 p -125.45 -170.5 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.514 1.134 . . . . 71.24 110.371 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -94.42 -52.79 4.18 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 1.127 . . . . 71.01 109.304 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.63 169.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 51.11 109.298 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 272' ' ' ILE . 3.8 mp -106.28 161.81 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.103 . . . . 74.44 109.306 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.895 HG13 HD12 ' A' ' 298' ' ' ILE . 3.6 mm -92.36 137.4 24.68 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.559 1.162 . . . . 65.11 109.294 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 -23.87 13.31 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.56 1.821 . . . . 60.54 110.976 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 74.05 161.72 7.8 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.53 1.144 . . . . 33.04 110.972 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 6.0 t30 81.69 22.15 0.3 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.521 0.777 . . . . 62.14 109.301 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.412 ' C ' ' OG1' ' A' ' 278' ' ' THR . 22.4 m -69.15 -178.23 1.25 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.497 1.123 . . . . 71.52 108.3 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.904 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.7 m -153.81 106.5 2.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 74.5 110.415 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.88 ' CG ' HD13 ' A' ' 306' ' ' LEU . 0.2 OUTLIER -60.53 173.09 0.76 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 63.13 111.038 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -168.43 92.21 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.107 . . . . 73.41 110.32 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.464 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 7.2 p90 -116.17 146.98 41.87 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.44 1.087 . . . . 64.2 110.977 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.407 ' OG ' ' CD2' ' A' ' 319' ' ' TYR . 82.9 p -72.57 -179.8 3.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 71.34 109.992 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 312' ' ' LEU . 1.9 m -156.67 175.77 13.61 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.495 1.122 . . . . 51.44 109.99 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' A' ' 285' ' ' ILE . 41.3 tt0 -98.48 139.4 34.28 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 72.12 110.288 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.505 HG23 ' HG2' ' A' ' 284' ' ' GLN . 1.6 pt 39.31 30.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.125 . . . . 73.04 109.324 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.445 ' N ' ' C ' ' A' ' 284' ' ' GLN . 4.7 m -142.34 172.08 13.17 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 72.21 110.033 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.87 141.42 34.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.457 1.098 . . . . 73.22 110.341 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 281' ' ' PHE . 11.6 p -48.34 149.6 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.466 1.104 . . . . 71.43 109.311 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.423 ' CD2' ' CE1' ' A' ' 308' ' ' PHE . 5.8 t80 -134.33 144.72 48.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.484 1.115 . . . . 72.24 111.011 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 41.1 m -114.17 121.93 45.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.506 1.129 . . . . 74.34 110.006 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.981 HD11 ' CD1' ' A' ' 308' ' ' PHE . 18.8 mt -101.86 128.56 54.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.52 1.138 . . . . 71.53 109.288 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.481 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.0 OUTLIER -68.06 99.66 0.9 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.481 1.113 . . . . 74.44 109.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.772 ' CG ' HD21 ' A' ' 306' ' ' LEU . 78.9 mtp -56.33 152.26 11.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 51.44 111.032 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . 0.714 ' HA3' ' HZ2' ' A' ' 304' ' ' LYS . . . -35.33 140.57 0.17 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.57 1.169 . . . . 64.02 111.025 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.407 ' HD3' ' HA2' ' A' ' 294' ' ' GLY . 18.1 Cg_endo -75.03 -22.98 14.2 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.521 1.8 . . . . 70.22 110.996 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -76.17 172.66 12.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.12 . . . . 52.13 109.61 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -107.59 124.3 49.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.147 . . . . 73.34 110.302 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.895 HD12 HG13 ' A' ' 273' ' ' ILE . 15.0 mt -47.07 -67.39 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 73.23 109.301 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.58 159.56 32.9 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.486 1.116 . . . . 65.21 111.026 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 19.2 mt -43.23 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.477 0.751 . . . . 73.14 109.317 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.479 ' HA ' ' CE ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 62.75 75.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 63.22 109.315 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 298' ' ' ILE . . . -135.07 173.46 21.6 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.453 1.096 . . . . 73.43 111.022 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -110.28 176.5 5.03 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.488 0.758 . . . . 72.41 110.293 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.714 ' HZ2' ' HA3' ' A' ' 294' ' ' GLY . 40.3 tptt -159.49 155.04 25.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 70.51 109.261 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 304' ' ' LYS . 5.4 mt-10 -130.25 139.96 50.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 51.11 110.294 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.88 HD13 ' CG ' ' A' ' 279' ' ' PHE . 16.0 mt -143.3 38.74 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.523 1.14 . . . . 73.44 109.285 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -49.55 148.3 2.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.959 -1.126 . . . . 75.04 107.959 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.981 ' CD1' HD11 ' A' ' 291' ' ' ILE . 12.5 t80 -147.43 168.18 22.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 73.41 111.026 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.2 OUTLIER -141.12 161.18 54.77 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.507 1.129 . . . . 61.43 111.013 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.98 -47.77 0.3 Allowed 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.007 -2.497 . . . . 74.11 111.018 -0.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 5.0 p 177.14 133.58 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 1.112 . . . . 71.34 109.951 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.6 mp -110.96 158.78 34.83 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.513 1.133 . . . . 72.42 109.351 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.07 146.65 32.67 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.493 1.786 . . . . 75.51 110.988 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.717 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.7 OUTLIER -124.64 161.98 45.37 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.492 1.12 . . . . 73.54 110.372 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.4 Cg_endo -75.02 -178.85 24.69 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 121.01 -2.496 . . . . 73.23 110.995 0.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.765 HD13 ' CE ' ' A' ' 321' ' ' MET . 1.7 mt -95.53 64.87 2.63 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.504 1.128 . . . . 64.15 109.284 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 32.4 t -81.16 123.08 28.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 53.43 110.006 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 317' ' ' SER . 44.0 t30 81.95 20.21 0.33 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 63.2 109.298 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.518 ' CD2' HD23 ' A' ' 316' ' ' LEU . 24.0 m-85 -101.99 114.05 27.82 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.562 1.164 . . . . 74.03 111.007 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.676 HG23 ' HD2' ' A' ' 322' ' ' LYS . 1.0 OUTLIER -37.75 -51.18 1.25 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.485 1.116 . . . . 61.45 110.377 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.765 ' CE ' HD13 ' A' ' 316' ' ' LEU . 7.1 ttm 30.93 52.93 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 64.31 110.985 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.676 ' HD2' HG23 ' A' ' 320' ' ' THR . 33.0 mttt -81.08 -170.18 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.55 109.264 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.489 HG22 ' CE1' ' A' ' 279' ' ' PHE . 5.8 t -151.61 130.32 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.525 1.141 . . . . 73.53 109.338 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 278' ' ' THR . 16.1 m -108.1 179.02 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 63.52 109.309 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -111.61 -172.4 2.03 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.153 . . . . 41.05 109.306 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.16 -4.8 15.02 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.503 1.127 . . . . 71.13 110.264 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.18 -7.12 33.19 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 71.34 109.321 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.12 54.63 6.83 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.503 1.127 . . . . 74.32 110.999 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.555 ' C ' HG12 ' A' ' 324' ' ' VAL . 0.3 OUTLIER -149.72 130.24 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.515 0.773 . . . . 72.42 110.302 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.854 ' N ' HG12 ' A' ' 324' ' ' VAL . 4.9 m -62.19 122.74 16.35 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 73.04 110.421 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.502 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.3 pt -105.4 -34.79 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 124.474 1.109 . . . . 75.3 109.256 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.884 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.6 mt -130.16 164.19 25.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 74.51 109.336 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 347' ' ' PRO . 0.9 OUTLIER -146.19 132.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 74.22 109.293 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.41 ' C ' ' N ' ' A' ' 336' ' ' CYS . . . -92.51 114.15 4.56 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.436 1.085 . . . . 72.24 111.035 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.763 ' NZ ' ' H ' ' A' ' 337' ' ' ALA . 0.0 OUTLIER -42.79 -27.72 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 0.75 . . . . 75.14 109.263 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 334' ' ' GLY . 0.8 OUTLIER 46.31 70.46 0.38 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 61.31 108.256 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.763 ' H ' ' NZ ' ' A' ' 335' ' ' LYS . . . -79.28 -171.46 2.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 63.12 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.45 61.82 2.93 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.523 1.139 . . . . 75.24 109.271 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 18.5 t -173.11 156.29 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 75.13 110.019 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -64.98 -30.14 71.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 60.43 109.289 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -65.64 136.22 56.03 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.524 1.14 . . . . 63.24 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.62 ' CD1' ' HE3' ' A' ' 321' ' ' MET . 49.1 mt -142.32 130.28 20.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.127 . . . . 70.25 109.27 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.63 HG22 ' CD2' ' A' ' 251' ' ' HIS . 13.6 p -127.58 83.57 2.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 53.43 110.382 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.884 HD23 ' HB3' ' A' ' 332' ' ' LEU . 8.9 mp -38.52 136.29 0.71 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 64.11 109.33 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 -70.6 0.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.111 . . . . 63.54 109.321 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.81 147.79 0.34 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.576 1.173 . . . . 74.32 109.994 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.461 ' HA ' HG11 ' A' ' 333' ' ' VAL . 18.4 Cg_endo -74.94 -55.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 74.23 111.024 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.562 1.164 . . . . 72.23 109.272 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 109.281 -0.637 . . . . 73.32 109.281 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . 0.471 ' HB2' HD12 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -177.07 90.31 0.25 Allowed Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 74.3 109.285 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.03 -17.2 19.66 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.532 1.807 . . . . 53.03 110.992 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -51.41 137.3 23.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.544 1.153 . . . . 71.42 109.297 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 1.02 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -122.92 103.05 8.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.51 1.131 . . . . 75.34 109.29 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -70.18 125.11 25.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 74.22 109.586 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.766 HG13 HD23 ' A' ' 265' ' ' LEU . 58.0 t -125.22 145.05 33.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 72.12 109.355 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -113.42 120.84 42.45 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.32 110.314 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 54.1 t -110.0 98.09 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 73.12 109.28 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.1 t -67.93 -70.77 0.24 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 75.45 110.024 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.894 ' HA ' HD23 ' A' ' 261' ' ' LEU . 0.2 OUTLIER 68.25 65.13 0.35 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.542 1.151 . . . . 71.12 109.3 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -103.26 165.33 11.09 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.496 1.122 . . . . 63.11 110.325 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 259' ' ' ASN . 0.7 OUTLIER -47.65 -57.16 5.84 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 1.116 . . . . 71.33 109.324 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 258' ' ' ASP . 8.2 t-20 -40.12 -62.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.522 1.139 . . . . 71.22 109.305 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -174.12 -160.56 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.476 1.11 . . . . 74.14 109.999 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.894 HD23 ' HA ' ' A' ' 256' ' ' ASN . 19.6 mt -93.68 -178.35 4.67 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.11 . . . . 72.3 109.308 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -177.01 104.28 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 72.45 109.549 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.518 ' CD1' ' CE2' ' A' ' 308' ' ' PHE . 59.1 m-85 -110.86 96.67 6.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 74.22 110.995 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.795 HG22 ' CE1' ' A' ' 266' ' ' TYR . 64.0 mt -91.86 104.31 15.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 61.14 109.289 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 306' ' ' LEU . 0.6 OUTLIER -89.72 129.15 36.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 75.32 109.321 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.795 ' CE1' HG22 ' A' ' 264' ' ' ILE . 14.8 m-85 -117.35 102.92 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.525 1.141 . . . . 61.25 110.987 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.503 ' HB2' HD13 ' A' ' 273' ' ' ILE . 53.4 t30 -59.3 106.97 0.5 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 60.25 109.296 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -100.94 -12.1 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.496 1.122 . . . . 75.31 109.302 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.461 ' O ' ' CD1' ' A' ' 300' ' ' ILE . 12.8 p -72.77 164.52 26.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 72.4 110.381 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.638 ' O ' HD11 ' A' ' 300' ' ' ILE . 22.0 m120 -67.17 -60.13 2.87 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 63.11 109.318 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.807 HD13 ' C ' ' A' ' 271' ' ' ILE . 0.0 OUTLIER -38.84 158.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.53 1.144 . . . . 75.32 109.347 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.469 ' N ' HG12 ' A' ' 271' ' ' ILE . 2.1 mp -114.41 117.35 55.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.485 1.116 . . . . 65.33 109.288 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 267' ' ' ASN . 1.4 mp -46.23 138.41 6.2 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.125 . . . . 45.04 109.317 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 273' ' ' ILE . 18.3 Cg_endo -75.04 -30.15 7.4 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.469 1.773 . . . . 75.31 111.047 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 276' ' ' ASN . . . 90.55 159.72 35.86 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.509 1.131 . . . . 44.31 111.019 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 275' ' ' GLY . 4.2 t30 76.23 27.08 0.9 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 0.766 . . . . 63.31 109.307 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.466 ' SG ' ' CD1' ' A' ' 331' ' ' ILE . 29.0 m -71.05 -178.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 71.31 108.288 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.843 ' O ' HG22 ' A' ' 324' ' ' VAL . 1.9 m -152.97 105.44 2.93 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 73.51 110.382 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.522 ' CG ' HD13 ' A' ' 306' ' ' LEU . 1.1 t80 -59.05 157.66 9.82 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 74.33 110.947 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -146.69 84.33 1.61 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.551 1.157 . . . . 73.54 110.252 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.632 ' CZ ' ' CD2' ' A' ' 308' ' ' PHE . 22.8 p90 -119.64 135.34 54.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 1.163 . . . . 64.12 110.985 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.489 ' O ' ' CE2' ' A' ' 319' ' ' TYR . 1.1 m -105.92 177.42 4.86 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 74.34 109.988 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 319' ' ' TYR . 4.8 p -123.14 -42.73 2.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.443 1.09 . . . . 72.43 109.979 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . 0.412 ' C ' ' N ' ' A' ' 286' ' ' SER . 4.1 tt0 -145.82 179.05 7.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.452 1.095 . . . . 74.11 110.26 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 10.0 tt -43.06 -28.27 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.511 1.132 . . . . 70.11 109.321 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 284' ' ' GLN . 57.8 m -51.26 -177.78 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.11 . . . . 65.11 110.004 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -55.5 -175.05 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.105 . . . . 74.54 110.315 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 289' ' ' PHE . 2.8 p -118.84 167.02 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 63.21 109.256 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.533 ' N ' HG22 ' A' ' 288' ' ' VAL . 1.8 t80 -103.37 159.57 15.45 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 70.15 110.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -150.74 122.34 7.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.545 1.153 . . . . 70.11 110.029 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 308' ' ' PHE . 47.0 mt -121.99 128.83 75.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.44 109.256 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.588 ' HA ' HG23 ' A' ' 278' ' ' THR . 0.5 OUTLIER -73.13 107.16 5.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.483 1.114 . . . . 62.22 109.324 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.772 ' HG2' HD21 ' A' ' 306' ' ' LEU . 87.4 mtp -70.17 147.48 49.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.157 . . . . 61.21 110.998 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -49.68 152.28 3.66 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.506 1.129 . . . . 42.45 111.022 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -29.26 8.39 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.498 1.789 . . . . 71.14 111.029 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -52.66 137.34 31.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.509 1.131 . . . . 65.04 109.599 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.22 147.03 29.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.517 1.136 . . . . 65.14 110.307 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.443 ' CG2' ' C ' ' A' ' 302' ' ' GLY . 18.1 mt -82.87 -76.62 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 74.15 109.342 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 76.21 -174.95 53.05 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.464 1.103 . . . . 71.23 110.976 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.638 HD11 ' O ' ' A' ' 270' ' ' ASN . 3.3 mm -64.43 137.6 24.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.5 0.765 . . . . 74.15 109.287 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.591 ' HG2' HG22 ' A' ' 300' ' ' ILE . 0.0 OUTLIER 66.47 9.43 6.51 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.503 1.127 . . . . 73.12 109.26 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.443 ' C ' ' CG2' ' A' ' 298' ' ' ILE . . . -97.82 140.86 15.27 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.517 1.136 . . . . 53.21 110.987 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -110.42 -179.52 3.79 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.55 0.794 . . . . 64.33 110.289 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.552 ' O ' HG23 ' A' ' 264' ' ' ILE . 19.3 tptt -145.72 164.23 32.47 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.428 1.08 . . . . 65.31 109.306 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.97 128.41 36.36 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.475 1.109 . . . . 61.23 110.291 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.961 HD12 HD11 ' A' ' 265' ' ' LEU . 12.3 mt -140.91 62.52 1.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.105 . . . . 71.43 109.302 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -76.44 128.95 35.81 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.543 1.152 . . . . 73.04 107.986 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.691 ' CD1' ' CD1' ' A' ' 291' ' ' ILE . 5.4 m-30 -115.79 178.55 4.27 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 71.5 111.052 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.516 ' HA ' ' C ' ' A' ' 310' ' ' PRO . 0.8 OUTLIER -159.29 157.04 26.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.5 110.992 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.4 Cg_endo -74.99 -35.14 3.02 Favored 'Cis proline' 0 C--N 1.361 1.194 0 C-N-CA 120.998 -2.501 . . . . 63.35 111.021 0.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.0 p 169.04 139.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 71.23 109.999 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 261' ' ' LEU . 5.1 mp -115.28 158.37 41.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 73.24 109.306 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 147.47 34.03 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.49 1.784 . . . . 73.45 111.002 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.725 HG22 HD12 ' A' ' 316' ' ' LEU . 0.6 OUTLIER -127.32 162.24 49.61 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.439 1.087 . . . . 73.51 110.416 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.3 Cg_endo -74.94 174.36 53.02 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.999 -2.5 . . . . 74.11 110.993 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.725 HD12 HG22 ' A' ' 314' ' ' THR . 5.3 mp -88.99 65.61 7.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 72.05 109.277 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 85.1 p -84.42 139.44 32.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.448 1.092 . . . . 60.2 110.008 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.74 23.48 4.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.464 1.102 . . . . 63.0 109.282 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.701 ' CD2' HD23 ' A' ' 316' ' ' LEU . 3.2 m-85 -104.07 165.77 10.84 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.468 1.105 . . . . 63.04 111.027 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.571 HG22 ' HG3' ' A' ' 322' ' ' LYS . 15.5 m -92.24 -49.47 6.16 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.44 110.37 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.878 ' SD ' HD13 ' A' ' 342' ' ' ILE . 1.7 ptp 30.13 63.35 0.17 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.545 1.153 . . . . 75.33 111.028 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.594 ' HG2' HG12 ' A' ' 333' ' ' VAL . 42.8 mttt -91.26 -171.09 2.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 75.25 109.351 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.482 HG21 HD21 ' A' ' 344' ' ' LEU . 2.2 t -150.26 132.2 5.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 72.1 109.296 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.843 HG22 ' O ' ' A' ' 278' ' ' THR . 9.0 m -118.29 179.62 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 73.25 109.276 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -108.4 -166.62 1.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.484 1.115 . . . . 73.52 109.317 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.84 -10.42 37.87 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 62.02 110.265 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -107.38 19.57 20.11 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.136 . . . . 74.43 109.327 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 55.09 18.12 11.8 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 75.44 110.986 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 331' ' ' ILE . 10.6 pt-20 -89.54 123.65 33.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.487 0.757 . . . . 71.45 110.276 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.593 ' N ' HG12 ' A' ' 324' ' ' VAL . 2.7 m -55.78 115.05 2.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.487 1.117 . . . . 63.42 110.4 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.466 ' CD1' ' SG ' ' A' ' 277' ' ' CYS . 5.4 pt -97.88 -41.82 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.533 1.145 . . . . 62.03 109.297 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.806 ' HB3' HD23 ' A' ' 344' ' ' LEU . 6.3 mt -138.34 162.57 34.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 55.31 109.322 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.594 HG12 ' HG2' ' A' ' 322' ' ' LYS . 26.8 m -149.0 128.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 71.24 109.293 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.441 ' HA2' HD12 ' A' ' 344' ' ' LEU . . . -86.85 113.15 3.88 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.476 1.11 . . . . 72.42 111.012 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.415 ' O ' ' SG ' ' A' ' 336' ' ' CYS . 0.0 OUTLIER -50.04 -24.17 2.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.478 0.752 . . . . 62.53 109.32 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 335' ' ' LYS . 0.5 OUTLIER 66.23 162.88 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 65.44 108.283 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -173.98 -173.44 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.572 1.17 . . . . 71.42 109.269 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.55 56.52 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 74.14 109.306 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 341' ' ' GLU . 35.0 t -178.4 138.55 0.18 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 54.23 109.998 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -44.76 -27.01 0.45 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 63.53 109.315 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 339' ' ' SER . 6.9 mt-10 -63.97 117.27 6.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.14 . . . . 74.51 110.323 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.878 HD13 ' SD ' ' A' ' 321' ' ' MET . 61.6 mt -141.62 122.8 12.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.433 1.083 . . . . 65.04 109.291 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 10.4 p -116.41 105.15 12.19 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.493 1.121 . . . . 72.3 110.402 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 1.02 HD22 HD22 ' A' ' 250' ' ' LEU . 5.9 mp -58.56 142.62 48.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.495 1.122 . . . . 72.03 109.264 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -77.29 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.541 1.151 . . . . 74.02 109.261 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . . . . . . . . . 2.1 p -179.85 145.56 0.41 Allowed Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.455 1.097 . . . . 74.12 109.979 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -59.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.524 1.802 . . . . 70.14 110.987 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 348' ' ' LEU . 2.2 tm? . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 73.21 109.329 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 4.9 m120 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.276 -0.638 . . . . 75.43 109.276 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.12 159.42 30.22 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.478 1.111 . . . . 72.21 109.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.764 ' HA ' HG22 ' A' ' 269' ' ' THR . 18.3 Cg_endo -75.0 -14.1 21.23 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.466 1.771 . . . . 74.13 111.02 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 1.008 ' O ' HD23 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -39.93 146.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.542 1.151 . . . . 51.25 109.304 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.678 HD22 HD22 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -125.3 103.12 7.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 74.4 109.294 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -63.51 136.3 57.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.498 1.124 . . . . 63.1 109.573 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.749 HG22 HD23 ' A' ' 265' ' ' LEU . 76.2 t -145.92 136.42 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.484 1.115 . . . . 53.21 109.301 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.06 128.79 56.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.482 1.114 . . . . 54.41 110.262 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.522 ' CG1' HG21 ' A' ' 314' ' ' THR . 14.2 t -105.47 105.45 18.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 70.45 109.291 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.76 -73.48 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.518 1.136 . . . . 61.3 109.973 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.591 ' HA ' HD23 ' A' ' 261' ' ' LEU . 8.6 t-20 55.33 78.38 0.19 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.467 1.104 . . . . 70.34 109.305 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -114.26 -166.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.544 1.152 . . . . 71.43 110.314 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.63 31.56 1.34 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 63.12 109.308 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -135.22 -45.16 0.7 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.481 1.113 . . . . 74.24 109.317 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m 174.08 -174.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 32.21 110.009 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.863 HD11 ' HB2' ' A' ' 312' ' ' LEU . 23.7 mt -93.24 167.65 11.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.48 1.112 . . . . 73.05 109.288 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -163.81 100.25 0.89 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.506 1.129 . . . . 72.24 109.608 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -107.19 101.55 10.93 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 73.1 110.992 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.816 HG22 ' CE1' ' A' ' 266' ' ' TYR . 56.9 mt -97.52 103.27 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.547 1.154 . . . . 75.04 109.263 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 1.056 HD11 HD12 ' A' ' 306' ' ' LEU . 0.4 OUTLIER -88.13 138.23 31.63 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.467 1.104 . . . . 74.2 109.301 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.816 ' CE1' HG22 ' A' ' 264' ' ' ILE . 13.1 m-85 -125.66 101.06 6.71 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.504 1.128 . . . . 60.05 111.009 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.67 97.8 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 53.11 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.39 30.26 5.46 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.486 1.116 . . . . 71.42 109.319 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.764 HG22 ' HA ' ' A' ' 248' ' ' PRO . 36.0 p -85.59 -167.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 64.24 110.394 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -92.68 -52.3 4.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.487 1.117 . . . . 75.15 109.303 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.41 ' H ' HG23 ' A' ' 271' ' ' ILE . 0.0 OUTLIER -65.47 173.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.113 . . . . 62.55 109.257 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.15 137.26 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.501 1.126 . . . . 65.52 109.291 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 273' ' ' ILE . 5.6 mm -61.95 135.92 94.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.47 1.106 . . . . 73.45 109.3 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -22.79 14.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.513 1.797 . . . . 42.2 111.03 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLY . . . . . . . . . . . . . . . 73.83 168.06 16.09 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.472 1.108 . . . . 64.44 111.02 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ASN . . . . . . . . . . . . . 1.7 t30 70.49 38.66 1.3 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 0.772 . . . . 70.45 109.271 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' CYS . . . . . 0.408 ' C ' ' OG1' ' A' ' 278' ' ' THR . 52.6 m -83.29 -177.48 6.75 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.515 1.134 . . . . 70.22 108.284 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.864 ' O ' HG22 ' A' ' 324' ' ' VAL . 2.8 m -154.24 99.76 2.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.479 1.112 . . . . 73.43 110.372 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.583 ' CD1' HG22 ' A' ' 323' ' ' VAL . 0.8 OUTLIER -55.4 162.64 1.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.492 1.12 . . . . 73.51 111.006 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -155.31 90.62 1.27 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.559 1.162 . . . . 74.22 110.328 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.446 ' CD1' ' CD2' ' A' ' 279' ' ' PHE . 12.2 p90 -118.94 153.83 33.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 70.2 111.001 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.59 170.2 16.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 72.53 110.017 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.3 p -149.77 -175.53 5.06 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.541 1.151 . . . . 74.41 110.032 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -66.89 -79.86 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.552 1.157 . . . . 61.11 110.285 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 18.7 tt -61.93 -46.47 96.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.131 . . . . 64.24 109.29 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.75 154.03 34.45 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.576 1.173 . . . . 54.21 109.993 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -103.82 178.45 4.55 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.498 1.124 . . . . 64.21 110.264 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.57 153.2 7.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.132 . . . . 60.41 109.3 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.09 133.7 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 73.43 110.979 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 18.4 p -110.7 121.86 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.476 1.11 . . . . 70.1 109.969 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.873 HD11 ' CD1' ' A' ' 308' ' ' PHE . 12.0 mt -103.54 132.13 50.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.517 1.135 . . . . 65.44 109.303 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.63 106.16 6.07 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.452 1.095 . . . . 73.43 109.297 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.819 ' HG2' HD21 ' A' ' 306' ' ' LEU . 92.5 mtp -77.77 145.7 36.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 71.35 110.996 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . -53.03 153.76 6.83 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.497 1.123 . . . . 60.34 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 -30.58 7.01 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.433 1.754 . . . . 63.4 111.023 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -42.88 143.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 61.31 109.607 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -92.69 124.52 36.76 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 63.31 110.308 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.526 HG23 ' C ' ' A' ' 302' ' ' GLY . 43.0 mt -62.02 -77.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.578 1.174 . . . . 65.12 109.309 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.32 -175.49 54.53 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.462 1.101 . . . . 65.11 111.008 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.681 ' N ' HD13 ' A' ' 300' ' ' ILE . 2.1 mm -66.68 133.86 30.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.499 0.764 . . . . 74.52 109.305 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.49 ' HG2' HG22 ' A' ' 300' ' ' ILE . 12.1 mmtm 74.21 3.71 4.41 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.505 1.128 . . . . 72.04 109.279 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.526 ' C ' HG23 ' A' ' 298' ' ' ILE . . . -93.35 146.72 18.26 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.501 1.126 . . . . 72.13 111.006 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -113.63 -176.04 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.479 0.753 . . . . 65.43 110.282 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 264' ' ' ILE . 39.5 tptt -147.56 162.93 38.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.474 1.109 . . . . 60.4 109.295 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -136.0 118.92 16.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 74.2 110.305 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 1.056 HD12 HD11 ' A' ' 265' ' ' LEU . 20.1 mt -128.16 55.04 1.69 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.496 1.122 . . . . 72.52 109.308 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' TRP . . . . . 0.424 ' O ' ' CD1' ' A' ' 307' ' ' TRP . 4.8 p90 -67.09 125.15 25.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.993 -1.114 . . . . 74.2 107.993 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.873 ' CD1' HD11 ' A' ' 291' ' ' ILE . 25.6 t80 -123.25 173.15 8.11 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.553 1.158 . . . . 71.35 111.042 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 309' ' ' PHE . 0.4 OUTLIER -150.55 161.72 29.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.509 1.131 . . . . 75.51 111.06 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 309' ' ' PHE . 18.3 Cg_endo -74.99 -43.15 0.72 Allowed 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 120.97 -2.513 . . . . 73.42 111.0 -0.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.5 p 179.59 158.4 0.67 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.511 1.132 . . . . 52.11 109.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.863 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.1 mp -135.28 158.73 74.02 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 70.33 109.33 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.04 151.1 38.91 Favored 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.482 1.78 . . . . 71.44 110.996 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' THR . . . . . 0.522 HG21 ' CG1' ' A' ' 254' ' ' VAL . 0.8 OUTLIER -134.49 161.27 64.69 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.518 1.137 . . . . 71.13 110.453 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.513 ' C ' ' HA ' ' A' ' 314' ' ' THR . 18.5 Cg_endo -74.91 -178.97 24.96 Favored 'Cis proline' 0 C--N 1.36 1.148 0 C-N-CA 121.002 -2.499 . . . . 75.41 111.038 -0.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.756 HD23 ' CE2' ' A' ' 319' ' ' TYR . 2.3 mt -101.27 57.39 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 65.52 109.318 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 318' ' ' ASN . 6.1 p -81.4 127.7 33.06 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.537 1.148 . . . . 60.4 109.989 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 317' ' ' SER . 30.8 t30 80.74 23.78 0.34 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.124 . . . . 73.3 109.3 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.756 ' CE2' HD23 ' A' ' 316' ' ' LEU . 6.8 m-85 -101.92 176.46 5.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 71.33 110.985 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.611 HG23 ' HZ3' ' A' ' 322' ' ' LYS . 1.2 m -93.21 -58.66 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 71.22 110.395 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.749 ' SD ' HD13 ' A' ' 342' ' ' ILE . 2.2 ptp 28.3 61.3 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.485 1.116 . . . . 73.42 110.991 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.611 ' HZ3' HG23 ' A' ' 320' ' ' THR . 28.4 mttp -91.29 179.12 5.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 1.151 . . . . 62.41 109.32 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 279' ' ' PHE . 3.5 t -140.81 129.67 24.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 72.52 109.284 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.868 HG12 ' N ' ' A' ' 330' ' ' THR . 15.4 m -108.47 178.53 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.497 1.123 . . . . 70.02 109.317 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 325' ' ' ASN . 0.1 OUTLIER -110.84 -172.34 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.437 1.086 . . . . 71.51 109.281 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -68.23 -4.7 14.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.44 110.267 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -7.46 31.96 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.545 1.153 . . . . 55.33 109.289 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 73.62 54.38 6.69 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.499 1.124 . . . . 61.45 111.005 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.571 ' C ' HG12 ' A' ' 324' ' ' VAL . 0.1 OUTLIER -149.55 130.5 14.32 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 0.755 . . . . 75.44 110.313 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' THR . . . . . 0.868 ' N ' HG12 ' A' ' 324' ' ' VAL . 1.7 m -60.97 119.44 8.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 70.13 110.386 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.499 ' CG2' ' OD1' ' A' ' 325' ' ' ASN . 2.2 pt -97.19 -34.68 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.472 1.108 . . . . 74.25 109.281 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 344' ' ' LEU . 4.8 mt -132.04 -171.46 2.64 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 73.52 109.341 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' VAL . . . . . 0.58 HG12 ' C ' ' A' ' 332' ' ' LEU . 0.1 OUTLIER -175.89 114.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 65.54 109.241 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.475 ' CA ' HD12 ' A' ' 344' ' ' LEU . . . -61.81 135.41 46.7 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.534 1.146 . . . . 62.24 111.011 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' LYS . . . . . 0.536 ' C ' ' SG ' ' A' ' 336' ' ' CYS . 0.1 OUTLIER -57.04 -19.54 19.41 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.582 0.813 . . . . 75.43 109.267 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.536 ' SG ' ' C ' ' A' ' 335' ' ' LYS . 0.8 OUTLIER 42.08 89.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 75.31 108.283 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -109.27 -175.32 2.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 62.53 109.324 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -77.31 61.86 2.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.141 . . . . 64.41 109.288 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -176.82 142.78 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.5 1.125 . . . . 62.2 109.961 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ASN . . . . . 0.453 ' O ' HG23 ' A' ' 254' ' ' VAL . 55.9 m-20 -52.18 -27.05 13.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 75.23 109.309 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.31 137.01 57.69 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.497 1.123 . . . . 72.12 110.293 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.749 HD13 ' SD ' ' A' ' 321' ' ' MET . 53.8 mt -146.17 137.28 18.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.532 1.145 . . . . 74.12 109.305 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 24.2 p -138.05 99.51 3.9 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.489 1.118 . . . . 73.23 110.414 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 332' ' ' LEU . 9.2 mp -54.78 132.27 45.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 63.35 109.265 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.623 ' O ' HD21 ' A' ' 332' ' ' LEU . 0.1 OUTLIER -112.72 -66.79 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 72.21 109.306 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' SER . . . . . 0.682 ' HA ' HD23 ' A' ' 332' ' ' LEU . 3.1 p 158.84 136.78 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 53.21 109.998 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.528 ' HB3' HG11 ' A' ' 333' ' ' VAL . 18.3 Cg_endo -75.04 -57.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.479 1.779 . . . . 74.21 111.002 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 348' ' ' LEU . 1.4 tp . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 73.15 109.317 -179.999 . . . . . . . . 1 1 . 1 stop_ save_